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Protective role of autophagy in mouse cecal ligation and 
puncture-induced sepsis model
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1Graduate School of Medicine, Chiba University, Chiba, Japan; 2Biomedical 
Research Center, Chiba University, Chiba, Japan
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Introduction  Autophagy is well known as one of the biogenic 
responses against various stresses, which possesses the benefi  cial roles 
for survival, but little is known about the dynamics and its signifi  cance 
during the septic condition. We hypothesized that autophagy is 
induced during the septic condition, and contributes to protect from 
tissue damage which subsequently leads to organ dysfunction. We 
confi  rm whether the autophagic process is accelerated or sustained in 
an acute phase of sepsis and we also determine its physiological role.
Methods Sepsis was induced by cecal ligation and puncture (CLP) in 
mice. We examined the kinetics of autophagosome and auto  lysosome 
formation which may explain the status of autophagy by western 
blotting, immunohistochemistry, and electron microscopy. To investigate 
a precise role of autophagy in CLP-induced sepsis, chloroquine, an 
autophagy inhibitor, was administered to the CLP-operated mice, and 
blood chemistry, pathology of the liver and survival were evaluated.
Results  Autophagy demonstrated by the ratio of LC3-II/LC3-I was 
induced over the time course up to 24 hours after CLP. The ratio was 
particularly increased in the liver, heart and spleen. Autophagosome 
formation became maximal at 6 hours and declined by 24 hours after 
CLP. Autolysosome formation as evaluated by both fusion of GFP-LC3 
dots with LAMP1 immunohistochemistry and electron microscopy 
was also increased after the procedure. Furthermore, inhibition of 
autophagy by chloroquine during the CLP procedure resulted in 
elevation of serum AST levels, and signifi  cantly increased mortality in 
mice.
Conclusion Autophagy was induced in several organs over the time 
course of the CLP sepsis model and then the process was gradually 
completed to degradation of the components. Our data suggest 
autophagy plays a protective role in organ dysfunction in sepsis.
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Reversible depressive eff  ect of TNFα on a model of isolated 
perfused rat heart
BV Nguyen1, M Guillouet2, MA Giroux-Metges2, G Gueret3, 
M Ould-Ahmed1, JP Pennec2
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Introduction Acute myocardial depression in septic shock is common 
[1]. Myocardial depression is mediated by circulating depressant 
substances, which until now have been incompletely characterized [2]. 
The aim of our study was to observe the eff  ects of TNFα on the model 
of perfused rat heart.
Methods  After profound anesthesia with pentothal, the Wistar rats 
were killed by exsanguination. After sternotomy, the heart was taken 
and connected to the Langendorf column. The apex of the heart was 
hooked to a strength sensor. Biopac student laboratory software was 
used to record and analyse heart contractions. Contractions were 
recorded every 5  minutes during periods of 20  minutes. Control 
measurements were fi   rst recorded. We measured four parameters: 
heart rate, contraction force, speeds of contraction and relaxation 
for control, during TNFα (20  ng/ml) exposure and after removal of 
TNFα. We express the variations of parameters as percentage of 
the control ± SEM. A paired t test was used to compare heart rate, 
contraction amplitude, speeds of contraction and relaxation with TNFα 
and control measurements and after removal of TNFα.
Results Eight rat hearts Wistar (weight = 325 ± 23 g) were studied. See 
Table 1.
Table 1 (abstract P2)
 TNFα  Removal  of  TNFα
Heart rate  78 ± 6*  91 ± 5
Contractile   62 ± 8*  91 ± 4
Speed of contraction  72 ± 6*  93 ± 2
Speed of relaxation  53 ± 10*  89 ± 4
Results expressed as percentage of control ± SEM. *P <0.05.
Conclusion  TNFα decreases signifi   cantly the heart rate, contractile 
force, speeds of contraction and relaxation on isolated perfused 
rat heart. TNFα probably plays a role in the pathophysiology of 
cardiomyopathy during septic shock. The partial reversibility of these 
eff  ects could explain why left ventricular hypokinesia in patients with 
septic shock is reversible.
References
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Introduction  The cholinergic anti-infl   ammatory pathway (CAP) is 
a physiological mechanism that inhibits cytokine production and 
minimizes tissue injury during infl   ammation. CAP-mediated anti-
infl   ammatory signals in vagal eff   erent nerve fi   bers result in the 
release of acetylcholine, which interacts with innate immune cells that 
express the nicotinic acetylcholine receptor subunit α7 (α7nAChR).  © 2010 BioMed Central Ltd
33rd International Symposium on Intensive Care 
and Emergency Medicine
Brussels, Belgium, 19-22 March 2013
Published: 19 March 2013
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© 2013 BioMed Central LtdEndothelial dysfunction during sepsis is responsible for increased 
endothelial permeability, leukocyte–endothelial interaction and 
functional breakdown of microvascular perfusion. Endotoxemia-
induced endothelial dysfunction can be reduced by cholinergic CAP 
activation [1]. The aim of this study was to determine the eff  ects of the 
α7nAChR-agonist cdp-choline on microcirculatory alterations during 
experimental endotoxemia.
Methods  Using fl   uorescent intravital microscopy, we determined 
venular wall shear rate, macromolecular effl   ux  and  leukocyte 
adhesion in mesenteric postcapillary venules of male Wistar rats. 
Endotoxemia was induced over 120 minutes by intravenous infusion 
of lipopolysaccharide (LPS). Control groups received an equivalent 
volume of saline. Cdp-choline was applied as an i.v. bolus in treatment 
groups. Animals received either (i)  saline alone, (ii)  cdp-choline 
10 minutes prior to saline administration, (iii) cdp-choline 10 minutes 
prior to LPS administration, (iv)  cdp-choline 30  minutes after LPS 
administration or (v) LPS alone.
Results  There were no signifi  cant diff  erences in venular wall shear 
rate between the groups after 120 minutes. There was no signifi  cant 
diff  erence in the number of adhering leukocytes between the cdp-
choline/LPS groups (iii, iv) and the LPS group after 120  minutes. 
Macromolecular effl   ux  signifi   cantly increased in all groups over 
120  minutes. All groups (i, ii, iii, iv) showed a signifi  cantly reduced 
macromolecular effl   ux compared with the LPS group after 120 minutes.
Conclusion  Cdp-choline has no eff  ect  on  leukocyte–endothelial 
interaction and microhemodynamic alterations during endotoxemia. 
By activating the CAP, cdp-choline reduces capillary leakage. Thus cdp-
choline might have a prophylactic and therapeutic anti-infl  ammatory 
eff   ect on LPS-induced endothelial permeability. These fi  ndings 
identify the endothelium as a target of anti-infl  ammatory cholinergic 
mediators and cdp-choline as a potential therapeutic substance in 
sepsis treatment.
Reference
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Introduction The purpose of this study was to evaluate the immune 
response of patients susceptible to infection by Gram-positive bacteria 
after ex vivo provocation with lipoteichoic acid (LTA) and to compare 
the reaction with the one of healthy adults.
Methods Blood sample was obtained from 10 healthy volunteers, 10 
hemodialysis patients with end-stage chronic renal failure (CRF), 10 
patients with type II diabetes mellitus (DM) and 10 ICU patients on the 
second day of hospitalization, who suff  ered nonseptic SIRS and had 
an APACHE II score >25. After suitable treatment the samples were 
incubated with 1 mg LTA for 8 hours and maintained at –20°C until the 
measurement of cytokines TNFα, IL-6, IL-1β, and IL-10, using the ELISA 
method. The results are presented as mean values ± SEM. Graph Pad 4.0 
was used, applying a t test to test the variation of each cytokine in each 
group, and ANOVA to assess the diff  erences between the four groups.
Results Baseline cytokine values in the three groups were increased 
compared with the control group, but the diff  erence was signifi  cant 
only for the ICU group (Table  1, data only for IL-6 and IL-10). The 
quotient IL-10/IL-6 of baseline values was between 0.23 and 0.96 
among healthy, ESRD and DM persons, and 1.32 among ICU patients. 
In all examined groups the levels of cytokines increased signifi  cantly 
after stimulation with LTA, although ICU patients showed a diff  erential 
response (a fi  vefold to ninefold rise compared with other groups who 
had an increase of 14-fold to 36-fold).
Conclusion  Severely ill patients and secondarily hemodialysis and 
diabetic patients are in a proinfl   ammatory state. The response of 
all examined groups to provocation by LTA was suffi   cient,  with  a 
diff  erential expression of severely ill patients, a fact that refl  ects their 
diff  erent immunologic status.
P5
Correlation of the oxygen radical activity and antioxidants and 
severity in critically ill surgical patients: preliminary report
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Introduction In septic patients, the oxygen radical (OR) showed toxic 
eff  ect to induce infl  ammation and antioxidant activity could aff  ect organ 
dysfunction. This study was designed to determine the relationship 
between antioxidant level and severity of organ dysfunction.
Methods The medical records of adult patients managed in a surgical 
ICU from August 2012 to December 2012 were reviewed prospectively. 
Abstracted data included age, body weight (with BMI), APACHE II 
scores, SOFA scores, MODS scores, fl  uid intake, fl  uid output, nutritional 
support, shock, antioxidant levels, OR activities, zinc and selenium 
levels, complication and mortality. In addition, length of stay (LOS) in 
the ICU and in hospital, and in-hospital mortality were collected. These 
data were investigated on the fi  rst, the third and the seventh day, 
respectively.
Results A total of 13 patients were enrolled. The in-hospital mortality 
rate was 7.7% and mean LOS in the ICU and hospital was 6.5 and 27.6, 
respectively. Mean APACHE II score was 20.2. On the fi  rst day of ICU, the 
mean antioxidant level and OR were 1.5 (± 0.5) mmol/l and 1.6 (± 0.5) 
mmol/l, respectively. At the same time, SOFA and MODS scores were 
7.3 and 5.0, respectively, and zinc and selenium were 32.6 μg/dl and 
68.4 ng/ml. On the third day, mean antioxidant and OR were 1.5 (± 0.4) 
and 1.8 (± 0.7) respectively (SOFA 6.6, MODS 4.9, zinc 50.0, selenium 
70.7). On the seventh day, mean antioxidant and OR were 1.4 (± 0.5) 
and 1.9 (± 0.7), respectively (SOFA 4.3, MODS 3.1, zinc 62.8, selenium 
77.3). In the correlation analysis, MODS scores and antioxidant level 
had signifi  cant correlations on the fi  rst and seventh days of ICU (P = 
0.001, P = 0.009).
Conclusion Antioxidant level had a correlation with organ dysfunction 
which might be used as a prognostic factor in critically septic patients. 
To prove this, large-scale data collection is required.
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Introduction  The core pathophysiological changes in sepsis 
involve systemic activation of the immune system followed by the 
Table 1 (abstract P4). Levels of cytokines before and after stimulation with LTA
  Control baseline LTA  ESRD baseline LTA  DM baseline LTA  ICU baseline LTA
IL-6   8.90 ± 0.76, 245.30 ± 26.68  86.60 ± 45.55, 1,310.00 ± 154.80  15.90 ± 1.89, 252.00 ± 35.52  372.40 ± 120.60, 3,659.00 ± 485.20
IL-10  3.00 ± 1.08, 40.90 ± 7.45  19.20 ± 7.14, 273.10 ± 126.50  15.30 ± 2.08, 350.50 ± 89.42  492.60 ± 66.72, 2,822.00 ± 432.70
Values in pg/ml.
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S2anti-infl   ammatory compensatory response. However, controversies 
exist regarding the status of the immune system in local tissue 
compartments during sepsis. The aim of this study was to compare 
selected markers of activation between the systemic circulation and 
local lung environment.
Methods Twenty patients with severe sepsis were included into this 
study. Peripheral blood (PB) samples and bronchoalveolar lavage fl  uid 
(BALF) samples were obtained on the day of diagnosis (D1). BALF was 
collected from 11 patients. Samples were stained with antibodies: 
CD15/CD64 and CD3/CD14/HLA-DR and isotypic control. Cells were 
analysed by fl  ow cytometry. Expression of markers of activation was 
analysed as the geometric median of fl  uorescence (GMF). All values 
are expressed as median values. Comparisons between groups were 
performed using Mann–Whitney and Wilcoxon tests.
Results  The mortality of sepsis reached 70%. Nonsurvivors had 
signifi  cantly (P = 0.001) elevated expression of CD64 on neutrophils. 
Expression of HLA-DR was higher in monocytes from BAL than PB 
GMF (1,032 vs. 342; P = 0.02) and this tendency was present in sepsis 
originating from both pneumonia and peritonitis. Percentage of HLA-
DR-positive T cells was lower in PB than in BAL (2.9% vs. 6.5%; P = 0.07), 
but the GMF values for HLA-DR were higher in the circulating T cells 
(1,904 vs. 1,346; P = 0.004). The expression of CD64 on neutrophils was 
not signifi  cantly diff  erent in PB and BAL, but there was a trend towards 
its higher expression in BAL from patients with pneumonia while its 
expression was higher in PB of patients with peritonitis.
Conclusion In this study we noticed that during sepsis some signifi  cant 
diff  erences in the status of activation of immune cells exist between 
peripheral blood and lung resident cells. The lung milieu seems to 
promote activation of monocytes while neutrophil activation is more 
dependent on the site of infection. However, these observations 
require further studies in a larger group of patients.
Acknowledgements  This study was supported by the Centre of 
Postgraduate Medical Education grant no 501-01-02-012 and by the 
sources of the Medical University of Warsaw.
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Introduction Nicotine exerts anti-infl  ammatory eff  ects in several cell 
types. α7-nicotinic acetylcholine receptor (α7-nAChR), which has 
high permeability to calcium, is believed to contribute signifi  cantly to 
nicotinic anti-infl  ammatory eff  ects. However, the molecular mechanism 
is largely unknown. Kupff  er cells in the liver play an important role in 
infl  ammatory response to pathogens invading, but whether there is 
α7-nAChR expression in Kupff  er cells or cholinergic anti-infl  ammatory 
pathway involved in this process remains unclear.
Methods  (1) Kupff   er cells, isolated by collagenase digestion and 
diff   erential centrifugation from mice and labeled with FITC-aBGT, 
were observed under laser scanning confocal microscope to test the 
expression of α7-nAChR. Protein level was also tested by western 
blotting, with RAW264.7 as positive control; (2) 100  nM LPS was 
given to Kupff  er cells, with or without 1 mM nicotine. TNFα, IL-10 and 
HMGB-1 were tested at 4 hours, 12 hours or 24 hours, respectively; (3) 
100 BALB/c mice were randomly divided into four group: Group I (only 
lethal dose of LPS was given), Group II (nicotine and LPS were given), 
Group III (LPS, nicotine and GdCl3 were given), and Group IV (LPS and 
nicotine were given and the left cervical vagus nerve was cut off  ). The 
mortality of mice was observed for 72 hours.
Results  (1) Expression of α7-nAChR in Kupff  er cells was confi  rmed 
by confocal microscope and western blotting; (2) after nicotine was 
administered, the level of TNFα and HMGB-1 increased and the level 
of IL-10 decreased. Given left cervical vagus nerve cut off   or aBGT, 
the eff  ect of nicotine was weakened; (3) Group I had the highest 
mortality rate, while in Group II nicotine did reduce the mortality rate 
dramatically. After the left cervical vagus nerve was cut off   or aBGT 
was given, the eff  ects of nicotine were weakened. Diff  erence for the 
mortality rate between Group III and Group IV was not signifi  cant.
Conclusion  Kupff   er cells played a crucial rule in modulating 
infl  ammation and the anti-infl  ammatory eff  ect of nicotine was partially 
weakened after left cervical vagus nerve cut off   or aBGT was given. It 
was verifi  ed that left cervical vagus nerve was essential for the anti-
infl  ammatory eff  ect of nicotine and α7 acetylcholine receptors might 
play a critical role.
References
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Introduction  Activation of apoptosis in lymphocytes determines 
the development of neutropenia and of sepsis [1,2]. We investigated 
prevention of sepsis and correction of lymphocyte apoptosis by 
recombinant human granulocyte colony-stimulating factor (hr-GCSF, 
fi  lgrastim) [1,2].
Methods With the permission of the ethics committee, a controlled, 
randomized, blind clinical trial included 69 term newborns on 
mechanical ventilation, without neutropenia and clinical signs of 
infection, with a content of lymphocytes in early apoptosis (AnnexinV–
FITC+PI–) of >9.59%, and in late (AnnexinV–FITC+PI+) of 0.56%. 
Lymphocytes in apoptosis were detected using antibodies to AnnexinV 
and propidium iodide staining method of immunophenotyping (fl  ow 
cytometry; Beckman Coulter Epics XL, USA). The survey was conducted 
at admission, at 3 to 5 days, and 20 days. The method of random 
numbers in Group I included 39 newborns who on admission (with 
written parental consent) received an intravenous infusion of hr-GCSF 
dose of 10 μg/kg, 3 days. Newborns of Group II (n = 30) did not receive 
hr-GCSF. Power of the study was 80% (α ≤0.05).
Results For 3 to 5 days, Group I signifi  cantly decreased apoptosis of 
lymphocytes in the early from 16.1% to 7.8%, and in late from 1.3% 
to 0.1%. The development of sepsis and neutropenia have been 
reported. We observed no clinical or laboratory signs of adverse eff  ects 
of the drug. Fatal outcomes (n = 4) are not associated with hr-GCSF, 
which was confi  rmed postmortem. Decreased duration of mechanical 
ventilation (P <0.05). In Group II, 27 patients at 3 to 5 days developed 
neutropenia and increased lymphocytes in apoptosis (P <0.05). Sepsis 
was diagnosed in 19 children; eight fatal outcomes.
Conclusion hr-GCSF reduces the incidence of septic complications and 
one of the mechanisms of its clinical eff  ectiveness is the reduction of 
apoptotic factors aff  ecting the development of neutropenia.
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Introduction Multi-trauma is one of the major indications for intensive 
care admission. Recovery is frequently complicated by post-injury 
immunological complications, caused by a dysfunctional immune 
system; for example, sepsis and multiple organ failure. In order to treat 
Critical Care 2013, Volume 17 Suppl 2 
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immune paralysis in vivo and the pathophysiological mechanisms of 
immune paralysis is essential. The aim of this study is to determine 
factors that could predict and/or induce immunological complications 
in these patients to ultimately fi  nd a suitable target and timeframe for 
intervention.
Methods Blood was drawn from adult multi-trauma patients (n = 94) 
admitted to the emergency room (ER) of the Radboud University 
Nijmegen Medical Center. Blood was drawn at the trauma scene by 
the helicopter emergency medical services (HEMS), at arrival in the ER 
and at days 1, 3, 5, 7, 10 and 14 after trauma. Plasma concentrations of 
TNFα, IL-6, IL-10, IFNγ, IL-8 and MCP-1 were determined by Luminex. 
Ex vivo 24-hour whole blood stimulations with LPS or pam3cys were 
performed and produced TNFα, IL-6 and IL-10 was measured using 
ELISA to determine the level of immune paralysis. Clinical data – for 
example, Injury Severity Scores, trauma mechanism, medication and 
survival – were collected from electronic patient fi  les.
Results The plasma IL-10 concentration at ER was 16.5-fold increased 
in comparison with time-point HEMS (P  <0.01). Similar but less 
pronounced eff   ects were found for IL-8 and MCP-1. A signifi  cant 
correlation (P  = 0.03, R  = 0.53) was found between injury severity 
scores and IL-10 plasma concentration at time-point ER. Time-courses 
of ex vivo produced cytokines suggest that LPS-induced IL-6 and TNFα 
production is already decreased in the fi  rst few hours after trauma 
and recovering from day 5. Ex vivo IL-10 production shows an inverse 
pattern.
Conclusion Immune paralysis can be established within hours after 
trauma. Production of anti-infl  ammatory IL-10 in the prehospital phase 
could play a crucial role in the pathogenesis. Patients with a higher 
injury severity score are more prone to produce excessive IL-10 in this 
phase. Immune stimulatory strategies applied by the HEMS or early 
after hospital admission could form a potential future approach to 
prevent immune paralysis in multitrauma patients in the intensive care 
ward.
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Introduction In the acute phase of sepsis several potential mechanisms 
may change the hemoglobin (Hb) concentration. On the one hand, 
endothelial activation may lead to increased vascular permeability and 
fl  uid sequestration to the interstitium, leading to hemoconcentration. 
On the other hand, degradation of the glycocalyx has been reported [1]. 
Shedding of this carbohydrate-rich layer with an estimated thickness of 
0.2 to 0.5 μm may lead to a substantial increase of the intravascular 
space, and thus to decrease of Hb concentration [2]. The aim of this 
study is to determine whether there is a decrease in Hb in the acute 
phase of sepsis.
Methods  In this single-center retrospective analysis we identifi  ed 
patients with sepsis as the primary reason for non-elective ICU 
admission from a standard patient database. Patients who fulfi  lled the 
international criteria of sepsis and organ failure during ICU admission 
were included in the sepsis group (S-group). The control group was 
formed by patients with other non-elective reasons for ICU admission 
(C-group). Exclusion criteria were (recent) bleeding, surgery in the last 
6 weeks, chronic renal failure (creat >177  μmol/l, or hemodialysis), 
untreated chronic anemia, pregnancy, polytrauma, age <18, 
hematologic or metastasized malignancies, cardiac arrest, and use of 
bone marrow suppressive drugs. Laboratory data were collected from 
blood samples, prior to in-hospital i.v. fl  uid therapy. In order to detect a 
diff  erence in Hb concentration of 0.2 mmol/l, we anticipated a sample 
size of 283 per group, based on a standard deviation (SD) of 1.2, α = 0.05 
and β = 0.8. Data are expressed as mean ± SD.
Results  We included 296 patients in the S-group and 320 in the 
C-group. The diff  erence in Hb between the S-group and C-group was 
not signifi  cant (8.76 ± 1.18 mmol/l vs. 8.93 ± 1.16 mmol/l, P = 0.07). After 
correction for a number of confounders, using a multivariate regression 
analysis, we observed a signifi  cant diff  erence in Hb of –0.23 mmol/l in 
the S-group in comparison with the C-group (P = 0.01).
Conclusion At fi  rst presentation, prior to in-hospital i.v. fl  uid therapy, 
Hb concentration in patients with sepsis is signifi   cantly lower in 
comparison with controls; however, the diff   erence is very small, 
without the existence of anemia.
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Introduction Traditional whole blood experiments suggest that sepsis 
causes abnormal red blood cell (RBC) deformability. To investigate 
this at the cellular level, we employed a novel biophysical method to 
observe individual RBC membrane mechanics in patients with septic 
shock.
Methods  We collected blood samples from patients with septic 
shock until either death or day 5 of admission. Thermal fl  uctuations 
of individual RBCs were recorded allowing a complete analysis of RBC 
shape variation over time. Mean elasticity of the cell membrane was 
then quantifi  ed for each sample collected.
Results We recruited nine patients with septic shock. Table 1 shows 
mean RBC thermal fl  uctuation and SOFA scores.
Conclusion RBC thermal fl  uctuation analysis allows variations in RBC 
elasticity during sepsis to be quantifi  ed at a cellular level. We could not 
identify any specifi  c trend between sepsis severity and erythrocyte 
elasticity. Cells demonstrated both increases and decreases in fl  uctua-
tion independent of SOFA score. This is contrary to current evidence 
that suggests RBC deformability is reduced during sepsis.
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Introduction Whole blood experiments suggest that cardiopulmonary 
bypass (CPB) causes red blood cell (RBC) trauma and changes in 
deformability that may contribute to postoperative microcirculatory 
Table 1 (abstract P11). Mean RBC fl  uctuation (daily SOFA score)
Day A  B  C  D  E  F  G  H  I
1  4.8 (10)  5.2 (9)  –  4.8 (12)  4.6 (16)  4.9 (13)  5.1 (16)  4.6 (18)  5.1 (15)
2  4.9 (9)  5.0 (10)  4.6 (13)  5.1 (11)  4.8 (17)  5.1 (13)  5.0 (16)  4.9 (19)  – (16)
3  4.0 (6)  5.1 (9)  4.7 (12)  4.8 (11)  4.9 (18)  4.8 (13)  5.0 (16)  4.7 (21)  5.3 (16)
4  –  4.8 (7)  4.6 (11)  5.0 (9)  5.9 (19)  –  – (18)  –  5.0 (15)
5  –  –  –  5.1 (6)  5.2 (18)  –  – (19)  –  5.0 (10)
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quantify the eff  ects of CPB on RBC elasticity at a cellular level.
Methods We collected blood samples from elective cardiac surgery 
patients pre (at induction) and post (immediately, each day until CICU 
discharge) CPB. Thermal fl  uctuations of individual RBCs were recorded 
using a high-frame-rate camera allowing a complete analysis of RBC 
shape variation over time. Mean elasticity of the cell membrane was 
then quantifi  ed for each sample collected.
Results Fifteen patients were recruited. Table 1 displays the results. 
RBC thermal fl  uctuation is measured relative to pre-bypass values. An 
increase in RBC fl  uctuation marks a decrease in stiff  ness. CPB caused 
two distinct changes in RBC elasticity; pre-fi   x A indicates samples 
where stiff  ness increases or shows no change, B those where stiff  ness 
decreases. Data on day 2 were not collected in patients discharged 
from the CICU. CPB type or time had no apparent impact on RBC 
response to CPB.
Conclusion  RBC thermal fl   uctuation analysis quantifi   es the impact 
of CPB on erythrocyte membrane elasticity. We clearly identifi  ed two 
separate RBC elasticity responses to CPB. This fi  nding is contrary to 
traditional fl  ow measurement techniques that suggest CPB impairs 
whole blood fl  ow and reduces RBC deformability.
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Introduction  Sepsis causes widespread microvascular injury and 
thrombosis. Some hemostatic factors mediate the mechanisms 
involved in sepsis-related organ ischemia and failure. Oxidative stress 
is also increased in sepsis and reactive oxygen species (ROS) favor 
secretion of von Willebrand factor (vWF) multimers from endothelium 
and inhibit vWF proteolysis by ADAMTS-13. Moreover, the enzyme 
indoleamine-2,3-dioxygenase, an important immune regulator, is 
activated in sepsis and, through generation of kynurenins, promotes 
antioxidative and anti-infective activities. This study evaluated the 
relative role of ADAMTS-13, vWF and fi  brinogen in the morbidity and 
mortality of patients with septic shock (SS). The above hemostatic 
factors were measured together with kynurenine and plasma protein 
carbonyls, marker of oxidative stress.
Methods One group of 12 patients with SS, defi  ned using standard 
criteria, was enrolled in the ICU of the ‘A. Gemelli’ Hospital (Rome, 
Italy). Biochemical, hematologic and hemodynamic parameters were 
measured on days 1 to 4, 7, 14 and 21. A group of 12 age-matched and 
gender-matched healthy subjects was used as controls.
Results  Low ADAMTS-13 activity was observed in SS patients 
(268 ± 123 ng/ml vs. 760 ± 80 ng/ml in controls). vWF levels (antigen 
and activity) were increased ~3-fold compared with controls. Likewise, 
plasma protein carbonyls and kynurenine were globally increased in 
patients (2.1 ± 1.5 nmol/mg vs. 0.3 ± 02 nmol/mg and 14.4 ± 9.7 μM 
vs. 2.3 ± 1.3 μM, respectively). Intra-ICU mortality (3 of 15) was strongly 
and inversely correlated with carbonyl levels (P = 0.04) and platelets 
(P = 0.022).
Conclusion Hence, we hypothesize that, in the SS setting, platelets 
contribute to oxidative stress that counteracts the organ failure-
associated mortality. Thus, low platelet count, irrespective of bleedings, 
may favor mortality in SS patients by generating lower ROS amounts.
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Introduction  Neutrophil gelatinase-associated lipocalin (NGAL)/
lipocalin2, known as a sensitive biomarker of acute kidney injury, 
prevents bacterial iron uptake, resulting in the inhibition of its 
overgrowth [1]. We previously demonstrated that this protein was 
discharged into gut lumen from crypt cells in septic conditions, and 
inhibited the growth of Escherichia coli [2]. However, it remains unclear 
which pathway is associated with the upregulation of NGAL. We 
therefore designed the present study to reveal whether the pattern-
recognition receptor of bacteria, the Toll-like receptor (TLR) family, 
plays a pivotal role for NGAL secretion from gut crypt cells.
Methods With our institutional approval, the ileum and colon of male 
C57BL/6J mice (6 to 7 weeks) were everted and washed by Ca2+ and 
Mg2+ free PBS buff  er fi  ve times. Tissues were incubated with Ca2+ and 
Mg2+ free PBS containing 30 mM EDTA for 1 hour to isolate crypt cells 
of gut. The cell suspension was fi  ltered through a cell strainer (40 μm) 
twice, and deposited the crypt cells by centrifugation at 700×g. The 
isolated crypt cells were resuspended in PBS and stained with 0.25% 
amido black for labeling paneth cells. The 5×105 crypt cells were 
resuspended in 50 ml HBSS containing 2.5% fetal bovine serum and 
1% penicillin–streptomycin. The crypt cells were incubated at 37°C with 
or without TLR ligands: lipopolysaccharide (TLR4 ligand, 10 μg/ml) and 
CpG-DNA (TLR9 ligand, 8 μg/ml). After a 2-hour incubation period, the 
crypt cells were deposited and eluted mRNA to measure the expression 
of both NGAL and TLR mRNA using real-time PCR.
Results  More than 70 to 80% of collected cells were stained by amido 
black. LPS signifi   cantly upregulated the expression of NGAL and TLR4 
mRNA in ileum and colon crypt cells (P <0.05). Although the CpG-DNA did 
not upregulate NGAL and TLR9 mRNA in ileum crypt cells, the apparent 
expression of NGAL and TLR9 mRNA was found in colon crypt cells (P <0.05).
Conclusion Bacterial stimulation of TLR4 and TLR9 pathways plays a 
pivotal role in the expression of NGAL mRNA in gut, suggesting that 
NGAL, derived from gut crypt cells, could contribute to the regulation 
of the intraluminal microfl  ora in the critically ill.
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Introduction Most individuals infected with the 2009 pandemic H1N1 
infl   uenza A virus (IAV) (H1N1pdm) experienced uncomplicated fl  u. 
Table 1 (abstract P12). Change in RBC thermal fl  uctuation relative to baseline: two distinct groups seen
Patient  A1 A2 A3 A4 A5 A6 A7 B8 B9  B10  B11  B12  B13  B14  B15
Post  CPB  +0.1 –0.4 –0.1 –0.5 –0.1 –0.2 –0.1 +0.5  0  +0.4 +0.1 +0.2  0  +0.2 +0.1
Day  1  0  0  +0.1 –0.1 –0.1 +0.1 +0.1  0  +0.5 +0.4 +0.7 +0.4 +0.6 +0.5 +0.7
Day  2  –0.2  +0.1  0  NA  NA  0  NA +0.5  –0.1  +0.4 NA +0.1 NA  NA  NA
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to primary viral pneumonia (PVP) and a minority of them developed 
ARDS. Inherited and acquired variability in host immune responses 
may infl  uence susceptibility and outcome of IAV infection. However, 
the molecular nature of such human factors remains largely elusive.
Methods We report three adult relatives with the autosomal dominant 
GATA-2 defi  ciency. P1 and his son P2 had a history of myelodysplastic 
syndrome and a few episodes of mild respiratory infections. They 
developed PVP by H1N1pdm which rapidly evolved to ARDS. They died 
at the age of 54 and 31, respectively.
Results  Patients were heterozygous for a novel R396L mutation in 
GATA2. Like other patients with GATA-2 defi  ciency, the three relatives 
had absence of peripheral NK and B cells and monocytopenia. However 
a high number of plasma cells, which were found to be pauciclonal, 
were observed in peripheral blood from P1 during H1N1pdm infection. 
P1 and P2 had normal levels of immunoglobulins and IgG antibodies 
against common viruses. Microneutralization test showed that P1 
produced normal titers of neutralizing antibodies against H1N1pdm 
and against the previous annual H1N1 strain. Our results suggest that 
a few clones of long-living memory B cells against IAV expanded in 
P1; and that these cells produced cross-reactive antibodies against 
H1N1pdm, similar to those recently described. During the fl  u episode 
P1 had a strong increase of IFNγ-producing T cells and of IFNγ 
production. The Th1-related chemokines CXCL10 and CXCL9, as well as 
IFNγ, MCP-1 and IL-8, were strongly elevated in serum from P1 and P2 
in the course of H1N1pdm infection.
Conclusion  GATA-2 defi   ciency is the fi   rst described Mendelian 
inborn error of immunity underlying severe IAV infection. Primary 
immunodefi  ciencies predisposing to severe IAV infections may debut, 
even in adults without a history of previous severe infections. The 
massive IFNγ-mediated cytokine storm may explain the fatal course of 
H1N1pdm infection in our patients.
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Introduction Some cases of multiple trauma are rapidly deteriorating; 
the mechanism was investigated.
Methods  Forty-one rabbits were assigned into two groups; sham-
operated and subject to crush of the right femur. Survival was 
recorded; peripheral blood was sampled for LPS measurement by the 
kinetic QCL-1000 LAL assay; quantitative tissue growth was assessed 
after death. Some rabbits were sacrifi   ced at 48  hours; blood was 
sampled from the portal vein for LPS measurement; splenocytes were 
isolated and incubated for 24 hours in the presence of 10 ng/gl LPS of 
Escherichia coli O55:B5 and of 5 μg/ml phytohemagglutin (PHA); TNFα 
was measured in supernatants by a bioassay on L929 fi  broblasts.
Results  Fifty percent of rabbits died early; that is, within the fi  rst 
48 hours. Mean ± SE log10 bacteria in the liver and lung of animals 
that died early was 2.27 ± 0.62 and 3.16 ± 0.78 cfu/g; respective values 
of rabbits that started dying late (that is, after 72 hours) were below 
the limit of detection. Mean circulating LPS at 24 hours was 2.09 EU/
ml and 1.99 EU/ml respectively (P = NS). Mean LPS of the portal vein 
of the sham and of the injury groups were 1.25 and 5.62 EU/ml (P = 
0.047). Concentrations of TNFα in splenocyte supernatants are shown 
in Figure 1.
Conclusion  Early death after injury is not related to peripheral 
endotoxemia and sepsis; bacterial translocation priming for enhanced 
proinfl  ammatory responses is a likely explanation.
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Introduction Adenosine exerts anti-infl  ammatory and tissue protective 
eff   ects during systemic infl   ammation. While the anti-infl  ammatory 
properties may induce immunoparalysis and impede bacterial 
clearance, the tissue protective eff  ects might limit organ damage. 
The eff  ects of a common loss-of-function variant of the adenosine 
monophosphate deaminase 1 gene (AMPD1), which is associated with 
increased adenosine formation, in patients with sepsis are unknown.
Methods  In a prospective cohort, genetic-association study, the 
eff  ects of the presence of the AMPD1 gene on immune function, 
multiorgan dysfunction and mortality in septic patients was studied. 
Pneumosepsis patients (n = 402) and controls without infection (n = 
101) were enrolled.
Results In pneumosepsis patients and controls, a similar prevalence 
of the 34C>T (rs17602729) mutation in the AMPD1 gene was found. 
Univariate logistic regression analysis showed a tendency of increased 
mortality in patients with the CT genotype, compared with patients 
with the CC genotype (OR 1.53; 95% CI 0.95 to 2.5). Moreover, carriers of 
the CT genotype tended to suff  er more from multiorgan dysfunction, 
OR 1.4 (0.84 to 2.3) and 3.0 (0.66 to 13.8), for CT and TT, respectively 
(P = 0.07). In septic carriers of the CT genotype, the ex vivo production 
of TNFα by LPS-stimulated monocytes was attenuated (P  = 0.005), 
Figure 1 (abstract P16). Stimulation of TNFα from isolated splenocytes. Figure 1 (abstract P17). Kaplan–Meier curve for the 402 sepsis patients.
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See Figure 1.
Conclusion The presence the 34C>T variant of the AMPD1gene is not 
related to infection susceptibility; however, it is associated with more 
pronounced immunoparalysis in patients with sepsis, and shows 
a tendency towards increased mortality. Mechanistically, the anti-
infl  ammatory eff  ects of adenosine may account for this and apparently 
overrule its tissue protective eff  ects.
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Introduction Infl  ammation, as seen in sepsis and systemic infl  ammatory 
response, is dependent on the activation of the NFκB pathway through 
Toll-like receptors (TLRs) [1]. Recreating an infl  ammatory  response 
using lipopolysaccharide (LPS) can provide results that are diff  erent to 
clinical sepsis [2]. By examining NFκB activation in murine and human 
cells, a species comparison can be made to investigate diff  erences at 
the cell level that may contribute to the translational disconnect seen 
in vivo.
Methods THP1 human monocytes (passages 9 to 11) and RAW 264.7 
murine macrophages (passages 15 to 20) were cultured in RPMI-1640 
and DMEM respectively and then challenged with LPS. After settling 
for 24 hours, cells were dosed with six or seven doses of LPS. After 
1 hour, nuclear extraction and proteins were separated by acrylamide 
gel electrophoresis. Membranes where then immunoblotted for actin 
and p65, followed by densitometric analysis in order to quantify the 
amount of p65 that had translocated from the cytoplasm to the nucleus 
(by subtraction from consistent nuclear actin).
Results  Murine cells required higher doses of LPS compared with 
human cells in order to detect p65 (human, 1 pg/ml to 100 ng/ml; 
murine, 30 pg/ml to 1,000 ng/ml). THP1 cells showed a greater fold 
increase in the p65:actin ratio compared with RAW 264.7 cells. Human 
cells responded to lower concentrations of LPS. Murine cells appeared 
to show a molecular resistance to lower doses, but their response was 
very sensitive at higher doses. A dose–response relationship of LPS 
dosing and NFκB activation was observed in both cell lines.
Conclusion  Immunoblotting for p65 is a reliable and reproducible 
method to determine NFκB activation in cultured cells. Macrophages 
are more responsive to LPS than monocytes [3] so diff  erences between 
cell lines would have been expected to be the reverse of what was 
observed. The species diff  erence in response to LPS may contribute 
to the apparent disconnect between human and murine responses to 
LPS and may partially explain the diffi   culties of translating therapeutic 
interventions into clinical human sepsis.
References
1.  Bonizzi G, Karin M: Trends Immunol 2004, 25:280-288.
2.  Remick DG, Ward PA: Shock 2005, 24(Suppl 1):7-11.
3. Takashiba  S,  et al.: Infect Immun 1999, 67(11):5573-5578.
P19
Hypogammaglobulinemia in sepsis is not correlated to high 
circulating angiopoietin-2 levels
U Kovačič1, F Starič2, M Kmet2, M Godnič2, R Kapš2
1Faculty of Medicine, University of Ljubljana, Slovenia; 2General Hospital Novo 
Mesto, Slovenia
Critical Care 2013, 17(Suppl 2):P19 (doi: 10.1186/cc11957)
Introduction  Hypogammaglobulinemia has been frequently found 
in adult patients with severe sepsis and septic shock. Furthermore, it 
seems that at least a low serum level of IgM is correlated with higher 
mortality in sepsis. The mechanisms of hypogammaglobulinemia in 
septic shock have not yet been explained. It has been hypothesized 
that outfl  ow of immunoglobulins into the extravascular space due to 
increased capillary permeability could reduce immunoglobulin serum 
concentrations. Angiopoietin-2, which directly disrupts the endothelial 
barrier, is markedly elevated in sepsis and other infl  ammatory states 
and its serum level has been correlated with microvascular leakage, 
end-organ dysfunction and death in sepsis.
Methods In the prospective, noninterventional study, we assessed the 
correlation between the capillary leakage marker angiopoetin-2 and 
serum levels of IgG and IgM in 41 patients with community-acquired 
severe sepsis or septic shock on admission. Blood samples were 
obtained during the fi  rst 12 hours after admission to hospital.
Results  Mean age of patients (17 females) was 70  years. Median 
APACHE II and SOFA scores at admission were 24 and 11, respectively. 
The mortality rate was 45%. Thirty-four percent of all patients had level 
of IgG <650 mg/dl. The median concentration of angiopoietin-2 in the 
hypo-IgG group was 11,958 pg/ml, which was not statistically diff  erent 
(Mann–Whitney; P >0.05) than in the rest of patients with normal levels 
of IgG (15,688 pg/ml). The concentration of IgM <40 mg/dl was found in 
only four patients (10%) and all died. Pearson’s correlation test showed 
that the correlation between the concentrations of angiopoietin-2 
and IgG (correlation coeffi   cient 0.191) or IgM (correlation coeffi   cient 
0.0408), respectively, were not statistically signifi  cant (P <0.05).
Conclusion  At present the hypothesis that increased microvascular 
leakage is responsible for hypogammaglobulinemia in septic patients 
could not be accepted. Studies on larger number of patients are 
needed. In addition, it is necessary to further explore other possible 
mechanisms, such as increased catabolism and consumption of 
antibodies or inadequate synthesis of immunoglobulins, which could 
also be responsible for hypogammaglobulinemia in sepsis.
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Introduction Sepsis and spontaneous bacterial peritonitis (SBP) are 
common sequelae in patients with cirrhosis. Cirrhotics admitted 
Figure 1 (abstract P20). TREM-1 expression in healthy controls compared with cirrhotic patients.
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translocation (MT) is the pathogenic mechanism implicated in SBP. The 
triggering receptor expressed by myelocytes-1 (TREM-1) modulates 
the immune response with resultant production of proinfl  ammatory 
cytokines and has been used as a biomarker in the diagnosis of bacterial 
infection. We wish to evaluate the role of TREM-1 as a biomarker in 
cirrhosis.
Methods Blood samples were obtained from 18 healthy controls (HC) 
and 29 cirrhotic patients (CA) as defi  ned by clinicoradiological criteria. 
Disease severity was graded according to Child–Pugh class (median 
10, range 5 to 13) and modifi  ed end-stage liver disease (MELD) score 
(median 14, range 6 to 21). Simultaneous ascitic fl  uid samples were 
taken from 10 patients in the CA group. Soluble TREM-1 and CD14 levels 
(a surrogate marker of MT) were measured by ELISA. Flow cytometry 
was used to quantify the expression of TREM-1 on monocytes and 
neutrophils in blood and ascitic fl  uid.
Results  TREM-1 expression is signifi   cantly higher in the CA group 
compared with HC across all monocyte subsets but not neutrophils, 
even in the absence of sepsis (see Figure 1). There is no correlation 
between cell surface TREM-1 expression and severity of cirrhosis by 
Child–Pugh or MELD score. sTREM and sCD14 levels were elevated in 
the CA group compared with HC (P = 0.0010 and 0.0016 respectively). 
In addition, plasma sTREM-1 levels correlated with disease severity 
according to MELD score (R = 0.71, CI = 0.22 to 0.92 P = 0.012) and serum 
bilirubin (R = 0.78,CI = 0.36 to 0.94, P = 0.004). There was no correlation 
with either form of TREM-1 with sCD14 levels. There was no diff  erence 
in cell surface or soluble TREM-1 expression between blood and ascitic 
fl  uid monocytes in culture-negative, non-neutrophilic ascites.
Conclusion  Blood monocyte and soluble TREM-1 are elevated in 
cirrhotic patients even in the absence of sepsis. Soluble TREM-1 levels 
correlate with disease severity in cirrhosis. Further studies are ongoing 
to ascertain the utility of TREM-1 as a biomarker in cirrhosis.
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Introduction  The blood–brain barrier (BBB) is highly restrictive of 
the transport of substances between blood and the central nervous 
system. Lipopolysaccharide (LPS) from Gram-negative bacteria was 
reported to aff  ect the permeability of the BBB. BBB disruption using a 
LPS is used as a model of septic encephalopathy in mice. The present 
study was designed to investigate the eff  ects of diff  erent doses and 
serotypes of LPS on BBB integrity in Sprague–Dawley rats.
Methods  Male Sprague–Dawley rats weighing 200 to 250  g were 
used in the study. Rats were given two diff  erent types of LPS (026:B6-
L5543 and 026:B6-L2762) in diff  erent doses (3, 5, and 10 mg/kg; i.v.). 
Rectal temperature and arterial blood pressure measurements were 
recorded for sepsis severity. The changes in the BBB permeability were 
measured using the Evans blue (EB) and sodium fl  uorescein (NaFl) dye 
extravasation techniques 24 hours after LPS administration.
Results Both LPS serotypes showed comparable arterial blood pressure 
and rectal temperature recordings and the severity of the disease 
increased with the increasing doses (5 mg/kg and 10 mg/kg) of LPS 
and the mortality rates were found to be 29% and 63% respectively. 
The extravasated contents of EB and NaFl tracers did not signifi  cantly 
increase in brain parenchyma following the administration of diff  erent 
doses of LPS with diff  erent serotypes.
Conclusion Our results showed no disruption to BBB by two diff  erent 
serotypes of LPS even administered in increasing doses. These result 
indicate that the BBB integrity of Sprague–Dawley rats are resistant to 
the eff  ects of two diff  erent serotypes of LPS.
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Introduction  Septic encephalopathy is a frequent complication in 
severe sepsis but its pathogenesis and mechanisms are not fully 
understood. Oxygen supply and utilization are critical for organ 
function, especially for the brain, a tissue extremely dependent on 
oxygen and glucose. Disturbances in oxygen utilization are common 
in sepsis and a number of mitochondrial dysfunctions have been 
described in diff  erent tissues in septic animals as well as in septic 
patients. Our group described mitochondrial dysfunctions in the brain 
during experimental sepsis.
Methods Experimental sepsis was induced by endotoxemia (LPS 10 mg/
kg i.p.) in Sprague–Dawley rats and by polymicrobial fecal peritonitis in 
Swiss mice. Brain glucose uptake was observed in vivo in endotoxemic 
rats using positron emission tomography with [18F]fl  uorodeoxyglucose 
and autoradiography with 2-deoxy-14C-glucose.
Results  Mice with polymicrobial sepsis present hypoglycemia, 
hyperlactatemia and long-term cognitive impairment. We observed 
a rapid increase in the uptake of fl  uorescent glucose analog 2-deoxy-
2-((7-nitro-2,1,3-benzoxadiazol-4-yl)amino)-D-glucose in brain slices 
from septic mice in vitro. A similar increase in brain glucose uptake 
was observed in vivo in endotoxemic rats. Remarkably, the increase 
in glucose uptake started 2 hours after LPS injection, earlier than 
other organs. The brains of mice with experimental sepsis presented 
neuroinfl  ammation, mitochondrial dysfunctions and oxidative stress, 
but mitochondria isolated from septic brains generated less ROS in 
vitro in the fi  rst 24 hours. This led us to investigate the role of NADPH 
oxidase, an enzyme induced during innate immune response, as a 
potential source of reactive oxygen species in experimental sepsis. 
Inhibiting NADPH oxidase with apocynin acutely after sepsis prevented 
cognitive impairment in mice.
Conclusion  Our data indicate that a bioenergetic imbalance and 
oxidative stress is associated with the pathophysiology of septic 
encephalopathy. We are observing a new metabolic phenotype in 
the brain during sepsis, characterized by a rapid increase in glucose 
uptake and mitochondrial dysfunctions that may be secondary to 
infl  ammation and hypoxia.
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Introduction  Pathophysiology of brain dysfunction associated 
with sepsis is still poorly understood. Potential mechanisms involve 
oxidative stress, neuroinfl  ammation and blood–brain barrier altera-
tions. Our purpose was to study the metabolic alterations and markers 
of mitochondrial dysfunction in a clinically relevant model of septic 
shock.
Methods  Twelve anesthetized (midazolam/fentanyl/pancuronium), 
invasively monitored, and mechanically ventilated pigs were allocated 
to a sham procedure (n = 5) or sepsis (n = 7), in which peritonitis was 
induced by intra-abdominal injection of autologous feces. Animals 
were studied until spontaneous death or for a maximum of 24 hours. 
In addition to global hemodynamic and laboratory assessment, 
intracranial pressure and cerebral microdialysis were assessed at 
baseline, 6, 12, 18 and 24 hours after sepsis induction. After death, 
brains were removed and brain homogenates were studied to assess 
markers of mitochondrial dysfunction.
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with lower arterial pressure, fever and organ dysfunction in comparison 
with control animals. In the septic animals, we observed increased 
brain dialysate glutamin levels at 12, 18 and 24  hours after sepsis 
induction, as compared with control animals. Moreover, after analyzing 
homogenates from the frontal cortex, we found higher concentrations 
of glutamin and glutamate in septic as compared with control 
animals (85.67 ± 14.98 vs. 28.77 ± 7.0; P = 0.01 and 132.1 ± 19.72 vs. 
53.33 ± 16.83; P = 0.02, respectively). See Figure 1.
Conclusion  We found higher concentrations of glutamate and 
glutamin in brain tissues of septic animals as compared with control. 
Furthermore, glutamin concentrations increased over time in the 
extracellular space as measured by cerebral microdialysis. These 
fi   ndings suggest an increased excitatory state that is potentially 
associated with high energy expenditure. However, associations with 
neuronal injury need further study.
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Introduction  Septic encephalopathy is a sepsis-related brain dys-
function with a deterioration of cortical functions. The experimental 
studies in the rat brain revealed a deranged neurotransmitter profi  le 
during septic encephalopathy. Glutamatergic synapses, essential in 
learning and memory, undergo use-dependent changes in synaptic 
strength, referred to as plasticity. Permanent strengthening of synapses 
after a brief stimulus, termed long-term potentiation (LTP), was 
discovered in the hippocampus, and here it has been most thoroughly 
studied. Cholinergic neurotransmission plays an important role in 
regulating the cognitive functions of the brain. It acts as a signal-to-
noise ratio modulator of sensory and cognitive inputs. The irregularities 
in brain functions give rise to the symptoms of delirium, including 
disorganized thinking and disturbances of attention and consciousness, 
which in turn might aff  ect learning and memory. Possible mechanisms 
for cholinergic defi  ciency include impairment of synaptic functions 
of acetylcholine. Imbalances in the cholinergic system during sepsis 
might therefore play an extensive role in the septic delirium.
Methods By using MRI imaging we identifi  ed functional changes in the 
hippocampal region of patients with severe sepsis. This fi  nding was 
further supported by the experimental recordings in the rat brains of 
lipopolysaccharide (LPS)-treated rats using the electrophysiological 
patch clamp technique.
Results Critically ill ICU patients diagnosed with septic delirium using 
the CAM-ICU method underwent diagnostic MRI scans. The serial MRI 
analysis revealed increased signal intensity in the hippocampal region 
in diff  usion-weighted MRI (DWI). We used endotoxemia model to induce 
sepsis in the rats. Electrophysiological analysis of the hippocampal 
neurons in LPS-treated rats showed impaired LTP in the excitatory 
synapses, as compared with controls. Application of physostigmine, a 
blood–brain barrier permeable cholinesterase inhibitor, resulted in a 
partial recovery of LTP in the hippocampal synapses of LPS-treated rats.
Conclusion The patients with septic delirium show functional changes 
in the hippocampus. Furthermore, we show that endotoxemia aff  ects 
synaptic plasticity in the rat hippocampus, suggesting the involvement 
of this brain region in the pathophysiology of septic delirium. Moreover, 
the eff  ect of the cholinergic neurotransmission onto the induction 
and maintenance of synaptic plasticity in the rat hippocampus during 
endotoxemia suggests that cholinergic neurotransmission might play a 
critical role in septic encephalopathy.
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Introduction  The neutrophil–lymphocyte count ratio (NLCR) is an 
easy to analyse biomarker reacting very early in the course of acute 
infl   ammation. It has previously been reported to correspond to 
bacteremia and recently to disease severity in community-acquired 
pneumonia [1]. We have looked at 205 consecutive patients with 
Escherichia coli infections (ECI) and found the same to be true for 
ECIs. This may be of great clinical importance since E. coli is the most 
frequently isolated pathogen in patients with infections requiring in 
hospital care.
Methods  This study is part of a 9-month consecutive study of 
community-acquired severe sepsis and septic shock in adults at 
Skaraborg Hospital in the western region of Sweden. The hospital 
serves a population of 256,000 inhabitants and has approximately 
60,000 annual visits to the ED. All patients admitted to the hospital 
receiving intravenous antibiotic treatment within the fi  rst 48  hours 
of admission were evaluated for severe sepsis and septic shock. Upon 
admission, two sets of blood cultures and other relevant cultures were 
obtained from each patient as well as sampling for NLCR and venous 
plasma lactate. The patient records were evaluated by one infectious 
diseases specialist. Approximately 2,300 patients were diagnosed 
as having a bacterial infection. From those, an informed consent to 
participate in the study could be obtained from approximately 1,600 
patients.
Results Of the 1,600 patients who gave consent to participate in the 
study, 205 had an ECI. Sixty-four had a positive blood culture for E. coli. 
Fifty of the patients met one or more criteria for severe sepsis or septic 
shock. The NLCR was signifi  cantly higher (P <0.001) within the severe 
sepsis group (median = 21.1 with quartiles 11.1 to 42.4) compared with 
the group with no severe sepsis (median = 11.6 with quartiles 7.6 to 
18.9).
Conclusion The NLCR can be used as a biomarker of disease severity 
even in ECIs. The biomarker reacts rapidly, is cheap and needs no extra 
sampling. The higher the value, the higher the probability for severe 
sepsis. A high value can even precede the development of severe 
sepsis or septic shock. However, a low value never excludes neither 
bacteremia nor severe sepsis. The method cannot be used in patients 
with disturbances in neutrophil or lymphocyte levels due to other 
causes than sepsis.
Reference
1.  de Jager C, et al.: The neutrophil–lymphocyte count ratio in patients with 
community acquired pneumonia. PLoS ONE 2012, 7:e46561.
Figure 1 (abstract P23).
Critical Care 2013, Volume 17 Suppl 2 
http://ccforum.com/supplements/17/S2
S9P26
Obesity and infl  ammatory markers in severe sepsis
P Simon1, D Thomas-Rüddel2, T Nemes1, K Reinhart2, F Bloos2, UX Kaisers1
1University Hospital of Leipzig, Germany; 2Center for Sepsis Control and Care, 
Jena, Germany
Critical Care 2013, 17(Suppl 2):P26 (doi: 10.1186/cc11964)
Introduction Chronic infl  ammation has recently been recognized as 
an important factor in the pathophysiology of obesity and associated 
morbidities [1]. In this clinical study we aimed at identifying possible 
eff  ects of obesity on infl  ammatory markers in severe sepsis.
Methods  With institutional ethical committee approval, 243 
consecutive patients treated for severe sepsis or septic shock in the 
ICUs of two university hospitals over a period of 5 months were studied. 
Six patients were excluded due to cachexia, syndromal disorders or 
missing clinical data. Diagnosis of sepsis was made according to SCCM 
criteria. Serum levels of C-reactive protein (CRP, mg/l) and procalcitonin 
(PCT, ng/ml) on day 1 of sepsis were compared among fi  ve body mass 
index (BMI) strata according to WHO defi  nitions. Two groups (BMI <30, 
normal weight, and BMI ≥30, obesity) were formed for further analysis, 
and PCT was logarithmically transformed (LogPCT), resulting in normal 
distribution. Statistical analysis was performed using a t test.
Results  Patients with BMI ≥30 had higher values of PCT and CRP 
(Table 1). The diff  erence in LogPCT was of borderline signifi  cance (P = 
0.052). However, patients with positive blood cultures had signifi  cantly 
higher LogPCT values (P = 0.017) (Figure 1). Diff  erence in CRP was not 
signifi  cant (P = 0.09). The trends over all fi  ve BMI strata (Table 1) were 
not signifi  cant.
Conclusion  Obesity with BMI ≥30 seems to be associated with an 
increase in infl   ammatory markers in patients with severe sepsis, 
particularly in bacteraemia. The role of adipose tissue in severe sepsis 
should therefore be studied in more detail.
Reference
1. Wellen  K,  et al.: Infl  ammation, stress, and diabetes. J Clin Invest 2005, 
115:1111-1119.
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Introduction Identifying a group of patients at high risk of developing 
infectious complications is the fi  rst step in the introduction of eff  ective 
pre-emptive therapies in specifi  c patient groups. Quantifying cytokine 
gene expression also furthers our understanding of trauma-induced 
immunosuppression. Our group has already demonstrated that a 
predictive immunological signature derived from mRNA expression in 
elective thoracic surgical patients accurately predicts pneumonia risk [1].
Methods In total, 121 ventilated polytrauma patients were recruited. 
mRNA was extracted from PaxGene tubes collected within 2 hours 
of the initial insult, at 24 and 72 hours. T-helper cell subtype specifi  c 
cytokines and transcription factors mRNA was quantifi  ed using qPCR. 
Ten healthy controls served as a comparator.
Results The Median Injury Severity Score (ISS) was 29. Time 0 bloods 
demonstrated a reduction in TNFα†, IL-12§, IL-23‡, RORγT* and T bet§, and 
an increase in IL-10* and IL-4† mRNA levels in comparison with the control 
group (*P <0.0001, †P <0.001 to 0.0001, ‡P <0.01 to 0.001, §P <0.05 to 0.01). 
There was a positive correlation between ISS and IL-10‡ whilst both IL-23§ 
Figure 1 (abstract P26).
Table 1 (abstract P26). PCT and CRP as median (IQR)
BMI  n  PCT (ng/ml)  CRP (mg/l)
18.5 to 24.9  196  4.8 (11.9)  153 (189)
≥30.0  47  7.3 (24.6)  228 (254)
18.5 to 24.9  101  4.9 (11.7)  147 (175)
25 to 29.9  95  4.4 (12.0)  157 (218)
30 to 34.9  32  6.9 (22.6)  212 (118)
35 to 39.9  7  7.4 (38.3)  241 (264)
≥40.0  8  11.4 (32)  278 (272)
Figure 1 (abstract P27). Cytokine mRNA levels in trauma (time 0) and control groups.
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increased and IFNγ†, IL-12*, IL-17A§, RORγT* and T bet* mRNA levels 
decreased over the initial 24 hours. Subsequent bacteraemia (18/121 
patients) was associated with a lower TNFα/IL-10 ratio‡ at baseline. 
Similarly, higher IL-10‡ and lower T bet‡ mRNA at 24 hours also predicted 
later bacteraemic episodes. Development of pneumonia followed a 
similar pattern. A multivariate logistical regression model proved highly 
accurate in predicting infectious complications from mRNA analysis of 
early blood samples. See Figure 1.
Conclusion Cytokine gene expression patterns indicate an immediate 
and sustained impairment in Th1, Th17 and innate immunity with 
concurrent upregulation of the Th2 response following major trauma. 
The magnitude of this response predicts subsequent infectious 
complications.
Reference
1. White  M,  et al.: Chest 2011, 139:626-632.
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Introduction The evaluation of sepsis severity is complicated by the highly 
variable and nonspecifi  c nature of clinical signs and symptoms. We studied 
routinely used biomarkers together with clinical parameters to compare 
their prognostic value for severe sepsis and evaluate their usefulness.
Methods A cohort study of 150 patients >18 years with severe sepsis 
according to the Surviving Sepsis Campaign, in an ICU of a university 
hospital. Demographic, clinical parameters and coagulation, infection 
and infl  ammation parameters during the fi  rst 24 hours from severe 
sepsis or septic shock onset were studied. Descriptive and comparative 
statistical analysis was performed using SPSS version 15.0 (SPSS Inc., 
Chicago, IL, USA).
Results We analyzed 150 consecutive episodes of severe sepsis (16%) 
or septic shock (84%) in the ICU. The median age of the patients was 
64 (interquartile range, 48.7 to 71) years; the main sources of infection 
were intra-abdomen (45%) and respiratory (38%); 70.7% had medical 
diseases. The 28-day mortality was 22.7%. The profi  le of death patients 
were men (64.7%, n =22), with signifi  cantly higher average age (63 vs. 
57 years; P = 0.049), as well as clinical severity scores, APACHE II (29.8 vs. 
24.1; P <0.001) and SOFA (12.1 vs. 8.9; P <0.001) and major dysfunction 
organ number (4.6 vs. 3.6; P <0.001). Bilirubin was the best predictor of 
28-day mortality with the largest AUC (0.71), followed by hemoglobin 
(0.69) and C3 (0.67). The multivariate logistic regression was adjusted 
for three risk parameters, hemoglobin (OR: 0.68; 95% CI: 0.51 to 0.94), 
bilirubin (OR:1.63; 95% CI: 1.08 to 2.45) and white blood cells (OR:1.04; 
95% CI: 1.01 to 1.08) and with these parameters a ROC analysis was 
performed, giving an AUC of 0.77 (0.69 to 0.84).
Conclusion  The assessment of routine biomarkers (bilirubin, white 
blood cells and hemoglobin) may be a helpful tool in the decision-
making process at the bedside, for the evaluation of early ICU admission 
of recoverable patients, as indicators of infl  ammatory response, organ 
dysfunction or catabolism level, and their signifi  cant predictive value 
on mortality.
Reference
1.  Glickman SW, Cairns CB, Otero RM, et al.: Disease progression in 
hemodynamically stable patients presenting to the emergency 
department with sepsis. Acad Emerg Med 2010, 17:383-390.
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Introduction We analyze procalcitonin (PCT) as a prognostic marker, in 
order to assess the clinical impact of a daily PCT measure.
Methods From November 2010 to November 2011 we collected clinical 
data, drug administration, scores and PCT values of 420 consecutive 
patients during hospitalization. Statistical analysis was made using 
SPSS software. We calculated ICU mortality, 1-month mortality and 
1-year mortality. Median percentage daily variation was calculated as: 
(PCT day after – PCT of the date value) / PCT of the date value×100. 
PCT variation in the last 48 hours of hospitalization was calculated as: 
(PCT at discharge – PCT at 48 hours before discharge) / PCT 48 hours 
before discharge×100. We compared peak values in dead patients 
versus alive patients. A logistic regression was performed in order to 
assess mortality odds ratio.
Results Of the 420 patients, 63 (15%) died in the ICU, 12 (2.86%) died 
1 month after ICU discharge and 16 (3.80%) died 1 year after ICU 
discharge. PCT values were higher during the last day of hospitalization 
in dead patients versus alive patients. PCT percentage variation during 
the last 48 hours of hospitalization had a slower trend in patients who 
died than in those who survived; these diff  erences are even more 
marked in patients who had a septic event. A slower descending trend 
of daily PCT values was found in patients who died than in those who 
survived. PCT peak levels during the ICU stay were higher in dead 
patients with respect to alive ones. At logistic regression analysis PCT 
decrease in the last 48 hours <–30% (OR 3.71), PCT peak higher than 
10 ng/ml (OR 2.38), and PCT last day/PCT peak ratio >50% (OR 2.064) 
were ICU mortality risk factors. PCT values were a higher predictive ICU 
mortality risk factor than SOFA and APACHE II scores. Other prognostic 
factors were age and lactate values. Only age was a risk factor in 
1-month and 1-year mortality.
Conclusion PCT is a good prognostic marker and is strongly correlated 
to the clinical status and gravity of the patients, so PCT seems to be a 
useful marker in an intensive care scenario.
References
1.  Jensen JU, Heslet L, Jensen TH, et al.: Procalcitonin increase in early 
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2006, 34:2596-2602.
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Introduction Although absolute values for C-reactive protein (CRP) and 
procalcitonin (PCT) are well known to predict sepsis in the critically ill, it 
remains unclear if and how changes in CRP and PCT predict evolution 
of infectious disease and how they compare in this respect.
Methods  In 72 critically ill patients with new-onset fever, CRP and 
PCT were measured on day 0, 1, 2 and 7 after inclusion, and their 
clinical course was documented over 1 week with follow-up to day 28. 
Infection was microbiologically defi  ned, as was bloodstream infection; 
septic shock was defi  ned as infection plus shock.
Results From peak at day 0 to 2 to day 7, CRP decreases most when 
(bloodstream) infection and septic shock (day 0 to 2) resolve and 
increases most when complications such as a new (bloodstream) 
infection or septic shock (day 3 to 7) supervene (area under the receiver 
operating characteristic curve 0.70 or higher, P = 0.04 or lower). PCT 
decreases most when septic shock resolves (AUC 0.72, P = 0.007) and 
increases most when a new bloodstream infection or septic shock 
supervenes (AUC 0.82 or higher, P <0.001). The day 7 value of PCT rather 
than of CRP was predictive for 28-day outcome (AUC 0.70, P = 0.005).
Conclusion The data, obtained during ICU-acquired fever and infections, 
suggest that CRP and PCT changes predict the course of infectious 
disease and its complications. CRP may be favoured over PCT courses 
in decisions on appropriateness and duration of antibiotic treatment, 
whereas PCT rather than CRP courses may help predicting complications 
such as bloodstream infection, septic shock and mortality.
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Introduction Diff  erentiation of acute heart failure from infection in 
patients with respiratory symptoms and a history of congestive heart 
failure (CHF) is challenging due to overlap of clinical symptoms and 
X-ray fi  ndings. The BACH study found higher mortality rates if patients 
presenting with dyspnea were treated with antibiotics and their 
procalcitonin (PCT) levels were low indicating absence of bacterial 
infection. Yet the BACH study was observational and causal inference 
cannot be drawn. Herein, we analyzed the eff   ects of PCT-guided 
antibiotic stewardship in CHF patients from a previous trial (ProHOSP).
Methods This is a secondary analysis of a previous randomized trial 
of adult ED patients with respiratory symptoms and a history of CHF. 
Patients were randomized to administration of antibiotics based on a 
PCT algorithm (PCT group) or standard guidelines without knowledge 
of PCT levels (control group). The primary endpoint of this analysis is 
the risk of adverse outcome defi  ned as death or ICU admission within 
30 days after ED admission.
Results A total of 233 patients met the inclusion criteria, with 116 in 
the PCT-guided group and 117 in the control group. In the subgroup 
of patients with low initial PCT levels <0.25 ng/l (n = 110), PCT-guided 
patients had a signifi  cant reduction in antibiotic exposure (mean 3.7 
vs. 6.5 days, diff  erence –2.8 (95% CI –4.4, –1.2), P <0.001). Furthermore, 
PCT-guided patients had a signifi  cant lower risk for death and ICU 
admission (4% vs. 20%, odds ratio 6.0 (1.3, 28.2), P = 0.02). See Figure 1.
Conclusion  In CHF patients with suspicion of respiratory infection, 
use of a PCT protocol resulted in a signifi  cant decrease of antibiotic 
exposure and signifi  cantly improved outcomes in patients with low PCT 
levels indicating absence of bacterial infection. Whether inadequate 
antibiotic therapy in these CHF patients requiring diuretic treatment 
explains this diff  erence in clinical outcomes needs verifi  cation.
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Introduction Pulmonary complications after cardiac surgery like ARDS 
are frequent and linked to high mortality [1]. Pro-adrenomedullin 
(pro-ADM) has a possible role in the development of ARDS [2] and a 
positive correlation between levels of pro-ADM and infl  ammation 
was found [3]. In this study we investigated whether intraoperative 
and postoperative pro-ADM transpulmonary gradient could predict 
postoperative morbidity.
Methods  In this prospective cohort study, 39 patients undergoing 
cardiac surgery using CPB were included. Blood was collected before 
surgery (T0), after induction of anesthesia (T1), after termination of CPB 
(T2), at ICU arrival (T3) and 3 hours (T4), 6 hours (T5) and 18 hours (T6) 
after arrival. Pro-ADM was measured with a sandwich immunoassay. 
Primary endpoints were length of ICU and hospital stay (ICU-LOS, 
hospital-LOS).
Results  An increase of arterial and venous pro-ADM plasma con-
centrations was observed after surgery. Immediately after termination of 
CPB the venous concentration was signifi  cantly lower than arterial pro-
ADM concentration, but at T6 the venous concentration was signifi  cantly 
higher, indicating a switch from a negative to positive transpulmonary 
gradient (Figure 1). The pro-ADM venous–arterial diff  erence at T5 was a 
signifi  cant predictor of ICU-LOS (P = 0.032) and the diff  erence at T3 was a 
signifi  cant predictor of hospital-LOS (P = 0.001).
Conclusion We found that the transpulmonary gradient of pro-ADM 
was a predictor for ICU-LOS and hospital-LOS at T3 and T5, respectively. 
Pro-ADM might be a promising marker for prediction on outcome of 
patients undergoing cardiac surgery on CPB. The transpulmonary shift 
of pro-ADM might be caused by an infl  ammatory response.
References
1. Apostolakis  E,  et al.: J Card Surg 2010, 25:47-55.
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Introduction Measurement of biomarkers is a potential approach to 
early assessment and prediction of mortality in septic patients. The 
purpose of this study was to ascertain the prognostic value of pro-
adrenomedullin (pADM), measured in all patients admitted to the ICU 
of our hospital with a diagnosis of severe sepsis or septic shock during 
1 year.
Methods A cohort study of 117 patients >18 years with severe sepsis 
according to the Surviving Sepsis Campaign, in an ICU of a university 
hospital. Demographic, clinical parameters and pADM, C-reactive 
protein and procalcitonin were studied during 1 year. Descriptive and 
comparative statistical analysis was performed using the statistical 
software packages Statistica Stat Soft Inc 7.1 and MedCalc 9.2.1.0.
Results We analyzed 117 consecutive episodes of severe sepsis (15%) 
or septic shock (85%) in the ICU. The median age of the patients was 
Figure 1 (abstract P31). Time to adverse outcome according to group 
allocation.
Figure 1 (abstract P32). Pro-ADM transpulmonary gradient at diff  erent 
time points.
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were respiratory tract (46%) and intra-abdomen (21%). The 28-day 
mortality was 32.5%. The profi  le of death patients had a signifi  cantly 
higher average age (64.7 vs. 57.6 years; P = 0.024), as well as clinical 
severity scores, APACHE II (26.6 vs. 23; P = 0.006) and SOFA (11.6 vs. 89.2; 
P <0.001). Kaplan–Meier survival analysis was signifi  cant. P = 0.0017 for 
patients with pADM <1.2 nmol/l. Cox regression analysis also showed 
statistical signifi  cance (P = 0.0033) and a likelihood ratio = 1.18 per each 
1 nmol/l increase in pADM.
Conclusion The protein pADM is an important prognostic biomarker 
of survival when measured on admission of septic patients to the ICU.
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Introduction IL-6, a proinfl  ammatory cytokine, is synthesized from fi  bro-
blasts, T lymphocytes, endothelial cells and monocytes. It serves as an 
important mediator during the acute phase response to infl  ammation in 
sepsis. We hypothesized that the plasma IL-6 is correlated with mortality 
and severity scores in critically ill patients with sepsis.
Methods We conducted a prospective study of plasma IL-6 level at the 
initial phase of sepsis and the risk of mortality. A total of 203 patients 
with sepsis, who were admitted to the medical ICU at Phramongkutklao 
Hospital, Bangkok during January to December 2011, were analyzed. 
Serum IL-6, C-reactive protein (CRP), and lactate were measured within 
the fi  rst 24 hours of ICU admission. Severity scores (APACHE II, SAP II, 
and SOFA scores) were measured. The primary outcome variable was 
28-day all-cause mortality.
Results We found that the overall 28-day mortality was 46% (93 out of 203 
patients). There was a signifi  cantly positive correlation between mortality 
rate and plasma IL-6 (survivors vs. nonsurvivors; 74 (4.4 to 1,718) vs. 206 
(19 to 5,000) pg/ml, P <0.05), lactate (survivors vs. nonsurvivors; 1.65 (0.7 
to 11.61) vs. 2.47 (0.94 to 19.13) mmol/l, P <0.05), but not CRP levels (P = 
0.24). Compared with the patients with plasma IL-6 <100 pg/ml, septic 
patients with IL-6 levels ≥100 were associated with an increased 28-day 
mortality with the odd ratio of 2.99 (95% CI 1.42 to 6.29, P <0.05). We 
also found that plasma IL-6 levels were well correlated with APACHE II 
(P <0.05), SAPS II (P <0.05), and SOFA (P <0.05) scores.
Conclusion The initial phase plasma IL-6 levels were correlated with 
severity and mortality in critically ill patients with sepsis.
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Introduction  Sepsis results from complex interactions between 
infecting microorganisms and host responses, often leading to 
multiple organ failures and death. Over the years, its treatment has 
been standardized in early goal-oriented therapies, which may benefi  t 
from circulating biomarkers for early risk stratifi  cation. We aimed to 
evaluate the prognostic value of presepsin (sCD14-ST), a novel marker 
of bacterial infection.
Methods  We performed a nested case–control study from the 
randomized controlled Albumin Italian Outcome Sepsis (ALBIOS) 
trial, enrolling patients with severe sepsis or septic shock from 100 
ICUs in Italy. Fifty survivors and 50 nonsurvivors at ICU discharge 
were selected, matched for age, sex, center and time of enrollment 
after inclusion criteria were present. EDTA-plasma samples were 
collected at days 1, 2 and 7 after enrolment for presepsin (immune-
chemiluminescence assay PATHFAST Presepsin, URL 320 pg/ml, CV 5%; 
Mitsubishi Chemicals) and procalcitonin assay (PCT, Elecsys BRAHMS 
Cobas® PCT, URL 0.046 ng/ml, CV 8.8%; Roche Diagnostics).
Results Clinical characteristics were similar between the two groups, 
except for a worse SOFA score at day 1 in decedents. Presepsin at 
day 1 was signifi  cantly higher in decedents (2,268 (1,145 to 4,305) pg/
ml, median (Q1 to Q3)) than in survivors (1,184 (855 to 2,158) pg/ml, 
P = 0.001), while PCT did not diff  er (18.5 (3.3 to 45.7) vs. 10.8 (2.6 to 
46.4) ng/ml, P = 0.31). Presepsin decreased over time in survivors, but 
remained elevated in decedents (974 (674 to 1,927) vs. 2,551 (1,438 
to 5,624) pg/ml at day 7, P = 0.02 for time–survival interaction); PCT 
decreased similarly in the two groups (P = 0.19). Patients with early 
elevated presepsin had worse SOFA score, higher number of MOFs, 
hemodynamic instability (lower mean arterial pressure at baseline 
and after 6 hours), and mortality rate at 90 days (75% vs. 42%, log-
rank P <0.001). The association between presepsin and outcome was 
more marked in patients with late enrollment (6 to 24 hours), and in 
septic shock. Early presepsin had better prognostic accuracy than PCT 
(AUROC 0.69 vs. 0.56, P = 0.07), and improved discrimination over SOFA 
score, especially in septic shock.
Conclusion  Early presepsin measurements may provide important 
prognostic information in patients with severe sepsis or septic shock, 
and may be of crucial importance for early risk stratifi  cation.
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Introduction The level of presepsin is useful for diff  erentiating sepsis 
from noninfectious systemic infl  ammatory response syndrome. It has 
been reported that the presepsin levels in patients with chronic renal 
failure are abnormally high. However, there are no studies investigating 
the usefulness of presepsin for diagnosis of sepsis in patients with acute 
kidney injury (AKI). Our purpose of this study is to clarify the diagnostic 
accuracy of presepsin in patients with AKI and the relationship between 
presepsin level and AKI severity.
Methods This study was conducted as a single-center retrospective 
study. Blood samples were collected from patients admitted to the 
emergency room at Fukuoka University Hospital between June 2010 
and October 2012. We enrolled 254 patients with suspected sepsis and 
other disease patients. We classifi  ed the patients into an AKI group 
according to the RIFLE criteria (Risk n = 52, Injury n = 39, Failure n = 41, 
Loss of kidney function and End-stage kidney disease n = 7) and a non-
AKI group (n = 115). The AKI patient group was further classifi  ed into a 
sepsis group and a nonsepsis group in each AKI stage and we analyzed 
the diagnostic accuracy of presepsin in patients with sepsis.
Results For the non-AKI patients, the median of presepsin in patients 
with nonsepsis (n = 78) and the sepsis group (n = 37) were 406 pg/ml 
(range: 86 to 4,374) and 1,065 pg/ml (range 86 to 9,960), respectively 
(P <0.0001). For the Risk patients, the median of presepsin in patients 
with nonsepsis (n = 25) and the sepsis group (n = 27) were 299 pg/ml 
(range: 71.2 to 3,361) and 831 pg/ml (range: 233 to 16,759), respectively 
(P <0.01). For the Injury patients, the median of presepsin in patients 
with nonsepsis (n = 12) and the sepsis group (n = 27) were 463 pg/ml 
(range: 122 to 1,197) and 1,451 pg/ml (range: 237 to 4,200), respectively 
(P <0.001). For the Failure patients, the median of presepsin in patients 
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(range: 454 to 8,516) and 1,523 pg/ml (range: 293 to 16,764), respectively 
(P = 0.175). The diagnostic accuracy of presepsin in patients with sepsis 
was determined by ROC analysis, the area under the curve was 0.789 
for the non-AKI patient group, 0.735 for the Risk patient group, 0.855 for 
the Injury patient group and 0.593 for the Failure patient group.
Conclusion In Failure and more progressed AKI patients, the diagnostic 
accuracy of the presepsin level was lower than the other groups.
References
1. Endo  S,  et al.: J Infect Chemother 2012, 18:891-897. 
doi:10.1007/s10156-012-0435-2
2. Bellomo  R,  et al.: Crit Care 2004, 8:R204-R212. doi:10.1186/cc2872
P37
Serum levels of presepsin refl  ects the APACHE II and SOFA scores in 
patients with sepsis
R Sato, Y Suzuki, M Sato, G Takahashi, M Kojika, Y Inoue, S Endo
Iwate Medical University, Morioka, Japan
Critical Care 2013, 17(Suppl 2):P37 (doi: 10.1186/cc11975)
Introduction As a method for the diagnosis of sepsis, we previously 
reported an ELISA method for measuring the serum levels of presepsin. 
That method, however, took approximately 2 hours to yield results.
Methods  To resolve this problem, we later developed a simplifi  ed 
assay kit making use of immunochromatography (Point of Care test; 
POC test), and are currently evaluating the usefulness of this kit for 
diagnosis of sepsis and evaluation of its severity. In 21 septic patients 
with sepsis, we analyzed the serum levels of presepsin in relation to 
APACHE II and SOFA scores.
Results APACHE II and SOFA scores at baseline were 28.7 ± 7.5 and 
10.8  ±  3.9, respectively, in these patients. These were signifi  cant 
correlations between the serum presepsin levels and the APACHE II 
score, and also between the serum presepsin levels and the SOFA score.
Conclusion  Furthermore, there was also a signifi  cant  correlation 
between the results of the POC test and the serum presepsin levels. 
These results indicate that measurement of the serum presepsin might 
be useful for evaluating the severity of sepsis.
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Introduction Serum nitrite/nitrate (NOx) levels in the early phase of 
septic acute lung injury (ALI)/acute respiratory distress syndrome 
(ARDS) have recently been reported to possibly play a key role in 
pathogenesis of ALI/ARDS.
Methods  NOx levels in the early phase of septic ALI/ARDS were 
measured by autoanalyzer (TCI-NOX 1000; Tokyo Kasei Kogyo Co., Ltd, 
Tokyo, Japan). Cytokine was measured by ELISA (Medogenix, Fleurus, 
Belgium).
Results Both NOx and TNFα levels were signifi  cantly higher in the ARDS 
group than in the ALI group. A negative correlation was found between 
the PaO2/FIO2 (P/F) ratio and serum NOx levels. In addition, a positive 
correlation was found between the TNFα and serum NOx levels. The 
30-day, 60-day and 90-day mortality rates were 8.7%, 15.2% and 19.6%, 
respectively, in the patients with ALI/ARDS. There were no diff  erences 
in the P/F ratio, serum NOx levels or TNFα levels in the early phase 
of ALI/ARDS between the 30-day survival and death groups. On the 
other hand, the P/F ratio, serum NOx levels and TNFα levels in the early 
phase of ALI/ARDS were signifi  cantly higher in the 60-day and 90-day 
death groups than in the corresponding survival groups. There were 
no signifi  cant diff  erences in the 90-day mortality rates between the ALI 
and ARDS groups.
Conclusion Our fi  ndings suggested that NOx may be involved in the 
pathogenesis of ALI/ARDS.
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Introduction  Ruling out Legionella sp. in patients presenting with 
community-acquired pneumonia (CAP) is important due to diff  erences 
in treatment regimens. Yet antigen tests as well as blood cultures have 
low sensitivity and an important time delay, making empirical broad 
spectrum coverage necessary particularly in severe cases. Fiumefreddo 
and colleagues recently proposed a clinical score based on six clinical 
and laboratory variables (fever, cough, sodium, lactate-dehydrogenase, 
C-reactive protein, platelet count) which allowed assessing the 
likelihood of Legionella [1]. Yet these variables need validation in 
an independent patient cohort before implementation into clinical 
routine.
Methods We analyzed data from a large multinational database of 
patients with CAP (CAPO) [2] between 2001 and 2012. We performed 
logistic regression analysis and the area under the receiver operating 
characteristics (AUC) curve to study the association of these variables 
with the diagnosis of Legionella.
Results  Data for 8,278 CAP patients were analysed; the infectious 
organism was known in 2,321 cases (28%), including a total of 101 
patients with urinary antigen-confi   rmed Legionnaires’ disease and 
983 patients with confi  rmed pneumococcal disease. All variables were 
predictors for Legionella with odds ratios ranging from 1.002 to 5.767. 
Combining the variables in a joint logistic regression model showed a 
high predictive accuracy with an AUC of 0.86.
Conclusion  This analysis validates the Legionella score in an inde-
pendent sample and shows high diagnostic accuracy. Interventional 
trials with adapted antibiotic regimes for non-inferiority in a real live 
population are warranted.
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Introduction It has been shown that polymorphic variants at some 
host genes can modify risk of community-acquired pneumonia (CAP), 
including those critical for the host response to CAP – innate immune 
system, the lung’s defense against inhaled microorganisms, and 
inhibition of fi  brinolysis and the renin–angiotensin system. The aim of 
the study was to analyze polymorphisms in genes potentially relevant 
to CAP pathogenesis mechanisms to reveal novel and confi  rm reported 
genetic risk factors in the general Russian population.
Methods Patients with CAP (n = 334), volunteers without a previous 
history of CAP, control group A (n  =  141) and a second control 
group B (n = 314) were included in the study. Using allele-specifi  c 
tetraprimer PCR, all subjects were genotyped for 13 polymorphic 
variants in the genes of xenobiotic detoxifi  cation CYP1A1 (rs2606345, 
rs4646903, rs1048943), GSTM1 (Ins/Del), GSTT1 (Ins/Del), ABCB1 
(rs1045642); immune and infl   ammation response IL-6 (rs1800795), 
TNFα (rs1800629), MBL2 (rs7096206), CCR5 (rs333), NOS3 (rs1799983), 
angiotensin-converting enzyme (ACE; rs4340), and occlusive vascular 
disease/hyperhomocysteinemia MTHFR (rs1801133).
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C/C, IL-6 C/C-G/G, NOS3 T/T-G/G, CCR5 Ins/Ins, and ACE Del/Del were 
associated with CAP. The highest eff  ect was detected for the CYP1A1 
rs2606345: in comparison with the control A, P  = 3.9×10–5, OR  = 
2.40, 95% CI: 1.59 to 3.64; and in comparison with the control B, P = 
1.4×10–5, OR = 2.0, 95% CI: 1.46 to 2.74. For the two genes CYP1A1 and 
GSTM1, associations remained signifi  cant after correction for multiple 
comparisons. Multiple analysis by the number of all risk genotypes 
showed a highly signifi  cant association with CAP (P = 2.4×10–7, OR = 
3.03, 95% CI 1.98 to 4.64) with the threshold for three risk genotypes. 
Using the ROC analysis, the AUC value for multi-locus model was 
estimated as 68.38, which is rather high for genetic markers.
Conclusion We have provided the fi  rst experimental evidence for the 
associations of genes coding detoxifi  cation enzymes with the risk of 
CAP. Our results also demonstrate that predisposition to CAP is strongly 
attributed to the eff  ects of a number of genes with low penetrance 
and therefore imply that inter-locus interactions may be regarded as 
an important component of polygenic and multifactorial factors of 
susceptibility to CAP.
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Introduction  Several comorbidities have been independently asso-
ciated with both predisposition to community-acquired pneumonia 
and a worse outcome. The goal of this study was to evaluate the impact 
of comorbidities on the outcome of patients with severe community-
acquired pneumonia (SCAP).
Methods  A prospective, multicentre, observational cohort study of 
all patients with SCAP consecutively admitted to 14 Portuguese ICUs 
during a 12-month period. Several comorbidities were evaluated: 
congestive heart failure, cancer, chronic renal failure, chronic respira-
tory failure, chronic hepatic disease, alcoholism, diabetes mellitus, 
neurologic disease, immunosuppression, HIV infection. To evaluate the 
impact of comorbidities associated with hospital mortality in univariate 
analysis, a logistic regression analysis adjusted to other variables 
(clinical relevant or statistically signifi  cant in univariate analysis) was 
performed.
Results A total of 536 (14%) of the 3,766 enrolled patients had SCAP. 
They were mostly male (66%) with median age 59 (29 to 82) years, 
median SAPS II 44 (21 to 80) and total SOFA score 8 (3 to 16). Thirty-
seven per cent of the cases were microbiologically documented (St. 
pneumoniae  – 24%; Enterobacteriaceae  – 20%; infl  uenza A (H1N1) 
virus – 18%) and 45% had septic shock. Antibiotic combination was 
used in 76% of the patients and 61% received a macrolide. Median 
hospital length of stay was 19 (3 to 70) days and hospital mortality 
was 35%. Comorbidities were present in 70% of the patients. The most 
frequent were: diabetes mellitus (21%), chronic respiratory failure 
(18%) and alcoholism (15%). Median Charlson’s comorbidity index 
(CCI) was 4 (0 to 13). In univariate analysis, the presence of at least one 
comorbidity (odds ratio (OR) 2.29; 95% CI 1.49 to 3.52), namely cancer 
(OR 3.80; 95% CI 2.14 to 6.74; P <0.001), chronic renal failure (OR 3.23; 
95% CI 1.53 to 6.82; P = 0.001), immunosuppression (OR 2.12; 95% CI 
1.15 to 3.92; P = 0.014) and neurologic disease (OR 1.87; 95% CI 1.10 to 
3.17; P = 0.02), increased the chances of dying in the hospital. Median 
CCI was also signifi  cantly higher in nonsurvivors (5 vs. 3; P <0.001; OR 
per point 1.10 (95% CI: 1.05 to 1.15)). The only independent risk factor 
for hospital mortality was the presence of at least one comorbidity (OR 
2.09; 95% CI 1.13 to 3.85).
Conclusion In SCAP, the presence of at least one comorbidity doubles 
the chances of dying in the hospital and is an independent risk factor 
for hospital mortality.
P42
Prognostic scores and infective endocarditis
P Fernandez Ugidos1, R Gomez Lopez1, P Vidal Cortes1, 
A Ceniceros Barros1, L Seoane Quiroga1, JM Lopez Perez2
1Complejo Hospitalario Universitario Ourense, Spain; 2Complejo Hospitalario 
Universitario A Coruña, Spain
Critical Care 2013, 17(Suppl 2):P42 (doi: 10.1186/cc11980)
Introduction  Infective endocarditis (IE) is a high-mortality disease, 
especially in the early surgery subgroup. The aim of this study was try 
to identify prognostic factors of IE that will require surgery during the 
same admission of their diagnosis, including evaluation of surgical 
severity scores.
Methods A retrospective study (5 years) of all patients admitted to 
a tertiary hospital in northern Spain with diagnosis of IE (modifi  ed 
Duke criteria) who required early surgery. Demographic, clinical and 
microbiology data were collected. Chi-square and Student t  tests. 
Signifi  cance: P <0.05. SPSS17.
Results  We had 73 patients, 79.5% men, age 65  years. Eighty-two 
percent had positive blood cultures. Forty-one percent of cases 
required previous ICU admission. Surgery was urgent in 35%. Fifty-six 
per cent of patients had postoperative shock and 58% suff  ered post-
surgery ARF. Hospital mortality was 31.5%. Regarding prognostic scales: 
the mean EuroSCORE was 11.38 ± 3.93 points. No patient was placed in 
the low-risk group. Ninety-four per cent of cases were at high risk. The 
Parsonnet mean score was 27.7 ± 11.6. The mean Beth Israel Medical 
Center was 37.6 ± 10 points. The mean Ontario scale was 7.09 ± 2.7. The 
mean Surgical risk scale of Roques was 6.69. And the mean by Pons 
Scale was 24.02. Dead patients are older, with previous heart disease, 
require urgent surgery and have previous ICU stay; usually they have 
MOF and they had received less than 7 days of antibiotic treatment. The 
etiology did not worsen the prognosis.
Conclusion In early surgery IE, it appears to be associated with mortality: 
age >70 years, previous heart disease, emergency surgery, antibiotics 
within 7 days before surgery, preoperative MOF, and high scores on 
scales of Pons and Ontario. The causal agent and echocardiography 
have no relation with worse prognosis. The general syndrome debut 
and the Streptococcus spp. etiology seem to have lower mortality. IE 
has pathologies with high .preoperative severity scores but these are 
not suffi   cient to guide therapeutic decisions.
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Introduction Urosepsis associated with urinary tract calculi is a critical 
disease. Patients with this condition occasionally require drainage, 
mostly ureteric stent placement and these patients need longer 
hospitalization. However, indications for timely ureteric stenting for 
urosepsis associated with urinary tract calculi have not been clearly 
determined. The objective of the study was to evaluate whether earlier 
stent placement might lead to shorter length of stay (LOS) in hospitals.
Methods  For patients who required ureteric stent procedures for 
urosepsis associated with urinary tract calculi in our hospital from 
July 2008 to July 2012, we compared the LOS in our hospital between 
patients with earlier stenting and those without it. A linear regression 
model was used for multivariable-adjusted comparison.
Results In a total of 30 patients (mean age, 72; 13 males), the mean 
days from emergency room admission to ureteric stenting was 3.5 days 
(range, 1 to 14 days) and the overall mean LOS was 36 days (range, 
8 to 102  days). The early-stenting group (mean LOS, 21  days) had 
signifi  cantly shorter LOS than the delayed-stenting group (mean LOS, 
50 days) with adjusted β coeffi   cient of –26 days (95% CI, –46, –6).
Conclusion In patients with urosepsis associated with urinary tract calculi, 
earlier stenting within 2 days of admission may reduce the hospital LOS.
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Introduction  Analysis of mortality-related factors in urinary sepsis 
patients.
Methods A retrospective descriptive study of urologic sepsis patients 
in the ICU from 2008 to 2010. Clinical, epidemiological and outcome 
variables were analysed. Quantitative variables are expressed as 
either mean and standard deviation or as median and interquartile 
range for asymmetric variables. Qualitative variables are expressed as 
percentages and absolute values. Mann–Whitney’s U test and Fisher’s 
exact test were applied (α error was 5% in both cases), as well as binary 
logistic regression for multivariate analysis.
Results There was a total number of 44 patients (aged 59.39 ± 17.71; 
63.8% females). APACHE II score upon admission was 18 ± 6. Out of 
these patients, 27.3% showed no underlying disorder and 18.2% (no = 
8) showed chronic renal failure; 25% were immunodepressed patients; 
31% underwent urinary instrumentation in the previous 15 days, yet 
only three of them had undergone permanent urine catheterization. 
Observed mortality was 25%, while sepsis-related mortality was 22.7%. 
The patients who died were, on average, older that those who survived 
(67.9 ±7 10.2 vs. 56.8 ± 18.7; P = 0.02). Besides, the former also reported 
greater delay in turning to the hospital after symptom onset (13.4 ± 6.6 
vs. 6.2 ± 4.7 days; P = 0.0001). Immunodepressed patients presented 
higher mortality rate: OR 8.7 (95% CI 1.7 to 42.3), as well as those who 
underwent inappropriate initial antibiotic treatment: OR 10.8 (95% 
CI 2.1 to 54.7). No relation was observed between germ typology or 
resistance to β-lactam antibiotics and mortality. After adjustment of 
mortality due to APACHE II score upon admission, delay in the onset 
of appropriate antibiotic treatment was an independent predictor of 
mortality in our patients: OR 1.2, 95% CI (1.02 to 1.42).
Conclusion Urinary sepsis mortality is associated with late-onset and/
or inappropriate antibiotic use, as well as with immunodepression and 
advanced age.
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Introduction  Infections are a major complication during the 
postoperative period after heart transplantation (HT). In our hospital, 
nosocomial pneumonia is the most frequent infection in this period. 
The objective of this study is to determine the epidemiological and 
microbiological characteristics of this disease in our centre.
Methods A descriptive retrospective study of all medical records of HT 
performed in a single institution from 1991 to 2009 followed until June 
2010. Clinical and microbiological variables were considered. Centre 
for Diseases Control (CDC) criteria were used to defi  ne nosocomial 
infections. Invasive aspergillosis was considered if there were criteria 
for probable aspergillosis according to IDSA criteria.
Results In 594 HTs there were 97 infectious episodes in 75 patients 
(12.6%). Eighty-fi   ve patients (14.3%) died during hospitalization. 
Infection is the second cause of mortality during the postoperative 
period (17.9% of dead patients). The most common locations of 
infections were pneumonia (n  =  31, 31.9% of infection episodes), 
bloodstream (n = 24, 24.7%), urinary tract (n = 14, 14.4%), surgical site 
(n = 13, 13.4%) and intraabdominal infections (n = 13, 13.4%). Patients 
with pneumonia were treated according to knowledge in a specifi  c 
moment, thus diff  erent antibiotics were used. The duration of antibiotic 
therapy was 20 ± 15.5 days. In nine episodes of pneumonia according 
to the CDC no germ was isolated in the cultures. Six of the episodes 
were polymicrobial infections. The most frequent microbes isolated 
were E. coli (n = 7, 22.5% of pneumonia cases), A. fumigatus (n = 7, 
22.5%), S. aureus (n = 3, 9.68%), P. aeruginosa (n = 3, 9.68%), P. mirabilis, 
K. pneumoniae, E. cloacae, E. faecalis, C. glabrata, and S. marcescens (one 
case each, 3.22%). Pneumonia was suspected but not confi  rmed in 75 
patients. Despite this, antibiotic treatment was maintained for a media 
of 17.35 ± 7.01 days: 56 wide-spectrum treatments and 18 targeted 
therapy after knowing the antibiogram. The length of ICU stay was 
38.4 ± 70.8 (3 to 264) days, of hospital stay was 66.2 ± 80.5 (3 to 304) 
days and of mechanical ventilation was 27.3 ± 50.2 (3 to 264) days. The 
mortality of patients with pneumonia was 32.3%.
Conclusion  Nosocomial pneumonia is the most frequent infection 
in our series. Despite when infection was not confi  rmed, antibiotic 
therapy was maintained in suspect cases. We found a high incidence of 
aspergillosis. Limitations because of wide duration of this study should 
be considered.
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Introduction  Despite many therapeutic interventions, ventilator-
acquired pneumonias (VAP) are frequent in the ICU and are associated 
with major morbidity and mortality. Sepsis causes a time-dependent 
modifi   cation of the infl   ammatory response. This reprogramming 
could promote the occurrence of a secondary infection and worsen 
the prognosis. In animals, peritonitis is associated with an alteration 
of pulmonary immunity and an increasing mortality from secondary 
pneumonia.
Methods  To investigate, in humans, the potential involvement of 
previous intra-abdominal infection (IIA) in preventing or promoting 
VAP, we realized a prospective observational study using data from a 
multicenter database (OUTCOMEREA), including all patients admitted 
Figure 1 (abstract P46). Cumulative incidence of VAP.
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ventilation for at least 72 hours.
Results In total, 2,623 patients were included, of which 290 had an 
IIA. A total of 862 patients (33%) developed a VAP, 56 (19%) in the IIA 
group and 806 (34%) in the non-IIA group (P <0.01). VAP, after sepsis, 
occurred less frequently and later in patients with IIA. The occurrence of 
IIA, in comparison with another sepsis, is a protective factor against VAP 
(HR = 0.643 (0.478 to 0.863), P = 0.003). There is, however, no signifi  cant 
diff  erence between the groups in terms of ICU mortality (28% vs. 32%, 
P = 0.16). See Figures 1 and 2.
Conclusion In this study, the presence of an abdominal sepsis, in a 
context of severe sepsis or septic shock, was associated with a lower 
incidence of later VAP. These results have to be confi  rmed in other 
studies, especially prospective. They open interesting new research 
directions.
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Introduction Ventilator-associated pneumonia (VAP) is a serious illness 
with substantial morbidity and mortality and increases the cost of 
hospital care. Even when bundles of care to prevent VAP have been 
implemented, the incidence of VAP was not dramatically improved. 
This study aims to determine the incidence and risk factors of VAP in 
the SICU of Siriraj Hospital.
Methods During a 1-year period, 228 patients admitted to the SICU 
were enrolled. All patients required ventilatory support longer than 
48 hours. Data were collected by reviewing patient medical records 
including demographic data, onset of VAP, type of organisms, 
medication used, number of central venous catheters (CVC) used and 
blood transfusion. VAP outcomes were also reported.
Results VAP occurred in 21 patients (9.21%) or 8.21 per 1,000 ventilator-
days. The onset of VAP was late in the majority of patients. The most 
common organism was A. baumannii (66%), followed by P. aeuruginosa 
(19%). Compared with non-VAP groups, patients in the VAP group had 
higher APACHE II score (18 vs. 13, P <0.001), blood transfusion (95% vs. 
75%, P = 0.04), numbers of CVC used (3 vs. 1, P <0.001), muscle relaxant 
used (43% vs. 3%, P <0.001) and steroid used (33% vs. 4%, P <0.001). 
The VAP group also had a signifi  cantly higher number of intubation, 
reintubation and self-extubation. Multiple logistic regression showed 
that numbers of CVC, intubation and surgery, the use of muscle 
relaxant and steroid were independent risk factors for developing VAP. 
Ventilator days and ICU length of stay were longer in the VAP group 
(25 vs. 6 and 25 vs. 7 days, respectively). Lastly, the hospital mortality 
rate was signifi  cantly higher in the VAP group (33% vs. 12%, P = 0.008).
Conclusion The incidence of VAP was 9.2% in the SICU of Siriraj Hospital, 
which was comparable with previous reports. Bundles of care to 
prevent VAP should include weaning from a ventilator. Muscle relaxant 
and steroid should be administered according to strong indication. 
Meticulous care of the airway should be implemented as protocol in 
order to prevent complications that can result in the development of 
VAP.
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Introduction  This is a 1-year prospective study to determine the 
incidence, source and etiology of hospital-acquired bloodstream 
infection (HABSI) in the Indian context. The resistance pattern was also 
reviewed.
Methods A single-centre prospective study in a 35-bed ICU. HABSI 
was defi   ned according to current CDC guidelines. HCAP, catheter-
associated UTI (CAUTI) and skin-related infections causing BSI was also 
defi  ned according to recent guidelines and analysed.
Results Out of 332 positive samples, 90 samples (n = 45) were HABSI. 
The microbiological analysis showed 60% were Gram-negative, 6% 
were candida and 27% were Gram-positive. The commonest isolate 
was klebsiella and MRSA was commonest in Gram-positive. The source 
of HABSI showed CRBSI was the commonest cause at 69%, which 
correlates with international data. Ventilator-associated pneumonia 
and CAUTI caused 9.5% BSI respectively. The resistance pattern among 
Gram-negative bacteria showed multidrug-resistant (MDR) and 
extreme drug-resistant (XDR) isolates were highest. See Tables 1 and 2.
Table 1 (abstract P48). Source
Source Total  (%)
CRBSI 69
HCAP 9.5
CAUTI 9.5
Devices 7
Skin 5
Table 2 (abstract P48). Resistance pattern
Resistance Total  (%)
Non-MDR 15
MDR 44
XDR 33
PDR 8
Conclusion The incidence of HABSI is 27%. Of this, CRBSI cause 70% 
and Gram-negative bacteria were commonest with high resistance. 
This is in contrast to western data where Gram-positive infections are 
common. Our study highlights need for stringent guidelines for CRBSI 
prevention.
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Figure 2 (abstract P46). Cumulative occurrence of death.
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Introduction  Preventing catheter-related bloodstream infections 
(CR-BSI) can reduce the duration of hospital stay, healthcare costs, and 
mortality rates. Identifying the risk factors and correction of modifi  able 
factors should be one of the main objectives of infection control 
measures. The aim of this study is to determine the risk factors of CR-BSI 
in a cohort of surgical ICU patients admitted to Baskent University 
Hospital.
Methods Following Institutional Review Board approval, data for 876 
patients admitted to the surgical ICU between January 2009 and July 
2012 were reviewed retrospectively. After completing the review, 25 
patients diagnosed with CR-BSI were compared with 66 appropriate 
matches who did not have CR-BSI. Demographical features, underlying 
diseases, APACHE II (Acute Physiology and Chronic Health Evaluation) 
and SOFA (Sequential Organ Failure Assessment) scores, length of stay, 
organ dysfunctions, laboratory values, use of vasopressors, mechanical 
ventilation, nutrition, antibiotics, transfusions, and features related to 
central venous catheterization were recorded. Patients who did not 
have a central venous catheter and were discharged within 2 days of 
ICU stay were excluded.
Results  Out of 91 patients included in the fi  nal analysis, 25 (27%) 
patients had CR-BSI. When compared with patients who did not have 
CR-BSI, those who did were older (P = 0.029), required more blood 
product transfusions during the fi  rst 3 days of ICU (P = 0.016), had a 
longer duration of catheter stay (P = 0.019), and were more frequently 
catheterized via the internal jugular vein (IJV) (P = 0.022). A logistic 
regression model revealed that advanced age (OR: 1.037; 95% CI: 1.001 
to 1.073; P = 0.042) was an independent risk factor for CR-BSI. Fourteen-
day and 28-day mortality rates for CR-BSI were 12% (P = 0.749) and 28% 
(P = 0.406), respectively.
Conclusion  Although age, blood product transfusion, duration of 
catheter stay, and use of IJV were diff  erent between patients who did 
and did not have CRBSI, advanced age was the only independent risk 
factor for CR-BSI. Early suspicion of CR-BSI by the other well-known risk 
factors has a substantial eff  ect on the treatment of CR-BSI.
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Introduction  Catheter-related bloodstream infection (CRBSI) is a 
complication of central venous catheters (CVCs) with an attributable 
morbidity, mortality and cost [1]. We examined patient risk factors for 
CRBSI in an adult parenteral nutrition (PN) population.
Methods  The study was carried out in a 525-bed tertiary-referral 
teaching hospital over a 14-year study period (1997 to 2010). All in-
patients referred for PN via CVCs were included. Prospectively collected 
data were recorded in a specifi  c PN record. The CRBSI audit group met 
quarterly to review all sepsis episodes, assigning a diagnostic category 
(CRBSI or non-CRBSI). Patient risk factors for development of CRBSI 
were examined using a logistic regression model to take account of 
the dichotomous nature of the outcome. Odds ratios from a model 
incorporating demographic and clinical data were tested for statistical 
signifi  cance.
Results The study population was 1,961 patients in whom 3,213 CVCs 
were utilised over 19,511 CVC days. There were 256 CRBSI episodes in 
216 patients. Median (IQR) patient age was 62 (23), and 58% were male. 
The incidence of CRBSI decreased signifi  cantly (P <0.001) during the 
study period from 16% of patients in the period 1997 to 2003 to 7% 
in 2004 to 2010. The corresponding rate of CRBSI infection (per 1,000 
CVC days) decreased from 18 to 10. There was a signifi  cant decrease 
(P  <0.001) in numbers of CVCs inserted per patient (from 1.87 to 
1.49). Each extra CVC PN day was associated with an increased risk of 
developing CRBSI of 3.4% (OR 1.034, P <0.05). The number of PN CVCs 
was associated with developing CRBSI (OR 1.218, P  <0.10). Patient 
factors signifi  cantly associated with CRBSI included perioperative PN 
use (compared with medical patients) (OR 2.414, P <0.01), and male sex 
(OR 1.952, P <0.01).
Conclusion This prospective study demonstrated that perioperative 
PN use was associated with increased risk of CRBSI. The association 
between CRBSI and CVC PN days is consistent with the theory 
suggesting benefi  t to limiting CVC duration and changing from PN to 
enteral nutrition as soon as appropriate.
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Introduction Many patients develop infections following operations. 
Decreased immune competence has been demonstrated in 
acute neurological conditions. A strong cytokine-mediated anti-
infl  ammatory response was observed in stroke patients at infection, 
although infection due to the decreased proinfl  ammatory mediators 
can be expected as well. To investigate this question the following 
experiment was performed.
Methods  Twenty-two urinary bladder cancer patients with radical 
cystectomy and lymphadenectomy were studied. Blood samples were 
taken on day 0 (before) and days 1, 3, 6, 9 and 14 after operation as 
well as on days 30, 60, 90 and 270 during follow-up. TNFα, soluble TNFα 
receptor I and IL-6 levels in sera were determined by HS ELISA and/or 
ELISA. Plasma ACTH and cortisol values were measured by RIA kits.
Results  From 22 patients, eight deep wound and urine infections 
were found in 14 days and six urine and wound infections in 30 days 
after surgery, all survived. All patients were bacterially contaminated, 
as wound samples taken at the end of operation demonstrated. On 
day 0 the circulating TNFα values were lower in infected patients. 
TNF started to increase from day 3 to day 9, never reaching values of 
the uneventful healing group. Soluble TNF receptor I, IL-6, ACTH, and 
cortisol concentrations did not demonstrate any diff  erence on day 0 
but from day 1 started to increase transiently, reaching higher levels in 
septic patients.
Conclusion A low proinfl  ammatory response is a key facilitating factor 
for the development of infection. Measuring serum TNFα levels before 
and after operations can thus predict the outcome.
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Introduction  Although hand hygiene is known as a core element 
in prevention of healthcare-associated infections, compliance to 
its program is not high. With a new campaign we tried to enlarge 
awareness on hand hygiene.
Methods We performed an experimental, before and after, study design 
on our 30-bed, mixed medical–surgical ICU. We conducted a baseline 
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hand hygiene compliance by control nurses and hand cultures of 50 
healthcare workers (HCW). Based on the WHO Guidelines on Hand 
Hygiene in Health Care [1], cleaning of hands with alcohol-based hand 
rubs (Sterillium) was prescribed before touching a patient and before 
aseptic procedures, after body fl  uid exposure risk and after touching 
a patient and touching his/her surroundings. Promotion of the hand 
hygiene program consisted of lectures and web-based self-learning, 
posters located near points of care and verbal reminders by control 
nurses. New observations of hand hygiene by control nurses during 
3 days and hand cultures of 50 healthcare providers were performed 
in September 2012. Consumption of alcohol-based hand rub (product 
volume use per patient-days) was used as a surrogate marker of hand 
hygiene over time. The diff  erence in hand hygiene compliance during 
the two periods was examined using a chi-squared test. Diff  erences 
in hand cultures were examined using a Student’s t test. Time trends 
in the consumption of alcohol-based hand rub were examined using 
linear correlation. P <0.05 was considered statistically signifi  cant. The 
study was approved by the institutional Ethics Review Board.
Results During the survey, in May 158 opportunities to observe hand 
hygiene were presented and 286 in September. Overall compliance 
improved from 34.2% (54/158) to 51% (146/286), χ2 = 11.7 (P <0.001). In 
May, 50 HCW had a mean of 63.20 ± 39.37 colony-forming units (CFU) 
on their hands compared with 43.0 ± 40.19 CFU on the hands of 50 
HCW in September (P = 0.024). We also observed an initial increased 
use of alcohol-based hand rubs from 21 ml per patient-day in May to 
a maximum 72 ml per patient-day in June, but a decline to 44 ml per 
patient-day in September, Pearson correlation coeffi   cient = 0.31 (P = 
0.61).
Conclusion Implementation of a new hand hygiene program at our ICU 
resulted in improved hand hygiene compliance and less CFU on the 
hands of HCW. There was no signifi  cant increased use of alcohol-based 
hand rubs over time. The results indicate that constant awareness is 
vital for success.
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Introduction  ICU-acquired infection is directly related to hospital 
mortality. Hand hygiene is an eff  ective, low-cost intervention that 
can prevent the spread of bacterial pathogens, including multidrug-
resistant organisms. Historical compliance with hand hygiene 
guidelines by physicians, nurses and other care providers is poor.
Methods Present expectations by the Infection Control Committee are 
to ‘pump in, pump out’ of every room, using 63% isopropyl alcohol. We 
performed 17,622 observations of hand hygiene in the surgical ICU 
from March through October 2012, and intervened to change behavior 
by providing monthly feedback to specifi   c provider groups and 
services. We made use of the Unit Coordinator to measure compliance 
of all individuals in the ICU.
Results Overall compliance by physicians was 82.1%, for nonphysicians 
was 84.8%. Feedback to physicians, individually and by service, 
dramatically increased hand hygiene compliance, defi   ned as both 
on entry and exit from the patient room, over the study period. See 
Figure 1.
Conclusion  Physician behavior is responsive to monthly feedback 
that is specifi  c to the individual or surgical service. Use of the Unit 
Coordinator was very eff  ective at gathering a very large sample size in 
a short period of time.
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Introduction The Benefi  ts of Universal Glove and Gowning (BUGG) 
study is a cluster-randomized trial to evaluate the use of wearing gloves 
and gowns for all patient contact in the ICU. The primary outcome is 
VRE and MRSA acquisitions; secondary outcomes include frequency of 
healthcare worker visits, infection rates, hand hygiene compliance and 
adverse events.
Methods We enrolled 20 ICUs in 15 states. ICUs collected nasal and 
perianal swabs on all patients at admission and discharge/transfer. 
After a 3-month baseline period, 10 units were randomized to the 
intervention arm and required to wear gloves and gowns for all patient 
contact. An intervention toolkit was created based on site feedback 
and compliance reports. Swab collection compliance was fed back 
and discussed during site conference calls on a weekly basis. Site 
coordinators monitored compliance with gloves and gowns, hand 
hygiene and frequency of HCW visits and reviewed patient charts for 
adverse events.
Results  During the 12-month study period, 100,210 swabs were 
collected. After the baseline period, we were able to achieve and 
maintain swab compliance rates between 85 and 97%. Monthly 
discharge compliance increased by 21% by the beginning of the 
intervention period (Figure 1). Observers found 86% compliance with 
universal glove and gowning over 1,242 30-minute observation periods 
(Figure 1). Ninety charts at each site were reviewed for adverse events.
Conclusion Over a diverse group of US hospitals, we achieved high 
compliance with surveillance cultures and implementing universal 
gloving and gowning was achieved quickly with high compliance.
Figure 1 (abstract P53). Figure 1 (abstract P54). Swab collection and gown/glove compliance.
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Introduction Sepsis accounts for a very high mortality. The Surviving 
Sepsis Campaign recommends a fi  rst 6 hours resuscitative bundle to 
improve patient outcome. Despite this, the bundle is poorly performed 
because of several organizational and cultural barriers. In recognition 
of this, we guess that an Educational and Organizational Intervention 
out of the ICUs could impact on septic patient outcome. In order to 
test our hypothesis we carried out, in 12 hospitals, a pre-intervention 
survey of the human and organizational resources (HOR) available 
in the management of septic patients. The aim is to seek any barrier 
potentially aff  ecting correct Guidelines implementation.
Methods Thirty-nine medical wards (MW) and 12 emergency depart-
ments (ED) were enrolled. Every unit was asked to fi  ll in a pre-agreed 
HOR Checklist focused on the main requirements suggested by the 
Guidelines.
Results Analysing the human resources available, we see that the bed-
to-doctor ratio signifi  cantly (P <0.01) increases from the day to the night 
shift: from 6 to 43 beds per doctor on the MW (median). Otherwise, 
the ED staff   remains roughly the same: from 3.5 to 2.5 doctors on duty 
(median). The analysis of the organizational tools (Table 1) points out 
a low percentage of hospitals having: a Diagnostic and Therapeutic 
Protocol for sepsis management (8.3%), some Hospital Empirical 
Antibiotic Therapy Guidelines (0%) and an Infective Source Eradication 
Protocol (8.3%). Moreover, just 25% of hospitals involve an infectious 
diseases expert in every case of severe sepsis or septic shock.
Conclusion We guess that the poor availability of HOR showed by the 
hospitals could have a role in the Guidelines implementation and in 
the patient’s outcome. Only a comparison between these results and 
data collected from a Clinical Checklist, focused on sepsis bundle 
compliance, and from a patient’s outcome summary could confi  rm our 
hypothesis. This is the aim for our next part of the study.
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Introduction  The incidence of patients carrying ESBL-positive 
bacteria in our ICU (12 in 780 admissions in 2011) was not considered 
problematic. However, routine cultures had identifi  ed ESBL-negative 
patients who had become colonized with ESBL strains during their 
ICU stay. Self-disinfecting siphons, preventing bacterial growth by 
antibacterial coating and intermittent heating, and biofi  lm formation 
by electromechanical vibration, were placed in all sinks in the ICU. The 
aim of the present study was to evaluate the eff  ect of this intervention.
Methods  An intervention study in a 12-bed ICU. The intervention 
involved placement of 19 self-disinfecting siphons (Biorec). All patients 
with an expected ICU stay of 2 days or more between January 2011 
and December 2012 were studied. Samples of throat, sputum and 
rectum were taken at admission and twice weekly, and cultured for 
ESBLs. Between June 2011 and October 2011, sinks in patient rooms 
were cultured regularly for ESBLs. After the intervention in April 
2012, multiple repeat cultures were taken. Whenever the species and 
antibiogram of bacteria cultured from patients and sinks matched, they 
were typed by AFLP.
Results Before intervention Multiple ESBL-forming strains were found in 
sinks of all patient rooms. Eighteen patients who were ESBL-negative 
on ICU admission became colonized with 11 diff  erent ESBL strains, 
that were present in sinks of their admission rooms (Figure 1). Four 
contaminations were proven by AFLP-tying. One patient died of ESBL-
positive E. cloacae pneumonia. After intervention All sinks were negative 
for ESBL strains. No further patients became ESBL colonized during the 
ICU stay.
Conclusion  Wastewater sinks were the likely source of ESBL 
colonization for 18 ICU patients. After placing self-disinfecting siphons 
Figure 1 (abstract P56). Design and results of the intervention.
Table 1 (abstract P55)
   Availability
Resource (%)
Diagnostic and therapeutic protocol for septic patient management  8.3
Use of early warning score for diagnosis and management  8.3
Sepsis team  25
Microbiology laboratory: open 7 days a week   66.6
Lactate dosage: 24 hours a day availability  83.3
Central venous catheter insertion (CVC) available 24 hours a day   91.6
Hospital empirical antibiotic therapy guidelines   0
Infectious diseases team advice in any case of severe sepsis septic shock  25
Infective source eradication 
  Infective source eradication protocols  8.3
  Intervention radiology available 24 hours a day   50
  Operating room available 24 hours a day   58.3
Specifi  c infection management protocol (that is, CVC infection)  58.3
Imaging reporting service available 7 days a week   41.6
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the disappearance of ESBL strains from all sinks.
P57
Hemodynamic and mitochondrial eff  ects of enalapril in 
experimental sepsis
AJ Pereira, V Jeger, T Corrêa, M Vuda, S Djafarzadeh, J Takala, S Jakob
University Hospital (Inselspital)/University of Bern, Switzerland
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Introduction  Sepsis may cause mitochondrial dysfunction. The 
renin–angiotensin system (RAS) activity is increased in sepsis, and 
can interfere with the mitochondrial function either directly or by 
modifying hemodynamics. We studied the eff  ects of ACE inhibition 
by enalapril on hemodynamics and hepatic mitochondrial function in 
sepsis. Two septic groups without enalapril and with diff  erent blood 
pressure targets served as controls.
Methods  Sepsis (fecal peritonitis) was induced in 24 anesthetized, 
mechanically ventilated pigs (40.1 ± 2.1 kg), divided into three groups 
(n = 8 for each): ENL (enalapril pretreatment for 7 days and at 0.005 to 
0.02 mg/kg/hour during the study; MAP target 75 to 85 mmHg), ML 
(target MAP 50 to 60 mmHg), and MH (target MAP 75 to 85 mmHg). 
Hemodynamic support with fl   uids, norepinephrine (NE; maximum 
dose 5,000 μg/hour), and antibiotics were started after 12 hours of 
peritonitis and continued for 48 hours.
Results  All enalapril pigs received the maximum NE dose without 
reaching the target MAP. Enalapril resulted in lower MAP, higher 
CO, and transiently increased regional blood fl  ows (Table  1). Fluid 
administration and urinary output were similar among groups. Liver 
mitochondrial respiration was reduced (State 3, State 4) in the enalapril 
group. One animal died in each ML and enalapril group.
Conclusion Enalapril enhances cardiac output and early regional blood 
fl  ows in sepsis despite lower MAP, and reduces liver mitochondrial 
respiration, suggesting that RAS is involved in the hemodynamic and 
metabolic changes in sepsis.
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cognitive functions in CLP-induced sepsis model in rats
F Esen1, E Senturk1, P Ergin Ozcan1, G Orhun1, S Gümrü2, M Kaya1, 
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Introduction The present study investigated the eff  ects of a single 
dose of intraperitoneal (i.p.) IgG and IgGAM administration on various 
behavioral alterations in a cecal ligation perforation (CLP)-induced 
sepsis model in rats.
Methods Female Wistar albino rats (200 to 250 g) were divided into fi  ve 
groups (n = 8): a naive Control group, a Sham operated group receiving 
conventional antibiotic treatment, a CLP group receiving CLP procedure 
and conventional antibiotic treatment, and IgG and IgGAM groups 
which were also applied 1 g/kg, i.p. IgG and IGAM therapy 5 minutes 
after the CLP procedure. Ten, 30 and 60 days after the surgery, animals 
underwent three behavioral tasks: an open fi  eld test to evaluate the 
locomotor activity, an elevated plus maze test to measure the level of 
anxiety, and a forced swim test to assess the possible depressive state. 
The results acquired from these tests were used to estimate the eff  ect 
of immunoglobulin therapy on behavioral changes in CLP-induced 
sepsis in rats.
Results  In the open fi  eld test, the CLP group showed a signifi  cant 
decrease in total squares passed on days 10 and 30. Similarly, total 
numbers of rearing and grooming were dramatically decreased in the 
CLP group in comparison with control and sham groups (P <0.005). 
In the elevated plus maze test, the number of entries to open arms 
decreased in the CLP group. In the forced swim test, there was a 
tendency for increase in immobility time in the CLP group, although 
the data were statistically insignifi  cant. All of these values which were 
indicating the importance of behavioral alterations were improved on 
day 60. Immunoglobulin therapy prevented the occurrence of these 
behavioral changes. Especially, animals in the IgGAM group conserved 
the values quite near to those of the control group in measured 
parameters.
Conclusion Sepsis, even though it has been treated with conventional 
antibiotics, caused a negative eff  ect on behavioral parameters. In this 
study, IgG and IgGAM treated animals in the presence of CLP did not 
show these behavioral changes. Therefore our results suggest that 
a single dose of i.p. IgG and IgGAM treatment, which was applied 
immediately after the sepsis procedure, prevents behavioral defects 
observed following sepsis.
P59
Clinical effi   cacy of recombinant human soluble thrombomodulin in 
patients with septic disseminated intravascular coagulation
Y Suzuki, R Sato, M Sato, S Endo
Iwate Medical University, Morioka, Japan
Critical Care 2013, 17(Suppl 2):P59 (doi: 10.1186/cc11997)
Introduction  Thrombomodulin is an endothelial cell cofactor and 
glycoprotein for thrombin-catalyzed activation of protein C. A recom-
binant human soluble thrombomodulin (rhsTM) has been recently 
developed, and this new agent has a unique amino-terminal structure 
exhibiting anti-infl   ammatory activity including sequestraction and 
cleavage of high-mobility group box 1(HMGB-1).
Methods In this study, 13 patients with septic disseminated intravascular 
coagulation (DIC) were treated with rhsTM, which is Recomodulin® Inj. 
12800 (Asahi Kasei Pharma Co., Tokyo, Japan). Patients with septic DIC 
were treated with 130 to 380 U/kg/day.
Results  There were signifi  cant results for improvement of APACHE 
II score and DIC diagnostic criteria score for critically ill patients after 
treatment using rhsTM (P <0.01). Improvement for platelet count and 
D-dimer level were also observed in this study (P <0.05). Activation 
of antithrombin (AT) also was signifi  cantly increased after treatment 
(P <0.05). Hospital mortality was 15.4% in this study.
Conclusion The rhsTM might be one of most important endogenous 
regulators of coagulation, acting as the major inhibitor of thrombin as 
well as AT III. This new agent may play an important role in treatment 
for septic DIC.
P60
Antithrombin III concentrate therapy may have an effi   cacy in sepsis
N Saito, M Takeda, T Harada, R Moroi, M Namiki, A Yaguchi
Tokyo Women’s Medical University, Tokyo, Japan
Critical Care 2013, 17(Suppl 2):P60 (doi: 10.1186/cc11998)
Introduction Antithrombin III (AT III) has been known to contribute to 
anti-infl  ammatory response as well as its anticoagulation. Our previous 
Table 1 (abstract P57). Hemodynamic variables, among times and groups
         P
  BL  R0h  R12h R24h R36h R48h  (time×group)
MAP (ENL/MH/ML)   66 (9)/72 (15)/  65 (11)/73 (10)/  57 (4)/82 (6)/  58 (8)/78 (6)/  56 (12)/80 (5)/  56 (11)/79 (9)/  0.003
  65 (9)  81 (16)  72 (13)  67 (12)  61 (6)  56 (13) 
CO (ENL/MH/ML)   106 (13)/89 (7)/  92 (17)/67 (11)/  169 (16)/95 (19)/  187 (22)/129 (28)/  161 (25)/139 (32)/  157 (37)/140 (21)/  <0.0001
  105 (13)  88 (22)  104 (13)  143 (31)  145 (13)  150 (18) 
Carotid fl  ow (ENL/MH/ML)  6 (2)/7 (2)/7 (2)  5 (1)/4 (1)/5 (2)  10 (3)/5 (1)/6 (2)  10 (3)/8 (1)/9 (2)  8 (2)/8 (2)/8 (2)  8 (3)/8 (2)/8 (2)  <0.0001
Femoral fl  ow (ENL/MH/ML)  4 (1)/3 (1)/4 (2)  2 (1)/2 (0)/2 (1)  4 (1)/2 (1)/2 (0)  4 (1)/3 (1)/3 (1)  3 (1)/3 (1)/4 (1)  3 (2)/3 (1)/4 (1)  0.004
Critical Care 2013, Volume 17 Suppl 2 
http://ccforum.com/supplements/17/S2
S21study showed AT III defi  ciency happened in the early stage of sepsis 
with no relation to DIC status. However, whether AT III concentrate 
is a benefi   cial therapy or not for septic patients is controversial. 
Our hypothesis is that AT III concentrate may have effi   cacy as anti-
infl  ammation for sepsis.
Methods From January 2009 to December 2011, adult septic patients, 
whom were given AT III concentrate in our medico-surgical ICU, were 
included in this study. AT III concentrate was administered 30 to 60 U/kg 
intravenously every 24 hours for 3 days in the patients with DIC status 
and AT III defi  ciency. Between before and after the AT III concentrate 
therapy, WBC (/mm3), CRP (mg/dl), platelet (×104/μl), PT (seconds), 
fi   brinogen (mg/dl), FDP (μg/ml), SOFA score and DIC score were 
evaluated. Values are expressed as mean ± SD. Data were analyzed by 
Wilcoxon signed-rank test. P <0.05 was considered signifi  cant.
Results There were 85 patients (52 men, 33 women; age range 19 to 
92 years (mean 69.0 ± 16.9)), and the mortality rate was 27.1% and 
APACHE II score was 20.1 ± 7.6. WBC, CRP, PT and SOFA score were 
signifi  cantly improved after AT III concentrate therapy (13,176 ± 9,400 
vs. 11,693 ± 7,089, P = 0.011, 15.9 vs. 13.3, P = 0.0015, 16.5 ± 4.4 vs. 
15.9 ± 5.9, P = 0.0045, and 9.7 ± 3.8 vs. 8.6 ± 4.6, P = 0.01, respectively). 
Platelet was signifi  cantly decreased (11.7 ± 9.7 vs. 10.6 ± 9.0, P = 0.028), 
while there were no signifi  cant diff  erences in fi  brinogen, FDP and 
DIC score (387.3 ± 202.6 vs. 381.8 ± 163.2, P = 0.088, 36.9 ± 52.7 vs. 
28.8 ± 39.9, P = 0.059, and 2.9 ± 1.6 vs. 2.6 ± 1.8, P = 0.25, respectively) 
after the therapy. One week after the therapy, platelet and DIC score 
were signifi   cantly improved compared with before the therapy 
(15.6 ± 10.0, P = 0.0036 and 1.8 ± 1.9, P = 0.0041).
Conclusion In the patients with septic DIC, WBC, CRP and SOFA score 
were immediately improved after the AT III concentrate therapy, while 
platelet and DIC score were improved later. AT III concentrate may also 
contribute to anti-infl  ammatory for septic DIC with anticoagulation.
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with sepsis or septic shock: eff  ects on endothelial function
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Introduction  Sepsis and septic shock are complex infl  ammatory 
syndromes. Multiple cellular activation processes are involved, and 
many humoral cascades are triggered. Presumably, endothelial cells 
play a pivotal rule in the pathogenesis of sepsis, not only because 
they may infl  uence the infl  ammatory cascade but also because, upon 
interaction with excessive amounts of infl  ammatory mediators, the 
function of these cells may become impaired. It is likely that a general 
dysfunction of the endothelium is a key event in the pathogenesis 
of sepsis [1]. HMG-CoA-reductase inhibitors have been shown to 
exhibit pronounced immunomodulatory eff  ects independent of lipid 
lowering. Most of these benefi  cial eff  ects of statins appear to involve 
restoring or improving endothelial function [2]. We hypothesize that 
statins can improve endothelial dysfunction in septic patients.
Methods  A double-blinded, placebo-controlled, randomized trial 
was undertaken. We enrolled adult patients within 24 hours of severe 
sepsis or septic shock diagnosis and randomized them to placebo or 
atorvastatin 80 mg/day for a short term. Endothelial dysfunction was 
assessed measuring plasmatic levels of IL-6, ET-1, VCAM-1 by ELISA and 
measuring fl  ow-mediated vasodilatation of the brachial artery at basal, 
24 and 72 hours after randomization.
Results We studied 47 patients, 24 in the placebo group (mean age 
52 ± 20 years, 29.1% male; APACHE II risk score 23.5 ± 7.3) and 23 in 
the statin group (mean age 49.5 ± 18 years, 53.4% male; APACHE II risk 
score 23 ± 6.9). The baseline characteristics of the placebo group were 
similar to statin patients as well as the mean length of stay in the ICU 
(8.6 ± 7.4 and 9.1 ± 8 days, respectively) and the time on vasopressors 
(49.3 ± 47.1 and 59 ± 91.1 hours, respectively). No signifi  cant diff  erence 
was observed on the temporal variation of biomarker levels (IL-6, 
VCAM-1, ET-1) between treatment and control groups. The intrahospital 
mortality rate was 26% in the statin group and 45% in the placebo 
group (P = 0.17).
Conclusion  Our data showed no benefi  t with the use of a potent 
statin acutely in patients with sepsis or septic shock with regards to 
improvement in endothelial function.
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Introduction  A novel sorbent hemoadsorption device for cytokine 
removal (CytoSorbents, USA) was developed and successfully tested 
in animal models of sepsis. The experience in the clinical setting is 
still limited to case reports. In this fi  rst clinical trial, we tested the 
hypothesis that treatment with sorbent hemoadsorption could safely 
and eff  ectively reduce cytokines in septic patients with acute lung 
injury (ALI).
Methods Ventilated patients fulfi  lling the criteria for severe sepsis and 
ALI were enrolled in this multicenter randomized, controlled, open-
label study comparing standard of care with or without hemoperfusion 
treatment. Primary endpoints were safety and IL-6 reduction. Treated 
patients underwent hemoperfusion at fl  ow rates of ~200 to 300 ml/
minute for 6 hours per day for 7 consecutive days. The overall mean 
reduction in individual plasma cytokines for the control and treatment 
groups during the treatment period was calculated using a generalized 
linear model.
Results  Forty-three patients (18 treated, 25 control) completed the 
study and were further analyzed. Incidence of organ dysfunction at 
enrollment (treatment vs. control) was: septic shock (94% vs. 100%, 
P = 0.42), acute respiratory distress syndrome (67% vs. 56%, P = 0.33), 
and renal failure (39% vs. 24%, P = 0.54). During 115 treatments no 
serious device-related adverse events occurred. On average, there 
were no changes in hematology and other blood parameters except 
for a modest reduction in platelet count (<10%) and albumin (<5%) 
with treatment. Hemoperfusion decreased IL-6 blood concentration 
signifi  cantly  (–49.1%,  P  = 0.01), with similar reductions of MCP-1 
(–49.5%, P = 0.002), IL-1ra (–36.5%, P = 0.001), and IL-8 (–30.2%, P = 
0.002). The 28-day mortality (28% vs. 24% control, P = 0.84) and 60-
day mortality (39% vs. 32% control, P = 0.75) did not diff  er signifi  cantly 
between the two studied groups.
Conclusion In this fi  rst clinical study of a novel sorbent hemoadsorption 
device in patients with severe sepsis and ALI, the device appeared to 
be safe and decreased the blood concentration of several cytokines. 
Further research is needed to study the eff  ect of the device on the 
clinical outcome of septic patients.
P63
Continuous renal replacement therapy with the adsorbent 
membrane oXiris in septic patients: a clinical experience
F Turani, F Candidi, R Barchetta, E Grilli, A Belli, E Papi, A di Marzio, M Falco
Aurelia Hospital/European Hospital, Rome, Italy
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Introduction Renal failure is an important complication of sepsis and 
CRRT with adsorbing membranes may be useful in this clinical setting 
[1]. The aims of the study in septic/septic shock patients are to evaluate: 
the safety of a new hemofi   lter membrane oXiris with adsorbing 
properties and anti-endotoxin activity; the renal and hemodynamic 
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molecules.
Methods  Forty septic/septic shock patients with renal failure were 
enrolled in the study. All patients had preoperative endotoxin 
>0.6 level/units (EAA Spectral D) and were submitted to high-volume 
hemodiafi   ltration (50  ml/kg/hour, Prismafl   ex; Gambro) with a new 
treated heparin-coated membrane (oXiris; Gambro). At T0 (pre-
treatment) and T1 (24 hours) the main clinical and biochemical data 
were evaluated. All data are expressed as mean ± SD. One-way ANOVA 
test with Bonferroni correction was used to evaluate the data changes. 
P <0.05 was considered signifi  cant.
Results Table 1 presents the main results of this study.
Conclusion In septic/septic shock patients with renal failure, CRRT with 
a new treated heparin-coated membrane (oXiris; Gambro)  is clinically 
feasible, and has a positive eff  ect on renal function and hemodynamics. 
An adsorbing eff  ect on proinfl  ammatory mediators may have a role in 
these results. These data and the trend toward a decrease of endotoxin 
during the treatment warrant further investigation.
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Introduction The usefulness of a pumpless extracorporeal lung assist 
system (pECLA) and continuous renal replacement therapy (CRRT) in 
critically ill patients has been demonstrated in previous studies [1,2]. 
The aim of this report was to examine combined use of pECLA and 
CRRT to improve carbon dioxide and infl  ammatory mediator removal, 
which allows for lung protective ventilation strategies.
Methods In our 10 patients with ARDS due to polytrauma and sepsis, 
pECLA was established by insertion of cannulae to the femoral artery 
and vein. CRRT cannulae were introduced by venous line of the same 
vascular access (Figure 1). We preferred regional anticoagulation with 
trisodium citrate for both CRRT and ILA.
Results Mean SAPS II and APACHE II scores were 55 and 23 respectively. 
Mean time on mechanical ventilation was 22 days. Mean ICU stay was 
30 days for survivors and 38 days for nonsurvivors. When compared 
with baseline values most relevant parameters were the improvement 
in tidal volumes, plateau pressures, PaCO2 levels and pH (Figure 2). Four 
patients survived while six patients died from sepsis-MOF.
Conclusion  We concluded that pECLA can eff   ectively address the 
impaired gas exchange in ARDS and CRRT is a safe procedure with 
potential therapeutic value for treating MOF. Citrate anticoagulation 
was well tolerated and fi  lter life was appropriate. The use of the same 
vascular access for ILA and CRRT may minimize invasive procedures 
and related side eff  ects.
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Introduction Endotoxin, a component of the outer membrane of Gram-
negative bacteria, is considered an important factor in pathogenesis 
of septic shock [1]. The aim of our study was to determine whether 
endotoxin elimination treatment added to the standard treatment 
would improve organ function in patients with septic shock.
Methods  Adult patients with septic shock who required renal 
replacement therapy (RRT), with a confi   rmed endotoxemia, and 
suspected Gram-negative infection were consecutively added to the 
study within the fi  rst 24 hours after diagnosis. All patients received 
full standard treatment for septic shock. Endotoxin elimination was 
performed using the membrane oXiris (Gambro, Sweden), a medical 
device for continued RRT with the unique feature of endotoxin 
adsorbtion. An endotoxin activity assay was used to monitor endotoxin 
elimination therapy at baseline (T0), 3  hours (T1), 12  hours (T2), 
24 hours (T3), 48 hours (T4), and 72 hours (T5). Our key indicators were 
the improvement in hemodynamics and organ function, and decrease 
of endotoxin activity (EA) in blood. Continuous variables are presented 
as mean values with standard deviations.
Results High EA level at baseline (0.74 ± 0.14 endotoxin activity units 
(EAU)) signifi   cantly decreased during RRT with oXiris membrane 
to 0.46 ± 0.02 (T1), 0.34 ± 0.01 (T2), 0.4 ± 0.02 (T3), 0.46 ± 0.04 (T4), 
0.35 ± 0.07 (T5) EAU (P <0.05). MAP increased from baseline 72 ± 14 
to 81 ± 18, 76 ± 6, 77 ± 7, 83 ± 13, 87 ± 10 mmHg (P <0.05), and the 
mean norepinephrine use decreased from 0.23 ± 0.04 to 0.19 ± 0.02, 
0.11 ± 0.01, 0.09 ± 0.01, 0.04 ± 0.01, 0.0 μg/kg/minute (P <0.05) at T0, T1, 
T2, T3, T4, T5, respectively. The SOFA score had decreased from 14 ± 4 to 
12 ± 2, 9 ± 3, 7 ± 3 points (P <0.05), and the procalcitonin level declined 
from 107 ± 123 to 45 ± 41, 29 ± 30, 17 ± 157 ± 1 ng/ml (P <0.05) at T0, 
T3, T4, T5.
Conclusion  RRT with oXiris membrane resulted in the eff  ective 
elimination of endotoxins from the blood. The therapy was associated 
with an increase in blood pressure, a reduction of vasopressor 
requirements, and an improvement of organ function. The application 
of the endotoxin activity assay was useful for bedside monitoring of 
endotoxemia in ICU patients.
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Figure 1 (abstract P64). ILA and CRRT connected to the patient.
Table 1 (abstract P63)
Parameter Units  T0  T1
Creatinine  mg/dl  1.9 ± 0.1  1.18 ± 0.1*
Diuresis  ml/24 hours  1,284 ± 78  1,573 ± 98
Norepinephrine  μg/kg/minute  0.17 ± 0.2  0.06 ± 0.1*
IL-6  pg/ml  572 ± 78  278 ± 57*
Procalcitonin  ng/ml  35 ± 7  15 ± 2*
Endotoxin  Level/U  0.64 ± 0.2  0.49 ± 0.1
*P <0.05 vs. T0.
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Introduction Severe sepsis and septic shock remain the most serious 
problem of critical care medicine with a mortality rate of 30 to 55% 
[1]. Several studies have demonstrated positive eff  ects of selective 
adsorption of LPS on blood pressure, PaO2/FiO2 ratio, endotoxin 
removal and mortality [2,3]. The purpose of the study was to evaluate 
the effi   ciency of using the selective adsorption of LPS, Toraymyxin – 
PMX-F (Toray, Japan) and Alteco® LPS Adsorber (Alteco Medical AB, 
Sweden), in the complex treatment of patients with severe sepsis.
Methods  Forty-six patients with Gram-negative sepsis in the 
postoperative period were enrolled into the study. Toraymyxin – PMX-F 
was used in the PMX-F group (n = 14), while Alteco LPS adsorption 
was used in the Alteco LPS group (n = 32). The clinical characteristics 
are listed in Table 1. The SOFA score, PaO2/FiO2, procalcitonin (PCT), 
C-reactive protein (CRP), endotoxin activity assay (EAA) was noted 
before, 24 and 48 hours after the selective adsorption of LPS.
Results At 48 hours after PMX-F, signifi  cantly decreased PCT from 17.5 
(5.0; 40.9) to 7.1 (4.8; 13.0) ng/ml, P = 0.028, decreased CRP from 180 
(133; 286) to 132 (68; 155) mg/l, P = 0.015 and SOFA score from 7.0 (3,0; 
8.0) to 6.0 (3,0; 7.0), P = 0.007. At 24 hours after Alteco LPS, signifi  cantly 
decreased PCT from 8.7 (3.0; 25.9) to 4.8 (2.1; 10.0) ng/ml. The 28-day 
mortality rate was 14.2% (n = 2) in the PMX-F group and 31.3% (n = 10) 
in the Alteco LPS group.
Table 1 (abstract P67). Clinical characteristics of the groups
Characteristic  PMX-F   Alteco LPS
Sex M/F  9/5  17/15
Age (years)   41.6 ± 17.1  42.1 ± 13.5
Shock  6 (42.9%)  13 (40.6%)
APACHE II   21 (17; 25)  21 (16; 24)
SOFA  7 (3.0; 8)  7 (3.5; 11)
Conclusion  The use of the LPS-selective adsorption (particularly 
PMX-F) in patients with severe sepsis leads to improvement of systemic 
infl  ammation and organ dysfunction.
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Figure 2 (abstract P64). Changes in tidal volume, plateau pressure, pH and PaCO2.
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Introduction  Septic shock is a common cause of mortality and 
morbidity in the ICU. Endotoxin hemoadsorption using a Polymyxin B 
fi  ber column can improve patient outcome [1]. This study investigated 
the therapeutic eff  ect of a new endotoxin hemoadsorption device in 
Gram-negative septic shock patients.
Methods An open, controlled, prospective, randomized, single-centre 
trial conducted between February 2010 and June 2012. Patients 
with septic shock due to intra-abdominal sepsis were recruited and 
randomized to either standard therapy (ST, n = 8) or standard therapy 
plus two 2 hourly sessions of Alteco endotoxin hemoperfusion (AT, n = 
7). Standard therapy included infective source control, appropriate 
early antibiotic, low-dose steroid, early continuous renal replacement 
therapy in the presence of acute kidney injury (RIFLE Injury class or 
more), hemodynamic optimization and lung-protected ventilatory 
support. Primary outcome was change in organ dysfunction at 48 
hours measured by Sequential Organ Failure Assessment (SOFA) 
scores. Secondary outcomes were change in vasopressor requirement 
(measured by vasopressor score), PaO2/FiO2 (fraction of inspired 
oxygen) ratio, total urine output at 72 hours and 28-day mortality.
Results This study was terminated early as interim analysis identifi  ed 
no signifi   cant clinical benefi   t. Baseline characteristics (age/APACHE 
IV score) were similar between two groups of patients. No signifi  cant 
diff  erence was noted between two groups with respect to change in 
total SOFA score (+1 vs. –5.5 for AT vs. ST, P = 0.382), vasopressor score 
(–29 vs. –46.6, P = 0.775), PaO2/FiO2 ratio (–26 vs. +163, P = 0.199), total 
urine output from 0 to 72 hours (3,850 ml vs. 4,570 ml, P = 0.355) and 
28-day mortality (14.3% vs. 37.5%, P = 0.569). No signifi  cant side eff  ect 
was noted when using this new hemoadsorption device.
Conclusion This small study cannot identify any extra clinical benefi  t 
on addition of Alteco endotoxin hemoadsorption to standard therapy 
in patients suff  ering from intra-abdominal sepsis with shock due to 
Gram-negative bacterial infection.
Reference
1. Cruz  DN,  et al.: JAMA 2009, 301:2445-2452.
P69
Steroid therapy in septic shock: survey of practice amongst UK 
critical care physicians
G Rajendran, K Dasari, A Dhrampal
Norfolk & Norwich University Hospital, Norwich, UK
Critical Care 2013, 17(Suppl 2):P69 (doi: 10.1186/cc12007)
Introduction  Corticosteroid (CS) therapy in sepsis remains contro-
versial and was fi  rst introduced in sepsis management for its anti-
infl  ammatory property. CS has found a role in septic shock amelioration 
with inconsistent outcomes. The Surviving Sepsis Campaign (SSC) 
includes CS as a Level 2C recommendation in septic shock [1]. Adapting 
and practicing SSC guidelines vary between critical care units. 
Accordingly, a survey was conducted to elucidate the usage of CS for 
septic shock by UK critical care physicians (CCPs).
Methods Following approval by the UK Intensive Care Society (ICS), the 
survey was publicised on the ICS website and its newsletter.
Results  A total of 81 intensivists responded to this online survey. 
Seventy-four (92.5%) CCPs prescribed CS only if the septic shock is 
poorly responsive to fl   uid resuscitation and vasopressor therapy. 
Six (7.5%) initiated CS at the same time as vasopressor therapy. 
None initiated CS for patients with severe sepsis. No CS other than 
hydrocortisone is being used. The most commonly used intravenous 
regimen is 50 mg 6 hourly (65%) followed by 50 mg 8 hourly (11%). 
Only 10% of CCPs would prescribe it by infusion. Less commonly used 
regimens were 100 mg 8 hourly (6%) and 100 mg 6 hourly (5%). Only 
5% would consider adding fl  udrocortisone. Prior to initiating CS, 5% of 
CCPs would perform a short synacthen test, while 94% would not. The 
majority (89%) of CCPs would stop CS after resolution of shock state 
or when vasopressor infusion is terminated whilst 11% after a fi  xed 
duration. Withdrawal of CS also diff  ered, in that 25% tapered/weaned 
steroids, 31% stopped it abruptly and 44% of CCPs would base their 
CS cessation pattern on the clinical context. Only 46% of CCPs believe 
that CS is benefi  cial whereas 44% were unsure of the benefi  ts in septic 
shock. Only 29 (36%) responders indicated that their critical care unit 
had a written protocol for CS in septic shock.
Conclusion The perceptions, usage and cessation of CS in septic shock 
vary but do appear to have shifted in the last decade. A UK survey in 
2003 identifi  ed that only 60% of ICUs used CS for septic shock and 
over 22% perform a short synacthen test [2]. It appears that many 
intensivists are using CS for septic shock, despite confl  icting outcome 
data. We all strive to practice evidence-based medicine but until we 
have a robust, reliable and methodical randomised control trial that 
attempts to resolve the CS debate, practice will remain diverse on this 
subject, as refl  ected by our survey.
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Introduction  It is postulated that clinical benefi   t of low-dose 
hydrocortisone in septic shock is related to reversal of relative adrenal 
insuffi   ciency [1]. This was proved in an animal model of sepsis.
Methods Sixty-nine Wistar male rats were assigned to the following 
groups: A, sham-operation; B, sepsis; C, bilateral adrenalectomy 
and sepsis; D, bilateral adrenalectomy, sepsis and hydrocortisone 
treatment; E, bilateral adrenalectomy, sepsis and ertapenem treatment; 
and F, bilateral adrenalectomy, sepsis, hydrocortisone and ertapenem 
treatment. Sepsis was induced by the i.p. infusion of 1×106 cfu/ml of 
Escherichia coli after adrenalectomy. Hydrocortisone 10  mg/kg was 
infused i.v. bid starting 1 hour after bacterial challenge. Ertapenem 
5  mg/kg was infused i.v. once daily starting 1  hour after bacterial 
challenge. Survival was recorded. In a separate set of experiments in 
18 rats, animal sacrifi  ce was performed to measure the free cortisol 
concentration.
Results Survival is shown in Figure 1. Experiments in each animal were 
starting at 7:00 am. At 8:00 am, respective mean free cortisol of groups 
A, C and D was 1.81, 0.55 and 2.05 μg/dl; at 1:00 pm they were 0.92, 0.47 
and 1.40 μg/dl.
Figure 1 (abstract P70). Survival of rats.
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tered, administration of hydrocortisone at a regimen restoring normal 
secretion is mandatory for survival.
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Introduction  The impact of appropriate antibiotic therapy on 
prognosis of patients with septic shock is well established. However, 
the prognostic infl  uence of time to initiation of antibiotics remains 
debated. We evaluated the eff  ect on 7-day mortality of time to initiation 
of appropriate antibiotic therapy in patients hospitalised in critical care 
for septic shock.
Methods Secondary analysis from the EPISS cohort. We included only 
patients admitted to the University Hospital Dijon. Septic shock was 
defi  ned as initiation of vasopressors in a patient with suspected or 
documented infection with at least one criterion of hypoperfusion 
(metabolic acidosis and/or renal insuffi   ciency and/or hepatic dys  func-
tion). We excluded patients with no available bacteriological data. Anti-
biotherapy was considered appropriate if at least one of the antibiotics 
prescribed was active against the germ identifi   ed. Bivariate and 
multivariate logistic regression analysis was used to assess the impact of 
time to initiation of appropriate antibiotherapy on 7-day mortality.
Results  In total, 383 patients were admitted with septic shock, of 
whom 253 (66%) were included; 231(92%) had appropriate antibiotic 
therapy, of whom 52 (22.5%) died at 7 days. Average time to initiation 
of appropriate antibiotic therapy was 9  ±  23 hours. By bivariate 
analysis, body mass index (BMI) <20, SAPS II ≥56, SOFA score ≥11 and 
bacteremia were signifi  cantly associated with 7-day mortality. Urinary 
tract infection (UTI) was a protective factor. Age, sex, comorbidities 
(particularly immunosuppression), Knaus score, nosocomial infection 
and type of germ had no infl  uence on 7-day mortality. By multivariate 
logistic regression, BMI <20 (OR = 4.87, 95% CI = 1.36 to 17.43, P = 0.01) 
and SOFA score ≥11 (OR = 7.99, 95% CI = 3.11 to 20.5, P <0.001) were 
the only factors signifi  cantly associated with 7-day mortality. UTI was a 
signifi  cant protective factor (OR = 0.30, 95% CI = 0.10 to 0.88, P = 0.03). 
Time to initiation of appropriate antibiotherapy was not associated 
with 7-day mortality (OR = 0.99, 95% CI = 0.99 to 1.00, P = 0.48).
Conclusion  Prognosis at 7 days of patients with septic shock is 
largely related to the number of failing organs. The majority received 
appropriate antibiotic therapy although time to initiation is longer 
than recommended. Further eff  orts are warranted to reduce mortality 
in patients with septic shock.
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Introduction From December 2009 to December 2010, 47 patients in 
Scotland presented with confi  rmed anthrax infection manifested by 
soft tissue disease related to heroin injection. These cases represent 
the fi  rst known outbreak of a recently recognized form of anthrax, 
termed injectional anthrax, which appears to be associated with a high 
mortality rate (28% in confi  rmed cases from the UK outbreak). While 
epidemiologic data from this outbreak have been published, no report 
has systematically described fi  ndings in patients at presentation or 
compared these fi  ndings in nonsurvivors and survivors.
Methods  To better describe injectional anthrax, we developed a 
questionnaire and sent it to clinicians who had cared for confi  rmed 
cases during the outbreak. Completed questionnaires describing 27 
patients, 11 nonsurvivors and 16 survivors, were returned.
Results  In preliminary analysis of categorical data, a signifi  cantly 
(Fisher exact test) greater proportion of patients with compared with 
without the following fi   ndings did not survive; history of alcohol 
use (P  = 0.05); the presence of lethargy (P  = 0.01), confusion (P =  
0.03), nausea (P = 0.04), abdominal pain (P = 0.02), or the need for 
vasopressors (P = 0.002), oxygen, mechanical ventilation, or steroids 
(all P = 0.004) at presentation; and excessive bleeding at surgery (P = 
0.01). Initial analysis of continuous data demonstrated that, compared 
with survivors at presentation, nonsurvivors had signifi  cantly (one-way 
ANOVA) increased respiratory rate, percent neutrophils on complete 
blood count, hemoglobin, INR, C-reactive protein, and bilirubin and 
signifi  cantly decreased temperature, systolic blood pressure, platelets, 
sodium, albumin, calcium (corrected for albumin), base excess and 
bicarbonate (all P ≤0.05).
Conclusion  The implications of the apparent diff  erences  noted 
between nonsurvivors and survivors in this survey of cases from the 
fi   rst known outbreak of injectional anthrax require further study. 
However, these diff  erences might inform the design of research during 
future outbreaks or of methods to identify patients most in need of 
anthrax-specifi  c therapies such as toxin-directed antibodies.
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Introduction Based on the results of our previous studies [1] we have 
identifi  ed clinical risk factors for the emergence of Gr(+) infections in 
our ICU and we have developed a new algorithm for combating them. 
The choice of the particular antibiotic drug is guided by additional 
risk factors for severity of illness and data on the infectious focus. The 
response to therapy and its duration are also stated. The aim of the 
current study was to evaluate the effi   cacy and safety of this preemptive 
approach.
Methods A randomized prospective controlled trial was carried out 
from September 2010 to September 2012. Patients were submitted 
to block randomization and stratifi  ed on the basis of their initial SAPS 
II exp score. Antibiotic therapy was started on the day of inclusion 
in the treatment group and only with proven Gr(+) pathogen in the 
control group. Initial data were gathered on demographics, diagnosis, 
proven risk factors for sepsis-related mortality, severity of infl  ammatory 
response, ventilator-associated pneumonia and organ dysfunction. 
Dynamics of SIRS, CPIS and SOFA scores, subsequent infectious isolates, 
ventilator-free days, length of ICU stay and outcome were followed for 
each patient.
Results A total of 170 patients were enrolled. No statistically signifi  cant 
diff  erences in their basal characteristics were found. The subsequent 
score values, length of ICU stay and the number of ventilator-free days 
were also comparable between groups. The majority of Gr(+) pathogens 
were isolated between 6 and 10 days of inclusion. No diff  erences were 
found regarding the concomitant Gr(–) fl  ora and the related antibiotic 
therapy. The new organ dysfunction severity was similar in both groups 
(P = 0.37). The in-hospital mortality was 26.2% in the treatment group 
versus 18.6% in the control group (P = 0.56). Signifi  cant diff  erences 
between the Kaplan–Meier estimates of survival were also not found 
(log-rank test P = 0.81). No major adverse reactions were observed.
Conclusion The implementation of this new policy failed to reduce 
the degree of organ dysfunction severity and was not associated with 
signifi  cant survival benefi  t. Moreover, even though it did not reach 
statistical signifi  cance, a second peak of Gr(+) isolates was observed 
as a possible complication of the preemptive therapy. Whether this 
approach could lead to vancomycin MIC creep or there could still be 
a niche for it later in the course of treatment and/or in nontrauma 
patients remains to be further explored.
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Introduction Urinary tract infection (UTI) can lead to both hospitali-
za  tion and severe sepsis. We theorized that UTI due to Gram-
negative (GN) multidrug-resistant P. aeruginosa (MDR-PA), extended-
spectrum β-lactamase (ESBL), E. coli (EC) and Klebsiella sp. (KP), and 
carbapenemase-producing Enterobacteriaceae (CPE) would be 
frequently isolated in the ICU.
Methods  We analyzed a large US-based microbiology database, 
Eurofi  ns TSN, between the years 2000 and 2009. We determined the 
proportion of isolates caused by MDR-PA, ESBL-EC, ESBL-KP, and CPE 
relative to their susceptible counterparts. We defi  ned MDR-PA as any 
isolate resistant to ≥3 drug classes. ESBL organisms were defi  ned as 
E.  coli and K. pneumoniae resistant to a third-generation cephalosporin. 
Enterobacteriaceae were considered CPE if resistant to both a third-
generation cephalosporin and a carbapenem. We further examined 
the evolution of the frequency of resistance among GN UTIs over time.
Results We identifi  ed 115,201 PA (13.7% MDR-PA), 359,090 EC (5.6% 
ESBL), 97,419 KP (12.9% ESBL), and 176,110 Enterobacteriaceae (0.6% 
CPE) UTI specimens. The prevalence of resistance rose for each organism 
of interest from 2000 through 2009: MDR-PA, 11.6 to 12.3%; ESBL-EC, 
3.3 to 8.0%; ESBL-KP, 9.1 to 18.6%; CPE 0 to 2.3%. For each organism 
the proportion of resistant pathogens was consistently higher among 
ICU specimens than among specimens from other hospital locations, 
reaching nearly 20% for MDR-PA (Figure 1).
Conclusion The microbiology of GN UTI hospitalizations has shifted 
over the last decade and greater antimicrobial resistance is evident. The 
prevalence of MDR-PA, ESBL-EC, ESBL-KP, and CPE is higher in the ICU 
than in other hospital locations.
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Introduction  Gram-negative resistance remains a major challenge 
in the care of critically ill patients. Traditionally, P. aeruginosa (PA) has 
represented the most concerning pathogen. However, carbapenemase-
producing Enterobacteriaceae (CPE) have emerged as a challenge, but 
the epidemiology of this pathogen is poorly understood.
Methods  We analyzed a large US-based microbiology database, 
Eurofi  ns TSN, between the years 2000 and 2009. We aimed to describe 
the prevalence of infection with either multidrug-resistant (MDR) PA or 
CPE. We defi  ned MDR-PA as any PA isolate resistant to ≥3 drug classes. 
Enterobacteriaceae were classifi  ed as CPE if resistant to both a third-
generation cephalosporin and a carbapenem. We evaluated specimens 
from respiratory, bloodstream, urinary tract (UTI) and complicated 
intra-abdominal infections.
Results We identifi  ed 327,912 PA (60,695 (18.5%) MDR-PA) and 279,600 
Enterobacteriaceae (2,558 (0.9%) CPE) specimens. More than one-
quarter (26.1%) of all PA were recovered from ICU patients as compared 
with 17.9% of all Enterobacteriaceae specimens. Of those specimens 
originating in the ICU, MDR-PA represented 21.9% of all PA organisms, 
while CPE represented 1.6% of all Enterobacteriaceae. Pneumonia and 
UTI accounted for 92.4% of all PA and 84.0% of all Enterobacteriaceae 
specimens. The proportion of both MDR-PA and CPE was highest in 
pneumonia (22.0% and 1.6%, respectively) and lowest in UTI (13.7% 
and 0.6%, respectively). Over the time frame of the study, CPEs emerged 
and stabilized at approximately 2.8% of all Enterobacteriaceae, while 
MDR-PA increased slightly from 16.0% of all PA in 2000 to 17.8% in 2009.
Conclusion Although CPE organisms have emerged as an important 
pathogen, MDR-PA remains an order of magnitude more prevalent 
in the United States. Pneumonia patients and those in the ICU are at 
an increased risk for both MDR-PA and CPE infections compared with 
those outside the ICU.
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Introduction  Antibiotic resistance is a major worldwide problem 
in the ICU [1]. The situation in developing countries like India is 
particularly serious. Since the presence of drug-resistant bacteria in 
the environment is a threat for public health, up-to-date information 
on local pathogens and the drug sensitivity pattern is very crucial to 
treat patients. This study was carried out to evaluate the prevalence 
of multidrug resistance (MDR), extensive drug resistance (XDR) and 
pandrug resistance (PDR) among multiple Gram-negative isolates in a 
medical–surgical ICU in a tertiary care hospital in North India.
Methods We conducted a prospective observational study. All data 
were analysed using descriptive statistics. All Gram-negative culture 
isolates over a period of 13 months (October 2011 to October 2012) 
were included in this study. Isolation and identifi  cation were performed 
using the bact alert system and VITEK2, respectively. Sensitivities were 
determined by Kirby Bauer disc diff  usion and broth dilution using 
VITEK2-AST cards and interpreted according to Clinical and Laboratory 
Standards Institute criteria. For the purpose of this study, we used MDR 
to denote isolates resistant to representatives three or more classes 
of antimicrobial agents, XDR as those resistant to all but one or two 
classes and PDR as those resistant to all classes of antimicrobial agents 
available [2,3].
Results Out of a total 2,796 culture specimens sent over 13 months, 
250 isolates were Gram-negative (8.9%). Among these 250 (n) Gram-
negative isolates, 195 (78%) were extended-spectrum β-lactamase 
(ESBL) producers and the remaining 55 (22%) were non-ESBL producers. 
Among the ESBL producers, PDR, XDR and MDR isolates were 14 
(5.6%), 113 (45.2%) and 68 (27.2%), respectively (Figure  1). Among 
the XDR-positive organisms, seven (6.1%) organisms were New Delhi 
metallo-β-lactamase-1 (NDM-1) producers and fi  ve (4.4%) organisms 
were NDM-2 producers. Among ESBL-positive isolates, the most 
predominant isolate was Klebsiella pneumoniae (29.7%) followed by 
Acinetobacter aeruginosa (22.5%) and Escherichia coli (20.5%) (Figure 2). 
Among non-ESBL-positive isolates, the most predominant isolate was 
Escherichia coli (34.5%) followed by Klebsiella pneumoniae (21.8%) and 
Pseudomonas aeruginosa (14.5%) (Figure 2).
Conclusion ESBL producers were the most frequently isolated Gram-
negative bacterial isolates in this tertiary-care hospital in north India. 
Figure 1 (abstract P74).
Critical Care 2013, Volume 17 Suppl 2 
http://ccforum.com/supplements/17/S2
S27Among ESBL producers, XDR organisms were most frequent, followed 
by MDR and PDR organisms. Few of the XDR isolates were NDM 
producers, which have propensity to spread to other bacteria. In view of 
signifi  cant prevalence of multidrug resistance amongst Gram-negative 
organisms in the ICU, regular surveillance of antibiotic susceptibility 
patterns plays a crucial role for setting orders to guide the clinician in 
choosing empirical or directed therapy of infected patients.
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Introduction Acinetobacter baumannii (A. baum) is a leading cause of 
septicemia of patients hospitalized in the ICU with high mortality rates. 
The aim of our study is to investigate the risk factors associated with 
A. baum bacteremia and its mortality rates.
Methods A total of 937 patients (457 women and 480 men, median 
age 59) admitted to the ICU during the period 1 January 2009 to 30 
September 2012 were enrolled in our retrospective study. Blood 
cultures were obtained from all patients. The identifi  cation and the 
antimicrobial susceptibility testing were performed by the automated 
system VITEK2 (Bio Merieux, France). Data collected included 
underlying diseases, malignancies and immune suppression (MIS), 
prognostic factors (APACHE score, adjusted mortality), age, sex, length 
of ICU stay (LS), recent administration of broad-spectrum β-lactam 
antibiotics (especially carbapenems; ABL), mechanical ventila-
tion (MV), implementation of invasive procedures (central venous 
catheter and urine catheter; INV.PR) and outcome. At fi  rst a univariate 
statistical model was used with signifi  cance level set at P = 0.05. For 
the multivariate statistical analysis model we used all variables with 
P  <0.05 from the previous model and those mentioned at recent 
medical literature as signifi  cantly related with A. baum septicemia and 
its mortality.
Results  A total of 101 patients (10.78%) developed bloodstream 
infection caused by A. baum and the mortality rate due to A. baum 
septicemia was estimated as 49.5% (50/101). Multiple regression 
analysis revealed adjusted mortality >55% (Exp(B) = 2.01, P = 0.013), 
MIS (Exp(B) = 1.97, P = 0.017), ABL (Exp(B) = 2.34, P = 0.009), LS >14 
days (Exp(B) = 1.34, P = 0.034), MV (Exp(B) = 2.67, P = 0.005) and INV.PR 
(Exp(B) = 3.27, P = 0.001) as independent risk factors associated with 
A. baum septicemia.
Conclusion  The fact that the probability of A. baum bacteremia 
increases in immunocompromised patients refl  ects the opportunistic 
characteristic of these infections. MV accelerates respiratory A. baum 
colonization, which is a risk factor for AB bacteremia. Recent INV.
PR increased the incidence of A. baum bacteremia and this result is 
probably related to the severe status in patients with central venous 
catheter. The administration of carbapenems inhibits the growth of 
other more susceptible bacteria, allowing the growth of multidrug-
resistant A. baum.
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Introduction The French military hospital at the Kaboul International 
Airport (KaIA) base provides surgical care for International Force 
and Afghan National Army soldiers, and also local patients. The 
development of multiresistant bacteria (MRB) nosocomial infections 
has raised a major problem complicating the care of combat casualties 
[1]. The aim of this study is to assess the prevalence of MRB carriage on 
admission to the ICU in this combat support hospital.
Methods  We used a prospective observation study on patients 
admitted to the French military ICU in KaIA over 3 months (July to 
September 2012). All hospitalized patients were assessed for the 
presence of colonization with MRB: nasal and rectal swabs were 
performed to identify, respectively, methicillin-resistant Staphylococcus 
aureus (MRSA) and extended-spectrum β-lactamases bacteria (ESBLB). 
The following data were recorded for each patient on admission: 
demographic characteristics, bacteriological results, length of stay, 
type of previous hospitalization.
Results Sixty-three patients were admitted. The mean length of stay 
(MLS) was 3 ± 3 days, and the mean age was 25 ± 14 (13 patients 
<15  years). Patients were hospitalized for combat-related trauma 
(74%), noncombat-related trauma, medical pathologies (10%), and 
postoperative care (8%). They were Afghans (92%) or westerners 
(8%). Swabs were not realized for eight patients. Forty-three percent 
revealed an ESBLB colonization: Escherichia coli (22 patients), Klebsiella 
pneumoniae (one patient), Acinetobacter baumanii (one patient). No 
patients were colonized with MRSA. Ten patients (16%) were directly 
admitted to the ICU, 12 (19%) had been hospitalized before admission, 
39 (62%) were transferred after resuscitative and stabilization care 
in a level 2 unit. For the two last categories, the MLS (for previous 
hospitalization) was respectively 14 ± 28 days and 8 ± 6 hours. Among 
patients transferred after care in a level 2 unit, MLS was no diff  erent 
between colonized and noncolonized patients: 8 ± 7 versus 9 ± 6 hours 
(P = 0.5, Mann–Whitney test).
Conclusion  In this study, prevalence of colonization with ESBLB 
at admission is very high, suggesting a high prevalence of MDR 
colonization in the local population in Afghanistan. It remains important 
to intensify the prevention policy against MRB cross-transmission in 
the deployed ICU.
Reference
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Figure 1 (abstract P76). Prevalence of drug-resistant Gram-negative 
isolates.
Figure 2 (abstract P76). Prevalence of Gram-negative isolates.
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Introduction Providencia stuartii, a member of the family of Entero-
bacteriacea, is a Gram-negative pathogen causing colonization and 
opportunistic infections in ICU patients.
Methods We retrospectively recorded the characteristics of P. stuartii 
infections in our ICU in a total period of 1 year (six-bed general ICU).
Results A total of 116 patients (80 males, 68.9%) were hospitalized in 
our ICU of mean age 58.5 ± 1.8, mean ICU stay: 23.2 ± 3.3 days, APACHE 
II: 19.3 ± 0.7, SAPS II: 45.7 ± 1.6, SOFA: 7.9 ± 0.4 and mortality: 18.9%. 
Admission diagnosis was multiple trauma (29.3%), emergency surgery 
(37.1%), and medical (33.6%). Of them 21 (18.1%) developed P. stuartii 
infection that was related to multiple trauma (P = 0.0289), length of ICU 
stay 69.8 ± 12.6 (median 51.0) versus 12.6 ± 1.7 (median 6.0) (P <0.0001) 
and illness severity APACHE II (21.7 ± 1.3 vs. 17.5 ± 0.8; P = 0.0056), SAPS 
II (54.9 ± 2.9 vs. 43.6 ± 1.8; P = 0.0296) and SOFA (10.6 ± 0.5 vs. 7.2 ± 0.4; 
P <0.0001). There was no statistically signifi  cant diff  erence regarding 
sex, age or mortality (P  = 0.3789). Mean day of fi  rst isolation was 
31.1 ± 2.1 (median 28.0). The number of isolations per site were – blood: 
11 (median day: 25.0), tracheal aspirates: 9 (median: 28.5), catheter tip: 
15 (median: 31.0), urine: 6 (median: 32.0), wound: 12 (median: 25.0), 
biological fl  uids: 4 (median: 29.5), other catheters: 1 (median: 28.0), 
middle ear: 2 (median: 32.5), and nose: 1 (median: 25.0). Six patients 
had only one site isolation and the remaining 15 had multiple sites 
of P. stuartii isolation. We totally recorded 63 isolates of which 82.5% 
were second-generation and third-generation cephalosporin-resistant, 
80.3% aztreonam-resistant and 81% carbapenem-resistant strains 
expressing an extended-spectrum β-lactamase phenotype. All patients 
had previously received colistin or meropenem or tygecycline for a 
median period of 18.5, 15 and 10.5 days, respectively.
Conclusion P. stuartii infection/colonization may develop in critically 
ill patients, especially those with multiple trauma and prolonged 
ICU stay, and maybe isolated in blood after the 25th day of ICU stay. 
Also, infections due to extended-spectrum β-lactamase-producing 
multidrug-resistant P. stuartii are an emerging problem.
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High-dose tigecycline use in severe infections
G De Pascale1, L Montini1, T Spanu2, V Bernini1, A Occhionero1, DL Grieco1, 
M Biancone1, P De Santis1, ES Tanzarella1, SL Cutuli1, MA Pennisi1, 
MA Antonelli1
1Sacro Cuore Catholic University, Rome, Italy; 2Institute of Microbiology, Sacro 
Cuore Catholic University, Rome, Italy
Critical Care 2013, 17(Suppl 2):P80 (doi: 10.1186/cc12018)
Introduction  The aim of this study is to describe the clinical and 
epidemiological profi  le of ICU patients receiving tigecycline (TGC) and 
to evaluate the potential benefi  ts of TGC higher doses.
Methods All patients admitted to our ICU between 1 June 2009 and 
31 May 2012 who received TGC were evaluated. Cases were excluded 
when infections were not microbiologically confi  rmed.
Results  Over the study period, 100 patients fulfi   lled the inclusion 
criteria: 54 in the SD group (50 mg every 12 hours) and 46 in the HD 
group (100 mg every 12 hours). The SD group and the HD group were 
not signifi  cantly diff  erent in terms of age, severity of disease, duration 
of TGC therapy, rate of concomitant other active antibiotic use and 
of inadequate empirical antimicrobial therapy (IIAT) (P  = NS). MDR 
A. baumannii and K. pneumoniae were the main pathogens isolated. 
The percentage of germs other than A. baumannii and K. pneumoniae 
was higher in the SD TGC group (P <0.01). Otherwise infections due to 
less susceptible germs (TGC MIC value ≥1 μg/ml) were mainly treated 
with TGC higher doses (P <0.01). No signifi  cant diff  erences were found 
in terms of ICU mortality (P = 0.8). The rate of abnormal laboratory 
measures during TGC treatment was similar between the two groups 
(P = NS). No patients required TGC discontinuation or dose reduction 
because of suspected adverse events. In the VAP subpopulation 
(63 patients: 30 received SD and 33 HD), the clinical cure rate and 
microbiological eradication percentage were higher when TGC was 
used at higher doses (57.6% vs. 33.3%; P = 0.08 and 57.1% vs. 30.4%; 
P = 0.1). Table 1 shows multivariate analysis of clinical cure predictors 
in the VAP subgroup.
Table 1 (abstract P80). Predictors of clinical cure in patients with VAP 
(multivariate analysis)
  OR (95% CI)  P value
HD TGC  5.93 (1.38 to 25.6)   0.02
IIAT  0.23 (0.06 to 0.85)   0.03
SOFA score  0.62 (0.45 to 0.86)   <0.01
Conclusion In critically ill patients, HD TGC use seems to be safe and, 
combined with other active antibiotics, may increase the rate of MDR 
germ VAP clinical success. IIAT and the severity degree of patients’ 
clinical condition still remain major determinants of VAP treatment 
failure.
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Introduction  Amikacin Inhale (NKTR-061, BAY41-6551) is a drug-
device combination in clinical development for adjunctive treatment 
of intubated and mechanically ventilated patients with Gram-negative 
pneumonia. The product uses a proprietary vibrating mesh nebulizer 
system (PDDS Clinical) with amikacin sulfate formulated for inhalation 
(3.2 ml of 125 mg/ml amikacin solution) for a 10-day twice-daily course 
of therapy. It is designed for use with two delivery systems: one system 
for intubated patients (On-vent; Figure 1), and a second Handheld (HH) 
system for patients who are extubated before completing the course 
of therapy (Figure 2). We investigated in vitro the amikacin lung dose 
delivered by PDDS Clinical.
Methods  An estimated lung dose (ELD) for On-vent setting was 
measured in vitro after collecting aerosolized amikacin from a fi  lter at 
the end of an endotracheal tube during ventilation. The ELD for the HH 
device was calculated from the fi  ne particle fraction (FPF <5 μm) post-
mouthpiece, multiplied by the in vitro delivered dose post-mouthpiece. 
FPF <5 μm refl  ects lung deposition observed during phase 2 clinical 
trials [1]. Eighty-one nebulizers with volume median diameter (VMD) 
Figure 1 (abstract P81). On-vent system with brown blinder shell for 
clinical trials.
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for each system. Delivered dose data were fi  t to the independent 
variables (that is, VMD and output rates) using a least-squares fi  t with 
95% confi  dence limits.
Results Total percentage recoveries for On-vent and HH test runs were 
between 85% and 115% of the nominal dose. The mean ELDs were 
50 ± 9% (On-vent) and 49 ± 11% (HH) of the nominal dose. Nebulizers 
with longer dosing times and lower VMDs had higher ELD values for 
both delivery systems.
Conclusion The results support the use of the PDDS Clinical with either 
system to administer aerosolized amikacin with high effi   ciency and no 
dose adjustment is required when switching from the On-vent to the 
HH system for extubated patients.
Reference
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Introduction  Recent studies demonstrate that a loading dose 
of 25  mg/kg (total body weight) of amikacin in septic patients is 
required to reach a suffi   cient peak concentration. This study examines 
parameters infl  uencing the relation between amikacin dose and peak 
concentration.
Methods In this retrospective study we looked at 47 patients (128 peak 
levels) between 2003 and 2012. Multivariate linear regression analysis 
was done for several parameters: administered dose calculated with 
total body weight, ideal body weight, adjusted body weight, type of 
intensive care patient, BMI, daily fl  uid balance, SOFA score and APACHE 
score, and patient characteristics were analyzed.
Results A linear correlation between dose and amikacin peak level was 
confi  rmed (Figure 1). A total 54.69% of all amikacin administrations did 
not result in a therapeutic peak level. The multivariate linear regression 
analysis showed the best linear correlation with adjusted body weight 
and SOFA score. The comparison of variables between four patient 
groups, based on the deviation between measured peak level and 
predicted peak level (according the linear correlation), showed new 
variables that may infl  uence peak level.
Conclusion This confi  rms that low doses (<18 mg/kg) of amikacin in 
intensive care patients seldom result in a therapeutic peak level. The 
proposed loading dose of 25 mg/kg is good for reaching a therapeutic 
level, although 29.6% remains subtherapeutic. Due to the linear 
correlation, more therapeutic levels may be reached with higher doses 
(25 to 30 mg/kg). New variables need further investigation to explain 
the high variability in achieved peak level.
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Introduction Antibiotic-associated diarrhoea (AAD) occurs in as many 
as 30% of patients receiving antibiotics, often leading to increased 
morbidity, prolonged in-hospital stay and additional healthcare 
resource utilisation. Age, antibiotics and prolonged postoperative ward 
and ICU stay have been suggested to be independent risk factors. In 
such patient populations, probiotics may be used to prevent antibiotic-
associated diarrhoea, yet they are not routinely recommended as a 
component of perioperative care. The aim of this study was to model 
the long-term costs associated with AAD and to assess the eff  ectiveness 
of probiotics as a preventive strategy.
Methods We developed a simulation model to determine clinical costs 
and outcomes attributable to AAD. To assess the cost-eff  ectiveness of 
probiotics, as part of a perioperative regime, we constructed a decision 
Figure 2 (abstract P81). Handheld system with brown blinder shell for 
clinical trials.
Figure 1 (abstract P82). Correlation between dose of amikacin and peak concentration.
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as compared with conventional therapy, from a societal perspective. 
Input parameters, extracted from meta-analysis, clinical trials and 
national databases, include incidence numbers, costs and quality-
adjusted health states for the remaining life (QALYs). Outcomes assessed 
were overall costs attributable to ADD and the cost-eff  ectiveness of 
probiotics, described as costs/QALY.
Results Our results indicate an estimated incremental lifetime cost of 
£13,272.53 per ADD patient, largely driven by increased ICU length of 
stay and readmission rates. The addition of probiotics to the standard 
perioperative regime is associated with a small survival benefi  t of 
1.2 months, yet a cost reduction of £917.3/ADD patient. The main cost 
was increased duration of ICU stay and readmissions, which contribute 
to 85% of total expenses.
Conclusion AAD is associated with a signifi  cant increase in costs from a 
societal perspective. The provision of probiotics can achieve substantial 
cost savings and can be recommended as a cost-eff  ective regime in the 
perioperative setting. Preventing ADD off  ers a potentially signifi  cant 
reduction of in-hospital costs and resource expenditures.
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Introduction Novel treatment strategies for invasive candidiasis (IC) 
are constantly emerging. Nevertheless, diffi   culties in diagnosis pose 
a challenge on their reliability, effi   cacy and safety. We have previously 
developed and approbated in our ICU an algorithm for empirical 
antimycotic therapy, combining the most signifi  cant risk factors for 
IC with three major clinical criteria for persistent nonbacterial sepsis 
[1]. On the other hand, preemptive therapy, based on identifi  cation of 
mycotic antigens and/or anti-mycotic antibodies in serum, is regarded 
as more reliable, even though it is known for its low sensitivity. The 
aim of the current study was to compare and evaluate the possible 
outcome benefi  t of our protocol implementation versus detection of 
galactomanan in patient’s serum as a trigger for antimycotic treatment 
initiation.
Methods A randomized prospective controlled trial was carried out 
from September 2010 to September 2012. After the implication 
of the inclusion and exclusion criteria, patients were submitted to 
block randomization and stratifi  ed on the basis of their initial SAPS 
II exp score. Antimycotic therapy was started on the day of inclusion 
in the control group and only with positive galactomanan serum 
test in the preemptive therapy group. Initial data were gathered on 
demographics, proven risk factors for IC-related mortality, severity of 
infl  ammatory response and organ dysfunction. Dynamics of SIRS and 
SOFA values, Candida colonization index, ventilator-free days, length of 
ICU stay and outcome were followed for each patient.
Results A total of 106 patients were enrolled. No statistically signifi  cant 
diff  erences in their basal characteristics were found. The subsequent 
SIRS and SOFA scores showed fi  rm dynamics in the control group, 
although the new organ dysfunction severity was insignifi  cantly lower. 
The length of ICU stay and the number of ventilator-free days were 
comparable. The in-hospital mortality was 47.1% in the preemptive 
therapy group versus 31.3% in the control group (P = 0.94). A total of 
seven adverse reactions were observed among treated patients, yet 
not associated with higher mortality risk.
Conclusion The choice of empirical versus preemptive therapy led to 
earlier and more stable reduction in the degree of organ dysfunction 
severity. It showed to be at least not inferior if not equal; in terms of 
survival benefi  t and expediency of treatment. Moreover, galactomanan 
detection fails to guide the choice of the individual antimycotic, based 
on the expected Candida spp.
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Introduction  Invasive candidemia is a major cause of increased 
mortality among ICU patients. Antifungal agents like liposomale 
amphotericin B and azoles could not accomplish the claim to be fi  rst 
choice in the treatment of invasive fungal infection (IFI) because of side 
eff  ects and eff  ectiveness. Especially, cardiothoracic surgery patients 
as a group of high-risk patients are in a focus for new strategies 
and agents. A new class of antimycotic agents, the echinocandins, 
with a low profi  le of side eff  ects, low interactive potential and high 
eff  ectiveness in the treatment of candidemia, is a powerful option in 
the treatment of IFI. We report our single-center experience with a 
modifi  ed clinical treatment approach based on clinical score of Leon 
and using echinocandins as fi  rst-line therapy for proven and suspected 
fungal infection.
Methods  From May 2011 to October 2012, 2,844 patients were 
treated on our cardiothoracic ICU. We evaluated 37 cardiothoracic 
postoperative patients with proven or suspected IFI or prophylaxis 
(Figure 1). The records were evaluated for cardiothoracic procedures, 
microbiological and yeast date, cardiothoracic surgery score (CASUS), 
ICU and clinical data.
Results  Mean age was 67.4  years with 64% male patients. Most 
patients had combined CABG and valve procedure (n = 20), other 
groups were HTX and LTX (n = 4), assist therapy (n = 4), TAVI (n = 3) 
and other procedures. Mean predicted mortality using the logarithmic 
CASUS score at the onset of IFI was 59%. C. albicans was isolated in 73%, 
C. glabrata in 21%. Length of antifungal treatment using micafungin in 
30 cases was 14 ± 5 days. Eradication of yeast was successful in 79% 
but mortality of all patients remains high at 36.8% but was lower than 
predicted in the CASUS score. Mortality was not yeast related.
Conclusion  Our described treatment approach shows encouraging 
results for the treatment of IFI especially in high-risk cardiothoracic 
patients.
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Introduction Infection is a common complication of the ventricular 
assist device (VAD) and is associated with poor outcome especially 
Figure 1 (abstract P85). Cologne antifungal strategy.
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fungal infection (IFI) in severely ill ICU patients with a VAD support is 
not described. This study analyzes the incidence and outcome of fungal 
infection and colonization in VAD patients in bridge to transplantation 
or in destination therapy.
Methods We conducted a retrospective review of all VAD implantations 
in our surgical ICU between 2007 and 2012. The incidence of fungal 
colonization, antifungal prophylaxis, bacterial sepsis and the mortality 
of IFI versus no IFI patients were compared.
Results  In the study period, 34 patients with severe heart failure 
or cardiogenic shock were selected for a VAD implantation (nine 
in destination therapy). The overall mortality rate was 50% during 
mechanical assistance. Confi  rmed (n = 8) and highly suspected (n = 2) 
IFI occurred during the ICU stay in 29% of patients who were treated 
with echinocandins, voriconazole and/or liposomal amphotericin B. The 
isolated fungi were: six Candida albicans, two parapsilosis, one glabrata 
and one invasive pulmonary aspergillosis. Antifungal prophylaxis with 
fl  uconazole was administered to 18% of patients at mean for 5 days 
mainly in the more recent implantations. In the no IFI population, 
54% (n = 13) had a systemic or VAD bacterial sepsis with a mortality 
rate about 54%. The mortality without any sepsis was reduced to 18%. 
Fungal colonization was signifi   cantly more present (90% vs. 50%) 
before IFI in VAD patients. The mortality rate was dramatically higher 
with IFI (80% vs. 38%) in accordance with the literature [1]. See Table 1.
Table 1 (abstract P86). Fungal colonization (FC), infection and outcome 
during VAD support
  n  FC Mortality
No IFI  24  12  9
IFI 10  9  8
P value     0.029  0.024
Conclusion In our center, we observed a high incidence of IFI in ICU 
patients with VAD that was associated with a mortality rate of 80%. 
Screening of fungal colonization appears to be very important during 
the ICU stay for VAD patients. Trials are needed for investigating the 
use, the drug choice and the timing of antifungal prophylaxis for such 
high-risk patients.
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Introduction  Echinocandins are recommended fi  rst-line  treatment 
for candidaemia [1]. A cost-eff  ectiveness model developed from a UK 
perspective examined costs and outcomes of antifungal treatment 
for candidaemia and other forms of invasive candidiasis based on 
European clinical guidelines [1].
Methods  Costs and treatment outcomes with the echinocandin 
anidula  fungin were compared with caspofungin, micafungin, 
fl  uconazole, voriconazole and amphotericin B. The model included 
non-neutropenic patients aged ≥16 years with confi  rmed candidaemia/
another form of invasive candidiasis receiving intravenous fi  rst-line 
treatment [2]. Patients were categorised as a clinical success or failure 
(patients with persistent/breakthrough infection); frequency data for 
each outcome were taken from a mixed-treatment comparison [3]. 
Successfully treated patients switched to oral therapy. Clinical failures 
switched to a diff  erent antifungal class. It was assumed that second-line 
treatment duration was equivalent to that of fi  rst-line treatment and 
only two lines of therapy were required to treat infection. Other inputs 
were all-cause 6-week mortality, cost of treatment-related adverse 
events (AEs) and other medical resource use costs. Life-years were 
calculated using a published model [4]. Antifungal agent-related AEs 
were taken from the product label/literature. Resource use was derived 
from the literature and discussion with clinical experts. Drug acquisition/
administration costs were taken from standard UK costing sources.
Results  First-line anidulafungin for treatment of candidaemia was 
cost-eff   ective per life-year gained versus fl  uconazole  (incremental 
cost-eff  ectiveness ratio £813). Anidulafungin was cost saving versus 
caspofungin and micafungin in terms of life-years gained due to 
lower ICU costs and a higher rate of survival combined with a higher 
probability of clinical success.
Conclusion  Anidulafungin was cost-eff   ective compared with 
fl  uconazole for treatment of candidaemia and was cost saving versus 
other echinocandins in the UK. European guidelines recommend 
echinocandins as fi   rst-line treatments for candidaemia [1]; this 
model indicates that anidulafungin marries clinical eff  ectiveness and 
cost-eff  ectiveness.
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Introduction Invasive fungal infections (IFI) aff  ect 1% of ICU patients 
and are increasing in incidence. IFIs are associated with a poor 
prognosis, which is further complicated by diffi   culties in identifi  cation 
of fungal organisms by traditional culture methods and the emergence 
of Candida species resistant to triazole therapy [1,2]. This study aimed to 
assess the prevalence of IFIs, the organisms responsible and outcomes 
of patients aff  ected.
Methods Patients admitted to the Heart of England NHS Foundation 
Trust ICUs who acquired an IFI were identifi  ed through the hospital 
Fungal Infection Risk Evaluation (FIRE) study database. All ICU patients 
admitted between October 2009 and March 2011 were used as a 
comparative cohort. Data collected included: baseline demographics, 
length of stay, ICU and hospital mortality, and nature of IFI. Data were 
analysed using Student’s t test for continuous data and Fischer’s exact 
test for categorical data.
Results A total of 2,426 patients were admitted to Heart of England 
NHS Foundation Trusts ICUs during the study period. Of these, 31 
patients were identifi  ed as having an IFI (1.3%). Baseline demographic 
data were similar between groups. Patients with IFI had signifi  cantly 
longer ICU length of stay (19 days vs. 5 days, P <0.0001) and required 
more days of advanced organ support (12 days vs. 3 days, P <0.0001). 
A trend towards higher hospital mortality (41% vs. 27%, P = 0.08) was 
observed. Candida albicans was the predominant organism cultured 
(64%), followed by Candida glabrata (23%), with other Candida species 
accounting for the remaining 13% of IFIs. Sites of IFIs were blood (45%), 
intra-abdominal (39%), and pleural (16%). Most patients (52%) who 
acquired an IFI had had intra-abdominal surgery prior to ICU admission. 
The majority of patients (71%) were treated with echinocandins, whilst 
of the nine patients who were initially treated with fl  ucanazole, six 
(67%) required therapy escalation to an echinocandin.
Conclusion The results of our study are consistent with other published 
data, in that whilst IFI prevalence is low, they are associated with 
increased morbidity in critically ill patients. This study has led to a 
change in hospital policy regarding antifungal use in the ICU, with 
echinocandins being fi  rst-line in the pre-emptive treatment of IFI. We 
keenly await the results of the FIRE study, which will provide important 
insights to identifi  cation of patients at risk of IFIs and optimal drug 
therapy.
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Introduction The aim of this study was to compare self-reported beliefs 
with actual clinical practice of oxygen therapy in the ICU. Hyperoxia is 
frequently encountered in ventilated patients and prolonged exposure 
has repeatedly been shown to induce lung injury and (systemic) 
toxicity.
Methods An online questionnaire for ICU clinicians was conducted 
to investigate beliefs and motives regarding oxygen therapy for 
critically ill patients. Furthermore, arterial blood gas (ABG) samples 
and corresponding ventilator settings were retrieved to retrospectively 
assess objective oxygenation between 1 April 2011 and 31 March 2012 
in the ICUs of three teaching hospitals in the Netherlands.
Results Analyzable questionnaire responses were received from 200 
ICU physicians and nurses. The majority of respondents believed 
that oxygen-induced lung injury is a concern, although barotrauma 
and volutrauma are generally considered to impose a greater risk in 
mechanical ventilation. Frequently allowed minimal saturation ranges 
in the questionnaire were 85 to 95% and 7 to 10 kPa (Figure 1). Self-
reported FiO2 adjustment in hypothetical patient cases with variable 
saturation levels was moderately impacted by the underlying clinical 
condition. To study actual clinical practice, a total of 107,888 ABG 
samples with corresponding ventilator settings, covering 5,565 patient 
admissions, were retrieved. Analysis showed a median (IQR) PaO2 of 
11.7 kPa (9.9 to 14.3), median FiO2 was 0.4 (0.4 to 0.5), median PEEP was 
5 (5 to 8). A total 63.5% of all PaO2 registries were higher than previously 
suggested oxygenation goals (7.3 to 10.7 kPa) [1]. In 56.8% of cases 
with PaO2 higher than the target range, neither FiO2 nor PEEP levels 
had been lowered when the next ABG sample was taken.
Conclusion  Most clinicians acknowledge the detrimental eff  ects of 
prolonged exposure to hyperoxia in the ICU and report a low tolerance 
for high saturation levels. However, the self-reported intention for 
conservative oxygen therapy is not consistently expressed in our 
objective data of actual clinical practice and a large proportion of 
patients was exposed to high and potentially toxic oxygen levels.
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Introduction  During mechanical ventilation, oxygenation can be 
infl   uenced by adjusting FiO2 and positive end-expiratory pressure 
(PEEP). There have been recommendations for how the FiO2 and 
PEEP should be set [1]. However, in a recent audit we found that the 
compliance of doctors of these recommendations is very low [2]. 
Therefore we invented a simple parameter called the FiO2/PEEP index 
(FPi) of which the physiologic value is ≤7 (that is, FiO2 = 21%/PEEP = 
3 cmH2O), which corresponds to the ARDSNet trial’s minimum FiO2/
PEEP settings: 35%/5 cmH2O [2]. The aim of this case–control study 
was to investigate the impact of an FPi ≤7 targeted protocol on clinical 
practice.
Methods A prospective observational study in 2010 and 2012. Every 
mechanically ventilated patient was recruited. Demographics, outcome 
data and Lung Injury Score (LIS) were recorded after admission. 
Respiratory settings, oxygenation and ventilation parameters were 
recorded after mechanical ventilation was commenced and the fi  rst 
arterial blood gas sample was taken (T0). Measurements were repeated 
in 24 hours (T1). Data are presented as mean ± SD, paired-sample and 
independent-sample t test and chi-square tests were used for statistics.
Results In 2010, 75 patients, and in 2012, 130 patients were included. 
There was no diff  erence in demographics, disease severity, but LIS 
was higher in 2012: 1.34 ± 1.13 versus 0.84 ± 0.98, P = 0.001. There 
was no signifi  cant diff  erence in FPi between the two groups at T0: 
10.91 ± 4.25 versus 10.26 ± 5.01 (2012 vs. 2010, respectively). At T24 the 
FPi was signifi  cantly lower in 2012 as compared with 2010: 7.28 ± 2.58 
versus 8.17 ± 3.3, P = 0.001; which was due to the higher PEEP applied: 
7.08 ± 2.87 versus 6.63 ± 2.91, P = 0.014. Although in 2012 signifi  cantly 
more patients, 112 (86%), were ventilated with FiO2 ≥50% at T0 as 
compared with 2010, 44 (58%) (P = 0.001), by T24 signifi  cantly less 
patients received FiO2 ≥50%, 46 (35%) vs. 34 (45%) (P = 0.011). There 
was no signifi  cant diff  erence between the two groups regarding FiO2, 
PaO2 and PaCO2 at T0 and T24.
Conclusion  Implementing an FPi ≤7-based algorithm signifi  cantly 
reduced the FiO2 and increased the PEEP applied in mechanically 
ventilated within the fi  rst 24 hours. Whether this has any impact on 
earlier weaning due to reaching the weaning criteria of FiO2 sooner, 
and as a result shortening the duration of mechanical ventilation, has 
to be investigated in the future.
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Introduction  High-fl   ow nasal canulae (HFNC) deliver high-fl  ow 
humidifi  ed gas at up to 60 l/minute. There are two types of respiratory 
circuit to generate mix gas fl  ow, Blender type (typeB) and Venturi type 
(typeV). The therapy is well established in the pediatric population 
and HFNC use has been described in the adult population. It has been 
reported that HFNC provide higher FIO2 compared with low-fl  ow 
canulae, and also create mild positive pharyngeal airway pressure, but 
the eff  ect on alveolar pressure is unknown. We aimed to investigate 
the eff  ect of HFNC on alveolar pressure, by measuring intratracheal 
pressure in patients with a cricothyrotomy catheter (CTC). At the same 
time, we measured the actual gas fl  ow rate (AGFR) by fl  owmeter and 
compared it with assumed fl  ow.
Methods Seven patients with a CTC were participated. A tube was 
connected to the CTC and the tube was then connected to a pressure 
transducer to measure intratracheal pressure. The HFNC (Optifl  ow 
Figure 1 (abstract P89).
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TypeB was used in three patients and typeV in four patients. The fl  ow 
was started at 10 l/minute. This fl  ow rate was titrated upwards to a 
maximum of 60 l/minute (10, 25, 30, 40, 50, 60 l/minute) and the AGFR 
was measured. Intratracheal pressure tracing was done over 1 minute. 
Airway pressure measurement was repeated and the maximal 
expiratory pressure was measured in mmHg.
Results The AGFR in the respiratory circuit was almost same in typeB, 
but there was obvious decrease in the AGFR in typeV (7.1  ±  1.0, 
17.7 ± 0.8, 21.9 ± 0.9, 29.9 ± 3.6, 36.9 ± 2.7, 45.0 ± 5.5 l/minute at assumed 
fl  ow, 10, 25, 30, 40, 50, 60 l/minute, respectively). HFNC signifi  cantly 
increased maximal expiratory pressure in both groups, 1.5  ±  2.1, 
2.0 ± 1.0, 3.0 ± 2.8, 4.5 ± 3.5 mmHg for typeV and 2.5 ± 0.7, 5.8 ± 2.4, 
6.0 ± 2.8, 8.0 ± 2.8 mmHg (maximum 10 mmHg) for typeB, when AGFR 
was set at 30, 40, 50, 60 l/minute. Higher AGFRs were found to result 
in larger increase in maximum expiratory pressure. The data indicate 
that HFNC are associated with an increase in intratracheal expiratory 
pressure. Because it was diffi   cult to determine end-expiratory pressure, 
we chose maximal expiratory pressure for a substitute. The reason why 
AGFR in typeV was lower than assumed fl  ow may be the resistance 
generated by NC. The larger increase in expiratory pressure in our study 
than previously reported may be due to the eff  ect of high respiratory 
resistance of Japanese who have relatively small airway structure 
compared with western people.
Conclusion HFNC are eff  ective in providing higher expiratory pressure. 
It is important to know the fl  ow rate is lower than expected when the 
Venturi type is used.
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Introduction  Many authors have proposed less invasive ways to 
measure oxygenation in patients with ALI. The aim of the present study 
is to compare the already popular oxygenation index (OI) and PaO2/
FiO2 ratio (PFr) with other recently proposed indices such as SpO2/FiO2 
ratio (SFr) and ventilation ratio (VR) in a mixed ICU population.
Methods During a 6-month prospective observational study carried 
out in a polyvalent 10-bed adult ICU, ABGs were obtained from 145 
patients. Two independent measurements were taken from each 
patient under the same mode of ventilation (SIMVPSV). PFr, SFr, VR 
and OI were calculated. Demographic data (APACHE II score, age, sex, 
diagnosis, body weight) were also recorded. Kolmogorov–Smirnov 
test for normality was calculated followed by bivariate nonparametric 
analysis (statistical signifi  cance: P <0.05).
Results A total of 290 measurements were included for further analysis. 
Mean ± SD values for age and APACHE II score were 61.2 ± 16 years and 
15.4 ± 1.8, respectively, while median ± SD values for PFr are 257 ± 135, 
for SFr 211 ± 58, for OI 4.8 ± 4.46 and for VR 1.19 ± 0.31. Relations 
between PFr, SFr and OI are displayed in Table 1.
Table 1 (abstract P92). Correlations (Spearman ρ) between VR, PFr, SFr and OI
 PFr  SFr  OI
VR –0.326*  –0.325*  0.373*
PFr –  0.759*  –0.939*
SFr –  –  –0.773*
*P <0.01.
Conclusion Our study identifi  ed a strong relation between PFr, SFr and 
OI but not VR. Thus, these markers may be used interchangeably as 
bedside indices of oxygenation in critically ill patients. Yet larger studies 
are needed to come to a safer conclusion.
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Introduction  Respiratory complexity (RC) as assessed by sample 
entropy (SampEn) is lower in patients failing spontaneous breathing 
trials. We evaluated the role of RC in monitoring subjects with severe 
acute respiratory distress syndrome (ARDS) treated with the Cardiohelp 
(Maquet, Rastatt, Germany) extracorporeal life-support system (ECLS). 
We hypothesized that RC is reduced during apnea.
Methods Six sheep sedated with midazolam were connected to the 
Cardiohelp via a 23F Avalon catheter. Blood fl  ow was ~2  l/minute 
and FiO2 was 0.5. Sheep were on CPAP of 8 cmH2O with FiO2 of 1 via 
tracheostomy. After ~6 hours of ECLS, ARDS was induced by injection 
Table 1 (abstract P93)
    Preinjury Preinjury Preinjury  Postinjury  Postinjury  Postinjury
  BL  pre-apnea apnea  post-apnea  pre-apnea apnea  post-apnea
RR (breaths/minute)  22 ± 2  22 ± 3  17 ± 2  23 ± 4  24 ± 7  5 ± 1*  25 ± 7
TV (ml)  388 ± 31  217 ± 32  145 ± 14  205 ± 21  211 ± 51  116 ± 30*  229 ± 40
HR (beats/minute)  156 ± 15  153 ± 21  152 ± 21  166 ± 21  162 ± 22  165 ± 21  151 ± 16
MAP (mmHg)  102 ± 4.12  102 ± 6.13  103 ± 6.91  104 ± 6.08  106 ± 3.76  108 ± 3.86  111 ± 5.69
PFR (unitless)  435 ± 24.80  417 ± 48.06  354 ± 49.52  429 ± 37.87  139 ± 50.90*  92 ± 30.43*#  91 ± 27.25*
IBI (ms)  2,765.1 ± 230.5  3,149.8 ± 378.0  5,151.7 ± 467.7  3,404.7 ± 663.0  2,253.2 ± 427.0  10,334.0 ± 1,739.2*#  2,162.0 ± 387.6
IBI Dev (ms)  771.8 ± 117.49  1,630.0 ± 230.64  4,505.7 ± 785.34  1,598.3 ± 292.45  1,404.8 ± 445.04  25,065.0 ± 11,480.37*#  844.6 ± 236.65
SampEn (unitless)  1.7 ± 0.12  1.6 ± 0.16  1.3 ± 0.13  1.6 ± 0.11  1.2 ± 0.14  0.5 ± 0.25*#  1.3 ± 0.20
FW (%)  29.9 ± 4.60  41.5 ± 7.43  41.8 ± 10.15  34.5 ± 6.10  44.0 ± 8.80  62.2 ± 4.16*  33.6 ± 5.26
BPwEn (unitless)  4.9 ± 0.18  4.3 ± 0.27  4.1 ± 0.37  4.6 ± 0.22  4.1 ± 0.42  2.7 ± 0.38*#  4.4 ± 0.24
DisNEn (unitless)  0.8 ± 0.03  0.7 ± 0.04  0.7 ± 0.06  0.8 ± 0.05  0.7 ± 0.07  0.4 ± 0.06*#  0.7 ± 0.04
StatAv (unitless)  0.42 ± 0.06  0.37 ± 0.09  0.37 ± 0.04  0.41 ± 0.10  0.31 ± 0.05  0.51 ± 0.07  0.42 ± 0.08
*Signifi  cant diff  erence versus Baseline. #Signifi  cant diff  erence between Preinjury and Postinjury apnea.
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ventilation) developed both before (Preinjury) and after ARDS 
(Postinjury). Heart rate (HR), mean arterial pressure (MAP), respiratory 
rate (RR) and tidal volume (TV) were recorded, and the PaO2:FiO2 ratio 
(PFR) calculated corresponding to sections of respiratory pressure 
waveforms containing 200 breaths during Baseline, during Preinjury 
and Postinjury apnea periods. Similar periods were selected before 
and after apneas. Inter-breath interval (IBI) and its deviation, SampEn, 
percentage of forbidden words (FW), bit per-word entropy (BPWEn), 
symbol distribution entropy (DisNEn), and stationarity (StatAv) 
were calculated using software. Statistics by one-way ANOVA with 
adjustment for multiple comparisons.
Results  See Table  1. SampEn was associated with PFR (r2  = 0.31, 
P <0.001).
Conclusion Respiratory complexity during apnea and ECLS remains 
unchanged in a healthy state but decreases after ARDS. It has a 
signifi  cant association with PFR and may serve as an index of injury 
severity.
P94
Acute respiratory distress syndrome – the Berlin defi  nition: impact 
on an ICU of a university hospital
A Agrifoglio, J Lopez, J Figueira, M Hernández, L Fernández, M Irazabal, 
S Yus, M Jiménez
Hospital Universitario La Paz, Madrid, Spain
Critical Care 2013, 17(Suppl 2):P94 (doi: 10.1186/cc12032)
Introduction The current defi  nition of ARDS was established in 1994 by 
the AECC. In 2011 emerged the Berlin defi  nition. The aim of this study 
was to fi  nd a new approach from the impact of ARDS in an ICU and to 
analyze APACHE II score, days of mechanical ventilation (MV), duration 
of ARDS and mortality.
Methods We analyzed the database of our ICU collected prospectively 
from October 2008 to January 2011 and regarded all patients 
undergoing MV for 48 hours or more and who met the AECC criteria. All 
patients were ventilated according to the ARDSNet protocol.
Results During this period 1,900 patients were admitted, 607 were 
under MV for at least 48 hours and 104 had ARDS criteria. Moderate 
ARDS 60.6%: 60% male, median age 53 years, APACHE II mean 22.49 
(95% CI = 20.71 to 24.27), mean duration MV 23.84 (95% CI = 18.08 to 
29.60), ARDS duration 12.87 (95% CI = 9.83 to 15.90), average stay 29.22, 
mortality 52.4%. Severe ARDS 39.4%: 63% male, median age 45 years, 
APACHE II mean score 23.19 (95% CI = 20.62 to 25.75), mean duration 
MV 18.52 (95% CI = 13.01 to 24.03), ARDS duration 12.15 (95% CI = 
8.72 to 15.58), average stay 22.65, mortality 48.8% with no statistically 
signifi  cant diff  erence with moderate ARDS (P = 0.72). Leading cause of 
death in both groups: multiorgan dysfunction (60%). See Tables 1 and 2.
Conclusion In this new approach of our ARDS patients we found no 
statistically signifi  cant diff  erences in relation to the variables of interest 
to analyze in the two groups. Patients with severe ARDS who survive 
ICU admission have a longer duration of ARDS, which means more days 
on MV and therefore increased ICU stay.
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Introduction We compared three diff  erent methods for diagnosing 
pulmonary edema induced by weaning from mechanical ventilation: 
the increase in extravascular lung water index (EVLWI), the increase 
in B-type natriuretic peptide (BNP) and blood volume contraction, 
refl  ected by increases in plasma protein and in hemoglobin concen-
trations, all observed during a spontaneous breathing trial (SBT).
Methods We included 12 diffi   cult-to-wean patients (22 recordings). 
Before and at the end of a SBT (T tube), we measured pulmonary 
occlusion arterial pressure (PAOP), EVLWI (PiCCO device), BNP, plasma 
protein and hemoglobin concentrations. Weaning-induced pulmonary 
edema was confi  rmed if a clinical intolerance to SBT was associated 
with an increase of PAOP >18 mmHg at the end of SBT.
Results A weaning-induced pulmonary edema was diagnosed in 12 
instances (PAOP signifi  cantly increased from 15.6 ± 0.6 to 25.8 ± 0.9 
in these cases). EVLWI, BNP, plasma protein and hemoglobin 
concentrations signifi  cantly increased in these instances (28.3 ± 5.7%, 
20.2 ± 7.8%, 9.6 ± 0.8% and 9.3 ± 1.3%, respectively) while they did not 
signifi  cantly changed in cases without weaning-induced pulmonary 
edema. The increase of EVLWI ≥8.5% (+1.5  ml/kg), an increase in 
BNP ≥6.7% (+23 pg/ml), an increase in plasma protein concentration 
≥5% and in hemoglobin concentration ≥5% exhibited good areas 
under the ROC curves to predict weaning-induced pulmonary edema 
(0.97 ± 0.03, 0.80 ± 0.11, 1.0 ± 0.00 and 0.92 ± 0.05, respectively). These 
areas under the ROC curves were not statistically diff  erent. The baseline 
values of EVLWI, BNP, plasma protein and hemoglobin concentrations 
did not predict weaning-induced pulmonary edema.
Conclusion The increases in EVLWI, in plasma protein and hemoglobin 
concentration and in BNP are valuable alternatives to the pulmonary 
artery catheter for diagnosing weaning-induced pulmonary edema.
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Introduction The primary aim of this study is to assess the impact of 
pressure support ventilation (PSV) on the rate of pneumothorax and 
mortality in critically ill patients with lung injury. The secondary aim is 
to evaluate pressure–volume (P–V) relationships. Spontaneous modes 
of ventilation have been associated with lower rates of atelectasis, 
less muscle atrophy, better airfl  ow distribution and importantly lower 
sedation requirements, which relates to lower mortality. Accordingly, 
we hypothesized that the use of PSV in patients with moderate/severe 
lung injury would have rates of pneumothorax and mortality within the 
standard of care. We further hypothesized that given its spontaneous 
nature, set pressures (PEEP and PS) but not tidal volume (Vt) would be 
related to airway pressures.
Methods  All adult patients admitted to two surgical/medical ICUs 
subjected to invasive mechanical ventilation (MV) were enrolled. 
Patients were stratifi   ed by Lung Injury Score (LIS) in two groups: 
<2.5 (LISL); ≥2.5 (LISH). Exclusion criteria included pneumothorax on 
admission, use of other ventilatory strategies, and inability to trigger 
ventilation. Patients were ventilated with PSV, and treated only with 
pro re nata  haldol, morphine and clozapine. Airway pressures and 
Table 1 (abstract P94). Subgroup analysis: moderate ARDS
Variable Survivors  Nonsurvivors  P value
APACHE II  20.06 ± 6.96  24.83 ± 6.17  0.006
MV (days)  25.63 ± 29.13  22.21 ± 15.43  0.557
ARDS (days)  10.29 ± 9.07  15.20 ± 12.92  0.107
ICU stay   34.33 ± 33.26  24.57 ± 16.91  0.142
Table 2 (abstract P94). Subgroup analysis: severe ARDS
Variable Survivors  Nonsurvivors  P value
APACHE II  20.82 ± 8.89   25.31 ± 5.63  0.761
MV (days)  26.95 ± 18.03  10.10 ± 11.64  0.001
ARDS (days)  15.8 ± 11.60  8.5 ± 8.6  0.031
ICU stay   33.52 ± 18.25  11.25 ± 11.80  0.001
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as mean ± 95% CI. *P > 0.05.
Results A total of 166 patients with mean age 55 (52 to 58) years, LIS 
of 2.27 (2.16 to 2.37) and MODS of 3.13 (2.9 to 3.3) were enrolled and 
stratifi  ed by LISL (65.8%) and LISH (34.2%). Mortality, and incidence 
of pneumothorax and atelectasis were 21% (14.9 to 28.2), 1.6% (0.8 
to 3.1) and 6.4 (3.2 to 11.2). Duration of MV was 6 days (4.83 to 7.16). 
Pneumothorax in LISL and LISH was 1% (0 to 5.2) versus 2.4% (0.7 
to 6.1)*, and mortality 11.4% (3.8 to 24.6) versus 25% (9.8 to 46.7)*. 
Mean parameters were: Vt 10.3 ml/kg (10.1 to 10.6); PEEP 10.6 (9.9 to 
11); PS 16.6 (15.9 to 17.1); plateau pressure (Ppl) 25.7 (25.1 to 26.2). 
Ppl was >26.2 only in 2.5%. PEEP and PS (P <0.0001), and MODS were 
associated with Pplt, but not Vt* or LIS. Only lower Vt was associated 
with barotrauma (OR = 0.996, P = 0.02).
Conclusion We demonstrate that PSV in minimally sedated patients 
with severe lung injury is safe as it is associated with low incidence 
of barotrauma, atelectasis and mortality, and with Ppl and duration 
of MV within standard of care. We also demonstrate in PSV that P–V 
relationships may diff  er and that in this setting higher Vt may not be 
deleterious.
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Introduction  The aim of this study is to compare two ventilation 
strategies, the ARDSNet protocol and open lung management, using 
computer control for 6 hours. The standard therapy for patients with 
ARDS does typically apply a mechanical ventilator to support breathing. 
The cost of therapy is high and it requires much attention from 
physicians to adjust the proper ventilation settings in a timely manner. 
A closed-loop ventilation concept has therefore been developed and 
tested with two induced ARDS pigs.
Methods The hardware system is composed of a ventilator (Servo 300), 
a spectrophotometry (CEVOX), a capnography device (CO2SMO+), an 
electrical impedance tomography device (GOE MF II) and a patient 
monitor (Sirecust). The software is developed with Labview 7.1. With 
approval from the ethical committee, two 27 kg pigs were exposed to 
surfactant depletion with a warm saline washout to induce ARDS (PaO2/
FiO2 <200 mmHg). One pig model was ventilated with an automatic 
ARDSNet protocol and another was automatically ventilated with open 
lung management. Blood gas analysis (BGA) was carried out every half 
an hour.
Results Artifi  cial ventilation using the auto ARDSNet protocol success-
fully stabilized oxygenation, minimized plateau pressure (<30 cmH2O), 
and controlled the pH value for acidosis and alkalosis management. On 
the other hand, auto open lung management off  ers a distinctive result 
of ventilation. A signifi  cant improvement of oxygenation and lung 
compliance was observed within a few breaths after the recruitment 
maneuvers. Both subjects were ventilated at the same tidal volume of 
6 ml/kg and the comparative results of automatic ventilation settings 
and BGA are provided in Table 1 for every 2 hours.
Conclusion  The auto open lung management concept gave much 
better gas exchange than the auto ARDSNet protocol. These 
preliminary results showed a necessity to evaluate the two diff  erent 
ventilation strategies. Therefore, further experiments with pig models 
will be implemented in the near future to obtain results with statistical 
signifi  cance and to ensure the safety of automation in a mechanical 
ventilation system.
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Introduction  Intellivent-ASV has been developed to provide fully 
closed loop mechanical ventilation using a ventilation controller keep-
ing EtCO2 and SpO2 within expert-based ranges. Ventilation of ARDS 
patients focuses on delivering adequate oxygenation and allowing 
elimination of CO2 while protecting the lung. The objectives were to 
compare Intellivent-ASV with conventional ventilation on safety and 
effi   cacy, and to compare the number of manual adjustments between 
the two ventilatory modalities.
Methods  A randomized, controlled study including all consecutive 
patients receiving mechanical ventilation for at least 48 hours. Patients 
were randomly ventilated either with Intellivent-ASV or conventional 
ventilation, with a S1 (Hamilton, Bonaduz, Switzerland). Parameters 
were adjusted by the clinician in charge of the patient. Ventilatory and 
oxygenation parameters were recorded cycle by cycle during 48 hours 
and blood gases were performed every 6 hours.
Results Twenty-four patients with ARDS were included, 10 female, 14 
male, median age 58 (46 to 63) years, APACHE II score 22 (17 to 29), 
PaO2/FiO2 at inclusion 136 (107 to 154). Eleven were ventilated in the 
conventional group and 13 in the Intellivent-ASV group. The study was 
stopped for one patient from the Intellivent-ASV group because of a 
pneumothorax not caused by ventilation. The delivered Vt was slightly 
higher during Intellivent-ASV (7.9 (7.5 to 8.5) vs. 7.2 (6.8 to 7.8) ml/kg, 
P = 0.013). The time spent by the various parameters in the suboptimal 
zone (safety) is the same for the two ventilation modes. The time spent 
in the optimal zone (effi   cacy) is the same for the two ventilation modes, 
Table 1 (abstract P97). Comparative results between auto ARDSNet protocol and auto open lung management
  Before auto ventilation  After 2 hours  After 4 hours  After 6 hours
  Auto ARDSNet  Auto OLM  Auto ARDSNet  Auto OLM   Auto ARDSNet  Auto OLM   Auto ARDSNet  Auto OLM
FiO2  1.0  1.0  0.40 0.25 0.40 0.25 0.50 0.25
RR  (bpm) 22 40 23 38 23 39 23 35
I:E  ratio  1:2 1:1 1:2 1:1 1:2 1:1 1:2 1:1
VT (ml/kg)  6 6 6 6 6 6 6 6
Pplat /PIP  (mmHg)  22  22  18  20.6 15.8 17.7 14.6 15.4
PEEP (cmH2O)  5 10 8 15 2 13  10  11
pH  7.34 7.30 7.32 7.52 7.37 7.60 7.38 7.51
pO2/FiO2  (mmHg)  59  59  180 380.8 155 387.2 122  404
pCO2  (mmHg)  52 64 56  39.6  58  31.5  54 41
OLM, open lung management.
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P = 0.001). Intellivent-ASV required less manual adjustments during 
48 hours (2 (0 to 7) vs. 17 (10 to 27), P <0.001). The total number of 
adjustments during 48 hours, including automatic regulation, was 
higher in the Intellivent-ASV group (379 (274 to 493) vs. 17 (10 to 27), 
P <0.001).
Conclusion Over 48 hours, Intellivent-ASV allowed safe ventilation for 
ARDS patients, with better oxygenation and an identical ventilation 
effi     cacy when compared with conventional ventilation, with less 
manual adjustments.
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Introduction ARDS is characterized by increased pulmonary capillary 
permeability secondary to diff  use alveolar infl  ammation and injury. 
Common risk factors can be classifi  ed into two groups: extrapulmonary 
causes (indirect etiologies: ARDSexp) or pulmonary causes (direct 
etiologies: ARDSp). There are few quantitative methods to distinguish 
between the diff  erences in these two ARDS categories.
Methods A subanalysis of the trial by the PiCCO Pulmonary Edema 
Study (prospective, observational, multi-institutional study) in 23 ICUs 
of academic tertiary referral hospitals in Japan. All consecutive adult 
patients requiring mechanical ventilation with the diagnosis of ARDS 
were monitored by the transpulmonary thermodilution technique 
system (PiCCO; Pulsion Medical Systems, Munich, Germany) for 3 days: 
day 0, day 1 and day 2. The pulmonary vascular permeability index 
(PVPI), extravascular lung water index and intrathoracic blood volume 
index were measured concurrently. Three experts retrospectively 
determined the pathophysiological mechanism causing ARDS by 
patient history, clinical presentation, chest computed tomography and 
radiography. Patients were classifi  ed into two groups: patients with 
ARDS triggered by ARDSexp and ARDSp.
Results During the study period from March 2009 to August 2011, a 
total of 173 patients were assessed including 56 ARDSexp patients 
and 117 ARDSp patients, with the most common cause of ARDSexp 
secondary to sepsis (71%) and of ARDSp pneumonia (80%). The 
measure  ment of PVPI was signifi  cantly elevated in the ARDSp group 
on all days. There were no signifi  cant diff  erences in mortality at 28 days, 
mechanical ventilation days, and hospital length-of-stay between the 
two groups, while the ARDSexp group seemed to be associated with 
prolonged mechanical ventilation days and hospital length-of-stay.
Conclusion This study suggests the existence of several diff  erences 
in pathogenetic pathways and the degree of pulmonary permeability 
between patients with ARDSexp and ARDSp. We therefore believe that 
using the PVPI may provide us with timely quantitative information to 
make clinical decisions.
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septic patients: surfactant protein D and Clara cell protein
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Introduction The injury of alveolar epithelium and endothelium is the 
basis of pathogenesis for the early stage of acute respiratory distress 
syndrome (ARDS). A prompt detection of this injury will provide us 
with a possibility for early ARDS diagnosis and treatment. Currently 
no biomarkers of alveolar epithelial injury are clinically available. The 
purpose of our study was to investigate the role of surfactant protein D 
(SPD) and Clara cell protein (CCP) as biomarkers of early ARDS.
Methods This observational study in ICU mechanically ventilated septic 
patients with intra-abdominal surgical infections was carried out at the 
V.A. Negovsky Research Institute of General Reanimatology in 2010 
to 2012. ARDS was diagnosed and staged according to the research 
institute criteria [1] and the American–European criteria. Plasma 
concentrations of SPD and CCP were measured on ARDS diagnosis 
(day 0) and days 3, 5, and 7 by immunoenzyme essay (Bio Vendor, USA). 
Data were statistically analyzed by STATISTICA 7.0, ANOVA method, 
and presented as mean ± σ, ng/ml. P <0.05 was considered statistically 
signifi   cant. Areas under the receiver operating curves (ROC) were 
calculated.
Results Fifty-fi  ve patients (out of 250 screened) were enrolled according 
to the inclusion/exclusion criteria. Patients were assigned into groups: 
ARDS (n = 30; subgroups – ARDS stage 1 (n = 15), stage 2 (n = 15)) and 
noARDS (n = 25). In the ARDS group SPD was higher at all points than 
in the noARDS group (day 0 – 352.5 ± 287.8 vs. 141.0 ± 103.4; day 3 – 
278.6 ± 204.8 vs. 151.8 ± 125.9; day 5 – 339.9 ± 331.4 vs. 162.3 ± 138.8; 
day 7 – 339.9 ± 300.1 vs. 169.8 ± 154.5; P <0.05). SPD levels were lower 
at ARDS stage 1 in comparison with stage 2 (day 0 – 154.6 ± 125.2 vs. 
451.8 ± 299.2; day 3 – 129.3 ± 74.9 vs. 362.9 ± 202.0; day 5 – 167.8 ± 120.4 
vs. 428.5 ± 372.4; day 7 – 186.2 ± 127.1 vs. 415.5 ± 337.0; P <0.05). 
Plasma SPD had a good diagnostic capacity for stage 1 ARDS: SPD on 
day 0 ≤253.0 ng/ml yielded a sensitivity of 90% and specifi  city of 74% 
(AUC = 0.83; 95% CI = 0.631 to 0.951; P = 0.0001). No such diff  erences 
for CCP were detected.
Conclusion Plasma SPD level ≤253.0 ng/ml is a sensitive and specifi  c 
biomarker of the early stage of ARDS in septic patients.
Reference
1. Kuzovlev  A,  et al.: Semin Cardiothorac Vasc Anesth 2010, 14:231-241.
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Introduction Emulsifi  ed perfl  uorocarbons (PFC) are synthetic hydro-
carbons that can carry 50 times more oxygen than human plasma. Their 
properties may be advantageous in applications requiring preservation 
of tissue viability in oxygen-deprived states [1,2], making them a 
potential candidate for combat and civilian prehospital resuscitation. 
Our hypothesis is that an intravenous dose of PFC increases vital organ 
tissue oxygenation, improves survival after hemorrhagic shock (HS) 
and may reduce or prevent the development of ventilator-associated 
ARDS. Here we report data from the fi  rst part (HS only) of a multiphase 
swine study to study the benefi  ts of PFC in treating HS and preventing 
ARDS. This initial study was designed to ensure safe use of PFC in 
traumatized animals.
Methods Anesthetized Yorkshire swine were hemorrhaged 55% of their 
estimated blood volume (Time 0 (T0)) over 15 minutes. At T15 minutes, 
pigs received a bolus of the PFC Oxycyte or 10% hydroxyethyl starch 
(HES). At T60 animals underwent continuous hemorrhage (0.5 cm3/kg/
minute) until death. Time to death and physiological parameters were 
primary endpoints.
Results  Average survival time after onset of second hemorrhage 
was 60 minutes in PFC-treated animals versus 65 minutes in the HES 
group. Mean arterial pressure (MAP) was similar between T0 and T60, 
thereafter PFC-treated animals had lower MAP, mean pulmonary artery 
pressure (MPAP), heart rate and cardiac output (P >0.05).
Conclusion There was no signifi  cant diff  erence in survival time, MAP 
and MPAP in the PFC group compared with HES control. These data 
suggest that it is safe to administer in this HS model. Regulatory 
approval of hemoglobin-based oxygen carriers has been halted due to 
possible side eff  ects related to vasoconstriction. In this model, and with 
this class of oxygen-carrying drugs (PFCs), we did not observe evidence 
of vasoconstriction. Using PFCs did not result in a survival advantage 
here; however, there was also no observation of adverse events. Based 
Critical Care 2013, Volume 17 Suppl 2 
http://ccforum.com/supplements/17/S2
S37on these data we will continue to the next phase of this project and 
test PFC in the prevention of ARDS alone, and in combination with HS.
References
1. Keipert  PE,  et al.: Enhanced oxygen delivery by perfl  ubron emulsion during 
acute hemodilution. Artif Cells Blood Substit Immobil Biotechnol 1994, 
22:1161-1167.
2. Habler  O,  et al.: IV perfl  ubron emulsion versus autologous transfusion in 
severe normovolemic anemia: eff  ects on left ventricular perfusion and 
function. Res Exp Med (Berl) 1998, 197:301-318.
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Introduction The role of the D allele of the angiotensin-converting 
enzyme (ACE) gene I/D polymorphism in the clinical outcomes of 
patients with acute lung injury and acute respiratory distress syndrome 
(ALI/ARDS) remains controversial. We assessed simultaneously the 
eff  ect of the ACE I/D polymorphisms as well as the serum and BALF ACE 
levels on prognosis of ARDS patients.
Methods We recruited 69 mechanically ventilated ALI/ARDS patients. 
ACE activity levels in serum and BALF were assessed by chemical 
methods. Patients were genotyped for ACE I/D polymorphisms. Time-
to-event analysis evaluated the variables associated with the 28-day 
and 90-day mortality.
Results In the multivariable model, age, lung compliance, serum lactate 
and serum ACE levels were signifi  cantly associated with both 28-day 
and 90-day mortality. No signifi  cant correlation was found between 
serum and BALF ACE levels (Spearman’s ρ = 0.054; P = 0.66). Serum 
ACE concentrations were signifi  cantly higher (P = 0.046) in patients 
with D/D genotype versus the two other groups combined (I/D and 
I/I genotypes). A meta-analysis of six studies (including ours) provided 
evidence that the D allele is signifi  cantly associated with increased 
mortality in ALI/ARDS patients, yielding a per-allele odds ratio of 1.76 
(95% CI: 1.19 to 2.59). See Figure 1 and Table 1.
Conclusion Serum ACE levels appear to be aff  ected by the I/D poly-
morphism and are correlated with prognosis in patients with ALI/ARDS, 
indicating that further investigation of the clinical signifi  cance of the 
ACE in ARDS might be of value.
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Introduction No recommendations available concerning protocols of 
static PV loop and esophageal pressure measurements use set positive 
end-expiratory pressure (PEEP). The aim of the study was evaluation 
of the signifi  cance of the lower infl  ection point (LIP) and esophageal 
pressure monitoring for PEEP adjustment in ALI and ARDS.
Methods A prospective study performed in one general ICU. We include 
72 patients who received mechanical ventilation before evaluation 
and met ARDS criteria by AECC (1994) – acute onset, PaO2/FiO2 lower 
than 250 Torr, bilateral infi  ltrates on chest X-ray. Exclusion criteria were 
age <15 years and pregnancy. We drew a static pressure–volume loop 
with sustained infl  ation 40×30 (PV loop) for all patients using a low-
fl  ow technique (Hamilton G5) and measured the esophageal pressure 
(Avea) in 36 of 72 patients. After that PEEP was set according to zero 
end-expiratory transpulmonary pressure. We compare PV loop data 
with esophageal pressure measurements.
Results The low infl  ection point median was 8 (95% CI = 5 to 10.5) 
mbar, which does not correspond to the empirically set optimal PEEP 
of 13 (95% CI = 12 to 15) mbar (P <0.001, Wilcoxon test). End-expiratory 
esophageal pressure (EEEP) median was 14 (95% CI = 12 to 18) mbar, 
the correlation between LIP and EEEP was poor (ρ = 0.279, P = 0.049). 
We fi  nd signifi  cant correlation between static compliance and EEEP 
(ρ = –0.421, P = 0.005). Sustained infl  ation did not lead to improved 
oxygenation (P >0.05). PEEP adjustment by EEEP led to an increase in 
PaO2/FiO2 – median 107 mmHg (95% CI = 18 to 147, P <0.001). EEEP was 
similar to empirically set PEEP (P >0.05).
Conclusion LIP has poor correlation with EEEP. PEEP adjustment by 
esophageal pressure was close to empirically set PEEP and can improve 
oxygenation.
Figure 1 (abstract P102).
Table 1 (abstract P102). Characteristics of the study population (n = 69)
Age (years)  64.4 ± 17.9; 69 (28 to 89)
Sex (males, %)  43 (62.3%)
APACHE II score  22.1 ± 6.2; 21 (14 to 35)
SOFA score  8.4 ± 3.2; 8 (4 to 16)
Lung compliance (ml/cmH2O)  29.4 ± 7.2; 30 (17 to 40)
PaO2/FiO2  139, 1 ± 47.1; 140 (72 to 223)
PEEP   8.1 ± 2.9; 8 (5 to 15)
Lung Injury Score  2.5 ± 0.6; 2.5 (1.75 to 3.50)
Blood lactate (mmol/l)  1.7 ± 1.7; 1.3 (0.5 to 5.2)
Septic status  39 (56.5%)
Serum ACE (U/l)  16.5 ± 10.8; 13.6 (4.8 to 39.8)
BALF (U/l)  2.3 ± 1.4; 2.0 (0.3 to 4.7)
ACE I/D polymorphism:
  D/D  27 (39.1%)
 I/D  28 (40.6%)
 I/I  14 (20.3%)
28-day mortality  34/69 (49.3%)
90-day mortality  43/69 (62.3%)
Ventilator-free days  5.1 ± 7.8; (0 to 23)
Days w/o cardiovascular failure  14.0 ± 10.2; 16 (0 to 27)
Days w/o renal failure  15.4 ± 10.6; 16 (0 to 28)
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Introduction In intubated critically ill patients, cyclic short recruitment 
manoeuvres (Sigh) introduced during pressure support ventilation 
(PSV) improve oxygenation, probably by increasing end-expiratory 
lung volume (EELV). We assessed Sigh eff  ects on regional distribution 
of EELV by electrical impedance tomography (EIT): a bedside, radiation-
free lung imaging technique. Moreover, we investigated baseline 
characteristics correlated with response to Sigh.
Methods We enrolled 20 intubated critically ill patients undergoing 
PSV with PaO2/FiO2 ≤300 mmHg and PEEP ≥5 cmH2O. We applied on 
each patient’s thorax a 16-electrode belt connected to an EIT monitor 
(PulmoVista 500®; Dräger Medical GmbH, Lübeck, Germany). Sigh was 
introduced as 35 cmH2O continuous positive airway pressure phase 
lasting 3 to 4 seconds at diff  erent rates (0, 0.5, 1, 2 per minute, random 
order) for 20 minutes. From raw EIT data, we calculated global changes 
in EELV (ΔEELVgl), calculated as changes in end-expiratory lung 
impedance calibrated versus tidal volume to estimate changes in ΔEELV 
and considering 0 Sigh/minute as baseline; and ΔEELV of nondependent 
and dependent lung regions (ΔEELVnondep and ΔEELVdep). Together, 
we collected ventilation parameters, hemodynamics and arterial blood 
gases.
Results Patients were 65 ± 13 years old, ventilation days were 9 ± 10 
and PaO2/FiO2 was 194 ± 49 mmHg at PEEP 8 ± 2 cmH2O. Introduction 
of Sigh improved PaO2/FiO2 ( P  <0.001) and ΔEELVgl (P  <0.001). 
The increase in EELV was diff   use across all lung regions as both 
ΔEELVnondep and ΔEELVdep changed (P <0.01 and P = 0.06). minute 
ventilation, arterial blood pH and hemodynamics were not signifi  cantly 
aff  ected by introduction of Sigh, while mean airway pressure increased 
(P <0.001), albeit only at the highest Sigh rate and by a limited extent 
(~2 cmH2O). Patients with mean ΔEELVgl over the three Sigh phases 
>200  ml (that is, Sigh-responders) had signifi   cantly lower PaO2/
FiO2 values at baseline (that is, at Sigh rate = 0/minute) than Sigh-
nonresponders (163 ± 25 mmHg vs. 222 ± 39 mmHg, P <0.01).
Conclusion  Introduction of Sigh in intubated critically ill patients 
undergoing PSV improves gas exchange by inducing alveolar 
recruitment across all lung regions with minimal increase of airway 
pressure. Patients with more severe gas exchange impairment present 
the highest degree of potentially recruitable lung.
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Introduction Ventilator-induced lung injury (VILI) is a well-known side 
eff  ect of mechanical ventilation. The pressures and volumes needed 
to induce VILI in healthy animals are far greater than pressure and 
volumes applied in clinical practice [1]. A possible explanation may be 
the presence of local pressure multipliers (stress raisers).
Methods We retrospectively analyzed CT scans of 147 patients with 
ARDS and CT scans of 100 healthy subjects. A homogeneous lung 
would have the same gas/tissue ratio in all its regions. If a lung region 
expands less than the neighbour regions these will be more strained 
to vicariate the non/less expanding region. We measured the stress 
raisers by computing the ratio between the gas fraction of the region 
of interest and the neighbouring regions: if the infl  ation would be the 
same (homogeneity), the ratio will be equal to one; if the infl  ation of the 
surrounding regions would be greater than the region of interest (that 
is, more strained), the ratio between the two will be greater than one 
and was taken as a measure of stress raiser. We considered pathological 
stress raisers as the regions showing infl  ation ratio greater than the 
95th percentile of the control group (1.61) and defi  ned as the extent 
of the stress raisers the fraction of lung volume above this threshold.
Results  The extent of stress raisers increased with the severity of 
ARDS (14 ± 5, 18 ± 8, 23 ± 1% of lung parenchyma in mild, moderate 
and severe ARDS, P <0.0001). The extent of stress raisers correlated 
with the dead space fraction (r2 = 0.34, P <0.001), with the fraction 
of poorly aerated tissue (r2 = 0.36, P <0.0001) and also has a negative 
correlation with the fraction of well infl  ated tissue (r2 = 0.47, P <0.0001). 
The response to PEEP, passing from 5 to 45 cmH2O is minimal (average 
decrease of stress raiser extent 6 ± 5%) and inter-individual variability 
is great (in 11 patients, stress raisers increased passing from PEEP 5 to 
PEEP 45). Stress raisers turn out to be greater in nonsurvivor patients 
than in survivor patients (17 ± 7 vs. 20 ± 9% of lung volume, P = 0.03).
Conclusion Stress raisers correlate with the severity of disease; lungs 
with greater stress raisers are subjected to higher local pressures and 
probably those patients are more susceptible to VILI. The application of 
PEEP has little eff  ect on stress raisers.
Reference
1. Protti  A:  Am J Respir Crit Care Med 2011, 183:1354-1362.
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Introduction  Positive end-expiratory pressure (PEEP) is commonly 
used in patients with ARDS to prevent end-expiratory collapse. The 
increase in gas volume and/or change in mechanical properties of 
the lung are used at the bedside to estimate lung recruitment and 
individualize PEEP selection.
Methods Retrospective analysis of patients who underwent whole-
lung CT scan at 5 and 15 cmH2O PEEP. Every chest CT was divided both 
into 10 apex-base levels of equal height and into 10 sterno-vertebral 
levels, yielding 100 units per scanned lung (200 units per patient); 
each unit was classifi  ed according to its average CT number (<–100 
not infl  ated, –100 to –500 poorly infl  ated, –500 to –900 well infl  ated 
and –900 overinfl  ated). Lung regions defi  ned as not infl  ated at PEEP 
5 cmH2O and infl  ated (poorly, well or over) at PEEP 15 cmH2O were 
classifi  ed as recruited. Moreover, a surrogate specifi  c lung compliance 
(CLsp) was determined on the expiratory limb of the pressure–volume 
curve (15 to 5 cmH2O PEEP at CT) and was defi  ned as Δgas/cmH2O 
PEEP/gram of tissue.
Results We included in our study the CT scans of 89 patients (24 mild, 
55 moderate and 10 severe ARDS, age 58 ± 17 years, BMI 25.6 ± 5.4, 
PaO2/FiO2 165  ±  66, PaCO2 42  ±  9, 60 discharged alive from ICU 
(67%)). At PEEP 5 cmH2O 39 ± 16% of the lung parenchyma was not 
infl  ated, 33 ± 13% poorly infl  ated, 28 ± 15% well infl  ated and 0 ± 1% 
overinfl  ated. The median lung recruitability between 5 and 15 cmH2O 
PEEP was 6% (3 to 10%) of lung parenchyma (71 g (26 to 182 g)). Mean 
EELV at PEEP 5 cmH2O was 1,233 ± 709 while it increased to 1,784 ± 848 
at PEEP 15 cmH2O (ΔEELV = 551 ± 407 ml). More than one-half (52% (31 
to 75%)) of the increase in end-expiratory lung volume (EELV) was due 
to an increase in infl  ation of the already well-aerated tissue; 38% (23 to 
43%) was due to the infl  ation of poorly aerated tissue, while only 4% 
(1 to 8%) to the recruitment of lung tissue. The CLsp of the well, poorly 
and recruited tissue was 0.07 (0.031 to 0.13), 0.03 (0.01 to 0.06) and 0.02 
(0.01 to 0.04) ml/cmH2O/g, respectively (P <0.0001).
Conclusion  Most of the PEEP-related EELV increase is due to an 
increased infl  ation of already well aerated lung tissue. In agreement 
with the baby lung theory [1], the well-aerated tissue showed near to 
normal mechanical properties.
Reference
1. Gattinoni  L,  et al.: Int Care Med 2005. 31:776-784.
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Intraoperative management of hypoxemia with recruitment 
maneuvers: are the benefi  ts worth the costs?
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Introduction Several strategies can be applied for the prevention and 
management of anesthesia-related hypoxemia. The aim of our study 
was to investigate the cardiovascular eff  ects of a specifi  c recruitment 
maneuver (RM) used for the management of intraoperative hypoxemia.
Methods  Forty-nine patients (29 male/20 female) of mean age 
57.4 ± 9.9 years, mean weight 80.2 ± 13.6 kg and ASA-PS classifi  cation I 
to IV (I: 2, II: 27, III: 16, IV: 6), undergoing general surgery procedures, who 
developed intraoperative hypoxemia (PaO2/FiO2 <200), were enrolled 
in our study. For the management of hypoxemia a total of 67 RMs 
have been applied, which consisted of a manual increase of the airway 
pressure to 40 cmH2O. This rise has been maintained for 10 seconds and 
was followed by an increase of positive end-expiratory pressure from 5 
to 10 cmH2O. Before RM application an oesophageal Doppler monitor 
probe was inserted into the patients for measuring stroke volume (SV), 
cardiac output (CO), peak velocity (PV) and fl  ow corrected time (FTc). 
Standard monitoring also included ECG, IBP, ETCO2 and SpO2. Heart rate 
(HR), systemic arterial pressure (SAP), SV, CO, PV and FTc were recorded 
directly before, during, right after and 5 minutes after RM application 
(T1 to T4). Kolmogorov–Smirnoff   was used to test normal distribution 
of data and ANOVA was used for the statistical analysis. P <0.05 was 
considered statistically signifi  cant.
Results HR, SAP, SV, CO, PV and FTc showed a statistically signifi  cant 
decrease during and right after RM compared with the baseline 
values but they were gradually restored to control values after RM 
discontinuation (Table 1).
Table 1 (abstract P107)
  T1 T2 T3 T3
HR (beats/minute)  69.8±7.1  60.2±10.6*  67.1±7.4*^  68.4±6.9^
SAP mean (mmHg)  89.8±7.7  53.4±5.7*  81.5±7.7*^  87.6±6.7^
SV (ml)  82.2±21.2  22.5±15.5*  75.4±21.7*^  79.6±6.4^
CO (l/minute)  5.75±1.7  1.4±0.9*  5.1±1.7*^  5.5±1.5^
PV (cm/second)  72.6±17.1  26±15.9*  68±16.8*^  70.7±15.9^
FTc (seconds)  0.4±0.06  0.19±0.08*  0.36±0.06*^  0.36±0.06^
*P <0.05 versus T1. ^P <0.05 versus T2.
Conclusion According to our results, RM application causes a profound 
impairment of the cardiovascular system. This can be attributed to the 
increase of the airway pressures, which results in preload decrease 
and afterload increase of the right ventricle and cardiac contractility 
attenuation. Nevertheless, these eff  ects are transient and reversible 
and RM application is a safe technique for the management of 
intraoperative hypoxemia, provided that adequate cardiac preload is 
ensured and the anesthesiologist is alert to discontinue the RM if it 
exceeds cardiovascular reserves.
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Haemodynamic changes during alveolar recruitment manoeuvre in 
patients with diastolic dysfunction
A Rubino, E Marini, B Ferro, M Collareta, F Forfori, F Guarracino, F Giunta
Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
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Introduction To investigate the haemodynamic eff  ects of an alveolar 
recruitment manoeuvre in intubated patients with diastolic dysfunction 
compared with patients with normal diastolic function in a mixed ICU.
Methods Between October 2011 and February 2012, 16 mechanically 
ventilated patients admitted to the ICU with normal systolic function 
and without inotropic support were enrolled. A transthoracic echo-
cardiography was performed to assess diastolic function: E/A, isovolumic 
relaxation time (IVRT), deceleration time (DT), E/e’ were assessed. Eight 
patients (fi  ve with poor relaxation pattern, three with decreased left 
ventricle compliance) were identifi  ed in diastolic dysfunction group 
(Group 1) and eight were included in the normal diastolic function 
group (Group 2). A recruitment manoeuvre was performed by applying 
a PEEP of 40 cmH2O for 30 seconds. Haemodynamic parameters of 
cardiac output (CO), stroke volume (SV), heart rate (HR), pulse pressure 
variation (PPV), and cardiac cycle effi   ciency (CCE) were continuously 
recorded during the manoeuvre using the MostCare pulse contour 
method.
Results No signifi  cant haemodynamic changes happened in the fi  rst 
part of the recruitment (t0 to t15 seconds). A signifi  cant decrease in 
CO (P <0.05), SV (P <0.01), systolic pressure (P <0.04) and PPV (P <0.04) 
occurred in Group 1 during the remaining part of the manoeuvre. No 
signifi   cant decrease in the same haemodynamic parameters were 
noted when only E/A was used to discriminate the diastolic dysfunction. 
See Table 1.
Table 1 (abstract P108). CO diff  erence associated with diastolic dysfunction 
parameters
  E/A <1  E/A >1  P value
CO 15 to 30  3.9  4.8  0.20
  E/e’ <1  E/e’ >1 
CO 15 to 30  3.92  5.6  0.02
Conclusion The recruitment manoeuvre can compromise left diastolic 
fi   lling by increasing the transpulmonary pressure. In patients with 
diastolic dysfunction a signifi  cant decrease in SV can be observed 
during the recruitment manoeuvre with no compensatory mechanisms 
evoked determining a signifi  cant decrease in CO. The E/A ratio is not 
able to discriminate between the two groups, confi  rming the power of 
tissue Doppler imaging to recognize the correct diastolic pattern.
Reference
1. Gernoth  C,  et al.: Respiratory and haemodynamic changes during 
decremental open lung positive end-expiratory pressure titration in 
patients with acute respiratory distress syndrome. Crit Care 2009, 13:R59.
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Introduction The aim of the ongoing Alveolar Recruitment for ARDS 
Trial (ART) is to evaluate whether a maximum stepwise alveolar recruit-
ment maneuver (MSARM) followed by ventilation at optimal PEEP may 
decrease 28-day mortality in patients with moderate to severe ARDS 
compared with ventilation with the ARDSNet strategy (NCT01374022). 
Here we report the results of a planned a priori preliminary analysis 
involving 100 patients to assess feasibility, physiologic variables and 
safety outcomes.
Methods ART is an event-driven multicenter randomized controlled 
trial planned to last until 520 deaths within 28  days are observed. 
Patients assigned to the experimental group receive a MSARM 
achieving PEEP of 45 cmH2O and plateau pressure of 60 cmH2O plus 
PEEP titrated according to the static compliance of the respiratory 
system (ART strategy). The target tidal volume is 4 to 6 ml/kg predicted 
body weight (PBW) and plateau pressure ≤30 cmH2O in both groups.
Results We randomized 101 patients between November 2011 and 
October 2012 in 51 centers. Considering 124 active sites in July 2013 
and the current recruitment rate, we will fi  nish enrollment by November 
2014. MSARM was complete in 34/47 (72%) of patients allocated to the 
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(8/9 (90%)). Mean titrated PEEP in the ART group was 16.1 ± 3.5 versus 
12.9 ± 3.4 cmH2O in ARDSNet (P <0.001). One hour after randomization, 
tidal volume was similar between the ART and ARDSNet groups 
(5.1 ± 0.8 vs. 5.3 ± 0.7 ml/kg PBW, respectively; P = 0.08). Mean values 
remained below 6 ml/kg PBW up to day 3. Few patients had plateau 
pressure >30  cmH2O 1  hour after randomization in the ART and 
ARDSNet groups (3/43 (7.0%) vs. 4/47 (8.5%), respectively; P = 1.00) and 
on subsequent days. PaO2/FiO2 was signifi  cant higher in the ART group 
(179.5 ± 84.5 vs. 143.3 ± 46.8, P = 0.01) and increased over time up to 
7 days after randomization (272.3 ± 136.5 vs. 192.6 ± 72.3, P = 0.003). 
The ART strategy did not increase the risk of barotrauma (relative risk 
(RR) = 0.78, 95% CI = 0.19 to 3.30) in the fi  rst 7 days after randomization 
or the need to initiate or increase vasopressors or mean arterial 
pressure <65 mmHg (RR = 1.14, 95% CI = 0.65 to 2.02, P = 0.67) 1 hour 
after randomization. However, the ART strategy increased the risk for 
severe acidosis (pH <7.10) 1 hour after randomization (RR = 3.20, 95% 
CI = 1.12 to 9.20, P = 0.03).
Conclusion ART is feasible. The incidence of adverse events was similar 
between groups except for severe acidosis 1 hour after randomization. 
Hence we adjusted the study protocol, increasing the respiratory rate 
(from 10 to 15/minute) during MSARM.
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Introduction Cardiac surgical procedures are associated with a high 
incidence of postoperative complications, increasing costs and 
mortality. The purpose of this study is to evaluate prospectively the 
impact of two protective mechanical ventilation strategies, both using 
low-tidal volume ventilation (6 ml/kg/ibw) after cardiac surgery.
Methods We prospectively evaluated 270 patients immediately after 
cardiac surgery, presenting hypoxemia and PaO2/FiO2 <250. Patients 
were randomized to an intensive alveolar recruitment maneuver (ARM) 
or a moderate ARM strategy. Intensive ARM group: recruitment with 
an inspiratory pressure amplitude of 15 cmH2O and PEEP of 30 cmH2O, 
followed by ventilation with PEEP  = 13  cmH2O, during 4  hours of 
protective mechanical ventilation with VT = 6 ml/kg/pbw. Moderate 
ARM group: recruitment with opening pressures of 20 cmH2O in the 
airways, followed by ventilation with PEEP = 8 cmH2O, during 4 hours of 
protective mechanical ventilation with VT = 6 ml/kg/pbw. The primary 
outcome was a composite endpoint of severe pulmonary complications 
in the postoperative period defi  ned as intra-hospital death, need for 
mechanical ventilation for more than 48 hours after surgery, pulmonary 
infection or after reintubation within 28 days after randomization. The 
secondary outcome was the incidence of nonpulmonary complications 
as postoperative myocardial ischemia, acute renal failure (RIFLE-R), 
respiratory mechanics and blood gas analysis after ARM, ICU length of 
stay, hospital length of stay and 30-day mortality.
Results The intensive ARM group compared with the moderate ARM 
group had lower incidence of the primary outcome, mainly due to 
the reduced rate of pulmonary infection (2.3% vs. 10.1%, P = 0.009). 
Moreover, the intensive ARM group presented higher lung compliance 
(68 ± 19 vs. 51 ± 17 ml/cmH2O, P <0.001) and PaO2/FiO2 ratio (360 ± 68 
vs. 240 ± 74, P <0.001) after intervention when compared with the 
moderate group. Also, the intensive ARM presented a lower length of 
ICU stay (3 days vs. 4 days, P = 0.027) than the moderate ARM. There are 
no diff  erences regarding severe nonpulmonary complications and 30-
day mortality between groups.
Conclusion An intensive ARM strategy reduces postoperative pulmo-
nary complications, reduces hypoxemia, increases lung compliances 
and decreases the length of ICU stay after cardiac surgery.
Reference
1. Amato  MB,  et al.: N Engl J Med 1998, 338:347-354.
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Introduction  Reliable measurement of esophageal pressure is a 
prerequisite for analysis of respiratory system mechanics in spontaneous 
breathing patients. For that purpose, various types of balloon catheters 
exist that diff  er in material, size and shape. In physical models we 
studied the quality of pressure measurement via six diff  erent balloon 
catheters, three of them containing a second balloon for measurement 
of gastric pressure.
Methods Nine balloons of six esophageal catheters were investigated 
in three conditions: measurement of balloon pressure during initial 
infl  ations immediately after unpacking; measurement of static pressures 
at diff  erent fi   lling volumes; and compliance estimation in physical 
models (27, 54, 90  ml/cmH2O) at diff  erent levels of superimposed 
pressure.
Results During the initial infl  ation most catheters showed pressure 
artifacts resulting from material adhesion. Those artifacts disappeared 
during following infl   ations. Static pressure measurements could 
be performed with an error below 1 cmH2O if the balloon was fi  lled 
appropriately. Overfi  lling of the balloon resulted in larger errors only in 
two catheters. Compliance estimations resulted in errors below 1 ml/
cmH2O. Superimposed pressure had no relevant eff  ect on compliance 
estimation.
Conclusion  The reliability of pressure measurements and also of 
compliance estimation via the tested catheters is high. Only in 
two catheters was the fi   lling volume a critical point for a precise 
measurement of pressure or for estimation of compliance. Immediately 
after unpacking, adhesion of the balloon material might prevent 
reliable pressure measurement, therefore before the fi  rst measurement 
overfi  lling of the balloon and retention of the excess gas seems strongly 
recommended.
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Introduction  Low tidal volume (VT) ventilation in intensive care 
patients without lung injury attenuates the systemic infl  ammatory 
response [1]. The contribution of the specifi   c organ infl  ammatory 
responses to the systemic picture remains to be elucidated. We 
investigated the eff  ect of low VT ventilation compared with medium 
high VT on hepatic, splanchnic and cerebral cytokine responses in an 
experimental large animal postoperative sepsis model.
Methods Twenty pigs, group Protective Ventilation (PV), were ventilated 
with low VT (6 ml/kg) and PEEP 10 cmH2O while 10 pigs, group Control 
(C), were ventilated with a VT of 10 ml/kg and PEEP 5 cmH2O. Catheters 
were introduced into an artery, the jugular bulb, the hepatic vein and 
the portal vein. Laparotomy for 2 hours simulated a surgical procedure 
after which baseline ensued and a continuous endotoxin infusion was 
started at 0.25 μg/kg/hour for 5 hours. Diff  erences were analyzed with 
ANOVA for repeated measures.
Results TNFα levels were higher in the hepatic vein than in the artery, 
the jugular bulb and the portal vein. IL-6 levels were higher in the 
artery and the jugular bulb compared with the portal and hepatic 
veins. IL-10 levels were higher in the portal vein compared with the 
jugular bulb and hepatic vein. The organ-specifi  c IL-10 concentrations 
were all higher than the arterial concentration. Comparison between 
the ventilation groups showed that TNFα, IL-6 and IL-10 in the hepatic 
vein were higher in group C compared with group PV at the end of 
the experiment. Peak concentrations of TNFα and IL-6 in the portal vein 
were higher in group C compared with group PV.
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liver while the results point to signifi  cant nonhepatic IL-6 and IL-10 
production. Ventilation with low VT and medium-high PEEP attenuated 
hepatic and splanchnic cytokine production compared with medium-
high VT and lower PEEP.
Reference
1. Determann  et al.: Crit Care 2010, 14:R1. doi:10.1186/cc8230
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Introduction Positive end-expiratory pressure (PEEP) is fundamental 
to prevent lung collapse in ARDS patients. A common method to 
titrate PEEP is to perform a PEEP test, recording the variation of cardio-
respiratory parameters after a PEEP change [1]. The aim of this study 
was to evaluate the time-course changes of gas exchanges following 
a PEEP test.
Methods  Mechanically ventilated patients (PEEP 10  cmH2O and TV 
7 ml/kg – Baseline) were randomized to two groups: in the PEEP 15 
group, PEEP was increased from 10 to 15 cmH2O; while in the PEEP 5 
group, PEEP was decreased from 10 to 5 cmH2O. Arterial gas analyses 
were performed in both groups after 5, 15, 30 and 60 minutes from the 
change of PEEP.
Results We enrolled 44 ARDS patients: 23 in the PEEP 15 group and 21 
in the PEEP 5 group. At Baseline, PaO2/FiO2 (P/F) and PaCO2 were similar 
in both groups (P/F 169.5 ± 78.8 vs. 165.4 ± 80.6; PaCO2 45.6 ± 8.5 vs. 
41.7 ± 5.0 mmHg, PEEP 15 vs. PEEP 5, respectively). In the PEEP 15 
group, P/F signifi  cantly continuously increased over time. In PEEP 5, 
P/F signifi  cantly decreased after 5 minutes and remained stable over 
time. In the PEEP 15 group, PaCO2 did not change within 60 minutes 
after PEEP increase. When PEEP was reduced (PEEP 5) PaCO2 remained 
stable for the fi  rst two steps, while at 30 and 60 minutes PaCO2 was 
signifi  cantly higher than at Baseline (Figures 1 and 2).
Conclusion  Our data indicate that it is important in critically ill 
patients to allow suffi   cient time for the full eff  ect of PEEP increase on 
oxygenation and to prevent excessive delay when P/F decrease occurs 
following the application of a lower level of PEEP.
Reference
1.  N Engl J Med 2006, 354:1775-1786.
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Introduction  Quantitative analysis of a lung CT scan is considered 
the reference method to study lung recruitability to optimize the 
ventilatory strategy in ARDS patients. However, CT implies a risk of 
radiation exposure, especially when CT analysis is necessary to monitor 
the evolution of ARDS. The aim of this study was to evaluate the impact 
of a lower radiation dose on lung CT quantitative analysis compared 
with analysis computed by standard CT.
Methods  Sedated and paralyzed patients underwent two chest CT 
scans: a Standard CT (120 kV, 110 mAs, pitch 1.2, collimation 0.6 mm; 
Care Dose Technology) and a CT performed by a lower radiation dose 
(Lowdose: 120  kV, 60  mAs). CTs were performed during the same 
inspiratory or expiratory hold, for diff  erent values of airway pressure. 
Each CT image was manually delineated excluding pleural eff  usions 
and mediastinal structures. We analyzed Standard and Lowdose CT 
images with dedicated software to quantify the tissue weight of 
lung regions with diff  erent degrees of infl   ation. Lung quantitative 
data computed by Standard and by Lowdose scans were compared 
according to Bland–Altmann analysis.
Figure 2 (abstract P113). Two-way ANOVA RM. P <0.05, #versus 
5 minutes.
Figure 1 (abstract P113). Two-way ANOVA RM. P <0.05, *versus Time 0, 
#versus 5 minutes, °versus 15 minutes.
Figure 1 (abstract P114). Total tissue weight.
Critical Care 2013, Volume 17 Suppl 2 
http://ccforum.com/supplements/17/S2
S42Results We enrolled 13 patients admitted to our ICU. In the Bland–
Altman analysis of the lung total tissue and not infl  ated tissue, the 
bias and agreement bands for Standard CT scan and Lowdose CT 
quantitative analysis were –16.97 g (–77.43 to +43.49 g) and –9.65 g 
(–116.81 to 77.51 g), respectively (Figures 1 and 2).
Conclusion  Lung CT quantitative analysis computed by Lowdose 
CT scans could be a useful tool for monitoring and ventilatory 
management of ARDS patients.
Reference
1.  N Engl J Med 2006, 354:1775-1786.
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Introduction  Airway pressure release ventilation (APRV) allows 
spontaneous breathing throughout the ventilation cycle. It increases 
venous return and cardiac index, which will signifi  cantly  improve 
organ perfusion. This is important in septic shock patients to prevent 
extrathoracic organ system failure secondary to poor perfusion. 
Benefi  ts of APRV with cardiovascular changes are noticed in patients 
with acute lung injury and acute respiratory distress syndrome. It is 
not well established whether applying APRV will improve the survival 
outcome for septic shock patients. The primary outcome is whether the 
use of APRV in septic shock patients restores hemodynamic stability 
earlier than the CMV mode. The secondary hypothesis is whether the 
use of APRV in septic shock patients improves their survival in the ICU.
Methods After Institutional Review Board approval, we retrospectively 
analyzed the clinical data of 129 septic shock patients who received 
ventilator support between January and December 2011 at a tertiary 
care hospital. The Cox proportional hazards model was used in 
adjusting potential confounding factors. The nonparametric Wilcoxon 
rank sum test was used to assess signifi   cant outcome diff  erences 
between groups. Time to event/survival data will be analyzed using 
Kaplan–Meier methods. These analyses were accomplished using SAS, 
version 9.3.
Results Among the 187 patients, 58 were excluded as per the exclusion 
criteria: incomplete data (n  =  28), do not resuscitate (n  =  16), ICU 
readmission (n = 12) and head injury (n = 4). Finally, 129 patients were 
included, from these 91 received CMV and 38 received APRV. At the 
beginning of the study, there were no diff  erences between the groups 
in relation to hemodynamic parameters. Reversal of shock achieved 
in less than 72 hours was statistically signifi  cant between the groups 
(APRV, n = 16 (42%) and CMV, n = 8 (9%), P = 0.0101). The proportion 
of patients recovering from septic shock after initiation of ventilator 
therapy was higher in APRV than the CMV group (72% vs. 49%, 
respectively, P <0.0001). The mortality rate was signifi  cantly higher in 
CMV (n = 46, 51%) as compared with APRV (n = 11, 29%) (P = 0.022).
Conclusion  The use of APRV in septic shock patients restores 
hemodynamic stability earlier than the CMV mode. There was a 
signifi  cant improvement in ICU survival using APRV over CMV. Early 
initiation of APRV in ventilated septic shock patients was associated 
with a decrease in ICU mortality.
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Introduction Obese patients are at risk of developing atelectasis and 
acute respiratory distress syndrome (ARDS) [1]. The prone position 
(PP) may reduce atelectasis, and improves oxygenation and outcome 
in severe hypoxemic patients in ARDS [2], but little is known about its 
eff  ect in obese ARDS patients.
Methods Morbidly obese patients (body mass index (BMI) ≥35 kg/m2) in 
PP with ARDS (PaO2/FiO2 ratio ≤200 mmHg) were matched to nonobese 
(BMI <30 kg/m2) ARDS patients in a case–control clinical study. The 
primary endpoints were safety and complications of PP; the second 
endpoints were the eff  ect on oxygenation (PaO2/FiO2 ratio at the end 
of PP), length of mechanical ventilation and ICU stay, nosocomial 
infections and mortality.
Results Between January 2005 and December 2009, 149 patients were 
admitted for ARDS. Thirty-three obese patients were matched with 
33 nonobese patients. Median PP duration was 9 (6 to 11) hours in 
obese patients and 8 (7 to 12) hours in nonobese patients (P = 0.28). 
We collected 51 complications, of which 25 in obese patients and 
26 in nonobese patients. The number of patients with at least one 
complication was similar across groups (n = 10, 30%). The PaO2/FiO2 ratio 
(Figure 1) increased signifi  cantly more in obese patients (from 118 ± 43 
to 222 ± 84 mmHg) than in nonobese patients (from 113 ± 43 mmHg 
to 174 ± 80 mmHg, P = 0.03). Length of mechanical ventilation, ICU stay 
and nosocomial infections did not diff  er signifi  cantly, but mortality at 
90 days was signifi  cantly lower in obese patients (27 vs. 48%, P <0.05).
Figure 2 (abstract P114). Not infl  ated tissue weight.
Figure 1 (abstract P116). Individual variations of PaO2/FiO2 ratio between 
supine and prone positions in obese and nonobese patients.
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oxygenation more than in nonobese patients. Obese patients could be 
a subgroup of ARDS patients who may benefi  t most from PP.
References
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Introduction  During the infl   uenza pandemic of 2009, clinicians 
delivered mechanical ventilation to pregnant women with little 
evidence to guide practice. The objective of this study was to compare 
the provision of mechanical ventilation to pregnant/postpartum 
women and a nonpregnant matched control group admitted to the 
ICU with H1N1 infl  uenza.
Methods  A case–control study was conducted following ethics 
approval. A case was defi  ned as a ventilated pregnant/postpartum 
woman reported to the Australian and New Zealand INFINITE H1N1 09 
study from 1 June 2009 to 31 August 2009. Controls were ventilated 
nonpregnant women (15 to 49 years) reported to the INFINITE H1N1 
09 study during the same time frame. Data were entered into SPSS 
and analysed using nonparametric statistics; two-tailed P <0.05 was 
considered signifi  cant.
Results We studied 36 index cases and 38 controls. Index cases were 
more likely to have a single arterial blood gas (ABG) taken prior to 
intubation (P  <0.05). Similar reasons were given for the trigger to 
intubate (high respiratory rate, low PaO2, increased work of breathing) 
apart from a high PaCO2, which was a trigger in the control group only 
(P <0.05). There were no diff  erences in the pre-intubation and post-
intubation ABGs apart from a lower PaCO2 (P <0.05) and lower HCO3 
(P <0.05) in cases, and cases presented with a lower haemoglobin 
(P <0.05). There were six diffi   cult intubations documented with no 
diff  erences between groups. Initial ventilator settings including mode, 
tidal volume, minute volume and respiratory rate demonstrated no 
diff  erences. Both groups showed increases in PaO2 and PaCO2, and 
a decrease in pH from the pre-intubation to post-intubation ABGs 
(P <0.05).
Conclusion  There were physiological diff  erences between the two 
groups with pregnant/postpartum women showing lower PaCO2 and 
HCO3. However, initial ventilator support was not signifi  cantly diff  erent 
for pregnant/postpartum women compared with controls.
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Introduction  The objective is to analyze the epidemiology and 
mortality of critical burn patients with inhalation injury.
Methods  A prospective, observational and descriptive study was 
carried out in all patients admitted to an ICU from October 2008 to June 
2011. Inhalation injury was defi  ned with two or more of the following 
criteria: history of injury in an enclosed space, facial burns with singed 
nasal hair, carbonaceus sputum or stridor. If they were intubated it 
was diagnosed by bronchoscopy. Demographic data, length of stay, 
ABSI, APACHE II, duration of mechanical ventilation, hospital course 
and mortality data were collected. Data are presented as number and 
percentage or as median and interquartile range and were analyzed 
with the Fisher exact test and Mann–Whitney test.
Results Of the 362 patients admitted, 84 (23.2%) had inhalation injury. 
Seventy-six percent were male and the average age was 52 (± 17.5) 
years. The mean total burn surface area (TBSA) was 28% (± 25). Forty-
fi  ve patients (53.5%) had TBSA >20%. These patients had higher severity 
scores: ABSI 8 (± 2.8) versus 6 (± 2.2) (P = 0.0001), APACHE II 13 (± 6.9) 
versus 7 (± 6.7) (P = 0.0001). They also had a higher need for mechanical 
ventilation (88.1% vs. 34.9%, P = 0.001) and shock (59.5% vs. 27.0%, P = 
0.001). The PaO2/FiO2 ratio at admission with and without inhalation 
was 245 versus 359 (P = 0.003), and at 72 hours was 207 versus 306 
(P = 0.002). There were no signifi  cant diff  erences in the appearance 
of sepsis, ARDS and renal failure. The length of stay with and without 
inhalation was 25.2 (1 to 95) days versus 22.5 (1 to 92) days (P = 0.4). The 
inhalation injury group showed a signifi  cantly higher mortality (9.0% 
vs. 28.9%, P = 0.001).
Conclusion In this study, inhalation injury is common in burn patients. 
They had higher severity scores (APACHE II, ABSI) and higher mortality. 
These patients had a higher need for mechanical ventilation and 
lower PaO2/FiO2 ratio, but there was no signifi  cant increase in ARDS or 
respiratory sepsis.
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Introduction Intrapulmonary percussive ventilation (IPV) is a therapy 
that is used to clear endobronchial secretions. The IPV ventilator was 
designed and developed by FM Bird in 1979. The ventilator consists 
of a phasitron that delivers rapid, high-fl  ow, mini bursts of oxygen, 
mixed with air. The potential aims of this mechanism are pulmonary 
recruitment, improved mucus clearance with a direct high-frequency 
oscillatory eff  ect. We investigated whether IPV has a positive eff  ect on 
ventilatory values in adult patients on the ICU.
Methods All patients presenting during a 4-month period in 2011 with 
respiratory insuffi   ciency on our mixed adult ICU were included in this 
study. Patients were monitored before, directly after and 15 minutes 
after therapy with IPV using a Bird Intrapulmonary Ventilator Model 
IPV-2C. All patients received IPV for a period of 20 minutes consisting 
of two cycles of 10 minutes. Peripheral oxygen saturation (SpO2), tidal 
volume (Vt), respiratory rate, end-tidal CO2 (ET-CO2), dynamic lung 
compliance (C-dyn) and work of breathing (WOB) were monitored 
at the diff  erent time points. Paired Student t tests were performed in 
order to compare the values immediately before IPV, with directly after 
therapy and 15 minutes later. P <0.05 was considered signifi  cant.
Results Eighty-three patients were examined. SpO2 improved signifi  -
cantly from 93.7 ± 3.7 before IPV to 95.7 ± 2.8 after IPV (P <0.001) and 
15 minutes later to 95.2 ± 2.8 (P <0.001). Vt improved from 418 ± 111 
before IPV to 476 ± 102 directly after (P <0.001) and to 480 ± 131 
15 minutes later (P <0.01). Respiratory rate improved from 24 ± 6 to 
23 ± 6 only after 15 minutes signifi  cantly (P <0.01). WOB and C-dyn did 
not change. ET-CO2 decreased from 34.9 ± 14.8 to 33.3 ± 13.3 (P <0.05) 
directly after IPV and to 32.1 ± 12.8 (P <0.01) 15 minutes later.
Conclusion In this study we demonstrated a benefi  cial eff  ect of IPV on 
oxygen saturation, tidal volume and end-tidal CO2. IPV has this eff  ect in 
addition to the mobilization of bronchial secretions.
Reference
1.  Salim A, Martin M: High-frequency percussive ventilation. Crit Care Med 
2005, 33:S241-S245.
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Introduction  ARDS is commonly observed in trauma patients. In 
some instances the severity of the clinical presentation is such 
that all conventional ventilatory support mode fails. In this setting, 
Critical Care 2013, Volume 17 Suppl 2 
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a rescue therapy.
Methods  Fifteen adult patients admitted to our ICU for acute 
traumatic and nontraumatic lung injury were submitted to HFOV when 
conventional mechanical ventilation failed.
Results Clinical and demographic data are shown in Table 1. Figure 1 
shows the trend of gas parameters during the recovery. At baseline 
PaO2 was 94 ± 28 mmHg; after 6 hours of HFOV: 135 ± 41 mmHg, 
P <0.01. At baseline PaO2/FiO2 was 182 ± 97 mmHg; after 6 hours of 
HFOV: 264 ± 101 mmHg, P <0.01. The benefi  ts are maintained when 
returned to conventional ventilation.
Conclusion  HFOV may therefore be anticipated to improve end-
organ perfusion and gas exchange; it should be considered in severe 
traumatic and nontraumatic respiratory failure [1].
Reference
1.  BMJ 2010, 340:c2327.
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Introduction  High-frequency oscillatory ventilation combined 
with tracheal gas insuffl     ation (HFO-TGI) can signifi  cantly  improve 
oxygenation in patients with ARDS. It has been demonstrated that 
oxygenation in patients with ARDS has a better response to HFO when 
extravascular lung water is >15 ml/kg body weight (BW). Our aim is to 
examine whether the extravascular lung water index (ELWI) correlates 
with changes in PaO2/FiO2 in patients ventilated with HFO-TGI.
Methods Data from 18 sessions of HFO-TGI in six patients were included 
in the analysis. HFO frequency, oscillatory pressure amplitude, and bias 
fl  ow were 3.5 Hz, 85 to 95 cmH2O, and 40 l/minute, respectively; a 2.5 to 
3.5 cmH2O tracheal tube cuff   leak was used. HFO mean airway pressure 
(mPaw) exceeded preceding conventional ventilation (CV)-mPaw by 
7 to 13 cmH2O. PaO2/FiO2, lung mechanics, and hemodynamics were 
documented during lung-protective CV (baseline) and 1 hour following 
the initiation of HFO-TGI ventilation. PULSION PICCOplus v7.0 was used 
for hemodynamic measurements including the ELWI.
Results  Oxygenation (PaO2/FiO2) improved signifi   cantly with HFO-
TGI compared with CMV (125.5 ± 54.7 vs. 195.6 ± 108.7, P <0.001). 
Changes in PaO2/FiO2 were positively correlated with ELWI at baseline 
(Spearman’s ρ = 0.56, P = 0.016). See Figure 1. There were no signifi  cant 
changes in patients’ fl  uid balance and hemodynamics including the 
ELWI.
Conclusion Estimation of the ELWI can help to predict the oxygenation 
response of ARDS patients considered for HFO-TGI ventilation. The 
possibility that HFO-TGI exerts an eff  ect on pulmonary oedema needs 
further investigation.
Acknowledgement This research has been cofi  nanced by the European 
Union and Greek national funds through the operating programme 
‘Education and Lifelong Learning’ – Research Funding Programme 
Heracleitus II.
Reference
1. Zeravik  J,  et al.: Acta Anaesthesiol Scand 1989, 33(Suppl 90):149-152.
Figure 1 (abstract P120). Mean PaO2, PaCO2, PaO2/FiO2 at baseline and during HFOV (P, percussionator; C, conventional). *P <0.05 versus baseline, †P <0.01 
versus baseline.
Table 1 (abstract P120). Clinical and demographic data
 Mean
Age (years)  64
Male/female 11/4
Dead 4
Trauma 3
SAPS II  45/40
APACHE   23/8
Figure 1 (abstract P121). Scatter plot and fi  t line of ELWI versus 
dPaO2/FiO2.
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Introduction Protective mechanical ventilation (MV) in ARDS is based 
on reduced stretch of pulmonary tissue, sometimes resulting in severe 
hypoventilation that can be avoided when using high respiratory rate. 
High-frequency positive-pressure ventilation (HFPPV) has not been 
fully explored, especially when associated with other strategies aiming 
to avoid hypercapnia.
Methods We induced ARDS in eight pigs by lung lavage with saline 
plus 3 hours of injurious MV with low PEEP and high driving pressure 
(DP). We then performed a recruitment maneuver (RM) followed 
by PEEP titration using the amount of alveolar collapse in electrical 
impedance tomography (EIT). Then stabilization during 1 hours with 
tidal volume (VT) at 6 ml/kg, respiratory rate (RR) 35 breaths/minute 
and PEEP selected with the PEEP-FiO2 table (ARMA study), which was 
kept constant during two steps of HFPPV with a RR 60: one without 
an inspiratory pause (HFPPV-60), and one with a pause of 30% of 
inspiratory time (HFPPV-60 w/P30%). In another HFPPV step, we used 
PEEP titrated with EIT after RM (HFPPV-60 w/RM). During each HFPPV 
step, VT was set to reach a PaCO2 of 60 ± 3 mmHg. Distribution of 
regional ventilation was analyzed using EIT. Equilibrium was considered 
if PaCO2 was stable (<5% of variation) for >30 minutes.
Results HFPPV allowed reduction in PaCO2 levels: 81 (77, 94) versus 
60 (58, 61), 59 (58, 60), 60 (58, 61) mmHg, besides using lower VT: 
5.2 (5.0, 5.9), 5.1 (4.5, 6.0), 4.7 (4.2, 5.7) and 4.8 (4.5, 5.6) ml/kg during 
stabilization, HFPPV-60, HFPPV-60 w/P30% and HFPPV-60 w/RM, 
respectively. It had no signifi  cant diff  erent results comparing HFPPV-60 
with and without an inspiratory pause. HFPPV-60 w/RM allowed a 
better alveolar homogenization and improvement in oxygenation, 
shunt, dead space and DP compared with the other steps. See Table 1.
Table 1 (abstract P122). Physiological variables
Variable  VT = 6, stabilization  HFPPV-60  HFPPV-60 w/RM
DP (cmH2O)  16 ± 2  16 ± 3  12 ± 2*
P/F ratio  95 ± 13  149 ± 60  246 ± 99*
*Tukey’s post-hoc analysis, P < 0.05 versus others.
Conclusion HFPPV with a conventional mechanical ventilator is able 
to maintain stable PaCO2 in clinically acceptable values, allowing 
reductions in VT. HFPPV-60 w/RM and PEEP titration using EIT allowed 
further physiologic benefi  ts in a severe ARDS model.
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High-frequency percussive ventilation at altitude: study in a 
hypobaric chamber with a mechanical test lung
AC Cirodde1, S Montmerle2, ND Donat1, CB Bourhillon2, P Jault1, 
L Bargues1, T Leclerc1
1Military Hospital Percy, Clamart, France; 2IRBA, Brétigny, France
Critical Care 2013, 17(Suppl 2):P123 (doi: 10.1186/cc12061)
Introduction High-frequency percussive ventilation (HFPV) is a rescue 
technique for most severe acute lung injury/acute respiratory distress 
syndrome (ARDS) patients [1], especially with smoke inhalation or 
respiratory burns [2]. This study aimed at characterizing HFPV as 
delivered by Percussionnaire VDR4® and at evaluating how hypobarism 
interferes with HFPV, in order to assess its usability at altitude.
Methods Using a mechanical test lung mimicking ARDS (compliance 
17 ml/cmH2O) with two resistance levels (5 and 15 cmH2O/l/second) 
and ventilated with VDR4® in a hypobaric chamber, ascents/descents 
between 0 and 5,000 and then 0 and 8,000 ft were performed. Adjustable 
VDR4® parameters were modifi  ed one at a time at each altitude. Besides 
these parameters (cross-measured with standalone hardware), oxygen 
consumption of the respirator and three calculated parameters were 
studied: low-frequency tidal volume (Vt, integrated from instantaneous 
fl  ows measured with a Fleisch pneumotachograph), end-inspiratory 
(PmEI) and end-expiratory (PmEE) mean pressures. PmEI and PmEE in 
HFPV refl  ect plateau pressure and positive end-expiratory pressure in 
conventional ventilation. The correction of altitude-induced off  set with 
the modifi  cation of working pressure was also tested.
Results Data displayed by VDR4® overestimated pulmonary pressures 
by more than 10%, but were reliable for other parameters. During 
ascent, an off  set appeared for all respiratory parameters: Vt increased 
by 59% and PmEI by 53% between 0 and 8,000 ft. During descent, 
the off  set was reversely directed with a 39% decrease in Vt and a 28% 
decrease in PmEE between 8,000 and 0 ft. Modifying working pressure 
adequately corrected PmEI and PmEE, but not Vt. In all cases, manually 
correcting VDR4® parameters to their 0 ft level also corrected these 
off   sets. Multivariate analysis further established that, adjusting for 
other parameters, Vt, PmEI and PmEE did practically not depend on 
altitude. Oxygen consumption of the respirator was high, 25 l/minute 
at 0 ft, and stable with altitude. It was reduced with percussive rate and 
with FiO2.
Conclusion HFPV can be safely used at altitude, provided that VDR4®-
displayed parameters are used to manually adjust settings in order to 
avoid exposing patients to volutrauma or barotrauma during ascent, 
and to major hypoventilation and alveolar collapse during descent. The 
high oxygen consumption is currently the main limit to its use for long-
range aeromedical evacuations.
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Introduction  The application of PEEP is commonly used in acute 
respiratory distress syndrome (ARDS) and has been shown to improve 
oxygenation. To identify patients that most benefi  t from the application 
of PEEP, the discrimination of recruiters and nonrecruiters has been 
postulated by Gattinoni and colleagues [1]. Recently, Dellamonica and 
colleagues [2] presented a method to predict alveolar recruitment. 
We hypothesised that the amount of recruitable volume allows the 
discrimination between ARDS patients and patients with healthy lungs 
(HL).
Methods  We recalculated the recruited volume (RV) in 25 patients 
with ARDS [3] according to the method proposed by Dellamonica and 
colleagues during an incremental PEEP manoeuvre (PEEP increased 
until the plateau pressure reached 45 cmH2O). RV was calculated as the 
change in end-expiratory lung volume minus total respiratory system 
compliance times the PEEP change (RV  = ΔEELV  – CTOT×ΔPEEP). 
For comparison, 12 patients with HL undergoing elective surgery in 
general anaesthesia were measured using the same protocol.
Results Both ARDS and HL patients exhibited typical P–V curves and 
stepwise recruitment (Figure 1). By raising PEEP from 0 to 12 cmH2O, 
ARDS patients recruited 331 ± 195 ml (mean ± SD) and HL patients 
435 ± 43 ml. There was a strong correlation (R2 = 0.88) of the total RV 
with the end-inspiratory volume at a plateau pressure of 45 cmH2O in 
both groups; that is, recruitment was found to the same extent in both 
groups (Figure 2).
Conclusion The relative contribution of RV to lung volume gain is similar 
in ARDS and in patients with healthy lungs. Our results question the 
relevance of recruitability as defi  ned by Dellamonica and colleagues as 
a typical phenomenon of ARDS, but support the baby lung concept, as 
the recruited volume was closely related to the size of the lung.
Critical Care 2013, Volume 17 Suppl 2 
http://ccforum.com/supplements/17/S2
S46References
1. Gattinoni  et al.: N Engl J Med 2006, 354:1775.
2. Dellamonica  et al.: Intensive Care Med 2011, 37:1595.
3. Stahl  et al.: Crit Care Med 2006, 34:2090.
P125
Nosocomial bloodstream infection and venovenous extracorporeal 
membrane oxygenation: a retrospective cohort study
B Serra de Oliveira, S Mendes Fernandes, C França
Hospital de Santa Maria CHLN, Lisboa, Portugal
Critical Care 2013, 17(Suppl 2):P125 (doi: 10.1186/cc12063)
Introduction  Venovenous extracorporeal membrane oxygenation 
(VV-ECMO) for respiratory failure in the ICU is used in a variety of 
clinical situations and has been demonstrated to signifi  cantly improve 
survival without disability in adult respiratory distress syndrome [1]. 
ECMO has been presented as a risk factor for bloodstream infection 
although recently published data do not support this view or the use 
of antibiotic prophylaxis [2]. We aimed to examine VV-ECMO as a risk 
factor for nosocomial bloodstream infection.
Methods  A retrospective cohort study from patients admitted to 
our ICU between April 2009 and June 2012. We compared incidence 
rates of nosocomial bacteremia using the Hospitals in Europe Link for 
Infection Control through Surveillance (HELICS) between general ICU 
and VV-ECMO patients and used multiple logistic regression analysis to 
control for possible confounders.
Results During the study period 1,146 patients were admitted and 16 
received VV-ECMO. The incidence of bloodstream infection in patients 
with ECMO was 19/1,000 exposure-days versus 4,9/1,000 exposure-
days in general ICU patients (incidence rate ratio of 3.82; 95% CI: 2.0 
to 7.3; P <0.001). Bacteremia was mostly due to Gram-negative agents 
(65%). The patients with bloodstream infections under ECMO (n  = 
10) had a nonsignifi  cant younger age (P = 0.08) and a lower SAPS II 
score (P = 0.03) compared with non-ECMO patients (n = 25). VV-ECMO 
patients had a signifi  cantly higher risk of primary bacteremia than non-
ECMO patients (P = 0.04). Patients with bloodstream infections in the 
VV-ECMO group had a lower crude mortality rate (OR: 0.1, P = 0.04), not 
confi  rmed in the adjusted analysis. There were no crude or adjusted 
diff  erences in the time to bacteremia or infections due to multiple 
drug-resistant microorganisms (OR: 0.26; P = 0.085) between groups.
Conclusion  This study suggests that VV-ECMO patients have a 
signifi  cantly higher risk for primary nosocomial bloodstream infection. 
A larger study is needed to confi  rm such fi  ndings and to assess the 
need for specifi  c intervention, namely routine antibiotic prophylaxis.
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Introduction aPTT is a common tool for anticoagulation monitor  ing 
during extracorporeal membrane oxygenation (ECMO). Thrombo-
elasto  graphy (TEG) is another available option in this setting.
Methods  A prospective observational study on 12 consecutive 
patients during venovenous ECMO. Anticoagulation was provided 
Figure 1 (abstract P124).
Figure 2 (abstract P124).
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Kaolin-activated TEG (K-TEG) was contemporarily measured but did not 
guide heparin infusion. Baseline K-TEG reaction time (R) >20 minutes 
is accepted for anticoagulation but when it exceeds 90  minutes 
anticoagulation may be too great [1].
Results Mean ECMO duration was 9 ± 4 days. A total of 152 K-TEGs were 
collected. Comparison between aPTT and K-TEG R is reported in Table 1. 
Four patients (33%) had hemorrhagic complications. Neither aPTT 
nor K-TEG R were signifi  cantly diff  erent in patients with hemorrhagic 
events compared with patients without hemorrhagic events but the 
latter received a signifi  cantly lower total heparin dose (P = 0.0097).
Table 1 (abstract P126). Comparison between aPTT and K-TEG R
    aPTT range (ratio)
K-TEG R range  Low  Therapeutic  High
(minutes)  (<1.5)  (1.5 to 2)   (>2)
Low (<20)  13 (9%)  8 (5%)  0  21 (14%)
Therapeutic (20 to 90)  10 (7%)  25 (17%)  11 (7%)  46 (30%)
High (>90)  15 (10%)  55 (36%)  15 (10%)  85 (56%)
  38 (25%)  88 (58%)  26 (17%)  152 total 
      samples
Conclusion Anticoagulation was excessive in more than one-half of the 
samples according to TEG monitoring, while negligible based on aPTT.
Reference
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Introduction The usefulness of extracorporeal membrane oxygenation 
(ECMO) is being rediscovered in the wake of the pandemic of H1N1 
infl  uenza. However, it has been reported that patients who received 
ECMO often developed virus-associated hemophagocytic syndrome 
(VAHS), compared with those without ECMO support. Although 
there is ample evidence that extensive cytokine activation is a key 
factor in VAHS, ECMO itself could be a potential trigger to exacerbate 
the pathology by amplifying cytokine activation. In this study, we 
investigated whether mediators such as cytokines may be produced 
by ECMO.
Methods  Patients with severe respiratory failure who were placed 
on ECMO were enrolled between June and July 2012. This study was 
approved by the ethics committee. Blood specimens were drawn from 
the blood circuit at the inlet of the centrifugal pump (before) and 
outlet of the hollow fi  ber oxygenator (after) at a frequency of three 
to four times per day. Blood IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, 
IL-12(p70), IL-13, IL-17, G-CSF, GM-CSF, IFNγ, MCP-1, MIP-1β, and TNFα 
were measured globally using a multiplex cytokine bead array system 
(Bio-Plex; Bio-Rad, Tokyo, Japan). HMGB1 was measured using an ELISA 
kit (Shino-Test, Tokyo, Japan).
Results Two patients with interstitial pneumonia were studied. The 
ECMO system consisted of a Rotafl  ow Centrifugal Pump (Maquet Japan, 
Tokyo, Japan), a Biocube TNC coating 6000 (NIPRO, Osaka, Japan), and 
a percutaneous cardiopulmonary support system (Capiox EBS; Terumo, 
Tokyo, Japan). The blood fl  ow rate was 2.0 ± 4.0 l/minute. A total of 34 
blood sets were collected. In most cases, blood levels of IL-1β, IL-2, IL-
4, IL-5, IL-12(p70), IL-13, IL-17, GM-CSF, IFNγ, and TNFα were below the 
detection limit and did not increase during ECMO. The other mediators 
were detected at the inlet (before), but no signifi  cant increase was 
observed at the outlet (after) (HMGB1, P = 0.33; IL-6, P = 0.12; IL-7, P = 
0.22; IL-8, P = 0.43; IL-10, P = 0.84; MCP-1, P = 0.10; and MIP-1β, P = 0.65; 
Wilcoxon signed-rank test).
Conclusion The use of ECMO in patients with severe respiratory failure 
did not induce systemic infl  ammatory changes. These observations are 
preliminary, but may nevertheless have important implications for the 
future management of patients with severe infections.
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Introduction  During severe exacerbation of chronic obstructive 
pulmonary disease (COPD) tachypnea, as a consequence of respiratory 
acidosis, and airfl  ow limitation, due to small airway obstruction, lead to 
lung hyperinfl  ation, respiratory distress and gas exchange impairment. 
Invasive mechanical ventilation could worsen lung hyperinfl  ation 
and produce a vicious circle. We investigated whether increasing 
extracorporeal carbon dioxide removal (ECCO2 Cl) could reduce 
the respiratory rate (RR), so prolonging time for lung emptying and 
allowing resolution of hyperinfl  ation.
Methods Six patients with COPD exacerbation with respiratory acidosis 
(PaCO2 83  ±  27  mmHg, pH 7.19  ±  0.1) and tachypnea (RR 39  ±  5) 
despite maximal non-invasive ventilation underwent venovenous 
extracorporeal membrane oxygenation (VV-ECMO). All patients were 
awake and spontaneously breathing an adequate air–oxygen mixture 
to correct hypoxemia (PaO2 72 ± 27 mmHg). While keeping the blood 
fl  ow stable (2.9 ± 0.5 l/minute), we changed the gas fl  ow of the artifi  cial 
lung to modify the extracorporeal CO2 clearance as a percentage of 
total patient CO2 production (% ECCO2 Cl/total VCO2) and we observed 
the variations of RR. We recorded RR at three levels of gas fl  ow in each 
patient (Figure 1).
Results In all patients RR decreased with the increase of extracorporeal 
CO2 removal and a negative correlation was found between RR and 
ECCO2 Cl/total VCO2 (r2 = 0.42, P <0.01). In all patients we were able to 
obtain a reduction of RR below 15 (28 ± 4 vs. 8 ± 4, RR at low gas fl  ow vs. 
RR at maximal gas fl  ow, P <0.001). The selected maximal gas fl  ow was 
variable between diff  erent patients (6.7 ± 2 l/minute), corresponding to 
diff  erent levels of ECCO2 Cl/total VCO2 (83 ± 17%, range 53 to 100%) and 
RR response (8 ± 4, range 5 to 14).
Conclusion  In patients with COPD exacerbation, who failed non-
invasive ventilation, VV-ECMO allows one to maintain spontaneous 
breathing. Titration of extracorporeal CO2 removal leads to control 
RR. This approach could interrupt the vicious circle of dynamic 
hyperinfl  ation and allow the defl  ation of lung parenchyma.
Figure 1 (abstract P128).
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ECCO2 removal with a phosphorylcholine-coated membrane 
oxygenator in diffi   cult respiratory weaning patients
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Introduction  ECCO2 removal may be a useful support in patients 
with diffi   cult respiratory weaning. The aim of this study is to evaluate 
a new phosphorylcholine-coated EECO2 removal system with no 
thrombogenic activity to assess the clinical safety of the system, the 
changes of main cardiorespiratory indices and CO2 removal by the 
system.
Methods  Ten patients were enrolled. Before starting with ECCO2 
removal all patients were ventilated with TV <6 ml/kg, peak pressure 
>35 cmH2O and pH <7.25. ECCO2 removal was initiated using a modifi  ed 
continuous venovenous hemofi   ltration system with a membrane 
oxygenator (ABYLCAP; Bellco, Mirandola, Italy; membrane surface 
area: 0.67 m2, blood fl  ow 280 to 350 ml/minute, phosphorylcholine 
coated). Femoral vein cannulation with a double-lumen catheter was 
used to connect the patients to the extracorporeal system. Heparin was 
infused to maintain ACT <190 to 240 seconds. All patients had ECCO2 
for 4 days. Every 12 hours the pH, PaCO2, peak pressure and PaO2 were 
evaluated. VCO2 was determined by indirect calorimetry using a gas 
analyser equipped on an Engstrom Carestation Ventilator. During the 
ECCO2 removal the patients were ventilated with TV ≤6 ml/kg and peak 
pressure <30 cmH2O. All data are expressed as mean ± SD. One-way 
ANOVA was used to compare the changes of parameters. P <0.05 was 
considered signifi  cant.
Results Table 1 presents the main results. The CO2 removal by mem-
brane oxygenator ranged from 56 to 37  ml/minute. All patients 
survived to the treatment and 7/10 were weaned from the ventilator 
at the end of ECCO2 removal. Only one oxygenator was used for every 
patient without clotting of the circuit or any major bleeding problem.
Table 1 (abstract P129)
  Day 0  Day 2  Day 4
pH  7.24 ± 0.06  7.38 ± 0.1  7.41 ± 0.07*
PaCO2 (mmHg)  70 ± 5  57 ± 8  52 ± 3*
PP (cmH2O)  48 ± 4  28 ± 4*  25 ± 4
VCO2 (ml/minute)  220 ± 15  201 ± 14  180 ± 13*
*P <0.05 versus T0.
Conclusion  ECCO2 removal with a phosphorylcholine-coated mem-
brane oxygenator is clinically safe, avoids clotting of the oxygenator 
circuit and allows adequate CO2 removal.
Reference
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Introduction We have previously shown, in an ex vivo porcine model, 
that lung elastance calculated as the PEEP change divided by lung 
volume increase (ΔPEEP/ΔEELV) is closely correlated to conventionally 
measured lung elastance using oesophageal pressure [1]. In this study 
we hypothesize that the successive change in lung volume during 
a PEEP-step manoeuvre could be predicted from ΔPEEP and lung 
elastance as ΔPEEP/EL. The objective of the study was to validate this 
hypothesis in patients with acute respiratory failure (ARF).
Methods Thirteen patients with ARF were studied during an incremental 
PEEP trial, 0–4–8–12–16 cmH2O. ΔEELV was determined as the change 
in expiratory tidal volume following each PEEP step. Conventional 
calculation of lung elastance was obtained from tidal variation in airway 
pressure minus tidal variation in oesophageal pressure divided by tidal 
volume. Position of the oesophageal catheter was verifi  ed according 
to Baydur [2]. The measured change in end-expiratory lung volume 
during the PEEP-step manoeuvre using spirometry was compared 
with the end-expiratory lung volume change calculated from EL and 
stepwise changes in PEEP as ΔPEEP/EL.
Results There was a close correlation between the measured build-up 
of end-expiratory lung volume during a PEEP-step manoeuvre and 
ΔPEEP/EL where EL was conventionally determined using oesophageal 
pressure measurements (see Figure 1).
Conclusion Esophageal pressure measurements are diffi   cult to perform 
[3] and rarely used in routine clinical practice. Our fi  ndings indicate that 
a change in PEEP together with measurements of the resulting change 
in end-expiratory volume by spirometry in the ventilator could be used 
to determine lung elastance separately, the relation between lung and 
chest wall elastance as well as the transpulmonary pressure.
References
1. Stenqvist  O,  et al.: Acta Anaesthesiol Scand 2012, 56:738-747.
2. Baydur  A:  Chest 2002, 121:324-326.
3. Hedenstierna  G:  Minerva Anestesiol 2012, 78:959-966.
P131
Feasibility of minimally invasive stimulation of the phrenic nerves 
for supporting ventilation in fully anesthetized swine
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Introduction  Long-term use of mechanical ventilators may lead to 
ventilator-induced diaphragmatic dysfunction (VIDD) and increase the 
duration of weaning from MV [1]. It was hypothesized that stimulating 
the diaphragm during MV may prevent VIDD and may lead to early 
weaning [2]. In this study, the feasibility of generating coordinated 
contraction of both diaphragms was investigated using a novel 
transvenous diaphragmatic pacing system.
Methods Two juvenile pigs were anesthetized with propofol (150 to 
250 μg/kg/minute) and ventilated (VENT) with an assist control mode 
MV (Nellcor Puritan Bennett 840). Using fl  uoroscopy, a novel multipolar 
neurostimulation catheter (Inspirx RL PICC53; Respithera, Bloomington, 
MN, USA) was threaded into the left internal jugular vein and advanced 
to the junction of right atrium and the superior vena cava using a 
Figure 1 (abstract P130). Correlation between spirometrically measured 
and calculated increase in EELV.
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and left phrenic nerves was confi  rmed by fl  uoroscopic visualization. 
Peak airway pressures (PAWP) and blood gases were determined after 
10 minutes MV (MV), MV and stimulation applied together (MV+STIM) 
and stimulation only (STIM).
Results  No animal–ventilator dyssynchrony during stimulation 
(MV+STIM) was noted while peak airway pressures were reduced. 
During STIM there was no discernible paradoxical movement of 
the diaphragm. In addition, PCO2 and PO2 confi  rmed that adequate 
ventilation and oxygenation can be provided by the system, while 
PAWP could be reduced (Table 1).
Table 1 (abstract P131). Ventilation parameters
 MV  MV+STIM  STIM
PAWP (cmH2O) 20  16 9
PO2 (mmHg)  89  101  95
PCO2 (mmHg)  32  26  26
Conclusion  It was possible to capture and stimulate both phrenic 
nerves using a minimally invasive approach to support respiration 
and sustain blood gases at physiological levels. This development 
could help wean MV-dependent ICU patients earlier. Further long-term 
studies are needed to assess the full potential of this novel system.
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Introduction Respiratory failure in COPD patients is a frequent call 
in French emergency dispatching centers. We have evaluated the 
prehospital management of COPD patients and severity signs, and 
analyse outcome in the emergency department or ICU.
Methods We conducted an observational, descriptive, retrospective, 
single-center study during a 4-month period. All COPD patients with 
respiratory failure and prehospital care were included. Diff  erent data 
were recorded.
Results Ninety patients were included (77% male, 23% female). Mean 
age 69  years (±  11.88). Fifty-fi   ve percent were smokers, 52% had 
arterial hypertension, 39% received long-term oxygenotherapy, 18% 
received antibiotics in the 7  days before, 18% corticosteroids, and 
14% were on long-term NIV support at home. An emergency medical 
ambulance was immediately sent for 86% of patients. Ninety-two 
percent had normal consciousness (Glasgow Coma Scale 15), 78% 
had bronchospasm, 71% had signs of respiratory struggle, and 12% 
were unable to speak. The mean respiratory rate was 31.4 cycles/
minute (± 8.18), the average cardiac pulse was 103.6 beats/minute 
(± 23.14). Nasal EtCO2 44.92 mmHg (± 16.38), pulse oximetry with air 
was 83.48% (± 12.09), and the average fl  ow rate of oxygen delivered 
was 5.69 l/minute (± 2.93). None of the patients had fever. Eighty-fi  ve 
percent were supported on spontaneous ventilation, 22% received 
prehospital non-invasive ventilation, they all showed signs of severity 
and 3% need tracheal intubation. Seventy-fi  ve percent of patients 
received β2-agonist and anticholinergic nebulization, 45% intravenous 
corticosteroids. Seventy-one percent were admitted to the emergency 
room, 29% to the ICU.
Conclusion  Most of the patients had signs of severity and 
bronchospasm. The absence of fever and antibiotics allows us to think 
that the cause of decompensation is not pneumonia. Although most of 
them were hypoxic and hypercapnic, they seem to be good candidates 
for NIV support in prehospital care. Very few studies report the use of 
NIV in cases of COPD respiratory failure in the fi  rst care delivered at 
home.
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in patients with exacerbation of chronic obstructive pulmonary 
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Introduction Plasma N-terminal pro-brain natriuretic peptide (NT-pro-
BNP) levels are elevated in patients with pulmonary disease especially 
in those with concomitant right ventricular dysfunction. The aim of the 
present study was to investigate the use of plasma NT-pro-BNP levels as 
a prognostic tool in patients with exacerbation of chronic obstructive 
pulmonary disease (COPD).
Methods  A retrospective medical records analysis of all patients 
hospitalized between June 2009 and June 2012 with the fi  nal diagnosis 
of acute exacerbation of COPD who had undergone NT-pro-BNP 
measurements at admission followed by echocardiogram.
Results  Seventy-two patients (mean age 69 years, 58% male) with 
COPD exacerbation but without clinical or echocardiography-oriented 
evidence of acute cardiac disease were enrolled. The mean forced 
expiratory volume in 1 second (FEV 1)/forced vital capacity ratio was 
44.2% and the mean FEV 1 was 0.82 l. Median NT-pro-BNP levels 
at admission were 424.4 pg/ml and the tertile limits were 262.1 and 
930 pg/ml. NT-pro-BNP levels signifi  cantly predicted 30-day mortality 
(OR: 7.2, 95% CI: 3.9 to 15.2; P <0.001), (OR: 25, 95% CI: 16.3 to 37.3; 
P <0.001) and (OR: 44, 95% CI: 44.5 to 76.2) for each tertile. These 
associations persisted after adjusting for arterial CO2 pressure, body 
mass index, age, gender and systolic pulmonary artery pressure.
Conclusion  Among patients with acute exacerbation of chronic 
pulmonary disease, NT-pro-BNP could be a useful marker for severity 
and poor prognosis.
P134
Novel biomarkers for prediction of mortality after acute 
exacerbation of chronic obstructive pulmonary disease
H Michalopoulou, H Michalopoulou, P Stamatis, F Kattis, D Stamatis
Metaxa Hospital, Athens, Greece
Critical Care 2013, 17(Suppl 2):P134 (doi: 10.1186/cc12072)
Introduction  Retrospective studies suggest that cardiac troponin 
levels are often elevated in patients with acute exacerbation of 
chronic obstructive pulmonary disease (AECOPD) indicating a poor 
survival. Novel high-sensitivity cardiac troponin (hs-cTnT) assays have 
better analytical precision than standard troponin (cTnT) assays. We 
elaborated a prospective cohort study to investigate the prognostic 
value of this novel biomarker in patients with AECOPD.
Methods Fifty-six patients (mean age 64 years, 68% male) with the 
fi  nal diagnosis of AECOPD were enrolled. Those who were diagnosed 
with acute coronary syndromes were excluded. We measured cardiac 
troponin T with a standard fourth-generation assay and a high-
sensitivity assay. Clinical, electrocardiographic and echocardiographic 
data were collected at admission and the primary prognostic endpoint 
was death during 30 days of follow-up.
Results Mean hs-cTnT levels at admission were 34 ng/l. During the 
follow-up period seven patients (12%) died. Thirty-eight percent of 
patients had hs-cTnT above the range of 14 ng/l. Prognostic accuracy 
of hs-cTnT for death was signifi  cantly higher, with area under the 
ROC curve (AUC) of 0.83 (95% CI: 0.72 to 0.86), than that of cTnT (AUC: 
0.63, 95% CI: 0.56 to 0.74; P <0.001). After adjustment for age, gender, 
creatinine levels, heart rate, left ventricular ejection fraction, arterial 
O2 pressure and systolic pulmonary artery pressure, hs-cTnT above the 
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CI: 1.5 to 6.7).
Conclusion In AECOPD, novel biomarkers such as hs-cTnT appear to be 
positively associated with COPD severity and could be a determinant 
of mortality.
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Introduction  Laboratory testing for viral infections is not routinely 
performed in adult patients admitted to the ICU. However, reports 
indicate that viruses may contribute to signifi   cant morbidity and 
mortality and that viral–bacterial co-infection is associated with poor 
outcome in this particular patient population. The aim of the study was 
to document the incidence of respiratory virus infections in critically ill 
adult patients admitted to the ICU for acute respiratory failure.
Methods  The prospective, observational study took place during 
two consecutive winter seasons in a mixed 16-bed ICU at the Medical 
Center Leeuwarden, the Netherlands. Adult patients admitted to 
the ICU, suspected of respiratory failure due to community-acquired 
pneumonia, were included. After informed consent brushed 
nasopharyngeal swab (Copan®) samples were taken within 24 hours 
after admission and analyzed by PCR assays for the presence of 
respiratory syncytial virus (RSV), infl   uenza virus, metapneumovirus 
(MPV), parainfl   uenza virus, adenovirus, rhinovirus and coronavirus. 
Data are presented as median (IQR).
Results Thirty-four patients were enrolled. Median age was 66 (54 to 
71) years; 65% of the patients were male; median APACHE IV score on 
admission was 76 (61 to 96). Median ICU stay was 8 (5 to 17) days, with 
an overall hospital mortality of 12%. Thirteen patients (38%) tested 
positive for a respiratory virus. The most frequently found virus was 
infl  uenza (37%), followed by RSV (15%), rhinovirus (15%), MPV (15%), 
corona virus (9%) and parainfl  uenza virus (9%). Two of the patients 
(6%) had a bacterial–viral co-infection (blood culture and PCR positive 
for Streptococcus pneumonia and rhinovirus in one patient and for 
Haemophilus infl   uenza and infl   uenza virus in the second patient). 
Length of stay in the ICU was signifi  cantly longer in PCR-negative 
patients, in comparison with PCR-positive patients (11 (6 to 20) vs. 7 (2 
to 8) days, respectively, P <0.05).
Conclusion  Respiratory viruses, and particularly infl  uenza virus, are 
frequently found in adult patients with respiratory failure admitted to 
the ICU.
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Introduction  Non-invasive positive-pressure ventilation (NIPPV) is 
the fi  rst-line treatment for hypercapnic acute respiratory failure (ARF) 
secondary to COPD exacerbation in selected patients. Limited data 
exist supporting the use of fi  beroptic bronchoscopy (FOB) during this 
clinical setting. The aim of this study is to assess the role of FOB during 
NIPPV in patients with decompensated COPD acute exacerbation.
Methods This study is a randomized prospective case–control pilot 
study carried out on 50 patients admitted to critical care units at 
Alexandria University Hospital, Egypt suff  ering from hypercapnic ARF 
secondary to COPD exacerbation with Kelly Matthay Score from 2 to 4. 
All patients received NIPPV. Patients were divided randomly into two 
equal groups: group I (cases, 25 patients) were subjected to additional 
intervention, early FOB during the fi  rst 6 to 12 hours from admission; 
while group II (control, 25 patients) received the conventional treatment 
and NIPPV only. Outcome parameters measured were changes in ABG 
data, duration of NIPPV, rate of its success, ICU stay and mortality as 
well as the safety of FOB and possible complications.
Results  No signifi  cant  diff   erence was detected between the two 
groups regarding the baseline characteristics. No serious complications 
happened from FOB, oxygen desaturation occurred in 4/25 patients 
(16%), tachycardia in 2/25 patients (8%). In group I, 23 patients (92%) 
were successfully weaned from NIPPV versus 16 patients (64%) in 
group II (P = 0.037). Total duration of NIPPV was 28.52 hours in group I 
versus 56.25 hours in group II (P = 0.001). Length of ICU stay was 4.84 
days in group I versus 8.68 days in group II (P = 0.001). Only one patient 
died in group I versus three patients in group II (P = 0.609).
Conclusion  The early application of FOB during NIPPV in patients 
with ARF due to COPD exacerbation was shown to be safe. Signifi  cant 
improvement in the outcome of patients who underwent FOB was 
noticed in terms of improved ABG data, shorter duration of NIPPV, 
higher percentage of success and shorter ICU stay while no signifi  cant 
diff  erence was detected in mortality.
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Introduction  British Thoracic Society guidelines on community-
acquired pneumonia (CAP) advocate ICU referral for patients with 
CURB65 score of 4 and 5. A recently developed scoring system, SMART-
COP, designed to identify patients at need of intensive respiratory or 
vasopressor support (IRVS), has been validated in a variety of settings. 
It predicts the need for ICU admission (defi  ned as need for IRVS) with 
greater accuracy than CURB65, but is not used routinely in our UK 
institution.
Methods  We retrospectively analysed critical care admissions of 
patients with a diagnosis of CAP in a UK district general hospital – 
ICNARC-coded diagnoses of pneumonia (bacterial, viral, no organisms 
isolated) over a 7-month period (August 2011 to January 2012). We 
ascertained the CURB65 and SMART-COP scores on referral to the ICU 
and matched them in relation to the need for IRVS, length of inotropic 
and ventilatory support and ICU length of stay.
Results Our search revealed 28 potential matches. Five patients were 
excluded (not CAP) and the notes for seven patients were not available 
for analysis. We analysed the notes of 16 patients matching our criteria. 
In this small sample, there was a strong association between increasing 
SMART-COP score and the need for IRVS (correlation coeffi   cient r = 
0.96). There was also a strong correlation with longer inotropic support 
(r = 0.85) and longer ventilatory support (r = 0.96) with increasing 
SMART-COP scores but a weaker correlation with length of ICU stay (r = 
0.49). Moreover, none of the patients admitted to the ICU had CURB65 
score higher than 3 at the time of ICU referral.
Conclusion  In our small sample, higher SMART-COP score was 
associated with increased likelihood of IRVS. This suggests that a further 
study with a larger sample size should be performed to investigate 
whether SMART-COP is an improvement on CURB65 in predicting the 
need for IRVS in UK intensive care patients.
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Introduction  Streptococcal pneumonia remains the most common 
cause of community-acquired pneumonia (CAP), bacterial meningitis 
and bacteremia. Severe pneumonia caused by streptococcal pneu-
monia frequently exists in the emergency room or ICU. We performed 
this study to evaluate the eff  ect of steroid therapy for severe strepto-
coccal pneumonia patients with mechanical ventilation retrospectively.
Methods We enrolled 13 adults of streptococcal pneumonia patients 
who required mechanical ventilation. Seven of 13 patients (S group) 
were administered with steroid (hydrocortisone 200 to 300 mg/day), 
and the remaining six patients received no steroid therapy (NS group). 
As the conventional therapies, mechanical ventilation was commenced 
when a patient’s PaO2/FiO2 showed less than 200 or they clinically 
complained of being short of breath. All patients received appropriate 
fl  uid therapies, vasoactive agents and blood transfusion according 
to the protocol of early goal-directed therapy in the Surviving Sepsis 
Campaign Guidelines 2008, and also were treated with antibiotics, 
immunoglobulins (5 g/day for 3 days) and sivelestat sodium hydrate 
(4.8 mg/kg/day for 7 days).
Results The APACHE scores in the S group and NS group were 27 ± 10 
and 23 ± 4, Sequential Organ Failure Assessment scores were 8 ± 4 
and 7 ± 3, respectively. These scores showed no signifi  cant diff  erence 
between the groups. Procalcitonin (PCT) in the S and NS groups was 
20.7  ±  21.7 and 45.0  ±  47.7  ng/ml, respectively, and there was no 
signifi  cant diff  erence between the groups. PCT declined signifi  cantly 
in both groups. PaO2/FiO2 of the NS group was signifi  cantly higher 
than the S group on ICU admission and 4 days after admission, but 
no signifi  cant diff  erence on 7 days after ICU admission. IL-6 of the NS 
group declined signifi  cantly after ICU admission, and the S group also 
tended to decline.
Conclusion  Steroid therapy for severe streptococcal pneumonia 
patients with mechanical ventilation may have a potential to maintain 
oxygenation of the lung, but no signifi  cant eff  ects on changes of 
infl  ammatory markers (IL-6, CRP).
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Introduction  Ventilator-associated pneumonia (VAP) is the most 
common nosocomial infection in ICU patients who require mechanical 
ventilation support. The aim of this study was to determine predictors 
for the development of VAP in surgical ICU patients admitted to Baskent 
University Hospital.
Methods Following Institutional Review Board approval we performed 
this retrospective study, including 876 patients admitted to the surgical 
ICU between January 2009 and July 2012. After completing a review of 
patient data, 45 patients diagnosed with VAP were compared with 26 
appropriate matches who were not. Patients’ demographical features 
(age, sex, body weight), underlying diseases, etiology for ICU admission, 
APACHE II and Sequential Organ Failure Assessment scores, duration of 
hospitalization, organ dysfunctions, fl  uid balances, laboratory values, 
use of vasopressors, mechanical ventilation, nutrition, antibiotics, 
transfusions, features related to central venous catheterization, urinary 
catheterization, and intubation were the recorded parameters. Patients 
who were not intubated and were discharged or died within 2 days of 
ICU admission were excluded.
Results Out of 71 patients who were included in the fi  nal analysis, 45 
patients (63%) had VAP. Comparing with the control group, patients 
who developed VAP were more likely to have diabetes mellitus and 
immunosuppression (P  = 0.020 and P  = 0.014, respectively). These 
patients also had higher APACHE II scores (P = 0.020) and a longer 
duration of mechanical ventilation (P <0.001), and more frequently had 
an open wound (P = 0.001). Following regression analysis, presence 
of diabetes mellitus (OR: 12.048; 95% CI: 1.157 to 125.000; P = 0.037), 
immunosuppression (OR: 16.949, 95% CI: 2.463 to 111.111; P = 0.004), 
and open wound (OR: 5.714; 95% CI: 1.017 to 37.258; P = 0.048), higher 
APACHE II scores (OR: 1.132; 95% CI: 1.022 to 1.254; P = 0.018), and 
prolonged duration of mechanical ventilation (OR: 1.084; 95% CI: 1.002 
to 1.171; P = 0.043) were determined as risk factors for VAP. Fourteen-
day and 28-day mortality rates for VAP were 19% and 29%, respectively 
(P = 0.760 and P = 1.000, respectively).
Conclusion The presence of diabetes mellitus and immunosuppression, 
higher APACHE II scores, longer mechanical ventilation duration, and 
presence of open wounds were predictors of VAP.
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Introduction Electrical impedance tomography (EIT) is a non-invasive 
and nonradiating imaging technique, which can be used to visualize 
ventilation distribution of the lungs and could distinguish between the 
dependent (dorsal) and nondependent (ventral) parts.
Methods The aim of this study was to observe ventilation distribution 
between dependent and nondependent lung regions, for the individual 
patient, during three diff   erent levels of support during pressure 
support (PS) and neurally adjusted ventilatory assist (NAVA) ventilation. 
Ten mechanically ventilated patients in the ICU were included.
Results  The ratio for dependent/nondependent distribution of 
ventilation is signifi  cantly higher at lower support levels compared 
with higher support levels in both PS and NAVA. However, during NAVA 
there was signifi  cantly less impedance loss between the diff  erent levels 
of assist compared with PS. Tidal volumes decreased when decreasing 
assist levels during PS whereas not during NAVA ventilation. The 
electrical activity of the diaphragm decreased in both PS and NAVA with 
higher levels of assist. Three patients showed an increase in dependent 
tidal impedance variation (TIV) after lowering the assist level from 15 to 
10 cmH2O. This increase in TIV did not occur during NAVA ventilation.
Conclusion There is more ventilation in the dependent part of the 
lung, compared with the nondependent part, at lower levels of assist. 
This could indicate that at higher support levels the contribution 
of the diaphragm is reduced. During NAVA ventilation, there is an 
autoregulation in which the patient is adjusting his tidal ventilation to 
maintain homogeneous ventilation distribution.
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Introduction Obesity as a comorbidity adds a challenge when treating 
children presenting to the PED in status asthmaticus. Bilevel positive 
airway pressure (BiPAP) is an accepted treatment modality for children 
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outcomes for children with status asthmaticus and obesity in our PED.
Methods Patients placed on BiPAP in the PED for status asthmaticus 
from 1 January 2010 to 31 August 2012 were included in the analysis. 
Subjects were divided into moderate and severe exacerbations and 
then further subdivided into the following growth curve-based weight 
subgroups: <90 percentile, 90 to 97 percentile and >97 percentile. 
Subjects received standard asthma therapies in addition to BiPAP. Data 
were obtained at the bedside by the respiratory therapist or collected 
retrospectively by study investigators. Data were stored and analyzed 
using a RedCap database.
Results Three hundred and fi  fty-nine subjects were analyzed. Table 1 
shows the time on BiPAP per visit. Children whose weight was >97 
percentile revealed trends towards longer treatment times on BiPAP 
compared with the other two groups. The moderate subjects who 
weighed >97 percentile had statistically signifi  cant longer treatment 
periods (P <0.006) when compared with the <90 percentile moderate 
group. Initial BiPAP settings are listed in Table 2. When controlling for 
age, higher BiPAP settings correlated with increasing weight. There 
were no weight-based trends for admissions to the PICU or overall 
hospital lengths of stay. No serious complications were noted.
Conclusion This is the fi  rst study to analyze the weight eff  ect on BiPAP 
application in children with status asthmaticus. Subjects who weighed 
more trended greater mean time on BiPAP and initial BiPAP settings. 
Weight did aff  ect PICU admissions or overall length of hospital stay.
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Introduction  Malignant obesity hypoventilation syndrome (MOHS) 
refers to the association between morbid obesity (body mass index 
>40  kg/m2), daytime hypercapnia (PCO2 >45  mmHg) after other 
respiratory or neuromuscular causes of alveolar hypoventilation have 
been excluded, and multiple organ disorders (diabetes mellitus, arterial 
hypertension, metabolic syndrome, obstructive sleep apnea syndrome) 
[1]. Acute respiratory failure (ARF) is a common life-threatening 
complication of MHOS. Non-invasive ventilation (NIV) provides the 
cornerstone of the therapeutic management of decompensated MOHS 
[2]. We aimed to identify the determinants of NIV success or failure in 
this indication.
Methods A monocentric prospective observational study including 48 
patients with MOHS and treated by NIV for ARF over a 2-year period.
Results NIV failed to reverse ARF in only seven patients. NIV failure 
was associated with a sixfold increase in in-hospital mortality (85.7% 
vs. 14.6%; P <0.001). Factors associated with NIV failure and need for 
endotracheal intubation included pneumonia (n = 5, 71.4% vs. n = 8, 
19.5%; P = 0.01), higher SOFA (11 vs. 5; P <0.001) and SAPS 2 (69 vs. 
39;  P  =  0.001) score at admission. The only factor associated with 
successful response to NIV was idiopathic decompensated MOHS 
(n = 19, 100% vs. n = 0, 0%; P = 0.03). In these patients, pH (7.23 vs. 7.28 
vs. 7.44, respectively, at H0, H2, H24; P <0.05) and PCO2 (74.5 vs. 68.5 vs. 
57 mmHg, respectively, at H0, H2, H24; P <0.05) dramatically improved 
with NIV.
Conclusion NIV provides a very effi   cient therapy to reverse hypercapnic 
ARF in morbidly obese patients. Multiple organ failure and pneumonia 
are the main factors associated with NIV failure in patients with MOHS.
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Introduction The benefi  ts of non-invasive ventilation (NIV) in patients 
with type 2 respiratory failure secondary to exacerbations of COPD 
are widely acknowledged [1], but its effi   cacy in respiratory failure of 
other aetiologies is less clear. We describe use of NIV (bilevel and/
or continuous positive airway pressure modes) in the subgroup of 
patients with a clinical diagnosis of pneumonia in a 35-bed adult 
critical care unit (ACCU).
Methods  A retrospective review of data recorded prospectively on 
an electronic clinical information management system at University 
College Hospital (UCH), London, UK. Patients requiring NIV acutely 
at UCH are managed on the ACCU. Electronic records reviewed for 
patients admitted from 1 November 2010 to 2 December 2011 with 
clinical diagnosis of pneumonia, and in whom NIV was recorded on ≥6 
occasions on the electronic chart. We concede some patients on NIV 
<6 hours may have been missed. We excluded patients in whom NIV was 
the ceiling of therapy and those using domiciliary NIV. The following 
data were collected: baseline patient demographics, comorbidities, 
therapy received in the ACCU, respiratory physiological variables, 
length of stay/unit outcome. Descriptive statistics of the cohort and 
variables associated on univariate analysis with requirement for 
intubation were generated using MedCalc Version 12.3.0.0 (MedCalc 
Software, Mariakerke, Belgium).
Results  Fifty-two patients fulfi  lled the inclusion criteria, 29 (55.8%) 
were male, median age was 62.4 (IQR 48.8 to 71.6), median unit stay 
was 8 days (IQR 4.5 to 16.5), mean duration of NIV use was 2 days (IQR 1 
to 3), 27 (51.9%) required intubation of whom 48% died. Total mortality 
was 13 (25%) – all intubated. Patients with recorded comorbidities were 
more likely to be intubated than those without (OR = 4.3, P = 0.0362); 
pH was signifi  cantly lower in those requiring intubation at all recorded 
time points; and mean FiO2 at 4 to 6 hours was signifi  cantly higher in 
those requiring intubation(0.72 vs. 0.56, P = 0.032). There was a trend 
Table 1 (abstract P141). Time on BiPAP by weight percentile and severity of asthma exacerbation (hours)
  Moderate exacerbation  Severe exacerbation  Combined
  <90   90 to 97  >97   <90   90 to 97  >97   <90   90 to 97  >97 
  percentile    percentile percentile percentile percentile percentile percentile percentile percentile
 ( n = 113) (n = 35) (n = 36) (n = 109) (n = 35) (n = 31) (n = 222) (n = 70) (n = 67)
Mean  3.53 4.03 5.01 5.67 5.56 5.88 4.58 4.85 5.41
SD  3.35 3.24 4.26 4.78 4.03 7.25 4.25 3.75 5.81
Median  2.50 3.00 3.75 3.83 4.00 4.00 3.00 3.38 4.00
Table 2 (abstract P141). Initial mean BiPAP settings by age and weight 
percentile
                        <90 percentile                90 to 97 percentile             >97 percentile
Age
(years) IPAP EPAP IPAP EPAP IPAP EPAP
3 to 4  12.6 ± 2.4  6.7 ± 1.4  13.0 ± 2.2  6.5 ± 1.2  13.1 ± 1.9  6.7 ± 1.0
5 to 6  13.4 ± 2.4  6.9 ± 1.4  12.4 ± 2.0  6.6 ± 1.5  14.2 ± 1.3  7.0 ± 0.9
7 to 9  14.2 ± 2.2  7.4 ± 1.4  14.9 ± 2.7  7.7 ± 1.8  14.1 ± 2.4  7.1 ± 1.3
10 to 12  14.1 ± 2.7  7.3 ± 1.7  15.4 ± 4.1  7.9 ± 2.0  15.1 ± 3.1  8.0 ± 1.6
13 to 16  15.2 ± 4.2  8.6 ± 1.8  14.0 ± 1.8  7.7 ± 1.5  16.5 ± 3.9  8.8 ± 1.8
Critical Care 2013, Volume 17 Suppl 2 
http://ccforum.com/supplements/17/S2
S53toward patients with COPD requiring intubation more often (OR = 8.4, 
P = 0.0711).
Conclusion NIV was successful in 48.1% of patients with pneumonia, 
the remainder requiring intubation. Given the high mortality in those 
patients who failed NIV we believe its use in a ward setting is hazardous. 
We conclude that NIV may be useful in some individuals with 
pneumonia, but they should be managed in the ACCU setting. Further 
work is required to identify those patients at risk of deterioration on NIV 
given the possible excess mortality.
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Introduction Benefi  ts of the use of NIV in emergency departments are 
well established. Training and available staff  , and choice of respiratory 
machines are essential criteria for success.
Methods We conducted an observational, descriptive, retrospective, 
single-center study in a 4-month period. COPD patients with respiratory 
failure who received prehospital NIV were included. We compared two 
groups: COPD patients with NIV, and COPD patients without NIV.
Results  Forty-two patients were included, mean age 68.86 years 
(± 11.98), 57.14% smokers, 64.28% arterial hypertension, 100% long-
term oxygenotherapy, 23.80% antibiotics in the 7 days before, 28.57% 
corticosteroids. A total of 88.09% had bronchospasm, 78.26% had 
struggle signs, 28.57% were unable to speak, 14.28% of patients were 
sweating. The mean respiratory rate was 30.5 cycles/minute (± 7.17), 
mean pulse rate was 105.76 (± 25.34). Nasal EtCO2 was 47.75 mmHg 
(±  16.53), pulse oxymetry in air was 85% (±  10.94), oxygen fl  ow 
rate was 5.45 l/minute (±  2.42), temperature was 37.14°C (±  8.15). 
Twenty patients received NIV. A total of 61.90% were admitted to 
the emergency department, 35.71% to the ICU, and one patient 
was left at home. One patient received tracheal intubation in the 
hosting service. Mortality in the fi  rst month was 13.04%. A signifi  cant 
diff  erence (P <0.05) was found for: sweats (30%/0), respiratory rate 
(34 ± 8.23/27 ± 6.11), nasal EtCO2 (55.0 ± 24.4/40.50 ± 9.03), pulse 
oxymetry in air (80%  ±  8.63/90%  ±  13.25), pulse oxymetry with 
oxygen (89.4% ± 4.24/87.90% ± 2.55), β2-mimetic and anti-cholinergic 
nebulization (60%  ±  0.5/90%  ±  0.29), emergency room admission 
(35%  ±  0.35/86%  ±  0.48), ICU admission (60%  ±  0.5/13%  ±  0.35), 
arterial blood gases on arrival in the host service (PaCO2 
76.6 ± 18.66/43.93 ± 11.78). No diff  erence in mortality at 1 month (2/3).
Conclusion Non-invasive ventilation has improved the management 
and prognosis of COPD patients admitted to the emergency room. 
Very few studies concern the prehospital management. NIV seems to 
show an eff  ect on prehospital care, especially in patients with signs of 
severity, hypercapnia, and without fever. Oxygenation and hypercapnia 
seem to be improved. Also fewer patients are admitted to the ICU. 
Bronchospasm does not seem to be an obstacle.
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Introduction Inadequate respiratory muscle activity has been linked 
to ventilator-induced diaphragm dysfunction. Current techniques for 
monitoring respiratory muscle activity during mechanical ventilation 
are specialized and relatively invasive. Visualizing diaphragm thickening 
during inspiration by ultrasound may permit non-invasive monitoring. 
We explored the feasibility, reliability and physiological signifi  cance of 
diaphragm thickening on ultrasound.
Methods Five healthy subjects participated. We monitored inspiratory 
fl   ow, volume, esophageal and gastric pressures, and diaphragm 
electrical activity (by esophageal and surface electromyography) while 
subjects performed a series of inspiratory maneuvers: tidal breathing, 
threshold-loaded breathing, a Muller maneuver, and inspiration to 
various lung volumes above functional residual capacity. At the end 
of each inspiratory eff  ort, subjects were instructed to close the glottis 
and relax the respiratory muscles (so as to maintain lung volume while 
eliminating diaphragm activation). Sonographic images of diaphragm 
thickening during these maneuvers were obtained using M-mode with 
a 13 MHz linear array probe placed in the right ninth, 10th, or 11th 
intercostal space between the middle and anterior axillary lines.
Results Diaphragm thickening in the zone of apposition was readily 
visualized by ultrasound in all fi   ve subjects. Mean end-expiratory 
diaphragm thickness was 2.1  mm (SD  =  0.3  mm). During tidal 
breathing, the diaphragm thickened by a mean of 35% (SD = 31%). The 
Bland–Altman coeffi   cient of reproducibility was 0.5 mm; approximately 
50% of measurement variability arose from caliper positioning on the 
ultrasound machine; diaphragm thickness measurements changed as 
the probe was placed in diff  erent intercostal interspaces. Diaphragm 
inspiratory thickening increased signifi   cantly with increasing 
inspiratory eff  ort but also varied with lung volume independent of 
eff  ort. At inspiratory volumes below 40% of inspiratory capacity, lung 
volume change contributed minimally to diaphragm thickening.
Conclusion  Visualizing diaphragm thickening in the zone of appo-
sition by ultrasound provides a feasible non-invasive technique for 
monitoring diaphragm activation in healthy subjects. Diaphragm 
thickening primarily refl  ects muscular eff  ort rather than altered muscle 
conformation induced by changes in lung volume, especially at lower 
inspiratory volumes.
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Introduction The theoretical advantages of monitoring the electrical 
activity of the diaphragm (EAdi) and neural triggering of support 
breaths (NAVA-Maquet) have not yet been shown to translate into 
signifi   cant clinical benefi   t [1]. Here we assess the eff   ect of EAdi 
monitoring, in patients at risk of prolonged weaning, on outcomes.
Figure 1 (abstract P146).
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clinical information system was searched to identify patients who 
received MV for >48 hours and who had signifi  cant chronic pulmonary 
disease or left/right ventricular impairment between April 2009 and 
March 2012. Age, APACHE II score, ventilated days, time in NAVA and 
outcome were compared between groups who had or had not received 
EAdi monitoring.
Results In total, 493/2,684 (18.3%) patients had heart–lung risk factors 
for prolonged weaning. One hundred and four patients received EAdi 
monitoring. Ventilated days were signifi  cantly reduced (Figure 1) in 
the EAdi monitored group (median 9) versus the nonmonitored group 
(median 12); P = 0.024 (Mann–Whitney U test). ICU mortality was not 
signifi  cantly diff  erent and there was no correlation between time spent 
in NAVA and days ventilated.
Conclusion EAdi catheter insertion was associated with a signifi  cant 
reduction in time spent on MV. A prospective RCT will be needed to 
confi  rm benefi  t and explore mechanisms.
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Introduction Patients with acute respiratory failure demand dynamic 
evaluation and interventions. Lung ultrasound is a bedside technique, 
very promising in this setting. Previously, Lichtenstein and colleagues 
proposed an algorithm approach with a diagnostic accuracy of 90.5%, 
named Bedside Lung Ultrasound in Emergency (BLUE protocol). 
However, this approach has never been validated in other populations 
or ultrasound operators. The aim of this study was to evaluate the 
diagnostic accuracy of the lung ultrasound algorithm (BLUE protocol) 
in ICU patients admitted with acute respiratory failure.
Methods A prospective study, single-center consecutive case series 
evaluating critically ill adult patients in acute respiratory failure, 
admitted to a 23-bed general ICU between October 2011 and 
November 2012. The ultrasound examination was performed by an ICU 
physician until 20 minutes after admission, without interfering with 
usual care, and the ultrasound operator was blinded to the medical 
history of the patient. Three items were assessed: artifacts (horizontal 
A lines or vertical B lines indicating interstitial syndrome), lung sliding, 
alveolar consolidation and/or pleural eff  usion. BLUE protocol results 
were compared with clinical diagnosis by the medical assistant team 
at the end of the ICU stay.
Results Forty-two patients were evaluated (42% male), mean age was 
73 years (SD ± 15) and APACHE II score was 18.77 (median 20). Based 
upon evaluation of the fi  ndings of BLUE protocol, a positive correlation 
was found in 83.78% of the sample. For the diagnosis of pulmonary 
edema (n = 15), sensitivity was 85% and specifi  city was 86%, while for 
the diagnosis of pneumonia (n = 17), sensitivity was 88% and specifi  city 
was 90%. In this sample there were only four cases of reversible airway 
obstruction and one case of pulmonary embolism. Five patients were 
excluded of the analysis because they had rare diagnoses.
Conclusion  Preliminary results demonstrate diagnostic accuracy of 
lung ultrasound examination performed on the admission of patients 
with acute respiratory failure similar to the original publication. Lung 
ultrasound, as proposed in the BLUE protocol, has good accuracy, and 
seems reproducible and useful in this group of patients.
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Introduction Despite 18 mmHg being recognized as a classical cutoff   
value, there is no defi  nite value of PAOP above which cardiogenic 
oedema develops. We aimed to assess the risks of weaning failure with 
PAOP ≥15 and with PAOP ≥18.
Methods A prospective enrollment of 30 adult medical ICU patients 
on invasive mechanical ventilation who were fulfi  lling the criteria for 
initiation of weaning from mechanical ventilation according to the 
Sixth International Conference Statement of Intensive Care Medicine. 
We followed the two-step weaning strategy, which involves assessment 
regarding readiness for weaning followed by a spontaneous breathing 
trial (SBT) as a diagnostic test to determine the likelihood of successful 
extubation. Invasive right heart catheterization to measure PAOP, and 
non-invasive transthoraxic echo and tissue Doppler parameters E/E’, 
E/A, DT, IVRT were measured before initiation and after termination of 
the SBT.
Results E/E’ was signifi  cantly correlated with PAOP (r = 503, P <0.001). A 
cutoff   value of septal E/E’ >11.3 predicted PAOP elevation ≥18 mmHg 
with a sensitivity of 90.9% and specifi  city of 87.8%, while a value of 
septal E/E’ >10.9 predicted PAOP elevation ≥15 mmHg with a sensitivity 
of 59.1% and specifi  city of 87.8%. The incidence of weaning failure 
was 23%, and 72% of patients who failed to be weaned exhibited 
signifi  cantly higher PAOP during the trial. Patients with PAOP ≥18 at 
the end of the SBT mostly (72.4%) failed weaning while a minority 
(27.6%) successfully weaned. The majority (91.3%) of the patients 
with PAOP <18 had a successful weaning outcome and 8.7% failed 
weaning outcome. PAOP ≥18 signifi  cantly negatively correlated with 
weaning success (P = 0.001, r = –0.627). On the other hand, PAOP ≥15 
did not show a signifi  cant correlation (P >0.05, r = –0.274). The PAOP 
≥18 weaning failure risk estimate was 8.2, with 95% CI 0.004 to 0.3. The 
PAOP ≥15 weaning failure risk estimate was 1.83, with a signifi  cant 95% 
CI of 0.913 to 3.648.
Conclusion  E/E’ was signifi   cantly correlated with PAOP (r  =  503, 
P <0.001). E/E’ > 11.3 predicted PAOP elevation ≥18 mmHg (sensitivity 
90.9% and specifi  city 87.8%), while E/E’ >10.9 predicted PAOP elevation 
≥15 mmHg (sensitivity 59.1% and specifi  city 87.8%). Weaning failure 
risk is greater (8.2 vs. 1.8) with PAOP ≥18 versus PAOP ≥15, respectively.
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Introduction Despite the extensive use of continuous positive airway 
pressure (CPAP) in various respiratory failure conditions, its role in acute 
asthmatic attack is uncertain [1-3]. This study aims at exploring the 
effi   cacy of CPAP when use in addition to the conventional treatment of 
acute asthma exacerbation in the emergency department (ED).
Methods  During May to December 2009, acute asthma patients 
attending ED were randomly assigned to CPAP and control groups. In 
addition to the conventional treatment, CPAP ventilation of 8 cmH2O 
was applied to patients in the CPAP group. Data collections in both 
groups included peak expiratory fl   ow rates (PEFR, %predicted) at 
each 15-minute interval (T0, T15, …), the number of short-acting 
bronchodilators (SABA) used, ED length of stay, relapse rate and 
admission rate. The primary outcome is the improvement in peak 
expiratory fl  ow rate during a short period stay in the ED.
Results  There were 86 patients enrolled, with 43 patients in each 
study group. PEFR in the CPAP group showed no diff  erence from the 
control group at T0 (52.7 ± 20.33 vs. 47.2 ± 16.64, P = NS) but was 
signifi  cantly better at T15 (65.58 ± 21.64 vs. 56.49 ± 18.53%, P <0.05). 
Such improvement was consistently observed for all subsequent PEFR 
measurement, along with the fewer SABA used and relapse rate, but 
the fi  gures did not meet statistical diff  erence.
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treatment in the ED could accelerate PEFR improvement with a trend 
showing fewer SABA needed, lower relapse rate and shorter ED length 
of stay.
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Introduction Emergency endotracheal intubation results in accidental 
oesophageal intubation in up to 17% of patients often with disastrous 
consequences. We have previously published a highly specifi  c and 
sensitive novel method to detect endotracheal intubation based on 
diff  erences in ventilation pressure waveforms in the oesophagus and 
in the trachea in patients with healthy lungs [1]. A detection algorithm, 
based on diff  erences in compliance/elasticity between the lung and 
the oesophagus, generated a D-value indicating tracheal intubation if 
D >0.5 and oesophageal intubation if D <0.5. The aim of the current 
study was to validate the algorithm in patients with lung disease.
Methods  After obtaining institutional approval, 20 intubated and 
ventilated ICU patients were included. Inclusion criteria were controlled 
mechanical ventilation and at least mild to moderate lung injury 
according to a Murray lung injury score >0.1. A connecting piece was 
placed between the endotracheal tube and the ventilation bag. This 
piece comprised a thin air-fi  lled catheter inserted through the tube 
lumen at 1 cm from the distal end, and a second catheter located at 
the proximal end of the tube. We performed three consecutive manual 
bag ventilations while recording the pressure curves through both 
catheters. For each ventilation, a D-value was calculated.
Results Mean age (SD) of the patients was 60 (16) years, 60% were 
male. The mean (SD) Murray score was 1.4 (0.6). Pathologies included 
pulmonary oedema, pneumonia, atelectasis and traumatic lung 
injury. All 60 D-values are represented in Figure  1. The median 
(IQR, range) D-value was 38 (16 to 74, 0.8 to 1,272). Our algorithm 
therefore confi  rmed a high sensitivity to detect correct endotracheal 
intubation also in patients with lung disease. Under the hypothesis that 
oesophageal compliance does not increase signifi  cantly in patients 
with lung disease, the specifi  city of our algorithm will not be aff  ected.
Conclusion The algorithm to detect correct endotracheal intubation 
performed excellent in patients with lung disease.
Reference
1. Kalmar  AF,  et al.: Resuscitation 2012, 83:177-182.
P151
Main indications, diagnostic and therapeutic yield of bronchoscopy 
in the ICU
J Iglesias, B Gonzalez, O Rajas
La Princesa Hospital, Madrid, Spain
Critical Care 2013, 17(Suppl 2):P151 (doi: 10.1186/cc12089)
Introduction Bronchoscopy (BC) is a frequently used diagnostic and 
therapeutic tool in our ICU. We planned to review the patients and 
conditions in which the procedure was performed. The objective was 
to determine indications, diagnostic and therapeutic yield.
Methods A retrospective, single-center observational study was carried 
out. All BC performed in a 20-bed polyvalent ICU of a tertiary university 
hospital over a period of 30 months (from January 2010 to June 2012) 
were included. The main variables collected were demographic data 
and clinical data including comorbidities, endobronchial techniques 
and results.
Results A total of 470 BC were carried out in 240 patients admitted to 
the ICU (68% were male and 32% were female). All of the procedures 
were performed in mechanically ventilated patients. The mean patient 
age was 61 ± 14 years, with an APACHE II score at admission of 20 ± 7. The 
main cause for ICU admission was respiratory failure (27%). The most 
common comorbidities were smoking, chronic obstructive pulmonary 
disease, cardiovascular risk factors and atrial fi  brillation. The  main 
indications for performing the BC were percutaneous tracheostomy 
endoscopically guided (28%), resolution of atelectasis (27%), aspiration 
of secretions (24%) and hemoptysis (10%). Bronchial brushing was 
performed in 435 cases (93%) obtaining microbiological growth in 64% 
of them, mainly Pseudomonas aeruginosa and Acinetobacter baumanii. 
Bronchoalveolar lavage was performed in 62 cases (13%) obtaining 
microbiological growth in 61% of them, mainly cytomegalovirus and 
Stenotrophomona maltophilia. Citology was performed in 60 cases 
(13%); 7% showed the presence of microorganism and 13% revealed 
precancerous/cancerous tissue changes.
Conclusion BC can be performed at the bedside, avoiding transfers 
outside the ICU that may cause clinical worsening. Most frequent 
indications were bronchoscopy-guided percutaneous tracheostomy, 
resolution of atelectasis, aspiration of secretions and hemoptysis. 
Microbiological results obtained revealed the presence of aggressive 
pathogens. BC in ICU provides valuable diagnostic information and has 
therapeutic utility.
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Introduction The aim was to compare two novel endotracheal tubes 
(ETT), Mallinckrodt TaperGuard (TG, tapered polyvinyl chloride (PVC) 
cuff   ) and KimVent Microcuff    (MC, cylindrical polyurethrane cuff   ), 
Figure 1 (abstract P150). D-value of individual test ventilations.
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cuff  s (microaspiration) under simulated clinical situations. It has been 
shown that globular PVC cuff  s protect poorly against leakages due 
to microchannels formed from infolding of redundant cuff   material 
[1]. We hypothesized that TG and MC better prevent microaspiration, 
which is a major mechanism of ventilator-associated pneumonia (VAP).
Methods  Each ETT was inserted into a silicone cylinder of 2  cm 
wide inclined at 35°. Then 20  ml water was added above the cuff   
and leakage measured every minute under fi  ve diff  erent simulated 
clinical conditions: mechanical ventilation for acute severe asthma 
(positive end-expiratory pressure (PEEP) 0 cmH2O), normal lungs (PEEP 
5 cmH2O) and acute respiratory distress syndrome (PEEP 10 cmH2O), 
and disconnection from the ventilator with and without spontaneous 
breathing eff   ort. Spontaneous breathing was simulated with a 
respiratory gas exchange simulator. Suction was applied at 200 cmH2O 
sustained for 3 minutes at the Murphy eye. Each scenario was repeated 
with cuff   pressures (Pcuff  ) 10, 20 and 30 cmH2O maintained by a Pcuff   
maintenance device.
Results PT leaked grossly in all scenarios without PEEP and at PEEP 
5  cmH2O in the presence of suction irrespective of Pcuff    (Pcuff   
30 cmH2O: PT 19.7 ± 0.4, TG 0.0 ± 0.1, MC 0.0 ± 0.0, P <0.001; Pcuff   
20 cmH2O: PT 19.9 ± 0.4, TG 7.4 ± 6.2, MC 0.0 ± 0.0, P <0.001; Pcuff   
10 cmH2O: PT 20.0 ± 0.0, TG 12.7 ± 5.1, MC 0.9 ± 0.8, P <0.001). Leakage 
under these scenarios can be reduced in TG and prevented in MC by 
Pcuff   ≥20 cmH2O (Figure 1).
Conclusion  Microcuff    outperformed the others in preventing 
microaspiration, while Portex leaked grossly even at a recommended 
Pcuff   of 20 to 30 cmH2O whenever PEEP was lost. The eff  ect of ETT type 
on the incidence of VAP warrants further investigation.
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Introduction  The most common cause of ventilator-associated 
pneumonia (VAP) is aspiration of oral secretion through the 
endotracheal tube (ET). Subglottic suction drainage (SSD) has been 
recommended as a safety measure against aspiration due to its 
high eff  ectiveness. Currently, two types of cuff   shape – spindle and 
tapered – are predominant in high-volume, low-pressure (HVLP) ETs 
with SSD. However, the shape most suitable for preventing dripping 
onto the subglottis has not been determined. The purpose of this study 
was to determine whether an ET with tapered-type cuff   can reduce the 
incidence of VAP.
Methods After approval from the appropriate ethics committee, we 
conducted a single-institutional prospective randomized clinical trial 
on the eff  ectiveness of using an ET with a diff  erent cuff   type. Adult 
patients (n = 399; ≥18 years old) were screened between April 2010 
and March 2012, and 289 patients expected to require mechanical 
ventilation (MV) for at least 48 hours were randomized. Patients were 
assigned to intubation with one of the following two HVLP ETs with 
SSD on the experimental tube: tapered type (Taperguard™ Evac®; 
Covidien, Dublin, Ireland) or spindle type (Hi-Lo Evac®; Covidien). Cuff   
pressure measurement was carried out every 6 hours, and cuff   pressure 
was maintained between 20 and 30 cmH2O. The primary outcome was 
VAP incidence based on semiquantitative bronchoalveolar lavage fl  uid 
culture of 3+ or phagocytosis on Gram staining in patients intubated 
for at least 48 hours. The other outcome was the rate of achieving an 
appropriate cuff   pressure (20 to 30 cmH2O), time to VAP onset, duration 
of MV, duration of ICU stay, mortality, and adverse events.
Results  The rate of microbiologically confi   rmed VAP was 21.7% 
(23/106) for the tapered-type ET patients and 21.7% (23/106) for the 
spindle-type ET patients (P = 1.00). The rate of achieving appropriate 
cuff   pressure was 83.2% (332/1,974) for the tapered type and 82.4% 
(328/1,867) for the spindle type (P = 0.549). No signifi  cant diff  erences 
between groups were observed for time to VAP onset, duration of MV, 
ICU stay. The incidence of reintubation due to laryngeal edema after 
extubation was slightly higher in patients with the tapered-type ET 
(11.5%, 6/52) than in patients with the spindle-type ET (2.0%, 1/49), but 
the diff  erence was not signifi  cant (P = 0.113).
Conclusion  Diff   erences in cuff    type and shape under identical 
conditions of cuff   pressure control have no infl  uence on the incidence 
of VAP.
Acknowledgement UMIN-CTR UMIN000003371.
P154
Eff  ect of body position changes on endotracheal tube cuff   pressure 
in ventilated patients
C Lizy1, W Swinnen2, S Labeau3, S Blot1
1Gent University, Ghent, Belgium; 2General Hospital Sint Blasius, 
Dendermonde, Belgium; 3University College Ghent, Belgium
Critical Care 2013, 17(Suppl 2):P154 (doi: 10.1186/cc12092)
Introduction In order to avoid either microaspiration (<20 cmH2O) or 
tracheal injury (>30 cmH2O), the target for endotracheal tube (ETT) cuff   
pressure (CP) is between 20 and 30 cmH2O. Our objective was to assess 
the eff  ect of patient positioning changes on CP in adult patients.
Methods A sample of 12 orally intubated and sedated patients was 
selected. Patients received neuromuscular blockade and were positioned 
in a neutral start position (backrest, head of bed elevation (HoB) 
30°, head in neutral position) and CP set at 25 cmH2O. Subsequently 
16 diff   erent position changes were performed: antefl  exion  head, 
hyperextension head, left and right lateral fl  exion of head, left and right 
rotation of the head, semirecumbent position (HoB 45°), recumbent 
position (HoB 10°), horizontal position, trendelenburg (–10°), left 
and right lateral positioning over 30°, 45° and 90°. Once the patient 
was correctly positioned, CP was recorded during an end-expiratory 
ventilatory hold. CP observed was compared with CP at start position 
(25 cmH2O). Also the number of values outside the target range (20 to 
30 cmH2O) was reported as considered clinically relevant.
Results A total of 192 measurements were performed (12 subjects×16 
positions). Results are shown in Table 1 (CP reported as median, IQR). 
In every position a signifi  cant deviation in CP was observed. In total, 
40.6% of values exceeded the upper limit of 30 cmH2O. No values 
beneath the lower target limit of 20 cmH2O were observed. In each 
position the upper target limit was exceeded at least once.
Conclusion  Simple changes in patient positioning may result in 
potentially harmful CP (>30 cmH2O). These observations call for strict 
CP monitoring.
Figure 1 (abstract P152). Downward leak in PEEP 0 cmH2O without 
suction. Each point represents the mean and standard deviation of eight 
repeated measures.
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Introduction National Audit Project 4 (NAP4) highlighted the need to 
improve airway management in ICUs and key recommendations were 
the continuous use of end-tidal carbon dioxide (ETCO2) monitoring, 
pre-intubation checklists and diffi   cult airway trolleys [1]. This complete 
cycle audit aimed to quantify the current state of airway management 
on our ICU and the eff   ectiveness of implementing the NAP4 
recommendations.
Methods  Data collection was carried out prospectively for both 
phases and included documentation of intubation, use of ETCO2 and 
the incidence of serious adverse events (SAEs). The contents of the 
intubation boxes were compared against the Diffi   cult Airway Society 
(DAS) guidelines [2]. The re-audit was carried out 6 months following 
the introduction of a pre-intubation checklist, a documentation sticker, 
a diffi     cult airway trolley and standardization of the basic bedside 
airway boxes with a checklist of contents. A training program in airway 
management for all ICU staff   was also introduced.
Results The baseline characteristics of both groups were similar. The 
initial audit included 45 patients and the re-audit 58 patients. In the initial 
audit 19% of patients had accurate documentation of intubation with 
the use of ETCO2. The continuous use of ETCO2 was 80%. Bedside airway 
boxes did not contain a checklist of standardized equipment. A diffi   cult 
airway trolley was not located on the ICU. Following introduction of the 
changes described, a signifi  cant improvement in the use of ETCO2 to 
confi  rm intubation (46% vs. 19%, P <0.01) and continuous use of ETCO2 
monitoring (100% vs. 80% P ≤0.0004) was observed. The use of the pre-
intubation checklist (7%) and stickers (11%) was poor. All bedside boxes 
had a checklist and the required equipment. A diffi   cult airway trolley is 
located on the ICU with an equipment list and DAS algorithm attached. 
No SAEs were recorded in either phase.
Conclusion  Serious airway complications are rare. Safer airway 
manage ment is essential in the ICU to prevent morbidity and mortality. 
This audit demonstrated that simple measures in conjunction with 
a structured training program can help to improve the safety of 
airway management in critically ill patients. Further work is required 
to improve compliance with the pre-intubation checklist alongside a 
continued education program.
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Introduction  The goal of this study was to assess the amount of 
biofi  lm within the endotracheal tube (ETT) by CT scan and to evaluate 
in a bench test a device aimed at ETT biofi  lm removal. Biofi  lm grows 
within the ETT soon after intubation, resulting in increased resistance 
to airfl  ow. Biofi  lm detachment from the ETT can result in bacterial 
colonization of the distal airways. The use of an ETT cleaning device 
could eff  ectively reduce the patient’s airfl  ow resistance burden. The 
quantifi  cation and distribution of biofi  lm within the ETT might help to 
evaluate ETT cleaning device eff  ectiveness.
Methods We collected ETTs of 11 critically ill patients after extubation. 
Micro-CT scan (SkyScan 1176; Bruker, Belgium) was performed using 
a resolution of 35 μm. Axial sections of the 20 cm above the cuff   were 
reconstructed, and the volume of secretions was assessed by a density 
criterion. Microbiological cultures of the ETT lavage fl  uid were then 
obtained. Patient’s demographics and clinical data were recorded. In 
a diff  erent set of bench experiments, we injected 1 ml water-based 
polymer into new ETTs of diff  erent sizes. We measured resistance to 
airfl  ow before and after using an ETT cleaning device (Airway Medix 
Closed Suction System; Biovo Technologies, Tel Aviv, Israel). We also 
obtained resistance values of intact ETTs as controls.
Results The studied ETTs remained in place for a median of 7 days 
(IQR range 4 to 15). The amount of secretions assessed by CT scan was 
0.293 ± 0.290 ml (range 0.032 to 0.777 ml). Secretion volumes were 
not related to patient severity at admission (SAPS 2, P/F ratio) or days 
of intubation; an inverse correlation with patient’s age was present 
(P  =  0.032,  R2  =  0.46). Bacterial growth was present in 9/11 (82%) 
ETT fl  uids cultures and Candida spp. showed an elevated prevalence 
(6/11, 55%). In the bench tests, the cleaning device reduced resistance 
to airfl  ow (diff  erence before and after cleaning 5.5 (95% CI = 8.9 to 
1.6)  cmH2O/l/second,  P  =  0.006). After cleaning, resistance resulted 
higher than intact ETTs, although with a clinically negligible diff  erence 
(diff  erence 0.3 (95% CI = 0.2 to 0.6 cmH2O/l/second), P = 0.032).
Conclusion Micro-CT scan is a feasible and promising technique to 
assess secretions volume in ETTs after extubation. The use of an ETT 
cleaning device decreases resistance to airfl  ow in bench tests; the 
eff  ectiveness of such a device in the clinical setting could be properly 
assessed by post-extubation CT scan.
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Introduction  Diffi     cult intubation (DI) in the ICU is a challenging 
issue, associated with severe life-threatening complications [1,2]. The 
objective was to develop and validate a simplifi  ed score for identifying 
patients with DI in the ICU and to report related complications.
Table 1 (abstract P154). Endotracheal tube cuff   pressure values following 
patient position changes
 Cuff    P for Δ from  Measurements
  pressure  start position  >30 cmH2O 
 (cmH2O)a (25  cmH2O) (n (%))
Antefl  exion head  33.5 (27.5 to 42.0)  0.005  9 (75)
Hyperextension head  30.5 (27.5 to 42.0)  0.004  6 (50)
Lateral fl  exion head, left  26.5 (25.3 to 28.8)  0.025  1 (8)
Lateral fl  exion head, right  27.0 (25.3 to 29.8)  0.049  2 (17)
Rotation head, left  27.0 (26.3 to 33.8)  0.003  3 (25)
Rotation head, right  28.0 (26.3 to 38.8)  0.020  4 (33)
Semirecumbent, 45° HoB   28.0 (25.3 to 31.5)  0.009  2 (17)
Recumbent, 10° HoB  28.0 (25.3 to 31.5)  0.016  3 (25)
Horizontal back rest   28.5 (25.3 to 31.5)  0.011  3 (25)
Trendelenburg, 10°  29.0 (25.3 to 32.0)  0.008  5 (42)
Left lateral position, 30°  30.5 (25.3 to 32.0)  0.010  6 (50)
Left lateral position, 45°  30.5 (27.3 to 32.8)  0.005  6 (50)
Left lateral position, 90°  34.0 (27.0 to 36.8)  0.006  7 (58)
Right lateral position, 30°  31.0 (27.0 to 34.5)  0.003  6 (50)
Right lateral position, 45°  32.5 (28.3 to 35.8)  0.002  8 (50)
Right lateral position, 90°  31.0 (29.3 to 35.0)  0.003  7 (58)
Total (192 measurements)  –  –  78 (40.6)
HoB, head of bed elevation. aCuff   pressure values reported as median (fi  rst to 
third quartile).
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consecutive intubations from 42 ICUs were used to develop a simplifi  ed 
score of DI, which was then validated externally in 400 consecutive 
intubation procedures from 18 other ICUs and internally by bootstrap 
on 1,000 iterations.
Results In multivariate analysis, the main predictors of DI (incidence = 
11.3%) were related to the patient (Mallampati score III or IV, 
obstructive sleep apnea syndrome, reduced mobility of cervical spine, 
limited mouth opening), to pathology (severe hypoxia, coma) and to 
the operator (non-anesthesiologist). From the β-parameter, a seven-
item simplifi  ed score (MACOCHA score; Table 1) was built, with an area 
under the curve (AUC) of 0.89 (95% CI = 0.85 to 0.94). In the validation 
cohort (prevalence of DI = 8%), the AUC was of 0.86 (95% CI = 0.76 
to 0.96), with a sensitivity of 73%, a specifi  city of 89%, a negative 
predictive value of 98% and a positive predictive value of 36%. After 
internal validation by bootstrap, the AUC was 0.89 (95% CI = 0.86 to 
0.93). Severe life-threatening events (severe hypoxia, collapse, cardiac 
arrest or death) occurred in 38% of the 1,000 cases. Patients with DI 
(n = 113) had signifi  cantly higher severe life-threatening complications 
than those who had a non-DI (51% vs. 36%, P <0.0001).
Table 1 (abstract P157). MACOCHA score calculation worksheet
   Points
Factors related to patient 
  Mallampati score III or IV  5
  Obstructive apnea syndrome  2
  Reduced mobility of cervical spine  1
  Limited mouth opening <3 cm  1
Factors related to pathology 
 Coma  1
  Severe hypoxemia (<80%)  1
Factor related to operator  
 Non-anaesthesiologist  1
Total   12
Conclusion DI in ICU is strongly associated with severe life-threatening 
complications. A simple score including seven clinical items 
discriminates diffi   cult and non-DI in ICU.
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Introduction  Our objective is to determine the incidence of major 
complications related to endotracheal intubations (death, cardiac 
arrest, severe hemodynamic instability or severe hypoxemia) per-
formed in the ICUs of nonacademic Brazilian public hospitals.
Methods This is a report of the baseline phase of a cluster randomized 
trial with two parallel arms. In this baseline phase, we collected data 
from sequential patients needing endotracheal intubation in 17 ICUs 
from Brazil. Patients needing endotracheal intubation after cardiac 
arrest were excluded. In a second ongoing phase, not reported 
here, we have randomized ICUs to a multifaceted intervention to 
prevent complications of endotracheal intubation. Primary outcome 
was defi   ned as the occurrence of death, cardiac arrest, severe 
cardiovascular instability (systolic blood pressure <60 mmHg at least 
one time, <90 mmHg and persisting >30 minutes or need to initiate 
vasopressors) or severe hypoxemia (SpO2 <80%) within 1 hour after 
intubation.
Results  We evaluated 246 intubations. The mean age was 
49 ± 21.9 years; the SAPS 3 admission score was 57.4 ± 15.4. The most 
common indications of intubation were acute respiratory failure 
(61.0%) and coma (17.1%). The primary outcome occurred in 138 of 
246 intubations (56.1%). Within the fi  rst hour, the incidence of severe 
hypotension was 47.2%, of severe hypoxemia was 20.3%, of cardiac 
arrest was 5.7% and of death was 4.5%.
Conclusion  Incidence of major complications associated with 
endotracheal intubation is unacceptably high in Brazilian public ICUs. 
There is an urgent need for eff  ective measures to increase safety of this 
common procedure in our environment.
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Introduction The Airway scope® (AWS), the KingVision® (KV) and the 
McGRATH® (MG) are new indirect video laryngoscopes designed 
to facilitate eff   ective and safe tracheal intubation under various 
conditions. However, there are few comparative studies as for 
performance in tracheal intubation attempted by inexperienced 
personnel. The purpose of this study was to evaluate success rates, time 
to intubation with use of these devices by inexperienced personnel in a 
simulated manikin diffi   cult airway.
Methods  Twenty-nine fi  fth-year medical students with no previous 
experience in tracheal intubation participated in this study. We used 
an advanced patient simulator (SimMan®; Laerdal Medical, Stavanger, 
Norway) to simulate normal and diffi   cult airway scenarios including 
cervical spine rigidity, swollen tongue, and pharyngeal edema. The 
sequences in selecting devices and scenarios were randomized. Success 
rate for tracheal intubation, and the time required for visualization 
of the glottis (T1), tracheal intubation (T2), and infl  ation of the lungs 
(T3) were analyzed. Also, numbers of audible dental click during the 
intubation attempt were recorded. The three diff  erent  intubation 
devices were tested in four diff  erent scenarios by 29 students.
Results  All three devices had very high success rates of tracheal 
intubation (AWS 100%; KV 100%; MG 99%). In the normal airway, T1, 
T2 and T3 were AWS: 4.4 ± 3.3 seconds, 7.5 ± 3.8 seconds, 11.1 ± 3.8 
seconds; KV: 6.9 ± 6.9 seconds, 10.3 ± 7.9 seconds, 14.1 ± 8.3 seconds; 
MG: 4.6  ±  1.3 seconds, 11.4  ±  5.2 seconds, 16.1  ±  5.4 seconds, 
respectively (NS). In the three diffi   cult airway scenarios, T1, T2 and T3 
were AWS: 5.3 ± 4.7* seconds, 10.4 ± 6.9* seconds, 14.2 ± 6.9* seconds; 
KV: 10.9 ± 12.8 seconds, 21.5 ± 18.1 seconds, 25.4 ± 18.3 seconds; 
MG: 13.0 ± 15.3 seconds, 26.2 ± 24.6 seconds, 31.0 ± 24.3 seconds, 
respectively (*P <0.05 AWS vs. KV and MG). The number of audible 
dental click sounds with the MG was greater than with the AWS and KV 
(AWS 5%*; KV 8%*; MG 28%*; *P <0.05 AWS and KV vs. MG).
Conclusion The AWS, KV and MG had very high success rates of tracheal 
intubation and are suitable as intubation devices for inexperienced 
personnel. In the diffi   cult airway, however, the intubation time with 
AWS was signifi  cantly shorter than with KV and MG. These fi  ndings 
suggested that AWS may be most useful device particularly in diffi   cult 
situations such as emergency settings. Further studies in a clinical 
setting are needed to confi  rm these fi  ndings.
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Introduction In mechanically ventilated neonates the fl  ow-dependent 
resistance of the endotracheal tube (ETT) causes a noticeable pressure 
diff   erence between airway and tracheal pressure [1]. This may 
potentially lead to retardation of the passive driven expiration and 
dynamic lung infl  ation consecutively but more importantly increases 
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resistive pressure drop of four commercially available neonatal ETTs 
with internal diameter (ID) of 2.0 mm.
Methods  The pressure–fl  ow relationship of neonatal ETTs (internal 
diameter 2.0 mm) of four diff  erent manufacturers (Mallinckrodt, Hi-
Contour, Covidien, Dublin, Ireland; Portex, Cole’s Neonatal Tube, Smith 
Medical, St Paul, MN, USA; Rüsch, Silko Clear, Telefl  ex Medical, Kernen, 
Germany; and Vygon, Pediatric Endotracheal Tube, Ecouen, France) 
was determined in a physical model consisting of a tube connector, 
an anatomically curved ETT and an artifi  cial trachea. The model was 
ventilated with a sinusoidal gas fl  ow with an amplitude of ±100 ml/
second and a ventilation rate ranging from 40 to 60 cycles/minute. The 
coeffi   cients of an approximation equation considering ETT resistance 
were fi   tted separately to the measured pressure–fl   ow curves for 
inspiration and expiration.
Results The pressure drop profi  les of all ETTs were nonlinearly fl  ow 
dependent. The expiratory pressure drop (Pexp) slightly exceeded 
the inspiratory one (Pinsp). The ETT of Portex Cole’s Neonatal Tube 
had a signifi  cant lower pressure drop (Pinsp 8.8 ± 0.3 cmH2O vs. Pexp 
–11.2 ± 0.2 cmH2O at an air fl  ow of 100 ml/second) compared with all 
other ETTs (Mallinckrodt: Pinsp 19.2 ± 0.4 cmH2O vs. Pexp –24.3 ± 0.7 cmH2O; 
Rüsch: Pinsp 28.3 ± 0.8 cmH2O vs. Pexp –33.0 ± 0.8 cmH2O; Vygon: Pinsp 
19.2 ± 0.4 cmH2O vs. Pexp –22.6 ± 0.6 cmH2O, all P <0.05) for all fl  ow and 
ventilation rates, respectively.
Conclusion The ETT resistance highly contributes to the total airway 
resistance in neonatal ventilation. The fl  ow-dependent pressure drop 
of shouldered Cole’s Neonatal Tube (Portex) was up to 70% less in 
inspiration (resp. 67% in expiration) compared with straight tubes 
with an internal diameter corresponding to the narrow part of Cole’s 
tube. We conclude that neonatal intubation with a Cole’s tube can 
clearly reduce the resistive load due to the endotracheal tube and thus 
potentially prevent additionally work of breathing.
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Introduction  Several factors can lead to weaning failure from 
mechanical ventilation (MV). Among these, cardiac dysfunction is one 
of the main causes. NT-proBNP has been proposed as a biomarker of 
cardiovascular function during weaning from MV. Unfortunately it does 
not provide for a continuous monitoring of cardiac function. Pulse 
wave analysis may serve as a continuous bedside monitoring tool of 
cardiovascular performance. Cardiac cycle effi   ciency (CCE) is an indirect 
index of left ventricular performance obtained by the pulse contour 
method MostCare (Vygon, Padova, Italy). The aim of this study was to 
evaluate the correlation between NT-proBNP and CCE and the potential 
usefulness of such variables during the weaning process from MV.
Methods Twenty-two long-term (>48 hours) mechanically ventilated 
patients capable of performing a weaning trial of spontaneous 
breathing (SBT) were enrolled in the study. Inclusion criteria were: 
age >18 years and equipment with a standard arterial catheter line. 
Exclusion criteria were: neuromuscular disease, tracheotomy, renal 
failure, and traumatic brain injury. During the weaning process, NT-
proBNP plasma levels, CCE, and standard hemodynamic and ventilatory 
data were collected 30 minutes before extubation (T1), 2 hours (T2) 
and 12 hours later (T3). After removal of tracheal tube, patients with 
a history of heart failure received continuous positive airway pressure 
(CPAP group). Patients with normal cardiac function were maintained 
with spontaneous breathing (SB group).
Results  Sixty-six paired NT-proBNP and CCE values were obtained. 
Patients in the SB group and in the CPAP group were 10 and 12, 
respectively. In both groups there was a trend towards an increase in 
NT-proBNP values after extubation, an opposite trend was observed 
regarding CCE values (P <0.05). NT-proBNP levels showed an increase 
after extubation (T2, T3) compared with T1; conversely, CCE showed 
an inverse trend. Overall, a negative correlation was found between 
NT-proBNP and CCE values (R = –0.81, P <0.001). Signifi  cant inverse 
correlations were found between NT-proBNP and CCE at T1, T2, and 
T3 (R  =  –0.91, –0.75 and –0.73 respectively; P < 0.001). The overall 
correlation between NT-proBNP and CCE was –0.74 in the SB group and 
–0.86 in the CPAP group. Standard hemodynamic and ventilatory data 
did not show signifi  cant changes during the study.
Conclusion NT-proBNP correlated well with CCE. The latter seems to be 
an additional attractive index of cardiovascular state that, in association 
with NT-proBNP changes, may provide information about cardiac 
function on a beat-by-beat basis during weaning process from MV.
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Introduction Tracheostomy is one of the more commonly performed 
procedures in critically ill patients requiring long-term mechanical 
ventilation. However, the optimal timing or method of performing 
tracheostomies in this population remains to be established. In the 
present study, we compared outcomes of early and late tracheostomy 
in critically adult patients with diff  erent clinical conditions.
Methods  All patients needing tracheostomy in the Critical Care 
Medical Center of Hiroshima Prefectural Hospital from January 2009 
to December 2011 were surveyed. Patients with tracheostomy who 
were not indicated for mechanical ventilation were excluded from the 
subjects. Early tracheostomy (ET) was defi  ned as <10 days after tracheal 
intubation and late tracheostomy (LT) was defi  ned as ≥10 days after 
intubation. We compared patient characteristics, type of tracheostomy 
procedure, length of weaning from ventilator and outcomes between 
the groups. Data are shown as the mean ± SD, with unpaired t test 
and Mann–Whitney U test used for statistical analyses. Statistical 
signifi  cance was accepted at P <0.05.
Results One hundred patients were surveyed. The ET and LT groups 
included 49 and 51 patients, respectively. Tracheostomy was performed 
using a percutaneous procedure in 48 patients (ET: 25, LT: 23) and a 
surgical procedure in 52 patients (ET: 24, LT: 28). Sixty-two patients (ET: 
34, LT: 28) survived to discharge and 16 patients died in the ICU (ET: 
7, LT: 9). Fifty-six patients (ET: 31, LT: 25) were weaned from ventilator 
support and tracheostomy cannula was removed in 20 patients (ET: 
11, LT: 9). There were no signifi  cant diff  erences in type of tracheostomy 
procedure, period from tracheostomy until ICU and hospital discharge, 
rate of patients who could be weaned from ventilator and removed 
tracheostomy cannula, and ICU and hospital mortality between the 
groups. The length of mechanical ventilation and the time to removal 
of tracheostomy cannula were signifi  cantly shorter in the ET group 
(5 ± 7 vs. 26 ± 41 and 29 ± 24 vs. 94 ± 83 days, respectively).
Conclusion  In this retrospective study, early tracheostomy reduced 
the length of weaning after tracheostomy and the time to removal of 
tracheostomy cannula, while there were no diff  erences in the length of 
ICU stay and patient outcome. In critically ill adult patients who require 
mechanical ventilation, a tracheostomy performed at an earlier stage 
may shorten the duration of artifi  cial ventilation. A further randomized 
clinical trial is essential to determine the eff  ectiveness and safety of 
early tracheostomy.
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Introduction Percutaneous dilatational tracheostomy (PDT) remains 
a frequently performed procedure in the ICU. However, there is great 
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risk of clinically relevant bleeding was recently reported for patients 
undergoing PDT [1]. We conducted a systematic review of reports 
evaluating clinical outcomes following use of ultrasound scanning (US) 
for PDT.
Methods Two investigators performed a search of the literature using 
the following databases: CENTRAL, Embase, MEDLINE and SCOPUS. 
The following eligibility criteria were used: population including adults 
>16 years managed in the ICU; use of ultrasound to guide decision-
making pre-PDT or guide PDT performance; report of clinically relevant 
outcome measures. Nonrandomised controlled trials were classifi  ed 
according to Cochrane Non-Randomised Study Methods Group criteria 
[2] and evaluated for risk of bias.
Results An initial search identifi  ed 2,043 reports, of which 10 studies 
met eligibility criteria: eight case series, one randomised controlled trial 
(RCT) and one prospective cohort study, incorporating 488 patients. 
Two studies specifi  cally reported data on patients with obesity (n = 29 
patients) and one study reported data for a group of patients with 
spinal cord fi  xation (n = 6). US was used to guide decision to perform 
PDT or surgical tracheostomy in fi  ve studies, with decision to perform 
surgical tracheostomy ranging from 0 to 27% of cases. US was used 
to guide insertion point in seven studies, and used real-time in four 
studies. Times to perform US-guided PDT were reported in four studies 
(ranging from 8 to 12 minutes). No studies compared time taken with 
or without US. Data on complications of procedure were reported 
in nine studies. Minor bleeding was reported for eight cases (1.6% 
overall). Prolonged bleeding was reported in two cases (0.4%). There 
were no episodes of catastrophic bleeding among 488 cases. High risk 
of bias was identifi  ed in fi  ve studies in terms of patient selection. An 
intervention protocol was not defi  ned in three reports. No attempt was 
made at blinding any aspect of the 10 studies.
Conclusion Use of US guidance could theoretically help minimise risk 
of haemorrhagic complications during PDT and perhaps reduce time 
taken to perform PDT. However, there is currently inadequate evidence 
from controlled cohort studies or RCTs to suggest that routine use 
for PDT in selected or unselected groups improves clinically relevant 
outcome measure.
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Introduction  Failed airway situations are potentially catastrophic 
events and require a correct approach with appropriate tools. Recently, 
Ventrain has been presented as a manual device for emergency 
ventilation through a small-bore cannula, which can provide expiratory 
assistance by applying the Venturi eff  ect.
Methods We used the SimulARTI Human Patient Simulator to evaluate 
Ventrain. Initially, we studied the eff   ectiveness and security in 
ventilating and oxygenating the patient. In a second phase, the Ventrain 
performance was compared with what is considered to be the present 
gold standard (Quicktrach II, Portex Mini-Trach II Seldinger Kit, Melker 
Emergency Cricothyrotomy Catheter Set). Seven anesthesiologists 
performed an emergency transcricoid ventilation with each device in 
the same setting.
Results Ventrain provided an average tidal volume of 334 ml and an 
average minute volume of 2.4 l in the considered situation, with a 
modifi  cation of PAO2 from 32 to 702 mmHg and of PACO2 from 54.5 
to 38.8 mmHg. In the second phase, the time needed to obtain an 
eff  ective oxygenation with Ventrain was found to be shorter than 
other devices (median diff  erence; vs. Minitrach –60 seconds; vs. Melker 
–35  seconds; vs. Quicktrach –25 seconds) (Figure  1); the ability to 
remove CO2 resulted bigger (average diff  erence: vs. Minitrach –11.9; 
vs. Melker –0.3; vs. Quicktrach –5.9) (Figure 2) and moreover the users 
judged it more favorably.
Conclusion  In this manikin study, Ventrain seemed to be able to 
appropriately oxygenate and ventilate a patient in a CICV situation. 
When compared with the best available choices, it has shown not to 
be inferior.
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Introduction  Eff   ective delivery of aerosolized bronchodilators for 
patients with asthma is crucial for adequate therapy in critical care 
and emergent settings. Often administered with pressure-metered 
dose inhalers (pMDIs), bronchodilator delivery depends on the correct 
patient technique during administration [1] and the ability to measure 
treatment response, which are diffi   cult to monitor at the point of 
care and particularly so in resource-poor settings where standard in-
hospital monitoring is unavailable [2].
Methods  A point-of-care device for airfl   ow measurement during 
bronchodilator delivery was designed and tested for use in resource-
limited settings. The handheld device was constructed from a clinical 
aerosol delivery tube with a bidirectional sensor for pressure diff  erential 
detection about the aerosol element (Figure 1). The custom low-cost 
Figure 1 (abstract P164). Oxygenation time to oxygen alveolar pressure 
>100 mmHg.
Figure 2 (abstract P164). Mean carbon dioxide alveolar pressure at the 
start and at the end of the test.
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needed apart from a computer or mobile device. Collection of airfl  ow 
signal and calibration was performed with a standard 3 l syringe with 
fl  ow volume measurement on one adult subject.
Results Calibration of the assembled device over range of 0.5 to 3 l/
second enabled conversion of pressure diff  erence to air fl  ow with a 
mean measured tube resistance of 0.258 (kPa*second)/l. Robust signal 
responses to an adult subject’s continuous respiratory maneuvers on 
the tube itself were demonstrated. Subject performance of the pMDI 
technique with subsequent tidal volume breathing was recorded and 
analyzed (Figure 1).
Conclusion  Design and calibration of a novel low-cost monitoring 
device for bronchodilator delivery monitoring enabled detection 
and recording of characteristic fl  ow volume respiratory patterns for 
point-of-care diagnostics in resource-limited settings. Future work will 
require clinical testing and automated detection of the correct pMDI 
patient technique.
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Introduction Protocol-based care of the tracheostomised patient is 
important, as adverse events confer a high rate of mortality. Little is 
known regarding the existence of formal evidence-based guidelines on 
tracheostomy care. The aim of this study was to perform a systematic 
review for evidence-based guidelines on adult tracheostomy care.
Methods  A systematic search of PubMed, MEDLINE, guideline 
clearinghouses, centres of evidence-based practice, and professional 
societies’ guidelines relating to care of adult patients with a 
tracheostomy was performed by two reviewers. In addition, a 
Google search of publicly available tracheostomy care guidelines 
was performed. Search terms: (tracheostom* OR tracheotom*) AND 
(protocol* OR guideline* OR standard* OR management OR consensus 
OR algorithm*). Filters: English language, human, from 1 January 
1990 to date, adult patients. Guideline appraisal criteria: the quality 
of guidelines retrieved was assessed using the Appraisal of Guidelines 
Research and Evaluation II (AGREE II) instrument [1].
Results The search results are summarised in Table 1. A total of 80 
guidelines were identifi  ed. Five were found to satisfy the AGREE II 
criteria and only three related to the entire spectrum of tracheostomy 
management. The majority was informal and was not published or 
evidence based.
Conclusion  Five evidence-based guidelines on adult tracheostomy 
management were identifi  ed. This may represent a paucity of evidence 
on the subject, suggesting that further clinical trials on the topic are 
needed to contribute to the evidence base. This also highlights the 
need for international consensus on the topic, to reduce duplication of 
eff  orts, standardise practice, and improve outcomes.
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Figure 1 (abstract P165).
Table 1 (abstract P166). Summary of results returned following systematic review
  Total  Results with  Full texts  Guidelines  AGREE instrument
Database results  limits  retrieved  found  compliant
PubMed 4,685  1,596  33   
MEDLINE 3,859  1,337  17  26  2
CINAHL 711  172  6   
Medical societies/guideline websites/clearinghouses  N/A  N/A  N/A  54  3
Google 17,600,000  497  N/A   
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Introduction  The 4th National Audit Project of the Royal College 
of Anaesthetists [1] concluded that the majority of airway-related 
signifi  cant complications in ICUs resulted from displaced or blocked 
tracheostomies and recommended together with the Intensive Care 
Society and the National Tracheostomy Safety Project that each ICU 
in the UK should have an emergency airway management plan and 
guidelines [2]. The aim of this survey was to establish whether such 
guidelines exist and are familiar to those working within the ICUs of the 
East of England (EoE), their ease of availability in an emergency and the 
degree of emergency tracheostomy training within the region.
Methods Data collection was via a telephone survey of 11 ICUs in the 
EoE training region during July 2012 with one senior ICU nurse and one 
ICU trainee questioned per hospital. Questions related to the existence 
and accessibility of guidelines for tracheostomy emergencies, and to 
the respondent’s degree of emergency tracheostomy training and their 
perceived availability of formal training.
Results All 11 ICUs questioned perform and manage tracheostomies. Of 
22 respondents, 10 knew of guidelines covering all of the emergencies 
described above and their location. Four respondents thought that 
these guidelines were accessible in an emergency setting, one-half 
of which were on computer systems requiring a login and search 
function. With regards to emergency management, 19 respondents felt 
competent in a tracheostomy emergency; almost exclusively through 
experience and in-house teaching. No respondents were aware of any 
formal emergency tracheostomy management courses.
Conclusion  Despite national guidance within the UK this survey 
highlights that implementation and awareness of emergency 
tracheostomy guidelines in ICUs in the EoE region is poor, and when 
present they are not readily accessible in an emergency. Emergency 
training has largely been informal and the availability of formal training 
courses has not been recognised. In order to improve patient safety 
there is a need to ensure that emergency tracheostomy management 
including guidelines, equipment and formalised tracheostomy 
emergency training are adopted and embraced universally.
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Introduction  A fatal incident related to a blocked tracheostomy 
tube prompted a review in our Trust. To provide safe tracheostomy 
care, changes in staffi     ng, education and operational policies were 
recommended. Training of potential fi  rst responders to tracheostomy 
or laryngectomy emergencies remains outstanding. We aim to quantify 
the training defi  cit. Tracheostomies are common in critical care but 
these patients require ongoing management of an artifi  cial airway on 
discharge to the ward and even the community. In 2010 our critical care 
unit cared for 108 tracheostomy patients, of which 30 were transferred 
to the wards. The 4th National Audit Project highlighted complications 
including hypoxic brain injury and death [1] and the National Patient 
Safety Agency recognised a number of avoidable aspects [2]. Existing 
guidelines for management of these patients including emergencies 
are not widely known.
Methods An anonymous online survey was sent to all trainees who 
may respond to a tracheostomy emergency in our organisation. 
Trainees in anaesthesia/critical care, general medicine, general surgery, 
ENT, thoracics and A&E were approached. All completed forms were 
included.
Results We achieved a response rate of 39% (65/168). Respondents 
comprised: 33% anaesthesia/critical care, 47% medicine and 14% 
surgery. Over one-half (36/65) had managed tracheostomy/laryngec-
tomy emergencies, with 42% (15/36) of these incidents occurring 
on the wards and one in an outpatient clinic. Only 20% (13/65) had 
received any formal training on management of a blocked/misplaced 
tracheostomy tube and only 18% (12/65) were aware of any guidelines. 
One-third of responders lacked confi  dence in management of these 
emergencies and 88% felt they would benefi  t from formal training 
including simulation.
Conclusion The population of patients with exteriorised tracheas is 
increasing and represents a high-risk group. Management of airway 
emergencies in these patients is not part of standard life-support 
courses. According to our trainees, these scenarios are relatively 
common and a signifi  cant proportion of fi  rst responders are poorly 
equipped to deal with them. Our Trust will be including specifi  c training 
on the emergency management of neck breathers as part of in-house 
resuscitation training. We would contend that national resuscitation 
courses should consider doing the same.
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Introduction Usually percutaneous tracheostomy is accomplished via 
the tracheal tube. Some severe complications during percutaneous 
dilatational tracheostomy (PDT) may be related to poor visualization 
of tracheal structures. The alternative implies extubation and re-
insertion of a laryngeal mask (LMA). An accidental extubation as well 
as an injuring of the vocal cords (because of the infl  ated cuff   during 
dislocation) appears impossible in this method. Subjectively, the 
bronchoscopic view obtained via a LMA seems to be better than that 
obtained with an endotracheal tube (ET) [1,2].
Methods  In this prospective observational study, the bedside PDT 
was performed using the Ciaglia Blue Dolphin method in 150 critically 
ill patients. The patient’s tracheal tube was exchanged for a LMA 
Fastrach™ before undertaking PDT. The insertion of the LMA, the quality 
of ventilation, the blood gas values, the view of the tracheal puncture 
site, and the view of the balloon dilatation were rated as follows: very 
good (1), good (2), barely acceptable (3), poor (4), and very poor (5).
Results PDTs with LMA were successful in 99.3% of the patients (n = 149). 
The ratings were 1 or 2 in 96% of cases with regards to ventilation and 
to blood gas analysis, in 96.6% for identifi  cation of relevant structures 
and tracheal puncture site, and in 93.3% for the view inside the trachea 
during PDT. A rating of 5 was assigned to one patient requiring tracheal 
reintubation for inadequate ventilation. There were no damages to the 
bronchoscope or reports of gastric aspiration.
Conclusion  The Blue Dolphin PDT using a LMA showed defi  nite 
advantages regarding inspection of dilation process. This method 
improves visualization of the trachea and larynx during a video-assisted 
procedure and prevents the diffi   culties associated with the use of an 
ET such as cuff   puncture, tube transection by the needle, accidental 
extubation, and bronchoscope lesions. The LMA results as an eff  ective 
and successful ventilatory device during PDT. This may be especially 
relevant in cases of diffi   cult patient anatomy where improved structural 
visualization optimizes operating conditions. The intensivist performing 
PDT should be scrupulous when deciding which method to use. In our 
ICU the Blue Dolphin PDT with LMA has become the procedure of choice.
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Introduction  Balloon dilatational percutaneous tracheostomy with 
radial outward dilation minimizes bleeding and injury to tracheal 
rings [1]. Using the bronchoscope during the puncture of the trachea 
holds a risk of inaccurate placement, of hypoventilation and of needle 
puncturing the bronchoscope. This study was conducted in order to 
evaluate the safety features and feasibility of combining real-time 
ultrasound-guided puncture of the trachea with visualization of 
the needle path during tracheal puncture [2]. We provide precise 
localization of tracheal cartilage and proper site puncture for the stoma 
by ultrasound, with subsequent performance of balloon dilatational 
percutaneous tracheostomy using the Blue dolphin technique.
Methods  Twenty-fi   ve patients including 15 males and 10 females, 
mean age 61 years, with age range from 23 to 102 years, underwent 
bedside percutaneous tracheostomy combining real-time ultrasound 
and the Blue Dolphin technique.
Results The median time for the procedure was 15 (12 to 20) minutes. 
Targeted placement for the tracheostoma between the second and 
third or the third and fourth tracheal ring was achieved in 100%. No 
signifi  cant complications (for example, tracheal bleeding, puncture 
posterior tracheal wall, misplacement of the tracheal cannula) occurred. 
One fractured tracheal ring was identifi  ed using bronchoscopy after 
the procedure. No conversion into a bronchoscopically guided or into a 
surgical open technique was necessary.
Conclusion  This study demonstrates the feasibility and safeness 
combining real-time ultrasound guidance and balloon dilatational 
percutaneous tracheostomy (Blue Dolphin technique) in critically 
ill patients. In our division, this technique has become the standard 
bedside tracheostomy procedure because it combines excellent 
patient safety features with avoidance of intraprocedural tube 
misplacement, hypoventilation and accidental bronchoscopy damage 
even in technically diffi   cult cases [3].
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Introduction Acute cor pulmonale (ACP) is associated with increased 
mortality in patients ventilated for acute respiratory distress syndrome 
(ARDS). Interventional lung assist (iLA) allows a lung-protective 
ventilatory strategy, whilst allowing CO2 removal, but requires adequate 
right ventricular (RV) function. RV restriction (including presystolic 
pulmonary A wave) [1] is not routinely assessed in ARDS.
Methods  A prospective analysis of retrospectively collected data 
in patients with echo during iLA was performed. Data included 
epidemiologic and ventilatory factors, LV/RV function, evidence of 
RV restriction and pulmonary hemodynamics. Data are shown as 
mean ± SD/median (interquartile range).
Results Thirty-two patients (45 ± 17 years), 22 male (68%), SOFA score 
11.15 ± 2.38 were included. Pulmonary hypertension (PHT) was 53%, 
and hospital mortality 43%. Mortality was not associated with age, 
days on iLA, length of ICU stay, inotropic support, nitric oxide or level 
of ventilatory support, but was associated with pressor requirement 
(P = 0.005), a worse PaO2:FiO2 ratio (9.4 (7.8 to 12.6) vs. 15.2 (10.7 to 
23.9), P = 0.009) and higher pulmonary artery pressures (56.5 mmHg 
(50 to 60) vs. 44.5 (40.5 to 51.2), P = 0.02). No echo features of ACP were 
found, with no signifi  cant diff  erence between RV systolic function, 
pulmonary acceleration time and pulmonary velocity time integral 
between survivors and nonsurvivors. The incidence of RV restriction 
was high (43%), and independent of PHT, RV systolic function and level 
of respiratory support, but correlated with CO2 levels (restrictive 7.1 kPa 
(7.4 to 8.0) vs. 6.1 (5.8 to 6.8), P = 0.03). See Figure 1.
Conclusion Typical echo features of ACP were not seen in this study, 
possibly because of the protective ventilatory strategies allowed by 
use of iLA. The incidence of RV restriction may refl  ect more subtle 
abnormalities of RV function. Further studies are required to elucidate 
RV pathophysiology in critically ill adult patients with ARDS.
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Introduction Global left ventricular electromechanical dyssynchrony 
(GLVD) is uncoordinated LV contraction that reduces the extent of 
intrinsic energy transfer from the myocardium to the circulation leading 
to a reduction in peak LV pressure rise, prolonged total isovolumic 
time (t-IVT) and fall in stroke volume [1]. This potentially important 
parameter is not routinely assessed in critically ill cardiothoracic 
patients.
Methods  A prospective analysis of retrospectively collected data 
in cardiothoracic ICU patients who underwent echocardiography 
was performed. In addition to epidemiological factors, echo data 
included comprehensive assessment of LV/RV systolic and diastolic 
function including Doppler analysis of isovolumic contraction/
relaxation, ejection time (ET) and fi  lling time (FT). t-IVT was calculated 
as (60 – (total ET + total FT)) and the Tei Index as (ICT + IRT) / ET. t-IVT 
>14 second/minute and Tei index >0.48 were used to defi  ne GLVD [2]. 
Data are shown as mean ± SD/median (interquartile range).
Results A total of 103 patients (63.5 ± 18.4 years), 65 male (63%), APACHE 
II score (14.6 ± 7.4) were included. The prevalence of GLVD was high 
(24/103, 22%) and associated with signifi  cantly increased mortality, 
7.5% vs. 25% (P = 0.02). There was no diff  erence in requirement for 
cardiorespiratory support between the two populations, but there 
were signifi  cant diff  erences (no GLVD vs. GLVD) in requirement for 
Figure 1 (abstract P171).
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S64pacing (35% vs. 62%, P = 0.02), atrial fi  brillation (20% vs. 41%, P = 0.03), 
QRS duration (92.0 (80.0 to 120.0) vs. 116.5 (95.0 to 154.0), P = 0.01) and 
QTc (460.0 (416.0 to 498.5) vs. 477.5 (451.2 to 541.0), P = 0.02). There 
was no signifi  cant diff  erence in ejection fraction (no GLVD 43.0 (35.0 
to 49.5) vs. GLVD 39.6 (29.5 to 49.7), P = 0.43), mitral regurgitation 
(40.5% vs. 62.5%, P = 0.06), or any other measures of LV systolic or 
diastolic function between the two groups. There was good correlation 
between the two methods used to assess dyssynchrony (LV t-IVT:LV Tei 
index correlation coeffi   cient = 0.80, P <0.001).
Conclusion  GLVD that limits cardiac output is common in the 
cardiothoracic ICU, and signifi   cantly related to mortality. When 
diagnosed, the underlying cause should be sought and treatment 
instigated to minimize the t-iVT (pacing optimization/revascularization/
inotrope titration/volaemia optimization).
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Introduction  Correction of coagulopathy before central venous 
catheter (CVC) insertion is a common practice; however, when 
ultrasound guidance is used this is controversial as mechanical 
complications are rare. Studies in oncology patients suggest that CVC 
placement without prior correction of coagulopathy is safe but no 
studies are available for critically ill patients and guidelines do not give 
recommendations [1,2]. We do not routinely correct coagulopathy, 
even if severe, when ultrasound guidance is used and the purpose of 
this retrospective study was to evaluate the safety of this practice.
Methods  Data for all ultrasound-guided interventions, including 
complications, are prospectively collected in our department for audit 
purposes; in this study we involved only CVC insertions in the ICU 
between February 2011 and November 2012. Electronic medical and 
laboratory records and paper-based nursing charts were retrospectively 
studied for all interventions, specifi   cally looking for blood results, 
coagulation abnormalities and intervention-related complications.
Results In the study period, ultrasound guidance was employed for a 
total of 291 central line insertions in 220 ICU patients. Coagulopathy 
was detected in 127 cases at the time of CVC placement (43.6%). On the 
day of CVC insertion, coagulation abnormalities were corrected in 20 
cases (15.7%); 33 out of 50 patients with severe coagulopathy (66.0%) 
and 74 out of 77 patients with coagulopathy of moderate severity 
(96.1%) had no correction at all. Correction was started only after CVC 
insertion for reasons unrelated to CVC placement in a further eight 
and two patients with severe and less severe coagulopathy (16.0% and 
2.6%), respectively. No bleeding complications were observed.
Conclusion  In patients undergoing CVC insertion in our ICU, 
coagulopathy is common. We observed uncomplicated CVC placement 
in all 41 patients with severe uncorrected coagulopathy and in a further 
76 patients with coagulopathy of moderate severity. When combined 
with other studies, our data suggest that ultrasound-guided CVC 
placement without routine correction of coagulation abnormalities 
may be safe in the ICU.
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Introduction  Early bleeding from the exit site after CVC or PICC 
placement is a very common event that causes diffi   culties  in  the 
patient’s care and logistical problems. In our experience, the rate of 
signifi  cant local bleeding after placement of PICCs without reverse 
tapering may be as high as 40% at 1 hour and 15% at 24 hours, while 
the rate of bleeding after placement of a large-bore dialysis catheter is 
above 50% at 1 hour.
Methods The aim of this pilot study was to verify the effi   cacy of a 
cyanoacrylate glue in reducing the risk of early bleeding at the exit 
site after CVC or PICC placement. We studied a group of adult patients 
consecutively undergoing placement of polyurethane CVCs or PICCs 
without reverse tapering in a non-intensive ward of our hospital. All 
lines were inserted according to the same protocol, which included 2% 
chlorhexidine antisepsis, maximal sterile barriers, ultrasound guidance, 
EKG guidance and securement with sutureless device. Two minutes 
after placement of the glue, the exit site was covered with a temporary 
gauze dressing, which was replaced by transparent membrane at 
24 hours. All patients were assessed at 1 hour and at 24 hours.
Results  In 65 consecutive patients (45 PICCs, 11 dialysis catheters 
and nine CVCs), there was no signifi  cant local bleeding at 1 hour or at 
24 hours after catheter placement. No local adverse reaction occurred. 
No damage to the polyurethane of the catheters was detected.
Conclusion Glue is an inexpensive and highly eff  ective tool for avoiding 
the risk of early bleeding of the exit site after catheter placement. We 
also suggest that in the next future the glue might prove to have 
benefi  cial collateral eff  ects on the risk of extraluminal contamination 
(by reducing the entrance of bacteria in the space between the catheter 
and the skin), as well as on the risk of dislocation (by increasing the 
stability of the catheter inside the skin breach).
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Introduction  About 10 years ago the use of chest radiographs as 
the golden standard to ensure correct positioning of central venous 
catheters (CVC) was questioned. The frequent use of CVCs was also 
challenged. We decided to retrospectively evaluate our routines in a 
large surgical unit in a Swedish university hospital.
Methods All X-rays were centrally registered. Chest X-ray performed in 
our unit is almost entirely used to confi  rm CVC positioning. The Certofi  x 
CVC set for the Seldinger technique in combination with Certodyn – 
Universaladapter (B Braun, Germany) is now used as the routine 
equipment and the right jugular vein is our standard approach.
Results In 2002 the total number of X-rays performed in patients at 
our unit was 2,306, which corresponds to the approximate number 
of inserted CVCs at that time, since a confi  rmatory X-ray was routine. 
X-rays were rarely performed on other indications in our unit. X-ray 
costs were at that time approximately €300,000 (~€130/each). The year 
after, 1,726 chest X-rays were performed, refl  ecting both the use of 
intracardiac confi  rmation of correct CVC position and also a reduced 
use of CVCs. This trend has continued over time. In 2011 approximately 
600 CVCs were inserted at our unit. X-rays were performed in about 
20% of these cases. The cost for a chest X-ray is today ~€200, meaning 
that X-ray costs were approximately €24,000. We have not experienced 
any medical problems when intracardiac ECG was used for positioning 
confi  rmation. On the contrary, aspiration of venous blood without 
apparent p-waves in a patient with sinus rhythm may suggest improper 
placement of the CVC; for example, the right brachial vein.
Conclusion If we had continued to use CVCs at the same frequency 
as we did 10 years ago, and used X-ray confi  rmation in practically all 
cases, we would have paid approximately €460,000 annually. Reduced 
use of CVCs, in combination with intracardiac confi  rmation of CVC 
positioning, has not only allowed us to reduce costs associated with 
CVC insertion by more than €400,000, corresponding to a reduction 
rate of more than 90%, but also decreased the patient’s exposure to 
X-ray irradiation.
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Introduction  In cases of arrhythmia, the beat-to-beat variation of 
arterial pressure (AP) may impair the accuracy of automated cuff   
measurements. Indeed, this oscillometric device relies on the detection 
of arterial wall oscillations. Our aim was to determine, in ICU patients, 
whether brachial cuff   measurements are really less reliable during 
arrhythmia than during regular rhythm.
Methods  Patients with arrhythmia and carrying an intra-arterial 
catheter were prospectively and consecutively included in this multi-
center study. After each arrhythmic inclusion, a regular rhythm patient 
was included. A second inclusion was possible in case of change in 
the cardiac rhythm. Three pairs of invasive and brachial cuff   (Philips® 
MP70 monitor) measurements of mean arterial pressure (MAP) were 
respectively averaged. Some patients underwent a second set of 
measurements, after a cardiovascular intervention (passive leg raising, 
volume expansion, initiation of/increase in catecholamine infusion) 
allowing the assessment of MAP changes.
Results  In the 111 analyzed inclusions (in 103 patients) there was 
only one failure in displaying a brachial cuff   measurement of MAP. 
Arrhythmic patients (atrial fi   brillation 88%, frequent extrasystoles 
7%, fl  utter 5%) were similar (P >0.3) to patients in regular rhythm 
for MAP (median 74 (IQR 67 to 80) vs. 75 (69 to 84) mmHg), SAPS II 
score, BMI, arm circumference, norepinephrine administration (36% 
vs. 35%), mechanical ventilation (80% vs. 81%), and site of the intra-
arterial catheter (radial artery: 80% vs. 85%). Between arrhythmic 
and regular rhythm patients: the agreement (Bland–Altman analysis) 
between invasive and brachial cuff   measurements of MAP was similar 
(mean bias –0.4 ± 7.2 (limits of agreement –14/14) mmHg vs. 3.0 ± 8.2 
(–13/19) mmHg, respectively); the detection of hypotension (invasive 
MAP <65 mmHg) by the brachial cuff   was of similar reliability (area 
under the ROC curve (AUC) = 0.91 (95% CI = 0.80 to 0.97) vs. AUC = 0.98 
(0.89 to 1), P = 0.2); and the detection of a response (>10% increase in 
MAP) to therapy was of similar reliability (AUC = 1 (0.85 to 1) (n = 22) vs. 
AUC = 0.99 (0.78 to 1) (n = 17), P = 0.5).
Conclusion These preliminary results suggest that arrhythmia does not 
impair the reliability of automated cuff   measurements of MAP.
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Introduction Signifi  cant changes in haemodynamics occur after brain 
stem death (BSD) and there is evidence that yield of transplantable 
organs may be decreased in donors who remain preload responsive 
prior to donation [1], suggesting that optimisation of the cardiac 
output (CO) may be benefi  cial in potential organ donors. We describe 
current UK practice with regard to CO monitoring in this group.
Methods We reviewed a database of 287 brain-stem-dead potential 
organ donors collected by specialist nurses in organ donation 
(SN-OD) over a 6-month period (30 April 2011 to 31 October 2011) 
across multiple UK centres. The database contained data on donor 
management in the period from initial SN-OD review to immediately 
prior to transfer to the operating theatre. We analysed data on CO 
monitoring and vasopressor/inotrope use. Where information was 
missing/not recorded in the dataset, the treatment referred to was 
interpreted as not given/not done.
Results Fifty-three patients (18.5%) had evidence of CO monitoring. 
LiDCO was the most popular method (Figure 1). A total of 264 (94%) 
patients received treatment with vasopressors and/or inotropes. CO 
data were utilised in a variety of ways (Figure 2).
Conclusion  The majority of potential donors require vasopressors 
and/or inotropes post BSD, but it seems only a minority currently have 
their CO monitored. There is variation in how CO data are utilised to 
direct haemodynamic management. We welcome the development of 
standardised bundle-driven donor management.
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Introduction  The indocyanine green plasma disappearance rate 
(ICG-PDR) is a dynamic liver function test that can be non-invasively 
measured by pulse densitometry. ICG-PDR is associated with mortality 
and other markers of outcome. Due to predominant use of ICG-PDR 
in the ICU setting, the normal range is based on scarce data available 
outside the ICU and given with 18 to 25%/minute.
Methods To prospectively re-evaluate the normal range and to analyze 
the potential impact of biometric data on ICG-PDR, we measured 
ICG-PDR (i.v. injection of 0.25  mg/kg ICG; LiMON, Pulsion, Munich, 
Figure 1 (abstract P177). CO device.
Figure 2 (abstract P177). Use of CO data.
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prevalence of primary sclerosing cholangitis (PSC) of 5% in UC, patients 
were asked regarding previous diagnosis of PSC. Additionally, serum 
bilirubin, AST, ALT, INR, AP, γGT and cholinesterase were determined. 
Association of biometric data (age, gender, height, weight) and 
diagnosis of PSC on ICG-PDR were evaluated using Spearman corre-
lation, ROC and multivariate analysis (statistics: IBM SPSS 20).
Results A total of 95 patients (54 male, 41 female), age 43.2 ± 15.5 (21 to 
76) years, weight 74 ± 16 kg, height 175 ± 10 cm, BMI 23.7 ± 4, bilirubin 
0.48 ± 0.27 mg/dl, AST 26.8 ± 11.4 U/l, ALT 26.8 ± 14.9 U/l, previous 
diagnosis of PSC 8/95 (8.4%). ICG-PDR ranged from 13.8 to 44.0 with a 
mean of 28.2 ± 6.8 and a median of 27.0%/minute. In univariate analysis 
ICG-PDR was signifi  cantly associated with age (r = –0.480; P <0.001), 
weight (r = –0.262; P = 0.011) and female gender (r = 0.221; P = 0.032), 
but not to height (P  =  0.681). In multivariate analysis (R  =  0.459) 
including the variables age, gender, height, weight and diagnosis of 
PSC, only age was independently (P <0.001) associated with ICG-PDR. 
With each year in age, ICG-PDR decreased by 0.206%/minute. In ROC 
analysis, ICG-PDR above the upper normal range (>25%/minute) was 
signifi  cantly associated with young age (AUC 0.746; P <0.001).
Conclusion ICG-PDR (normal) values should be corrected for age. With 
a decrease in ICG-PDR of 0.206% per year, the range between the upper 
and lower normal level (25 to 18%/minute) is passed through within 
about 35 years of life. These fi  ndings are in accordance with functional 
loss of other organ functions (for example, cardiac output, glomerular 
fi   ltration rate) with increasing age. Normal ranges of innovative 
markers of organ function mainly derived from ICU populations should 
be re-evaluated outside the ICU.
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Introduction Hepatic dysfunction has been associated with outcome of 
ICU patients. However, most scoring systems including APACHE II only 
marginally refl  ect acute liver dysfunction on admission. Indocyanine 
green (ICG) is eliminated by hepatobiliary excretion. Therefore, the 
ICG plasma disappearance rate (ICG-PDR) is used as a dynamic liver 
function test. ICG-PDR has been associated with mortality in several 
studies.
Methods  A prospective study to compare prediction of 28-day 
mortality by ICG-PDR, other markers of liver function and scoring 
systems (primary endpoint). In the subgroup of patients with trans-
pulmonary thermodilution (TPTD) monitoring (PiCCO device; Pulsion, 
Munich, Germany), predictive capabilities of ICG-PDR were compared 
with cardiac index (CI), extravascular lung water index (EVLWI), 
global end-diastolic volume index (GEDVI) and pulmonary vascular 
permeability index (PVPI). ICG-PDR (i.v. bolus of 0.25 mg/kg ICG; LiMON 
device, Pulsion) and all other predictors were determined within 
48 hours after admission. Statistics: IBM SPSS 20.
Results A total of 154 patients (46 female, 108 male), age 59 ± 13 years, 
APACHE II score 16.0 ± 5.7, SOFA score 7.6 ± 4.2. Etiology: sepsis 14.4%, 
cirrhosis 28.8%, GI bleeding 8.9%, ARDS 17.8%, cardiogenic shock 
4.1%, acute renal failure 3.4%, various 22.6%. The 28-day mortality was 
signifi  cantly predicted by APACHE II (ROC-AUC: 0.762; P <0.001) and 
SOFA (AUC: 0.784; P <0.001). Among markers of hepatic function on 
admission, ICG-PDR provided the largest AUC (0.742; P <0.001), which 
was larger than for GOT (AUC: 0.646; P = 0.019), bilirubin (AUC: 0.641; 
P = 0.023) and INR (AUC: 0.614; P = 0.067). Among TPTD parameters, only 
PVPI signifi  cantly predicted 28-day mortality (AUC: 0.643; P = 0.043), 
whereas CI, GEDVI and EVLWI were not predictive. Prediction of 28-day 
mortality by SOFA could not be improved by models including any 
hepatic parameter. By contrast, ICG-PDR was independently (P = 0.036) 
associated with mortality when included in a model (R = 0.58) with 
APACHE II. This model based on APACHE II and ICG-PDR provided 
the largest of all ROC-AUCs (AUC: 0.804; P <0.001). ICG-PDR itself was 
independently associated with age (P = 0.025), but not with any other 
biometric parameter (gender, weight and height).
Conclusion  ICG-PDR on admission is an independent predictor of 
28-day mortality. Predictive capabilities particularly of APACHE II can 
be improved by combination with ICG-PDR. Among TPTD-derived 
parameters, only PVPI provides signifi  cant prediction of mortality.
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Introduction  Mixed venous oxygen saturation (SVO2) represents a 
well-recognized parameter of oxygen delivery (DO2)–consumption 
(VO2) mismatch and its use has been advocated in critically ill patients 
in order to guide hemodynamic resuscitation [1] and oxygen delivery 
optimization. Nevertheless, the pulmonary artery catheter (PAC) is not 
readily available and its use is not devoid of risks. Furthermore, its use 
has been decreasing in recent years in surgical and cardiac surgical 
patients as the benefi  t of guiding therapy with this device is unclear 
[2-4]. Central venous oxygen saturation (ScVO2) has been suggested 
as an alternative to SVO2 monitoring due to its feasibility in several 
settings. Unfortunately concerns arise from its capability to correlate 
with SVO2, the relationship being infl  uenced by several factors, such 
as hemodynamic impairment and pathological process. Hemodynamic 
instability and shock often complicate cardiac surgery, and the SVO2–
ScVO2 relationship has not been specifi  cally investigated in this setting. 
The aim of this study is to compare SVO2 and ScVO2 values in patients 
with cardiogenic shock after cardiac surgery.
Methods  A prospective observational study was designed and 
conducted. Inclusion criteria were: patients who had underwent 
elective or urgent/emergent cardiac surgery, with cardiac index (CI) 
<2.5 l/minute/m2 estimated by means of a PAC, left ventricle ejection 
fraction (LVEF) <40%, lactate >2 mmol/l, age >18 years. A central venous 
catheter (CVC) and a PAC were inserted for each patient before surgery 
in the same right internal jugular vein in accordance with standard 
procedure. Proper position of the PAC was confi  rmed with pressure 
tracings and chest X-ray. Mixed and central venous blood samples 
were collected from the distal ports of the PAC and CVC respectively 
30 minutes after ICU admission, and every 6 hours for a total of three 
samples in a 24-hour period for each patient. All blood samples were 
analyzed by a co-oximeter (Radiometer ABL800 fl  ex;  Radiometer, 
Copenhagen, Denmark). Statistical analysis was performed by Stats 
Direct (Ver.2.5.8, Cheshire, UK) and GraphPad (Vers. Prism 4.0; San 
Diego, CA, USA). All data were tested for normal distribution with the 
Kolmogorov–Smirnov test. Statistical analysis was performed by linear 
regression analysis. The agreement between absolute values of ScvO2 
and SvO2 were assessed by the mean bias and 95% limits of agreement 
(LOA) ((mean bias ± 1.96)×standard deviation) according to the method 
described by Bland and Altman [5].
Results A total of 20 patients were enrolled. In 18 out of 20 cases all 
three blood samples were collected. In two patients only two blood 
samples were drawn as they exited the inclusion criteria. Linear 
regression analysis between the two variables resulted in an r2 of 0.708. 
Bland–Altman analysis (Figure 1) for the pooled measurements of SvO2 
and ScvO2 showed a mean bias and LOA of 6.82% (SD of bias 5.3) and 
–3.71 to +17.3% respectively.
Conclusion  ScVO2 has been advocated as an attractive and simple 
indicator of DO2–VO2 mismatch [6]. Its role as a surrogate of the well-
established SVO2 has been investigated in several settings, and it 
has been purposed in the hemodynamic resuscitation of critically 
ill septic patients [1]. Nevertheless, the SVO2–ScVO2 relationship 
can be infl  uenced by several factors due to ScVO2 dependency from 
global blood fl  ow redistribution that can occur during hemodynamic 
impairments. It has been shown previously that in healthy people 
ScVO2 values tend to underestimate SVO2 values, due to the higher 
oxygen content from inferior vena cava [7]. During circulatory shock, 
not homogeneous oxygen extraction and regional blood fl  ow 
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global adequacy of cardiac output rather than ScVO2. In this study 
we aimed at evaluating SvO2–ScVO2 diff   erences in patients with 
cardiogenic shock, as defi  ned by hyperlactatemia, low CI, and LVEF 
<40%, after cardiac surgery. Our results highlighted a great variability 
for these two parameters, with a clinically unacceptable mean bias and 
LOA. As expected, ScVO2 values were consistently higher.
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Introduction The acute respiratory distress syndrome and pulmonary 
hypertension (PH) is one of the factors of septic mortality. Some data 
demonstrate arginine defi  ciency as an important pathogenic factor of 
septic PH. We suppose that intravenous L-arginine infusion improves 
NO production and reduce PH.
Methods We examined 46 patients with sepsis, severe sepsis and septic 
shock in accordance with San Antonio Criteria. Organ dysfunction 
severity was defi  ned according to SOFA. The mean pulmonary artery 
pressure (MPAP) was estimated by Doppler method, cardiac output 
(CO), and stroke volume (SV) – by ultrasound M-mode. SpO2, mean 
arterial pressure (MAP), blood gas, and plasma NO level was evaluated. 
The patients of Group 1 (n = 21, age 22.1 ± 8.5 months) had respiratory 
and hemodynamic support, and antibiotics. Group 2 (n  =  25, age 
27.0  ±  11.2  months) had the same treatment with continuous i.v. 
infusion of 5  ml/kg body weight 4.2% L-arginine solution during 
24 hours.
Results  The patients of Groups 1 and 2 did not have statistical 
diff  erence of SOFA (4.1 ± 1.0 vs. 4.4 ± 0.7), need for ventilator support 
(57.0 ± 11.0% vs. 44.0 ± 10.0%), and dose of inotropes (P >0.05). The 
reduction of MPAP and increase of SaO2 was signifi  cantly higher in 
Group 2 compared with Group 1 (P <0.001). The increase in plasma NO 
level was signifi  cantly higher in Group 2 (Table 1).
Conclusion L-Arginine i.v. infusion 5 ml/kg during 24 hours increased 
NO blood level and decreased MPAP in pediatric sepsis, but did not 
deteriorate hemodynamic system values.
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Introduction While TEE is providing a direct assessment of the cardiac 
function and volume status as a diagnostic tool, until recently it has 
been impractical to be continuously available for monitoring. A new 
disposable, monoplanar TEE probe (ImaCor) can remain in the patient 
for up to 72 hours, allowing repeated measures of ventricular function 
and volume status, parameters needed to monitor response to therapy.
Methods  We assessed the benefi  t these TEE data provided in the 
assessment of fi  ve domains: hypovolemia, right ventricular dysfunction, 
left ventricular dysfunction, sepsis, and valvular abnormality. Bedside 
practitioners listed their diagnoses before and after seeing primary 
TEE images perform by trained physicians. We used a 0 to 5 Likert scale 
to assess diff  erential diagnosis before and after the TEE, comparing 
changes using a paired t test.
Results All requests for TEE were to access hemodynamic instability. A 
total of 18 patients were screened and nine were eligible, in which 16 
total TEE studies were performed. There were no complications with 
TEE and all patients tolerated the long-term placement of the probe 
well. Of the fi  ve diagnostic domains studied, right ventricular failure was 
the most commonly underdiagnosed contributor to the hemodynamic 
instability among patients prior to TEE (P = 0.054) (Figures 1 and 2).
Figure 1 (abstract P180).
Table 1 (abstract P181). Hemodynamic parameters before and after 
treatment
  Group 1  Group 1  Group 2  Group 2
Value  before after before after
MAP (mmHg)  66.9 ± 3.4  68.8 ± 3.0  72.8 ± 2.0  71.8 ± 1.3
MPAP (mmHg)  43.5 ± 2.6   44.3 ± 3.4  50.8 ± 3.0   28.8 ± 2.1
CO (l/minute/m2)  4.2 ± 0.2  5.0 ± 0.4  4.8 ± 0.2  4.8 ± 0.3
SpO2 (%)  93.7 ± 1.2   93.4 ± 1.5  94.6 ± 0.7   98.1 ± 0.3
Figure 1 (abstract P182). Ventricular function according to the Likert 
scale.
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TEE for monitoring and management of hemodynamically unstable 
patients increases awareness of right ventricular dysfunction in the ICU.
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Introduction Although rapid progress in ICU monitoring with advanced 
equipments has been developed, there were limited data on ICU 
monitoring in Thailand. The objective of this study was to determine 
the current utilization of monitoring in Thai ICUs.
Methods  A self-administered questionnaire was developed by the 
TSCCM research subcommittee. Data verifi  cation was processed by an 
online medical research tools program (OMERET).
Results A total of 350 questionnaires were sent to ICUs throughout 
Thailand. In total, 256 questionnaires were confi   rmed after being 
received at the end of June 2012. Of these, 140 fi  lled forms (56.9%) 
were returned for fi  nal analysis. More than 70% of the ICUs had basic 
hemodynamic monitoring. Less than 10% of general and regional 
hospitals could perform cardiac output monitoring by thermodilution 
technique compared with 60% of academic teaching hospitals. 
New and advanced hemodynamic monitoring techniques such as 
pulse pressure variation, systolic pressure variation, stroke volume 
variation, PiCCO, Vigileo-Flo Tract, Pleth variability index device and 
echocardiography were available only in ICUs of academic teaching 
hospitals except ultrasound-based techniques including transthoracic 
and transesophageal echocardiography and USCOM. For respiratory 
monitoring, all ICUs had a SpO2 monitoring device but only one-half of 
them had end-tidal CO2 monitoring. Nearly 80% of ventilator support 
in participating ICUs was capable of displaying graphic waveform 
monitoring. Only 43.6% of participating ICUs had a ventilator machine 
that could calculate lung mechanics data. Advanced respiratory 
monitoring such as EIT and esophageal pressure monitoring are 
available only in ICUs of academic teaching hospitals. There was no 
ICU in Thailand that was capable of measuring extravascular lung 
water. None of the Thai ICUs used transcutaneous PCO2, near-infrared 
spectroscopy, gut mucosal tonometry and sublingual sidestream dark-
fi  eld for tissue perfusion monitoring. Only four ICUs had transcutaneous 
PO2. However, measuring the level of lactate as one of the tissue 
perfusion markers was routinely performed in about 50% of the ICUs.
Conclusion There were variations in monitoring performance in Thai 
ICUs. These vary by type of hospital. Academic ICUs had a tendency for 
advance monitoring in overall aspects. Some advance monitoring used 
in developed countries is also unavailable in Thailand.
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Introduction Echocardiography is increasingly utilized by inten sive care 
physicians in everyday practice. Standardization of echocardiographic 
studies and reporting, quality assurance and medicolegal requirements 
necessitate establishment of a dedicated system within the critical 
care setting. We describe the process of setting up a critical care 
echocardiography (CCE) laboratory based on our experience from 
three separate ICUs.
Methods A retrospective review and analysis of the process involved in 
establishment of echocardiography laboratories within ICUs.
Results  Creating a CCE service involves a number of stages and 
takes several years to achieve. Major components include staffi   ng, 
equipment, quality control, study archiving and networking capability. 
For staffi   ng the objective is to identify and recruit staff   with adequate 
training and expertise in CCE, providing 24/7 specialist cover in 
addition to supporting and training junior medical and nursing staff  . 
There is further a need to acquire funding for high-quality ultrasound 
machines and related hardware as well as long-term DICOM-based 
archiving and reporting systems. This should be based on projections 
of annual volumes of echo studies and corresponding digital storage. 
Networking connectivity is highly desirable, including obligatory 
back-up solutions and site allocations. A business case incorporating 
all the above should precede any development as identifi  able funding 
sources and administrative approval are essential. The implementation 
stage requires the presence of a project leader who can organize the 
trialing of scanners, archiving, reporting and research systems, ensure 
compatibility with existing hospital and cardiology networks, and who 
can assist in individualizing archiving and reporting software refl  ecting 
institutional and ICU specifi  cs. Coordination with the IT department 
is very important. Clear contractual vendor obligations for service, 
maintenance and future upgrades of hardware and software need to 
be specifi  ed. Training and credentialing of staff   is best achieved within 
a systematic framework that includes ongoing competency review, 
education and QA programs. Partnership with cardiology may benefi  t 
both groups. Major pitfalls are associated with poor initial training, lack 
of expertise and leadership, and bad vendor contracts.
Conclusion  Establishment of a CCE laboratory requires careful 
planning, and allocation of adequate human and fi  nancial resources. 
Many potential problems can be identifi  ed and prevented in advance. 
Strong expert leadership plays an important role.
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Introduction  Contrast-enhanced ultrasonography (CEUS) is a 
dynamic digital ultrasound-based imaging technique, which allows 
quantifi  cation of the microvascularisation up to the capillary vessels. As 
a novel method for assessment of tissue perfusion it is ideally designed 
for use in the ICU. CEUS is cost-eff  ective and safe and can be repeatedly 
performed at the bedside without radiation and nephrotoxicity.
Figure 2 (abstract P182). Volume status, valve, sepsis according to the 
Likert scale.
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ICU was retrospectively evaluated for the period from 1 September 
2011 to 1 September 2012. Furthermore, contributions of this novel 
method to the management of critically ill ICU patients as well as its 
accuracy were assessed.
Results In total, 33 CEUS studies were performed in critically ill ICU 
patients. The most frequent indications included: assessment of the 
liver perfusion, assessment of the pancreas and kidney perfusion after 
pancreas and kidney transplantation, assessment of the renal perfusion 
in acute kidney injury (AKI), assessment of active bleeding and 
assessment of the bowel perfusion. In all studies, the correct diagnosis 
was achieved and the transport of critically ill patients to the radiology 
department for further diagnostic procedures as well as application 
of iodinated contrast agents was avoided. In 16 cases signifi  cant new 
fi  ndings were detected. Twelve of them were missed by conventional 
standard Doppler ultrasound prior to CEUS. In assessment of seven 
cases with AKI, impaired or delayed perfusion and microcirculation 
of the kidney was observed in six patients. In three patients urgent 
surgical intervention was performed because of CEUS results. In three 
cases active bleeding was excluded at the bedside due to absence of 
contrast agent extravasation into hematoma (thigh and perihepatic) or 
into abdominal cavity, without need for complementary CT imaging or 
angiography. In one case the regular perfusion of intestinal anastomosis 
was confi  rmed with no need for surgical exploration. None of patients 
undergoing CEUS manifested any adverse reactions or developed any 
complications associated with the imaging technique.
Conclusion  Contrast-enhanced ultrasonography clearly improves 
visualization of the perfusion in various tissues. It is very likely to be 
superior to standard Doppler ultrasound, and is safe and well tolerated 
in critically ill patients. Promising indications for the use of CEUS in the 
ICU may be the assessment of kidney microcirculation and assessment 
of liver perfusion in liver transplant and liver trauma patients.
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Introduction Even though invasive hemodynamic devices are usually 
used for assessment of septic shock victims, they cannot evaluate the 
heart function. LV dysfunction as well as right heart syndrome are not 
uncommon in sepsis and critical patients. Intensive care ultrasound 
discloses these data and leads to appropriate treatment.
Methods  The study was a prospective cross-sectional study. The 
measurement was performed within 24 hours of ICU admission. We 
excluded patients with history of COPD and pulmonary hypertension 
from any diseases. Only good-quality images acquired from subjects 
were included for analysis. The primary objective was to disclose how 
the hemodynamic changed in septic patients by ICU-US.
Results A total of 133 septic patients were measured by ICU-US. Good 
image quality was acquired in 115 cases (86.47%). The mean ages were 
57.48 ± 17.87 years. The three major causes of sepsis were pneumonia, 
unknown source, abdominal infection and bacteremia. Heart failure at 
admission was found only in 1.79%. Previous history of hypertension, 
DM, and coronary artery disease was found in 12.17%, 11.30%, and 
1.74% of patients. The mean LV ejection fraction (LVEF) was 54 ± 15.43%. 
The percentages of patients with LVEF <35%, 35 to 40%, 41 to 45% 
and >45% were 13.2%, 7.5%, 8.5%, and 70.8% respectively. Diastolic 
dysfunction defi  ned by E/A ratio <1 was observed in 47.5% of patients. 
A total 44.6% of cases had cardiac output under 4 l/minute whereas 
CO over 6 l/minute was found in 18.1% of cases. The average mean 
pulmonary artery pressure was 34.75 ± 15.13 mmHg. The proportion of 
patients with meanPAP over 25 mmHg was 76.2%. RV to LV ratio >1 was 
found in 42.4% of septic patients.
Conclusion Cardiac dysfunction, namely left ventricle and probably 
right ventricle, was not uncommon in septic shock patients. Without 
intensive care ultrasound, all crucial information was delayed until 
patient deterioration and initial treatment may be harmful. Thus 
cardiac ultrasound should be used initially to disclose hemodynamic 
features before routine resuscitation is initiated.
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Introduction Speckle-tracking echocardiography (STE) has emerged as 
an ultrasound technique for accurately evaluating myocardial function 
also in critically ill patients. By tracking the displacement of the speckles 
during the cardiac cycle, the strain rate can be measured offl   ine after 
adequate image acquisition. The aim of the study was to evaluate the 
eff  ects of the positive end-expiratory pressure (PEEP) on four-chamber 
longitudinal strain (LS) analysis in critically ill patients.
Methods We enrolled 20 consecutive patients (mean age 64 ± 18) who 
needed mechanical ventilation and were admitted to the ICU due to 
heterogeneous causes. Inclusion criteria were: hypoxia requiring PEEP 
titration, invasive arterial pressure monitoring, age >18. Exclusion 
criteria were: myocardial dysfunction, cardiac arrhythmias and 
valvular pathologies. The same operator performed three standard 
echocardiography measurements (MyLab 70 Xvision; Esaote), each 
of them after having increased PEEP at 5, 10, and 15 cmH2O (T1, T2, 
T3, respectively). Blood gas analysis, respiratory, and hemodynamic 
parameters provided by a pulse contour method were also recorded. 
STE analysis was performed offl   ine (XStrain™MyLab 70 Xvision; Esaote).
Results Left peak atrial LS (LA-PALS) was signifi  cantly reduced from 
T1 to T2, and from T2 to T3 (40.2 ± 12%, 35.9 ± 9%, 28.4 ± 8%, T1, 
T2, T3, respectively; P  <0.05). Right peak atrial LS (RA-PALS) and 
right ventricular (RV)-LS showed a signifi  cant reduction only at T3 
(RA-PALS: 44.7 ± 48.5% at T1, 35.9 ± 11% at T3; RV-LS: –20.2 ± 2% at 
T1, –16.3 ± 1.1% at T3; P <0.05). Left ventricular (LV)-LS did not change 
signifi  cantly during titration of PEEP. Cardiac chambers’ volumes and 
cardiac output (CO) showed a signifi  cant reduction at higher levels of 
PEEP. Pulse pressure variation was signifi  cantly aff  ected by higher levels 
of PEEP (P <0.05).
Conclusion  In hypoxic patients with normal cardiac function, PEEP 
titration determined a reduction of LA-LS, RA-LS and RV-LS values. 
LV-LS values were not infl  uenced by PEEP changes. The fall in CO, 
observed with higher values of PEEP, seemed to be related to the 
impairment of preload and not of myocardial contractility. Whenever 
interpreting data on cardiac function obtained with longitudinal strain 
analysis, attention of the clinician should be drawn to diff  erent levels 
of PEEP. The higher the PEEP, the more the probability of misleading 
interpretation of STE data.
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Introduction  After calibration by thermodilution (TD), the PiCCO 
device is able to assess cardiac index (CI) using pulse contour (PC) 
analysis. The manufacturer suggests recalibration by TD after 8 hours. 
Recently, we suggested a calibration index indicating a certain 
probability of a relevant bias and triggering the next calibration. With 
changes of CIpc compared with the previous CItd being a key predictor 
of the bias of CIpc compared with the following CItd, the manufacturer 
implemented a soft alarm indicating changes in CIpc compared with 
the last CItd (thresholds adjustable to 15%, 25% and 35%). The aim of 
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15% alarm regarding a bias of CIpc compared with CItd exceeding 
critical thresholds of 15%, 20% and 25%.
Methods A prospective analysis of 329 routine TPTD measurements 
in 70 patients. The CI-trend alarm was set to 15%, and CIpc, trend 
alarm (yes/no), relative and absolute changes in CIpc were recorded 
immediately before TD providing exact measurement of CItd. Predictive 
capabilities of the 15% trend alarm regarding the bias were evaluated 
using Spearman correlation, chi-square test, ROC analysis and Wilcoxon 
test (IBM SPSS 20).
Results A total of 70 patients (24 female, 46 male), age 62 ± 14 years, 
APACHE II score 19.5 ± 7.5, SOFA score 8.9 ± 4.4. At 937 ± 904 (50 to 5,795) 
minutes after the last CItd, CIpc provided a bias of –0.0566 ± 0.761 l/
minute*m2 compared with the next CItd. Percentage error was 34.6%. 
Absolute and relative bias of CIpc compared with the new CItd did not 
correlate to time to last TD, but correlated (all P <0.001) to CIpc itself 
(r = 0.333; r = 0.385) and relative (r = 0.531; r = 0.537) and absolute 
(r = 0.533; r = 0.529) changes in CIpc compared with last CItd. The 15% 
CIpc trend alarm was indicated before 83/329 measurements (25.2%). 
The amount of bias exceeded 15% and 20% in 101 (30.7%) and 79 
(24%) of TDs. In TDs with indicated trend alarm (≥15% deviation of CIpc 
to the last CItd), the amount of bias more frequently exceeded 15% 
(P = 0.019), 20% (P <0.001) and 25% (P <0.001). Time to last calibration 
≥8 hours was not associated with bias exceeding 15% (P = 0.735), 20% 
(P = 0.888) or 25% (P = 281).
Conclusion Bias of CIpc compared with the next CItd does not depend 
on the time since last CItd. Changes in CIpc itself compared with the 
last CItd are associated with the bias. A 15% change in CIpc trend alarm 
provided by the new PiCCO algorithm is signifi  cantly associated with 
bias values exceeding 15%, 20% or 25% of CItd, whereas time to last 
calibration >8 hours is not associated with bias exceeding these critical 
thresholds.
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Introduction Thermodilution (TD) is considered a gold standard for 
measurement of cardiac index (CI) in critically ill patients. The aim of 
this study is to compare intermittent bolus TD CI with intermittent 
automatic calibration CI (AutoCI) and two continuous CIs obtained by 
pulse contour analysis with PiCCO2 (PiCCI) and Pulsiofl  ex (PuCCI).
Methods Interim results of an ongoing prospective multicentre study 
in 53 patients. Age 58.7 ± 15.4, SAPS II score 51.4 ± 14.7 and SOFA score 
10 ± 3.2. All patients underwent PiCCO monitoring via a femoral line 
whilst a radial line was kept in place during four 8-hour time periods 
(in the fi  rst two periods, the Pulsiofl  ex was connected to a radial line; 
in the last two it was connected to a femoral line). In the fi  rst and third 
periods, the Pulsiofl  ex was calibrated with TDCI, for the second and 
fourth periods Pulsiofl  ex was calibrated with AutoCI. Simultaneous 
PiCCI and PuCCI measurements were obtained every 2 hours while 
simultaneous TDCI and AutoCI were obtained every 8 hours. We also 
looked at the eff  ects of 40 interventions.
Results In total, 940 CCI and 382 TDCI values were obtained: 940 paired 
PiCCI and PuCCI; 358 paired AutoCI-TDCI measurements. TDCI values 
ranged from 1.5 to 6.9 l/minute/m2 (mean 3.6 ± 1.1), AutoCI from 1.8 
to 7.2 (3.6 ± 0.9), PiCCI from 1.0 to 7.1 (3.5 ± 1.1) and PuCCI from 1.3 to 
7.6 (3.6 ± 1). Pearson’s correlation coeffi   cient comparing mean PuCCI 
and PiCCI values per patient had an R2 of 0.79. Comparison between 
AutoCI and TDCI had an R2 of 0.51. Changes in AutoCI correlated well 
with changes in TDCI (R2 = 0.44, concordance coeffi   cient = 95.7), as 
did changes in PuCCI versus changes in PiCCI (R2 = 0.99, CC = 93.4%). 
Changes in PiCCI and PuCCI induced by an intervention correlated 
well with each other (R2 = 0.86, CC = 100%). The percentage error 
(PE) obtained by Bland and Altman analysis and R2 for the diff  erent 
comparisons are presented in Table 1.
Conclusion The preliminary results indicate that in unstable critically 
ill patients, CI can be reliably monitored with Pulsiofl  ex technology via 
a femoral line. Pulsiofl  ex was also able to keep track of changes in CI.
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Introduction The Nexfi  n monitor (BMEYE, the Netherlands) enables 
continuous non-invasive analysis of blood pressure (MAP) as well as 
cardiac output (CO) measurements. The aim of the present study was 
to validate the Nexfi  n in a mixed population of medical ICU patients.
Methods Interim results of a prospective ongoing study in 77 patients 
admitted to the medical ICU (46 patients mechanically ventilated, M/F 
ratio 1/1). Age 65.6 ± 15.9, BMI 25.6 ± 4.8, APACHE II score 22.9 ± 10.9, 
SAPS II 48 ± 20.1, SOFA score 7.5 ± 4.5. A modifi  ed outreach score (SOS) 
was calculated on admission. For all patients, simultaneous recording 
of arterial pressure by radial line (n = 78), PiCCO (n = 44) or by NIBP with 
arm cuff   (n = 47) was compared with the Nexfi  n monitor. Statistical 
analysis was performed with Student’s t test, Pearson correlation and 
Bland–Altman analysis.
Results A total of 103 measurements in 77 patients were performed. 
In seven patients measurement with Nexfi  n was not possible. For CO 
(55 paired measurements), values were 6 ± 2.1 l/minute (range 2.6 
to 12). Pearson’s correlation coeffi   cient  comparing  Nexfi  n-CO  with 
reference CO showed a good correlation (R2 = 0.52). Bland–Altman 
analysis comparing both CO techniques revealed a mean bias ± 2SD 
(LA) of 0.3 ± 3.6 l/minute (58% error). The MAP was 84.2 ± 15.6 mmHg 
(53 to 131.5) and values obtained with the Nexfi  n correlated well 
with the reference method with an R2 of 0.72. Bland–Altman analysis 
comparing both MAP techniques revealed a mean bias ± 2SD (LA) of 
–0.3 ± 18 mmHg (20.9% error). However, Nexfi  n-MAP did not correlate 
well with NIBP (R2 = 0.36). Hemoglobin values obtained with Nexfi  n 
Massimo technique did not correlate well with laboratory values 
(R2 = 0.26, 33% error). The 26 patients that died in the ICU had higher 
APACHE II (P = 0.017), SAPS II (P <0.0001), SOFA (P <0.0001) and SOS 
(P = 0.004) scores and signifi  cantly lower MAP (P <0.0001), hemoglobin 
(P = 0.01) and lower dp/dtmax (P = 0.003), a marker for contractility. 
There were no outcome diff  erences with regard to subgroup analysis in 
patients with either low or high CO or SVR.
Conclusion  In unstable critically ill patients, MAP (and CO) can be 
monitored with the Nexfi   n. The exact patient population for this 
Table 1 (abstract P189). Results of Bland and Altman analysis
Pulsiofl  ex  AutoCal  PE (CCl) (%)  n R2  PE (TD-Pi) (%)  n R2  PE (TD-Pu) (%)  n R2
All  All  37.9 940 0.73 22.8 382 0.88 38.5 382 0.66
All  Yes 43.4 510 0.50 20.4 210 0.88 42.3 210 0.47
All  No 27.8 430 0.83 25.6 172 0.85 32.5 172 0.74
Fem  All  30.6 464 0.73 20.2 192 0.88 33.0 192 0.66
Rad  All  44.2 476 0.58 25.2 190 0.85 43.7 190 0.56
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needed for pattern recognition, although the results indicate that low 
MAP and dp/dtmax are associated with poor outcome. In the future, 
Nexfi  n data could theoretically be incorporated in a new outreach 
score.
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Cost-eff  ectiveness analysis of stroke volume variation guided 
perioperative hemodynamic optimization
J Benes, J Zatloukal, A Simanova, I Chytra, E Kasal
The Medical Faculty and Hospital in Plzen – Charles University Prague, Plzen, 
Czech Republic
Critical Care 2013, 17(Suppl 2):P191 (doi: 10.1186/cc12129)
Introduction  Perioperative goal-directed therapy (pGDT) can sub-
stantially improve the outcome of high-risk surgical patients [1]. But the 
approach needs an initial investment and increases the staff   workload. 
Economic factors might participate in the weak adherence to the 
pGDT concept. Some model studies support pGDT cost-eff  ectiveness, 
but real economic data based on a recent clinical trial are lacking. We 
performed an economic analysis of hemodynamic optimization using 
the stroke volume variation trial [2] in order to elucidate this issue.
Methods The hospital care invoices of all 120 patients included in the 
trial were retrospectively extracted. Due to the nature of the data we 
have adopted the healthcare payer’s perspective. We performed a 
comparison of induced costs between the Vigileo (n = 60) and Control 
(n = 60) groups and constructed a cost tree using the study group and 
complications occurrence as distributive parameters. The incremental 
cost-eff  ectiveness ratio per complication avoided was calculated and, 
fi  nally, diff  erent reimbursing categories were assessed as potential cost 
drivers.
Results  A decreased rate (18 vs. 35 patients) and number of 
complications (34 vs. 78) were observed in the original trials Vigileo 
group. The mean cost of intervened patient was lower (€2,877 ± 2,336 
vs. €3,371  ±  3,238; P  =  0.38). According to the cost-tree analysis, 
patients with complications (n = 53; 44%) consumed signifi  cantly more 
resources (€235,623; 63%). A gain of €634 per avoided complications 
confi  rms that the lower complications rate was the most important cost 
driver. Both the clinical care for patients costs (€505 vs. 912; P = 0.04) 
and ward stay costs (€244 vs. 402; P = 0.03) were decreased by the 
intervention. On the contrary, the intervention increased anaesthesia 
costs (€880 vs. 688; P = 0.001).
Conclusion Intraoperative fl  uid optimization with the use of stroke 
volume variation and the Vigileo/FloTrac system showed not only a 
substantial improvement of morbidity, but was also associated with an 
economic benefi  t. This observed benefi  t highly exceed the increased 
monitoring costs in our trial.
Acknowledgements The study was supported by the MSM0021620819 
and the Charles University Research Fund (project number P36).
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Introduction  Hemodynamic monitoring is important in high-risk 
surgical patients in order to detect and correct circulatory instability, 
thereby improving outcome [1]. The extravascular lung water index 
(EVLWI) refl  ects pulmonary edema [2]. The new EV1000/VolumeView 
(Edwards Lifesciences) can accurately measure EVLWI corrected for the 
actual volume of lung parenchyma (EVLWIc). The aim of our study is to 
prove a stronger correlation between EVLWIc and PaO2/FiO2 compared 
with EVLWI in patients undergoing pulmonary resection.
Methods  A prospective observational study. Seven patients with 
lung cancer undergoing pulmonary resection were monitored using 
the EV1000 plathform. EVLWI was assessed by thermodilution at 
the following time points: after intubation (t1); during single-lung 
ventilation (t2); after lung resection (t3); after ICU admission (t4); 
12 hours (t5) and 18 hours after ICU admission (t6). EVLWIc values were 
also collected at t3 and t4. PaO2/FiO2 was measured at the same time 
points.
Results No signifi  cant correlation was found between EVLWI and PaO2/
FiO2 (r = –0.3124, P >0.05), while a signifi  cant correlation was seen 
between EVLWIc and PaO2/FiO2 (r = –0.528, P =0.009; Figure 1).
Conclusion Despite the small sample size, this study shows that in 
patients undergoing pulmonary resection the EVLWIc is more strongly 
correlated to PaO2/FiO2 than EVLWI. Therefore, the EV1000 may be 
a valuable tool for more reliable hemodynamic monitoring in this 
subgroup of patients.
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Introduction  A goal-directed resuscitation therapy (GDT) through 
optimization of cardiac output reduces complications in noncardiac 
surgeries. We investigated whether the implementation of a GDT 
protocol in high-risk cardiac surgery with the use of LiDCO Rapid 
reduces postoperative complications as compared with the standard 
of care.
Methods We performed a prospective and randomized study whereby 
consecutive patients fulfi  lling one high-risk criteria (EuroSCORE >5, 
ejection fraction <50%, recent myocardial infarction, unstable angina 
Figure 1 (abstract P192). Correlation between PaO2/FiO2 and EVLWIc.
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hemodynamic therapy. We excluded patients with endocarditis, 
previous use of dobutamine, need for IABP, high dose of vasopressors 
and emergency surgery. The GDT protocol involved hemodynamic 
resuscitation aimed at a target of a cardiac index >3  l/minute/m2 
through a three-step approach: fl  uid therapy of 250 ml lactated Ringer’s 
solution, dobutamine infusion up to a dose of 20 μg/kg/minute, and 
red blood cell transfusion to reach a hematocrit level above 28%.
Results Twenty patients from the GDT group were compared with 20 
control patients. Both groups were comparable concerning baseline 
characteristics and severity scores, except for a higher prevalence of 
hypertension and heart failure in the GDT group. Intraoperative data 
showed no diff  erence regarding length of extracorporeal circulation, 
fl  uid balance, transfusion or inotropic requirement. Patients from the 
GDT group were given more fl  uids within the fi  rst 8 hours as compared 
with the conventional group (1,250  ml vs. 500  ml, P  <0.001). GDT 
patients showed a median ICU stay of 3 days (95% CI: 3 to 4) compared 
with 5 days in control patients (95% CI: 4 to 7). Moreover, hospital stay 
was less prolonged in GDT patients (10 days vs. 14 days, P = 0.043). 
Inotropic dependence was lower in the GDT group (29  hours vs. 
55 hours, P = 0.003) as well as the cumulative dobutamine dosage (8 vs. 
19 μg/kg/day, P = 0.025). Also, GDT group presented a lower incidence 
of infections, tachyarrithmias and acute renal failure (RIFLE R) when 
compared with the control group.
Conclusion A hemodynamic therapy tailored to an optimized cardiac 
output reduced the length of ICU stay, vasoactive drug requirement 
and postoperative complications.
Acknowledgement Grants received from FAPESP 2011/19987-5.
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Introduction  Pulmonary complications are the primary reason for 
extending a patient’s stay in the ICU. The aim of this study was to 
investigate whether perioperative volume management can infl  uence 
the PaO2/FiO2 value and total length of stay in the ICU.
Methods Sixteen patients were divided into two groups: one group 
was treated with a restrictive approach (≤8 ml/kg/hour), and the other 
with a liberal approach (> 8  ml/kg/hour). Patients were randomly 
allocated using sealed envelopes. During the thoracic part of the 
surgical procedure, all patients received one-lung ventilation (OLV).
Results  In the group treated with a restrictive volume approach, 
patients received fl  uids at the rate of 7.0 ± 1.0 ml/kg/hour. PaO2/FiO2 
was 288 ± 14 after intubation and 270 ± 22 before extubation. In the 
group treated with a liberal volume approach, fl  uids were replaced 
at 11.0 ± 2.0 ml/kg/hour. PaO2/FiO2 was 259 ± 24 after intubation and 
223 ± 43 before extubation. Surgery combined with OLV was found to 
signifi  cantly aff  ect the PaO2/FiO2 value (ANOVA, F1,14 = 15.85a, P = 0.001, 
partial η2 = 0.531). The average PaO2/FiO2 level was signifi  cantly higher 
in the restrictive-replacement group than in the liberal-replacement 
group (ANOVA, F1,14 = 9.66, P = 0.008, partial η2 = 0.408). There was 
no interaction between the groups (ANOVA, F1,14 = 1.7a, P = 0.215, 
partial η2 =0.108). Mean length of stay in the ICU was similar between 
the restrictive-replacement group (5.2  ±  2.3 days) and the liberal-
replacement group (6.3 ± 1.6 days) (ANOVA, F1,14 = 0.814a, P = 0.382, 
partial η2 = 0.055).
Conclusion Results from this small sample indicate that esophageal 
carcinoma surgery by itself had a detrimental eff  ect on the PaO2/FiO2 
value, which restriction of perioperative volume did not signifi  cantly 
aff  ect. Volume restriction also did not aff  ect length of stay in the ICU.
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goal-directed therapy in high-risk surgical patients: a meta-analysis
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Introduction We hypothesized that goal-directed therapy (GDT) is not 
associated with an increased risk of cardiac complications in high-risk, 
noncardiac surgical patients. Patients with limited cardiopulmonary 
reserve are at risk of mortality and morbidity after major surgery [1]. 
Augmentation of the oxygen delivery index (DO2I) with a combination 
of intravenous fl  uids and inotropes (GDT) has been shown to reduce 
the postoperative mortality and morbidity in high-risk patients [2]. 
However, concerns regarding cardiac complications associated with 
fl  uid challenges and inotropes used to augment cardiac output may 
deter clinicians from instituting early GDT in the very patients who are 
more likely to benefi  t.
Methods  Systematic search of MEDLINE, Embase and CENTRAL 
databases for randomized controlled trials of GDT in high-risk surgical 
patients. Studies including cardiac surgery, trauma, and pediatric 
surgery were excluded to minimize heterogeneity. We reviewed the 
rates of all cardiac complications, arrhythmias, acute myocardial 
ischemia, and acute pulmonary edema. Meta-analyses were performed 
and forest plots drawn using RevMan software. Data are presented as 
odd ratios (ORs) (95% CIs), and P values.
Results We identifi  ed 23 randomized controlled trials including 2,219 
patients, who reported cardiac complications. GDT was associated 
with a reduction in total cardiovascular complications (OR = 0.55 (0.39 
to 0.78), P = 0.0007), and with a signifi  cantly reduced incidence of 
arrhythmias (OR = 0.59 (0.38 to 0.91), P = 0.02). GDT was not associated 
with an increase in acute pulmonary edema (OR = 0.68 (0.42 to 1.10), 
P = 0.11) or acute myocardial ischemia (OR = 0.70 (0.38 to 1.27), P = 0.23). 
Subgroup analysis of overall cardiovascular complications revealed that 
the benefi  t is most pronounced in patients receiving fl  uid and inotrope 
therapy (OR = 0.55 (0.34 to 0.89), P = 0.01) to achieve a supranormal 
oxygen delivery target (OR = 0.50 (0.32 to 0.79), P = 0.003), guided by 
the use of minimally invasive cardiac outmonitoring (OR = 0.50 (0.33 to 
0.77), P = 0.002).
Conclusion  Perioperative, physiologically guided, GDT in high-risk 
surgical patients is not associated and actually reduces postoperative 
cardiovascular complications.
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Introduction  Many studies have demonstrated the ability of peri-
operative hemodynamic goal-directed therapy (pGDT) to decrease 
post  operative morbidity in patients undergoing medium-to-high-risk 
surgery [1]. As a result, pGDT may be a cost-saving strategy. Our goal 
was to provide an estimation of potential cost-savings based on recent 
literature.
Methods  The largest and most recent meta-analysis [1] on pGDT 
was used to estimate what could be the reduction of postoperative 
morbidity if pGDT was to be adopted. Costs related to the treatment 
of patients developing at least one (1+) postoperative complication 
were obtained from two recent US [2] and Swiss [3] publications. 
Potential cost-savings related to the adoption of pGDT were calculated 
according to the actual morbidity rate, assuming 0% pGDT use so far, 
and 100% compliance rate after implementation.
Results The 2011 meta-analysis [1] of 29 RCTs (4,805 patients) showed 
that pGDT is associated with a reduction in the rate of patients 
developing 1+ postoperative complications with odd ratios ranging 
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related to the morbidity rates. In the US publication [2], extra costs for 
treating patients with 1+ complication were $17,949. In the Swiss (CH) 
publication [3], they were $34,446. See Table 1.
Conclusion  Depending on the pre-implementation morbidity rate, 
the degree of pGDT-induced morbidity reduction and the country, 
cost-savings ranged between $808 and $13,434 per patient. This large 
variability suggests that local/hospital estimations are desirable before 
starting pGDT implementation. These tailored evaluations would also 
allow more precise cost-saving estimations by taking into account the 
actual and expected pGDT compliance rates.
References
1. Hamilton  MA,  et al.: A systematic review and meta-analysis on the use of 
preemptive hemodynamic intervention to improve postoperative 
outcomes in moderate and high-risk surgical patients. Anesth Analg 2011, 
112:1392-1402.
2. Boltz  et al.: Synergistic implications of multiple postoperative outcomes. 
Am J Med Qual 2012, in press.
3. Vonlanthen  R,  et al.: The impact of complications on costs of major surgical 
procedures. Ann Surg 2011, 254:907-913.
P197
Cardiac output estimation: Vigileo and Mostcare versus 
echocardiography
S Romagnoli, D Quattrone, AR De Gaudio
Azienda Ospedaliero Universitaria Careggi, Florence, Italy
Critical Care 2013, 17(Suppl 2):P197 (doi: 10.1186/cc12135)
Introduction  In the present study we analyzed the reliability for 
cardiac output (CO) measurement of Vigileo (Edwards Lifescience, 
Irvine, CA, USA) and MostCare (pressure recording analytical method; 
Vygon-Vytech, Padova, Italy) in comparison with transthoracic Doppler 
echocardiography (as the reference method) in patients undergoing 
vascular surgery.
Methods Both Vigileo and MostCare were connected to the FloTrac 
transducer (Edwards Lifescience) for CO calculation. The data from 
Vigileo and MostCare were registered (COVIG and COMC respectively) 
and compared with those calculated with the echocardiographic 
standard formulation (stroke volume = cross-sectional area×velocity 
time integral; COECHO  =  SV×heart rate). In every patient CO was 
measured twice: at baseline (T1) and after volume loading (500 ml 
lactate Ringer solution) (T2). Agreements between COVIG, COMC, and 
COECHO were evaluated by means of simple linear regression (r2) and 
Bland–Altman analysis.
Results Twenty patients were enrolled in the study. Values of r2, bias 
and limit of agreement at T1 and T2 are summarized in Table 1. CO 
values ranged from 3.9 and 8.6 l/minute (echo), from 3.4 to 9.9 (Vigileo) 
and from 4 to 8.3 (MostCare); the Pearson’s and Bland–Altman methods 
showed poor agreement between COECHO and COVIG, demonstrating 
a tendency to overestimation (see Figure 1). The percentage of error (PE) 
was 51.7% at T1 and 49.3% at T2. On the contrary, MostCare measures 
showed good agreement with echocardiography (see Table 1) with a 
PE of 22.4% at T1 and of 17% at T2.
Conclusion Vigileo did not prove to be a substitute to the reference 
system; pre-loaded data, necessary for vascular impedance estimation, 
may be one of the main limitations that made Vigileo measurements 
less accurate than the MostCare ones. On the contrary, MostCare, an 
uncalibrated totally independent system, was shown to properly 
estimate the vascular impedance in these hemodynamically stable 
patients. Further comparisons in unstable conditions are needed to 
confi  rm our observations.
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Table 1 (abstract P196)
Actual morbidity rate no pGDT (%)  10  20  30  40  50  60
Expected morbidity rate pGDT (%)  3.5 to 5.5  7 to 11  11 to 17  14 to 22  18 to 28  21 to 33
Expected cost reduction/US patient ($)  808 to 1,167  1,615 to 2,333  2,423 to 3,500  3,231 to 4,667  4,039 to 5,833  4,846 to 7,000
Expected cost reduction/CH patient ($)  1,550 to 2,239  3,100 to 4,478  4,478 to 6,545  6,200 to 8,956  7,578 to 11,023  9,300 to 13,434
Table 1 (abstract P197)
 Pearson  r2 Bias    LoA
COECHO vs. COVIG (T1)  0.31 (CI 0.24 to 1.63)  –0.49  –3.41 to 2.43
COECHO vs. COMC (T1)  0.71 (CI 0.56 to 1.08)  –0.055  –1.19 to 1.08
COECHO vs. COVIG (T2)  0.27 (CI 0.16 to 1.53)  –0.49  –3.24 to 2.34
COECHO vs. COMC (T2)  0.79 (CI 0.66 to 1.107)  –0.023  –0.94 to 0.9
CI, confi  dence interval; LoA, limits of agreement.
Figure 1 (abstract P197). Bland–Altman analysis (T1).
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Introduction  Pulse waveform characteristics (pulse wave transit 
time and augmentation index) are measures of arterial stiff  ness. 
Previous studies have found an association between severity of 
acute infl   ammatory states and increased arterial stiff  ness but it is 
not known whether non-invasive pulse waveform analysis could 
predict development of multiple organ failure in septic patients. The 
purpose of this study was to evaluate the photoplethysmographic 
brachial artery pulse wave transit time and augmentation index and 
their changes in response to induced forearm ischemia in septic ICU 
patients and correlate these indices to the development of subsequent 
end organ damage.
Methods  A prospective observational study in patients with sepsis 
within 24 hours of admission. Severity of sepsis was assessed with 
APACHE II score (median 18.5) and SOFA score (median 7.5). Three-
minute signal recording was done concurrently from the brachial 
artery at the elbow and the radial artery at the wrist with an originally 
designed photoplethysmograph at rest and after 5 minutes of induced 
forearm ischemia. Recordings were analyzed to obtain the pulse wave 
transit time and augmentation index at rest and 60  seconds after 
induced ischemia. The SOFA score was recalculated at 48 hours post 
recording.
Results We studied 14 consecutive general ICU patients. There was 
a negative linear relationship between the pulse wave transit time 
(median 22.6  ms) at rest and increase in SOFA score in 48  hours 
(P = 0.02, r = 0.96). The postischemic pulse wave transit time increased 
in all patients (median 25.7  ms) but no association was found 
between the proportion of increase and subsequent change in SOFA. 
Correlation between rest (median 7.6) and postischemic (median 7.2) 
augmentation index and 48-hour SOFA scores was not statistically 
signifi  cant (r = 0.57, P = 0.46).
Conclusion This study indicates that in early sepsis pulse waveform 
characteristics could predict the risk of developing end organ failure. 
The pulse wave transit time is more robust than the augmentation 
index and could be easier to use in patients with poor perfusion. 
Vascular reactivity indices do not seem to have predictive value in this 
context.
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Introduction  This study evaluated the potential of the NAVIGATOR 
(Applied Physiology) haemodynamic monitor to improve consistency 
of cardiovascular assessments amongst ICU members with diff  erent 
levels of expertise and experience.
Methods Patients (n = 20) post cardiac surgery were monitored by 
NAVIGATOR to display heart effi     ciency (Eh), mean systemic fi  lling 
pressure (Pms) and vascular resistance (SVR) against targets for 
mean arterial pressure and cardiac output set by the clinical team. 
Four categories of staff    participated: nine consultants (C), eight 
senior registrars (SR), nine registrars (R) and 11 nurses (N) (median 
ICU experience 15, 7, 2 and 10 years, respectively) and were asked 
to score Eh, Pms, and SVR ranging (discrete steps of one) from –5 
(grossly subnormal) to 0 (normal) to 5 (grossly supranormal) fi  rst 
without (BLIND) and then given (OPEN) access to the NAVIGATOR 
display. Recommendations for therapeutic interventions were noted. 
Agreement (maximum two steps deviation for each assessment 
between staff   ; number of patients), disagreement (median and 
interquartile range of steps) and therapeutic agreement (intervention/s 
to change Eh, Pms and SVR in similar direction/s, number of patients) 
were recorded and analysed for statistical diff  erence BLIND versus 
OPEN (Fisher’s exact test, Mann–Whitney test, P <0.05).
Results  Eh was commonly overestimated, Pms commonly under-
estimated with no clear trend for SVR. Agreement amongst all 
categories of staff   increased and disagreement score decreased for 
Eh, Pms and SVR (Table 1) comparing BLIND versus OPEN assessments. 
Agreement for therapeutic interventions also increased signifi  cantly 
from 4/20 (BLIND) to 18/20 patients (OPEN).
Table 1 (abstract P199)
 BLIND  OPEN
Eh  6/20, 2 (1 to 3)  17/20*, 1 (0 to 1)*
Pms  6/20, 2.5 (2 to 4)  17/20*, 2 (1 to 2)*
SVR  8/20, 2 (1 to 2)  16/20*, 1 (1 to 2)*
Patients (n/20) and score (median and IQR). *P <0.05.
Conclusion  The assessment of heart function, intravascular fi  lling 
and resistance state in postoperative cardiac patients was made 
signifi   cantly more consistent amongst diff  erent ICU staff   members 
using the NAVIGATOR haemodynamic monitor. Such enhanced 
consistency could potentially make the haemodynamic management 
more eff  ective with improved clinical outcomes.
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Introduction  In clinical practice, blood volumes (BV) are typically 
measured by thermodilution. Recently, contrast-enhanced ultrasound 
(CEUS) has been proposed as an alternative minimally invasive 
approach for BV assessment [1]. This method measures BV using a 
single peripheral injection of a small bolus of ultrasound contrast 
agent (UCA) detected by an ultrasound scanner. By measuring the 
acoustic backscatter, two indicator dilution curves (IDCs) can be 
derived from two diff  erent sites in the circulatory system. IDC analysis 
permits deriving the mean transit time (MTT) the bolus takes to travel 
between the injection site and two measurement sites. Assessment of 
the BV between these sites is obtained by multiplying the diff  erence 
in MTT (ΔMTT) by the blood fl  ow. In this study, we compare diff  erent 
volumes in an in vitro set-up by CEUS with true set-up volumes and 
thermodilution acquired volumes.
Methods The in vitro set-up consisted of a centrifugal pump, a network 
of tubes with variable volumes, an electromagnetic fl  owmeter  to 
measure and adjust the generated fl  ow, heating devices to maintain 
constant temperature (37°C), two thermistors for thermodilution 
measurement, an ultrasound transducer and a pressure stabilizer. A 
small bolus of UCA diluted in cold saline (1 mg SonoVue® in 20 ml saline 
at 4°C) was injected into the system. The cold UCA passage through a 
fi  rst and a second region of interest (ROI) was measured simultaneously 
with the ultrasound transducer and the thermistors. The measurements 
were performed at diff  erent fl  ows and volumes. BVs were estimated 
using the two diff  erent approaches, namely CEUS and thermodilution. 
The IDCs were processed and fi  tted separately with a dedicated model 
to estimate the ΔMTT of the cold UCA bolus between the two ROIs and 
the two thermistors. All the measurements were repeated three times.
Results A linear relation between BVs estimated by the two techniques 
was observed with a correlation coeffi     cient of 0.94. The bias of 
CEUS with respect to the true volumes was –40.1  ml; the bias of 
thermodilution was 84.3 ml. The most prominent diff  erences between 
the two techniques were observed in case of high volume and low fl  ow, 
possibly due to diff  erent transport kinetics between UCAs and heat.
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CEUS and thermodilution, CEUS is not inferior to thermodilution with 
the advantage of being minimally invasive.
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major trauma centre and impact on time to CT, fl  uid resuscitation 
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Introduction The use of cardiac output monitoring has been shown to 
be benefi  cial in the setting of perioperative medicine and critical illness 
[1,2]. More recently, its application in the setting of major trauma has 
been described [3]. Here, we describe our preliminary experience of 
embedding bioreactance fl  ow monitoring within the major trauma 
primary survey of severely injured patients and the subsequent eff  ect 
on patient management.
Methods Institutional ethical approval was obtained. Intubated major 
trauma patients were sequentially enrolled. Exclusions included major 
thoracic burns and children. Bioreactance fl  ow monitoring (NICOM; 
Cheetah) was applied at the same time as ECG leads and the calibration 
step performed during handover from the prehospital team. Time to 
availability of oxygen delivery data was recorded and trauma team 
members surveyed regarding for perceived benefi  ts and concerns from 
this monitoring. The infl  uence of fl  ow monitoring on fl  uid resuscitation, 
time to CT and defi  nitive disposal (to OR/ICU) was measured and 
compared with a control population matched for injury severity score, 
age and sex.
Results Cardiac index was available at mean 10.6 minutes (median 
9 minutes; SD 3.9), fl  uid responsiveness at mean 35.9 minutes (median 
35; SD 11.3) and oxygen delivery calculation at mean 25.3 minutes 
(median 25; SD 7.7). Passive leg raise was not performed in 63% of 
patients due to concerns about pelvic or brain injury. Volume of fl  uid 
infused (mean 738 vs. 925 ml; P = 0.124), time to CT (mean 57.4 vs. 
68.8 minutes; P = 0.08), and time to defi  nitive disposal (mean 124.9 vs. 
146.1 minute; P = 0.069) were all reduced in the fl  ow monitored group, 
although not signifi  cantly diff  erent when compared with a matched 
control group (Mann–Whitney U rank sum). Eighty-four percent of 
trauma team members surveyed felt the fl  ow monitoring data to be 
useful, and only 11% felt it may impair clinical management.
Conclusion Cardiac index, fl  uid responsiveness and oxygen delivery 
data can be obtained inform a primary survey. Rather than introducing 
delays, the use of fl  ow monitoring was associated with a trend towards 
decreased time to imaging; less fl  uid use pre-damage control point 
and reduced time to defi  nitive disposal. Further research is required to 
confi  rm benefi  ts and mechanism.
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Introduction  Pulse pressure variation (PPV) is a dynamic indicator 
of fl  uid responsiveness, which is known to have a low sensibility and 
specifi  city in patients ventilated in pressure support (PS) [1]. We aim 
to investigate patient–ventilator asynchrony as a potential source of 
hemodynamic interference in PS.
Methods We performed a prospective study including PS ventilated 
patients who met inclusion criteria for fl  uid depletion [1]. Patients who 
showed an asynchrony index (AI) exceeding 10% were included in the 
asynchrony group (AG). The remaining patients were included in the 
synchrony group (SG) [2]. Beat-to-beat hemodynamic variables were 
recorded through PRAM (Mostcare; Vytech Health srl, Padova, Italy). 
PPV cutoff   of 13% was used to identify fl  uid responders/nonresponders. 
A fl  uid challenge of 500  ml normal saline was given in 5  minutes. 
An increase of 15% of cardiac index after 10 minutes indicated fl  uid 
responsiveness.
Results So far, eights patients showed an AI >10% while 16 did not. 
Overall sensitivity was 28.6% versus 50% in SG; overall specifi  city was 
76.5% versus 91.7% in AG. Overall Cohen’s k was 33.3% versus 61.2% in 
AG (see Figure 1). However, because none of the responders in the AG 
group was detected by PPV, statistical analysis was not feasible within 
this subgroup.
Figure 1 (abstract P202).
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during PS seems to be more reliable in the patients with better patient–
ventilator synchrony.
References
1. Heenen  S,  et al.: Crit Care 2006, 10:R102.
2. Vitacca  M,  et al.: Chest 2004, 126:851-859.
P203
Comparison of pulse pressure variation with radial arterial systolic, 
diastolic and pulse transit time interval variation in pediatric 
patients undergoing liver transplantation
YJ Moon, IG Jun, WJ Shin, BH Sang, GS Hwang
Asan Medical Center, Seoul, South Korea
Critical Care 2013, 17(Suppl 2):P203 (doi: 10.1186/cc12141)
Introduction In pediatric patients, dynamic preload indices to predict 
fl  uid responsiveness have confl  icting results in comparison with adults. 
A recent study demonstrated that pulse pressure variation (PPV) ≥16% 
has provided an accurate method for predicting fl  uid responsiveness 
in pediatric congenital heart surgery. We aimed to compare PPV and 
respiratory systolic, diastolic and pulse transit time interval variation 
(STV, DTV and PTTV, respectively) as predictors of fl  uid responsiveness 
during pediatric liver transplantation.
Methods A total of 61 data from 16 pediatric patients, median age 5.4 years 
(range 0.1 to 9 years), were retrospectively evaluated from electrically 
recorded radial arterial and central venous pressure (CVP) waveform. The 
time from the onset of systolic upstroke to the dicrotic notch was defi  ned 
as the systolic time interval (STI), and the time from dicrotic notch to the 
beginning of systolic upstroke was defi  ned as the diastolic time interval 
(DTI). The time from peak R wave on electrocardiography to the onset of 
systolic upstroke was defi  ned as the pulse transit time (PTT) interval. STV 
was calculated by averaging of three consecutive respiratory cycles with 
the following: (STImaximum – STIminimum) / STImean. The same method was used 
for calculating DTV, PTTV and PPV. STV, DTV and PTTV were corrected 
by cardiac period. Averaged CVP was used as a static preload index. PPV 
threshold ≥16% was used to discriminate fl  uid responsiveness. Receiver 
operating characteristic (ROC) curves and Pearson’s correlation analysis 
were used for the comparison.
Results PPV showed correlations with STV, DTV and PTTV (r = 0.65, 
0.57 and 0.60, respectively), but less with CVP (r = –0.30). Area under 
ROC curves (AUC) of STV, DTV, PTTV and CVP were 0.834, 0.872, 0.832 
and 0.613, respectively. Cutoff   values of STV, DTV, PTTV and CVP were 
7.7% (sensitivity/specifi   city, 0.80/0.83), 7.7% (sensitivity/specifi  city, 
0.70/0.88), 8.7% (sensitivity/specifi  city 0.67/1.0) and 3.1% (sensitivity/
specifi  city 0.50/0.85), respectively.
Conclusion This study shows that STV, DTV and PTTV can be used as 
a surrogate for PPV ≥16%, suggesting that this novel method can be 
used to predict hemodynamic response during pediatric surgery.
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Introduction  The mini-fl  uid challenge is a widely used strategy to 
manage fl  uid loading in the ICU and OR. Although it might be a rational 
strategy, data on the mini-fl  uid challenge and its reliability are very 
limited. We investigated the value of changes in pulse contour cardiac 
output as a result of a mini-fl  uid challenge of 50 and 100 ml to predict 
fl  uid loading responsiveness.
Methods We measured the eff  ects after the administration of 50, 100 
and 500 ml bolus colloid infusions on CO (Modelfl  ow (COm) and LiDCO 
(COli)), CVP and MAP in 21 patients on mechanical ventilation after 
elective cardiothoracic surgery. From the data we analysed the smallest 
volume that was predictive for the eff  ects of 500 ml on cardiac output.
Results COli and COm increased after 50, 100 and 500 ml fl  uid loading. 
Best results are observed for changes in COm after 100 ml fl  uid loading 
(area under the ROC 0.86, 95% CI between 0.65 and 1.00). A change in 
Modelfl  ow CO of at least 4.3% has a sensitivity of 67% and a specifi  city 
of 100% after 100 ml fl  uid loading. Sensitivity is 60% and specifi  city 
83% for a similar cutoff   in CO measured with the LiDCO device after 
100 ml fl  uid loading. In our patient population, MAP and COli did not 
predict responsiveness with more accuracy than mathematical chance. 
See Figure 1.
Conclusion Changes in pulse contour CO can be used in a mini-fl  uid 
challenge to assess fl  uid responsiveness in our postcardiac surgery 
patients.
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Introduction The objective is to compare stay in surgery monitored 
with oesophageal Doppler with unmonitored.
Methods A randomized trial. We present preliminary results obtained 
in the fi   rst 55 cases. The surgeries were general and urological. 
ISRCTN93543537.
Results There were no diff  erences in any of the baseline variables. A 
total of 69.1% were men. The mean age was 65.80 years. There were 
63.6% general surgery and 36.4% urologic surgery. There were 81.5% 
open surgeries and 18.5% laparoscopic. The results were favorable to 
the intervention group for most outcomes; these diff  erences did not 
Figure 1 (abstract P204). Cardiac function curve: a fl  uid challenge of 50 ml in a (non)responder.
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postoperative stay of 3.4 days. Only complications results were against 
the intervention.
Conclusion The preliminary results obtained for the postsurgical length 
of stay, as for most of the outcomes, were favorable to monitoring by 
oesophageal Doppler.
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Introduction Fluid responsiveness is defi  ned based on an arbitrary 
increase of cardiac output (CO) or stroke volume (SV) of 10 to 15%. We 
hypothesise that the variation of heart effi   ciency (Eh) and the slope 
(S) defi  ned by the relative increase of CO over the relative increase of 
mean fi  lling pressure (Pmsa) can be used as alternative defi  nitions of 
fl  uid responsiveness.
Methods Patients admitted to the ICU were monitored with a calibrated 
LiDCOplus (LiDCO, UK) and Navigator (Applied Physiology, Australia) to 
estimate Pmsa and Eh (Pmsa – central venous pressure/Pmsa). A 250 ml 
fl  uid challenge was performed over 5 minutes. Categorical data were 
compared by Pearson chi-square test. Correlation was assessed by 
Kappa test. The infl  exion point of S to defi  ne responders was obtained 
by ROC curve analysis.
Results A total of 104 fl  uid challenges were observed in 40 patients. ROC 
curve analysis reveals an area under the curve of 0.93 (95% CI = 0.85 
to 1, P <0.001). The best cutoff   for the slope was 0.76 (sensitivity 0.92, 
specifi  city 0.93). The proportions of responders identifi  ed by the ΔEh 
(Table 1) and by the slope method (Table 2) are smaller compared with 
the relative increase of SV method. Signifi  cant correlation was found 
between both methods and the ΔSV (ΔEh κ = 0.54, P <0.001; S κ = 0.55, 
P <0.001). See Figure 1.
Conclusion  Moderate agreement is observed between new and 
current defi  nitions of fl  uid responsiveness.
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Introduction Fluid overload is associated with poor outcome in the 
critically ill. Thus, an accurate predictor of a positive haemodynamic 
response (increase in stroke volume) to fl  uid challenge is vital.
Methods We studied the predictive value (positive response defi  ned 
as change in stroke volume >15% after 10 ml/kg fl  uid bolus) of a range 
of haemodynamic variables: static (CVP, active circulating volume, 
central blood volume, total end diastolic volume), dynamic (systolic 
pressure variation, stroke volume variation) and contactility (dp/dt), 
in a group of 100 ventilated children (median weight 10 kg). Variables 
were measured using transpulmonary ultrasound dilution and PRAM 
(an arterial pulse contour method).
Results We performed 168 paired measurements (pre-fl  uid and post-
fl  uid challenge), with a SV response rate of 45%. Overall predictive 
values were poor, but slightly better for static versus dynamic variables 
(Table 1). When SV response was analysed as a continuous variable, 
the two predictive multivariable variables were change in TEDVI and 
baseline dp/dt (r2 = 0.30, both P <0.001).
Table 1 (abstract P207). ROC areas for haemodynamic variables
 AUC 95%  CI
CVP 0.50  0.41  0.59
ACVI 0.62  0.54  0.71
CBVI 0.59  0.50  0.68
TEDVI 0.65  0.56  0.73
SPV 0.59  0.50  0.69
SVV 0.48  0.39  0.58
dp/dt 0.59  0.50  0.68
Conclusion  The predictive ability for typical static and dynamic 
haemodynamic variables, when taken in isolation, is poor. However, 
improved prediction is seen when baseline contractility is taken into 
account.
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Introduction This study compared the eff  ect of pulse pressure variation 
(PPV) and cardiac index (CI)-guided fl  uid therapy versus mean arterial 
Figure 1 (abstract P206).
Table 1 (abstract P205). Analysis of the outcome variables
   ODM  Control
Outcome Units  (n = 32)  (n = 23)  P value
Surgery time  Minutes  206.20  225.59  0.532
Total  stay  Days 13.92 18.19 0.292
Postsurgery    Days 10.93 14.36 0.280
Time to enteral  Days  2.73  3.13  0.567
Time to deambulation  Days  2.52  3.00  0.359
Complications %  34.4  21.7  0.377
Table 1 (abstract P206). Distribution of events according to ΔSV and ΔEh
  Response by ΔSV ≥10%  Response by ΔEh ≥0  P value
Nonresponder  62 (59.6%)  76 (73.1%)  <0.001
Responder   42 (40.4%)  28 (26.9%)  <0.001
Table 2 (abstract P206). Distribution of events according to ΔSV and the 
slope (S)
  Response by ΔSV ≥10%  Response by S ≥0.76   P value
Nonresponder  62 (59.6%)  75 (72.1%)  <0.001
Responder   42 (40.4%)  29 (27.9%)  <0.001
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patients undergoing abdominal surgery.
Methods  Patients undergoing elective abdominal surgery were 
randomized into a PPV/CI-guided group (n = 11) or a MAP-guided 
(n = 12) group. PPV, CI and MAP were measured using the non-invasive 
fi  nger arterial blood pressure measurement device ccNexfi  n (Edwards 
Lifesciences BMEYE, Amsterdam, the Netherlands). Tidal volumes were 
≥8  ml/kg with PEEP ≥8  mmHg. In both groups, MAP of 70  mmHg 
was maintained. In the PPV/CI group, an intraoperative algorithm 
was used keeping the PPV under 12% and CI above 2.5  l/minute/
m2 using fl  uid therapy and dobutamine and noradrenaline infusion, 
respectively. Sublingual microvascular perfusion was measured after 
anesthesia induction, and every subsequent hour using sidestream 
dark-fi  eld imaging (Microscan; Microvision Medical, Amsterdam, the 
Netherlands). The perfused small vessel density (PVD) values were 
offl   ine quantifi  ed.
Results The fi  rst hour during surgery, the PPV/CI-guided group tended 
to receive more fl  uids than the MAP-guided group (1,014 ± 501ml vs. 
629 ± 463 ml; P = 0.07). At this time point, the PVD was slightly lower in 
the PPV/CI-guided group (16.7 ± 3.1 mm/mm2) when compared with 
the MAP-guided group (17.9 ± 3.9 mm/mm2; P = 0.41). In both groups 
the PVD remained stable during the fi  rst 2 hours of surgery. However, 
2 hours after the start of surgery, the PVD in the PPV/CI group restored 
and tended to be higher than in the MAP-guided group (21.1 ± 1.9 vs. 
18.1 ± 3.4 mm/mm2; P = 0.09). After 1 hour of surgery, the administered 
fl  uid volume correlated inversely with PVD (r = –0.59, P = 0.011).
Conclusion  Goal-directed fl   uid management resulted in a higher 
administered fl  uid volume in the beginning of surgery, and this was 
associated with a slightly reduced microcirculatory perfusion when 
compared with MAP-guided fl   uid management. Microcirculatory 
perfusion tended to improve as surgery progressed in the goal-directed 
fl  uid therapy group. Our fi  ndings suggest that goal-directed and MAP-
guided fl   uid management are associated with distinct patterns in 
fl  uid resuscitation, which may be of consequence for microvascular 
perfusion.
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Introduction  Sidestream dark-fi   eld (SDF) imaging was introduced 
recently to study the sublingual microcirculation in humans. Patients 
with ileostomies off  er a unique access to the intestinal microcirculation. 
To date, no reference ranges for standard microcirculatory parameters 
of the gut are available. Therefore, the aim of our study was to 
establish a database for postoperative microcirculatory parameters for 
ileostomies.
Methods For this observational prospective cohort study 77 patients 
were screened. In total, 165 SDF measurements could be obtained. All 
patients included had bowel surgery for chronic infl  ammatory bowel 
disease or intestinal malignancies and received an ileostomy. Patients 
were excluded if they had signs of local infection or bleeding, or if they 
were admitted to the ICU for sepsis or perioperative complications. The 
SDF device was gently inserted into the stoma at a depth of 3 to 4 cm, and 
fi  ve real-time images were recorded. All videos recorded were analyzed 
offl     ine using AVA® software (Microvision Medical, Amsterdam, the 
Netherlands). The following parameters were quantifi  ed: microvascular 
fl  ow index (MFI), total vessel density (TVD), perfused vessel density 
(PVD), and proportion of perfused vessels (PPV). Patients were followed 
for 3 days post surgery with fi  ve images captured every day.
Results We were able to capture clear images of the small intestine 
microvasculature. Distinct villi were visible with a dense network 
of microvessels (diameter: 6 to 17 μm). Mean TVD (± 2SD) was 19.3 
(± 1.0) mm/mm2, PVD: 18.5 (± 1.1) mm/mm2, PPV: 94.5 (± 5)% and 
MFI: 2.8 (± 0.1). Patients’ age, sex and comorbidity had no signifi  cant 
impact on postoperative microvascular parameters. No signifi  cant 
changes of the microvascular parameters were observed during the 
fi  rst 3 postoperative days.
Conclusion SDF imaging is a feasible, non-invasive bedside method 
to study the postoperative intestinal microcirculation. The established 
reference ranges are useful for early detection of postoperative local 
complications and studies of microcirculatory changes induced by 
systemic pathologies; for example, in sepsis.
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Introduction  Tissue capnometry has been used to assess organ 
perfusion but it is not generally available at the bedside [1,2]. Our aim 
was to test a new sublingual capillary tonometer in haemorrhagic 
shock.
Methods Thirty-six mini-pigs were anaesthetised, ventilated and divided 
into sham operated and shock groups. Instrumentation included: 
intestinal and sublingual tonometry, haemodynamic monitoring 
(PiCCO; Pulsion, Germany) and orthogonal polarization spectroscopy 
(OPS). After baseline measurements (T0) haemorrhagic shock was 
induced and maintained by reducing mean arterial pressure (MAP) 
to ~40  mmHg for 60  minutes. Measurements were repeated every 
30 minutes (T1 to T6). Fluid resuscitation started after T2 aiming to 
increase MAP to 75% of the baseline value. OPS imaging was performed 
at T0, T2 and T6. Data are presented as the median (interquartile 
range), for statistical analysis Friedmann ANOVA, Mann–Whitney and 
Spearman tests were used as appropriate.
Results Bleeding resulted in a signifi  cant decrease in MAP and cardiac 
index, and an increase in heart rate. Macrohaemodynamic changes 
were accompanied by signifi  cant changes in red blood cell velocity 
(RBCV) and a signifi   cant increase in the intestinal and sublingual 
mucosal-to-arterial carbon dioxide partial pressure diff  erence (PCO2 
gap): from 4 (2 to 11) to 30 (23 to 37) mmHg in the sublingual, and from 
25 (17 to 31) to 50 (33 to 64) mmHg in the ileum. RBCV decreased from 
1,075 (945 to 1,139) to 520 (449 to 621) μm/second in the sublingual 
area, and from 646 (596 to 712) to 419 (350 to 451) μm/second in the 
ileum. There was signifi  cant correlation between RBCV and PCO2 gap in 
sublingual and intestinal regions alike: r = –0.58; r = –0.71, P <0.0001, 
respectively.
Conclusion  In this model of haemorrhagic shock, sublingual PCO2 
gap showed good correlation with RBCV, suggesting that this new 
sublingual capillary tonometer may be an appropriate tool for 
monitoring microcirculation at the bedside.
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Introduction  Microvascular alterations play an important role in 
development of organ failure [1]. It is not known whether increased 
intra-abdominal pressure (IAP) is associated with microcirculatory 
perfusion derangements. Our hypothesis was that transiently 
increased IAP is related to microcirculatory alterations in laparoscopic 
cholecystectomy patients.
Methods  Sixteen patients (14 female, two male) who underwent 
laparoscopic cholecystectomy were studied. Sublingual orthogonal 
polarization spectral (OPS) imaging was used to detect microcirculatory 
function. OPS was done before surgery, at least 15  minutes after 
initiation of pneumoperitoneum and 1 hour after the end of pneumo-
peritoneum. The microcirculation cutoff   value for vessels was 20 μm. 
Data are presented as medians with interquartile ranges.
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BMI 29.7 (24.9 to 34.7), haemoglobin concentration 138 (133 to 142) g/l, 
and hematocrit 42 (39 to 43). IAP was held at 12.5 (12 to 13) mmHg, 
median duration of pneumoperitoneum was 45 (24 to 55) minutes. 
Median MAP was 86 (69 to 93), abdominal perfusion pressure (APP) 
73 (57 to 81)  mmHg during the pneumoperitoneum. Median fl  uid 
administration during anesthesia was 1,050 (1,000 to 1,400)  ml. 
Altogether 448 microcirculation videos were taken. Interobserver 
variability was 24%. The following microcirculatory parameter values 
describe before, during and after pneumoperitoneum periods. Total 
vascular density was 19.4 (17.0 to 21.1); 18.5 (17.0 to 20.9); 19.3 (16.9 to 
20.9) n/mm2. Perfused vessels density was 13.3 (10.9 to 15.2); 13.8 (8.9 
to 18.0); 13.1 (11.0 to 16.0) n/mm2. Proportion of perfused vessels (PPV) 
was 61 (50 to 69); 64 (45 to 76); 60 (54 to 67)%. Microvascular fl  ow index 
was 2.4 (2.0 to 2.5); 2.5 (2.0 to 3.0); 2.3 (2.0 to 2.9) and heterogeneity 
index was 0.8 (0 to 0.9); 0.6 (0 to 1.0); 0.6 (0 to 0.8). No signifi  cant 
diff  erences in microcirculatory parameters were observed between 
time points. PPV was somewhat less than that of described in healthy 
volunteers (61% vs. 90%) [2].
Conclusion  Microcirculatory alterations are mild during transient 
increase of intra-abdominal pressure in laparoscopic surgery patients.
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Introduction  Previous studies demonstrate that loss of glycocalyx 
integrity is associated with impaired microvascular function. We 
investigated whether glycocalyx dimensions are reduced in patients 
undergoing cardiac surgery with or without cardiopulmonary bypass 
(CPB), and are paralleled by loss of microcirculatory perfusion using in 
vivo microcirculation measurements.
Methods  Patients undergoing on-pump surgery with nonpulsatile 
(n = 11) or pulsatile (n = 13) CPB or off  -pump surgery (n = 13) underwent 
sublingual sidestream dark-fi  eld imaging at baseline, during coronary 
grafting and upon ICU admission to assess perfused microvascular 
vessel density. Glycocalyx integrity was evaluated using the GlycoCheck 
Measurement Software, and expressed as the perfused boundary 
region (PBR). An increase in PBR represents deeper penetration of 
erythrocytes into the glycocalyx, and is indicative for compromised 
glycocalyx thickness.
Results  The perfused vessel density remained stable during off  -
pump surgery, while the PBR decreased from 2.6 ± 0.1 μm (baseline) 
to 2.3  ±  0.1  μm (ICU). Nonpulsatile CPB was associated with loss 
of microcirculatory perfusion during bypass (15.1  ±  2.7  mm/mm2) 
and ICU admission (15.3  ±  2.6  mm/mm2) compared with baseline 
(19.8  ±  2.8  mm/mm2). Pulsatile CPB reduced the perfused vessel 
density from 20.9 ± 2.4 to 16.7 ± 2.6 mm/mm2, but this was restored 
towards baseline levels upon ICU admission (20.3  ±  2.3  mm/mm2; 
P = 0.02 between groups). The PBR increased upon initiation of CPB 
in both groups, but remained elevated in the nonpulsatile fl  ow group 
only. In the pulsatile group, the PBR started at 2.4 ± 0.1 μm, increased 
to 2.7 ± 0.1 μm during bypass but restored already during CPB towards 
a PBR value of 2.3 ± 0.1 μm (ICU). The PBR and perfused vessel density 
showed a good correlation (r = –0.65; P = 0.002), demonstrating loss of 
perfused vascular density when the glycocalyx is damaged.
Conclusion  The glycocalyx is damaged after initiation of CPB, and 
restoration is impaired after exposure to nonpulsatile fl  ow during the 
use of the heart–lung machine. A reduction in glycocalyx thickness, 
represented by an increased PBR, correlates with impairment of 
perfused microvascular vessel density. Our data support the use 
of intraoperative PBR monitoring as a novel clinical indicator of 
microcirculatory perfusion.
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Introduction Cold exposure can be adapted for exercise or therapeutic 
purposes, but its impact on microcirculation in healthy humans has not 
been well defi  ned. We hypothesize that whole body cold stress may 
impair microcirculation.
Methods Seven volunteers were recruited for the water immersion 
procedure. During the cooling protocol the volunteers every 
20 minutes of immersion were asked to step out from the bath and 
rest for 10 minutes in a room environment and then return to the 
water bath for the next 20  minutes of immersion. This head-out 
immersion procedure in bath water at 14°C continued until the rectal 
temperature was dropped to 35.5°C or the time of 180 minutes was 
terminated. Maximum cold water immersion time was 120 minutes. 
Before, at the end of whole body cooling and 1 hour after cooling was 
ended, systemic hemodynamics and direct in vivo observation of the 
sublingual microcirculation were obtained with sidestream dark-fi  eld 
imaging. Assessment of microcirculatory parameters of convective 
oxygen transport (microvascular fl   ow index (MFI), proportion of 
perfused vessels (PPV)), and diff  usion distance (perfused vessel density 
(PVD) and total vessel density (TVD)) was done using a semiquantitative 
method.
Results During cooling and 1 hour after cooling was ended, a signifi  cant 
increase in cardiac output (P = 0.028 and P = 0.043) was observed, 
but there were no changes in heart rate or mean arterial pressure in 
comparison with baseline variables. There were no signifi  cant changes 
in PPV, MFI, PVD and TVD of small vessels in comparison with baseline 
variables during all observational time.
Conclusion  Defined cold exposure had no effect on the micro-
circulation.
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Introduction  Vasodilation and increased skin blood fl  ow  (also 
sweating) are infl  uential in heat dissipation during heat exposure and 
exercise. It is unclear how heat stress infl  uences microcirculation. Side 
dark-fi  eld imaging visualizes the blood fl  ow at the capillary level and 
helps to assess perfusion heterogeneity. Clinical and experimental 
data show that the sublingual region is clinically relevant for 
detecting microcirculatory alterations and more represents central 
microcirculation than cutaneous perfusion. We hypothesize that whole 
body heat stress may increase capillary density.
Methods Eight healthy men with no history of cold and/or heat injury 
were recruited to this study. Passive body heating was performed by 
continuous immersion up to the waist in the water bath at 44°C and 
continued until rectal temperature reached 39.5°C. Before, at the end 
of whole body heating and 1 hour after heating was ended, systemic 
hemodynamics and direct in vivo observation of the sublingual 
microcirculation were obtained with sidestream dark-fi  eld imaging. 
Assessment of microcirculatory parameters of convective oxygen 
transport (microvascular fl   ow index (MFI), proportion of perfused 
vessels (PPV)), and diff  usion distance (perfused vessel density (PVD) 
and total vessel density (TVD)) was done using a semiquantitative 
method. Vessels were separated into large (mostly venules) and small 
(mostly capillaries) using a diameter cutoff   value of 20 μm.
Results Whole body heating resulted in signifi  cantly increased heart 
rate (P = 0.012) and cardiac output (P = 0.046) in comparison with 
baseline variables. One hour after heating was ended, the heart rate 
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values. During all observational time the mean arterial pressure remain 
unaltered. There was no signifi  cant diff  erence in MFI and PPV of small 
vessels at the end of heating and 1 hour after heating in comparison 
with baseline variables. One hour after heating we observed signifi  cant 
increase in PVD (P  =  0.046) and TVD (P  =  0.028) of small vessels 
regardless of lack of diff  erence at the end of heating (P = 0.753 and 
P = 0.075, respectively) in comparison with baseline variables.
Conclusion Whole body heating induced time-dependent changes in 
capillary density.
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Introduction  Sidestream dark-fi   eld (SDF) imaging is an important 
new technology that has been used to demonstrate microcirculatory 
abnormalities in a variety of critical illnesses [1]. The microcirculation 
is also aff  ected by age and chronic comorbidities. However, the eff  ect 
of these conditions on SDF microcirculatory parameters has not been 
well described.
Methods Sublingual SDF images were obtained from fi  ve groups of 
20 participants: healthy volunteers under 25 years, healthy volunteers 
over 55 years, and stable patients over 55 years with one of diabetes 
mellitus (DM), cirrhosis and stage  5 chronic kidney disease (CKD). 
Microcirculatory parameters [1] between the groups were then com-
pared for signifi   cance using ANOVA for parametric data and the 
Kruskal–Wallis test for nonparametric data. This was approved by the 
local ethics committee.
Results All DM patients were type 2, with mean glycated haemoglobin 
(HbA1c) of 8.8% (SD 1.7%). Seventeen cirrhotic patients were Child–
Pugh–Turcotte score A and one was score B. For CKD, the mean 
estimated glomerular fi   ltration rate was 11.5  ml/minute (SD 2.9). 
Median microvascular fl  ow index (MFI) was 2.85 (IQR 2.75 to 3.0) for 
participants aged <25, 2.81 (2.66 to 2.97) for those aged >55, 2.88 (2.75 
to 3.0) for those with DM, 3.0 (2.83 to 3.0) for those with cirrhosis and 
3.0 (2.78 to 3.0) for those with CKD (P for diff  erence = 0.14). There were 
no signifi  cant diff  erences in the proportion of perfused vessels and 
perfused vessel density between the groups. See Figure 1.
Conclusion Older age, diabetes, and chronic kidney and liver disease 
need not be considered confounding factors for comparison of SDF 
microcirculatory parameters in the critically ill.
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Introduction Serial measurements of lactate over time may be a better 
prognosticator than a single lactate concentration [1]. Early lactate-
guided therapy also reduces ICU length of stay and ICU and hospital 
mortality [2]. This study aims to assess the prognostic value of the 
lactate clearance (LC) in the fi  rst 24 hours in surgical patients.
Methods In a prospective cohort during 1 year, we followed consecu-
tively enrolled patients admitted immediately postoperative to the 
surgical ICU of Hospital Santa Luzia, Brasília, Brazil. Patients were 
assigned to two groups: LC >10% and LC ≤10%. The primary outcome 
measure was mortality at 7 and 28  days. The secondary outcome 
included hospital and ICU length of stay (LOS).
Results A total of 417 patients were followed. In total, 50.4% were 
male and 83% underwent elective surgery. The mean age was 59 ± 16, 
APACHE II score 8 ± 5, SAPS 2 26 ± 11. The mortality at 7 days was 0.95% 
(n = 4) and the mortality at 28 days was 2.15% (n = 9), respectively. 
Hospital mortality was 4.79% (n = 20). Sixty-one percent (n = 255) of 
the patients had LC >10% versus 39% (n = 162) with LC ≤10%. Those 
who had LC ≤10% were older (62 ± 16 vs. 57 ± 17, P = 0.00) and had 
greater APACHE II score (9 ± 6 vs. 7 ± 4, P = 0.00) and SAPS 2 (28 ± 12 
vs. 25 ± 10, P = 0.02). There was no diff  erence in ICU LOS (5 ± 12 vs. 
4 ± 9 days, P = 0.54) and hospital LOS (10 ± 15 vs. 9 ± 11 days, P = 0.48). 
Initial lactate levels were lower in the group with LC ≤10% (1.1 ± 0.9 
vs. 1.9 ± 1.6, P = 0.00); however, mean lactate was higher in 24 hours 
(2.0 ± 1.8 vs. 1.0 ± 0.7, P = 0.00). All of the patients who died in the 
fi  rst 7 days had LC ≤10% (2.46%, n = 4, P = 0.02); this group also had a 
higher mortality at 28 days (4.32%, n = 7 vs. 0.78%, n = 2; P = 0.03). The 
relative risk for mortality LC ≤10% in 7 and 28 days was 1.02 (95% CI: 
1.00 to 1.05) and 5.07 (95% CI: 1.17 to 27.09), respectively. Signifi  cant 
diff  erence was observed in the Kaplan–Meier survival curves for 7 and 
28 days (P = 0.01 and 0.02, respectively). The sensibility of LC ≤10% was 
100% (95% CI: 51 to 100%) for 7-day mortality and 78% (95% CI: 45 to 
94%) for 28-day mortality. The specifi  city was 62% (95% CI: 57 to 66%) 
for 7-day mortality and 62% (95% CI: 57 to 66%) for 28-day mortality.
Conclusion Despite initial lactate levels, lactate clearance ≤10% proved 
to be a good predictor of mortality in 7 and 28 days in surgical patients 
admitted in the postoperative period to the ICU.
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Introduction The use of peripheral perfusion objective parameters to 
anticipate successful resuscitation in septic shock has been recently 
investigated [1]. The mottling score, a perfusion parameter used for 
decades, has been proposed to correlate with septic shock survival [2], 
and was tested in this study as a clinical tool in predicting mortality.
Methods  A prospective observational study was conducted, with 
patients consecutively admitted to a tertiary hospital ICU in Brasília, 
Brazil. From July 2011 to May 2012, all patients diagnosed with septic 
shock were enrolled. Demographic data, diagnoses, shock origin and 
severity scores were recorded. After initial resuscitation, the score 
was registered in the fi  rst 3 days by the same observer, considering 
the score on the lower limb without an arterial catheter, or the worst 
between the lower limbs, and the worst in the 3 days. Exclusion criteria 
were terminal illness with no intervention decision and incomplete 
Figure 1 (abstract P215).
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2 and 3) and Group 3 (scores 4 and 5) to compare mortality. Statistical 
analysis was made using the chi-square test.
Results One hundred and seventeen patients were analyzed; 20 were 
excluded (18 terminal illness, two with incomplete data). Ninety-seven 
patients were included; the mean age was 72.8 years, mean SAPS II 
score was 46.8 (SD ± 15.7), mean APACHE II score was 19.2 (SD ± 8.1); 
mean norepinephrine dose was 1.25 μg/kg/minute; mean length of 
stay in ICU was 19.2 days (1 to 176); mottling score distribution was: 
score 0: 41 patients; score 1: 33 patients; score 2: 14 patients; score 3: 
two patients; score 4: three patients; score 5: four patients. The sepsis 
origin was as follows: 65, pulmonary (67%); 18, abdominal (18.5%); 
nine, urinary (9.5%); two, osseous (2%); one, mediastinal; one, skin and 
soft tissue; and one, central nervous system (1% each). Comparing 
the mortality in Groups 1, 2 and 3, we found a signifi  cant diff  erence 
(P = 0.042), even greater when considering 28-day mortality (P = 0.004). 
The Kaplan–Meier survival method showed P = 0.000.
Conclusion The mottling score was an objective reproducible system 
to bedside use and a good predictor of septic shock mortality.
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Introduction  This study aimed to compare the cerebral eff  ects of 
terlipressin (TERLI) with conventional prehospital fl  uid resuscitation 
with lactated Ringer’s solution (LR) in a model of haemorrhagic shock 
(HS).
Methods Pigs (20 to 30 kg) were randomized into one of the groups: 
Sham (n = 2), HS (n = 9), LR (3× volume bled; n = 9) or TERLI (2 mg bolus; 
n = 9). HS induced to target MAP of 40 mmHg was maintained for 
30 minutes. Brain tissue oxygen pressure (PbtO2), intracranial pressure 
(ICP), cerebral perfusion pressure (CPP), haemodynamics and blood gas 
analyses were assessed prior to HS (baseline) up to 120 minutes after 
treatment. Tissue markers of brain oedema (aquaporin-4 (AQP4) and 
Na–K–Cl cotransporter-1 (NKCC1)), apoptosis (pre-apoptotic protein 
(Bax)) and oxidative stress (thiobarbituric acid reactive substances 
(TBARS)) were also measured.
Results  Sham animals had no signifi   cant changes in the variables 
assessed. HS resulted in a signifi  cant decrease in CPP (mean varied 
from 36 to 39 mmHg), PbtO2 (from 23.6 to 26.6 mmHg), ICP (from 1 
to 2 mmHg) and haemodynamics (MAP from 38 to 40 mmHg; CI from 
1.8 to 2.1 l/minute/m2), and a signifi  cant increase in blood lactate (from 
6.7 to 8.9 mmol/l) and cerebral AQP4 (mean ± SE; 167 ± 54% of sham), 
NKCC1 (237 ± 47% of sham), Bax (167 ± 44% of sham) and TBARS. Fluid 
resuscitation was followed by an increase in ICP (from 7 to 9 mmHg) and 
a decrease in CPP (from 41 to 52 mmHg), with an increased expression 
of cerebral AQP4 (210 ± 56% of sham), NKCC1 (163 ± 32% of sham) and 
Bax (137 ± 24% of sham). Only TERLI restored baseline values of CPP 
(from 54 to 61 mmHg) and did not change the cerebral expression of 
AQP4 (100 ± 6% of sham), NKCC1 (100 ± 1% of sham), Bax (102 ± 6% of 
sham) and TBARS. Both TERLI and LR recovered baseline levels of PbtO2 
(TERLI from 30.0 to 34.2 mmHg; LR from 29.4 to 40.7 mmHg) and MAP 
(TERLI from 53 to 64 mmHg; LR: 48 to 61 mmHg). Blood lactate levels 
were not recovered in any group (TERLI from 5.7 to 8.1 mmol/l; LR from 
4.5 to 7.7 mmol/l).
Conclusion  TERLI recovered cerebral perfusion and oxygenation 
with no signifi  cant changes in ICP and cerebral markers of oedema, 
apoptosis and oxidative stress. LR did not recover CPP probably due to 
a signifi  cant increase in ICP caused by brain oedema, which may have 
contributed to the cerebral apoptosis. None of the treatments caused 
cerebral oxidative stress.
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Introduction The shock index (SI) is an easy-to-use clinical tool that 
rapidly identifi  es patients at risk of haemodynamic decompensation. 
Previous studies focused primarily on patients suff  ering  from 
pneumonia, pulmonary embolism, ruptured ectopic pregnancy and 
traumatic haemorrhagic shock. Modifi  ed SIs have also been studied. 
Could the SI be accurate in patients suff  ering from gastrointestinal (GI) 
haemorrhage? The aim of this study was to compare the performance 
of the SI with various modifi  ed SIs and conventional vital signs in 
predicting 30-day mortality in a population of patients with a GI 
haemorrhage.
Methods  A single-center post-hoc analysis was conducted of 
prospectively collected data from patients diagnosed with a GI 
haemorrhage episode in an academic emergency department (ED) 
from March 2008 to December 2011. Data were extracted from two 
databases used at our ED. The SI (pulse/systolic blood pressure) and 
nine modifi  ed SIs were calculated from the available fi  rst documented 
vital signs. ROC curves were used to determine sensitivity and 
specifi  city of the diff  erent SIs in predicting 30-day mortality.
Results Of the 770 patients included in the analysis, 52 died within 
30  days. The standard SI at a cutoff   point of 0.7 had the highest 
predictability and sensitivity of 30-day mortality (area under the curve 
(AUC) = 0.7, sensitivity = 0.79, specifi  city = 0.56). In comparison, one 
of the modifi  ed SIs (pulse/diastolic blood pressure) had 0.65 sensitivity 
and 0.71 specifi  city (AUC = 0.73). A heart rate >100 bpm predicted 30-
day mortality with 0.40 sensitivity and 0.82 specifi  city (AUC = 0.63).
Conclusion  To our knowledge, this is the fi   rst study to examine 
the relationship between the SI and mortality in patients with a 
GI haemorrhage. It appears that the standard SI, when compared 
with various modifi   ed SIs and conventional vital signs, had the 
highest combined predictability and sensitivity of 30-day mortality 
in a population of patients suff  ering from GI haemorrhage. Further 
prospective studies are needed to confi  rm these fi  ndings.
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Introduction Shock induces mitochondrial damage, which can lead 
to tissue injury and infl   ammation. Resuscitative adjuncts to limit 
mitochondrial injury may be eff  ective to reduce tissue injury and 
protect against the sequelae of hemorrhagic shock (HS). Others and we 
have demonstrated the protective eff  ects of inhaled carbon monoxide 
(CO) or nebulized sodium nitrite (NaNO2) in models of HS. Our aim was 
to test the hypothesis that CO and NaNO2 protect against hemorrhagic 
shock-induced tissue injury/infl  ammation by limiting mitochondrial 
damage and preventing bioenergetic failure.
Methods Twenty anesthetized female Yorkshire pigs were subjected 
to severe hemorrhage until unable to compensate or 90 minutes, and 
were then resuscitated with volume/pressors. Muscle and platelet 
samples were obtained at baseline (BL) and 2 hours after resuscitation 
(EndObs). Animals were randomized to: standard of care (HSR, n = 5); 
HSR+CO (CO; 250 ppm×30 minutes, n = 6); or HSR+NaNO2 (NaNO2; 
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initiated ~30 minutes before resuscitation. Primary endpoints were 
changes in muscle and platelet mitochondrial respiration between 
BL and EndObs, quantifi  ed by muscle respiratory control ratio (RCR, 
traditional respirometry), and by the change in proton-leak respiration 
(PLR) and mitochondrial reserve capacity in platelets. Secondary 
endpoint was mortality at EndObs.
Results Skeletal muscle RCR decreased in the HSR group (P = 0.04) but 
not in sham. Decrease in RCR was primarily due to decreased ADP-
dependent respiration, without change in state 4 respiration. HSR 
also resulted in platelet mitochondrial dysfunction as demonstrated 
by increased PLR and decreased reserve capacity. This correlated 
with increased platelet activation (%CD62P+ by fl  ow cytometry) in 
HSR. CO or NaNO2 treatment prevented these deleterious changes in 
both muscle and platelet mitochondrial respiration, as well as limited 
HSR-induced platelet activation. CO treatment also improved reserve 
capacity compared with baseline. Mortality was higher in HSR than in 
CO or NaNO2 (80 vs. 33 and 33%, respectively).
Conclusion In severe HS, mitochondrial injury in platelets and muscle 
was limited by CO or NaNO2. Although not powered for a secondary 
endpoint, mortality was double in HSR versus adjunctive therapies. 
This suggests that CO and NaNO2 may protect mitochondrial function 
by maintaining ATP-coupled respiration and reserve capacity, and that 
this may confer a survival advantage. However, further investigations 
are required.
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Introduction  Norepinephrine has been widely used in septic 
shock. However, its eff   ect remains controversial. We conduct a 
systematic review and meta-analysis to compare the eff  ect between 
norepinephrine and other vasopressors.
Methods  The PubMed, Embase, and Cochrane Library databases 
from database inception until October 2012 were searched. We 
selected randomized controlled trials in adults with septic shock and 
compared norepinephrine with other vasopressors. The quality of 
each study included was assessed with Jadad score. After assessing for 
heterogeneity of treatment eff  ect across trials using the I2 statistic, we 
used a fi  xed eff  ect model (P ≥0.1) or random-eff  ects model (P <0.1) and 
expressed results as the risk ratio (RR) for dichotomous outcomes or the 
standardized mean diff  erence (SMD) for continuous data with 95% CI.
Results  Eighteen trials (n  =  2,715) met inclusion criteria, which 
compared norepinephrine with fi  ve diff  erent vasopressors (dopamine, 
vasopressin, epinephrine, terlipressin and phenylephrine). The mean 
Jadad score was 3.11. Overall, there was no diff  erence in mortality 
in the comparisons between norepinephrine and vasopressin, 
epinephrine, terlipressin and phenylephrine (P  >0.05, respectively). 
However, norepinephrine had a trend in decreasing mortality 
compared with dopamine (RR, 0.84; 95% CI, 0.68 to 1.02; P = 0.08). There 
were a decreased heart rate (HR) (SMD, –2.10; 95% CI, –3.95 to –0.25; 
P = 0.03), cardiac index (SMD, –0.73; 95% CI, –1.14 to –0.03; P = 0.004) 
and an increased systemic vascular resistance index (SVRI) (SMD, 1.03; 
95% CI, 0.61 to 1.45; P <0.0001) with the treatment of norepinephrine 
compared with dopamine.
Conclusion  There is not suffi     cient evidence to prove that 
norepinephrine is superior to vasopressin, epinephrine, terlipressin 
and phenylephrine in terms of mortality. However, norepinephrine is 
associated with a decreased HR, cardiac index and an increased SVRI, 
and appears to have a greater eff  ect on decreasing mortality compared 
with dopamine.
References
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Introduction Vasoplegic syndrome is a common complication after 
cardiac surgery, with negative impact on patient outcomes and 
hospital costs. Pathogenesis of vasodilatory phenomenon after cardiac 
surgery remains a matter of controversy. Loss of vascular tone can 
be partly explained by the depletion of neurohypophyseal arginine 
vasopressin stores. Vasopressin is commonly used as an adjunct to 
catecholamines to support blood pressure in refractory septic shock, 
but its eff  ect on vasoplegic shock is unknown. We hypothesized that 
the use of vasopressin would be more eff  ective on treatment of shock 
after cardiac surgery than norepinephrine, decreasing the composite 
endpoint of mortality and severe morbidity.
Methods  In this prospective and randomized, double-blind trial, 
we assigned patients who had vasoplegic shock to receive either 
vasopressin (0.01 to 0.06 U/minute) or norepinephrine (0.01 to 1 μg/
kg/minute) in addition to open-label vasopressors. All vasopressor 
infusions were titrated and tapered according to protocols to maintain 
a target blood pressure. The primary endpoint was major morbidity 
according to STS (30-day mortality, mechanical ventilation >48 hours, 
mediastinitis, surgical re-exploration, stroke, acute renal failure). 
Secondary outcomes were time on mechanical ventilation, ICU and 
hospital stay, new infection, the time to attainment of hemodynamic 
stability, occurrence of adverse events and safety.
Results  A total of 300 patients underwent randomization, were 
infused with the study drug (148 patients received vasopressin, and 
152 norepinephrine), and were included in the analysis. Patients who 
received vasopressin had a lower rate of morbidity (23.5% vs. 34%, 
P = 0.001) as compared with the norepinephrine group. The 30-day 
mortality rate was 6.1% in the norepinephrine group and 4.6% in the 
vasopressin group (P = 0.570). There were no signifi  cant diff  erences in 
the overall rates of serious adverse events (7.4% and 6.6%, respectively; 
P = 0.772).
Conclusion Vasopressin reduces major morbidity after cardiac surgery 
as compared with norepinephrine among patients with cardiac surgery 
with vasoplegic shock.
Acknowledgement Clinical Trials number NCT01505231.
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Introduction Counterpulsation is an important support for patients 
with cardiac diseases. The use of these devices has been limited 
typically to hospitals with a cardiac surgery service. The aim of this 
study is to describe the management of patients with an intraaortic 
balloon pump (IABP) in our second-level institution.
Methods An observational study that includes all patients with IABP 
in our hospital from January 2010 to September 2012, followed to 
November 2012. Epidemiological and clinical variables as an indication 
of IABP, therapeutic management and outcome were collected. 
Because of the small size sample, statistical analysis was limited to 
descriptive parameters.
Results Seventeen patients (76.5% men, age 66.6 ± 11.6 (43 to 85) years, 
APACHE score 21.5 ± 14.9 (3 to 46) points) were treated with IABP. The 
reason for ICU admission was STEMI (n = 6 patients, 35.3%), no-STEMI 
(n = 5, 29.4%), acute heart failure (n = 4, 23.5%) and out-of-hospital 
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cardiogenic shock (n = 12, 70.6%), high-risk percutaneous coronary 
intervention (n = 2, 11.8%), refractory angina (n = 1, 5.9%), refractory 
pulmonary edema (n = 1, 5.9%) and electrical storm (n = 1, 5.9%). 
Five IABPs (27.4%) were inserted in the ICU and the rest in the 
catheterization laboratory. Six patients (35.3%) suff   ered a cardiac 
arrest prior to hemodynamic stabilization. Three patients (17.6%, the 
electrical storm and the out-of-hospital cardiac arrest) died before 
coronary catheterization was performed and the other three were 
treated with mild therapeutic hypothermia. Thirteen patients (76.5%) 
needed invasive mechanical ventilation. In six patients (35.3%) invasive 
hemodynamic monitoring was performed (one pulmonary artery 
catheter, fi  ve PICCO). Transthoracic echocardiography was performed 
in all patients and transesophageal in six (35.3%). Six of the patients 
(35.3%) were transferred to the reference centre for immediate coronary 
artery bypass grafting (CABG). No complications were reported during 
the transfer. During the ICU stay, femoral artery pseudoaneurysm was 
reported in one of the patients and inguinal hematoma after IABP 
withdrawal in two (no transfusion required). Four patients (27.4%) died 
because of refractory cardiogenic shock despite revascularization. The 
length of mechanical support was 1.67 ± 1.5 days (0 to 6).
Conclusion  In our hospital the IABP was mainly used in refractory 
cardiogenic shock because of myocardial ischemia, with an all-cause 
mortality of 41.2%. Low rates of complications were observed. Transfer 
of patients with IABP was performed safely.
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Introduction Myocardial dysfunction in septic shock is common and 
the presentation is broad. There are confl  icting data regarding the 
prognostic implications of low left ventricular (LV) ejection fraction and 
elevated E/e’ ratio on mortality in this patient population. We sought 
to assess the impact of LV dysfunction and elevated E/e’ ratio on 30-
day mortality in mechanically ventilated patients with severe sepsis or 
septic shock.
Methods  Fifty-eight mechanically ventilated patients with severe 
sepsis or septic shock admitted from 1 August 2007 to 31 January 
2009 were prospectively evaluated with transthoracic echocardiogram 
within 24 hours of admission. Left ventricular ejection fraction was 
assessed using the modifi  ed Simpson method as recommended by 
the American Society of Echocardiography. Normal LV function was 
defi  ned as LVEF 40%. Mitral infl  ow pulsed wave Doppler of peak E 
waves and tissue Doppler imaging (TDI) of the septal mitral annulus 
peak velocities were measured, the E/e’ ratio was obtained. Elevated LV 
fi  lling pressures was defi  ned as E/e’ >15.
Results All cause 30-day mortality was 50% (n = 29). Forty-six patients 
(79%) had normal LV function. Forty-four (76%) patients had normal 
LV fi  lling pressures. Patients who survived had lower E/e’ ratio, (median 
E/e’ 10.6 ± 4 vs. 13.6 ± 7, P = 0.1) but this was not statistically signifi  cant. 
However, when defi  ned as E/e’ >15, the mortality was 71%. On the 
contrary, patients with low LVEF had a mortality of 41% and LVEF was 
no diff  erent between survivors and nonsurvivors (55 ± 16 vs. 58 ± 14, 
P = 0.34).
Conclusion Myocardial dysfunction is a well-known entity in patients 
with septic shock. The clinical spectrum of this entity is broad, including 
LV, RV and diastolic dysfunction. Although the E/e’ ratio has been a 
known prognostic indicator in other cardiac conditions, its role in these 
patients is less clear. This study demonstrated that when septal mitral 
annulus E/e’ was >15, it was a better marker for mortality than LVEF 
in mechanically ventilated patients with severe sepsis or septic shock. 
Larger studies incorporating diastolic evaluation and TDI should be 
performed to further clarify this fi  nding.
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Introduction In our busy emergency departments the identifi  cation of 
patients at risk of rapid hemodynamic decompensation is crucial. The 
shock index (SI) (pulse/systolic blood pressure) is a non-invasive clinical 
sign associated with more complications if higher than 0.7. The eff  ect 
of β-blockers (BB) and calcium channel blockers (CCB) on the SI has 
not yet been described. Most studies excluded these patients, owing 
to the medications’ eff  ect on the cardiac pulse. Considering that BB 
and CCB are commonly prescribed, we studied their eff  ect on the SI’s 
predictability on 30-day mortality in a urosepsis population.
Methods This single-center post-hoc analysis of prospectively collected 
data was conducted in an academic Canadian emergency department 
(ED) between March 2008 and February 2011. Data were extracted 
from two institutional databases. We included patients with a fi  nal 
diagnosis of urosepsis, sepsis, pyelonephritis and urinary tract infection. 
Selected patients also had a documented positive urine culture. The SI 
predictability on 30-day mortality was calculated for patients taking 
BB and/or CCB as well as patients taking none of these medications. 
Sensitivity and specifi  city were determined using ROC curves. t tests 
were used to compare mean SI between both groups.
Results Our urosepsis population contained 364 patients, of which 129 
(35.4%) were either using a BB, a CCB or both before their admission. 
Mean age was 74.9 years and 48.1% of the patients were women. A total 
of 36 patients died (9.9%) in a 30-day period. The group taking either BB 
or CCB had a signifi  cantly lower mean SI (0.76, 95% CI: 0.72 to 0.81 vs. 
0.93, 95% CI: 0.89 to 0.98, P <0.0001). In our urosepsis population, a SI 
of 0.7 had a sensitivity of 0.76 and a specifi  city of 0.27 (area under the 
curve (AUC): 0.596) for patients taking neither BB nor CCB. In the group 
taking either or both medications, a SI of 0.7 had a sensitivity of 0.57 
and a specifi  city of 0.42 (AUC: 0.578). In both groups, lowering the SI to 
0.5 increased the sensitivity to more than 0.95 but lowered specifi  city 
signifi  cantly.
Conclusion To our knowledge this is the only study analysing the eff  ect 
of BB and CCB on the SI predictability of 30-day mortality. Our results 
indicate that SI cannot be used to accurately predict mortality with 
patients suff  ering from urosepsis. In both our groups, SI performance 
was poor, as shown by the ROC curves. BB or CCB did not infl  uence 
these results.
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Introduction  Levosimendan improves haemodynamic performance 
and may have cardioprotective eff  ects. Small trials have demonstrated 
effi   cacy in well-defi  ned populations [1]. Given the uncertain benefi  ts 
we describe contemporaneous patient selection, utilisation of 
levosimedan, haemodynamic eff  ects and outcomes.
Methods  The study was performed at a single centre’s three ICUs. 
Data from 38 consecutive admissions, from 2010 to 2012, treated 
with levosimendan were collected retrospectively. Demographics, 
illness severity, comorbidity, haemodynamic, metabolic, biochemical, 
resource utilisation, organ support and hospital outcomes were 
analysed.
Results Our cohort had a mean age of 58 (95% CI = 53.4 to 64.4). Only 
18% underwent cardiothoracic surgery: sepsis, pulmonary emboli and 
myocardial/pericardial diseases were also treated with levosimendan. 
Admission characteristics included mean PaO2/FiO2 ratio (PFR) of 
186.7 mmHg (95% CI = 160 to 212) and mean cardiac index (CI) of 2.3 
(95% CI 1.9 to 2.8). The median APACHE II score was 24 (interquartile 
range 18.5 to 30). Levosimendan was initiated at a variable point 
during ICU treatment (days 0 to 14) and was usually the third inotrope 
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resulted in improved CI and PFR with reductions in EVLW, BE, lactate 
and creatinine. The ICU length of stay was 15.4 days (95% CI = 13.2 to 
17.6) and the hospital mortality was 54%. No signifi  cant adverse eff  ects 
were reported.
Conclusion Levosimendan is usually used in patients with cardiogenic 
shock unresponsive to conventional inotropes or mechanical 
augmentation. The mortality of this group is high but represents 
patients with shock refractory to conventional treatment. Its use in 
sepsis, myocarditis and pulmonary embolism is not well established. 
In this group levosimendan appears to have a favourable eff  ect on 
gas exchange, renal function and tissue perfusion. Limitations include 
retrospective analysis and missing data.
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Introduction Tako-tsubo cardiomyopathy is a clinical entity charac-
terized by a dysfunction of the left ventricle, usually transient, which 
manifests itself with symptoms that can mimic an acute coronary 
syndrome. It is characterized by transient ballooning modifi  cation of 
the left ventricular apex, probably due to neurogenic stimuli resulting in 
low cardiac output syndrome. The aim of this prospective randomized 
study was to evaluate, by serial transesophageal echocardiography 
(TEE), what is the best drug treatment between levosimendan and 
dobutamine to restore a satisfactory cardiac function in the case of low 
cardiac output.
Methods  Twelve adult patients, aged 18  years, were admitted to 
the ICU with Tako-tsubo cardiomyopathy at entrance. The patients 
were divided randomly into two groups: levosimendan (six patients) 
treated with levosimendan and standard treatment, and the control 
group (six patients) with dobutamine and standard treatment. In all 
patients, serial TEE was performed studying the systolic function, by 
ejection fraction of the left ventricle with Simpson’s method. The TEEs 
were performed at the entrance of the patient, after 12 and 24 hours 
of treatment. The results were expressed as mean with standard 
deviation. For the comparison between the two groups we used the 
Fisher test, considered signifi  cant with P <0.05.
Results Patients in the two groups were statistically comparable with 
respect to sex (P = 0.31) and age (P = 0.53). The causes of the syndrome 
of Tako-tsubo were: subarachnoid hemorrhage (six patients) after 
coronary artery bypass graft (four patients), and polytrauma (two 
patients). All patients had low cardiac output. In the levosimendan 
group the ejection fraction at entrance was 25 ± 6%, after 12 hours 
36 ± 10%, and 47 ± 5% after 24 hours. In the control group the ejection 
fraction at entrance was 24 ± 7%, after 12 hours 28 ± 6% and after 
24 hours 33 ± 4%. Comparing the two groups we reached statistical 
signifi  cance, P = 0.026.
Conclusion Comparing the two groups, we noticed that both started 
from a low cardiac output. However, in the group who used the drug 
therapy based on levosimendan we saw a return of systolic function 
of the left ventricle to near-normal levels within 24 hours, while in the 
control group there remains a dysfunction in systolic function. We 
have shown the drug therapy based on levosimendan contributes to 
improving the systolic function of the left ventricle compared with 
treatment with dobutamine despite the initial cardiac stunning.
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Introduction  Dobutamine and levosimendan improve cardiac 
contractility in patients with heart failure, septic cardiomyopathy or 
cardiac surgery. Tachycardia in these cases is undesired because of 
aggravating ischemia. Ivabradine, a selective sinus node inhibitor, 
does not aff  ect contractility. A combination of ivabradine with positive 
inotropic drugs might be favorable. Thus, we compared the cardiac 
eff  ects of dobutamine or levosimendan alone, and combined with 
ivabradine using the Langendorff   method of isolated perfused hearts.
Methods  Isolated guinea pig hearts (n  =  37) were perfused with 
incremental doses of dobutamine (10 nM to 10 μM) or levosimendan 
(30 nM to 10 μM) either alone or combined with 3 μM ivabradine. 
Heart rate (HR), left ventricular pressures, contractility (+dLVP/dt) and 
relaxation (–dLVP/dt) were recorded. Data for each drug (dobutamine 
or levosimendan) were analyzed by two-way ANOVA for repeated 
measures including the two main eff  ects of ivabradine and drug dose 
and their interaction. Data are reported as mean ± standard deviation.
Results Ivabradine decreased the HR from 223 ± 18 to 196 ± 15 bpm 
(P <0.05). Contractility and relaxation remained unchanged. Ivabradine 
reduced the positive chronotropic eff  ect at all doses of dobutamine 
(10 nM: 232 ± 37 vs. 187 ± 19, 100 nM: 265 ± 37 vs. 211 ± 40, 1 μM: 
316 ± 35 vs. 250 ± 39, 10 μM: 320 ± 33 vs. 235 ± 40 bpm; P <0.05). It 
shifted the maximum positive inotropic action of dobutamine to lower 
dose ranges (100 nM: 2,924 ± 841 vs. 2,978 ± 955, 300 nM: 3,743 ± 925 
vs. 4,795 ± 1,298, 1 μM: 4,138 ± 935 vs. 4,896 ± 1,861 mmHg/second; 
P  <0.05). A comparable shift was seen for relaxation (100  nM: 
–2,178 ± 686 vs. –2,520 ± 742, 300 nM: –2,615 ± 726 vs. –3,150 ± 888, 
1  μM: –2,903  ±  752 vs. –2,972  ±  967  mmHg/second; P  <0.05). 
Levosimendan increased the HR only at high doses. With ivabradine, no 
positive chronotropic eff  ect of levosimendan was observed (100 nM: 
185 ± 30 vs. 162 ± 22, 1 μM: 208 ± 28 vs. 166 ± 29, 10 μM: 242 ± 27 vs. 
168 ± 36 bpm; P <0.05). Ivabradine attenuated the positive inotropic 
eff  ect of levosimendan (100 nM: 2,303 ± 303 vs. 1,737 ± 262, 1 μM: 
2,977 ± 481 vs. 1,940 ± 449, 10 μM: 3,480 ± 941 vs. 2,189 ± 542 mmHg/
second; P <0.05) but did not signifi  cantly alter its lusitropic eff  ect.
Conclusion  Addition of ivabradine to dobutamine attenuates its 
chronotropic actions without diminishing its inotropic eff  ects.  A 
combination of levosimendan with ivabradine does not seem to 
provide benefi   t. Clinical studies are necessary to confi  rm  these 
experimental results.
P229
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Introduction Inotropic agents (catecholamines or calcium-sensitizers) 
are frequently used in hypothermic as well as hyperthermic patient 
conditions. Divergent results from animal experiments raise doubt as 
to whether they act to the same extent at diff  erent body temperatures. 
Thus, we studied the infl  uence of clinically relevant temperatures on 
the hemodynamic eff  ects of dobutamine and levosimendan using the 
Langendorff   model of isolated perfused hearts.
Table 1 (abstract P226). Treatment outcomes
Variable Mean  95%  CI
CI Δd5 – d0  +1.34  0.4 to 2.2
PFR Δd5 – d0  +284  223 to 345
BE Δd5 – d0  +2.9  0.85 to 5
Lac Δd5 – d0  –1  –2 to 0.2
d0, treatment commenced.
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incremental doses (10 nM to 10 μM) of dobutamine or levosimendan 
either at normothermic (37°C), hyperthermic (40°C) or hypothermic 
(34°C) perfusion conditions. Contractility (+dLVP/dt), relaxation 
(–dLVP/dt), left ventricular pressures and heart rate were recorded. Data 
with increasing drug dosage were calculated in percent from baseline 
for each temperature tested. Data for each drug were analysed by two-
way ANOVA for repeated measures including the two main eff  ects of 
temperature and drug dose and their interaction. Data are reported as 
mean ± standard deviation.
Results The positive inotropic action of dobutamine was least at 37°C, 
more pronounced at 40°C and best at 34°C (37°C vs. 40°C vs. 34°C: 300 
nM 280 ± 71 vs. 301 ± 94 vs. 345 ± 99%, 1 μM 310 ± 74 vs. 327 ± 92 
vs. 389 ± 144%, 10 μM 297 ± 69 vs. 339 ± 96 vs. 359 ± 175%; P <0.05). 
Dobutamine’s positive lusitropic eff  ect was not signifi  cantly altered by 
temperature. The positive inotropic action of levosimendan was best at 
37°C, in hyperthermia and hypothermia only the three highest doses 
of levosimendan increased contractility (37°C vs. 40°C vs. 34°C: 100 nM 
121 ± 21 vs. 134 ± 15 vs. 87 ± 12%, 300 nM 135 ± 22 vs. 137 ± 17 vs. 
94 ± 15%, 1 μM 153 ± 22 vs. 147 ± 21 vs. 108 ± 21%, 3 μM 172 ± 19 
vs. 150 ± 24 vs. 115 ± 23%, 10 μM 173 ± 31 vs. 156 ± 28 vs. 117 ± 28%; 
P <0.05). The positive lusitropic eff  ect of levosimendan at 37°C was 
almost absent in hypothermia and hyperthermia (P <0.05).
Conclusion  In isolated perfused hearts, dobutamine has its best 
positive inotropic eff   ect in hypothermia whereas levosimendan 
increases contractility best at normothermic conditions. Clinical studies 
are necessary to confi  rm these experimental results.
P230
Confl  icting results between V/Q SPECT and angioscan in pulmonary 
embolism: what to do?
JM Martel, MN Nadeau, RD Daoust, JP Paquet, JC Chauny
Hôpital du Sacré-Coeur de Montréal, Canada
Critical Care 2013, 17(Suppl 2):P230 (doi: 10.1186/cc12168)
Introduction  The objective of this study is to determine the fi  nal 
clinical diagnosis of patients who underwent the double investigation 
for pulmonary embolism with confl  icting results. Pulmonary embolism 
is a prevalent pathology in the emergency department (ED). A certain 
proportion of patients undergo a double radiological investigation 
(V/Q SPECT and angioscan), which incurs higher costs and X-ray doses. 
However, no study to date has addressed this issue.
Methods This retrospective study included patients who underwent 
a double investigation in the ED of Hôpital du Sacré-Coeur de 
Montréal from April 2008 to October 2012. Patients were selected 
from a computerized database of medical prescriptions (MediaMed 
Technologie). Data were then extracted from the patient’s fi  les: patient 
characteristics, radiology report, diagnosis and treatment. Descriptive 
statistics were conducted.
Results In all, 125 patients underwent the double investigation. Our 
sample had a mean age of 63.1 years (SD ±18.6) and was composed of 
82 (65.6%) women. One hundred and fi  fteen patients (92%) underwent 
the V/Q SPECT fi  rst. The result of 66 (52.8%) SPECT was intermediate 
or indeterminate. The fi  nal diagnosis was pulmonary embolism for 
23 patients (18.4%). A signifi  cant proportion of patients (19, 38.0%) 
had confl  icting results with the two tests. In this subpopulation, four 
(21.1%) had a fi  nal diagnosis of pulmonary embolism. In the 16 patients 
with a result of high probability V/Q SPECT and negative angioscan, 
one (6.3%) had a fi  nal diagnosis of pulmonary embolism, but three 
(100%) with low probability SPECT and positive angioscan were given 
this fi  nal diagnosis.
Conclusion  Most patients underwent the double investigation 
because of intermediate or indeterminate V/Q SPECT results. In case 
of confl  icting results, clinicians based their decision on the angioscan. 
In future studies, it would be useful to identify contributing factors for 
this discordance.
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Introduction Intraabdominal hypertension (IAH), especially abdominal 
compartment syndrome (ACS), can aff   ect organ function leading 
to multiple organ failure. Appropriate and prompt management 
could improve survival. Less recognition of this problem in critically 
ill patients has been reported. The aim of this study was to study the 
prevalence, predictive factors and clinical outcome of IAH and ACS in 
a mixed population of critically ill patients by intermittent measuring 
bladder pressure during the ICU stay.
Methods This prospective observational study was done in 130 adult 
patients (age >18 years) admitted to a medical and general surgical 
ICU at a third referral university hospital during June to November 
2011. Variables about the patient’s profi  le laboratory data and clinical 
outcome as ICU and hospital length of stay, and ICU, in-hospital and 
28-day mortality were recorded.
Results There were 33 (25.4%) medical and 93 (74.6%) surgical ICU 
patients in this study. Surgical patients had higher prevalence of IAH 
than medical patients (57.8% vs. 33.3%, P = 0.015). Medical patients 
were admitted with severe sepsis/septic shock, AKI, pneumonia and 
ARDS. Surgical patients were more acutely ill with high ASA (III to IV), 
severity score, underwent emergency abdominal surgery and received 
more transfusion but were no diff  erent in type of fl  uid replacement. 
Signifi  cant risk factors of IAH were coagulopathy (OR  =  2.09, 95% 
CI = 1.62 to 2.69), intraabdominal infection (OR = 1.87, 95% CI = 1.40 
to 2.48), retroperitonium hematoma (OR = 1.82, 95% CI = 1.36 to 2.44), 
marked ascites (OR = 1.76, 95% CI = 1.32 to 2.36), acidosis (pH <7.2) 
(OR = 1.82, 95% CI = 1.37 to 2.43), severe sepsis/septic shock (OR = 1.63, 
95% CI  =  1.14 to 2.33), and massive transfusion (OR  =  1.51, 95% 
CI = 1.10 to 2.08). Patients with IAH had more reopened surgeries and 
had higher ICU, hospital and 28-day mortality. Sixteen (12.3%) patients 
had ACS, 15 patients underwent emergency surgery, two patients 
had temporary abdominal closured and one-half of the patients had 
severe abdominal sepsis and massive transfusion. Fourteen patients 
died despite temporary abdominal closure. Delayed release abdominal 
tamponade were most causes of death.
Conclusion The prevalence and morbidity/mortality of IAH and ACS 
were high in this institute. Early appropriate and prompt management, 
especially fl  uid and releasing a tamponade eff  ect, were important.
P232
Red cell distribution width predicts cardiovascular complications 
after high-risk surgery
M Geisen, HD Aya, C Ebm, MA Hamilton, J Ball, M Grounds, A Rhodes, 
M Cecconi
St George’s Healthcare NHS Trust, London, UK
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Introduction  The red-cell distribution width (RDW) is associated 
with cardiovascular morbidity and mortality and is a predictor of ICU 
survival. It was the aim of this study to investigate the potential of RDW 
to predict postoperative cardiovascular complications (new onset of 
treated arrhythmias, myocardial ischaemia or initiation of vasopressor 
support) and its association with markers of tissue perfusion (serum 
lactate >2.5 mmol/l).
Methods  Analysis of prospectively recorded data for a register of 
patients admitted to an 18-bed ICU in a large teaching hospital 
after undergoing high-risk surgery. Haemodynamic and laboratory 
parameters during the fi  rst 12  hours of ICU stay were recorded as 
well as demographic characteristics. Assessment for postoperative 
complications was performed using the postoperative morbidity 
survey and the Clavien-Dindo classifi   cation. In addition, clinical 
outcome data (hospital mortality, length of ICU stay, length of hospital 
stay, readmission to the ICU) were recorded.
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patients developed complications postoperatively. Thirty patients 
(25.2%) developed cardiovascular complications. These patients had 
a higher median RDW than patients without cardiovascular compli-
cations (14.7 vs. 13.8%, P <0.05). RDW on ICU admission was associated 
with serum lactate concentration on ICU admission: receiver operating 
characteristic analysis showed an area under the curve of 0.68 (SE = 0.06, 
P = 0.005; see Figure 1). RDW >14.35% predicted hyperlactataemia with 
a sensitivity of 76.0% and a specifi  city of 71.1%.
Conclusion  RDW is a potential parameter for perioperative risk 
stratifi  cation. Further studies will have to elucidate the ability of acute 
elevations in RDW to refl  ect impaired tissue perfusion.
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Introduction  Obesity is a disease that aff   ects a large part of the 
population and has been associated with worse outcomes after cardiac 
surgery. The aim of our study is to evaluate the consequences of 
obesity related to postoperative complications, hospital length of stay 
and mortality.
Methods An observational, prospective, multicenter study of patients 
included in the ARIAM registry of adult cardiac surgery between March 
2008 and March 2011. We analyzed clinical variables, the surgical 
procedure, postoperative complications and mortality, comparing 
the group of patients with body mass index (BMI) greater or less than 
30 kg/m2.
Results The study included 4,712 patients with a mean age of 64.03 (SD 
±12.08) years, BMI 28.53 (SD ±4.7) and EuroSCORE 5.58 (SD ±2.91). In 
1,940 patients (35.7%) BMI was >30 kg/m2. There were no diff  erences 
in the development of overall postoperative complications (33% in 
obese and 35.8% in nonobese, P = 0.07), although less appreciated 
were reoperation rate or stroke, as well as further development of 
postoperative renal failure. After adjusting for severity and length 
of cardio bypass time, obese patients had lower mortality without 
being statistically signifi  cant, OR = 0.94 (0.79 to 1.04). There were no 
diff  erences in ICU length of stay, but obese patients had greater ward 
length of stay, 9.04 (10.43) versus 1.18 (9.2) days, P = 0.01.
Conclusion Obese patients undergoing cardiac surgery have mortality, 
rate of complications and length of stay similar to nonobese patients. 
Obese patients required less reoperation but developed more frequent 
postoperative renal failure.
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Introduction In the critically ill, the incidence of raised cardiac troponin 
T (cTnT) levels is high. Although the mechanisms of myocardial injury 
are not well understood, raised cTnT levels are associated with increased 
mortality. The aim of our study was to determine the incidence, 
prevalence and outcome of silent myocardial injury as determined by 
raised cTnT levels and concomitant ECG changes in critically ill patients 
admitted for noncardiac reasons.
Methods ECGs were taken and cTnT was measured daily during the fi  rst 
week and on alternate days during the second week until discharge 
from the ICU or death. After completion of the study, all cTnT levels and 
ECGs were analysed independently and patients were classifi  ed into 
four groups: defi  nite MI (cTnT ≥15 ng/l and defi  nite ECG changes of MI), 
possible MI (cTnT ≥15 ng/l and ischaemic changes on ECG), troponin 
rise alone (cTnT ≥15 ng/l with no ischaemic ECG changes), or normal. 
All medical notes were reviewed independently by two ICU clinicians.
Results  A total of 144 patients were included in the analysis (42% 
female; mean age 61.9 (SD 16.9); mean APACHE II score 19.4). In total, 
121 patients (84%) had at least one cTnT level ≥15 ng/l during their 
stay in the ICU. Twenty patients (14%) fulfi  lled criteria for a defi  nite MI, 
of whom 65% were septic and 50% were on noradrenaline at the time 
(ICU and hospital mortality: 25% and 30%, respectively). Thirty-nine 
patients (27%) had a possible MI, of whom 69% were septic and on 
noradrenaline (ICU and hospital mortality: 31% and 41%, respectively). 
Sixty-two patients (43%) had a raised troponin without ECG, of whom 
69% were septic and 50.7% were on noradrenaline (ICU and hospital 
mortality: 23% and 31%, respectively). Twenty-three patients had 
normal cTnT results and serial ECGs, of whom 61% had sepsis. ICU 
and hospital mortality was 4%. Only 25% of defi  nite MIs and 18% of 
possible MIs were recognised by the clinical teams at the time.
Conclusion Eighty-four per cent of critically ill patients had a raised 
cTnT level at some stage during their stay in the ICU. More than 40% of 
patients fulfi  lled criteria for a possible or defi  nite MI, of whom only 20% 
were recognised clinically. ICU and hospital outcome were signifi  cantly 
worse in patients with a cTnT rise. The proportion of patients with sepsis 
was similar between the patients with a defi  nite, possible or no MI.
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Introduction The Global Registry of Acute Coronary Events (GRACE) 
risk score provides an estimation of the probability of death within 
Figure 1 (abstract P232). Prediction of hyperlactataemia according to 
RDW.
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syndrome (ACS). Our aim was to assess the validity of this risk score 
in our contemporary cohort of patients admitted to our third-level 
hospital.
Methods  The study involved 1,185 consecutive patients with ACS 
evaluated between February 2004 and February 2009. Their virtual 
status was determined 6 months after hospital discharge and the 
validity of the GRACE risk score was evaluated.
Results In total, 450 (38.8%) patients were admitted for STEMI and 725 
(61.2%) for NSTEMI. Percutaneous revascularisation was performed 
in 846 (71.5%). The median GRACE risk score was 121 (interquartile 
range 96/144). Mortality after discharge was 4.4%. The calibration of 
the GRACE score was Hosmer–Lemeshow P >0.2 and its discriminatory 
capacity was excellent. Area under the ROC curve was 0.86, 95% CI 
0.807 to 0.916, in all patients. See Table 1.
Table 1 (abstract P235)
GRACE risk  Total  STEMI  NSTEMI
Low  270 (22.7)  177 (38.3)  93 (12.8)
Medium  334 (28.2)  141 (30.7)  193 (26.7)
High  580 (49)  142 (30.9)  438 (60.5)
Conclusion The GRACE risk score for predicting death within 6 months 
of hospital discharge was validated and can be used in patients with 
ACS. It would be perfect in the future to include the GRACE risk score 
in the medical records of this type of patients. Also it would be very 
interesting to validate this in a multicentric study.
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Introduction  This is a prospective study in which all ACS cases 
attending a level 3 hospital were collected consecutively from February 
2004 to 2010, and were clinically followed-up until 2012.
Methods Of a total 4,589 cases, only 2,515 were revascularized with ICP 
(1,742 complete and 907 incomplete; 160 failed). We split the cases into 
two main groups: STEMI and NSTEMI.
Results We observed a 0.6 higher accumulative survival rate in patients 
with complete ICP over patients who underwent surgery, incomplete 
ICP or mixed treatment. Those with conservative measures solely have, 
obviously, worst prognosis. See Figures 1 and 2.
Conclusion In our study patients undergoing ICP have higher survival 
rates in comparison with cardiac surgery except those >65 years old 
and diabetic groups in which cardiac surgery has higher ratios than ICP. 
In the rest of the groups, no matter how many coronary arteries were 
aff  ected, only those with complete ICP present higher survival rates. It 
would be important to repeat this study in a multicentric cohort.
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Introduction In patients with severe and inoperable aortic stenosis, 
some trials have proven that TAVI excels standard procedures and has 
also been proven less cost-eff  ective. We aim at reviewing short-term 
results after 2 years since the implementation of this technique in our 
premises.
Methods A study of a retrospective cohorts of patients who underwent 
isolated aortic valve replacement (AVR) by either conventional 
surgery or TAVI (CoreValve device) from June 2010 to December 2011 
at the University Hospital Carlos de Haya (Málaga, Spain). Clinical 
epidemiologic, complication and short-term outcome variables were 
registered. Qualitative variables are expressed as percentages, while 
quantitative variables are expressed as means and SD. Fisher’s exact 
test and Mann–Whitney’s U-test were used where necessary (5% 
maximum error ratio).
Results A total number of 27 TAVI and 154 isolated AVR procedures 
were completed. Intervention typology was chosen according to the 
recommendations of scientifi  c societies, apart from patients’ fulfi  llment 
of the anatomic criteria required for percutaneous implant. Mean age 
was 67 ± 11 years (54% males) in AVR and 80 ± 6 years (44% males) 
in TAVI (P <0.05). The additive EuroSCORE in AVR was 7 ± 2 and 9 ± 2 
in TAVI (P <0.05). However, 55.6% of the percutaneous-valve patients 
presented previous coronary-tree alterations with stent implantation, 
while only 7% of AVR patients showed these alterations (P <0.001). ICU 
mortality in TAVI and AVR patients was 3.7% and 8.2%, respectively 
(P  =  NS). Regarding complications, 48.1% of TAVI patients showed 
altered heart rhythm and 33% required a permanent pacemaker. 
Electrical disorders were observed in 4% of AVR patients, while 1.9% 
of these patients required a permanent pacemaker (P <0.001 for both). 
Reoperation was necessary in 14.8 and 1.9% of TAVI and AVR patients, 
respectively (P <0.001).
Conclusion  Even with our limited experience, TAVI patients are 
observed to be older, to involve higher surgical risk, and to have 
undergone previous coronary-tree interventions. Although no 
Figure 1 (abstract P236). FEVI and prognosis.
Figure 2 (abstract P236). Incomplete and complete revascularization.
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of complications was observed in TAVI patients. With no short-term 
diff  erences, a signifi  cant rate of postsurgical complications, and a cost-
effi     ciency handicapped technique, analysis of long-term outcomes 
seems necessary to assess TAVI’s advantages over conventional AVR.
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Time to recover from shock is determinant of a positive fl  uid 
balance in septic shock
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Introduction  Excess fl   uids may be harmful in critically ill patients. 
We aimed to evaluate the cumulative fl  uid balance during 7 days in 
patients with septic shock after recovery from shock.
Methods  A prospective and observational study in septic shock 
patients. Patients with MAP >65 mmHg and lactate <2.0 mEq/l were 
included <12  hours after weaning from vasopressors. Daily fl  uid 
balance was registered during 7 days after the enrollment. Patients 
were divided into two groups according to the full cohort’s median 
cumulative fl  uid balance administered during the period of shock (use 
of vasopressors) calculated on study day 1: Group 1 ≤4.4 l (n = 20) and 
Group 2 >4.4 l (n = 20).
Results  Cumulative fl   uid balance was 1.6  ±  1.8 l in Group 1 and 
10.2 ± 4.1 l in Group 2 and 8.5 ± 5.3 l in Group 1 and 18.5 ± 7.9 l in 
Group 2 on study day 8 (P <0.001 for both). Time for recovery from 
shock was predictive of receiving larger volume of fl  uids (OR: 1.38, 95% 
CI: 1.08 to 1.75, P = 0.009). After zeroing fl  uid balance on study day 2, 
7 days cumulative fl  uid balance continues to increase in both groups 
(Figure 1). Patients in Group 2 had more prolonged length of stay in the 
ICU and in hospital than patients in Group 1.
Conclusion After recovery from septic shock we notice a huge accu-
mulated fl  uid balance. A more positive fl  uid balance was associated 
with a more prolonged length of stay in the ICU and in the hospital.
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Introduction There is no useful predictor of sustained upper gastro-
intestinal bleeding (UGIB). Glasgow–Blatchford scoring (GBS) is based 
on simple clinical and laboratory variables and can predict whether a 
UGIB patient needs an intervention or not. However, the intervention 
which the GBS mentions includes not only endoscopy but also blood 
transfusion. Therefore, we cannot determine whether a UGIB patient 
needs urgent endoscopy or just blood transfusion by GBS alone. We 
hypothesized that high lactate clearance (CLac) would decrease the 
likelihood of sustained UGIB.
Methods This is a retrospective study. UGIB patients, who visited the 
emergency department (ED) of the National Center for Global Health 
and Medicine from April 2011 to March 2012 and received urgent 
endoscopy in the ED, were enrolled. We collected for each patient 
the GBS, the blood lactate value on arrival in the ED, the blood lactate 
value after bolus administration of 20 to 40 ml/kg Ringer’s acetate 
(initial fl  uid therapy) and the report of urgent endoscopy. We classifi  ed 
the severity of UGIB according to GBS. A score ≤12 was classifi  ed as 
moderate, and a score ≥13 was classifi  ed as severe. CLac was defi  ned 
as the percentage decrease in blood lactate from the time of arrival 
in the ED to the time when an initial fl  uid therapy was fi  nished. CLac 
<50% was defi  ned as low, and CLac ≥50% was defi  ned as high. Whether 
a patient had sustained bleeding or not was determined based on 
the report of urgent endoscopy. The relationship between CLac and 
sustained bleeding was examined by Fisher’s exact test, and P <0.05 
was considered statistically signifi  cant.
Results  Seventy-nine patients were enrolled. Fifty-one patients 
were with moderate UGIB, and 28 patients were with severe UGIB. 
As indicated in Tables  1 and 2, there was a signifi  cant relationship 
between CLac and sustained bleeding in moderate UGIB (P = 0.02). On 
the other hand, there was no signifi  cant relationship between CLac and 
sustained bleeding in severe UGIB (P = 0.58).
Table 1 (abstract P239). Relationship between lactate clearance and 
sustained bleeding in moderate UGIB (n = 51)
  Sustained bleeding  Nonsustained bleeding
 ( n = 19)  (n = 32)  P value
CLac <0.5  18 (95%)  21 (65%)  0.02
CLac ≥0.5  1 (5%)  11 (34%) 
Table 2 (abstract P239). Relationship between lactate clearance and 
sustained bleeding in severe UGIB (n = 28)
  Sustained bleeding  Nonsustained bleeding
 ( n = 6)  bleeding (n = 22)  P value
CLac <0.5  4 (67%)  18 (82%)  0.58
CLac ≥0.5  2 (33%)  4 (18%) 
Conclusion If an initial fl  uid therapy for moderate UGIB results in high 
CLac, the bleeding might already have stopped. For such a patient, we 
may save urgent endoscopy.
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Muscular glucose assessed by microdialysis and blood glucose can 
predict mortality in septic shock
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Introduction The aim of our study was to assess the muscular glucose 
by microdialysis and its association with mortality in septic shock 
patients.
Methods We conducted a preliminary prospective study. We included 
septic shock patients hemodynamically optimized according to 
international recommendations. A microdialysis catheter was inserted 
in the femoral quadriceps. Interstitial fl  uid samples were collected 
every 6 hours for 5 days. The determination of muscular glucose was 
performed by the CMA 600 analyzer (CMA/Microdialysis AB, Sweden). 
We also performed a dosage of concomitant blood glucose. The 
study population was divided into two groups according to hospital 
mortality. Statistic analysis: Mann–Whitney test and chi-squared test: 
Figure 1 (abstract P238).
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as mean  ±  standard deviation or median (interquartile range) as 
appropriate.
Results We included 12 patients with septic shock. The mortality rate 
was 50%. Demographics were comparable between groups except 
for age (66 ± 9 vs. 41 ± 12, dead patients vs. survivors, respectively; 
P = 0.002). Pneumonia was the major cause of septic shock (10 patients). 
We analysed 167 blood samples and 166 muscular glucose samples. 
We found a positive association between muscular glucose, blood 
glucose and mortality. Tissue glucose was signifi  cantly higher among 
dead patients compared with survivors at the 54th hour. Comparing all 
data, muscular glucose (P = 0.02) and blood glucose (P = 0.007) were 
signifi  cantly higher in dead patients (Table 1).
Table 1 (abstract P240). Association between muscular glucose, blood 
glucose and mortality
 Dead  patients  Survivors
 ( n = 6)  (n = 6)  P value
Muscular glucose (mmol/l)   9.4 (5.66; 13.71)  7.87 (5.62; 10.41)   0.02
Blood glucose (mmol/l)   10.9 (8.3; 15.5)   8.6 (6.9; 11.4)   0.007
Conclusion  Our data suggest that muscular glucose assessed by 
microdialysis and blood glucose are associated with mortality in septic 
shock patients. Therefore, muscular glucose may refl  ect the metabolic 
alterations and microcirculatory dysfunction induced by septic shock.
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Introduction Constipation can be defi  ned as a failure of the bowels to 
open for 3 consecutive days. It is a common problem in intensive care 
settings but not many studies have so far raised the subject.
Methods  The audit had the Trust Audit Committee’s approval. The 
existing protocol was used as the benchmark. Patients were studied 
prospectively to assess compliance with the local bowel protocol, 
incidence of constipation and relationship to weaning from respiratory 
support and feeding. All HDU and all mechanically ventilated 
ICU patients who stayed on the ward for more than 3  days were 
included, except for patients after bowel surgery and patients with 
encephalopathy.
Results  Among the 24 HDU and 21 ICU patients audited in the 
Royal Liverpool University Hospital, 67% and 57% respectively were 
constipated. Laxatives were prescribed when patients had not opened 
their bowels for 3 days in 25% HDU and 75% ICU cases. Taking into 
consideration that the median age, APACHE II score and length 
of stay for constipated and nonconstipated patients were similar, 
the relationship to feeding and respiratory support were assessed. 
Constipated patients required mechanical ventilation for an average of 
6.8 days and nonconstipated for 4.3 days. Failure to feed was observed 
at least once in 58% constipated and 44% nonconstipated ICU patients 
and 19% constipated and 12.5% nonconstipated HDU patients.
Conclusion There was a high prevalence of constipation among critical 
care patients with poor adherence to the bowel protocol, which requires 
improvements in staff   awareness and new recommendations (drug chart 
amendment, and so forth). Duration of mechanical ventilation and failure 
to feed were greater in constipated than nonconstipated patients. This 
may indicate a common correlation and further studies are warranted. 
Due to the possible signifi  cant impact of constipation on patients’ 
recovery, each critical care unit should introduce a bowel protocol or 
ensure compliance with the existing one before the evidence is clearly 
established.
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Introduction It was noted on our unit that dislodgement of nasogastric 
tubes occurred commonly. This can lead to an increased risk of 
aspiration, interruptions in nutritional support, skin breakdown and 
radiographic exposure [1]. It is recommended that the position of 
nasogastric tubes should be confi  rmed by aspiration and pH testing, 
with radiographic confi  rmation used only when this is not possible [2].
Methods We performed a retrospective review of chest X-ray (CXR) 
requests for the 3-month period June to August 2012 using the trust 
radiology information system. The proportion of CXR requests for 
confi  rmation of position and patient demographics were measured 
with an estimation of the fi  nancial cost performed.
Results There were 541 patients admitted to the critical care area in 
the study period. In total, 207 out of 2,340 (8.8%) CXRs performed were 
for confi  rmation of position. Repeated X-rays were required in some 
patients (see Table 1); these patients were older and tended to have 
a longer length of stay. A mobile CXR costs £25 in our trust, if one CXR 
is accepted per patient with a nasogastric tube; there was an excess of 
160 images with a cost of £4,000 in the 3-month period.
Table 1 (abstract P242)
        Mean  days 
CXR for    Total NG  Total    from fi  rst to  Mean
NG Patients  CXR  CXR  Proportion  last  CXR  age
1 47  47  321  0.15  8.45  67.55
2 16  32  181  0.18  15.94  69.63
3 7  21  87  0.24  17.86  70.00
4 10  40  149  0.27  15.90  69.20
5 3  15  52  0.29  23.33  66.00
6 3  18  61  0.30  40.00  76.67
8 2  16  52  0.31  39.50  80.00
9 2  18  46  0.39  29.50  83.00
Conclusion  An excess of CXRs were performed for confi  rmation 
of nasogastric tube in our patient population. The recommended 
methods for position confi  rmation were reinforced amongst medical 
staff  . The high number of repeated imaging for some patients indicates 
that dislodgement of tubes was also a problem. We propose that 
nasogastric tubes should be bridled after fi   rst dislodgement or at 
tracheostomy insertion to minimise dislodgement in the future.
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Introduction  Protein turnover measurements by stable isotope 
techniques can be applied to assess the nutritional/metabolic status in 
critically ill patients and their response to feeding. Because of uncertain 
gastrointestinal transport and uptake of nutrients, their contribution 
needs to be measured separately. We studied whole-body protein 
kinetics, with special emphasis on the contribution of dietary protein, 
in ICU patients and healthy controls.
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were recruited from an interdisciplinary ICU. Healthy, overnight-fasted 
volunteers (n = 6) served as reference. A primed constant i.v. infusion 
of  2H-labeled phenylalanine (Phe) and tyrosine was used to quantify 
whole-body protein metabolism. Patients remained on parenteral 
nutrition (PN) as clinically indicated; controls received PN starting 
2.5 hours before starting enteral feeding. Intrinsically 13C-Phe-labeled 
casein was infused for 6 hours by nasogastric tube at 0.75 g protein/
hour, together with maltodextrin at 2.73 g/hour. Protein breakdown, 
synthesis, net balance, and Phe splanchnic extraction were calculated 
before and at the end of the enteral feeding period, using equations 
for steady-state whole-body protein kinetics. Comparisons were made 
by Wilcoxon matched pairs and Mann–Whitney U tests; values are 
reported as mean ± SD.
Results Protein net balance was lower in patients than in the reference 
group at baseline (–1.8 ± 1.7 vs. 0.6 ± 0.6 mg/kg BW/hour, P = 0.003), 
and after enteral feeding (–1.1  ±  1.5 vs. 0.6  ±  0.6  mg/kg BW/hour, 
P  =  0.049). Recovery of labelled Phe from enteral feeding into the 
systemic circulation was higher in the reference group as compared 
with patients (20.3 + 11.2% vs. 7.0 + 4.8%, P = 0.005). Enteral feeding 
did not aff  ect protein metabolism in the reference group. In patients, 
protein breakdown became slightly lower during enteral feeding 
(10.6 ± 3.3 vs. 11.2 ± 3.3 mg/kg BW/hour, P = 0.086) and protein net 
balance became slightly higher (–1.1 ± 1.5 vs. –1.8 ± 1.7 mg/kg BW/
hour, P = 0.086).
Conclusion  Intrinsically isotope-labelled casein can be used to 
quantify dietary contribution to protein metabolism in critically ill 
patients. Hypocaloric enteral feeding marginally improved protein 
balance in these patients. The low recovery of enterally administered 
labelled amino acid underlines the need to quantify uptake from 
the gastrointestinal tract when protein turnover measurements are 
performed in critically ill patients on enteral nutrition.
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Introduction Placement of nasogastric tubes (NGTs) is commonplace 
in critical care. Misplacement of NGTs is rare and considered a never 
event [1]. Strategies to avoid never events (by confi  rming NGT position) 
include pH analysis of gastric secretions or chest X-ray confi  rmation 
of tube position. For this reason the authors set out to establish the 
effi   ciencies surrounding safe placement of NGTs in a 17-bed adult 
cardiothoracic critical care unit in a large teaching hospital.
Methods This small-scale study of 25 NGT placements during a 5-week 
period collated data supplied by questionnaire by healthcare workers 
responsible for NGT placements.
Results  Analysis of Adverse Incident Reports identifi   ed no never 
events of misplaced NGTs within the previous 10  years. This audit 
revealed that the commonest type of NGT was a radio-opaque tube 
with stylet (corfl  o) (92% of placements), with occasional use of the 
electromagnetic placement system (cortrak) (8% of placements). 
Sizes 10 (40%) and 12 (56%) were most common. Tube placement was 
confi  rmed by: X-ray (72%); pH of aspirates (35%); electromagnetic tube 
placement (one patient). The time taken from decision to place NGT to 
use varied (range 15 to 510 minutes). Little distinction was seen in the 
time taken to use and NGT confi  rmed by aspirate alone (205 minutes) 
or by X-ray (220  minutes), although the shortest interval was seen 
in electromagnetic NGT placement (15  minutes). The cost of NGTs 
confi  rmed by aspirate alone was low (approximately £10.00), higher 
with X-ray confi   rmation/electromagnetic placement (approximately 
£45.00).
Conclusion  Despite the small dataset the results demonstrate a 
concerning delay in the application of enteral feeding and/or drug 
administration. Whilst reassuring in the steps taken to avoid never 
events, this study demonstrates that there may be delays in time-critical 
administration of enteral medicine or optimal nutritional practices. 
This study reveals a signifi   cant problem with aspirating gastric 
contents for pH testing, necessitating a large number of X-ray position 
confi  rmations. Even if the frequency and volume of gastric aspiration 
were greater, there is a belief that pH testing may not be suffi   ciently 
accurate (since many factors alter patients’ gastric pH). It is possible 
that new technologies such as electromagnetic NGT placement may 
allow faster/equally safe practices. Further study including cost/benefi  t 
analysis will be needed to confi  rm this.
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Introduction For such a simple procedure, the insertion and position 
checking of nasogastric (NG) tubes can be very problematic. The UK’s 
National Patient Safety Agency declared that ‘Placement of NG tubes 
together with confi  rmation of correct placement can carry signifi  cant 
risks’ and recommends that measuring the pH of NG aspirate should 
be the fi  rst-line method of determining correct NG position (safe range 
≤5.5) [1].
Methods In order to assess the usefulness of pH testing of NG aspirates 
in critical care patients, a prospective survey of pH testing of NG tube 
aspirate was carried out. This was undertaken both in patients who 
had a newly placed NG tube and in patients who were having regular/
routine checks of their existing NG tube.
Results A total of 168 separate pH readings in 41 ICU patients receiving 
continuous enteral nutrition were recorded. In total, 137/168 patients 
were receiving proton pump inhibitors (PPIs). Eighteen readings were 
from newly placed NG tubes and 150 readings from old NG tubes. Fifty-
three per cent of routine pH readings were falsely high; that is, pH 6 or 
above despite the NG tube being in the stomach (Figure 1). Twenty-
eight per cent of newly placed NG tubes had falsely high pH readings 
(Figure 2).
Conclusion In this population of ICU patients, routine/daily checks of 
NG pH aspirate appear to be limited. This is almost certainly due to the 
use of continuous NG feed together with PPIs. The usefulness of pH 
testing in newly placed NG tubes, however, appears more reliable.
Figure 2 (abstract P245). pH values – new NG tubes.
Figure 1 (abstract P245). pH values – routine checks.
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Introduction Sepsis is the most common cause of death in ICUs [1]. 
Destruction of intestinal barrier function and increased translocation 
of bacteria to systemic blood fl  ow can lead to sepsis [2]. Probiotics 
may have benefi  cial eff  ects in improvement of critically ill patients 
by modulating intestinal barrier and reduction of infl  ammation 
[3]. The aim of this trial was to determine the eff  ect of probiotic on 
infl  ammatory biomarkers and mortality rate of sepsis in critically ill 
patients in the ICU.
Methods  This double-blind, randomized controlled trial was 
conducted on 40 critically ill patients admitted to the ICU. They were 
randomly assigned to receive placebo or probiotic for 7  days. The 
APACHE score, Sequential Organ Failure Assessment (SOFA) and 
systemic concentrations of IL-6, procalcitonin (PCT) and protein C were 
measured before initiation of the study and on days 4 and 7. Also, 28-
day mortality was evaluated for each patient.
Results IL-6 and PCT levels decreased and protein C levels increased 
signifi  cantly in probiotic group over the treatment period (P <0.001). 
There was a signifi  cant diff  erence in IL-6, PCT and protein C levels of the 
7th day between two groups (P = 0.001, 0.006 and <0.001, respectively). 
Compared with controls, probiotic was eff  ective in improving APACHE 
and SOFA scores in 7 days (P <0.001). There was signifi  cant diff  erence 
between the probiotic and control group in the 28-day mortality rate 
(20% vs. 55% respectively, P = 0.048).
Conclusion  Probiotics reduce infl   ammation and mortality rate in 
critically ill patients and might be considered as an adjunctive therapy 
to sepsis.
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Introduction The aim of this study is to establish whether diff  erent 
types of sepsis have an impact on selenium levels. Selenium is an 
essential trace element involved in antioxidant and immunological 
reactions. Selenium levels have been shown to be low in patients 
with systemic infl  ammatory response syndrome and sepsis. Selenium 
replacement has been recommended in patients with sepsis [1,2]. 
Greater than 5 days of supplementation may also help to prevent the 
development of new infections on ICUs [3].
Methods  This is a prospective survey where selenium levels were 
collected from patients admitted with septic shock to a tertiary ICU, for 
6 months from October 2010 to March 2011.
Results Selenium levels were measured in 31 patients with septic shock. 
Abdominal and chest sepsis were the main sources of infection. Those 
with an abdominal source of sepsis had the lowest levels, as shown in 
Table 1. All septic shock patients who had selenium levels taken within 
the fi  rst 10 days of admission had subnormal levels (<0.8 mg/dt), and 
after 10 days had levels within the normal range, as shown in Figure 1.
Table 1 (abstract P247). Mean selenium levels in diff  erent sources of sepsis
Source Quantity  Level  (mg/dl)
Abdominal 12  0.43
Chest 12  0.71
Skin 3 0.55
CNS 2 0.53
GU 2  0.58
Conclusion All patients admitted with early septic shock had subnormal 
selenium levels. Patients with an abdominal source of septic shock had 
the lowest levels. This survey supports previous studies indicating early 
supplementation may be benefi  cial in septic shock patients.
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Introduction  Glutamine regulates many biological functions in 
preserving the cell, acts as a key respiratory fuel and nitrogen donor 
for rapidly dividing cells, and modulates the expression of many genes 
associated with metabolism, cell defences and repair, and cytokine 
production. In severe thoracic trauma, glutamine supplementation 
is essential because the body consumes more than it produces and 
glutamine eff  ects become dependent on its route of delivery.
Methods Fifty-two patients 19 to 78 years old with surgery for severe 
thoracic trauma were assessed in two groups: Group A received 0.3 
to 0.5 g/kg/day i.v. glutamine + 20 g enteral glutamine for 7 days, 
supplementation to enteral nutrition; Group B receive only i.v. 
glutamine supplementation to enteral nutrition 0.3 to 0.5 g/kg/day for 
7 days. Weaning time, the duration of p.o. ileus, incidence and time to 
resolution of VAP, glycemic level and the percentage decrease of CRP at 
96 hours were assessed in both groups.
Figure 1 (abstract P247). Selenium levels before and after 10 days of 
admission.
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lower in Group A; although the incidence of VAP is similar in both 
groups, the time of VAP resolution is lower, the glycemic control is 
better in Group A. The percentage of CRP decrease is higher in Group 
A. See Figure 1.
Conclusion  Glutamine becomes an essential amino acid in severe 
thoracic trauma and when the patients are fed other than TPN (enteral, 
oral); although hard evidence is lacking, both administration routes 
may be effi   cient as soon as possible.
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Introduction  Omega-3 fatty acids have been shown to decrease 
infl   ammatory responses after trauma and surgery resulting in 
Figure 1 (abstract P248). Results.
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n-6:n-3 polyunsaturated fatty acid (PUFA) ratio in parenteral nutrition 
(PN) also infl  uences the immune modulation. The aim of this study 
was to evaluate the optimal ratio of PUFA in postoperative patients 
following abdominal surgery.
Methods  In a prospective, randomized, open-label, comparative, 
multicenter, phase 3 clinical study, we compared the safety and 
effi   cacy of a 2.1:1 ratio of n-6:n-3 fatty acid compared with 2.5:1 in 
postoperative patients requiring PN. Fifty-four patients were assigned 
to receive PN with Combifl  ex Omega peripheral® (CFO, low ratio group, 
n = 28) or SMOFKabiven peripheral® (KAB, high ratio group, n = 26) for 
3 days after abdominal surgery. Safety and effi   cacy were monitored 
daily with laboratory parameters, vital signs, and adverse events from 
the operation day (day 0) until the end of the study (day 4).
Results Total cholesterol (TC) and low-density lipoprotein-cholesterol 
(LDL-C) levels were less changed signifi  cantly in the low ratio group 
(3 ± 18 vs. 16 ± 23 mg/dl, P = 0.027 for TC, 4 ± 12 vs. 12 ± 18 mg/dl, 
P = 0.026 for LDL-C) compared with the high ratio group in postoperative 
patients. Other laboratory parameters and adverse events did not show 
statistically signifi  cant diff  erences between the groups. See Table 1.
Table 1 (abstract P249). Lipid emulsion composition of CFO and KAB
 CFO  KAB
LCT (g/l)  60  60
MCT (g/l)  50  60
Olive oil (g/l)  50  50
Fish oil (g/l)   40  30
n-6:n-3   2.1:1   2.5:1
Conclusion CFO containing low n-6:n-3 PUFA ratio was comparable 
with KAB in safety and effi   cacy in postoperative patients requiring PN 
and also had advantages with regard to lipid metabolism aspect.
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Introduction  Trauma patients who receive fat-based parenteral 
nutrition (PEN) achieve better glucose control compared with those fed 
with glucose-based PEN [1,2]. Therefore, we determined whether fat-
based enteral nutrition (EN) has the same benefi  t on glucose control 
and exogenous insulin demand in medical intensive care patients 
compared with glucose-based EN. Here we present preliminary data 
for this ongoing randomized controlled cohort study.
Methods  Medical critically ill patients with need for mechanical 
ventilation and without contraindications for EN are included in the 
study. Patients are randomly assigned to receive either fat-based 
(n = 30) or glucose-based (n = 30) EN. To evaluate the individual calorie 
demand, indirect calorimetry is performed after an overnight fast. The 
determined amount of EN is administered continuously for 5  days. 
Glucose concentrations are measured at least three times per day and 
averaged. Furthermore, exogenous insulin demand per 24 hours and 
calorie achievement per 24 hours are evaluated daily.
Results So far, 37 patients, 16 with fat-based, 21 with glucose-based EN 
have been included in the study. Both groups had similar age (62 ± 10 
vs. 58 ± 16 years, P = 0.44), body mass index (26.7 ± 5.8 vs. 28.4 ± 4.4 kg/
m2, P = 0.302), SAPS II score (62.4 ± 12.7 vs. 64 ± 12.3, P = 0.697), 
and fasting plasma glucose (132 ± 34 vs. 121 ± 26 mg/dl, P = 0.269). 
Furthermore, resting energy expenditure was similar in both groups 
(1,522 ± 365 vs. 1,573 ± 313 kcal/day, P = 0.647). Throughout the entire 
study period, average blood glucose, exogenous insulin demand, 
and calorie achievements per day were similar between the groups 
(day 1: gluc: 139 ± 30 vs. 127 ± 20 mg/dl, P = 0.143; ins: 27.8 ± 28.4 
vs. 16.2 ± 19.4 IE, P = 0.155; EN: 52.9 ± 25.6 vs. 61.7 ± 25%, P = 0.304; 
day 3: gluc: 129 ± 17 vs. 133 ± 21 mg/dl, P = 0.578; ins: 35.1 ± 30.9 vs. 
32.3 ± 30.5 IE, P = 0.802; EN: 78.3 ± 28.9 vs. 83.4 ± 29%, P = 0.617; day 5: 
gluc: 124 ± 16 vs. 132 ± 17 mg/dl, P = 0.276; ins: 25.7 ± 37 vs. 33 ± 26.4 
IE, P = 0.562; EN: 73.9 ± 41.4 vs. 87.1 ± 23%, P = 0.354). Interestingly, 
the calorie achievement was not associated with insulin demand (day 
1: R = 0.241, P = 0.156) or average blood glucose (day 1: R = 0.248, 
P = 0.14) throughout the study.
Conclusion  Medical critically ill patients with fat-based or glucose-
based EN achieve similar glucose control. EN was not associated with 
glucose concentrations or insulin demand.
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Introduction The optimal feeding of critically ill patients treated in the 
ICU is controversial. Present guidelines for protein feeding are based 
on weak evidence obtained with suboptimal methods. Whole body 
protein kinetics is an attractive technique to assess optimal protein 
intake by measuring the eff  ect of protein feeding strategies on protein 
synthesis rates, protein degradation rates and protein balance. Here 
protein kinetics were measured in critically ill neurosurgical patients 
during hypocaloric and normocaloric parenteral nutrition.
Methods Neurosurgical patients on mechanical ventilation (n = 16) 
were studied. Energy expenditure was measured with indirect 
calorimetry. After that, the patients were randomized to receiving 
24 hours of 50% of measured energy expenditure followed by 24 hours 
of 100% or 100% before 50%. Whole body protein kinetics were 
measured during the last half hour of the feeding periods using stable 
isotope-labeled phenylalanine as a tracer. During a continuous infusion 
of labeled phenylalanine and tyrosine, plasma samples were obtained 
and later analyzed for the content of the labeled amino acids using 
mass spectrometry. Protein kinetics were calculated using standard 
steady-state kinetics. In addition, amino acid concentrations were 
analyzed by HPLC. Student’s t test was used for statistical analyses.
Results The patients received 0.5 ± 0.1 and 1.1 ± 0.2 g amino acids/
kg/day (P <0.001) on the days with 50 and 100% of measured energy 
expenditure respectively. Energy expenditures were 23.4  ±  2.7 and 
24.5 ± 2.3 kcal/kg/day (P = 0.05) on the 50 and 100% days respectively. 
Plasma amino acids concentrations were 2.8 ± 0.5 and 2.9 ± 0.4 mM 
(P = 0.085) on the 2 days respectively. Whole body protein synthesis 
was 12% lower when 50% of energy expenditure was given, 11.7 ± 3.0 
versus 13.3 ± 2.2 mg/kg/hour (P = 0.025), whilst protein degradation 
was unaltered 13.6 ± 3.5 versus 14.0 ± 2.6 mg/kg/hour (P = 0.56). Also 
protein oxidation was unaltered 3.0 ± 2.1 versus 2.9 ± 1.4 mg/kg/hour 
(P = 0.85). This resulted in a 60% higher whole body protein balance 
with the normocaloric nutrition, –1.9 ± 2.1 versus –0.7 ± 1.3 mg/kg/
hour (P = 0.014).
Conclusion The protein kinetics measurements and the protocol used 
were useful to assess the effi   cacy of nutritional support in critically ill 
patients. In the critically ill neurosurgical patients treated in the ICU, 
hypocaloric feeding was associated with a more negative protein 
balance, while the amino acid oxidation was not diff  erent.
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Introduction  ICU-acquired weakness (ICUAW) is a frequent and 
important complication of critical illness [1]. A large randomized 
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that withholding parenteral nutrition during the fi  rst week of ICU stay 
whereby tolerating substantial caloric defi   cit (late PN) accelerated 
recovery and shortened weaning time as compared with early 
parenteral substitution for defi   cient enteral feeding (early PN). We 
examined the impact of late PN, as compared with early PN, on 
incidence and recovery of ICUAW.
Methods A preplanned subanalysis of adult patients included in the 
EPaNIC trial. The study was performed between October 2008 and 
November 2010 and included those patients who required intensive 
care for ≥8 days as well as a computer-generated, admission category-
matched, random sample of short-stay ICU patients, the latter to 
correct for possible bias evoked by earlier ICU discharge in one of the 
two study groups. Assessors blinded for treatment allocation evaluated 
muscle strength clinically three times weekly from awakening onward 
and performed nerve conduction studies and electromyography (NCS 
and EMG) weekly. The primary outcome was the incidence of ICUAW, 
diagnosed clinically by the Medical Research Council (MRC) sum score 
(<48/60) [3] at fi  rst evaluation. Secondary outcomes included ICUAW 
at worst and last MRC evaluation, recovery from ICUAW and incidence 
of abnormal fi  ndings on NCS and EMG. All analyses were performed 
on the total dataset and on a for-baseline characteristics propensity 
score-matched sample to correct for possible imbalances between the 
groups.
Results  Clinical ICUAW evaluation was performed in 600 patients 
(matched  n  =  558), electrophysiological testing in 730 (matched 
n = 684). Late PN reduced the incidence of ICUAW at fi  rst evaluation 
from 43.1% to 34.4%, P = 0.03 (matched: early PN 41.6%, late PN 33.3%, 
P = 0.04). Signifi  cantly fewer patients in the late PN group developed 
weakness at any time during ICU stay (late PN 37.0%, early PN 46.4%, 
P = 0.02; matched: late PN 36.2%, early PN 45.2%, P = 0.03). ICUAW 
may have recovered faster with late PN than with early PN (P = 0.05, 
matched P = 0.06). Other outcomes were not diff  erent.
Conclusion As compared with early PN, late PN reduced the incidence 
of ICUAW and may have accelerated recovery thereof.
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Introduction The goal of enhanced nutrition in critically ill patients is 
to improve outcome by reducing lean tissue wasting. However, such 
eff  ect has not been proven. This study aimed to assess the eff  ect of 
early administration of parenteral nutrition (PN) on muscle volume and 
composition by repeated quantitative computer tomography (qCT).
Methods  We performed a preplanned substudy of a randomized 
controlled trial (EPaNIC) that compared early initiation of PN 
when enteral nutrition was insuffi   cient (early PN) with tolerating a 
pronounced nutritional defi  cit for 1 week in the ICU (late PN) [1]. Late 
PN prevented infections and accelerated recovery. We studied 15 
EPaNIC study neurosurgical patients requiring prescheduled repeated 
follow-up CT scans and six healthy volunteers matched for age, gender 
and BMI. Repeated abdominal and femoral qCT images were obtained 
in a standardized manner on median ICU day 2 (IQR 2 to 3) and day 9 
(8 to 10). Intramuscular, subcutaneous and visceral fat compartments 
were delineated manually. Muscle and adipose tissue volume and 
composition were quantifi  ed using standard Hounsfi  eld Unit ranges.
Results Critical illness evoked substantial loss of femoral muscle volume 
in 1 week, irrespective of the nutritional regimen. Early PN reduced the 
quality of the muscle tissue, as refl  ected by the attenuation, revealing 
increased intramuscular water/lipid content. Early PN also increased the 
volume of adipose tissue islets within the femoral muscle compartment. 
These changes in skeletal muscle integrity correlated with caloric 
intake. In the abdominal muscle compartments, changes were similar, 
albeit smaller. Femoral and abdominal subcutaneous adipose tissue 
compartments were unaff  ected by disease and nutritional strategy.
Conclusion  Early PN did not prevent the pronounced wasting of 
skeletal muscle observed over the fi  rst week of critical illness. Moreover, 
early PN increased the amount of adipose tissue within the muscle 
compartments.
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Introduction Cholestatic liver dysfunction (CLD) during critical illness, 
defi  ned by hyperbilirubinemia, often occurs and is associated with 
poor outcome. Parenteral nutrition (PN) is assumed to aggravate CLD. 
However, hyperbilirubinemia more frequently occurred when the start 
of PN was delayed until day 8 in the ICU (late PN) [1]. Late PN accelerated 
recovery as compared with early initiation of PN.
Methods This was a preplanned subanalysis of a large randomized 
controlled trial on early versus late initiation of PN (n = 4,640) [1]. Plasma 
total bilirubin was quantifi  ed in all patients daily while in the ICU. Liver 
enzymes ALT, AST, GGT and ALP were quantifi  ed twice weekly in all 
patients while in the ICU. In a random predefi  ned subset of patients, 
circulating bile salts were also quantifi  ed with MS-HPLC at baseline 
and on day 3, day 5 and the last day in the ICU (n = 280). Gallbladder 
sludge was evaluated by ultrasound on ICU day 5 by blinded assessors 
(n = 776).
Results From day 1 after randomization until the end of the 7-day 
intervention window, plasma bilirubin was higher in the late PN than 
in the early PN group (all P <0.001). In the late PN group, as soon as 
PN was started on day 8, plasma bilirubin also fell and the two groups 
became comparable. Maximum levels of GGT, ALP and ALT during the 
ICU stay were higher in the early PN group (all P <0.01). Compared with 
baseline, the circulating glycine and taurine conjugated primary bile 
salts were elevated on day 3, day 5 and last day of the ICU stay (P <0.01 
for all). However, there was no diff  erence between the two groups. 
More patients in the early PN than in the late PN group had gallbladder 
sludge on day 5 (45% vs. 37%; P = 0.04).
Conclusion  Tolerating substantial caloric defi  cit by withholding PN 
until day 8 of critical illness increased circulating levels of bilirubin but 
reduced the occurrence of gallbladder sludge and lowered GGT, ALP 
and ALT levels. These results suggest that hyperbilirubinemia during 
critical illness dies not necessarily refl  ect cholestasis and instead may 
be an adaptive response. Additional analyses on a propensity score-
matched patient population are ongoing.
Reference
1. Casaer  et al.: N Engl J Med 2011, 365:506-516.
P255
Impact of early parenteral nutrition on catabolism
J Gunst1, I Vanhorebeek1, MP Casaer1, G Hermans1, PJ Wouters1, J Dubois2, 
K Claes1, M Schetz1, G Van den Berghe1
1KU Leuven, Belgium; 2Jessa Hospital, Hasselt, Belgium
Critical Care 2013, 17(Suppl 2):P255 (doi: 10.1186/cc12193)
Introduction  Prolonged critically ill patients enter a state of 
hypercatabolism and muscle weakness, which has been associated 
with increased morbidity and mortality. Early, full feeding of ICU 
patients has been advocated to counteract catabolism. However, a 
large, multicenter study found that early parenteral nutrition (PN) had 
no signifi  cant impact on mortality and even increased dependency 
on intensive care with, among others, a signifi  cant prolongation of 
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intervention on early markers of catabolism has not been investigated.
Methods  We studied the impact of early versus late PN on daily 
markers of catabolism in the ICU in the total study population and in 
propensity score-matched subgroups of long-stay patients. In addition, 
we calculated the net incorporation rate of the extra amino acids 
supplied by early PN.
Results Plasma urea, the urea/creatinine ratio and nitrogen excretion 
increased over time in the ICU. Early PN further increased these markers 
of catabolism, from the fi  rst day of amino acid infusion onward, and 
only marginally improved the nitrogen balance. Also in the group 
that received PN only after the fi  rst week in the ICU, ureagenesis was 
increased by infusing amino acids. Over the fi  rst 2 weeks, approximately 
two-thirds of the extra amino acids supplied by early PN were net 
wasted in urea. The above fi  ndings were confi  rmed in propensity score-
matched subgroups of long-stay patients. The higher urea levels with 
early PN, rather than the kidney function as such, may have driven the 
observed longer duration of RRT, as supported by multiple regression 
analysis.
Conclusion  The extra amino acids supplied by early PN appeared 
ineffi   cient to reverse the negative nitrogen balance, not because of 
insuffi     cient amino acid delivery, but rather because of insuffi   cient 
incorporation with, instead, increased degradation into urea. The 
substantial catabolism of the extra amino acids, leading to pronounced 
urea generation, may have prolonged the duration of RRT in the early 
PN group.
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Introduction  Muscle weakness of critical illness is associated 
with prolonged dependency on ventilatory support and delayed 
rehabilitation. Muscle wasting related to poor nutrition has long been 
considered a major determinant, whereas the importance of myofi  ber 
integrity only recently emerged [1-4]. We hypothesized that nutrient 
restriction early during illness aggravates atrophy while preserving 
myofi   ber integrity by activating the crucial cellular quality control 
pathway autophagy. The latter could be important to preserve muscle 
function.
Methods Critically ill patients (n = 122) were randomized to early (early-
PN) or late (late-PN) initiation of parenteral nutrition to complete failing 
enteral nutrition, while maintaining normoglycemia (80 to 110 mg/
dl) with insulin, in the EPaNIC study [5]. Vastus lateralis biopsies were 
harvested after 1 week and compared with matched controls (n = 20).
Results As compared with controls, muscle from critically ill patients 
showed reduced myofi  ber density, a shift to smaller (especially type I) 
myofi  bers, lower myosin and actin mRNA, upregulated mRNA of the 
ubiquitin ligases muscle-ring-fi  nger-1 and atrogin-1, a small increase 
in the autophagosome formation marker LC3-II/LC3-I, and increases 
in the autophagic substrates ubiquitin and p62 (all P ≤0.006). Late-PN, 
resulting in a larger caloric defi  cit than early-PN, had no substantial 
impact on atrophy markers. In contrast, late-PN increased LC3-II/LC3-I 
(P = 0.02), which coincided with less accumulation of ubiquitinated 
proteins/aggregates (P = 0.05). Fewer patients on late-PN developed 
muscle weakness as compared with early-PN (42% vs. 68%, P = 0.05). 
In multivariable analysis, a lower LC3-II/LC3-I ratio (P = 0.05) and higher 
myofi  ber density (P = 0.04) were independently associated with muscle 
weakness.
Conclusion  Early-PN did not counteract muscle atrophy whereas 
it suppressed autophagy and aggravated weakness. Statistically, 
muscle weakness was not explained by atrophy or wasting but rather 
by impaired autophagy and preservation of muscle density. Thus, 
tolerating nutrient restriction early during critical illness may preserve 
myofi  ber integrity by activating autophagy.
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Introduction  Closure of an acute hospitals emergency department 
(ED) has important ramifi  cations for those centres expected to take up 
the resultant workload. The continued reconfi  guration of emergency 
care is likely to produce an increasing number of these scenarios. Little 
evidence is available to support planning of such initiatives and thus the 
implications are diffi   cult to anticipate. This study aims to demonstrate 
one hospital’s experience of the rationalisation of emergency care and 
its eff  ect on workload.
Methods This retrospective study was conducted in a large teaching 
hospital. Activity data were analysed for a 12-month period following 
the closure of a neighbouring ED. The results were subsequently 
compared against the year prior to closure. Attendance, triage data, 
admission rates and waiting times were compared across the two 
periods, as were workload data for all grades of physician. The chi-
squared test was used to examine diff  erences between groups.
Results In the period studied, the gross attendance fi  gure increased 
by 20,480 (33.72%), whilst the admission rate rose from 22 to 27%. 
Following closure of the neighbouring ED, the proportion of high-
acuity patients attending our institution increased dramatically, 
with the proportion of category one and two patients (Manchester 
Triage Scale) increasing by 8.33% (P = 0.076) and 18.80% (P <0.001), 
respectively. Likewise, ambulance arrivals increased out of proportion 
to the total increase in attendances (P = 0.016). Admissions from the ED 
to the ICU increased by 63.04%. Consultants workloads now include 
50% more category 1 and 2 patients (P = 0.001).
Conclusion  Reconfi   guration of emergency care can have dramatic 
implications for existing services; these may not always be anticipated. 
Rationalisation of ED’s may result in a concentration of high-acuity 
patients accompanied by a downturn in the numbers of patients 
whose presentations are amenable to care delivered in other settings. 
This abrupt change in case mix requires a re-examination of existing 
workforces and their seniority.
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Overcrowding estimation in the emergency department: is the 
simplest score the best?
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Introduction  Emergency department (ED) overcrowding is a major 
international problem with a negative impact on both patient care and 
providers. Among validated methods of measurement, emergency 
physicians have to choose between simple and complex scores [1,2]. 
The aim of the present study was to compare the complex National 
Emergency Department Overcrowding Scale (NEDOCS) with the 
simple occupancy rate (OR) determination. We further evaluated the 
correlation between these scores and a qualitative assessment of 
crowding.
Methods The study was conducted in two academic hospitals and one 
county hospital in Liège, Chênée and Verviers; each with an ED census 
of over 40,000 patient visits per year. Samplings occurred over a 2-week 
period in January 2011, with fi  ve sampling times each day.
Results ED staff   considered overcrowding as a major concern in the 
three EDs. Median OR ranged from 68 to 100, while the NEDOCS 
ranged from 64.5 to 76.3. We found a signifi  cant correlation between 
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between the OR, the NEDOCS and the subjective evaluation (P = 0.001).
Conclusion Crowding evaluation in the ED requires validated, easy-to-
use, scores. Our study indicates that the simple OR is as accurate as the 
complex NEDOCS, allowing continuous crowding assessment.
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Introduction It is evident that accident and emergency departments 
are overloaded with patients, which results in delays in healthcare 
provision [1]. A large proportion of patients consist of patients with 
minor illness that can be seen by a healthcare provider in a primary care 
setting. The aim of the study was to determine the characteristics of 
patients using GP walk-in services, patients’ satisfaction and the eff  ect 
on emergency department (ED) services.
Methods  The survey was conducted in Sheffi   eld  and  Rotherham 
walk-in centres over 3 weeks during September and October 2011. 
A self-reported, validated questionnaire was used to conduct survey 
on the patients presenting at these centres. We estimated that a 
sample size of around 400 patients from each centre was required to 
achieve statistically robust results. A post-visit, short questionnaire 
was also sent to those who agreed for the second questionnaire and 
provided contact details. ED data were also obtained from April 2008 
to March 2010, 1 year before and 1 year after the opening of the GP 
walk-in centre. Data were entered and analysed in PASW Statistics 18. 
Ethical approval of the study was obtained from the NHS ethical review 
committee.
Results A total of 1,030 patients participated in the survey (Rotherham 
501; Sheffi   eld 529). The mean age of the participants was 32.1 years at 
Sheffi   eld and 30.88 years at Rotherham. A higher proportion of users 
were female, around 59% at both centres. Most of the patients rated 
high for convenience of the centre opening hours and location (above 
85%, apart from the location of Sheffi   eld centre, which was rated high 
by around 72% of the research participants). Overall 93% patients 
were satisfi  ed with the service at Rotherham centre and around 86% 
at the Sheffi   eld centre. Based on the estimation of the monthly counts 
of patients attending ED and the GP walk-in centre, around 14% 
monthly reduction in minor attendances at ED was expected. However, 
ED routine data did not show any signifi   cant reduction in minor 
attendances as a result of the opening of the GP walk-in centre.
Conclusion  These walk-in centres have been shown to increase 
accessibility to healthcare service through longer opening hours and 
walk-in facility. Although the eff  ect on the reduction of patients’ load at 
the ED is not visible as these centres cover a fraction of the population, 
the centre has a potential to divert patients from the ED.
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Introduction  Overcrowding in emergency departments (EDs) is a 
widely known problem. It causes problems and delays in the ED and 
has a negative impact on patient safety [1]. The aim of this study was 
to analyse whether a reform of emergency care can reduce patient fl  ow 
into the ED.
Methods A substantial reform of emergency care took place in the 
province of Kanta-Häme in Southern Finland. Three separate out-of-
hours services in primary healthcare (PHC) and one ED in the hospital 
were combined into one large ED in April 2007. Basic principles of 
the new ED were: the ED is only for those patients who are seriously 
ill or injured, and need immediate care; PHC (healthcare centres) take 
care of acute ordinary illnesses and nonserious injuries during offi   ce 
hours. To achieve these principles a regional fi  ve-scale triage system 
was planned and implemented. The information plan was established. 
Citizens were systematically informed about the principles of the new 
ED by mail, articles in the newspapers and interviews in the radio and 
television. The ED’s Internet pages were planned and established. The 
number of patient visits (Hämeenlinna region) was analyzed 2 years 
before and after establishing the new ED.
Results  During the 2-year period before the establishment of the 
new ED the mean number of GP patient visits was 1,845 ± 43/month. 
During the 2-year period after the reform the number was diminished 
to 1,364 ± 21/month. This change was not associated with the increase 
of the patient visits taken care of by specialists and hospital residents. 
See Figure 1.
Conclusion An extensive reform of the emergency services can notably 
reduce patient fl  ow into the ED.
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Introduction  Rio de Janeiro’s Fire Squad is responsible for EMS in 
the city. During 2010 we implemented 10 ambulances with EKG 
transmission capability in our city. Our intention was to access the 
prevalence of acute myocardial infarction in the prehospital setting.
Methods We used the Aerotel HeartView EKG system to acquire patient 
examination and a blackberry phone to transmit and receive the PDF 
EKG trace. The PDF comes with the cardiologist’s interpretation from a 
remote hospital, the HCOR São Paulo.
Results  We realized 503 EKG examinations in total. Of these, 248 
(49%) had as the chief complaint chest pain, 101 (20%) shortness of 
breath, 47 (9%) syncope, 36 (7%) palpitation; other complaints were 
15%. We detected 32 examinations (6.36%) with ST elevation MI and 
Figure 1 (abstract P260). GP patient visits before and after the reform of 
emergency services.
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detected in 43 examinations (8.5%). See Figures 1 and 2.
Conclusion  This experience gave us an idea of the prevalence for 
acute ST elevation MI in the prehospital setting, so that we can better 
develop our prehospital thrombolysis protocol and focus our training 
for cardiology care.
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Introduction In emergency situations, patients may need a fast and 
reliable peripheral venous access, which sometimes may be diffi   cult 
to obtain, because of poor visualization of the superfi  cial veins due 
to edema, obesity, hypovolemia or local abnormalities. In such cases, 
insertion of a central line is potentially time consuming and possibly 
associated with complications. Furthermore, central lines inserted 
in emergency are known to be at high risk of infection, so guidelines 
recommend that they should removed within 24 to 48 hours. In this 
setting, ultrasound-guided placement of a peripheral venous access 
might be more rapid, safer and more cost-eff  ective than a central line.
Methods We have reviewed retrospectively our experience with the 
emergency use of 18 G or 20 G polyurethane catheters, 8 to 10 cm long, 
inserted by direct Seldinger technique.
Results  In 1  year, 76 long peripheral catheters were inserted in 
emergency conditions, using ultrasound guidance. The success rate 
was 100%; most lines lasted >1 week and were used for diff  erent 
purposes, including contrast medium injection.
Conclusion  The direct Seldinger technique allows a rapid and safe 
placement of the catheter in a vein of the arm or of the forearm, 
even when the vessel cannot be palpated or seen, as long as it can 
be visualized by ultrasound and it is not deeper than 2 cm. The long 
life of this type of peripheral line (up to 2 weeks) is guaranteed by the 
material (polyurethane being more biocompatible than Tefl  on) and 
by the length of the catheter (which reduces the risk of dislodgment). 
Also, these catheters are particularly cost-eff  ective if compared with a 
central line or with a midline catheter, since a complete kit including 
catheter, 20 G needle and 20 cm guidewire costs between €15 and €20.
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Introduction  The lumbar plexus block provides excellent analgesia 
after hip and knee surgery. One approach to the three major nerves 
(femoral, lateral cutaneous and obturator) of the lubar plexus is 
the fascia iliaca compartment block, fi  rst described by Dalens and 
colleagues. Using this blind approach, complete nerve block in the 
distribution of the lumbar plexus may be achieved only in 38% of cases. 
Ultrasound-guided regional techniques off  er a number of advantages 
including real-time needle guidance and direct observation of local 
anesthetic spread within tissue planes.
Methods We hypothesized that real-time UFIB could be successfully 
performed in the ED and would provide an excellent adjunct or 
alternative to repeat doses of IVMS for pain control in patients with HFx. 
The study was conducted at University Hospital, Birmingham, where 
we see about 90,000 patients every year. All patients with confi  rmed 
femoral (neck/shaft) fractures and pain score >7 were included in 
the study. Patients with local wounds, or suspected signifi  cant pelvic 
injury were excluded. A combination of 15 ml lignocaine 1% and 15 ml 
bupvivcaine 0.25% was used. VAS (0 to 10), pain on movement of the 
leg and patient satisfaction were used to assess the outcome. The 
assessments were made before the FIB, at 15 minutes, 30 minutes and 
45 minutes.
Results A convenience sample of 19 patients was enrolled in this study. 
The compartment block was placed by three mergence ultrasound 
trainers. The mean age was 58.5 years. There were 13 females and 
six males. The mean pain score was 9.5 at time 0. The mean pain 
score had improved to 5.5 at 15 minutes, 4.5 at 30 minutes and 3 at 
45 minutes, respectively. The patient satisfaction was scored 4.5 on a 
scale of 1 to 5 where 5 was the most satisfi  ed. No patient required any 
further analgesia up to 90 minutes and no issues were raised about 
the pain or discomfort upon patient transfer. We have no documented 
complications or side eff  ects.
Conclusion  FIB is now widely used by non-anaesthetic trainees to 
combat pain in preoperative care due to its safe landmarks. Our 
results have shown that it can be used safely and eff  ectively for pain 
management in hip fracture by emergency physicians, who are trained 
in the technique, on the shop fl  oor.
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Introduction Abdominal pain in adolescent females has undergone 
recent changes with regards to its management under various 
specialities. The authors report a single-centre audit looking at the 
correct investigation and management of 12-year-old to 16-year-old 
girls with abdominal pain in the emergency department setting.
Methods A single-centre audit and retrospective analysis of patients 
took place using case notes and computerised records. Documentation 
was analysed using statistical analysis and minimum standards were 
set and reviewed.
Results After exclusion criteria 62 females between the ages of 12 and 
16 presented to the paediatric emergency department in Leicester 
with abdominal pain as the predominant admission symptom during 
a 12-month period. Documentation of the gynaecological history 
was poor (menstrual history 47%, sexual history 14%, contraception 
8%), as was the performance of basic investigations (urine dipsticks 
65%, pregnancy test 42%). Documentation was analysed with regard 
to discharge diagnosis. Ultrasound investigation was performed on 
seven of the patients but only once admitted to various specialities. No 
ultrasound was undertaken upon admission.
Conclusion Improvement in documentation of minimum standards 
for these patients is needed. A multidisciplinary care pathway could 
improve outcome. Consideration should be given to whether early 
ultrasound investigation is appropriate and there is a further need for 
investigation as to whether this would improve longer term outcomes.
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acuity in patients presenting with ocular trauma
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Introduction  This study aimed to implement a multidisciplinary 
quality improvement project in Perth Royal Infi  rmary A&E department 
to improve documentation of visual acuity (VA) in patients presenting 
with ocular injury.
Methods  The improvement project involves a three-pronged multi-
disciplinary approach: ensure that equipment required for VA testing 
(Snellen chart and pinhole mask) was readily available; encourage VA 
testing at fi  rst point of contact with A&E staff  , both nursing/medical staff  ; 
and refresher online course on how to test for VA quickly and accurately, 
in the 6/X format. We compared the pre-intervention (2 September to 
2 October 2012) and post-intervention (11  October to 19 November 
2012) rates of VA documentation using the chi-square test.
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who presented to A&E with eye injury, only 36 patients (95%) had their 
VA tested. Following intervention, there was signifi  cant improvement 
in VA testing, where all 43 patients presenting to A&E with eye injuries 
had their VA tested (100%, P = 0.02). Documentation of VA in the correct 
(6/X) format increased from 82 to 84% following intervention. There 
was a 15% improvement in documentation of best-corrected VA, from 
48 to 63% post intervention. See Figure 1.
Conclusion Through a multidisciplinary approach, we were successful 
in achieving our target of 100% VA documentation rate in all patients 
presenting with eye injury to PRI A&E.
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Critical Care 2013, 17(Suppl 2):P266 (doi: 10.1186/cc12204)
Introduction BiPAP utilization for the treatment of severe refractory 
status asthmaticus patients has become an accepted therapy but is 
not well described for moderate exacerbations. We sought to analyze 
outcomes from our BiPAP quality database for children presenting in 
status asthmaticus at varying levels of severity.
Methods  PED status asthmaticus patients requiring BiPAP from 
1  January 2010 to 31  August 2012 had a bedside interview and 
documentation of information at the time therapies were given. 
Incomplete data were collected retrospectively. All data were stored 
and analyzed using a RedCap database. Subjects were stratifi  ed into 
severity groups based on asthma score at the time of BiPAP placement.
Results  There were 206 subjects in the moderate severity group 
and 197 in the severe group. Table  1 shows the groups were well 
matched and compares other pertinent data. Children with severe 
presentations were placed on BiPAP sooner (P <0.001) and remained 
on BiPAP longer (P <0.001). The moderate group had a longer wait 
until BiPAP placement. Tables 2 and 3 demonstrate higher initial BiPAP 
(IPAP/EPAP) settings with increasing age and severity. Figure 1 trends 
initiation and termination asthma scores stratifi  ed by severity at BiPAP 
Figure 1 (abstract P265).
Table 1 (abstract P266). Comparison of children receiving BiPAP for status 
asthmaticus by severity of illness
 Moderate  Severe
 ( n = 206)  (n = 197)  P value
Age (years)  6.8 ± SD 2.8  7.1 ± SD 4.2  X
Gender  62% male  61% male  X
History of asthma  92%  87%  X
Prior PICU admission  21%  32%  X
Prior history of BiPAP use  19%  24%  X
Prior history of intubation  6%  7%  X
Mean triage for BiPAP start (hours)  2.8 ± SD 2.1   1.2 ± SD 1.25  <0.0001
Mean time on BiPAP (hours)  3.9 ± SD 3.6  5.6 ± SD 5.2  <0.0001
Median time on BiPAP (hours)  2.7  3.8  X
Admission to PICU  58%  75%  X
Total length of hospital stay  42 ± SD 26  50 ± SD 33  <0.06
Serious complications  None  None  X
72-hour returns  n = 1 (0.5%) –   n = 4 (2%) –   X
  no admits  no admits
Figure 1 (abstract P266). Initiation and termination asthma scores grouped by severity.
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had overall longer hospitalizations (P <0.06). None experienced severe 
complications.
Conclusion BiPAP is a benefi  cial therapy for children presenting to 
the PED with severe asthma exacerbations. It may have utility for less 
severe asthma exacerbations.
P267
Report of an outbreak of toxicity from a novel drug of abuse in the 
UK: Eric-3
C Morden, S Haig, C Kelly
Great Western Hospital, Swindon, UK
Critical Care 2013, 17(Suppl 2):P267 (doi: 10.1186/cc12205)
Introduction We present a case series of toxicity due to a novel sub-
stance in the UK: Eric-3. Novel drugs of abuse are becoming more 
common throughout the world, and they represent particular 
diffi     culties in their acute management. A recent report from the 
European Monitoring Centre for Drugs and Drug Addiction and 
Europol has reported 49 new psychoactive substances reported via its 
early warning system.
Methods This was a retrospective case-note review over a 6-month 
period. Patients were included if their presentation was due to recent 
ingestion of Eric-3. Physiological data, symptoms, outcome and 
destination of the patient from the emergency department were 
collected. Postmortem toxicological analysis was obtained for one of 
the two patients who died.
Results  Forty-one attendances were identifi   ed from 18 patients. 
Two patients died and fi  ve were admitted to the ICU. Heart rate and 
temperature on arrival tended to be above normal (mean heart rate 
was 112 bpm, with an SD of 18; mean temperature was 37.45°C with an 
SD of 0.95). In total, 63.4% of attendances included agitation and 34.1% 
choreiform movements. α-Methyltryptamine and 3-/4-fl  uoroephedrine 
were found in the blood of one of the patients who died.
Conclusion In this outbreak in the UK, Eric-3 gave symptoms similar 
to other stimulants known as legal highs, including death. It may have 
been a novel substance, 3-/4-fl  uoroephedrine. This underlines the need 
for prospective data collection and early national and international 
information sharing.
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Thallium group poisoning incident in Japan 2011
Y Namba, R Suzuki, J Sasaki, M Takayasu, K Watanabe, D Kenji, M Hayashi, 
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Introduction Thallium is an odorless, tasteless, heavy metal that has 
been often used for intentional poisonings. In severe patients, thallium 
poisoning produces neuromuscular symptoms such as extreme pain 
and muscle weakness.
Methods Five case reports.
Results All patients worked at a pharmaceutical factory. They joined 
a tea party held at their workplace at the end of April 2011. The fi  ve 
patients drank tea from a teapot someone had put thallium in. A few 
days later, they complained of femoral numbness and pain caused by 
pressure. About a week later, three of fi  ve patients had profound hair 
loss. Three weeks after the party, they came to our ER. We thought that 
their symptoms might be caused by some chemicals. We searched the 
keywords: ‘lower extremity pain’, ‘hair loss’ and ‘poison’ in the Internet. 
As a result, thallium, mercury, lead, and so forth, were suspicious 
metals. In those metals, thallium was most likely because it was used 
in their factory. We immediately examined the blood concentration of 
several metals and ordered iron(III)hexacyanoferrate(II) that is known 
as the antidote for thallium poisoning. Only thallium was positive in 
the blood metal concentration test. Three patients consented to oral 
administration of an antidote. Two patients rejected administration 
because their symptoms were mild and getting better. All symptoms of 
all patients gradually disappeared by August. We also followed up the 
course of blood concentration of thallium. The concentration in three 
patients who took the antidote was reduced more rapidly than the two 
patients who did not take it.
Conclusion All patients recovered without any sequelae. Three patients’ 
hair started to grow 3 months from ingestion of thallium, and after half 
a year their hair was restored to their former state. We had diffi   culty 
ordering iron(III)hexacyanoferrate(II) because this is also known as an 
antidote for cesium. On 11 March 2011 a megathrust earthquake and 
tsunami hit Japan and the giant tsunami gave rise to an accident at 
a nuclear power generation plant. Because the rumor of radioactive 
substances including cesium might be spread was the talk in the city 
near the nuclear power plant, the authorities put the antidote under 
heavy supervision. We could also collect the data for the course of 
thallium concentration. Thallium concentration of the patients who 
had an antidote was reduced more rapidly but these patients had a 
loose stool, thought to be a side eff  ect of this antidote.
Reference
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Heart rate variability in children with tricyclic antidepressant 
intoxication
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Introduction Tricyclic antidepressant (TCA) intoxication is among the 
most common causes of poisonings in our country. The TCA group of 
Table 2 (abstract P266). Mean settings by age: moderate group
Age (years)  IPAP  EPAP
<3 (n = 22)  12.1 ± SD 2.1  6.4 ± SD 1.3
3 to 4 (n = 48)  12.1 ± SD 1.6  6.4 ± SD 1.2
5 to 6 (n = 51)  13.0 ± SD 2.3  6.6 ± SD 1.3
7 to 8 (n = 24)  13.9 ± SD 2.1  7.2 ± SD 1.2
9 to 10 (n = 28)  13.9 ± SD3.2  7.4 ± SD 2.0
11 to 12 (n = 25)  13.8 ± SD 1.8  7.0 ± SD 1.3
13 to 14 (n = 10)  13.8 ± SD 3.2  7.4 ± SD 1.4
15 to 17 (n = 8)  17.0 ± SD 2.4  9.5 ± SD 0.9
Table 3 (abstract P266). Mean settings by age: severe group
Age (years)  IPAP  EPAP
<3 (n = 21)  12.7 ± SD 2.0  6.8 ± SD 1.3
3 to 4 (n = 50)  13.3 ± SD 2.8  6.8 ± SD 1.4
5 to 6 (n = 26)  13.9 ± SD 2.2  7.3 ± SD 1.3
7 to 8 (n = 29)  15.0 ± SD 2.4  7.7 ± SD 1.5
9 to 10 (n = 26)  15.7 ± SD 3.5  8.0 ± SD 1.8
11 to 12 (n = 22)  14.5 ± SD 3.2  7.6 ± SD 1.6
13 to 14 (n = 9)  15.3 ± SD 3.2  8.0 ± SD 1.7
15 to 17 (n = 14)  17.5 ± SD 3.0  9.5 ± SD 1.8
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in severe arrhythmia and death. Heart rate variability (HRV) analysis is a 
non-invasive assessment method that allows evaluation of the cardiac 
autonomic (sympathetic and parasympathetic) activity. The aim of this 
study was to evaluate HRV in children requiring ICU stay due to TCA 
poisoning.
Methods Twenty children with isolated TCA poisoning aged between 3 
and 16 years who were hospitalized in the pediatric ICU, between March 
2009 and July 2010, and 20 healthy children as a control group were 
enrolled. Clinical and electrocardiographic (ECG) fi  ndings were noted 
in the TCA poisoning group. In both groups, 24-hour time domain 
HRV analysis (SDNN, SDANN, SDNNi, RMSDD, NN50, and pNN50) was 
performed. We also recorded frequency domain analysis results at the 
fi  rst 5 minutes and the last 5 minutes of the 24-hour record (VLF, nLF, 
nHF, LF/HF ratio).
Results The average level of TCA in the study group was 1,116 ± 635 
and TCA levels were positively correlated with the duration of QRS 
interval (P  <0.01). In time-domain nonspectral evaluation, SDNN 
(P <0.001), SDNN (P <0.05), RMSDD (P <0.01), and pNN50 (P <0.01) 
were found signifi  cantly lower in the TCA intoxication group compared 
with the control group, while NN50 (P <0.01) was signifi  cantly higher 
in value. The spectral analysis (frequency domain) of data recorded at 
fi  rst 5 minutes after intensive care admission showed that the values of 
the nLF (P <0.05) and LF/HF ratio (P = 0.001) were signifi  cantly higher 
in the TCA intoxication group than the controls, while nHF (P = 0.001) 
values were signifi  cantly lower. The frequency domain spectral analysis 
of data recorded at the last 5 minutes showed a lower nHF (P = 0.001) 
in the TCA intoxication group than the controls, and the LF/HF ratio 
was signifi   cantly higher (P  <0.05) in the intoxication group. SDNN 
(P <0.001), RMSDD (P <0.01), SDNNi (P <0.01), and pNN50 (P <0.01) 
levels were higher in patients with positive ECG fi  ndings than those 
without positive ECG fi  ndings. The LF/HF ratio was higher in seven 
children with seizures (P <0.001).
Conclusion  Existing fi  ndings give us an idea about HRV’s value to 
determine arrhythmia and predict convulsion risk in TCA poisonings. 
HRV can be used as a non-invasive method in determining the 
treatment and prognosis of TCA poisoning.
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Introduction Humans can be incidentally parasitized by third-stage 
Anisakis larvae after ingestion of raw or undercooked seafood. 
Although the clinical symptom of anisakiasis is abdominal pain, the 
clinical fi  nding is nonspecifi  c and may be misdiagnosed as appendicitis, 
ileus, and so forth. Every year, >40,000 patients visit our ED and our 
hospital near the Tsukiji market (famous seafood market in Tokyo). We 
often observed cases of anisakiasis in patients who visited the hospital 
with abdominal pain as the chief complaint. Thus, we researched to 
determine factors useful to diagnose anisakiasis.
Methods We retrospectively reviewed data of 83 patients (58 men, 
25 women) diagnosed with anisakiasis in our ED (22 July 2003 to 22 
July 2012) and examined the usefulness of clinical history, blood test, 
diagnostic imaging, and so forth, for anisakiasis diagnosis. Diagnosis 
was made after (A) endoscopically proven Anisakis polypide and (B) a 
hematologically positive Anisakis antibody (IgG, IgA) and CT diagnostic 
imaging.
Results Of the 83 patients, 39 had gastric anisakiasis and 44 had small 
intestinal anisakiasis. All gastric and small intestinal anisakiasis patients 
were diagnosed by methods A and B, respectively. A blood test was 
unable to show the specifi  c infl  ammatory reaction. A history of raw 
or undercooked seafood ingestion was noted in 95.2% (79/83) of the 
patients. This was observed in 100% (39/39) of the gastric anisakiasis 
patients and 91% (40/44) of the small intestinal anisakiasis patients. 
With regard to the development of symptoms, symptoms for gastric 
anisakiasis developed within 48 hours and reached a peak in less than 
6 hours, whereas the symptoms for small intestinal anisakiasis reached 
a peak in 48 hours and persisted for a maximum of 5 days. Diagnostic 
CT imaging revealed that all the patients with gastric anisakiasis 
demonstrated edematous wall thickening of gastric mucosa, and 
ascites was observed in 44.4% (12/27) of these patients. The patients 
with small intestinal anisakiasis demonstrated limited edematous wall 
thickening of the intestinal tract, and ascites was observed in 90.9% 
(40/44) of these patients. Furthermore, phlegmon of mesentery fat was 
observed in 72.7% (32/44) of the small intestinal anisakiasis patients.
Conclusion When the cause of abdominal pain cannot be determined 
by initial assessment, anisakiasis should be considered, especially if the 
patient has a history of raw or undercooked seafood ingestion. In the 
ED, certain methods of diagnosis are evaluation of the time to develop 
symptoms and CT imaging, and a history of raw or undercooked 
seafood ingestion should be considered in the diagnosis.
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Introduction Sepsis has high incidence around the world, approximately 
400,000 new cases occur annually in Brazil. In developing countries 
it is still an important cause of death due to poor adherence to best 
practice medicine protocols, mainly in community hospitals. The 
Brazilian mortality rate of septic shock is around 60%. The aim of this 
study is to describe the fi  rst Brazilian initiative of implementation of a 
Telemedicine (TM) Project for therapeutic support of septic patients in 
a community hospital in São Paulo, Brazil.
Methods Since May 2012, a TM Program has been implemented at 
two hospitals in São Paulo – Hospital Municipal Dr. Moysés Deutsch 
(HMMD), a public, secondary hospital, and Hospital Israelita Albert 
Einstein (HIAE), a tertiary private philanthropic entity  – due to a 
partnership with Brazilian Health Ministry. A TM Central Command 
was located at HIAE with Endpoint 97 MXP Cisco® Solution and a 
mobile Intern MXP ISDN/IP Cisco® for the remote hospital (HMMD) via 
dedicated GB/sec connection. Imaging examinations were evaluated 
using PACS technology. At HMMD, the Sepsis Protocol, based on the 
Surviving Sepsis Campaign, was started for every recruited patient 
admitted to the emergency department (ED) or the ICU, and assessed 
by the Central Command through TM with an experienced consultant.
Results Over a 6-month period, 33 patients with diagnosis of sepsis 
(including severe sepsis and septic shock) admitted to HMMD were 
evaluated by skilled doctors of HIAE via TM, and the Surviving Sepsis 
Campaign protocol was instituted. In total, 87.8% of the consultations 
originated from the ICU and 12.2% from the ED; 16 patients were 
male (48.4%), mean age was 44.2 years old. TM improved diagnosis in 
12.1% and infl  uenced clinical management in 87.9% of the cases; in 
11 patients (33.3%) TM consultation led to antibiotic change. Hospital 
mortality rate was 33.3%.
Conclusion The implementation of the TM Project at a community 
hospital has a major impact in the eICU and eED Sepsis Management 
Program, and improved compliance with recommended care bundles.
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S102Introduction Stroke is the leading cause of death in Brazil, the number 
of stroke patients receiving thrombolysis therapy in the developing 
world is extremely low. Prehospital delay, fi  nancial constraints, and 
lack of infrastructure are the main barriers for thrombolysis therapy in 
developing countries. In this way, telemedicine (TM) allows knowledge 
transfer of medical expertise to remote community hospitals, where 
there is a shortage of specialized doctors. The aim of this study is 
to describe the fi  rst Brazilian initiative of a Telestroke Program for 
therapeutic support and monitoring cases of acute stroke, and venous 
thrombolysis of eligible cases in a community hospital in São Paulo, 
Brazil.
Methods Since May 2012 a TM Program has been implemented at 
two hospitals in São Paulo – Hospital Municipal Dr. Moysés Deutsch 
(HMMD), a public, secondary hospital, distant about 60  minutes 
from the nearest tertiary center, and Hospital Israelita Albert Einstein 
(HIAE), a tertiary private philanthropic entity – due to a partnership 
with Brazilian Health Ministry. Patients admitted to the community 
hospital’s emergency department with acute ischemic stroke as 
possible diagnosis are submitted to brain imaging examinations, 
and considered for remote consultation. A TM Central Command was 
located at HIAE with Endpoint 97 MXP Cisco® Solution and a mobile 
Intern MXP ISDN/IP Cisco® for the remote hospital (HMMD). Imaging 
examinations were evaluated using PACS technology. At HIAE the 
TM Center has skilled doctors, including neurologists, available for 
consultation 24 hours, 7 days a week. They discussed the neurological 
cases via TM, and selected stroke patients for intravenous thrombolysis 
when timely (3 hours symptom onset).
Results  HMMD receives an average of 30 cases of stroke monthly, 
and thrombolysis did not occur before the implementation of the TM 
Project, because of the lack of neurologists available to conduce the 
cases. After implementation of the TM Program, six cases of ischemic 
stroke were thrombolyzed with alteplase; only one case (16%) 
progressed to death from septic shock, and one case (16%) presented 
symptomatic intracranial hemorrhage.
Conclusion  Thrombolysis in ischemic stroke reduces 30% the risk 
of disability and 18% the mortality rate. This procedure has been 
only feasible to be done in the community setting because of the 
implementation of the TM Project, which permits the presence of a real 
time consultation with a specialized neurological team from a tertiary 
center.
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Introduction  Following patients referred by the French emergency 
dispatching centre (SAMU 15) in diff  erent hospital services (emergency 
or ICU) is not always easy. The purpose of this study was to analyze each 
call arriving in the emergency dispatching centre, defi  ne resources for 
transportation, the host hospital department, and analyze the short-
term outcome of these patients.
Methods  We conducted a prospective, observational study, by 
collecting all data recorded at the emergency dispatching centre 
in a continuous 24-hour period. Each call creating a medical fi  le 
was included. We identifi  ed the type of call, various administrative 
information, the purpose of call, resources triggered, medical advice, 
hospital department admission, and clinical evolution.
Results A total of 877 patients were included; 67.80% calling from 
home, 15.63% calling from a public place. Firemen ambulances were 
sent in 38.89%, private ambulance in 24.65% and an emergency 
medical ambulance (SMUR) in 11.23%. Simple medical advice without 
transportation was given in 13.19% of cases. In total, 22.18% of patients 
were entrusted to the family; 2.89% of patients refused transportation; 
69.94% of triggered fi  remen ambulances were done by a centre 18 
call, without any medical regulation by an emergency physician. A 
total of 68.59% patients were referred to the emergency department, 
1.2% in ICU, and 1.8% in cardiac ICU. In the emergency room, 50.78% 
of patients received a simple medical consultation with biological 
analyses, and then returned home. In total, 25.50% of patients were 
hospitalized in a medical or surgical department, and 12.42% in the 
short-term hospitalised unit of the emergency department (stay 
duration <24  hours). Some 5.10% of patients worsened and were 
oriented in the ICU. A total 3.77% of patients in a cardiac ICU. In total, 
73.84% of patients had stay duration less than 6 hours in the ED, 24.45% 
<24 hours. Forty percent of patients supported by fi  remen and 54% 
supported by private ambulance left the hospital after a single medical 
consultation.
Conclusion  Nearly 70% of patients calling the French emergency 
medical dispatching centre are sent to hospital. Those transportations 
are supported for two-thirds of cases by a private ambulance or 
fi  remen ambulance. One out of two patients only receive a simple 
medical consultation in the ED, and go back home. This may concur 
to the defi   ciency of using general medicine in town. They prefer 
using emergency services for free. Only one patient out of four was 
hospitalized more than 24 hours.
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Introduction Early onset eff  ective care in the emergency department 
(ED) has been reported to have a great infl  uence on the intensive care 
patients’ morbidity and mortality [1]. Little is known about the infl  uence 
of the reorganisation of the ED on patient intake to the ICUs. The aim 
of this study was to analyse monthly intake of patients from the ED 
to the cardiac care unit (CCU) and ICU before and after the reform of 
emergency services.
Methods In Kanta-Häme Central Hospital, a new ED started on 1 April 
2007. Four older emergency rooms were combined into one bigger 
emergency department and an observation ward was introduced 
with continuous follow-up of vital signs. This study is a retrospective 
analysis of the patient intake to the CCU and ICU 1 year before and after 
the reorganisation. Using as data the Finnish Intensive Care Quality 
Consortium (Intensium, Finland) database and the cardiac database 
of the hospital, patient transfer from ED to the ICU and CCU was 
collected and analysed. Monthly pre/post comparisons were carried 
out statistically by a nonparametric Wilcoxon signed-rank test.
Figure 1 (abstract P275). Combined patient fl  ow to the ICU and CCU 
before and after the reformation of the ED.
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and CCU was 30.1% (P = 0.003); that is, from the mean of 47.7 ± 8.2 to 
33.3 ± 8.3 patients (Figure 1). The 7.1% decrease in patients taken into 
the ICU (12.9 ± 4.1 to 12.0 ± 4.6 patients) was not statistically signifi  cant. 
However, the intake from the ED to the ICU decreased by 38.6% (from 
34.8 ± 6.5 to 21.3 ± 5.1 patients) (P = 0.002).
Conclusion According to our results the reform of the ED may have a 
signifi  cant role in the total infl  ow of patients to the CCU and ICU.
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P276
Overtriage and undertriage in a prehospital system over 7 years
L Carenzo, F Barra, A Messina, D Colombo, T Fontana, F Della Corte
Universitè del Piemonte Orientale A. Avogadro, Novara, Italy
Critical Care 2013, 17(Suppl 2):P276 (doi: 10.1186/cc12214)
Introduction The Novara 118 emergency medical system (EMS) dispatch 
center manages medical emergency calls coming from a region that 
spreads out over 1,400 km2 and includes 88 towns and a population of 
385,000 people; inhabitant density is 275 inhabitants/km2.
Methods Data collection from 1 January 2005 to 31 December 2011 
was obtained (EMS software SaveOnLine® Suite 4; REGOLA s.r.l., Turin, 
Italy). Triage used was the Medical Priority Dispatch System and severity 
was defi  ned by color codes.
Results  During the study period the Novara 118 dispatch center 
managed a total of 122,384 EMS interventions. Median (interquartile) 
overestimation (regardless of severity) was 10.0% (2.4 to 14.1%) while 
median underestimation was 1.5% (0.8 to 2.5%). See Tables 1 and 2.
Table 1 (abstract P276). Overtriage (%)
      Overtriage
  2005 2006 2007 2008 2009 2010 2011
Other  3.03 2.47 5.30 4.95 4.06 4.58 4.17
Cardiac  13.23 15.30 27.06 23.72 19.28 19.17 20.14
Drunk  0.00 0.00 0.00 0.00 0.00 0.00 0.00
Poisoning  10.19 18.92 17.91  8.47  8.85  15.20 11.81
Oncological  0.00 2.78 1.05 1.03 3.03 2.47 0.00
Neurologic  9.97  10.05 15.59 15.18 14.57 13.32 13.32
Not  identifi   ed 13.03 13.15 11.84 11.07 10.33 11.79  7.23
Mental  1.30 0.41 2.09 2.34 2.30 1.27 2.35
Respiratory  10.67 10.89 22.09 18.63 16.29 18.23 14.12
Trauma  12.97  12.68  10.42  8.59 6.78 7.74 7.56
Table 2 (abstract P276). Undertriage (%)
      Undertriage
  2005 2006 2007 2008 2009 2010 2011
Other  1.01 0.77 2.87 1.66 1.44 1.48 1.31
Cardiac  2.16 1.44 1.64 1.60 2.15 1.60 1.14
Drunk    0.00 1.89 0.00 0.00 0.00 0.00 0.00
Poisoning  8.33 0.00 0.00 1.69 0.00 1.60 0.00
Oncological  95.74  0.56 0.00 1.03 3.03 2.47 0.00
Neurologic  2.42 2.32 2.96 3.67 3.05 1.40 2.46
Not  identifi   ed 1.72 2.13 1.87 2.20 2.04 2.74 3.50
Mental  1.74 0.83 1.05 1.17 0.00 0.42 0.39
Respiratory  2.30 4.16 3.76 3.75 2.57 2.72 2.46
Trauma  1.07 0.92 1.50 1.41 1.36 1.31 1.46
Conclusion Overall there were no statistical diff  erences between the 
observation years either for overtriage or undertriage. When observed 
individually, trauma showed the only signifi  cant overtriage reduction 
over time; there were no individual modifi  cations in undertriage over 
time.
Reference
1.  Neely KW, Eldurkar JA, Drake ME: Acad Emerg Med 2000, 7:174-180.
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Introduction On 11 May 2011 two moderate magnitude earthquakes 
hit the city of Lorca, southeast Spain. They caused 11 deaths, including 
two pregnant women and their babies, more than 350 injured, and 
moderate or severe damage to 80% of the building in the city, including 
Lorca’s public hospital that had to be evacuated.
Methods A descriptive study of the fi  les of Lorca’s hospital and the 
clinical records of patients that attended our service in the 20 hours 
following the second earthquake on 11 May.
Results A total of 225 patients were relocated. Simultaneously 224 
patients were treated by the emergency service, until the evacuation 
was completed and after then, from 10:00 pm to 3:00 pm the next day, 
47 more in a fi  eld hospital placed just outside the hospital building. See 
Figures 1 and 2.
Figure 1 (abstract P277). Hospital evacuation.
Figure 2 (abstract P277). Emergency service taking care of patients 
during evacuation.
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were given attention by the emergency service of Lorca’s hospital, 
with the support of personnel from other services of the hospital. The 
emergency service of the hospital continues to be operative in the 
building until evacuation is completed and in a fi  eld hospital later.
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Introduction We intended to compare paediatric traumatic injuries 
due to war and others related to civilian accidents (CA).
Methods We conducted an observational epidemiologic retrospective 
study on paediatric cases (<18 years old) seen at the emergency room 
of Kabul International Airport NATO role 3 medical treatment facility 
between 2009 and 2012.
Results During 3 years, 341 children were admitted to the emergency 
room (ER) with a mean age of 10 years (9.49 to 10.51). Eighty-eight 
per cent of children (301) were traumatized, 39% of them (118) due to 
war injuries (WI) and 61% (183) due to CA. Forty-three per cent of WI 
(gunshot wound 34%, explosion 66%) but only 19% of injuries due to 
CA (falls 24%, transport accidents 56%, burns 9%, penetrating injuries 
9%, unknown cause 2%) involved polytraumas defi  ned as a New Injury 
Severity Score (NISS) >15 (P <0.001). Patients experiencing a traumatic 
injury related to war had lower Paediatric Trauma Scores (PTS) than 
those injured in a CA (PTS = 6.4 (5.7 to 7.0) vs. PTS = 9.0 (8.7 to 9.4) 
respectively, P <0.00001), higher ISS (ISS = 16.7 (13.8 to 19.6) vs. ISS = 8.9 
(7.5 to 10.2) respectively, P <0.00001), NISS (P <0.0001), mortality rate 
predicted by the Trauma Injury Severity Score (TRISS, P <0.02) or A 
Severity Characterization of Traumas (ASCOT, P <0.001). The result is 
longer overall hospitalization of patients having WI (P < 0.001) and a 
higher number of surgeries (P <0.02). After the ER, 54% of patients with 
WI were hospitalized in the ICU (86% of them after surgery) but only 
26% of patients involved in a CA (71% after surgery). As many patients 
with WI as involved in a CA (40%) were admitted to the ward (89% of 
patients with WI after surgery but only 63% of patients with injuries 
due to a CA). Thirty-three per cent of patients involved in a CA returned 
home and one was transferred, whereas only three patients with WI 
returned home after being in the ER, three patients were transferred 
and one died in the operating room. Observed paediatric mortality in 
our medical treatment facility was 2.9% (10 children out of 341): three 
children died of WI, three due to a CA and one of septic shock due to a 
medical cause.
Conclusion War injuries are more prone to cause polytrauma than CA. 
According to the PTS, ISS, NISS, TRISS and ASCOT, children experiencing 
WI have higher severity scores and predicted mortality rate than others, 
stay longer in the hospital and have more surgeries.
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Introduction There were several catastrophes in the last decades. The 
make-up of systematic measuring and life-saving medical systems, 
including intensive care, is thought to be an urgent and essential issue. 
Our eff  orts for establishing a disaster medicine and education system 
are presented.
Methods Mega-disasters or catastrophes are researched basically on 
actual medical experience; that is, the 9/11 attack in 2001, Hurricane 
Katrina in 2005, Indian Ocean earthquake with tsunami in 2004, the 
Chernobyl incident in 1986 as well as the Higashinihon earthquakes 
with tsunami, which was followed by the severest degree of nuclear 
disaster in 2011.
Results  Our research indicated that disaster medicine should be 
established systematically or it is necessary to compile a compendium 
of disaster medicine from a broad perspective or from a bird’s-eye and 
long-term view. The Japanese version was tentatively completed with 
22 volumes as of the fi  nancial year 2005, of which nearly three-quarters 
are written in Japanese. Although this worked partly during the above-
shown catastrophe in Japan 2011, several problems are left to be 
solved; that is, the insuffi   cient operation system of the Japan DMAT or 
Disaster Medical Assistant Team that seemed to have caused a large 
number of preventable deaths.
Conclusion The large number of casualties during a major disaster is a 
global problem, even in the developed countries. When the role of the 
intensivist is reviewed, many roles were verifi  ed to be important; that 
is, as a leader of a medical team or triage offi   cer as well as a professional 
in the fi  eld of specifi  c intensive care. However, there are many problems 
to be solved in the fi  elds of disaster medicine. In order to solve the 
diversifi   cation or the various medical problems, it is necessary to 
compile or systematize a disaster medicine of the world version. The 
concept of the compendium and our process of trial are shown in 
relation to intensive care.
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Introduction  The study aimed to determine factors related to ICU 
mortality in critically ill patients transferred by Adult Retrieval Victoria 
(ARV) medical staff  . Patients who died in the ICU after interhospital 
transfer were compared with those who survived.
Methods This is a retrospective cohort study of ARV cases between 
1 January 2009 and 30 June 2010. Retrieval data were linked with data 
from the ANZICS CORE APD (Australia and New Zealand Intensive Care 
Society Centre for Outcome and Resource Evaluation Adult Patient 
Database). Victoria Data Linkage (VDL) performed linkage of the data. 
Data included demographic and clinical data obtained during transfer 
and data related to outcome measures in the ICU.
Results Of the 601 cases transferred by ARV during the study period, 
549 were eligible for linkage to 25,543 ANZICS APD case records for 
the same period. VDL matched 460 of these cases (83.8%). Logistic 
regression analysis revealed the variables associated with mortality 
were advanced age (OR = 1.02, 95% CI = 1.00 to 1.04, P = 0.02), cardiac 
principal referral problems (OR = 1.84, 95% CI = 1.02 to 3.32, P = 0.04), 
lower mean arterial blood pressure (OR = 0.97, 95% CI = 0.95 to 0.99, 
P = 0.005) and tachycardia (OR = 1.02, 95% CI = 1.00 to 1.03, P = 0.008) 
on arrival at the destination hospital.
Conclusion Advanced age, lower mean arterial blood pressure and 
tachycardia towards the completion of transfer were associated with 
increased ICU mortality in this population. Clinicians should be aware 
of the additional risk for cardiac patients.
References
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Introduction Survival rates following traumatic cardiac arrest (TCA) 
are known to be poor but resuscitation is not universally futile [1]. 
Critical Care 2013, Volume 17 Suppl 2 
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cardiac arrests and TCA. Traumatic pathologies associated with an 
improved chance of successful resuscitation include hypoxia, tension 
pneumothorax and cardiac tamponade [1]. The authors believe a 
separate algorithm is required for the management of out-of-hospital 
TCA attended to by a highly trained physician and paramedic team.
Methods A suggested algorithm for TCA was developed based on the 
Greater Sydney Area Helicopter Emergency Medical Service’s standard 
operating procedures and current available evidence.
Results An algorithm for the general management of TCA can be seen in 
Figure 1. In TCA, priority should be given to catastrophic haemorrhage 
control (tourniquets, direct pressure, haemostatic agents, pelvic 
and long bone splintage) and volume resuscitation. Simultaneous 
oxygena  tion optimisation should occur with proactive exclusion of 
tension pneumothoraces with bilateral open thoracostomies. Cardiac 
ultrasound (US) should be used to help exclude cardiac tamponade 
and assist in prognostication. The US presence of true cardiac standstill 
versus low pressure state/pseudo-PEA, and an ETCO2 <1.3 kPa carries 
a grave prognosis in TCA. Given the high incidence of hypovolaemia, 
hypoxia and obstructive shock prior to TCA, the role of adrenaline and 
chest compressions are limited. Figure 2 shows a suggested algorithm 
for the management of penetrating TCA requiring prehospital 
thoracotomy.
Conclusion The suggested algorithm is designed for a highly trained 
physician-led prehospital team and aims to maximise the number of 
neurologically intact survivors in out-of-hospital TCA.
Reference
1. Lockey  D,  et al.: Ann Emerg Med 2006, 48:240-244.
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Introduction A winch-capable helicopter emergency medical service 
(HEMS) off  ers several advantages over standard rescue operations. 
Little is known about the benefi  t of physician winching in addition 
to a highly trained paramedic. We analysed the mission profi  les and 
interventions performed during rescues involving the winching of a 
physician in the Greater Sydney Area HEMS (GSA-HEMS).
Methods All winch missions involving a physician from August 2009 
to January 2012 were identifi  ed from the prospectively completed 
GSA-HEMS electronic database. A structured case-sheet review 
for a predetermined list of demographic data and physician-only 
interventions (POI) was conducted.
Results  We identified 130 missions involving the winching of a 
physician, of which 120 case sheets were available for analysis. The 
majority of patients were traumatically injured (90%) and male (85%) 
with a median age of 37 years. Seven patients were pronounced life 
extinct on the scene. A total of 63 POI were performed on 48 patients. 
Administration of advanced analgesia was the most common POI 
making up 68.3% of interventions. Patients with abnormal RTSc2 
scores were more likely to receive a POI when compared with those 
with normal RTSc2 (P = 0.03). The performance of POI had no effect 
on median scene times (45 vs. 43 minutes; P = 0.51). See Tables 1 
and 2.
Conclusion Our high POI rate of 40% coupled with long rescue times 
and the occasional severe injuries supports the argument for winching 
doctors. Not doing so would deny a signifi  cant proportion of patients 
time-critical interventions, advanced analgesia and procedural 
sedation.
Figure 1 (abstract P281). Traumatic cardiac arrest algorithm.
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Introduction The aim was to assess the content and state of repair of 
equipment carried for transfer of critical care patients to other hospitals. 
By chance, several items of date-expired stock were identifi  ed in the 
transfer kit whilst moving a patient to a tertiary centre. This raised the 
possibility of a more extensive problem with the equipment bags. 
Due to the geographical location of our district general hospital we 
undertake around 70 transfers of critical care patients to other hospitals 
per year (16% by air) and it is clearly important that our equipment is 
well maintained for these journeys.
Figure 2 (abstract P281). Thoracotomy algorithm.
Table 1 (abstract P282). Demographic data, timings and Coded Revised 
Trauma Score (RTSc2)
   Total  (n = 120)
Male   102 (85)
Median (IQR) age (years)  37 (26 to 53)
Received a physician-only intervention  48 (40)
Pronounced life extinct on arrival  7 (5.8)
RTSc2
 7.8408  104  (86.7)
  7.0001 to 7.8407  2 (1.7)
  6.0001 to 7.0000  4 (3.3)
  5.0001 to 6.0000  4 (3.3)
  4.0001 to 5.0000  0 (0)
 <4.0001  6  (5)
Table 2 (abstract P282). Interventions performed
Physician-only intervention  Number of interventions (n = 63)
Analgesia/procedural sedation
  Intravenous ketamine  42 (66.7)
  Intravenous fentanyl  1 (1.6)
  Fascia iliaca compartment block  1 (1.6)
Airway management
  Rapid sequence induction and intubation  4 (6.3)
  Surgical airway  1 (1.6)
Circulatory support
  Adult intraosseous access  1 (1.6)
  Blood transfusion  2 (3.2)
Orthopaedic manipulation of joint/limb  6 (9.5)
Thoracostomy 1  (1.6)
Diagnostic ultrasound  1 (1.6)
Hypertonic saline administration  3 (4.8)
Data presented as n (%).
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fl  uid, airway management items, and so forth) and drug bags to take 
on transfers; one equipment and one drug bag taken on each trip. 
The contents of all four bags were checked and itemised. By careful 
consideration of the aims of the bags (to provide emergency equipment 
and drugs for managing one patient during an en-route emergency) a 
new inventory was devised. Excess items were removed to lighten the 
bags and improve accessibility to the essential items. Expired stock was 
removed. A daily checking procedure and tamper-proof seals on the 
bags were instigated and the bags were reassessed 12 months later.
Results A total of 13.9% of drug items and 29.2% of equipment items 
had expired or would do so within 30 days of the initial assessment. The 
combined weight of one equipment and one drug bag was reduced 
from 14 to 9 kg (36% reduction) by introducing the new inventory. At 
reassessment in November 2012, only 10 items of equipment (3.2%) 
were expired or near to expiry and there were no expired drug items 
(4.1% near to expiry). In total, 0.3 kg (26 small items) of extraneous 
equipment had been added through over-restocking and was removed.
Conclusion These bags are designed for a clinician to manage a patient 
when an emergency arises during transfer of a critical care patient. By 
the introduction of simple measures, the risks posed by expired items 
or cluttered equipment bags have almost been eradicated. Signifi  cant 
weight savings have been made; this off  ers improved ergonomics 
for staff    and is also an important consideration for aeromedical 
operations. Our department was surprised to discover the extent of 
decline of our equipment and it may be that other departments would 
fi  nd themselves in a similar position. The anaesthetic registrars who 
routinely escort the transfer patients have a vested interest to maintain 
this equipment and this has secured their buy-in to the new checking 
procedure with clear results.
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Introduction The aim was to assess care of patients during intrahospital 
transfer. The UK Royal College of Anaesthetists has defi  ned auditable 
standards for the care of patients and the training of escorting medical 
and nursing staff   in this context [1].
Methods Patients in a 27-bed combined general and neurosurgical 
critical care unit were studied in January 2011 and May 2012. Patients 
undergoing radiology department imaging or intervention were 
identifi  ed from the electronic imaging library. Records of these transfers 
were sought in the critical care electronic notes and the standards of 
documentation graded on a fi  ve-point scale (very good, good, average, 
minimal, absent). Documentation of the grade and training of escorting 
staff   was also sought. Between the two study periods, a transfer safety 
checklist was introduced.
Results  A total of 20.9% of 143 patients underwent one or more 
transfers in January 2011 (40 transfers). In May 2012, 26.4% of 151 
patients underwent 57 transfers. In the fi  rst period, documentation 
was graded as minimal (limited to a statement that the patient had 
left the critical care unit) or absent in 77.5% of transfers. In the 62.5% 
of patients transferred whilst on invasive ventilation, 88.0% had no 
documentation by the doctor and in 84.0% it was not known which 
doctor had escorted the patient. There was only slight improvement 
in the second period (71.9% minimal or absent documentation, 80.0% 
no documentation by the doctor, 72.0% not known which doctor 
escorted). In the documentation available, six severe complications 
were noted during the second period (including episodes of severe 
bradycardia, hypotension and pupil dilatation).
Conclusion  On average our unit conducts nearly two critical care 
transfers each day. Severe complications seem to complicate at least 
10% of these, stressing the risk, need for good care and ongoing 
training. The intervention made in this audit had little impact on the 
standard of documentation. However, it has raised the issue within the 
consciousness of the staff  . It is important to identify interventions that 
have failed to reach a gold standard to provide the impetus to seek 
other solutions. As a result of this study, the author has devised new 
hospital protocols and specifi  c training courses to improve standards 
of transfer medicine locally. The study also identifi  ed our portable head 
CT scanner to have the potential to reduce transfers by 52% and so this 
has been strongly promoted.
Reference
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Introduction The association between hyperoxemia and neurological 
outcome in trauma patients is not clear. We examined the association 
between prehospital hyperoxemia and neurological outcome in 
polytraumatized patients.
Methods This was a retrospective study of polytraumatized patients 
with traumatic head injury who were endotracheal intubated and 
ventilated with supplemental oxygen (100%) in the prehospital 
emergency setting. Arterial partial oxygen pressure (PaO2) was 
measured after arrival at the hospital trauma center. We included 
patients with initial PaO2 above 160  mmHg (hyperoxemia group). 
The severity of the trauma was determined upon the admission to 
the hospital by the Injury Severity Scale (ISS) and the outcome was 
assessed at the discharge from the hospital using the Glasgow Coma 
Scale (GCS), Glasgow Outcome Scale (GOS) and Cerebral Performance 
Categories scale (CPC). Mann–Whitney’s test was used for data analysis.
Results Sixty patients were involved in the study. Forty-eight (80%) of 
them were men and 86.7% sustained blunt trauma. Hyperoxemia was 
present in 41.6% of patients. Initial average ISS was 38, in patients with 
normoxemia 32.5 and in patients with hyperoxemia 35.4. Discharge 
GCS, GOS and CPC in the hyperoxemia group compared with the 
normoxemia group were 9.86 versus 9.33 (P  =  0.503), 2.52 versus 
2.24 (P = 0.613) and 3.10 versus 3.19 (P = 0.936) with the duration of 
hospitalization of 26.64 days versus 27.72 days (P = 0.984).
Conclusion Prehospital hyperoxemia did not infl  uence the functional 
neurological outcome. One of the reasons for this fi  nding could be 
the short arrival time to the trauma center where repeated analyses of 
arterial blood gases were performed. Therefore, correction of fraction 
of inspired oxygen according to the arterial blood gas analysis shortens 
the time of hyperoxemia, thus reducing neuronal brain damage.
References
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Introduction The soluble form of urokinase-type plasminogen activator 
(suPAR) has been identifi  ed as a marker for immune activation and is 
demonstrated to accurately predict outcome in patients with sepsis or 
infectious diseases. In multi-trauma patients a considerable immunological 
response also occurs that is related to multiple organ failure and patient 
outcome. We investigated the kinetics of suPAR, correlation with the 
immune response and outcome in multi-trauma patients.
Methods Blood was obtained from adult multi-trauma patients (n = 63) 
on arrival at the emergency room (ER) of the Radboud University 
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Plasma concentrations of TNFα, IL-6, IL-10, IFNγ, IL-8 and MCP-1 were 
determined by Luminex, and SuPAR concentrations using ELISA. Clinical 
data were collected from electronic patient fi  les. Concentrations, areas 
under the curve (AUC) and regression coeffi   cients were statistically 
analyzed. Spearman correlation coeffi     cients were calculated and 
diff  erences between survival/nonsurvival groups were analyzed using 
unpaired Student t tests.
Results SuPAR values at admission to the ER were higher in nonsurvivors 
compared with survivors (n = 16, mean ± SEM 4.1 ± 0.6 ng/ml vs. n = 40, 
3.0 ± 0.2 ng/ml, P = 0.03). SuPAR levels increased in time. An increase of 
suPAR did not predict or precede death, however. SuPAR AUC from ER 
to day 5 tended to correlate with injury severity score (r = 0.5, P = 0.07). 
Plasma cytokines in the ER did not correlate with suPAR measured at 
the same time (for example, TNFα: r = 0.2, P = 0.37, IL-10: r = –0.02, 
P = 0.91), while cytokine concentrations at the ER did correlate with 
suPAR levels at days 3 (TNFα: r = 0.6, P <0.01, IL-10: r = 0.5, P = 0.02) and 
5 (TNFα: r = 0.7, P <0.01).
Conclusion Plasma concentrations of SuPAR measured at admission 
to the ER are associated with overall survival of multi-trauma patients. 
Furthermore, suPAR concentrations increased during hospital 
admission, with most pronounced increases found in patients that 
suff  ered more serious injury and related to the innate immune response 
determined in the ER. These results indicate that suPAR is an innate 
immune response-induced late mediator in multi-trauma patients.
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Introduction Severe burn patients are often noted to have subsequent 
neurocognitive problems. Experimentally, we have found striking, 
prolonged elevations of infl   ammatory markers in the brain (for 
example, IL-6) even when the injury occurs in a remote anatomic 
location. This neuroinfl  ammatory response can also be signifi  cantly 
blunted by a single post-burn dose of estrogen. Sonic hedgehog (SHH), 
an important signaling protein found in the brain, controls and directs 
diff  erentiation of neural stem cells, infl  uencing brain regeneration and 
repair by generating new neurons throughout life. As estrogens not 
only blunt infl  ammation but also exert an infl  uence on a variety of stem 
cells, we hypothesized that 17β-estradiol (E2) might aff  ect levels of SHH 
in the post-burn rat brain.
Methods Male rats (n = 44) were assigned randomly into three groups: 
controls/no burn (n = 4); burn/placebo (n = 20); and burn/E2 (n = 20). 
Burned rats received a 40% 3° TBSA dorsal burn, fl  uid resuscitation and 
one dose of E2 or placebo (0.5 mg/kg intraperitoneally) 15 minutes post 
burn. Eight animals from each of the two burn groups (burn/placebo 
and burn/E2) were sacrifi  ced at 24 hours and at 7 days, respectively 
(sham group at 7 days only), with four each of the two burn groups 
sacrifi  ced at 45 days. Brain tissue samples were analyzed by ELISA for 
SHH.
Results Mean levels of SHH levels were signifi  cantly elevated within 
24 hours as much as 45 days post injury in burned animals receiving 
the 17β-estradiol (>1,200  pcg/mg) as compared with the placebo-
treated burned animals (<700 pg/mg) and controls (<300 pcg/mg). See 
Figure 1.
Conclusion  Early, single-dose estrogen administration following 
severe burn injury signifi  cantly elevated levels of SHH in brain tissue. 
This fi  nding may represent an extremely novel and important pathway 
for both neuroprotection and neuroregeneration in burn patients.
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Introduction Many proposed resuscitative therapies for cardiac arrest 
and trauma will require the earliest possible intervention and would 
occur under volatile circumstances, making true informed consent for 
clinical trials unfeasible. The purpose here was to report our experience 
using exception to informed consent during the inaugural pilot study 
of infusing estrogen for acute injury, the so-called RESCUE Shock study.
Methods  Fifty patients were enrolled in RESCUE Shock in which 
estrogen or placebo was infused as soon as possible in the emergency 
department for trauma patients with a low systolic blood pressure 
(<90 mmHg) at two level I trauma centers. They were all treated with 
a single-dose estrogen or placebo infusion within 2  hours using 
exception from informed consent following US federal guidelines.
Results  Investigator-initiated exception from informed consent 
studies is feasible, with our FDA IND approval obtained in 31 days, 
IRB 1 approval in 25 days, and IRB 2 approval in 24 days. Community 
consultation/notifi  cation was successfully accomplished with no one 
opting out and 47/50 enrolled patients or their legal representatives 
were notifi  ed of participation (one died unidentifi  ed, two died with no 
known contact). The average number of days to verbal notifi  cation of 
patients or advocates was 6.55 days (range 0 to 51 days) as the study 
team began notifi  cation only after the patient or family was able to 
reasonably understand information about the study. No one decided 
against continued follow-up. Overall, patients and their families were 
very enthusiastic about participation and the data safety monitoring 
board had no safety concerns after reviewing all study data.
Conclusion Although delayed notice of participation occurs for many 
justifi  able reasons, the use of exception from informed consent for 
novel, time-sensitive resuscitation studies is not only crucial, but 
can be feasible, and well accepted by patients, their advocates and 
communities at large.
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Early administration of a single dose of parenteral estrogen 
decreases infl  ammation in the heart for 45 days after severe burns
PE Pepe, JG Wigginton, JW Gatson, AH Idris
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Introduction  Patients with severe burn injury experience a rapid 
elevation in multiple circulating proinfl  ammatory cytokines, with the 
levels correlating with both injury severity and outcome. In animal 
Figure 1 (abstract P287).
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remote organs, including the heart, brain and lungs. However, data 
are lacking regarding the long-term levels of cytokines in the heart 
following severe burn injury and also how infusion of parenteral 
estrogen, a powerful anti-infl   ammatory agent, would aff  ect  these 
levels. Using a rat model, we studied the eff  ects of a full-thickness third-
degree burn on cardiac levels of IL-6 and TNFα over 45 days with and 
without 17β-estradiol infusion.
Methods A total of 168 male rats were assigned randomly to one of 
three groups: (1) Sham burn (no actual injury) group (n = 8); (2) Placebo 
(no treatment) burn group (n = 80); and (3) E2 (estrogen treatment) 
burn group (n = 80). Groups 2 and 3 had 40% TBSA third-degree dorsal 
burns, early fl  uid resuscitation and, 15 minutes post burn, 0.5 mg/kg 
intraperitoneal estrogen (Group 3) or placebo (Group 2). From each 
group of 80, eight animals were sequentially sacrifi  ced (and cardiac 
tissue was sampled for IL-6, TNFα, IL-1β) at one of 10 respective time 
points: 0, 0.5, 1, 2, 4, 6, 8, 18, 24 hours and day 7 post burn (at day 7 only 
for the eight shams). The markers were measured by ELISA method.
Results In the burned rats, 17β-estradiol signifi  cantly decreased the 
cardiac levels of TNFα at all time points through 45 days post burn, with 
the sham animal levels (30 pg/mg) more comparable with the estradiol 
group (70  pg/mg), and signifi  cantly less than the placebo animals 
(332 pg/mg). Similarly, IL-6 levels in the sham animals (70 pg/mg) were 
comparable with the estradiol group (86.5 pg/mg), and signifi  cantly 
less than the placebo group (730 pg/mg), even at 45 days post burn.
Conclusion Following severe burn injury in an animal model, an early 
single dose of estrogen can decrease the prolonged let alone the early 
onset of cardiac infl  ammation. Based on these data, clinical studies 
of estrogen infusions should be seriously entertained as estrogen 
may not only be an inexpensive, simple adjunctive therapy in burn 
management, it may also obviate the need for many subsequent 
interventions altogether and even diminish mortality.
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Introduction  Blunt abdominal trauma (BAT) is a leading cause of 
morbidity and mortality. Rapid diagnosis and treatment with the 
Advanced Trauma Life Support guidelines are vital, leading to the 
development of focused assessment with sonography in trauma (FAST).
Methods A retrospective study carried out from January 2007 to 2008 
on all patients who presented with BAT and underwent FAST scan. All 
patients subsequently had a CT scan within 2 hours of admission or a 
laparotomy within 2 days. The presence of intraperitoneal free fl  uid was 
interpreted as positive.
Results One hundred patients with BAT presented; 71 had complete 
data. The accuracy of FAST in BAT was 59.2%; in these, 31 (43.7%) were 
confi  rmed by CT and 11 (15%) by laparotomy. There were 29 (40.8%) 
inaccurate FAST scans, all confi  rmed by CT. FAST had a specifi  city of 
94.7% (95% CI: 0.75 to 0.99) and sensitivity of 46.2% (95% CI: 0.33 to 
0.60). A positive predictive value of 0.96 (0.81 to 0.99) and negative 
predictive value of 0.39 (0.26 to 0.54). Fisher’s exact test shows positive 
FAST is signifi   cantly associated with intra-abdominal pathology 
(P  =  0.001). Cohen’s chance corrected agreement was 0.3. Twenty-
one out of 28 who underwent laparotomies had positive FAST results, 
indicating accuracy of 75% (95% CI: 57 to 87%).
Conclusion Patients with false negative scans requiring therapeutic 
laparotomy is concerning. In unstable patients, FAST may help in 
triaging and identifying those requiring laparotomy. Negative FAST 
scans do not exclude abdominal injury. Further randomised control 
trials are recommended if the role of FAST is to be better understood.
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Introduction  The aim was estimation of the clinical and predictive 
signifi  cance of the level of lipopolysaccharide-binding protein (LBP) in 
blood serum and examination of microbial landscape with account of 
severity of sepsis syndromes in polytrauma.
Methods  Clinical examination was performed, which included 99 
patients with polytrauma according to sepsis syndrome: SIRS (n = 18), 
local infection (n = 36), sepsis (n = 27), severe sepsis (n = 12), septic shock 
(n = 6) to the criteria of АССР/SССМ. The microorganism identifi  cation 
was performed using iEMS Reader MF (Labsystems) with the La Chema 
multimicrotests. The content of LBP in blood serum was assessed 
with IMMULITE ONE (USA) with the reagents DPC (USA). Statistical 
analysis of the data was performed with Statistica 6.0. The numerical 
characteristics of variables are presented as Me (LQ to UQ). The analysis 
of diff  erences was carried with the Kruskal–Wallis test for multiple 
comparison of independent groups, with Friedman one-way analysis 
of variance. The diff  erences were statistically signifi  cant with P <0.05.
Results In 81% of the critically ill patients with polytrauma the post-
traumatic period was accompanied with development of infectious 
complications, Gram-negative (K. pneumoniae, Acinetobacter spp., 
E. coli) and Gram-positive (S. Epidermidis, S. aureus). Sepsis was diagnosed 
on 8 to 10 days in 45% of the patients. The signifi  cant increase of LPS-BP 
was found in the fi  rst 3 days of the follow-up, compared with the control 
values (6.7 times higher in SIRS group (χ2(n = 18, df = 3) = 52.8666, 
P <0.001); 9.9 times higher in the group with local infection (χ2(n = 36, 
df = 3) = 91.6629, P <0.001); 15.2 times higher in the sepsis group; 20.5 
times higher in the severe sepsis group; 47.3 times higher in the septic 
shock group (χ2(n = 6, df = 3) = 11.0339, P = 0.0115)), whereas the fi  rst 
positive results of the microbiological examination were obtained only 
on 5 to 7 days. The diagnostic sensitivity of threshold concentration of 
LBP in blood serum (335 mkg/ml) was 84%, diagnostic specifi  city was 
88% (ROC curve: 0.88).
Conclusion The high incidence of the diagnostic levels of LBP in blood 
serum in patients with sepsis in the early term, before microbiological 
confi  rmation of infection, allows one to use this parameter as an early 
marker of development of purulent septic complications conditioned 
by Gram-negative microfl  ora.
P292
Risk factors for the development of complications following blunt 
chest trauma: a new risk stratifi  cation tool
C Battle1, H Hutchings2, S Lovett2, P Evans2
1Morriston Hospital, ABMU Health Board, Swansea, UK; 2Swansea University, 
Swansea, UK
Critical Care 2013, 17(Suppl 2):P292 (doi: 10.1186/cc12230)
Introduction The aim of the study was to investigate the risk factors 
for the development of complications following blunt chest trauma 
and to develop a risk stratifi  cation tool to assist in the management of 
this patient group. The diffi   culties in the management of this patient 
group in the emergency department (ED) due to the development of 
late complications are well recognised in the literature [1].
Methods Between 2009 and 2011 a total of 276 patients were admitted 
to hospital from the ED of a regional trauma centre in Wales, with the 
primary diagnosis of blunt chest trauma. Patients with immediate life-
threatening injuries were excluded. Data were collected retrospectively 
and included risk factors (age, number of rib fractures, comorbidity, 
pre-injury anticoagulant use, smoking status, oxygen saturations and 
respiratory rate on initial assessment in the ED), and outcomes (mortality, 
any pulmonary morbidity, length of stay of 7 days or more and need 
for ICU admission). Development of complications was defi  ned as the 
occurrence of one or more of the outcomes investigated. Multivariable 
logistic regression using fractional polynomials was used to identify 
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factors in the model were selected using backward elimination with 
the Akaike Information Criterion (AIC) at a signifi  cance level of 0.05. The 
c index and the Hosmer–Lemeshow (H–L) test were calculated to assess 
discrimination and calibration of the risk stratifi  cation tool respectively.
Results A total of 161 patients out of the 276 admitted developed 
complications following blunt chest trauma. Implementation of 
backward elimination using AIC values resulted in a fi  nal model based 
on the signifi  cant risk factors; age, oxygen saturations, number of rib 
fractures, presence of chronic lung disease and pre-injury anticoagulant 
use (all P <0.05). The c index for the tool was 0.80 and the H–L score was 
9.22 (P = 0.32), indicating good predictive capabilities of the tool.
Conclusion The results of this study highlight the risk factors for the 
development of complications following blunt chest trauma. A risk 
stratifi  cation tool has also been developed that could assist in the 
prediction of poor outcomes in this patient group. The next stage is to 
complete a prospective validation study.
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Introduction We have reported the risk of chest drain insertion inferior 
to the diaphragm when using current international guidelines [1]. 
Another complication is damage to signifi   cant peripheral nerves, 
such as the long thoracic nerve causing winging of the scapula [2]. 
We assessed these risks using: the European Trauma Course method, a 
patient’s handbreadth below their axilla just anterior to the midaxillary 
line; the British Thoracic Society safe triangle [3]; and the Advanced 
Trauma Life Support (ATLS) course guidance [4].
Methods We used the above guidelines to place markers (representing 
chest drains) in the thoracic wall of 16 cadavers bilaterally (32 sides), 
1 cm anterior to the midaxillary line. Subsequent dissection identifi  ed 
the course and termination of the long thoracic nerve, the site of lateral 
cutaneous branches of intercostal nerves, and their relation to the 
markers.
Results The long thoracic nerve was found in the fi  fth intercostal space 
in 16 of 32 cases, always in or posterior to the midaxillary line. Contrary 
to the description in Grays’ Anatomy (40th edition) it terminated before 
the inferior border of serratus anterior. Most commonly it was found 
to end by branching in the fourth (right) or fi  fth (left) intercostal space 
(range third to sixth). Lateral cutaneous branches of intercostal nerves 
were found in the fi  fth intercostal space in 25 of 32 cases. Contrary to 
the description in Last’s Anatomy (12th edition) they always passed 
anterior to the midaxillary line (and marker).
Conclusion Placement 1 cm anterior to the midaxillary line minimises 
risk to the long thoracic nerve and lateral cutaneous branches of 
intercostal nerves. We therefore conclude that not all areas of the British 
Thoracic Society safe triangle are indeed safe, and anteroposterior 
placement should follow the European Trauma Course and ATLS 
guidelines: just anterior to the midaxillary line (for example, 1 cm).
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Introduction Whole body computed tomography (WBCT) appears to 
be useful for the early detection of clinically occult injury, although its 
indications have been controversial. The purpose of this study was to 
develop a clinical prediction score to clarify the indications for blunt 
trauma patients with multiple injuries (MI) who require WBCT.
Methods We conducted a retrospective study of 173 patients with 
blunt trauma who underwent WBCT at our emergency center between 
June 2011 and July 2012. We chose the presence or absence of MI 
(Injury Severity Score ≥15) in need of surgical intervention as the 
outcome variable. We used bivariate analyses to identify variables 
potentially predicting the presentation of MI. The predictor variables 
were confi   rmed by multivariate logistic regression analyses. We 
assigned a score based on the corresponding coeffi   cients.
Results Among the 173 patients enrolled, 53 were in the MI group. Four 
predictors were found to be independently signifi  cant by the logistic 
analysis: (1)  body surface wound ≥3 regions, (2)  positive focused 
assessment with sonography for trauma, (3) white blood cell count 
≥11,000/μl, and (4) D-dimer ≥8 μg/ml. Score 1 was assigned to predictor 
(1), score 2 was assigned to predictors (2), (3) and (4). A prediction score 
was calculated for each patient by adding these scores. The area under 
the receiver operating characteristic curve was 0.89. No patients with a 
score of 1 or less had MI (Figures 1 and 2).
Conclusion In patients with a score of 1 or 0, the presence of MI is less 
likely. These patients may not require WBCT, and selective CT scans of 
body parts based on clinical presentation should be considered.
Figure 1 (abstract P294). Prediction versus MI probability (validation 
group).
Figure 2 (abstract P294). Clinical scorings. Multivariate, logistic 
regression analyses.
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Introduction There is an emerging body of evidence suggesting that 
early packed red blood cell transfusion accompanied by fresh frozen 
plasma, while limiting crystalloids, confers a survival benefi  t in major 
trauma [1]. Prehospital blood transfusion has been infrequently 
described, and concerns over expense, transfusion reactions, risk of 
disease transmission, short shelf half-life and diffi   cult storage have 
limited the interest of prehospital providers.
Methods  All Greater Sydney Area HEMS (GSA-HEMS) prehospital 
missions involving a blood transfusion over a 66-month period were 
identifi   ed and reviewed. The prospectively completed GSA-HEMS 
electronic database was utilised to identify patients and extract data.
Results  We identifi   ed 158 missions involving a prehospital blood 
transfusion, of which 147 patient datasets were complete. The majority 
of patients had a blunt mechanism of injury (93.9%) and were male 
(69.3%) with a median (IQR) age of 34.5 (22 to 52) years (Table 1). The 
majority of patients were haemodynamically unstable, with a median 
(IQR) heart rate and systolic blood pressure of 115 (90 to 130) and 80 
(65 to 105)  mmHg, respectively. Twenty-two patients (15.0%) were 
pronounced life extinct on the scene. A total of 382 units of packed 
red blood cells were transfused, with a median of 3 units (range 1 to 
6). No early transfusion reactions were noted. A variety of prehospital 
interventions accompanied the transfusions, ranging from rapid 
sequence intubation through to thoracotomies (Table 2).
Conclusion  Despite the controversies over the role of fl  uids in the 
prehospital environment, the carriage and use of blood is both feasible 
and safe in a physician-led helicopter emergency medical service.
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Introduction Severe hyperkalemia (serum potassium ≥6.0 mmol/l with 
electrocardiography (ECG) change) should be detected and treated 
immediately [1,2]. Among symptomatic or extreme bradycardia 
patients, we sought its prevalence and prediction rule by history, vital 
sign, and ECG [3,4].
Methods  A retrospective cross-sectional study was performed on 
patients with symptomatic (heart rate (HR) ≤50/minute with dyspnea, 
chest pain, altered mentality, dizziness/syncope/presyncope, general 
weakness, oliguria, or shock) or extreme (HR ≤40/minute) bradycardia 
at an ED of an academic hospital from June 2008 to March 2012. 
Risk factors of severe hyperkalemia were chosen by multiple logistic 
regression analysis among history (gender, age, comorbidity, and 
current medication), vital sign, and ECG (maximal precordial T wave 
amplitude, PR and QRS intervals). Scoring index was derived by 
summing up of simplifi  ed regression coeffi   cients of independent risk 
factors.
Results A total of 169 cases were enrolled. Mean age was 71.2 years (SD, 
12.5 years). Females numbered 87 (51.5%). Thirty-six cases (21.3%) had 
severe hyperkalemia. Four variables were independent risk factors of 
severe hyperkalemia (simplifi  ed scores in parentheses): medication of 
calcium channel blocker (CCB: 2); maximal precordial T ≥8.5 mV (2); PR 
(atrial fi  brillation or junctional bradycardia: 1); and HR ≤40/minute (1). 
(Nagelkerke R2 = 0.503, AUC = 0.849 (95% CI 0.786 to 0.899).) Sensitivity 
and specifi  city reached 0.75 and 0.83 when total score was ≥3. For score 
≥4, positive likelihood ratio reached 5.54 (sensitivity 0.50, specifi  city 
0.91).
Conclusion Severe hyperkalemia is prevalent among symptomatic or 
extreme bradycardia patients and could be detected immediately by 
a scoring index composed of quantitative ECG parameters and history 
of medication of CCB.
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Table 1 (abstract P295). Demographics of patients receiving a prehospital 
blood transfusion
   Total  (n = 147)
Male (%)  102 (69.3)
Age (years), median (IQR)  34.5 (22 to 52)
Mechanisms of injury (%)
  Motor vehicle collision   87 (59.1)
  Motor bike collision  20 (13.6)
  Pedestrian versus car  9 (6.1)
  Gunshot wound/stabbing  9 (6.1)
  Fall from a height  5 (3.4)
 Recreational  6  (4.1)
 Other  11  (7.5)
Number of patients trapped on arrival (%)  45 (30.6)
Scene time (minutes), mean (SD)  49.9 (27.8)
Time from tasking to arrival at hospital (minutes), mean (SD)  126.5 (51.3)
Heart rate, median (IQR)  115 (90 to 130)
Systolic blood pressure (mmHg), median (IQR)  80 (65 to 105)
RTSo
2, median (IQR)  5.967 (4.083 to 6.904)
Total number of PRBC units transfused  382
Total number of PRBC units wasted  66
Volume of crystalloid (ml), median (IQR)  500 (0 to 1,500)
Pronounced life extinct on scene  22 (15.0)
Table 2 (abstract P295). Interventions performed
Intervention Total  (n = 147)
Rapid sequence intubation  96 (65.3)
Cold endotracheal intubation  15 (10.2)
Surgical airway  1 (0.7)
Thoracostomy (open or tube)  59 (40.1)
Thoracotomy 3  (2.0)
Pelvic binder or fracture splintage  89 (60.5)
Intraosseous insertion sites  22 (15.0)
 Humerus  19
 Tibia    10
 Femur  1
Tourniquet application  15 (10.2)
Hypertonic saline administration  16 (10.9)
E-FAST performed   27 (18.4)
 Negative  results  9
  Positive results (fi  ndings)  18
    Abdominal free fl  uid   14
  Pneumothorax    2
  Haemothorax  1
Thoracic ultrasound only; all negative  2 (1.3)
Cardiac ultrasound only; no cardiac motion  1 (0.7)
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Introduction Multivariate analyses have identifi  ed factors that have 
enabled the development of sophisticated equations and scoring 
models with the ability to predict outcomes following out-of-hospital 
cardiac arrest (OHCA). However, implementation of such outcome 
prediction models in research and clinical practice has been slow. 
The more crucial aspect of these predictions is the lack of prehospital 
risk stratifi  cation for OHCA patients. Prehospital risk stratifi  cation for 
patients after OHCA may help clinicians guide in-hospital strategies, 
particularly in the emergency department. The purpose of this study 
was to develop a simple and generally applicable prehospital risk-
stratifi  cation scheme for patients after OHCA.
Methods We analyzed data for 390,226 adult patients (age ≥18 years) 
after nontraumatic OHCA, from a prospectively recorded nationwide 
Utstein-style Japanese database for 2005 to 2009. The endpoint was 
1-month survival with favorable neurological outcome (Cerebral 
Performance Category (CPC) 1 to 2).
Results Multivariate logistic regression analysis indicated the following 
three prehospital variables as signifi   cant high-ranking factors for 
predicting favorable 1-month outcomes: shockable initial rhythm 
(odds ratio (OR), 5.87; 95% CI, 5.23 to 6.60), witnessed arrest (OR, 3.05; 
95% CI, 2.83 to 3.28), and age (≥18 to <71 years; OR, 3.24; 95% CI, 2.97 
to 3.53). Using recursive partitioning analysis for development cohort 
data (2005 to 2008, n = 307,896), we stratifi  ed prehospital risk: if OHCA 
with shockable initial rhythm was witnessed, the probability of CPC 1 to 
2 was 20.0% (age, ≥18 to <71 years; grade 1) or 10.3% (age, ≥71 years; 
grade 2); if OHCA with shockable initial rhythm was unwitnessed, the 
probability was 6.8% (age, <81 years; grade 3) or 1.8% (age, ≥81 years; 
grade 4a); if OHCA with unshakable initial rhythm was witnessed, the 
probability was 1.4% (grade 4b); and if OHCA with unshakable initial 
rhythm was unwitnessed, the probability was 0.3% (grade  5). The 
c-statistics for risk stratifi  cation of the development and validation 
cohorts (2009 external data, n = 82,330) were 0.853 (95% CI, 0.846 to 
0.859) and 0.875 (95% CI, 0.865 to 0.885), respectively. The odds ratios 
for CPC 1 to 2 at 1 month between patients at very high and very low 
were 79.5 (95% CI, 72.5 to 87.4) and 122.1 (95% CI, 102.0 to 147.3), 
respectively, in these cohorts.
Conclusion  Prehospital risk stratifi  cation (grade 1 to 5) of patients 
after OHCA using three prehospital factors (shockable initial rhythm, 
witnessed arrest, and age) accurately classifi  es the severity of OHCA 
and may help clinicians guide in-hospital strategies.
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Introduction  In the last years, ICU admission has been high in 
cancer patients due to increased survival related to advances in 
treatment. Patients with cancer reportedly have poor outcomes from 
cardiopulmonary resuscitation (CPR). The goal of this study was to 
evaluate the eff  ectiveness of a multidisciplinary Medical Emergency 
Team System in the CPR outcomes in cancer patients.
Methods We performed a prospective study between January 2011 
and December 2012 at a university cancer reference hospital in 
Brazil. Consecutive patients undergoing cardiac arrest and receiving 
CPR were identifi  ed, and a database was used to register baseline 
characteristics of patients, data for CPR and 30-day survival. During the 
fi  rst 12 months of the study (phase 1), patients received CPR according 
to the institution’s protocol guided by diff  erent physicians. During 
the last 11 months of the study (phase 2), a multidisciplinary Medical 
Emergency Team System consisting of a specialized team of ICU nurses, 
physiotherapists and physicians using an electronic calling system was 
responsible for the CPR.
Results A total of 182 patients experienced in-hospital cardiac arrest 
and received CPR. Most patients were in hospital due to medical 
admission (82%), had solid tumors (85%), and had localized disease 
(60%). Pulseless electric activity was the predominant arrest rhythm 
(54%) and 45% of patients were resuscitated on the ICU. Overall 30-day 
survival was 9.3%. In the phase 1 of the study, 30-day survival was 3.7%, 
and in phase 2, survival was 14% (P = 0.017). There were no diff  erences 
in the two phases of the study regarding baseline characteristics of 
patients, rhythm and place of CPR.
Conclusion  Overall survival from CPR in cancer patients compares 
favorably with survival rates in noncancer patients. A multidisciplinary 
Medical Emergency Team System increases survival in cancer patients 
undergoing cardiopulmonary resuscitation.
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Introduction Focused cardiac ultrasound is recognized as a vital tool 
in critical care medicine. Few studies, however, have examined the 
utility of this modality in resuscitation. While integration of ultrasound 
can supplement resuscitation by potentially establishing the etiology 
of cardiac arrest, it must be done safely to avoid interruption of 
compressions. The aim of this study was to examine the integration of 
focused cardiac ultrasound into resuscitations in our hospital.
Methods We performed a retrospective observational study of patients 
undergoing resuscitation at Beth Israel Deaconess Medical Center, 
Boston, USA, from 2009 to 2012. Inclusion criteria were age >17 years 
Figure 1 (abstract P299). Ultrasound fi  ndings.
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Recorded variables included admission data, code demographics and 
diagnosis, therapy outside standard ALS protocol, time to return of 
spontaneous circulation (ROSC), and outcomes data.
Results Of 33 eligible patients, 12 were excluded due to incomplete cardiac 
ultrasound reports; 21 patients were enrolled. Cohort demographics 
included: 57.1% male, average age 64.3  years, average BMI 28.5  kg/
m2, average Charlson score 5.5. Resuscitations took place on the wards 
(52.4%), ICU (42.9%), or operating room (4.8%). Most patients had an initial 
unshockable rhythm (71.5%). The most common ultrasound fi  nding was 
cardiac standstill (47.6%) (Figure 1). The most common intervention as a 
result of the ultrasound was initiation of a pressor infusion (33.3%), of which 
71.4% were ionotropes. Additional therapies included blood transfusion 
(4.8%), heparin (9.5%), tPA (4.8%), cardiac catheterization (4.8%), and 
surgery (9.5%). ROSC was achieved in 37.5% of patients; average time to 
ROSC was 13 minutes. A total 33.3% of patients who underwent ALS were 
alive at hospital discharge and 28.6% at 1 year.
Conclusion Focused cardiac ultrasound is a feasible adjunct to ALS 
resuscitation and may assist in the early identifi  cation of reversible 
causes of cardiac arrest. Care must be taken to ensure no interruptions 
to cardiac compressions are made by performance during pulse checks. 
Further studies are needed to examine the outcomes associated with 
its integration into resuscitations.
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Introduction In this case report, we describe a patient who presented 
with a cardiac arrest as a result of an obstructive shock, which 
progressed into cardiac arrest, caused by an acute para-esophageal 
gastric herniation.
Methods Our patient, with a medical history of a laparoscopic repair 
of a symptomatic diaphragmatic hernia 6  months prior, presented 
herself at the emergency department with pain in the upper abdomen 
and nausea. The physical examination, laboratory tests and X-ray 
of the thorax were normal and she was sent home. Twenty-four 
hours later paramedics were summoned to our patient because of 
increased complaints. On arrival of the paramedics she had a normal 
electrocardiogram (ECG) and during the transfer from her bed to the 
stretcher she collapsed due to pulseless electric activity (PEA), for which 
cardiopulmonary resuscitation was started. Sinus rhythm and output 
was regained after several minutes and the patient was transported to 
the hospital. At arrival in the hospital, the X-ray of the thorax showed 
an intrathoracic stomach and a signifi  cant mediastinal shift to the right.
Results After emergency laparotomy, which concerned correcting the 
gastric herniation and resection of an ischemic part of stomach, the 
patient remained hemodynamically stable. Cardiac ischemia was ruled 
out based on ECG, laboratory fi  ndings, cardiac ultrasound and cardiac 
computed tomography. The ultrasound in the emergency department 
did show a distended right ventricle and normal left function, which 
disappeared later (after repositioning the stomach), which is evidence 
for the mediastinal shift as a cause for the PEA.
Conclusion  We are the fi   rst to describe a patient requiring 
cardiopulmonary resuscitation for progressive obstructive shock, due 
to an intrathoracic stomach. Especially after a laparoscopic repair of a 
diaphragmatic hernia, this is a rare cause for shock and cardiac arrest, 
which requires a diff  erent medical approach.
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Introduction  Early bystander cardiopulmonary resuscitation (CPR) 
is a key factor in improving survival from out-of-hospital cardiac 
arrest (OOH-CA). The ALERT algorithm, a simple and eff  ective 
compression-only telephone CPR protocol, has the potential to help 
bystanders initiate CPR. This study evaluates the eff  ectiveness of the 
implementation of this protocol in the Liege dispatching centre.
Methods We designed a before-and-after study based on a 3-month 
retrospective assessment of the adult victims of OOH-CA in 2009, before 
the implementation of the ALERT protocol in the Liege dispatching 
centre, and the prospective evaluation of the same 3-month period in 
2011, immediately after the implementation of this protocol. Data were 
extracted from ambulance, paramedical and medical intervention 
teams fi  les, as well as the audio recordings of the dispatching centre.
Results There were 233 OOH-CAs detected in the fi  rst period and 235 
in the second. Victims were predominantly male (59%, both periods), 
aged 66 and 64 years, respectively. Callers were family members in 52% 
in 2009 and 64% in 2011. In 2009, only 9.9% victims benefi  ted from 
bystander CPR, while there were 22.5% in 2011 (P < 0.0002). Reasons for 
protocol underuse were: assistance not off  ered (42.3%), caller remote 
from the victim (20.6%) or emotionally distressed (15.5%). Mean no-
fl  ow time decreased from 253 seconds in 2009 to 168 seconds in 2011 
(NS). Ten victims were admitted in ROSC to hospital in 2009 and 13 in 
2011 (P = 0.09).
Conclusion Using the ALERT protocol in the Liege dispatching centre 
signifi  cantly improved the numbers of patients in whom bystander CPR 
was attempted. Dispatchers must embrace this new opportunity to 
help callers and be encouraged to accept the responsibility of initiating 
such assistance.
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Introduction  Epinephrine has been a cornerstone of cardiac 
resuscitation and advanced cardiac life support since the 1960s. 
However, there is little evidence from clinical trials that epinephrine 
administration after out-of-hospital cardiac arrest (OHCA) improves 
long-term survival. There would be subsets of patients for whom 
epinephrine administration is in fact benefi  cial. Our objective was to 
determine whether prehospital epinephrine administration would 
improve survival at 1 month in OHCA patients with unshockable initial 
rhythm.
Methods  We analyzed data for 383,045 adult OHCA patients with 
unshockable initial rhythm, from a prospectively recorded nationwide 
Utstein-style Japanese database for 2007 to 2010. We divided these 
patients into two cohorts: prehospital epinephrine administration 
cohort (n  =  30,237) and non-epinephrine administration cohort 
(n  =  352,808). The endpoints were 1-month survival after OHCA, 
prehospital return of spontaneous circulations (ROSCs), and 1-month 
survival with favorable neurological outcome (Cerebral Performance 
Category (CPC) scale, categories 1 to 2) at 1 month.
Results The rate of 1-month survival was 3.72% for the epinephrine 
administration cohort and 2.49% for the non-epinephrine adminis-
tration cohort, 17.9% versus 3.0% for prehospital ROSC, and 0.57% 
versus 0.77% for CPC 1 to 2 (all P <0.0001). Positive associations were 
observed between epinephrine administration and 1-month survival 
(adjusted odds ratio (aOR), 1.18; 95% CI, 1.11 to 1.27), and prehospital 
ROSC (aOR, 5.50; 95% CI, 5.29 to 5.72; all P <0.0001). Negative association 
was observed between epinephrine administration and CPC 1 to 2 
(aOR, 0.56; 95% CI, 0.48 to 0.66; P <0.0001). Multivariate logistic analysis 
revealed that age (<66 years; aOR, 4.31; 95% CI, 2.47 to 8.01), total dose 
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time (<5 minutes; aOR, 3.58; 95% CI, 1.98 to 6.69), witnessed arrest (aOR, 
2.17; 95% CI, 1.51 to 3.16), and pulseless electrical activity as an initial 
rhythm (aOR, 2.02; 95% CI, 1.46 to 2.80) were signifi  cantly associated 
with CPC 1 to 2 at 1 month in the epinephrine administration cohort.
Conclusion  In OHCA patients with unshockable initial rhythm, 
prehospital epinephrine administration signifi  cantly increased the rate 
of survival at 1 month after cardiac arrest. The best single predictor for 
favorable neurological outcomes at 1  month following prehospital 
epinephrine administration after cardiac arrest was age (<66 years) 
followed by total dose of epinephrine (1 mg) and then by call-response 
time (<5 minutes).
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Introduction  What can one anticipate from the introduction of 
termination of resuscitation (TOR) for patients suff  ering out-of-hospital 
cardiopulmonary arrest (OHCA) in Japan? Irrespective of whether 
patients have made a living will requesting that medics do not attempt 
resuscitation, eff  orts are made to resuscitate over 90% of OHCA patients 
in Japan [1,2]; the number of people resuscitated exceed 120,000 
every year. The 2010 American Heart Association (AHA) Guidelines for 
cardiopulmonary resuscitation (CPR) and emergency cardiovascular 
care (ECC) defi  ned the criteria for TOR; this initiative may help reduce 
the number of unnecessary hospital transports by 40 to 60% and hold 
down medical costs [3].
Methods  This was a single-center retrospective cohort study of 
patients who suff  ered OHCA and were transported to our hospital 
between April 2009 and March 2011. We investigated the patients’ 
characteristics, whether they met the TOR criteria, and their outcome 
at the time of hospital discharge.
Results A total of 195 patients (mean age, 69 years), 67% of whom 
were male, were transported to our hospital after suff  ering OHCA. 
Cardiopulmonary arrest was witnessed in 52 cases (27%). The 2010 
AHA Guidelines for CPR and ECC regarding the criteria for TOR were 
applied in 126 cases (65%), of whom 113 (90%) were dead on arrival, 
and 13 were successfully resuscitated and admitted. The outcomes for 
these 13 patients were as follows: 10 died in the hospital, two patients 
were discharged with a Glasgow Pittsburgh Cerebral Performance 
Category (CPC) score of 1, and one patient was transferred to another 
hospital with a CPC score of 3.
Conclusion In our study, 65% of the patients who were transported to 
the hospital after OHCA met the criteria for TOR. Outcomes for patients 
who met the TOR criteria were signifi  cantly worse than those who did 
not meet the criteria (2.4% vs. 14.5%, P <0.005). In Japan, eff  orts are 
made to resuscitate almost all individuals who suff  er OHCA, but 75% 
of those patients die within a day. In light of the fact that even the 
medical cost for each of these patients who die within a day amounts 
to US$1,500 [4], the introduction of TOR will have a particularly strong 
impact in Japan.
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Introduction Detection and treatment of cardiopulmonary arrest and 
their antecedents may be less eff  ective at night and weekend than 
weekdays because of hospital staffi   ng and response factors [1]. Early 
detection and resuscitation of cardiopulmonary arrest are crucial for 
better clinical outcome. We conducted our study to evaluate event 
survival of in-hospital cardiopulmonary arrest after regular working 
hours in nonmonitored areas of a tertiary-care center.
Methods  A retrospective chart review of all adult patients who 
developed in-hospital cardiopulmonary arrest between January 
2010 and December 2011. Working hours are defi  ned as 07:00 to 
17:00 Saturday to Wednesday. Event survival is defi   ned as return 
of spontaneous circulation (ROSC) for more than 20  minutes. 
Adult patients 18 years and above who suff   ered from in-hospital 
cardiopulmonary arrest were included. Patients were excluded if 
they had cardiopulmonary arrest in the emergency department, had 
implantable cardiovascular device, arrested in monitored areas or had 
pre-existing DNR orders. Data analysis was accomplished using SAS, 
version 9.3 (SAS institute, Inc., Cary, NC, USA).
Results  A total of 430 cardiopulmonary arrest events occurred in-
hospital between January 2010 and December 2011. A total of 326 
patients were excluded because 252 occurred in the ICU, 70 in the 
coronary care unit and four in the stork unit. In total, 104 patients 
were enrolled; 50.9% where female and 49.1% male. Median age was 
61 years. A total 41.3% of the arrests were due to respiratory arrest 
and 58.7% due to cardiac arrest. Out of 104 patients who developed 
cardiopulmonary arrest, 47 (45.19%) occurred during regular working 
hours, and 57 (54.81%) occurred after regular working hours (P = 0.0081). 
The event survival was 87.23% during regular working hours compared 
with 47.37% for the patients who developed cardiopulmonary arrest 
after regular working hours (P <0.0001). In total, 53.19% of those who 
developed cardiopulmonary arrest during regular working hours were 
discharged alive from the ICU compared with 26.32% of those who 
developed cardiopulmonary arrest after regular working hours.
Conclusion Event survival and survival to discharge were signifi  cantly 
higher in patients who developed cardiopulmonary arrest during 
regular working hours.
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Introduction Before the introduction of primary percutaneous coronary 
intervention (PCI) and therapeutic hypothermia (TH) to out-of-hospital 
cardiac arrest (OOHCA) management, survival to hospital discharge 
with intact neurological function was poor [1,2]. We aimed to quantify 
the survival and degree of neurological impairment in OOHCA patients 
admitted to our ICU since the adoption of post-OOHCA bundles.
Methods Sixty-nine consecutive OOHCA patients admitted to the ICU 
at Hammersmith Hospital from 1 January 2011 to 30 June 2012 were 
identifi  ed and reviewed from hospital databases. Cognitive status was 
scored using Cerebral Performance Category (CPC); 1 to 2 normal–mild 
and 3 to 4 moderate–severe neurological impairment. Scores were 
determined from ICU summaries, occupational and physiotherapy 
reports. Hospital discharge outcomes were determined from hospital 
databases.
Results TH was initiated in 93% (64/69) of OOHCA patients and 87% 
(40/46) with ischaemic cardiac aetiology underwent PCI. ICU survival 
was 58% (40/69); 65% (26/40) scoring CPC 1 to 2 and 35% (14/40) CPC 3 
to 4 at ICU discharge. Two patients with CPC 2 improved to CPC 1 during 
their hospital stay. All patients with CPC 1 to 2 survived to hospital 
discharge; two required general rehabilitation before returning home. 
Only 43% (6/14) of CPC 3 to 4 patients survived to hospital discharge; 
none returned home. Two went into hospice care, one was repatriated 
to another hospital and three went to neuro-rehab. No CPC 3 to 4 
patients improved CPC scores after ICU discharge. Overall hospital 
survival was 46%. See Table 1.
Conclusion OOHCA patients admitted to our ICU had a 46% chance 
of surviving to hospital discharge. Most patients left hospital with 
good neurological status (CPC 1 to 2); moderate–severe neurological 
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[1]. A higher proportion (35%) of patients discharged from the ICU had 
moderate–severe neurological disability; most subsequently died 
in hospital (62%). These fi  gures may represent better ICU outcomes 
subsequent to adoption of OOHCA bundles but suggest further work is 
required in neuro-disabled survivors.
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Introduction During cardiopulmonary resuscitation (CPR) monitoring 
possibilities are limited. Parnia and colleagues investigated the 
feasibility and role of near-infrared spectroscopy (NIRS) during CPR 
in cardiac arrest patients (CA) [1]. NIRS could have a role in predicting 
return of spontaneous circulation (ROSC). Recently, the Equanox® with 
four wavelengths sensor was validated to provide absolute data on 
regional cerebral saturation [2]. We measured cerebral oxygenation 
(rSO2) during CPR with NIRS technology and analyzed the diff  erences 
between initial cerebral saturations in patients achieving ROSC 
compared with patients without ROSC.
Methods  With IRB approval, rSO2 was measured with NIRS during 
resuscitation in 18 out-of hospital CA patients. The Equanox® Advance 
(NONIN), a NIRS monitoring device that measures absolute rSO2 values, 
was applied on the right side of the patient’s forehead when the 
medical emergency team arrived in a resuscitation setting. Placement 
of the probe did not interfere with the advanced life support algorithm. 
The sensor remained on the patient’s forehead during resuscitation, 
and if ROSC was reached the probe was removed on arrival at the 
emergency department. If ROSC was not achieved, the probe was 
removed prehospital. ROSC was defi  ned as ROSC during more than 
20 minutes. The Mann–Whitney test was utilized for comparison of 
survivor and nonsurvivor data. Student’s t  test was performed to 
compare the initial rSO2.
Results Of the 18 patients, nine patients had ROSC (survivors). The 
initial rhythm was the same in both groups, six patients in each 
group had asystole as initial rhythm. In the group of survivors were 
six female patients, in the nonsurvivors were two female patients. The 
mean age in ROSC and no-ROSC groups is respectively 75.8 years (SD 
±12.8) and 69.4 years (SD ±22.9, P = 0.48). The mean rSO2 at arrival of 
the emergency medical team was 31.56% (SD ±29.4) and 12.78% (SD 
±12.7) respectively in the ROSC group and no-ROSC group (P = 0.1). 
The mean time between collapse and start of CPR (basic life support 
of bystanders) was 6.9 minutes (SD ±8.2) in the no-ROSC group and 
8.2 minutes (SD ±7.08, P = 0.69) in the ROSC group.
Conclusion Initial rSO2 values in out-of hospital CA patients with ROSC 
showed a tendency towards higher values compared with nonsurvivors, 
but no signifi  cant diff  erence could be demonstrated, probably related 
to the small number of patients included in this preliminary report.
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Introduction  In-hospital (IHCA) and out-of-hospital cardiac arrest 
(OHCA) are associated with high mortality [1]. Studies suggest that 
up to 68% of OHCA is due to acute coronary syndrome, with 38% 
requiring percutaneous coronary intervention (PCI) [1]. However, 
revascularisation may not always be available or address the underlying 
pathology. This study aimed to establish the prevalence of diff  erent 
aetiologies for IHCA and OHCA, and the use of emergency treatment 
for these patients.
Methods  A retrospective case-note review of all patients admitted 
between 2008 and 2011 to the ICU of an inner-city university hospital 
after OHCA or IHCA. Biometric data, presenting cardiac rhythm, 
presumed cause of arrest, management and outcomes were recorded. 
The Kruskal–Wallis test was used for numerical data analysis and chi-
square test for categorical data.
Results Data were analysed for 64 patients – 44 (69%) following OHCA 
and 20 (31%) after IHCA. The median APACHE score for OHCA was 
17 and for IHCA was 23.5 (P = 0.001). Hospital survival rate was 10% 
(n = 2) for IHCA and 38.6% (n = 17) for OHCA (P <0.02). A total of 34.1% 
(n = 15) OHCA were due to myocardial infarction (MI) compared with 
10% (n = 2) of IHCA (P <0.05). The most prevalent aetiologies were MI 
(n = 17), hypoxia (n = 10), cardiac other (n = 5), sepsis (n = 4), arrhythmia 
(n = 3) and PE (n = 3). In two IHCA patients more than one likely cause 
of arrest was reported and in 19 cases no cause was identifi  ed. The 
presenting rhythm was ventricular fi  brillation (VF) in 45.3% (n = 29), 
pulseless electrical activity in 32.8% (n = 21) and asystole in 20.3% 
(n = 13). A total of 9.4% (n = 6) were thrombolysed and one (1.6%) 
patient was referred for emergency PCI.
Conclusion  As previously reported [2], IHCA was associated with a 
worse prognosis than OHCA. The OHCA survival rate was better than 
reported elsewhere [3]. The percentage of IHCA attributed to MI was 
low. Only one OHCA patient was referred for emergency PCI. Routine 
coronary angiography with ad hoc PCI in VF OHCA has been associated 
with increased survival [4]. Greater availability of PCI post OHCA could 
further improve mortality in patients with a primary cardiac pathology. 
Further investigation should include management of noncardiogenic 
cardiac arrest.
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Introduction Mild therapeutic hypothermia (MTH) is the most powerful 
therapy to improve survival and neurologic outcome after out-of-
hospital cardiac arrest. Such benefi  t may also occur for unconscious 
patients after in-hospital cardiac arrest. The aim is to compare 1-year 
evolution of neurological outcomes of patients treated with MTH after 
in-hospital versus out-of-hospital cardiac arrest.
Methods  A prospective study of patients treated with MTH after 
cardiac arrest in a community hospital in São Paulo, Brazil. After return 
of spontaneous circulation, unconscious survivors received MTH using 
topical ice and cold saline infusions in order to achieve a 32 to 34°C 
goal temperature, within 6 hours of cardiac arrest, and maintained 
Table 1 (abstract P305). Discharge and neurological status of OOHCA patients
  Discharge  Hospital discharge destination
      Neuro-
Score ICU  Hospital  Home  rehab  Repatriation  Hospice
CPC  1 20 22 19 0  3  0
CPC  2  6 4 4  0  0  0
CPC  3  4 3 0  3  0  0
CPC 4  10  3  0  0  1  2
Total  40 32 23 3  4  2
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intravenous sedation-analgesia was maintained for 48  hours after 
initiation of MTH. The Glasgow Outcome Scale (GOS) was used to 
analyze the neurological outcomes after hospital discharge.
Results From January 2009 to April 2012, 84 patients submitted to MTH 
were divided into two groups: Group 1, 54 patients presented out-
of-hospital cardiac arrest; and Group 2, 30 patients had intra-hospital 
cardiac arrest. Both groups were similar regarding to gender; Group 
2 tended to be older (mean age 44.3 years vs. 33.5 years, P = 0.07), 
and had more frequently asystole as the cardiac arrest rhythm (45% 
vs. 15 %, P  =  0.10). Group 2 had shorter duration of resuscitation 
(12.3 minutes vs. 33.7 minutes, P = 0.03), longer time to hypothermia 
initiation (309.3 minutes vs. 212.8 minutes, P = 0.04), longer hospital 
stay after cardiac arrest (50.7 days vs. 32.4 days, P = 0.01) and worse 
neurological outcome, characterized by the presence of GOS ≤3 at 30 
days (68.4% vs. 35.1%, P = 0.03). Hospital mortality was 5.5% in Group 1 
and 13.3% in Group 2 (P = 0.21). The 1-year survival rate was 85.1% in 
Group 1 and 83.3% in Group 2 (P = 0.43); after 1 year follow-up, GOS 
≤3 was present in 30.4% of Group 2 patients and in 11.1% of Group 1 
patients (P = 0.04).
Conclusion Midterm neurological outcome of MTH after in hospital 
cardiac arrest seems to be not as good as after out-of-hospital cardiac 
arrest. Delay in hypothermia initiation, older age and associated 
comorbidities could explain the worse evolution of this group of 
patients.
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Primary percutaneous coronary angioplasty and therapeutic 
hypothermia in out-of-hospital cardiac arrest
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Introduction The benefi  t of primary percutaneous intervention (PCI) 
in the management of out-of-hospital cardiac arrest (OHCA) is not 
clear cut [1]. It has historically been used in patients with ST elevation 
on post-resuscitation electrocardiogram (ECG) although this is a poor 
predictor of acute coronary occlusion after cardiac arrest [2]. This 
study investigates the benefi  t of PCI regardless of post-resuscitation 
ECG. Benefi  t is widely claimed for therapeutic hypothermia, so cooling 
parameters were included.
Methods We analysed all 41 consecutive adults admitted post OHCA to 
a university hospital ICU between January 2010 and December 2011. 
Patients received PCI regardless of ECG changes. A Cox proportional 
hazards model was used to determine the relationship between PCI, 
cooling and survival to discharge. Routinely collected data such as 
demographics and details of resuscitation (OHCA Utstein data) were 
also included.
Results Survival to hospital discharge was 41% with 29% of survivors 
discharged to a neurological rehabilitation centre. Multivariate 
analysis using a Cox proportional hazards model showed PCI to be an 
independent predictive factor of survival, unrelated to ECG (hazards 
ratio, 0.0583; 95% CI, 0.0076 to 0.4485). Cooling had no signifi  cant 
impact on patient survival. See Figure 1.
Conclusion In this small retrospective study primary PCI appears to 
be an independent predictor of survival after OHCA. This is consistent 
with other studies suggesting benefi  t for primary PCI regardless of the 
post-resuscitation ECG [3]. Cooling was not found to improve survival 
to discharge but further analysis is required to determine impact on 
neurological function.
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and therapeutic hypothermia
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Introduction  Sedation and therapeutic hypothermia (TH) modify 
neurological examination and alter prognostic prediction of coma after 
cardiac arrest (CA). Additional tools, such as EEG and evoked potentials, 
improve prediction of outcome in this setting, but are not widely 
available and require signifi  cant implementation.
Methods Using a new device for infrared pupillometry, we examined the 
value of quantitative pupillary light reactivity (PLR) to predict outcome 
in comatose post-CA patients treated with TH. Twenty-four comatose 
CA patients treated with TH (33°C, 24  hours) were prospectively 
studied. The percentage variation in PLR was measured during TH 
(12 hours from CA), using the NeuroLight Algiscan® (IDMED, Marseille, 
France). For each patient, three consecutive measures were performed 
and the best value was retained for analysis. The relationship of PLR 
Figure 1 (abstract P309). Comparison of hazards ratios post Cox analysis.
Table 1 (abstract P310). False-positive and false-negative rates for outcome 
(% of patients)
 Outcome
   Good  Bad
    (CPC 1 to 2)  (CPC 3 to 5)
   (%)  (%)  P value  FNR (%)  FPR (%)
PLR
 ≤10%  0  100  <0.0001  0  0
 >10%  100  0
BRS
 Absent  0  33  0.02  0  28
 Present  39  28
MR
 Absent  11  50  0.02  11  11
 Present  28  11
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analyzed, and the predictive value of PLR was compared with that of 
standard clinical examination (motor response and brainstem refl  exes) 
performed at 48 hours from CA.
Results Quantitative PLR was strongly associated with survival (median 
left-eye PLR 14% (11 to 16%) variation in survivors vs. 5.5% (4 to 8.5%) 
in nonsurvivors, P < 0.0001) and 3-month neurological outcome (14% 
(11 to 21%) in patients with CPC 1 to 2 vs. 5.5% (4 to 8.5%) in those 
with CPC 3 to 5, P <0.0001). Comparable fi  ndings were obtained using 
right-eye PLR. A PLR >10% was 100% predictive of patient prognosis, 
with false-positive and false-negative rates of 0% for outcome. Clinical 
examination was signifi   cantly associated with outcome; however, 
motor response (MR) and brainstem refl  exes (BRS) yielded higher false-
positive and false-negative rates than PLR (Table 1).
Conclusion Quantitative PLR appears highly accurate and superior to 
standard neurological examination to predict outcome in patients with 
post-CA coma. Further study is warranted to confi  rm these promising 
fi  ndings.
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patients treated with hypothermia
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Introduction Maintenance of adequate brain perfusion is an essential 
component of post-resuscitation care. Mean arterial pressure (MAP) 
and PaCO2 are important determinants of brain perfusion; however, no 
precise guidelines exist for optimal MAP and PaCO2 targets in comatose 
post-cardiac arrest (CA) patients.
Methods Using NIRS, we examined changes in non-invasive cerebral 
tissue oxygen saturation (SctO2) following moderate hyperventilation 
(HV) and induced hypertension (IH) in comatose CA patients treated 
with therapeutic hypothermia (TH). A prospective pilot study including 
comatose patients successfully resuscitated from out-of-hospital CA 
treated with TH (33°C for 24 hours, using cold saline and surface cooling 
device), monitored for continuous SctO2 with the Foresight NIRS system 
(CAS Medical Systems, Branford, CT, USA). Moderate hyperventilation 
was induced for approximately 30 minutes by decreasing PaCO2 from 
~40 to ~30  mmHg, at stable MAP. After PaCO2 normalization, MAP 
was increased from ~70 to ~90  mmHg by intravenous infusion of 
norepinephrine, at stable PaCO2. Eff  ects of MV and IH on SctO2 were 
analyzed with a paired t test.
Results Ten patients (mean age, 69.5; mean time to ROSC, 19 minutes) 
were studied during the stable TH maintenance phase. Results are 
summarized in Figure 1. MV was associated with a signifi  cant reduction 
of SctO2 from baseline (75% (73 to 76) to 69% (67.5 to 71.5), P <0.001). 
No signifi  cant changes in SctO2 were found after IH (74 (72 to 76) vs. 75 
(73 to 75.5), P = 0.24).
Conclusion  Moderate HV was associated with signifi  cant reduction 
in cerebral saturation, whilst IH may be detrimental after CA and TH, 
whilst increasing MAP to supranormal levels with vasopressors does 
not improve cerebral oxygenation. These data stress the importance of 
strict control of PaCO2 following CA and TH to avoid secondary cerebral 
ischemic insults.
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National Science Foundation (FN 320030_138191) and The European 
Critical Care Research Network (ECCRN).
P312
Eff  ects of viscosity on cerebral blood fl  ow after cardiac arrest
L Bisschops, G Pop, S Teerenstra, J Van der Hoeven, C Hoedemaekers
Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
Critical Care 2013, 17(Suppl 2):P312 (doi: 10.1186/cc12250)
Introduction After cardiac arrest, microcirculatory reperfusion dis orders 
develop despite adequate cerebral perfusion pressure. Increased blood 
viscosity strongly hampers the microcirculation, resulting in plugging 
of the capillary bed, arteriovenous shunting and diminished tissue 
perfusion. The aim of the present study was to assess blood viscosity in 
relation to cerebral blood fl  ow in patients after cardiac arrest.
Methods  We performed an observational study in 10 comatose 
patients after cardiac arrest. Patients were treated with hypothermia for 
24 hours. Blood viscosity was measured ex vivo using a Contraves LS300 
viscometer. Mean fl  ow velocity in the middle cerebral artery (MFVMCA) 
was measured by transcranial Doppler (TCD) at the same time points.
Figure 1 (abstract P311). Changes in SctO2 after moderate HV and IH tests (n = 10 patients).
Figure 1 (abstract P312).
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second, and remained stable at 3 and 6 hours after admission. From 
6 hours after admission, viscosity decreased signifi  cantly to 3.66 (3.12 
to 4.04) mPa.second (P <0.001). Median MFVMCA was low (27.0 (23.8 
to 30.5) cm/second) on admission, and signifi  cantly increased to 63.0 
(51.0 to 80.0) cm/second at 72 hours (P <0.001). There was a signifi  cant 
association between viscosity and the MFVMCA (P  =  0.0019). See 
Figure 1.
Conclusion Viscosity decreases in the fi  rst 3 days after cardiac arrest 
and is strongly associated with an increase in cerebral blood fl  ow. 
Since viscosity is a major determinant of cerebral blood fl  ow, repeated 
measurements may guide therapy to help restore cerebral oxygenation 
after cardiac arrest.
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Therapeutic mild hypothermia after cardiac arrest in shockable 
and nonshockable rhythms: does it improve both survival and 
neurological outcome?
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Introduction  Although therapeutic mild hypothermia (TMH) after 
resuscitation from cardiac arrest (CA) has been postulated and studied 
to be associated with good outcome of the patients, there is no dearth 
of data that does not favour TMH. Our aim was to fi  nd out whether 
TMH is associated with good outcome after CA in shockable rhythm 
(SR) compared with nonshockable rhythm (NR), in terms of survival as 
well as neurological outcome.
Methods We reviewed medical records of all CA patients (in-hospital 
or out-of-hospital arrest) in whom cardiopulmonary resuscitation (CPR) 
was performed at our hospital from 1 February 2011 to 31 January 2012 
(12 months). The following information was collected: fi  rst documented 
rhythm, whether TMH done or not, and two outcome measures 
including survival to hospital discharge and neurological outcome 
at the time of hospital discharge. A measure of good neurological 
outcome was Cerebral Performance Category score 1 or 2 (CPC, fi  ve-
point scale; 1 = good cerebral performance to 5 = brain death). Then 
we quantifi  ed the association of TMH with SR as well as NR for both 
the parameters of outcome – that is, survival to hospital discharge and 
good neurological outcome – by logistic regression analysis.
Results We had 297 CA patients (168 SR, 129 NR) in whom CPR was 
done. Return of spontaneous circulation was achieved in 90 patients. 
TMH was induced in 57 patients (33 SR, 24 NR). Survival to hospital 
discharge was observed in 27 patients (18/33 (54.5%) SR, 9/24 (37.5%) 
NR), out of which 18 patients (10/33 (30%) SR, 8/24 (33%) NR) had good 
neurological outcome. On analysis, TMH was found to be associated 
with increased odds of survival to hospital discharge (although 
statistically not signifi  cant) in SR patients compared with NR patients 
(odds ratio (OR) = 2.00; 95% CI = 0.68 to 5.85; P = 0.2837), but it was not 
associated with any better neurological outcome in terms of CPC score 
in patients presenting with SR rather than NR (OR = 0.87; 95% CI = 0.28 
to 2.68; P = 1.0000). Rather, the odds for good neurological outcome 
were more in favour of NR (pulseless electrical activity/asystole).
Conclusion Although TMH might be associated with better survival 
chances in patients presenting with SR, neurological outcome was no 
better (rather worse) in this group of patients when compared with 
patients with NR as the fi  rst documented rhythm.
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Introduction  Measurement of temperature during treatment with 
therapeutic hypothermia can yield variable values depending on 
where temperature is measured. Measurements of temperature can 
be made rectally, intravascularly, vaginally, or from the bladder, but 
agreement between these sites is often uncertain. We measured 
temperature at multiple sites during experimental induction and 
reversal of hypothermia in swine with a novel esophageal cooling 
device, hypothesizing that agreement between sites would fall within 
standard acceptance criteria (average diff  erence  ±  1.96  standard 
deviation of the diff  erence) in Bland–Altman analyses.
Methods  Five female Yorkshire swine (mean weight 65  kg) were 
anesthetized and cooled for 24 hours, then gradually rewarmed, with 
a novel esophageal heat transfer device powered by an external chiller 
(Gaymar MediTherm III). Swine temperature was measured intra-
vascularly, rectally, and either vaginally or in the bladder. Comparisons 
between temperature readings were then made via Bland–Altman 
plots.
Results  Agreement between the diff   erent sources of temperature 
measurement was generally high, with less than 10% outliers beyond 
±1.96 SD. The best agreement was seen between intravascular 
tempera  ture measurement and bladder temperature measurement 
(SD  =  0.14°C), with vaginal measurements showing less agreement 
(SD = 0.23°C), and rectal measurements showing the least (SD = 0.31°C) 
with intravascular.
Conclusion  Bladder temperature measurements demonstrated the 
best agreement with intravascular temperature measurements during 
cooling with an esophageal heat transfer device; however, reasonable 
agreement was demonstrated with rectal and vaginal temperature 
measurements, suggesting that these sites are also acceptable for use.
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Introduction  Optimal oxygenation level during post-cardiac arrest 
(PCA) care is currently undefi   ned, and studies have suggested 
harm from hyperoxia exposure [1]. We aimed to assess the optimal 
oxygenation level and possible associations of time-weighted exposure 
to hyperoxia on outcome in patients during PCA care.
Methods We conducted a prospective observational cohort study in 
21 ICUs in Finland between 2009 and 2010. The Utstein Guidelines 
were used for collecting resuscitation and PCA care data, such as 
initial rhythm and delay to return of spontaneous circulation (ROSC). 
Measured arterial blood oxygen values during the fi  rst 24 hours from 
admission to the ICU were divided into the following predefi  ned 
oxygenation categories: low (<10  kPa), normal (10 to 19  kPa), 
intermediate (20 to 29 kPa), and high (>30 kPa). Exposure to hyperoxia 
was defi   ned as paO2 levels higher than 40 kPa [1]. Time spent in 
diff  erent oxygenation categories and the highest, lowest and median 
oxygen values during the fi  rst 24 hours were calculated and included 
in separate multivariate regression models along with age, delay to 
ROSC, initial rhythm and the use of therapeutic hypothermia for the 
prediction of 6-month mortality.
Results A total of 489 patients were included. The average number of 
paO2 measurements during the fi  rst 24 hours was eight per patient. 
A total of 6% of patients experienced paO2 values higher than 40 kPa 
at any time during the fi  rst 24 hours. Average times spent in each 
time oxygenation category during the fi  rst 24 hours were as follows: 
low 14%, normal 69%, intermediate 14%, and high 2% of the time. 
Survivors spent less time in the low band (P = 0.029) and more time 
in the intermediate band (P = 0.029) compared with nonsurvivors. The 
median paO2 during the fi  rst 24 hours was higher in survivors than in 
nonsurvivors (15 kPa vs. 14 kPa, P = 0.016) but there was no diff  erence 
in lowest (11 kPa vs. 10 kPa, P = 0.162) or the highest paO2 values 
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time spent in the low or the intermediate categories, or the median, 
highest or lowest paO2 was found to correlate with mortality.
Conclusion In this multicentre observational study we were unable 
to defi  ne an optimal oxygenation level during PCA care, but hypoxia 
seemed to be more harmful than hyperoxia. Exposure to hyperoxia was 
less common than in previous trials, and we were unable to confi  rm 
previous fi  ndings indicating an association with mortality.
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Introduction Neuron-specifi  c enolase (NSE) values >33 μg/ml [1] and 
low bispectral index (BIS) [2] values correlate with bad outcome after 
cardiac arrest (CA).
Methods In this nonblinded prospective study, we observed all CA 
patients from February 2011 until September 2012 surviving at least 
24 hours. NSE was measured between 24 and 72 hours after CA. From 
October 2011 onward, we recorded BIS and suppression ratio (SR) 
values as soon as possible after arrival in the ICU. Patients treated 
with therapeutic hypothermia (TH) (33°C for 24  hours) received 
cisatracurium. Cerebral Performance Category (CPC) [3] 1 and 2 were 
considered good outcome, CPC 3 to 5 bad outcome and were recorded 
after 3 months. Statistical analysis was performed using SPSS statistics 
19.
Results  NSE >45 occurred in 24/68 patients (35.3%) and invariably 
correlates with bad outcome. The positive predictive value (PPV) NSE 
>45 for bad outcome is 100%. No patient in this group ever had a GCS 
≥12. NSE >33 and <45 occurred in 16/68 patients (23.5%). Thirteen 
out of 16 patients (81.2%) had bad outcome. However, 7/16 patients 
(43.8%) woke up at some time (GCS ≥12). NSE <33 occurred in 28/68 
patients (41.2%), 17/28 patients (60.7%) had good outcome and 23/28 
patients (88.4%) had GCS ≥12 at some time. The PPV NSE <33 for good 
outcome is 60.7%. The BIS and SR were measured in only 28 patients. 
Initial BIS ≤10 occurred in 13/28 patients (46.4%) and correlates with 
bad outcome in 12/13 patients (92.3%). BIS >30 occurred in nine 
patients, 6/9 (66.7%) had good outcome. Initial SR ≥75 occurred in 
11/28 patients (39.3%) and invariably correlates with bad outcome. 
NSE >25 and SR >60 occurred in 15/28 patients (53.6%) and invariably 
correlates with bad outcome.
Conclusion NSE >45 uniformly correlates with bad outcome after CA. 
However, we urge caution for the use of intermediate values (33 to 45). 
In preliminary data, we report that SR >75 might correlate with bad 
outcome and that combining NSE and SR might improve the predictive 
value. Also, low NSE and good initial BIS values correlate with preserved 
cerebral potential and should encourage the clinician.
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Introduction  Accurate prediction of neurological outcome after 
cardiac arrest is desirable to prevent inappropriate withdrawal of life-
sustaining therapy in patients who could have a good neurological 
outcome, and to limit active treatment in patients whose ultimate 
neurological outcomes are poor. Established guidelines to predict 
neurological outcome after cardiac arrest were developed before the 
widespread use of therapeutic hypothermia. The American Association 
of Neurology guidelines [1] currently recommend that absent or 
extensor motor scores on day 3 post arrest are reliable indicators or 
poor neurological outcome with a false positive rate of 0 to 3%.
Methods A review of existing literature was undertaken to examine 
whether the utility of motor scores to predict poor neurological 
outcome is infl  uenced by the use of therapeutic hypothermia.
Results Six studies were identifi  ed [2-7] that investigated the use of 
motor scores on day 3 post cardiac arrest in patients who had received 
therapeutic hypothermia. False positive rates (defi  ned as 1 – specifi  city) 
for predicting poor neurological outcome were calculable in fi  ve of the 
six studies [2-6] and were 14%, 24%, 11%, 25% and 12% respectively. 
In all studies the FPR for motor scores of extension or worse were 
signifi  cantly higher than the 0% (0 to 3% 95% CIs) in the AAN guidelines.
Conclusion  Motor scores at day  3 post cardiac arrest of extension 
or worse do not reliably predict poor neurological outcome when 
therapeutic hypothermia has been used. Clinical neurological fi  ndings 
may not be valid predictors of poor neurological outcome after 
therapeutic hypothermia.
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Introduction  It has been reported that the young are much more 
resistant to transient cerebral ischemia than the adult.
Methods  In the present study, we compared the chronological 
changes of calcium binding proteins (CBPs) (calbindin 28k (CB-D 28k), 
calretinin (CR) and parvalbumin (PV)) immunoreactivities and levels 
in the hippocampal CA1 region of the young gerbil with those in the 
adult following 5 minutes of transient cerebral ischemia induced by the 
occlusion of both the common carotid arteries.
Results In the present study, we examined that about 90% of CA1 
pyramidal cells in the adult gerbil hippocampus died at 4 days post 
ischemia; however, in the young hippocampus, about 56% of them 
died at 7 days post ischemia. We compared immunoreactivities and 
levels of CBPs, such as CB-D 28k, CR and PV. The immunoreactivities 
and protein levels of all the CBPs in the young sham were higher than 
those in the adult sham. In the adult, the immunoreactivities and 
protein levels of all the CBPs were markedly decreased at 4 days post 
ischemia; however, in the young, they were apparently maintained. At 
7 days post ischemia, they were decreased in the young; however, they 
were much higher than those in the adult.
Conclusion In brief, the immunoreactivities and levels of CBPs were not 
decreased in the ischemic CA1 region of the young 4 days after transient 
cerebral ischemia. This fi  nding indicates that the longer maintenance 
of CBPs may contribute to a less and more delayed neuronal death/
damage in the young.
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Introduction Poor outcomes in clinical trials on the use of therapeutic 
hypothermia following traumatic brain injury (TBI) may be due to the 
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and rapid induction of hypothermia will mitigate neuronal injury and 
improve survival in a swine model of TBI.
Methods Twenty domestic cross-bred pigs (34 to 35 kg) were subjected 
to a 5 ATM (100 ms) lateral fl  uid percussion TBI. The brain temperature 
and ICP were measured using Camino®. Serum biomarkers for neuronal 
injury  – S-100β, neuron-specifi  c enolase, glial fi  brillary acid protein 
(GFAP), and neurofi  laments heavy chain – were measured daily using 
enzyme-linked immunosorbent assay. Twelve of the injured animals 
were rapidly cooled to 32°C within 90  minutes of the injury using 
a transpulmonary hypothermia technique [2]. Hypothermia was 
maintained for 48 hours. Eight injured control animals were maintained 
at 37°C. In both groups, anesthesia (isofl  urane 1%) was discontinued 
and the animals were weaned off   the ventilator after 48 hours. Five days 
post injury, the surviving animals were euthanized and necropsied. The 
data were analyzed using a log-rank (Mantel–Cox) test, and ANOVA.
Results Ten of the 12 hypothermia and four of the eight normothermia 
animals survived to the end of the 5-day study (χ2 = 2.597, df = 1, 
P = 0.1071). Although the probability of type I error between survival 
curves was 11%, the study was clinically signifi  cant and showed a clear 
trend toward improved survival with hypothermia. The intracranial 
pressures were signifi  cantly (P <0.05) lower in the hypothermia group. 
Both interventions – that is, general anesthesia and hypothermia – 
mitigated the rise of serum biomarkers following TBI. However, the 
suppression of biomarkers was sustained during the recovery period 
only in the hypothermia group. With the exception of the GFAP levels, 
the curves of all biomarkers were signifi  cantly diff  erent between the 
groups.
Conclusion  Our preliminary fi   ndings show early initiation, rapid 
induction, and prolonged maintenance (48  hours) of cerebral 
hypothermia to lower intracranial pressure, blunt the rise in serum 
biomarkers, and improve survival following TBI.
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Introduction  Traumatic brain injury (TBI) is a contributing factor 
to approximately one-third of all injury-related deaths in the USA 
annually. Updated statistical records for TBI in Egypt are lacking. The 
current research is aiming to estimate the prevalence of TBI in Egypt in 
order to develop a comprehensive TBI prevention program.
Methods  A 1-year period (one calendar month every quarter of 
2010) descriptive epidemiological study of moderate and severe TBI 
cases admitted to the emergency department, Cairo main university 
hospital. The data collection sheet included personal data (age, sex and 
residency), incident-related data (cause, nature and time of injury) and 
both clinical and radiological fi  ndings.
Results Table 1 shows the magnitude of the problem, highlighting the 
leading causes of TBI in Egypt in 2010. Male sex was predominantly 
aff  ected, 79% of cases. Moderate and severe injuries account for 17.2% 
of all TBI presented cases.
Conclusion TBI is a serious public health problem in Egypt. Further 
data interpretation over wider periods of time should be conducted 
for better understanding of TBI prevalence is highly recommended to 
develop eff  ective injury prevention programs.
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Alcohol intoxication impedes the recognition of traumatic brain 
injury in the prehospital setting and may worsen 6-month outcome
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Introduction Transport directly to a neurosurgical trauma center has 
shown to reduce mortality in patients with traumatic brain injury (TBI). 
We hypothesized that alcohol intoxication may impede prehospital 
recognition of TBI, resulting in transportation to a non-neurosurgical 
hospital.
Methods  A retrospective analysis of TBI patients admitted to a 
designated neurosurgical trauma center’s ICU in 2009/10 and primarily 
treated by the Emergency Medical Service (EMS). Patients were divided 
into two categories based either direct or indirect trauma transfer by 
the EMS. Directly transferred patients are directly transported to the 
neurosurgical trauma center from the injury scene while indirectly 
transported patients are initially transported to another non-
neurosurgical hospital before re-transfer to the trauma center. Data 
from patient journals and EMS forms were extracted. The blood alcohol 
level (BAL) was measured by the EMS using an alcohol breath-test. 
Logistic regression modeling was used to identify variables present at 
scene associated with transport destination.
Results  Totally 470 patients met the inclusion criteria; 60% were 
transported directly and 40% indirectly. In the direct group 15% of 
patients had a positive BAL, compared with 26% for those indirectly 
transported. In the logistic regression model, factors associated 
with direct transport were: BAL ≥2.3‰ (OR: 0.06, CI: 0.01 to 0.36), 
male gender (OR: 0.35; CI: 0.16 to 0.76), GCS 13 to 15 (OR: 0.28; CI 
0.10 to 0.74), high-energy trauma (OR: 9.42; CI 2.15 to 41.20), major 
extracranial injury (OR: 7.92; CI 2.57 to 24.41), EMS physician telephone 
consultation (OR: 6.02; CI 2.51 to 14.11) or presence on scene (OR: 8.63; 
CI 3.50 to 21.26) and incident at a public place outside (OR: 3.05; CI: 
1.34 to 6.4) and inside (OR: 2.92; CI: 1.07 to 8.01). Median time delay 
to trauma center admission was 1:07  hours (IQR: 0.52 to 1:28) for 
directly transported patients and 4:06 (IQR: 2.54 to 5:43) for those 
indirectly transported (P  <0.001). There was a clear trend towards 
poorer neurological outcome for patients with delayed trauma center 
admission in univariate analysis (P = 0.001).
Conclusion  Heavily alcohol intoxicated TBI patients are commonly 
initially transported to a non-neurosurgical trauma center and this may 
worsen 6-month neurological outcome.
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Table 1 (abstract P320). Causes of TBI in diff  erent age groups in Egypt
  NO = 844/      Abuse/  Violence/  Struck by/  Other causes/ 
Age (years)  4 months  FFH  MVC   neglect   assaults  against   not known
1 to 5  54 (6%)  20 (37%)  10 (19%)  8 (15%)  –  8 (15%)   8 (14%)
6 to 18  91 (11%)  28 (31%)  20 (22%)  5 (6%)  6 (5 %)  22 (25%)  10 (11%)
19 to 29  150 (18%)  49 (33%)  45 (30%)  –  14 (9%)  18 (12%)  24 (16%)
30 to 55  381 (45%)  114 (30%)  134 (35%)  –  19 (5%)  50 (13%)  64 (17%)
Above 55  168 (20%)  47 (28%)  41 (24%)  11 (7%)   5 (3%)  25 (15%)  39 (23%)
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Predictive ability of the IMPACT-TBI prognostic model is improved 
by adding markers of coagulation
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Introduction One of the most used prognostic models for traumatic 
brain injury is the IMPACT-TBI model, which predicts 6-month mortality 
and unfavorable outcome. Our aim was to study whether adding 
markers of coagulation improves the model’s predictive power when 
accounting for extracranial injury.
Methods Patients with a TBI admitted to a designated trauma center 
in 2009/10 were screened retrospectively and included according 
to the IMPACT study criteria. The predictive outcome was calculated 
for included patients using the full IMPACT-TBI model. To assess 
coagulopathy and extracranial injury we used the prothrombin time 
percentage (PT), platelet count (109), and injury severity score (ISS). 
PT, platelets and ISS were added to the IMPACT model, creating 
new models. The predictive power of the new models was tested by 
comparing their area under the receiver operating characteristic curve 
(AUC) with the original model.
Results Totally 342 were included. Six-month mortality was 32% and 
unfavorable outcome 57%. The IMPACT model’s predictive power 
for mortality and neurological outcome; AUC: 0.85, CI: 0.81 to 0.89; 
and AUC: 0.81, CI: 0.76 to 0.86. Nonsurvivors and patients with an 
unfavorable outcome had lower platelets (159; 165 vs. 191; 198), PT 
(76; 77 vs. 86; 90) and higher ISS (50; 44% ISS >25 vs. 34; 32% ISS >25) 
compared with survivors and favorable outcome (P <0.05). Addition of 
PT but not ISS nor platelets resulted in a signifi  cant improvement of the 
IMPACT model’s predictive power for 6-month mortality; AUC: 0.87, CI: 
0.81 to 0.89, P = 0.017 (Figure 1). In multivariate analysis PT remained 
an independent signifi  cant predictor of outcome when adjusting for 
IMPACT prognosis and ISS (OR: 0.985, CI: 0.975 to 0.996).
Conclusion  Addition of PT to the IMPACT model improves the 
predictive power for 6-month mortality but not neurological outcome 
when adjusting for ISS.
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Introduction Evidence suggest that endogenous lactate, produced by 
aerobic glycolysis, is an important substrate for neurons, particularly in 
conditions of increased energy demand. This study aimed to examine 
brain lactate metabolism in patients with severe traumatic brain injury 
(STBI).
Methods  A prospective cohort of STBI patients monitored with 
cerebral microdialysis (CMD) and brain tissue oxygen (PbtO2) was 
studied. Brain lactate metabolism was assessed by quantifi  cation 
of elevated CMD lactate samples (>4 mmol/l). These were matched 
to pyruvate and PbtO2, and dichotomized as hyperglycolytic (CMD 
pyruvate >119 μmol/l) versus nonhyperglycolytic or as hypoxic (PbtO2 
<20 mmHg) versus nonhypoxic. Data were expressed as percentages 
per patient. Global brain perfusion (categorized as oligemic, normal or 
hyperemic) was assessed with CT perfusion (CTP).
Results Twenty-four patients (total 1,782 CMD samples) were studied. 
Samples with elevated CMD lactate were frequently observed (41 ± 8% 
SEM of individual samples). Brain lactate elevations were predominantly 
hyperglycolytic (73 ± 8.2%), whilst only 14 ± 6.3% of them were hypoxic. 
Trends over time of both lactate patterns are shown in Figure 1. On CTP 
(n = 17; average 48 hours from TBI) hyperglycolytic lactate was always 
associated with normal or hyperemic CTP, whilst hypoxic lactate was 
associated with oligemic CTP (Table 1).
Table 1 (abstract P323). Lactate elevations and brain perfusion
  Oligemia (%)  Normal (%)  Hyperemia (%)
HG lactate  0  58  42
HX lactate  100  0  0
HG, hyperglycolytic; HX, hypoxic.
Conclusion  Our fi  ndings suggest predominant nonischemic lactate 
release after TBI and identify, for the fi  rst time, an association between 
cerebral hyperglycolytic lactate production and normal to supranormal 
brain perfusion. Our data support the concept that lactate may be used 
as energy substrate by the injured human brain.
Acknowledgement  Supported by the Swiss National Science 
Foundation.
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Introduction  In the prehospital setting, it is diffi     cult to use the 
Glasgow Coma Scale (GCS) to evaluate the consciousness state using 
in pediatric patients with severe trauma. The Japan Coma Scale (JCS) is 
a consciousness scale used widely in Japan and, with its four grades, is 
simpler and quicker to use than the GCS. This study examined whether 
Figure 1 (abstract P322).
Figure 1 (abstract P323).
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pediatric patients aged 3 to 15 years in the prehospital setting.
Methods This retrospective study analyzed data from the Japan Trauma 
Data Bank. Registered pediatric patients aged 3 to 15 years with severe 
trauma (maximum Abbreviated Injury Scale score ≥3 or Injury Severity 
Score ≥9) were divided into four groups according to JCS score in the 
prehospital setting (Grade 0: alert, Grade 1: possible eye-opening, not 
lucid, Grade 2: possible eye-opening upon stimulation, Grade 3: no 
eye-opening and coma). TBI was defi  ned as maximum head AIS ≥3.
Results A total of 1,562 patients were included (Grade 0: 673, Grade 1: 
410, Grade 2: 230, Grade 3: 249). Victims of blunt trauma accounted for 
98.1%. Median age was 9 (interquartile range: 7 to 12) years, median 
ISS was 16 (9 to 21). There was strong agreement between the JCS in 
prehospital setting and GCS scores on arrival at hospital (r = –0.745, 
P <0.001). Multivariate analysis adjusted for age and ISS revealed that 
the JCS was independently associated with TBI (odds ratio (OR): 2.5; 
95% CI: 2.1 to 2.8, P <0.001) and hospital mortality (OR: 3.8; 95% CI 2.4 
to 6.0, P <0.001). See Table 1.
Table 1 (abstract P324)
 TBI,  n (%) Mortality  (%)
JCS grade 0  213 (31.6)  0.1
JCS grade 1  225 (62.2)  0.7
JCS grade 2  184 (80.0)  2.6
JCS grade 3  230 (92.4)  15.7
Conclusion  There was strong association between JCS score and 
clinical outcome in pediatric patients with severe trauma. The results 
support the use of the JCS in the prehospital transport destination 
criteria for children.
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Introduction Non-invasive ocular ultrasonography has recently been 
proposed to detect elevated intracranial pressure (ICP). On the other 
hand, the eff  ect of positive end-expiratory pressure (PEEP) on ICP is 
well documented. The aim of the present ongoing study is to record the 
eff  ect of changes of airway pressures on optical sheath nerve diameter 
(OSND).
Methods  In this prospective observational study, measurements of 
OSND were carried out in 21 patients of a polyvalent 10-bed adult 
ICU before and 2 minutes after changes of PEEP from a baseline of 5 
with 1 cmH2O increments, to a maximum of 12. Two measurements 
were performed with a 7.5 MHz probe (MicroMaxx; Fujifi  lm Sonosite 
Inc., USA) in each eye before and after PEEP changes. Demographic 
data (APACHE II score, age, sex, diagnosis) Ppeak and Pm were also 
recorded. Exclusion criteria were intracranial pathology, ocular neuritis 
and trauma. Normality with P–P plots and the Kolmogorov–Smirnov 
test were calculated followed by bivariate and single linear regression 
analysis (IBM SPPS v17, signifi  cance P <0.05).
Results Seventy-two measurements were included for further analysis. 
Mean  ±  SD values were: PEEP (7.9  ±  2.3), Ppeak (24.35  ±  5), Pm 
(12.03 ± 3.16), OSNDright (4.03 ± 0.79), OSNDleft (4.1 ± 0.79), ΔOSND 
(0.24 ± 0.2), while values for age and APACHE II score were 62 ± 4 years 
and 14.4 ± 1.4 respectively. PEEP and OSND seem to have a moderate 
relation (tendency equation: OSND = 2.454 + 0.581×PEEP) compared 
with the weaker eff  ect of Ppeak and Pm (Table 1).
Table 1 (abstract P325). Correlations (r2) between airway pressures and OSND
 OSNDright  OSNDleft
PEEP 0.581*  0.571*
Ppeak 0.467*  0.448*
Pm 0.491**  0.467**
*P <0.01, **P <0.05.
Conclusion Our study identifi  ed a moderate relation between PEEP 
and OSND and a weaker one between Ppeak, Pm and OSND. Thus, 
in selected cases OSND could serve as a bedside marker of eff  ect of 
airway pressure to ICP. Yet, larger studies are needed to come to a safer 
conclusion.
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Introduction Following primary neurological insult, initial manage ment 
of traumatic brain-injured (TBI) patients has a clearly defi  ned pathway 
[1]. However, after arrival at tertiary centers, further manage ment is not 
Figure 1 (abstract P326).
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hypoxia, hyperpyrexia and hypocapnia have all been shown to 
independently increase mortality [2]. Despite numerous studies, there 
is currently no level 1 evidence to support any specifi  c management 
[3]. Our objective was to provide an overview of the current clinical 
management protocols in the UK.
Methods  Thirty-one ICUs managing patients with severe TBI were 
identifi  ed from the RAIN (Risk Adjustment In Neurocritical care) study, 
and a telephone survey was conducted.
Results  A total 97% of units used a cerebral perfusion pressure 
protocol for the initial management, with 83% targeting pressures of 
60 to 70 mmHg and 17% aimed for >70 mmHg. Ninety-one percent of 
units monitored CO2 routinely with 61% targeting CO2 of 4.5 to 5 kPa 
(Figure 1). Regarding osmotherapy, mannitol was still the preferred 
agent, with 48% of units using it as fi  rst line; 32% used hypertonic saline, 
while 20% of units used either depending on clinicians’ preference.   
Sixteen percent questioned were currently enrolled on the Eurotherm 
hypothermia trial, while 16% never used hypothermia and one unit 
used prophylactic hypothermia routinely. The remaining 65% of units 
used hypothermia only to manage refractory ICH.
Conclusion There is no clear consensus on the initial targets used. The 
surviving sepsis campaign showed that protocol-led care can reduce 
mortality [4]. Perhaps it is time for a similar approach to be adopted, 
with specialists coming to together to review the evidence and 
formulate guidelines that can then be tested.
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Introduction Traumatic brain injury (TBI) is a major cause of permanent 
disability and death in young patients. Controversy exists regarding the 
optimal cerebral perfusion pressure (CPP) required in TBI management. 
A tool for monitoring autoregulation and determining an optimal 
CPP is the pressure reactivity index (PRx), defi   ned as a moving 
correlation coeffi     cient between the mean arterial blood pressure 
(MAP) and intracranial pressure (ICP) at a frequency of at least 60 Hz. 
This requirement of high frequency has constrained its use to a few 
academic centers. An association was shown between outcome and 
continuous optimal CPP based on 4 hours of PRx [1]. We present a 
novel low-frequency autoregulation index (LAx), based on correlations 
between ICP and MAP at a standard minute-by-minute time resolution.
Methods  A total of 182 patients from the Brain-IT [2] multicentre 
European database had registered outcome and ICP and MAP for 
the fi   rst 48 ICU hours. Twenty-one TBI patients admitted to the 
university hospitals of Leuven, Belgium and Tubingen, Germany were 
continuously monitored using ICM+ software (Cambridge Enterprise) 
allowing for continuous PRx calculation. Autoregulation indices versus 
CPP plots for PRx and LAx were computed to determine optimal CPP 
every minute during the fi  rst 48 ICU hours [1].
Results On the Brain-IT database, LAx resulted in an optimal CPP for 
90% of the fi  rst 48 hours. Table 1 shows recommendations with respect 
to outcome. In the Leuven–Tübingen database, PRx and LAx resulted in 
44% and 92% recommendations respectively. The average diff  erence 
between methods was 5.26 mmHg.
Conclusion The diff  erences in optimal CPPs derived from PRx and LAx 
were not clinically signifi  cant. LAx allowed for recommendations to be 
computed for longer periods. Signifi  cantly better outcome (Table 1) 
was observed in patients for whom optimal CPP derived from LAx was 
maintained.
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Introduction  Pediatric patients with altered mental status (AMS) 
present with poor histories resulting in delayed testing and potential 
poor outcomes. Non-invasive detection for altered cerebral physiology 
related to TBI would improve resuscitation and outcome. Cerebral 
rSO2 (rcSO2) studies demonstrate its utility in certain neurological 
emergencies.
Methods A retrospective analysis of rcSO2 utility in AMS. rcSO2 data were 
collected every 30 seconds for AMS patients who had a head CT. Patients 
with a negative head CT were compared with those with an abnormal 
head CT. ROC analysis was performed to fi  nd the AUC for each summary 
statistic and performance characteristics. Subgroup analysis was done to 
determine whether rcSO2 predicted injury and location.
Results rcSO2 readings across 5, 15, 20, and 30 minutes were stable 
(Figure  1). rcSO2 readings with one or both sides <50% or a wide 
diff  erence between L and R cerebrum was predictive of an abnormal 
CT scan. A mean diff  erence of 4.2 was 82% sensitive for detecting a CT 
lesion with 62% specifi  city, 88% PPV, and 52% NPV; a mean diff  erence 
of 12.2 was 100% specifi  c for an abnormal head CT. Lower mean rcSO2 
readings localized to the CT pathology side, and higher rcSO2 readings 
trend toward the EDH group.
Conclusion  Cerebral rcSO2 monitoring can non-invasively detect 
altered cerebral physiology and pathology related to TBI as the cause 
for pediatric altered mental status. The utility of rcSO2 monitoring has 
shown its potential for localizing and characterizing intracranial lesions 
among these altered children. Further studies utilizing rcSO2 monitoring 
as an adjunct tool in pediatric altered mental status evaluation and 
management are ongoing.
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Introduction  Fever is a dangerous secondary insult for the injured 
brain [1]. We investigated the cerebral and hemodynamic eff  ects of 
intravenous (i.v.) paracetamol administration for the control of fever in 
neurointensive care unit (NICU) patients.
Methods The i.v. paracetamol (1 g in 15 minutes) was administered to 
NICU patients with a body temperature (Temp.) >37.5°C. Its eff  ects on 
mean arterial pressure (MAP), heart rate (HR), intracranial pressure (ICP), 
cerebral perfusion pressure (CPP), jugular venous oxygen saturation 
(SjVO2) and Temp. were recorded at the start of paracetamol infusion 
(T0) and after 30 (T30), 60 (T60) and 120 (T120) minutes. Interventions 
for the maintenance of CPP  >60  mmHg or ICP  <20  mmHg were 
recorded.
Table 1 (abstract P327)
 Nonsurvivors  Survivors  P value
Time within CPPopt-%   18.3 (15.5; 24.4)  24.8 (19.7; 28.7)  0.0004
|CPP-CPPopt| (mmHg)  7.05 (4.98; 9.73)  5.37 (4.49; 6.82)  0.0024
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traumatic brain injury, mean age 54.9 ± 16.8, seven (50%) males, median 
GCS 7) were prospectively studied. We analyzed the administration 
of one dose of paracetamol for each patient (total 14 cases). After 
infusion of paracetamol we found a decrease of Temp. (from 37.8 ± 0.3 
to 37.4 ± 0.4°C, P <0.001), MAP (from 94.7 ± 9.9 to 86.1 ± 6.7 mmHg, 
P = 0.008), CPP (from 79.6 ± 13.1 to 70.8 ± 7.6 mmHg, P = 0.011) and 
HR (from 71.5 ± 14.9 to 63.8 ± 16.3 bpm, P <0.001) with respect to the 
starting value (ANOVA for repeated measures), whereas ICP and SjVO2 
remained unchanged (Figure 1). In fi  ve cases norepinephrine infusion 
was started for CPP <60 mmHg. In another two cases, for the same 
reason, the norepinephrine dosage was augmented. The proportion of 
patients who had infusion of norepinephrine increased from 42.8% at 
T0 to 78.6% at T120 (P = 0.02, chi-square for trends).
Conclusion  Use of i.v. paracetamol is eff  ective in the maintenance 
of normothermia in acute brain-injured patients. However, adverse 
hemodynamic eff  ects, which could represent a secondary insult for the 
injured brain, must be rapidly recognized and treated.
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Figure 1 (abstract P328).
Figure 1 (abstract P329). *P <0.05 versus T0.
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Introduction  Standard clinical practice in patients with elevated 
intracranial pressure (ICP) is to keep cerebral perfusion pressure (CPP) 
at (or above) 60  mmHg: we performed this retrospective study to 
analyze whether induction of barbiturate coma impedes compliance 
to this target CPP value. It has been repetitively shown that, although 
proven as an effi   cient therapy for refractory elevated ICP, barbiturate 
coma may cause a decrease in mean arterial pressure (MAP) and CPP 
[1].
Methods All patients that had received sodium thiopental in our ICU 
during 2011 were identifi  ed and their medical and nursing records 
were retrospectively analyzed. The eff  ect of administration of sodium 
thiopental (loading dose 3 to 5  mg/kg, followed by a continuous 
infusion adjusted to obtain an EEG burst suppression ratio between 40 
and 80%) on MAP, ICP and CPP was evaluated. Values are reported as 
mean ± SD. The changes over time in ICP, MAP and CPP are reported as 
means with their 95% CI.
Results In 2011, a total of 20 patients were treated in our ICU with 
barbiturate coma for refractory elevated ICP. In fi  ve patients, systemic 
hypothermia was simultaneously induced. These patients were 
excluded from further analysis. Six patients died during their stay in the 
ICU and nine patients could be discharged to the neurosurgical ward. 
The mean peak ICP value before induction of barbiturate coma was 
26 ± 3 mmHg, and the ICP value 6 hours later was 20 ± 6 mmHg. The 
MAP at those same time points was 91 ± 12 mmHg and 81 ± 11 mmHg, 
respectively. The CPP, calculated from both previous values, was 
66 ± 13 mmHg and 61 ± 11 mmHg, respectively. At both time points, 
the dose of noradrenaline was comparable (10.1 ± 9.6 μg/minute and 
11.5 ± 13.2 μg/minute, respectively). Analysis of the change in ICP, 
MAP and CPP over the 6-hour period showed a signifi  cant decrease 
in ICP of –5.8 mmHg (–9.3; –2.3) (mean, 95% CI). The MAP signifi  cantly 
decreased by –10.4 mmHg (–19.1; –1.7). The decrease in CPP was not 
signifi  cant (–4.6 mmHg (–14.2; 5.0)).
Conclusion This retrospective study indicates that inducing a thiopental 
coma in patients with refractory elevated ICP eff  ectively reduces ICP. 
Although the concomitant reduction in MAP was signifi  cant,  the 
resulting decrease in CPP was small and nonsignifi  cant. Moreover, the 
target CPP of 60 mmHg was maintained after induction of barbiturate 
coma.
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Introduction Evaluating resource utilization is paramount in critically 
ill patients with traumatic brain injury (TBI), but little is known 
on readmissions after hospital discharge. We evaluated rates and 
determinants of unplanned readmission following TBI.
Methods We conducted a multicenter retrospective cohort study from 
April 1998 to March 2009. Data were obtained from a Canadian provincial 
trauma system, based on mandatory contribution from 59 trauma 
centres, and a hospital discharge database. Patients aged ≥16 years 
with TBI (ICD-9 or ICD-10 codes of 850-854 and S06, respectively) were 
included. Patients who died during the index hospitalization, who 
lived outside the province, who could not be linked with the hospital 
discharge database were excluded. We collected baseline and trauma 
characteristics, hospital admissions in the 12 months preceding index 
admission, and readmissions in the 12 following months. Primary 
outcome was unplanned readmission 30 days, 3 months and 6 months 
post discharge. We evaluated sociodemographic and clinical factors 
associated with readmissions using a logistic regression model.
Results Among 18,342 adult patients with TBI identifi  ed in the registry, 
14,777 patients were included among which 2,363 had severe, 1,106 
moderate and 11,308 mild traumatic brain injury. Most patients were 
young (mean age: 52 ± 23 years) and had no comorbidity (73.6%). 
Overall, 1,032 patients (7.0%) were readmitted within 30 days, 12.7% 
within 3 months and 17.6% within 6 months. At 30 days post discharge, 
311 (30.1%) were readmitted for a complication. The median length of 
stay was 8 days (Q1 to Q3: 3 to 20). More than 10% of patients aged 
≥75 years with ≥1 comorbidity or with ≥1 admission prior to index 
hospitalisation were readmitted. The severity of the TBI was not an 
independent predictor of readmission. Age, highest AIS, number of 
comorbidities, number of admissions prior to index hospitalization, 
level of index trauma center and discharge destination were associated 
with readmissions on multivariate analysis.
Conclusion Readmissions in the months following TBI are frequent, but 
were not found to be associated with the TBI severity. Further studies 
evaluating reasons for readmission are warranted in order to develop 
strategies to prevent such events.
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Introduction  Pituitary disorders following traumatic brain injury 
(TBI) are frequent, but their determinants are poorly understood. 
We performed a systematic review to assess the risk factors of TBI-
associated pituitary disorders.
Methods  We searched MEDLINE, Embase, Scopus, The Cochrane 
Library, BIOSIS, and Trip Database, and references of narrative reviews 
for cohort, cross-sectional and case–control studies enrolling at least 
fi  ve adults with TBI in whom ≥1 pituitary axis was tested and one 
potential predictor reported. Two independent investigators selected 
citations, extracted data and assessed the risk of bias. We pooled the 
data from all studies assessing a specifi  c predictor, regardless of the 
pituitary axis being evaluated. When more than one pituitary axis was 
assessed, we used the data related to hypopituitarism or the data from 
the most defective axis. When a pituitary axis was evaluated several 
times, we used assessment farthest from the injury. A meta-analysis 
was performed using random eff  ect models and I2 was used to evaluate 
heterogeneity. Studies were considered at low risk of bias if the authors 
defi  ned inclusion/exclusion criteria, did not use voluntary sampling, 
and tested > 90% of patients with proper detailed diagnostic criteria.
Results Among 13,559 citations, we included 26 studies (1,708 patients). 
Increased age was associated with pituitary disorders (weighted mean 
diff  erence = 3.2, 95% CI = 0.3 to 6.1, 19 studies, 1,057 patients, I2 = 59%). 
This fi  nding was no longer signifi  cant when only considering studies 
with low risk of bias. TBI severity was associated with an increased risk 
of developing pituitary disorders (RR = 1.49, 1.24 to 1.77, I2 = 17% for 
moderate/severe vs. mild TBI; RR = 1.78, 1.09 to 2.91, I2 = 80% for severe 
vs. mild/moderate TBI), while sex was not (RR for male = 1.05, 0.98 to 
1.13, 15 studies, 870 patients, I2 = 0%). Among CT scan fi  ndings, only 
skull fractures were associated with pituitary disorders (RR = 1.75, 1.13 
to 2.70, six studies, 345 patients, I2 = 47%). An insuffi   cient number of 
studies with low risk of bias assessing the association between GCS, 
CT scan fi   ndings and pituitary disorders was retrieved to perform 
meta-analysis.
Conclusion Age, TBI severity and skull fractures are associated with an 
increased risk of pituitary disorders. Further studies are necessary to 
identify additional factors that will help developing targeted screening 
strategies.
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Vasopressin reduces the cumulative epinephrine dose in 
hypothermic swine with traumatic brain injury
AD Goldberg, MG Kashiouris, L Keenan, A Rabinstein, M Kumar
Mayo Clinic, Rochester, MN, USA
Critical Care 2013, 17(Suppl 2):P333 (doi: 10.1186/cc12271)
Introduction Prevention of secondary neurologic injuries is paramount 
for improved neurologic outcomes after traumatic brain injury (TBI). 
Evidence suggests that although therapeutic hypothermia (TH) lowers 
intracranial pressure and attenuates secondary cerebral insults after TBI 
[1], it also induces hypotension. Brief episodes of mild hypotension in 
brain-injured patients can trigger secondary injuries, which have been 
associated with increased mortality in patients with TBI [2]. Vasopressin 
mitigates hypotension in septic shock and improves coronary perfusion 
in hypothermic cardiac arrest models [3]. We hypothesized that a low-
dose vasopressin infusion may reduce the cumulative epinephrine 
dose in hypothermic, brain-injured swine.
Methods Six domestic cross-bred pigs were subjected to epinephrine 
infusion after general anesthesia, standardized TBI and transpulmonary 
hypothermia (32°C for 48 hours). All animals received the same care, 
aiming for a mean arterial pressure >60 mmHg. At hour 24, animals 
received additional vasopressin infusion at 0.04 units/minute. We 
measured the cumulative epinephrine dose for each animal pre 
and post vasopressin infusion (Figure 1) and performed a two-
sample Wilcoxon rank-sum test, comparing the median cumulative 
epinephrine doses in the two groups.
Results The median cumulative epinephrine dose in the animals that 
received the vasopressin infusion was 715 mg with a 25th to 75th 
interquartile range (IQR) of 320 to 930 mg. The median cumulative 
epinephrine dose in the control group was 2,044 mg (IQR 1,640 to 
2,344 mg). This was statistically signifi  cant (P = 0.003), based on the 
Wilcoxon rank-sum test.
Conclusion  A low-dose infusion of vasopressin can signifi  cantly 
reduce vasopressor requirements and improves hemodynamics in 
hypothermic, brain-injured swine. This hemodynamic stability may 
improve neurological outcomes.
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Introduction Severe traumatic brain injury (TBI) is a major cause of death 
and of severe neurologic sequelae. Long-term functional outcome 
of TBI and its best timing of assessment are not well understood, 
and may be evaluated too prematurely in clinical studies because of 
resources required to do so without too much missing data. Hence, 
we conducted a systematic review of studies in severe TBI patients 
to evaluate the long-term functional outcome. We hypothesized that 
functional impact measured by the Glasgow Outcome Scale (GOS), 
or the extended version (GOSe), may plateau after several months in 
patients with severe TBI.
Methods We performed a systematic review of randomized controlled 
trials and cohort studies (prospective and retrospective) in patients 
with severe TBI. We searched MEDLINE, Embase, Cochrane Central, 
BIOSIS, CINAHL and Trip Database from their inception to December 
2011. References of included studies were searched for additional 
studies. Two reviewers independently determined study eligibility and 
collected data. The primary outcome measure was the proportion of 
unfavourable functional outcome (GOS 1 to 3 or GOSe 1 to 4) at 6 to 
12 months, 12 to 18 months, 18 to 24 months and more than 24 months 
after severe TBI. We calculated Freeman Tukey-type arcsine square-
root transformations and pooled data using random-eff  ect models. 
Heterogeneity was assessed with the I2 test and sensitivity analyses 
were based on a priori hypotheses.
Results In total, 4,432 studies were assessed for eligibility; 209 studies 
(n = 31,540) were included. In the 188 studies using the GOS, a poor 
functional outcome was observed in 56.6% (95% CI = 54.0 to 59.1%, 
I2 = 91%), 51.9% (95% CI = 38.0 to 59.0%, I2 = 84%), 57.0% (95% CI = 48.2 
to 55.5%, I2 = 93%) and 56.9% (95% CI = 48.2 to 65.1%, I2 = 93%) of 
patients at 6 to 12 months, 12 to 18 months, 18 to 24 months and 
beyond 24  months, respectively. In the 18 studies using GOSe, a 
poor functional outcome was observed in 62.9% of patients at 6 
to 12 months (95% CI = 55.9 to 69.2%, I2 = 90%) and 54.6% at 12 to 
18  months (95% CI  =  43.2 to 65.8%, I2  =  90%). Heterogeneity was 
present in most analyses and was not entirely explained by the planned 
sensitivity analyses.
Conclusion  Considering that the incidence of patients with an 
unfavourable outcome remained constant at diff  erent assessments, 
a follow-up of severe TBI patients longer than 12 months does not 
provide incremental information. Functional outcomes measured 
longer than 12 months after the injury may not be warranted in clinical 
studies.
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Introduction Prevention of secondary brain injury is the cornerstone 
in the management of patients with severe traumatic brain injury (TBI) 
and raised intracranial pressure (ICP). Although a variety of monitoring 
methods are available, due to lack of strong evidence their use varies 
considerably [1]. The objective of this survey was to provide an 
overview of the current practice in monitoring of patients with severe 
TBI in all neuro-ICUs across the UK.
Methods  The ICUs managing adult patients with severe TBI were 
identifi  ed from the RAIN (Risk Adjustment In Neurocritical care) study 
sites, and the Society of British Neurosurgeons. Thirty-one centers were 
identifi  ed, and a telephonic survey was conducted by the investigators. 
Data were collected using a single-page questionnaire containing 18 
questions.
Results All 31 (100%) units used ICP monitoring and parenchymal ICP 
bolt was the most widely used method (77%). Thirty (96.7%) units used 
a cerebral perfusion pressure protocol to guide therapy. Twenty-eight 
(90.3%) units used continuous capnography. Twelve (38.7%) units 
used transcranial Doppler. Eight (25.8%) units used partial pressure of 
oxygen in brain tissue. Four (12.9%) units used microdialysis. Only one 
unit used jugular bulb oximetry. None of the units used near-infrared 
spectrometry or optic nerve sheath diameter. Eight units (25.8%) used 
a cerebral function monitor and seven (22.5%) units used the bispectral 
index for guiding depth of sedation.
Figure 1 (abstract P333). Eff  ect of vasopressin on cumulative amount of 
epinephrine administered.
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what types of monitoring should be used to guide management of 
patients with TBI. A CPP protocol, based on measurement of ICP, is the 
most widely used method, although a recent randomized control trial 
did not show any benefi  t in outcome [2]. Other invasive monitoring 
methods, although they may help in individualized care, are still not 
yet popular to due lack of strong evidence. Larger multicentre portfolio 
studies are needed to establish their benefi  ts.
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Introduction Intracranial bleeding after head injury is an important 
issue in the emergency department (ED), and elevated INR increases 
this risk [1]. A retrospective study showed an association between 
diff  erent levels of normal INRs (<1.6) and elevated risk of intracranial 
bleeding, with a signifi  cant elevation of this risk over an INR threshold 
of 1.3 [2]. The objective of the study was to evaluate clinical impact 
of an INR within the normal range in patients with head trauma. We 
compared mortality between patients with INR <1.3 and those with INR 
≥1.3 to <1.6.
Methods A post hoc analysis of prospective data collected from 3,356 
patients seen in a tertiary-care ED from March 2008 to February 2011. 
We included patients aged 16 years old and over with an INR <1.6 and 
a head CT performed within 24 hours of the trauma. We followed these 
patients until December 2012, performed a chi-square test between 
mortality of the two groups and calculated the hazard ratio (HR) from 
survival analysis using Cox regression.
Results Patient mean age was 55.1 years (SD ±23), 65% were men and 
mean follow-up duration was 3.1 years (SD ±0.8). A total of 115 patients 
(15.9%) died during follow-up: 16 (36.4%) in the group with INR ≥1.3 
and 99 (14.6%) in the group with INR <1.3 (P <0.001). Results showed a 
signifi  cantly higher risk of death in the group with INR ≥1.3: HR = 2.99 
(95% CI = 1.8 to 5.1); P <0.001 (Figure 1).
Conclusion In patients with head injury and normal INR (<1.6), there 
is an association between an INR ≥1.3 and higher risk of death. 
Therefore, it would be useful to request an INR in patients presenting 
with a head injury when bleeding is suspected, even in the absence of 
anticoagulant.
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Introduction Traumatic brain injury (TBI) is a leading cause of death 
and disability worldwide. Because mortality seriously underestimates 
the impact of TBI, an outcome tool including vegetative state and 
severe disability should be used. Our purpose was to study the long-
term outcome of a small cohort of severe TBI patients in Brazil.
Methods This was a retrospective analysis of a prospectively collected 
database. We included 34 consecutive adult patients admitted with 
severe TBI to a tertiary private hospital in Rio de Janeiro, Brazil between 
2009 and 2011. We analyzed data on demographics, admission, clinical 
scores, imaging and complications, as well as hospital mortality and 
1-year extended Glasgow Outcome Scale (eGOS) of all patients.
Results We analyzed 33 patients with severe TBI. Mean age was 36 (± 20) 
years and 79% were male. All patients were mechanically ventilated 
and 70% underwent ICP monitoring. Overall hospital mortality was 
36% and 60% had unfavorable outcome (eGOS <4) after 1 year. In 
univariate analysis, higher APACHE II scores, the presence of midriasis 
and intracranial hypertension were more frequent in nonsurvivors 
compared with survivors. Furthermore, older age, higher APACHE II 
score and worse GCS on admission were associated with unfavorable 
outcome after 1 year, as measured by eGOS <4.
Conclusion  Our descriptive results suggest a signifi  cant burden of 
severe TBI in a small cohort of young patients. Moreover, severity 
of the primary disease, age and pupil refl  exes, as well as intracranial 
hypertension seemed to be associated with worse neurological 
outcome.
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Introduction  Pulmonary complications are frequently occurring 
medical complications after aneurysmal subarachnoid hemorrhage 
(aSAH) [1]. Early respiratory deterioration (ERD) may be associated 
with delayed cerebral ischemia (DCI) or outcome and would then be a 
potential target for therapeutic interventions. We investigated whether 
respiratory deterioration within the fi   rst 72  hours after admission 
predicted DCI or poor outcome.
Methods We conducted a retrospective study in 137 consecutively 
admitted patients with aSAH, admitted between October 2007 and 
October 2011 to the ICU of a university hospital. ERD was defi  ned as 
increased need for ventilatory support the second or third day after 
admission (Table 1). Elective intubation for a surgical procedure was 
not included as ERD. Inclusion criteria were availability of detailed 
information on respiratory status and level of support, admission 
within 48 hours after hemorrhage and age ≥18 years. Multivariable 
Figure 1 (abstract P336). Survival analysis of patients with INR <1.3 and 
with INR ≥1.3.
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and Glasgow Outcome Scale (GOS) with ERD adjusted for condition 
on admission, Hijdra score, treatment of ruptured aneurysm and 
pulmonary comorbidity. GOS was assessed at 3 to 6 months after the 
bleed. DCI was defi  ned as described recently [2].
Results Mean age of the patients was 55.9 (± 12.7) and 63.5% was 
female. A total 46.7% of the patients developed DCI. Mortality was 
25.6%. Forty percent of the patients were classifi  ed as having ERD. ERD 
was not associated with DCI (adjusted HR = 1.48; 95% CI = 0.88 to 2.49; 
P = 0.14). ERD showed a trend towards an association with mortality 
(adjusted HR = 2.22; 95% CI = 0.96 to 5.14; P = 0.06; additionally adjusted 
for age, and rebleed). A clear association was found between absence 
of ERD and functional outcome with ordinal logistic regression analysis 
(0.98 point increase in GOS score at 3 to 6 months; 95% CI = 0.14 to 1.82; 
P = 0.02; additionally adjusted for age and rebleed).
Conclusion ERD within 72 hours after admission is associated with 
increased risk of poor functional outcome after aSAH, but not DCI. 
Further investigations are required to assess whether prevention of 
ERD may improve outcome.
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Introduction  Delayed cerebral ischemia (DCI) worsens neurological 
outcome in patients with aneurysmal subarachnoid hemorrhage 
(aSAH). DCI pathogenesis is multifactorial and not completely 
understood, but vasospasm plays a central role. Transcranial color-
coded duplex sonography (TCCDS) is a non-invasive bedside tool to 
explore cerebral vessels, but specifi  city is still suboptimal. The aim 
of this study was to evaluate the proximal–distal gradient of mean 
cerebral blood fl  ow velocity (CBF-V) in middle cerebral artery (MCA) as 
a possible indicator of critical vasospasm.
Methods Consecutive aSAH patients (WFNS 1 to 5, age 18 to 80 years) 
admitted to NeuroICU between November 2011 and September 2012 
were included in this study. TCCDS was used to assess CBF-V in MCA of 
both sides: we defi  ned TCCDS vasospasm as CBF-V >120 cm/second. 
Magnetic resonance angiography (MRA, 3D TOF HR) was performed to 
evaluate vasospasm at early (<3 days) and delayed (7 to 10 days) time 
points. When patients underwent MRA, in the same clinical conditions, 
we recorded CBF-V with TCCDS at two levels: at the origin (proximal 
CBF-V) and at the end (distal CBF-V) of the MCA. Then we calculated the 
absolute value of proximal–distal CBF-V gradient for MCA of both sides. 
We defi  ned clinical vasospasm as the appearance of a new neurological 
defi  cit confi  rmed by imaging. The relationships between the absolute 
value of TCCDS CBF-V gradient and (1) TCCDS vasospasm, (2)  MRA 
vasospasm and (3) clinical vasospasm were explored.
Results We included 26 consecutive aSAH patients (WFNS 1 to 5, age 
57 ± 12 years). The absolute value of MCA CBF-V gradient was higher in: 
(1) vessels aff  ected by TCCDS vasospasm when compared with vessels 
not aff  ected (63 cm/second, IR 23 to 85 and 15 cm/second IR 7 to 23 
respectively, P <0.001); (2) vessels aff  ected by MRA vasospasm when 
compared with vessels not aff  ected (43 cm/second, IR 18 to 78 and 
13 cm/second IR 6 to 22, P <0.001); and (3) in patients who developed 
clinical vasospasm than in patients who did not (56 cm/second IR 11 
to 124 and 16 cm/second IR 8 to 30 respectively, P <0.01). Considering 
only the subset of MCAs aff   ected by MRA vasospasm, the CBF-V 
gradient was higher when clinical vasospasm was also present (75 cm/
second IR 56 to 124 and 23 cm/second IR 17 to 30 respectively, P <0.05).
Conclusion Proximal–distal CBF-V gradient of MCA might be a reliable 
indicator of critical vasospasm but further studies are warranted to 
defi  ne threshold values and specifi  city in aSAH patients.
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Introduction Microthrombosis has been demonstrated in early and 
delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage 
(aSAH). Markers of coagulation activation as microparticles (MPs) are an 
established risk factor for thrombosis. Our hypothesis was that levels 
of microparticles might correlate with aSAH severity, early cerebral 
ischemia (ECI) and delayed cerebral ischemia (DCI).
Methods Consecutive aSAH patients (age 18 to 80) admitted to our 
department between November 2011 and September 2012 were 
enrolled in the study. Total MPs (anxV+), platelet MPs (PLT-MPs, anx+/
CD41+), tissue factor MPs (TF-MPs, anx+/CD142+), and endothelial 
MPs (E-MPs, anx+/CD144+) were assessed in venous blood samples. 
Measurement of MPs levels were obtained at early (<3 days) and delayed 
phase (7 to 10 days). Multiparameter MRI (T2; FLAIR; T1; AngioRM 3D TOF 
HR; DWI) was performed to evaluate ischemic damage and vasospasm 
at the same time points. Qualitative evaluation of severity of ischemic 
damage was performed on DWI sequences. Levels of MPs were evaluated 
comparing diff  erent groups in terms of SAH severity (World Federation 
of Neurological Surgeons score or WFNS), ECI severity and occurrence of 
delayed complications (vasospasm and DCI).
Results Twenty-fi  ve patients (age 57 ± 12 years, WFNS 1 to 5) were 
included in the analysis. Overall increased levels of MPs were observed 
at early phase after aSAH when compared with controls. Contrarily 
to our hypothesis, in the early phase no signifi  cant  diff  erences of 
MP level were observed in WFNS 4 to 5 (n = 9) when compared with 
WFNS 1 to 2 (n = 16) patients. Interestingly, patients with most severe 
ECI and DCI showed the highest values of MPs, but this trend did not 
reach statistical signifi  cance, probably because of the small number of 
patients included in the study.
Conclusion  Microparticles and microthrombosis may increase the 
severity of early and delayed ischemic damage after aSAH.
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Introduction Elevated intracranial pressure (ICP) may have deleterious 
eff   ects on cerebral metabolism and mortality after aneurysmal 
subarachnoid hemorrhage (SAH) [1,2], but its relevance has not yet 
been well explored. Aims of this study are to track ICP changes after 
SAH, to identify clinical factors associated with it and to explore the 
relationship between ICP and outcome.
Table 1 (abstract P338). Categories of respiratory support
  Level of respiratory support
Category  (compared with fi  rst admission day)
1  Up to 5 l O2
2  >5 l O2 by nasal canulla or Venturi mask
3  Nonrebreathing mask or non-invasive positive-pressure 
 ventilation
4  Invasive mechanical ventilation
When mechanically   Decreased PaO2/FiO2 ratio
terminated
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were enrolled. Episodes of ICP >20 mmHg for at least 5 minutes and the 
mean ICP value for every 12-hour interval were analyzed. The highest 
mean ICP collected in every patient was identifi  ed. ICP values were 
analyzed in relation to clinical and CT fi  ndings; 6-month outcome and 
ICU mortality were also introduced in multivariable logistic models.
Results Eighty-one percent of patients had at least one episode of 
elevated ICP and 36% had a highest mean ICP >20 mmHg. The number 
of patients with highest mean ICP >20 mmHg or with episodes of 
HICP was maximum at day 3 after SAH and decreased only after day 7. 
Neurological status, aneurysmal rebleeding, amount of blood on 
CT and CT ischemic lesion occurred within 72 hours from SAH were 
signifi  cantly related to highest mean ICP >20 mmHg in a multivariable 
model. Patients with highest mean ICP >20 mmHg showed signifi  cantly 
higher mortality in ICU. However, ICP is not an independent predictor 
of 6 months unfavorable outcome.
Conclusion Elevated intracranial pressure is a common complication in 
the fi  rst week after SAH. It is associated with early brain injury severity 
and ICU mortality.
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Introduction Pituitary disorders are an often-neglected consequence 
of aneurysmal subarachnoid hemorrhage (aSAH). We systematically 
reviewed their prevalence, aiming particularly at studies with low risk 
of bias.
Methods We searched Embase, MEDLINE, The Cochrane Library, Trip 
Database, references of included studies and narrative reviews. We 
included cohort studies, cross-sectional studies and RCTs published 
in any language that tested the integrity of ≥1 pituitary axis in adults 
with aSAH. Studies including more than 50% of non-aneurismal SAH 
were excluded. Studies were considered at low risk of bias if the authors 
defi  ned inclusion/exclusion criteria, avoided voluntary sampling, and 
tested >90% of included patients with proper detailed diagnostic 
criteria. Studies testing all pituitary axes were considered as evaluating 
hypopituitarism, which was defi  ned as the dysfunction of ≥1 axis. 
We used a Freeman Tukey-type arcsine square-root transformation 
and pooled prevalences using the DerSimonian–Laird random-eff  ect 
method. We determined the degree of heterogeneity with I2 values.
Results  Among 12,363 citations, we included 28 studies (1,628 
patients). Patients were mostly female (64%) aged 50.5 ± 5.4. Sixteen 
studies reported the severity of aSAH, 14 reported the procedure for 
securing the aneurysm and 13 reported the location of aneurysm. 
Overall, hypopituitarism was observed in 53.4% of patients at short-
term (<3 months), 36.5% at mid-term (3 to 12 months) and 34.2% at 
long-term (>12 months) (Table 1). There was an insuffi   cient number of 
studies with low risk of bias to perform sensitivity analyses according 
to study quality.
Conclusion The exact prevalence of pituitary disorders following aSAH 
remains uncertain, mainly due to high heterogeneity and the small 
number of studies with low risk of bias. However, the prevalence seems 
to decrease during the recovery phase. The prevalence, risk factors and 
clinical signifi  cance of pituitary disorders in aSAH will require further 
rigorous evaluation.
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Introduction  Aneurysmal subarachnoid haemorrhage (aSAH) 
is associated with a high morbidity and mortality. Although UK 
Anaesthesia Guidelines advocate early coiling or clipping of the 
aneurysm within the fi  rst 72 hours of admission for all grades of aSAH, 
the optimal timing of treatment and whether this is linked with better 
neurological long-term outcome are a subject of debate [1]. We aimed 
to investigate whether the timing of the occlusion of the aneurysm 
translates into better outcome.
Methods  A retrospective analysis of prospective collected data in 
a tertiary neuroscience centre from January to September 2012. All 
Table 1 (abstract P342)
 Hypopituitarism  GH  ACTH  TSH  Gonadal  ADH
Short term       
All studies  53.4% (20.5 to 84.7)  30.4% (11.5 to 53.2)  13.2% (4.4 to 25.1)  49.2% (0.1 to 17.7)  26.1% (8.8 to 48.0)  6.3% (2.7 to 11.0)
n (patients)  5 (235)  8 (346)  13 (537)  7 (327)  8 (351)  3 (481)
I2  96.0% 93.5% 90.2% 89.1% 93.0% 61.1%
Studies of low risk of bias (patients)  2(56)  –  –  2(56)  1(26)  –
Mid-term       
All studies   36.5% (13.6 to 62.8)  7.3% (0.6 to 18.3)  8.9% (1.3 to 21.0)  8.8% (2.4 to 18.0)  3.9% (0.0 to 11.9)  3.7% (0.6 to 13.5)
n (patients)  4 (109)  6 (158)  7 (208)  5 (176)  6 (178)  2(56)
I2  85.7% 70.9% 79.4% 59.4% 66.8% 29.0%
Studies with low risk of bias (patients)  1(40)  –  –  1(40)  –  –
Long-term       
All studies  34.2% (18.7 to 51.4)  17.1% (9.4 to 26.4)  11.2% (4.8 to 19.4)  2.3% (0.4 to 5.3)  3.2% (0.7 to 6.8)  0% (0 to 1.5)
n (patients)  12 (486)  13 (531)  13 (531)  12 (486)  13(351)  3 (142)
I2  92.5% 82.9% 82.9% 49.0% 62.9%  0%
Studies with low risk of bias (patients)  2(40)  2(40)  2(40)  2(40)  1(10)  –
Critical Care 2013, Volume 17 Suppl 2 
http://ccforum.com/supplements/17/S2
S130patients were managed according to the local Guidelines for the 
management of aSAH. Outcome was assessed at 3 months using the 
extended Glasgow Outcome Scale (GOSE) defi  ning good recovery as a 
GOSE ≥7 and poor outcome as GOSE ≤6.
Results A total of 28 patients were included within the study period. 
Three patients were not expected to survive the fi  rst 24 hours and were 
not included in the study. Seventeen patients were classifi  ed as good 
grade aSAH (WFNS I to III) and eight as poor grade (IV to V). Twenty-two 
patients underwent successful coiling while the other three required 
clipping due to unsuccessful coiling. We did not fi  nd any correlation 
between the timing of coiling/clipping and the 3-month GOSE 
(Figure 1). A total 44% of the patients had a poor 3-month GOSE while 
56% had a good long-term functional outcome. The overall mortality 
rate was 21%.
Conclusion  Overall mortality in patients with aSAH is low when 
aneurysm is treated early post rupture of aneurysm. We did not fi  nd 
any correlation between the timing of occlusion of aneurysm and the 
3-month functional outcome.
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Introduction Early and delayed cognitive dysfunctions are an under-
studied issue after aneurysmal subarachnoid hemorrhage (aSAH), 
irrespective of neurological outcome. The aim of this study was to 
describe early and delayed changes of cognitive functions, activities of 
everyday life, and quality of life in aSAH patients.
Methods Consecutive aSAH patients admitted to our ICU between 
November 2011 and September 2012 were prospectively studied. 
Patients underwent neuropsychological evaluation at early (<3 days, 
10 days) and delayed time points (1 month, 3 months). Patients were 
tested for language, verbal fl  uency, short-term and long-term memory, 
attention, executive functions, praxis, and neglect. Impairments in 
activities of everyday life were assessed using the Activities of Daily 
Living scale and the Instrumental Activities of Daily Living scale. 
The SF-36 was used to assess the quality of life at 3 months. Since 
complications of aneurysm treatment in addition to aSAH severity may 
signifi  cantly aff  ect cognitive status, patients were evaluated according 
to the World Federation of Neurological Surgeons score after treatment 
(WFNSpt).
Results All WFNSpt 1 to 2 patients completed neuropsychological tests 
at each time point. WFNSpt 3 and WFNS 4 patients were testable in 80% 
and 50% of the cases respectively at early time points. WFNS 5 patients 
were not testable at any time point. In all testable patients, cognitive 
functions were severely impaired at early time points. At 3 months in 
WFNS 1 to 3 a good recovery of language defi  cits while only a partial 
recovery of attention, memory and executive functions were observed; 
at the same time point 70% of WFNS 4 patients became testable, but 
they had a worse recovery of all cognitive functions. At 1 month after 
SAH less than 30% of patients return to work, at 3 months approximately 
50%. Despite a good recovery of everyday life activities at 3 months, for 
all patients quality of life was lower than a normal population.
Conclusion Cognitive dysfunction has diff   erent time courses after 
aSAH: signifi  cant defi  cits in diff  erent cognitive domains, worse quality 
of life and diffi   culties in return to work persist in more than 50% of 
patients at 3 months following SAH.
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Introduction Stroke is a major cause of death. This study investigated 
the preventative eff  ect of a new synthetic drug on brain function in 
experimentally induced ischemic stroke.
Methods Male Sprague–Dawley rats were administered aspirin (ASA), 
decursinol (DA) or ASA-DA before and after ischemic insults. Brain 
and neuronal damage were examined by TTC staining, PEP-CT, NeuN 
immunohistochemistry and F-J B histofl  uorescence. Gliosis was also 
observed by GFAP and iba-1 immunohistochemistry.
Results Pretreatment with 20 mg/kg, but not 10 mg/kg, of ASA-DA 
protected against ischemic neuronal death and damage, and its 
neuroprotective eff  ect was much more pronounced than that of ASA 
or DA alone. In addition, treatment with 20 mg/kg ASA-DA reduced the 
ischemia-induced activation of astrocytes and microglia.
Conclusion Our fi  ndings indicate that ASA-DA, a new synthetic drug, 
prevents against transient focal cerebral ischemia, which provides a 
resource for the development of its clinical application for stroke.
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Introduction Acute neurological injury is a leading cause of morbidity 
and mortality in children. Global prevalence and regional disparities 
of etiology, interventions, and outcomes are unknown. The aim of 
this point-prevalence study was to measure the burden of pediatric 
neurological injury and to describe variations in interventions and 
outcomes in ICUs.
Methods  One hundred and three ICUs on six continents enrolled 
subjects on 4 specifi  c days in a 1-year period. Included subjects were 
between ages 7 days and 17 years who were diagnosed with acute 
traumatic brain injury, stroke, cardiac arrest, central nervous system 
infection or infl   ammation, status epilepticus, spinal cord lesion, 
hydrocephalus, or brain mass. Sites completed a secure web-based 
case report form that included subject and hospital demographics, 
details about the neurological disease, interventions, length of stay, 
and Pediatric Cerebral Performance Category (PCPC) score (good 
outcome = PCPC 1 to 3) and mortality at hospital discharge.
Figure 1 (abstract P343). Time of coiling/clipping versus GOSE boxplot.
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The mean number of subjects enrolled per site for each study day was 
2.4. Most sites were dedicated pediatric ICUs with a mean number of 
22 ICU beds (range 3 to 72). ICUs had resources to invasively monitor 
intracranial pressure (93%), continuous electroencephalography (14%), 
invasive and non-invasive brain tissue oxygenation (14% and 57%), 
and somatosensory evoked potentials (39%). There were on average 
11 ICU faculty and six fellows per site, and nearly one-half reported 
a neurocritical care ICU team. Subjects were 58% male and 52% 
white, and 60% had normal pre-admission PCPC scores (85%). Status 
epilepticus and cardiac arrest (both 21%) had the highest prevalence. 
Sixty-one per cent of subjects were mechanically ventilated during ICU 
admission. ICU length of stay was a mean 29 days (median 43 days) and 
hospital LOS was a mean 43 days (median 61 days). Survival at hospital 
discharge was 87% with 58% of subjects discharged home and 17% to 
inpatient rehabilitation.
Conclusion Acute neurological disease is a signifi  cant pediatric health 
issue. These data suggest a vital need for increased research and 
healthcare resources to assist in the challenge of improving outcomes 
for these children.
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Introduction The newly approved oral anticoagulant dabigatran has 
no eff  ective antidote. We therefore suspected an overall increase in 
mortality in patients presenting to the emergency department (ED) 
with a bleeding complication on dabigatran compared with warfarin 
or aspirin.
Methods We conducted a post hoc analysis on a database of all patients 
admitted to a tertiary-care ED with any kind of bleeding or suspicion 
of one from March 2011 to August 2012 who were taking dabigatran, 
warfarin, or aspirin. The primary endpoint was long-term survival. 
Patients were censored at death or at the end of the study period 
(7 December 2012). We performed a Cox proportional hazard model, 
controlled for age, to calculate the hazard ratio (HR) for dabigatran 
versus warfarin and one for warfarin versus aspirin. Statistical 
signifi  cance was set at α = 0.05 and results are presented with 95% CI.
Results In total, 943 patients met the inclusion criteria with a mean 
follow-up period of 1 year. The mean age was 74.3 years and 50.4% 
were men. A total of 108 deaths (11.5%) were recorded within the 
follow-up period; eight (25%) for dabigatran compared with 44 (12.6%) 
for warfarin and 56 (9.9%) for aspirin. The mortality risk for patients 
on dabigatran was signifi  cantly higher than for patients on warfarin: 
HR = 2.1 (95% CI: 1.0 to 4.5), P = 0.05 after controlling for age. Aspirin 
had a lower (but not statistically signifi  cant) mortality risk compared 
with warfarin; HR = 0.75 (95% CI: 0.50 to 1.14), P = 0.18 after controlling 
for age.
Conclusion  The results showed higher overall mortality in patients 
who presented to the ED with a bleeding complication and were 
taking dabigatran compared with warfarin or aspirin. Physicians 
should be aware of the potential higher mortality with dabigatran over 
warfarin when treating a bleeding patient. However, this was a single-
centre retrospective analysis with a small number of patients taking 
dabigatran (n = 32), and further studies are needed to corroborate the 
results.
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Introduction  Dose adjustments of low molecular weight heparin 
(LMWH) based on daily anti-Xa measurement by chromogenic 
assay remain controversial in daily clinical practice. One of the major 
obstacles is the cost of such a test. An aff  ordable and reliable bedside 
test could change practice to an individual tailored dosing of LMWH. 
The aim of our study was to evaluate whether a prophylactic dose 
regimen of 40 mg enoxaparine in cardiac surgical patients increases 
the anti-Xa activity to the level necessary for effi   cient prevention of a 
thromboembolic event [1]. Secondarily we tested whether there was a 
reliable correlation between a bedside anti-Xa measurement compared 
with a two-stage chromogenic assay at the laboratory [2].
Methods This was an open, single-centre, prospective, nonrandomized 
clinical trial at a university hospital. All patients that needed 
prophylactic dosing of enoxaparine after cardiac surgery were duly 
informed and after giving written consent we included 44 patients with 
a mean Euroscore of 1.66. The demographic specifi  cations, medical 
and surgical history of all patients were collected. Anti-Xa activity was 
measured at three diff  erent points in time. We determined baseline, 
peak and trough anti-Xa activity: preoperatively, and respectively 
4 hours after the third dose of enoxaparine and 30 minutes before the 
fourth dose. Each measurement was done with both techniques, the 
two-stage chromogenic assay at the laboratory (Biophen®) and the 
bedside assay (Hemochron® Jr).
Results  Our dose regimen of enoxaparine achieved in one-half of 
the included patients a suffi   cient anti-Xa activity for prevention of 
thromboembolic events. One-half of the patients with insuffi   cient anti-
Xa activity had a body mass index over 30 kg/m2. Comparison of the 
bedside assay with the two-stage chromogenic assay by means of the 
Pearson’s correlation coeffi   cient showed correlation of the two tests if 
no variables were taken into account. In the Bland–Altman analysis we 
could not confi  rm this correlation.
Conclusion The bedside anti-Xa activity assay with a Hemochron device 
tends to show some correlation with the two-stage chromogenic assay, 
but insuffi   cient to be used as an alternative, in this small but uniform 
patient population. Use of a standard dosing protocol for enoxaparine 
administration is prone for underdosage in post-cardiac surgery 
patients and may increase postoperative morbidity.
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Introduction We hypothesized that higher doses of enoxaparin would 
improve thromboprophylaxis without increasing the risk of bleeding. 
Critically ill patients are predisposed to venous thromboembolism, 
leading to increased risk of adverse outcome [1]. Peak anti-factor 
Xa (anti-Xa) levels of 0.1 to 0.4 IU/ml, 4 hours post administration of 
enoxaparin, refl  ect adequate thromboprophylaxis for medico-surgical 
patients.
Methods The sample population consisted of 78 patients, randomized 
to receive subcutaneous (s.c.) enoxaparin: 40 mg ×1 (control group), 
versus 30 mg ×2, 40 mg ×2 or 1 mg/kg ×1 (test groups) for a period 
of 3 days. Anti-Xa activity was measured at baseline, and at 4, 12, 16 
and 24 hours post administration on each day. Patients did not diff  er 
signifi  cantly between groups.
Results On day 1 of administration, doses of 40 mg ×1 and 40 mg 
×2 yielded similar mean peak anti-Xa of 0.20 IU/ml and 0.17 IU/ml 
respectively, while a dose of 30  mg ×2 resulted in subtherapeutic 
levels of anti-Xa (0.08 IU/ml). Patients receiving 1 mg/kg enoxaparin 
achieved near-steady-state levels from day 1 with mean peak anti-Xa 
levels of 0.34 IU/ml. Steady-state anti-Xa was achieved for all doses of 
enoxaparin at day 3. At steady state, mean peak anti-Xa levels of 0.13 IU/
ml and 0.15 IU/ml were achieved with doses of 40 mg ×1 and 30 mg ×2 
respectively. This increased signifi  cantly to 0.33 IU/ml and 0.40 IU/ml for 
doses of 40 mg ×2 and 1 mg/kg enoxaparin respectively (P = 0.0000) 
(Figure 1). A dose of 1 mg/kg enoxaparin yielded therapeutic anti-Xa 
levels for over 80% of the study period. There were no adverse eff  ects.
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(Europe) or 30 mg ×2 (North America) yield levels of anti-Xa thought to 
be subtherapeutic for critically ill patients. A weight-based dose yielded 
the best anti-Xa levels, allowed the establishment of near-steady-state 
levels from the fi  rst day of enoxaparin administration, and may thus be 
more appropriate, convenient, and eff  ective. A new study using 1 mg/
kg enoxaparin s.c. with clinical endpoints has recently been approved 
by the Danish Ministry of Health.
Reference
1. Cook  D,  et al.: N Engl J Med 2011, 364:1305-1314.
P350
Abstract withdrawn
P351
Anti-Xa activities following 5,000 IU and 7,500 IU of s.c. dalteparin in 
critically ill patients and 5,000 IU in medical patients: a prospective 
randomized study
GH Heinz1, U Priglinger2, I Pabinger3
1University Clinic of Internal Medicine II, Vienna, Austria; 2University Clinic of 
Emergency Medicine, Vienna, Austria; 3University Clinic of Internal Medicine I, 
Vienna, Austria
Critical Care 2013, 17(Suppl 2):P351 (doi: 10.1186/cc12289)
Introduction  Unfractionated heparin is preferred over LMWH in 
ICU patients but LMWH is used more frequently in many European 
ICUs. Thromboprophylaxis with standard doses of nadroparin and 
enoxaparin has been shown to result in signifi  cantly lower anti-Xa in 
ICU patients when compared with medical patients [1,2].
Methods ICU patients (SAPS 44 ± 16, MV, n = 44; pressors n = 32) 
received 7,500 IU (Group 1, n = 25) or 5,000 IU dalteparin s.c. (Group 2, 
n = 29). Twenty-nine medical patients receiving 5,000 IU dalteparin 
served as controls (Group 3).
Results  Group 2 had signifi   cantly lower areas under the Xa curve 
(AUC) compared with Groups 1 and 3 (Table 1). Diff  erences were not 
signifi  cant between Groups 1 and 3. Peak anti-Xa activities (Cmax-anti-Xa) 
were delayed (tmax-anti-Xa) in Group 2 compared with Groups 1 and 3 
(Table 1).
Conclusion In ICU patients a s.c. dose of 5,000 IU dalteparin results 
in signifi  cantly lower Xa activities when compared with normal ward 
patients. A s.c. dose of 7,500 IU dalteparin in ICU patients resulted in 
kinetics and peak anti-Xa activities comparable with medical patients 
receiving 5,000 IU dalteparin.
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Introduction  Anemia is very frequently encountered on the ICU. 
Increased hepcidin production is one of the cornerstones of the 
pathophysiology of anemia of infl  ammation. The fi  rst-in-class hepcidin 
antagonist NOX-H94, a PEGylated anti-hepcidin L-RNA oligonucleotide, 
is in development for targeted treatment of anemia of infl  ammation. 
We investigated whether NOX-H94 prevents the infl  ammation-induced 
serum iron decrease during experimental human endotoxemia.
Methods  A randomized, double-blind, placebo-controlled trial in 
24 healthy young men. At T = 0 hours, 2 ng/kg E. coli endotoxin was 
administered intravenously (i.v.), followed by 1.2 mg/kg NOX-H94 or 
placebo i.v. at T = 0.5 hours. Blood was drawn serially after endotoxin 
administration for measurements of infl  ammatory  parameters, 
Figure 1 (abstract P349). Peak anti-Xa over 3 days with varying doses of enoxaparin.
Table 1 (abstract P351). Pharmacokinetics
  Group 1 (n = 25)  Group 2 (n = 29)  Group 3 (n = 29)
  ICU, 7,500 IU  ICU, 5,000 IU  Normal ward, 5,000 IU  P overall
AUC-anti-Xa0–12 hours (U/l*hour)  2.51 (1.15 to 4.61)  1.27 (1.15 to 4.4)  2.58 (1.45 to 4.87)  <0.001*
AUC-anti-Xa12_00 (U/l*hour)  1.37 (0.58 to 13)  1.47 (0.65 to 6.3)  0.89 (0.35 to 3.88)  0.003**
Cmax-anti-Xa (U/l)  0.29 (0.10 to 0.52)  0.14 (0.1 to 0.43)  0.33 (0.14 to 0.65)  <0.001***
tmax-anti-Xa (hours)  3 (3 to 12)  4.5 (1 to 12)  3 (3 to 6)  0.017§
Cmax, peak anti-Xa level; tmax, time of anti-Xa peak. Medians and range. *Group 1 versus 2, P = 0.001; Group 1 versus 3, P = 0.51. **Group 1 versus 2, P = 0.96; Group 1 
versus 3, P = 0.045; Group 2 versus 3, P = 0.13. ***Group 1 versus 2, P = 0.001; Group 1 versus 3, P = 0.29. §Group 1 versus 3, P = 0.09; Group 1 versus 2, P = 0.8; Group 2 
versus 3, P = 0.018.
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parameters. The diff  erence of serum iron change from baseline at 
T = 9 hours was defi  ned as the primary endpoint.
Results  Endotoxin administration led to fl   u-like symptoms. Infl  am-
matory parameters (CRP, body temperature, leucocytes, and plasma 
levels of TNFα, IL-6, IL-10, and IL-1RA) peaked markedly and similarly in 
both treatment groups. NOX-H94 was well tolerated. Plasma concen-
trations peaked at 0.7 ± 0.4 hours after the start of administration, after 
which they declined according to a two-compartment model, with a 
T1/2 of 22.5 ± 4.28 hours. In the placebo group, serum iron increased 
from 19.0 ± 7.6 μg/l at baseline to a peak at T = 3 hours, returned close to 
baseline at T = 6 hours and decreased under the baseline concentration 
at T = 9 hours, reaching its lowest point at T = 12 hours. In the NOX-H94 
group, serum iron concentrations rose until T = 6 hours and then slowly 
declined until T = 24 hours. From 6 to 12 hours post LPS, the serum iron 
concentrations in NOX-H94-treated subjects were signifi  cantly higher 
than in placebo-treated subjects (P <0.0001, ANCOVA).
Conclusion  Experimental human endotoxemia induces a robust 
infl   am  matory response and a subsequent decrease in serum iron. 
Treatment with NOX-H94 had no eff   ect on innate immunity, but 
eff  ectively prevented the infl  ammation-induced drop in serum iron 
concentrations. These fi  ndings demonstrate the clinical potential of the 
anti-hepcidin drug NOX-H94 for further development to treat patients 
with anemia of infl  ammation.
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Introduction The association between haemoglobin concentrations 
and mortality has been studied in patients with various comorbidities 
[1,2]. This study aims to determine the association between haemo-
globin levels on admission to intensive care and patient length of stay 
and mortality.
Methods A retrospective collection of data from patient admissions 
to a single fi  ve-bed ICU over a 15-year period identifi  ed 5,826 patients 
between April 1994 and November 2012. Patients were split into groups 
according to haemoglobin concentration on admission. The data were 
analysed to determine whether there was any relationship between 
haemoglobin concentration at ICU admission and any of our outcome 
measures (unit and hospital mortality, unit and hospital length of stay).
Results  Patients with haemoglobin concentrations ≤10  g/dl and 
>10.1  g/dl were used in mortality comparisons. Patients with a 
haemo  globin concentration ≤10 g/dl had an increase in ICU mortality 
compared with those with haemoglobin levels >10 g/dl (OR = 1.36, 95% 
CI = 1.30 to 1.71, P <0.0001). A similar diff  erence was seen with hospital 
mortality (≤10 g/dl 37.7% vs. >10 g/dl 27.3%, P <0.0001). Unit length 
of stay was signifi  cantly longer in patients with admission Hb ≤10 g/
dl (5.34 days) compared with an admission Hb >10 g/dl (4.08 days), 
P  <0.0001. Hospital length of stay was also signifi   cantly longer in 
patients with Hb ≤10 g/dl versus Hb >10 g/dl (21.6 days vs. 15.5 days, 
P  <0.0001). There was seen to be an inverse correlation between 
haemoglobin concentration and patient age (r = –0.174; P <0.0001).
Conclusion Haemoglobin concentrations ≤10 g/dl on admission to the 
ICU are associated with an increase in ICU mortality, hospital mortality, 
unit length of stay and hospital length of stay when compared with 
patients admitted with haemoglobin concentrations >10 g/dl.
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Introduction According to many authors, acute necrotizing pancreatitis 
(ANP) still remains one of the diffi   cult problems of abdominal surgery. The 
complexity of the pathogenesis of the disease, features of the pancreas 
pathomorphology, abdominal hypertension, and high mortality (30 to 
70%) necessitate a search for new ways to treat this disease.
Methods The study was conducted in 44 patients with ANP, who were 
divided into two groups according to type of analgesia: epidural or opioids. 
Patients from the fi  rst group (n = 23) had epidural analgesia by ropivacaine 
6 to 14 mg/hour during 7 to 10 days, and from the second group (n = 21) 
opioid analgesia by trimeperidine 20 mg three times a day during the 
same period. We monitored the level of septic and thrombohemorrhagic 
complications by clinical and instrumental data, during the month after 
treatment starting. The hemostatic system was evaluated using indicators 
of hemoviscoelastography (Mednord-01M analyzer).
Results  It was found that all patients with ANP initially have 
hypercoagulation and fi   brinolysis inhibition. Levels of hemostatic 
disorders correlate with the level of septic complications, treatment 
in the ICU, and mortality. In the fi  rst group we noted a deep vein 
thrombosis, two pneumonia, seven pseudopancreatic cysts and 
abscesses, two deaths and time of stay in the ICU as 15.4 days. In the 
second group: three cases of deep vein thrombosis, four pneumonia, 10 
pseudopancreatic cysts and abscesses, two episodes of gastroduodenal 
bleeding, fi  ve deaths and time of stay in the ICU as 27.8 days.
Conclusion Using epidural anesthesia in patients with ANP reduced 
the number of septic complications on 36.6%, and reduced the 
mortality rate from 23.8% (second group) to 8.7% (fi  rst group). We 
think that violations of blood coagulation and microcirculation are the 
basis for ischemia, necrosis in tissues and septic complications. Epidural 
analgesia is an eff  ective method to decrease the level of septic and 
thrombohemorrhagic complications and mortality in ANP patients.
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Introduction  Deep vein thrombosis of lower extremities and 
pulmonary embolism occupy an important place in the structure of 
postoperative morbidity and mortality.
Methods After ethics approval and informed consent, we studied the 
functional state of hemostasis in a group of 57 healthy volunteers, 
who were not receiving drugs aff  ecting coagulation, and 43 patients 
with postphlebothrombotic syndrome (PPTS). In the PPTS patients 
we conducted baseline studies of coagulation state and daily 
monitoring of dynamic changes in the functional state of hemostasis, 
a comparative evaluation of performance low-frequency piezoelectric 
vibration hemoviscoelastography (LPVH) and platelet aggregation test 
(PAT), standard coagulation tests (SCT), and thromboelastogram (TEG).
Results We found that LPVH correlated with SCT, PAT and TEG. However, 
our proposed method is more voluminous: indexes ICC (the intensity 
of the contact phase of coagulation), t1 (the time for the contact 
phase of coagulation), and AO (initial rate of aggregation of blood) 
are consistent with PAT; indexes ICD (the intensity of coagulation 
drive), CTA (a constant thrombin activity) and CP (the clot intensity of 
the polymerization) are consistent with SCT and TEG. In addition, the 
advantage of this method is to determine the intensity of fi  brinolysis – 
with the indicator IRIS (the intensity of the retraction and clot lysis).
Conclusion LPVH allows one to make a total assessment of all parts 
of hemostasis: from initial viscosity and platelet aggregation to 
coagulation and lysis of clots, as well as their interaction. These fi  gures 
are objective and informative, as evidenced by close correlation with 
the performance of traditional coagulation methods.
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Introduction  Fondaparinux is currently the fi  rst therapeutic choice 
in several clinical settings such as deep venous thrombosis (DVT) 
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The main drawback of FOND is that routine monitoring is not currently 
available. This could be a problem during the management of critical 
and surgical patients, especially in cases of old patients and renal failure. 
The aim of this study is to evaluate the ability of thromboelastography 
(TEG) to determine the level of anticoagulation due to FOND in a 
surgical population.
Methods  We prospectively analyzed all patients to whom elective 
major orthopedic surgery was consecutively performed in a 2-month 
period. All the patients received FOND 2.5 mg in the postoperative 
period according to ACCP 2012 Guidelines. Native and heparinase 
(hep) TEG (Haemoscope Corporation, Niles, IL, USA) tests activated 
with kaolin were performed using whole blood citrated samples 
at four times: T0, before FOND administration; T1, 2  hours after 
administration; T2, 17 hours after administration (half-life); T3, 24 hours 
after administration. The following native and hep TEG parameters 
were analyzed: reaction time (R), α angle, maximum amplitude (MA) 
and coagulation index (CI). These parameters were compared with 
levels of anti-Xa. Unvariate analysis and Spearman’s test were applied 
to our data.
Results  Eighteen patients were analyzed. Ten patients met the 
inclusion criteria. The mean R value increased from T1 to T3. The mean 
R parameter was in the normal range at any phase of the study and 
there was no signifi  cant diff  erences between the R mean value at the 
diff  erent phases. The lowest value of R was at T1, which coincides with 
plasmatic peak concentration of FOND. This value did not correlate with 
anti-Xa mean value at T1, which showed the highest value at that time. 
There was signifi  cant diff  erence between the mean native and hep R 
value only at T2 (P <0.05), native and hep α angle at T3, MA and MA hep 
at T2 (P <0.01) and CI and CI hep at T3 (P <0.02). Only the parameter MA 
had signifi  cant variation over time (P <0.02).
Conclusion R represents the time necessary to thrombin formation 
and in the presence of FOND we hypothesized a prolonged R time. In 
our population, TEG performed with citrated kaolin-activated whole 
blood was not able to detect prophylatic doses of FOND in every 
phase. On the contrary, levels of anti-Xa were able to reveal the exact 
pharmacokinetics of the drug. Further studies including a large number 
of patients are necessary.
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Introduction  Coagulopathy, particularly a trend toward hyper-
coagula  bility and hypofi  brinolysis, is common in critically ill patients 
and correlates with worse outcome. Available laboratory coagulation 
tests to assess fi  brinolysis are expensive and time demanding. We 
investigated whether a modifi   ed thromboelastography with the 
plasminogen activator urokinase (UKIF-TEG) [1] may be able to evaluate 
fi  brinolysis in a population of critically ill patients.
Methods  UKIF-TEG was performed as follows: fi   rst urokinase was 
added to citrate blood to give fi  nal concentrations of 160 UI/ml, then 
thromboelastography (TEG) analysis was started after kaolin activation 
and recalcifi  cation with calcium chloride. Basal TEG (no addition of 
urokinase) was also performed. Fibrinolysis was determined by the 
loss of clot strength after the maximal amplitude (MA), and recorded as 
Ly30 (percentage lysis at 30 minutes after MA) and as Ly60 (percentage 
lysis at 60 minutes after MA).
Results  UKIF-TEG was performed on 17 healthy volunteers and 18 
critically ill patients. Ly60 was predicted by Ly30 according to an 
exponential function, so we used Ly30 as an indicator of clot lysis. Basal 
TEG showed increased coagulability and a trend toward less fi  brinolysis 
in critically ill patients compared with healthy volunteers (reaction time 
8.7 ± 3.4 minutes vs. 12.2 ± 1.9 minutes, P <0.001; α-angle 59.7 ± 9.4 vs. 
47.2 ± 11.8, P <0.01). This reduction of fi  brinolysis was more evident at 
a urokinase concentration of 160 UI/ml (Figure 1).
Conclusion  UKIF-TEG could be a feasible point-of-care method to 
evaluate fi  brinolysis in critically ill patients.
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Introduction Bleeding complications in association with insertion of 
central venous catheters are reported in 0.5 to 1.6% of cases, are rarely 
fatal, but sometimes require intervention. The aim of this study was 
to map pre-procedural variables at the insertion of a central venous 
catheter and to investigate whether any independent variable could 
be identifi  ed as an independent risk factor for bleeding complications 
associated with insertion of central venous catheters.
Methods In this retrospective study, we investigated 1,737 consecutive 
insertions of central venous catheters on 1,444 patients in a large 
university hospital during 2009 to 2010. Pre-procedural coagulation 
status, blood component use, type of catheter, insertion site, and 
complications during insertion were recorded and compared with 
bleeding complications documented in electronic charts.
Results No serious bleeding complications were recorded in connection 
with the insertions of central venous catheters. Sixteen out of 1,769 
(0.9%) insertions caused grade 2 bleeding, being defi  ned as a bleeding 
requiring prolonged compression at the insertion site. Insertion of a 
large-bore central dialysis catheter was found to be an independent risk 
factor for bleeding complications. Neither conventional coagulation 
tests nor accidental arterial puncture or the number of needle passes 
could predict bleeding complications in this study.
Conclusion  This retrospective study shows that serious bleeding 
complications in association with central line insertion are uncommon 
and that insertion of dialysis catheter is an independent risk factor 
for mild bleeding complications. Coagulopathy, measured with 
conventional coagulation tests, is not an independent risk factor for 
bleeding complication at insertion of central venous catheters.
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Introduction  Despite signifi   cant progress in obstetric care, the 
problem of bleeding during labor remains unsolved. Annually in the 
world, 125,000 women die from obstetric hemorrhage.
Figure 1 (abstract P357).
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patients who underwent cesarean section. Patients were divided into 
two groups: the fi  rst group (n = 19) received preoperative (30 minutes 
before operation) tranexamic acid 10 mg/kg; the second group (n = 18) 
received preoperative placebo. The condition of hemostasis was 
monitored by haemoviscoelastography.
Results All patients included in the study before surgery had moderate 
hypercoagulation and normal fi  brinolysis: increasing the intensity of 
clot formation (ICF) to 11.4% compared with normal rates; the intensity 
of the retraction and clot lysis (IRCL) was 16.45 ± 1.40 in both groups. 
At the start of the operation in patients (Group 1), ICF decreased by 
9.7% (P <0.05), and IRCL decreased by 27.6% (P <0.05) compared with 
preoperatively. In Group 2, there was ICF decrease by 8.8% (P <0.05), and 
IRCL increase by 11.4% (P <0.05) compared with preoperatively. At the 
end of the operation, the condition of hemostasis in both groups came 
almost to the same value  – moderate hypocoagulation, depressed 
fi  brinolysis. In both groups there were no thrombotic complications. 
Intraoperative blood loss in the fi  rst group was 300 ± 40.5 and in the 
second was 500 ± 60.6.
Conclusion Using of tranexamic acid before surgery signifi  cantly reduces 
intraoperative blood loss by 60%, without thrombotic complications.
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Introduction  Rotational thromboelastography (ROTEM) can detect 
dilutive and hypothermic eff   ects on coagulation and evaluate 
corrective treatments. The aim of this in vitro study was to study 
whether fi  brinogen concentrate alone or combined with factor XIII 
could reverse colloid-induced and crystalloid-induced coagulopathies 
in the presence and absence of hypothermia.
Methods  Citrated venous blood from 10 healthy volunteers was 
diluted by 33% using 130/0.42 hydroxyethyl starch or Ringer’s acetate. 
ROTEM was used to evaluate the eff  ect of addition of either fi  brinogen 
concentrate corresponding to 4  g/70  kg, or this fi  brinogen  dose 
combined with factor XIII equivalent to 20 IU/kg. Blood was analyzed at 
33 or 37°C with ROTEM ExTEM and FibTEM reagents.
Results  A signifi  cant dilutive response was shown in both groups: 
hypocoagulation was greater in the starch group. Hypothermia 
lengthened the following: ExTEM clotting time (CT), clot formation 
time and α angle; FibTEM maximal clot formation (MCF). Irrespective 
of temperature, fi  brinogen overcorrected Ringer’s acetate’s eff  ects on 
all ROTEM parameters and partially reversed starch’s eff  ects on ExTEM 
CT and FibTEM MCF. FibTEM demonstrated that factor XIII provided an 
additional procoagulative eff  ect in the Ringer’s acetate group at both 
temperatures but not the starch group. The only ExTEM parameter to 
be improved by addition of factor XIII was MCF at 33°C.
Conclusion  ROTEM shows that fi   brinogen concentrate can reverse 
dilutive coagulation defects induced by colloid and crystalloid at both 
33 and 37°C. Some additional reversal was provided by factor XIII: 
higher doses of both fi  brinogen and factor XIII may counteract starch’s 
eff  ects on clot structure.
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Introduction  Natural colloid albumin induces a lesser degree of 
dilutional coagulopathy than synthetic colloids. Fibrinogen concentrate 
has emerged as a promising strategy to treat coagulopathy, and factor 
XIII (FXIII) works synergistically with fi  brinogen to correct coagulopathy 
following haemodilution with crystalloids. Objectives were to examine 
the ability of fi  brinogen and FXIII concentrates to reverse albumin-
induced dilutional coagulopathy.
Methods High and low concentrations of both fi  brinogen and FXIII 
were used to reverse coagulopathy induced by 1:1 dilution in vitro with 
5% albumin of blood samples from healthy volunteers, monitored by 
rotational thromboelastometry (ROTEM).
Results Haemodilution with albumin signifi  cantly attenuated EXTEM 
maximum clot fi  rmness (MCF), α angle (AA), clotting time (CT) and 
clot formation time (CFT), and FIBTEM MCF (P  <0.001). Following 
haemodilution, both doses of fi  brinogen  signifi   cantly corrected all 
ROTEM parameters (P ≤0.02), except the lower dose did not correct 
AA. Compared with the lower dose, the higher dose of fi  brinogen 
signifi   cantly improved FIBTEM MCF and EXTEM MCF, AA and CFT 
(P <0.001). The lower dose of FXIII did not signifi  cantly correct any of 
the ROTEM parameters, and the high dose only improved EXTEM CT 
(P = 0.004). All combinations of high/low concentrations of fi  brinogen/
FXIII signifi  cantly improved all ROTEM parameters examined (P ≤0.001). 
Fibrinogen concentration generally had a greater eff   ect on each 
parameter than did FXIII concentration; the best correction of ROTEM 
parameters was achieved with high-dose fi  brinogen concentrate and 
either low-dose or high-dose FXIII.
Conclusion Fibrinogen concentrate successfully corrected initiation, 
propagation and clot fi  rmness defi  cits induced by haemodilution with 
albumin, and FXIII synergistically improved fi  brin-based clot strength.
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Introduction  Postpartum hemorrhage (PPH) remains the leading 
cause of maternal mortality. After IOCS introduction in our north of 
France tertiary-care obstetric unit, the consecutive cohort of severe 
PPH was collected prospectively and compared regarding the use of 
IOCS or not.
Methods A case–control prospective open-label study comparing the 
management and outcome of a consecutive cohort of 324 severe PPHs 
in elective and emergency hemorrhagic caesarean sections (CS) over 
3 years.
Results IOCS was used in 70 severe PPHs and 254 severe PPH controls 
were managed without IOCS. Placenta accreta can be selected as 
the best indication for RBC restitution. In the 1,500 to 3,000 ml PPH, 
allogeneic transfusion was decreased in the IOCS group: 17.6 versus 
56.3% (P = 0.006); PRBC: 0 (0 to 3) versus 3 (0 to 6) (P = 0.045). IOCS 
spared 87 blood bank PRBC (17,374 ml); that is, 24.2% of the total 
transfusion need. No amniotic fl  uid embolism has been observed in 
the group with IOCS whereas one case appeared in the control group 
without IOCS.
Conclusion Regarding the literature [1-4] and our study, IOCS could be 
used safely in PPH during CS. A leukocyte fi  lter for retransfusion has 
been recommended and Rhesus isoimmunization must be precluded 
and monitored by repeated fetal RBC testing.
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Introduction  Cardiac surgery is associated with signifi  cant  blood 
loss. Teoh and colleagues demonstrated a reduction in postoperative 
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heparin rebound [1]. The aim of this study was to see whether the use 
of postoperative protamine infusions in our cardiac ITU was associated 
with a reduction in heparin rebound and blood loss.
Methods Data from 240 cardiac surgery patients were retrospectively 
analysed. Of these, 157 had routine management with a bolus of 
protamine to correct the activated clotting time and then expectant 
management of subsequent bleeding, and 47 had the same but also 
a protamine infusion of 10 to 80 mg/hour for between 3 and 8 hours 
postoperatively. Blood loss was measured at 1, 6, 12 and 24 hours. In 
all, excessive bleeding was investigated using thromboelastography 
(TEG). Rebound heparinisation was determined by a ratio of R-times 
(heparinase/plain) <0.8. The Mann–Whitney U test and the chi-squared 
test were used to assess statistical signifi  cance.
Results There was no signifi  cant diff  erence in blood loss between the 
two groups. Blood loss at 1 hour in the infusion and non-infusion group 
was 145 and 88 ml, respectively (P = 0.06); at 6 hours: 450 and 392 ml 
(P = 0.5); at 12 hours: 620 and 595 ml (P = 0.62); and at 24 hours: 971 
and 872 ml (P = 0.12). There was also no signifi  cant diff  erence in those 
getting heparin rebound with 40% in the infusion group and 47% in 
the non-infusion group (P = 0.54).
Conclusion  Unlike Teoh and colleagues [1], we did not fi  nd  an 
advantage in using protamine infusions. That there were still cases 
of heparin rebound in the infusion group suggests that the infusion 
was not as eff  ective as expected and/or the dose was inadequate. 
However, previous studies assessed heparin rebound using isolated 
clotting parameters [1,2]. Here, we used TEG. As TEG measures the 
thrombodynamic properties of whole blood coagulation, perhaps it is 
a more reliable indicator of heparin activity? As a retrospective study, 
there are limitations; namely, the nonstandardised management of the 
patients and the potential bias in the anaesthetists’ selection of patients 
for an infusion. This group may be inherently higher risk for bleeding. 
However, heparin rebound is common and protamine is a simple, 
relatively safe and low-cost intervention compared with transfusion 
and so further study is needed.
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Introduction The purpose of this study was to evaluate whether a 
restrictive strategy of red blood cell (RBC) transfusion was superior to 
a liberal one for reducing mortality and severe clinical complications 
among patients undergoing major cancer surgery.
Methods The trial was designed as a phase III, randomized, controlled, 
parallel-group, superiority trial. The inclusion criteria were adult patients 
with cancer who were undergoing major abdominal surgery requiring 
postoperative care in an ICU. The patients were randomly allocated to 
treatment with either a liberal RBC transfusion strategy (transfusion 
when hemoglobin levels decreased below 9 g/dl) or a restrictive RBC 
transfusion strategy (transfusion when hemoglobin levels decreased 
below 7 g/dl). The primary outcome was a composite endpoint of death 
or severe complications. The patients were monitored for 30 days.
Results A total of 1,521 patients were screened for eligibility and 248 
met the inclusion criteria. After exclusions for medical reasons or a 
lack of consent, 198 patients were included in fi  nal analysis, with 101 
allocated to the restrictive group and 97 to the liberal group. The 
primary composite endpoint  – all-cause mortality, cardiovascular 
complications, acute respiratory distress syndrome, acute kidney injury 
requiring renal replacement therapy, septic shock or reoperation at 
30 days – occurred in 19.6% of the patients in the liberal strategy group 
and in 35.6% in the restrictive group (P = 0.012). The liberal strategy 
group had a signifi  cantly lower 30-day mortality rate as compared with 
the restrictive group (8.2% (95% CI, 4.2 to 15.4%) vs. 22.8% (95% CI, 15.7 
to 31.9%), respectively, P = 0.005). The occurrence of cardiovascular 
complications was lower in the liberal group than in the restrictive 
group (5.2% (95% CI, 2.2 to 11.5%) vs. 13.9% (95% CI, 8.4 to 21.9%), 
respectively, P = 0.038). The restrictive strategy group had a higher 60-
day mortality rate as compared with the liberal group (23.8% (95% CI, 
16.5 to 32.9%) vs. 11.3% (95% CI, 6.5 to 9.2%), respectively, P = 0.022).
Conclusion The liberal RBC transfusion strategy with a hemoglobin 
trigger of 9 g/dl was associated with fewer major postoperative 
complications in patients undergoing major cancer surgery compared 
with the restrictive strategy.
Acknowledgement ClinicalTrials.gov NCT 01560494.
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Introduction  Red blood cell (RBC) transfusion is associated with 
morbidity and mortality in critically ill patients. Congenital cardiac 
surgeries are associated with high rates of bleeding and consequently 
with high rates of allogeneic transfusion. We aimed to evaluate the 
association of transfusion with worse outcomes in children undergoing 
cardiac surgery.
Methods We performed a prospective cohort study of 205 patients 
undergoing cardiac surgery for congenital heart disease. We 
recorded baseline characteristics, RACHS-1 score, intraoperative data, 
transfusion requirement and severe postoperative complications as 
need for reoperation, acute kidney injury, arrhythmia, severe sepsis, 
septic shock, bleeding, stroke, and death during 30 days. We performed 
univariate analysis using baseline, intraoperative and postoperative 
variables. Selected variables (P  <0.10) were included in a forward 
stepwise multiple logistic regression model to identify predictive 
factors of a combined endpoint including 30-day mortality and severe 
complications.
Results  One hundred and thirty-six patients (66.3%) were exposed 
to RBC transfusion. In the intraoperative room, 63.4% of patients 
received at least one RBC unit, and in the ICU, 11.2% of children were 
transfused. From all patients, 66 (32.1%) presented the combined 
endpoint. Patients with complications had higher RACHS-1 score, were 
younger (69 months (0 to 137) vs. 73 months (37 to 138), P <0.001), 
had a lower weight (13 kg (3 to 23) vs. 20 kg (12 to 36), P <0.001), a 
longer time of surgery (475 minutes (410 to 540) vs. 353 (275 to 433), 
P <0.001), a longer duration of cardiopulmonary bypass (205 minutes 
(175 to 235) vs. 106 minutes (73 to 123), P = 0.003), a lower SVO2 at 
the end of surgery (59% (IQR 39 to 80) vs. 78% (71 to 83), P <0.001), a 
higher arterial lactate at the end of surgery (6.9 mmol/l (4.3 to 9.2) vs. 
2.7 mmol/l (73 to 123), P = 0.003), a lower intraoperative hematocrit 
(26.2 ± 5.6% vs. 29.5 ± 6% (P <0.001)) and a lower hematocrit at the end 
of surgery (33.4 ± 6.7% vs. 36.9 ± 6.9% (P <0.001)) as compared with 
patients without complications. Patients with complications were more 
exposed to RBC transfusion in the intraoperative room (75% vs. 57%, 
P = 0.011) and in the ICU (21% vs. 6.4%, P = 0.002). In an adjusted model 
of logistic regression, RBC transfusion is an independent risk factor of 
combined endpoint (OR 4.25 (95% CI, 1.359 to 13.328), P = 0.013).
Conclusion Blood transfusion after pediatric cardiac surgery is a risk 
factor for worse outcome including 30-day mortality. Avoiding blood 
transfusion must be a goal of best postoperative care.
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Red blood cell transfusion results in worse outcomes in patients 
with left ventricular dysfunction undergoing on-pump cardiac 
surgery
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Introduction  Cardiac surgeries are associated with high rates of 
bleeding and consequently with high rates of allogeneic transfusion. 
Patients with left ventricular dysfunction usually present a higher 
incidence of complications after cardiac surgery, including low output 
syndrome and organ dysfunction. It is a matter of controversy whether 
this subgroup of patients need higher hemoglobin levels to optimize 
oxygen delivery. We aimed to evaluate the association of transfusion 
with worse outcomes in patients with left ventricular dysfunction.
Methods A prospective cohort study was conducted in 215 patients 
undergoing cardiac surgery, presenting ejection fraction <35%. We 
recorded baseline characteristics, intraoperative data, transfusion 
requirement and severe postoperative complications as need for 
reoperation, acute kidney injury, arrhythmia, severe sepsis, septic 
shock, bleeding, stroke, and death during 30  days. We performed 
univariate analysis using baseline, intraoperative and postoperative 
variables associated with severe postoperative complications. Selected 
variables (P <0.10) were included in a forward stepwise multiple logistic 
regression model to identify predictive factors of a combined endpoint 
including 30-day mortality and severe complications.
Results Two hundred and fi  fteen patients were included in the study. 
The mean ejection fraction was 31%. From all patients, 129 (54.4%) 
presented the combined endpoint. The incidence of RBC transfusion 
was higher in the group with complications compared with the 
group without complications both intraoperative and postoperative, 
P  <0.001. Patients with complications were older, had lower initial 
hemoglobin levels and had higher EuroSCORE. At multivariate analysis, 
age (OR = 1.07, 95% CI = 1.013 to 1.137, P = 0.016) and perioperative 
RBC transfusion (OR = 7.78, 95% CI = 2.13 to 28.41, P = 0.002) were 
independent predictors of severe postoperative complications after 
cardiac surgery.
Conclusion  In patients with left ventricular dysfunction, red blood 
transfusion after cardiac surgery is a risk factor for worse outcome 
including 30-day mortality.
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Introduction We do not have enough criteria to make a judgment 
of the need for a massive transfusion (MT) in severe blunt traumatic 
patients. As a scoring system to predict the need for a MT, we usually 
use the Assessment Blood Consumption score (ABCs) and/or the 
Trauma-Associated Severe Hemorrhage score (TASHs). However, for 
these scoring systems, the procedure is slightly complicated. The aim 
of this study was to establish a predictor of a MT using coagulation or 
fi  brinolysis markers.
Methods A retrospective analysis of MT was conducted in patients 
with severe blunt traumatic injury, which was defi  ned as Injury Severity 
Score (ISS) of 16 or more admitted to the ICU between 1 June 2009 
and 31 December 2010. Blood samples were collected from patients 
immediately after arriving at our level I trauma center. We defi  ned 
the patients who received more than 10 unit packed red blood cells 
(PRBCs) within the fi  rst 24 hours as a MT group and who received less 
than 9 units PRBCs as a non-MT group. After the demographic data, 
number of units of PRBCs and the need for massive transfusions were 
recorded and analyzed in each groups, we compared data between 
two groups.
Results There were 114 patients who met the inclusion criteria. Fifty 
patients received blood transfusions (43.9%; 50/114). There were 27 
patients in the MT group (23.7%; 27/114) and 87 in the non-MT group. 
The MT group was signifi  cantly higher in the ratio of females (P <0.001), 
ISS (P <0.01), PT-INR (P <0.001), APTT (P <0.05), ABCs (P <0.001) and 
TASHs (P <0.001) than in the on-MT group. On the other hand, the 
MT group was signifi   cantly lower in Ps (P  <0.05) and fi  brinogen 
level (P  <0.001) than the non-MT group. In the receiver operating 
characteristics (ROC) analysis, the area under the curve (AUC) to 
distinguish a MT was the highest for TASHs (0.831, P <0.001), followed 
by fi  brinogen (0.758, P <0.001), and ABCs (0.732, P <0.001). Fibrinogen 
was only a predictor of a MT without a scoring system such as ABCs and 
TASHs, and the optimal cutoff   value was 205 mg/dl.
Conclusion  We found that the level of fi   brinogen was the most 
valuable predictor of a MT in the coagulation or fi  brinolysis markers. 
It is certain that the level of fi  brinogen at admission was not as useful 
as the TASHs about predicting a MT in this study. Whereas the scoring 
systems require the assessment of several factors, the measurement 
of fi  brinogen is simple, easy and quick. We strongly suggest that the 
level of fi  brinogen will be a useful predictor of a MT at in severe blunt 
traumatic patients.
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Introduction Red blood cell (RBC) transfusions are frequent in critically 
ill children. Their benefi   ts are clear in several situations. However, 
issues surrounding their safety have emerged in the past decades. It is 
important to identify the potential complications associated with RBC 
transfusions, in order to evaluate their risk–benefi  t ratio better.
Methods  A single-center prospective observational study of all 
children admitted to the pediatric intensive care unit (PICU) over a 
1-year period. The variables possibly related to RBC transfusions were 
identifi   ed before the study was initiated, and their presence was 
assessed daily for each child. In transfused cases (TCs), a variable was 
considered as a possible outcome related to the transfusion only if it 
was observed after the fi  rst transfusion.
Results During the study period, 913 admissions were documented, 
843 of which were included in the study. Among them, 144 (17%) were 
transfused. When comparing TCs with nontransfused cases (NTCs), 
the odds ratio (OR) of new or progressive multiple organ dysfunction 
syndrome (NPMODS) was 2.39 (95% CI = 1.58 to 3.62, P <0.001). This 
association remained statistically signifi  cant in the multivariate analysis 
for children with admission PRISM score ≤5 (OR = 2.41, 95% CI = 1.08 to 
5.37, P = 0.032). TCs were ventilated longer than NTCs (14.1 ± 32.6 days 
vs. 4.3 ± 9.6 days, P <0.001). This diff  erence was still signifi  cant after 
adjustment using a Cox model. Moreover, we observed an adjusted 
dose–eff   ect relationship between RBC transfusions and length of 
mechanical ventilation. The PICU length of stay was signifi  cantly 
increased for TCs (12.4 ± 26.2 days vs. 4.9 ± 10.2 days, P <0.001), even 
after multivariate adjustment (hazard ratio of PICU discharge for TCs: 
0.61, 95% CI = 0.5 to 0.74, P <0.001). We also observed an adjusted 
dose–eff  ect relationship between RBC transfusions and PICU length of 
stay. The paired analysis for comparison of pre-transfusion and post-
transfusion values showed that the arterial partial pressure in oxygen 
was signifi  cantly reduced after the fi  rst transfusion (mean diff  erence 
42.8 mmHg, 95% CI = 27.2 to 58.3, P <0.001). The paired analysis also 
showed an increased proportion of renal replacement therapy, while 
the proportions of sepsis, severe sepsis and septic shock did not diff  er.
Conclusion  RBC transfusions were associated with prolonged 
mechanical ventilation and prolonged PICU stay. The risk of NPMODS 
was increased in some transfused children. Moreover, our study 
questions the ability of stored RBCs to improve oxygenation in critically 
ill children. These results should help to improve transfusion practice 
in the PICU.
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Introduction Microcirculatory alterations during sepsis impair tissue 
oxygenation, which may be further worsened by anemia. Blood 
transfusions proved not to restore O2 delivery during sepsis [1]. The 
impact of storage lesions and/or leukocyte-derived mediators in red 
blood cell (RBC) units has not yet been clarifi  ed [2]. We compared 
the eff   ects of leukoreduced (LR) versus nonLR packed RBCs on 
microcirculation and tissue oxygenation during sepsis.
Methods  A prospective randomized study. Twenty patients with 
either sepsis, severe sepsis or septic shock requiring RBC transfusion 
randomly received nonLR (Group 1, n = 10) or LR (Group 2, n = 10) fresh 
RBCs (<10 days old). Before and 1 hour after transfusion, microvascular 
density and fl  ow were assessed with sidestream dark-fi  eld imaging 
sublingually. Thenar tissue O2 saturation (StO2) was measured 
using near-infrared spectroscopy and a vascular occlusion test was 
performed.
Results The De Backer score (P = 0.02), total vessel density (P = 0.08), 
perfused vessel density (P  =  0.04), proportion of perfused vessels 
(P = 0.01), and microvascular fl  ow index (P = 0.04, Figure 1) increased 
only in Group  2. The StO2 upslope (Figure  2) during reperfusion 
increased in both groups (P <0.05). In Group 1 the baseline StO2 and 
StO2 downslope during ischemia increased, probably refl  ecting a lower 
O2 consumption.
Conclusion Unlike nonLR RBCs, the transfusion of fresh LR RBCs seems 
to improve microvascular perfusion and might help to restore tissue 
oxygenation during sepsis.
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Introduction  Obstetric haemorrhage remains a leading cause 
of maternal mortality and severe morbidity. Cardiovascular and 
haemostatic physiology alters in pregnancy and massive transfusion 
protocols have been implemented for obstetric haemorrhage based 
on limited evidence. The objective of this study was to examine the 
pattern and rate of blood products used in massive transfusion for 
obstetric haemorrhage in a tertiary obstetric hospital.
Methods Massive transfusion was defi  ned as 5 or more units of red 
blood cells within 4 hours in accordance with the Australian Massive 
Transfusion Registry defi  nition. Following ethics approval, all cases 
fi  lling this criterion were identifi  ed in the hospital’s birthing and blood 
bank systems. Data were extracted from the medical histories and 
analysed using SPSS. P <0.05 was considered statistically signifi  cant.
Results Twenty-eight women in three years (2009 to 2011) underwent 
a massive transfusion for obstetric haemorrhage, with nine receiving 
more than 10 units of RBCs in 24 hours. Eleven (39%) were admitted to 
the ICU and 11 underwent a hysterectomy, of which six were admitted 
to the ICU. The median estimated blood loss was 4,335 ml (IQR 3,000 
to 5,000). Median blood product delivery was RBC 8 units (IQR 6 to 13); 
FFP 4 units (IQR 4 to 8); platelets 4 units (IQR 0 to 8) and cryoprecipitate 
3 units (IQR 0 to 10). One-half of the women received the fi  rst four units 
of RBCs in less than 34 minutes. Other blood products were started 
a median of 49 minutes, 44 minutes and 75 minutes after the RBC 
transfusion commenced, respectively. Eight women had a fi  brinogen 
level <0.8 g/l on the initial coagulation test during the haemorrhage. 
The remaining 20 women had a median fi  brinogen level of 3.7 g/l (IQR 
3.15 to 4.9). There was no diff  erence in the transfusion of RBCs (P = 0.20), 
FFPs (P = 0.96) and platelets (P = 0.48) in women who showed an initial 
low fi  brinogen and those who did not, although there was a diff  erence 
in the number of units of cryoprecipitate (P <0.05). The median lowest 
Hb during the haemorrhage was 66 g/l (IQR 51 to 80) and median 
discharge Hb was 103 g/l (IQR 96 to 113). No blood product reaction 
was noted and there was one death.
Conclusion Massive transfusion for obstetric haemorrhage involved 
rapid blood product administration with no consistent pattern in the 
ratio of products administered.
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Introduction Blood transfusions are associated with longer ICU and 
hospital inpatient durations, and an increase in mortality [1]. This study 
was undertaken to investigate whether the practice of packed red cell 
Figure 2 (abstract P369). Blood transfusion and microvascular reactivity.
Figure 1 (abstract P369). Blood transfusion and microvascular fl  ow.
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evidence. A number of studies, most notably the TRICC study [2], have 
shown that indications for ICU blood transfusions are a haemoglobin 
(Hb) level of <7  g/dl or evidence of acute haemorrhage [3]. These 
criteria were therefore employed.
Methods  This study prospectively examined episodes of PRC unit 
transfusions over a 2-month period in the ICU of a large level 1 trauma 
centre and a tertiary cardiac unit. The number of PRC units transfused 
in each episode was recorded by nurses, along with the proposed 
indication and concurrent Hb level. The data were analysed to assess 
the number of transfusions administered contrary to the guidelines, 
along with the average Hb level at which a PRC unit was transfused and 
the average number of units administered per episode.
Results  A total 175  units of PRC were transfused in the ICU, over 
105 episodes during the 2-month period (excluding immediately 
postoperative transfusions). Ninety-four units (53.7%) administered in 
64 transfusion episodes (61.0%) occurred contrary to the guidelines. 
In 89.3% of these cases the recorded reason for transfusion was an 
apparently low Hb level. The median (IQR (range)) Hb level at which 
patients were transfused: within guidelines was 6.9 g/dl (6.6 to 7.7 (4.8 
to 13.9)); within guidelines, excluding cases of acute blood loss, was 
6.6 g/dl (6.5 to 6.8 (5.5 to 6.9)); and outside the guidelines was 7.7 g/dl 
(7.4 to 8.2 (7.0 to 9.7)). One unit of PRC was transfused in 57 episodes 
(54.3%), 2 units of PRC were transfused in 36 episodes (34.3%), and 3 to 
6 units were transfused in 12 episodes (11.4%), with two-thirds of the 
latter due to acute haemorrhage.
Conclusion  Our results indicate a liberal transfusion threshold 
currently exists in the ICU. Patients are frequently receiving excessive 
PRC transfusions for Hb levels above the recommended concentration. 
In the 2-month study period, these were associated with a cost of 
approximately £12,220. We recommend increased staff   awareness of 
the guidelines to reduce the number of unnecessary transfusions. This 
would decrease exposure of ICU patients to unnecessary risks of blood 
transfusion, reduce cost of treatment and help to preserve a valuable 
resource.
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Introduction  Transfusion-related acute lung injury (TRALI) has a 
high incidence in critically ill and surgical patients and contributes 
to adverse outcome, while specifi  c therapy is absent. Recently it was 
demonstrated that complement activation plays a pivotal role in TRALI. 
We aimed to determine whether a C1 inhibitor is benefi  cial in a two-hit 
mouse model of antibody-mediated TRALI.
Methods BALB/c mice were primed with lipopolysaccharide (LPS, from 
E. coli 0111:B4) that was administered intraperitoneally in a dose of 
0.1 mg/kg, after which TRALI was induced by injecting MHC-I antibody 
against H2Kd (IgG2a,k) at a dose of 2 mg/kg. Mice infused with PBS or 
LPS served as controls. Concomitantly, mice infused with the MHC-I 
antibody were treated with C1 inhibitor (Cetor®; Sanquin, Amsterdam, 
the Netherlands) in a dose of 400 IU/kg intravenously. After infusion, 
mice were mechanically ventilated with a lung-protective pressure-
controlled mode for 2  hours and then sacrifi   ced, after which a 
bronchoalveolar lavage (BAL) was done. Statistics were analyzed by 
one-way ANOVA, values expressed as mean and standard deviation.
Results  Injection of LPS and MHC-I antibodies resulted in TRALI, 
indicated by increased levels of protein in the BAL fl  uid,  wet/dry 
ratios and levels of KC, MIP-2 and IL-6. C1 inhibitor Cetor® signifi  cantly 
reduced total protein in BAL fl  uid from 792 (169) to 421 (230) μg/ml 
(P <0.001) and tended to reduce the wet/dry ratio from 5.3 ± 0.3 to 
4.9 ± 0.5 (P = 0.09). Cetor® also reduced BALF levels of MIP-2 from 214 
(54) to 127 (22) pg/ml (P <0.01). KC and IL-6 levels were not aff  ected.
Conclusion  In a model of antibody-mediated TRALI, C1 inhibitor 
attenuated pulmonary infl  ammation. C1 inhibition may be a potential 
benefi  cial intervention in TRALI.
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Introduction  Transfusion-related acute lung injury (TRALI) is a 
syndrome that presents as a sudden onset of respiratory distress 6 
hours after transfusion of blood products. The diagnosis is based on 
clinical and radiographic fi   ndings. Particularly at risk for TRALI are 
cardiac surgery patients. However, specifi  c patient risk factors and 
data on outcome are largely unknown. The aim of this study was to 
investigate incidence, risk factors and outcome of TRALI in cardiac 
surgical patients on cardiopulmonary bypass.
Methods All thoracic surgery patients from a university hospital in the 
Netherlands of 18 years and older admitted to the ICU from January 
2009 until December 2011 were screened. Included patients were 
observed during surgery and the fi  rst 24 hours on the ICU for the onset 
of possible TRALI. The Canadian Consensus Conference TRALI defi  nition 
was used. Two independent physicians blinded to the predictor 
variables scored the chest radiographs for the onset of bilateral 
interstitial abnormalities on 2K monitors. When interpretation diff  ered, 
chest radiographs were reviewed by a third physician to achieve 
consensus. The European System for Cardiac Operative Risk Evaluation 
(EURO score) and the American Association of Anesthesiology (ASA) 
were scored before surgery. By calculating the Acute Physiology and 
Chronic Health Evaluation (APACHE) II and IV scores the severity of 
illness was determined on arrival in the ICU.
Results In total, 1,787 cardiac surgical patients were included. A total of 
19 (1.1%) patients developed TRALI within 24 hours following surgery. 
Patients developing TRALI were older compared with patients not 
developing TRALI, mean age respectively 71 and 65 years (P = 0.035). 
Furthermore, patients developing TRALI had higher APACHE II, APACHE 
IV, EURO and ASA score (P = 0.000, P = 0.000, P = 0.000 and P = 0.37). 
Compared with patients not developing TRALI, patients developing 
TRALI had a longer cardiopulmonary bypass time. Of the 19 patients 
developing TRALI, four patients (21.1%) died during ICU stay, in total six 
patients (31.6%) died during hospital stay. Patients developing TRALI 
were ventilated longer and had a longer ICU and hospital stay.
Conclusion Older age, higher APACHE II, IV, EURO and ASA scores and 
a longer time on cardiopulmonary bypass and ventilation time are risk 
factors for the development of TRALI. The ICU and hospital stay are 
longer, and the prognosis is bad for patients developing TRALI.
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Introduction Volume resuscitation is essential to restore normovolemia 
during hemorrhagic shock, burns and sepsis. However, synthetic 
colloids cause dilutional coagulopathy. The aims were to determine 
whether the natural colloid albumin induces a lesser degree of 
coagulopathy compared with synthetic colloids, and the comparative 
eff   ectiveness of fi   brinogen concentrate to reverse coagulopathy 
following dilution with these solutions.
Methods  Rotational thromboelastometry-based tests were used 
to examine coagulation parameters in samples from 10 healthy 
volunteers, in undiluted blood and samples diluted 1:1 with saline, 
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130/0.4, 3% dextran 60, 6% dextran 70 or 5% albumin. Samples were 
analyzed before and after addition of 2 mg/ml fi  brinogen concentrate.
Results  EXTEM maximum clot fi   rmness (MCF), clot formation time 
(CFT) and α angle (AA) decreased signifi   cantly upon dilution with 
all colloid solutions (P  <0.001), although a signifi  cantly  greater 
coagulopathic eff   ect was seen for samples diluted with synthetic 
colloid solutions versus albumin (P ≤0.001). A signifi  cant reduction in 
the platelet component of clot strength (EXTEM MCF – FIBTEM MCF) 
was seen for samples diluted with synthetic colloids (P <0.001) but 
not albumin (P = 0.10). Following addition of fi  brinogen, FIBTEM MCF, 
EXTEM MCF and EXTEM AA were signifi  cantly higher, and EXTEM CFT 
was signifi  cantly shorter in samples diluted with albumin versus those 
treated with HES or dextran (P ≤0.001).
Conclusion Hemodilution using albumin induced a lesser degree of 
coagulopathy compared with the synthetic colloids HES and dextran. 
In addition, albumin-induced coagulopathy was more eff  ectively 
reversed following addition of fi  brinogen concentrate compared with 
coagulopathy induced by synthetic colloids.
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Introduction Fluid resuscitation is widely practiced in treating sepsis. 
Comparative assessment of the diff  erent fl  uid modalities is hampered 
by a paucity of direct trials. We present a network meta-analysis for 
assessing the relative eff  ectiveness of two fl  uid treatments in sepsis 
when they have not been compared directly in a randomized trial but 
have each been compared with a common treatment.
Methods  A systematic review of trials sepsis yielded 13 trials for 
assessment in network meta-analysis. The indirect comparison between 
albumin, HES and crystalloid was conducted using Bayesian methods 
for binomial likelihood, fi  xed-eff   ects network meta-analysis with a 
Monte Carlo Gibbs sampling method. Studies in septic patients with 
crystalloid as a reference treatment compared with any formulation of 
the colloid treatments albumin or HES were included, as were direct 
head-to-head trials between the two colloids.
Results Odds ratios between the diff  erent treatments were obtained 
(Figure 1). Ranking the interventions [1] demonstrated that albumin 
ranked highest in lowering mortality at a 96.4% probability compared 
with 3.6% and 0.01% for crystalloid and HES, respectively.
Conclusion Albumin as a fl  uid therapy in sepsis is associated with the 
lowest mortality of the three modalities studied.
Reference
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Introduction Hospital-acquired infections create a signifi  cant burden 
to the healthcare system. To understand the economic impact, a model 
was developed to assess the cost of diff  erences in catheter-related 
bloodstream infections (BSI) in ICUs based on either closed or open 
albumin systems.
Methods  A model was developed with the aim of showing the 
economic consequences of diff   erences between intravenous (i.v.) 
infusions of albumin via open or closed infusion containers. The model 
took a healthcare perspective in the UK. The impact of central venous 
catheter-related BSI was evaluated. The model took diff  erences  in 
BSI rates and the associated cost consequences for the hospital into 
account. The model bases on the evidence that closed system delivery 
helps to reduce the risk of external contamination, which decreases the 
BSI rate and reduces overall mortality [1-3]. We assessed the total costs 
using public list prices and literature. The model assumes that infection 
rates for using open and closed albumin delivery systems are similar to 
any other closed or open nonalbumin i.v. fl  uid delivery system used in 
the ICU. The model looks at reduction in central-line-associated BSI and 
the potential cost saving of this reduction.
Results  The economic model shows the potential cost saving by 
switching from open to closed albumin administration systems. It is 
measured in occurrence of BSI in the ICU, estimated occurrence of BSI 
in the albumin population and incidence of overall mortality in the ICU 
and cost of BSI per albumin patient. Finally, the model describes the 
potential cost savings by switching to a closed system. Using closed 
albumin delivery systems may overall provide a cost saving for the 
hospital and healthcare sector. Assuming 800 patients treated in an ICU 
per year with all in all 4,800 ml albumin, the total annual cost saving 
would be £24,000 switching from open to closed albumin infusions.
Conclusion  Switching from an open to a closed albumin infusion 
system may result in a reduction in the risk of external contamination, 
resulting in less infection and may provide a cost saving for the 
healthcare system.
References
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Introduction Despite the fact that colloids are widely used, doubt still 
remains as to which colloid is the best and what is the ideal volume of 
administration. The aim of our study was to compare the hemodynamic 
eff  ects of six diff  erent colloids.
Methods A total of 180 patients were enrolled in our study undergoing 
general surgery procedures, who were assigned to six groups (A, B, C, D, 
E, F). After fasting fl  uid replacement and induction of anesthesia, 500 ml 
Gelofusine, Haemaccel, Voluven, HES 6%, HES 10% and Hemohes were 
administered to each group respectively. An oesophageal Doppler 
monitor probe was inserted into the patients for measuring stroke 
volume (SV) and cardiac output (CO). Standard monitoring included 
ECG, IBP, ETCO2 and SpO2, and heart rate (HR). Systemic arterial pressure 
Figure 1 (abstract P375). Forest plot of results of Bayesian fi  xed-eff  ect 
network meta-analysis of mortality.
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S141(SAP), SV and CO were recorded directly before the administration of 
any colloid (T0) and every 5 minutes for the next 1 hour (T1 to T12). 
Kolmogorov–Smirnov was used to test normal distribution of data and 
ANOVA was used for the statistical analysis. P <0.05 was considered 
statistically signifi  cant.
Results  Demographic data and ASA classifi   cation did not diff  er 
statistically signifi  cant among the six groups of the study. CO, SV, HR 
and SAP did not show any statistically signifi  cant evolution compared 
with their baseline value during the study period. Moreover, there were 
no statistically signifi  cant diff  erences among the six study groups with 
regard to any of the recorded parameters.
Conclusion According to our results, volume replacement with the 
six colloids tested in our study did not result in any hemodynamic 
response. Within comparison of these six colloids did not reveal any 
statistically signifi  cant diff  erence in any of the parameters recorded 
according to our protocol.
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Introduction The biochemical characteristics of infused fl  uids may be 
important in regulating acid–base balance, by modifying plasmatic 
volume and strong ion diff  erence. In vitro and animal studies [1,2] have 
shown that volume and strong ion diff  erence of infused fl  uids (SIDin) 
as well as the arterial baseline bicarbonate concentration (HCO3-a) 
infl  uence acid–base variations. Our aim was to verify these changes in 
critically ill patients after surgery.
Methods  An electronic-dedicated database was created to retro-
spectively collect volume, type of fl  uids infused and plasmatic acid–
base balance variations in postoperative ICU patients from admission 
to 9:00 am of the day after. SIDin was calculated as the average SID of all 
fl  uids infused during the whole study period (crystalloids, colloids and 
blood products). Arterial base excess variation (ΔBEa) was computed 
as the diff  erence between values at 9:00 am on the day after and those 
at entry. We report data from all patients admitted in 2006 and 2007 
(650 patients).
Results  Nine patients not receiving intravenous infusions were 
excluded. The remaining population was divided into three groups 
according to SIDin distribution (Group 1, 18 ± 12; Group 2, 47 ± 6; 
Group  3, 55  ±  0  mEq/l). We observed a progressive increment in 
ΔBEa between the groups (1.1 ± 2.0 vs. 2.8 ± 2.9 vs. 3.0 ± 2.8 mmol/l, 
P <0.001). We further subdivided each group by the median value of 
baseline HCO3-a (24.3 (22.3 to 26.1) mmol/l) and we analyzed the ΔBEa: 
we observed a greater increase in patients with lower baseline HCO3-a 
(Group 1, 1.8 ± 2.9 vs. 0.2 ± 2.6, mmol/l, P <0.001; Group 2, 4.0 ± 2.7 
vs. 1.5 ± 2.6, mmol/l, P <0.001; Group 3, 4.4 ± 2.8 vs. 1.7 ± 2.0 mmol/l, 
P <0.001), as compared with those with higher baseline levels. When 
the study population was divided into quartiles of the diff  erence 
between SIDin and HCO3-a, ΔBEa appeared to increase with the rise of 
such diff  erence (P <0.001).
Conclusion SIDin aff  ects the acid–base status per se and in relation-
ship with HCO3-a. We verifi  ed this hypothesis in critically ill patients, 
highlighting the importance of the diff   erence between SIDin 
and HCO3-a, which better describes and predicts the acid–base 
modifi  cations to fl  uid therapy.
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Introduction Fluid resuscitation should improve tissue oxygenation in 
hypovolemia, besides restoring macrohemodynamic stability [1]. We 
evaluated the microvascular response to fl  uid challenge with diff  erent 
colloid solutions and its relation to macrohemodynamics.
Methods An observational study of patients receiving a fl  uid challenge 
(500 ml colloids in 30 minutes) according to the attending physician’s 
decision. Before and after the infusion, sublingual microcirculation was 
evaluated with sidestream dark-fi  eld imaging (Microscan; Microvision 
Medical, Amsterdam, the Netherlands). Microvascular fl  ow and density 
were assessed for small vessels [2]. The cardiac index (CI), intrathoracic 
blood volume index (ITBVI) and extravascular lung water index (ELWI) 
were measured in seven patients with PiCCO2 (Pulsion Medical System, 
Munich, Germany).
Results  Ten patients (two sepsis, four trauma, three intracranial 
bleeding, one post surgery) received either saline-based hydroxyethyl 
starch (HES) 130/0.4 (Amidolite®; B.BraunSpA; n = 5) or balanced HES 
130/0.42 (Tetraspan®; B.BraunSpA; n = 5). The CI (P = 0.02) and ITBVI 
(P = 0.07) tended to increase, the EVLWI did not change. Microvascular 
fl  ow and density improved in the whole sample. No correlation was 
found between macro-circulatory and micro-circulatory parameters. 
Balanced HES led to a greater increase in capillary density than NaCl 
HES (Figure 1).
Conclusion Balanced HES may be more effi   cacious than saline-based 
HES in recruiting the microcirculation, thereby improving tissue O2 
delivery.
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Introduction Are safety guidelines being followed when administering 
procedural sedation in the emergency department? Between 
November 2004 and November 2008, the NPSA received 498 alerts 
of patients being given the wrong dose of midazolam for procedural 
sedation [1]. In the fi  rst 5 years of midazolam use there were 86 deaths, 
most related to procedural sedation [2].
Methods  We searched through the controlled drugs book in 
resuscitation over a 2-month period and found a list of patients who 
had received midazolam or fentanyl. From this, we could make a search 
for the relevant A and E notes for these patients. From these notes, we 
looked for (see shorthand in Table 1): verbal consent documentation 
(consent), past medical history recorded (pmhx), safe initial dose of 
midazolam (midaz), pre-procedure monitoring (pre), post-procedure 
monitoring (post), and monitoring for 1 hour before discharge (1hr). 
Following introduction of a reminder in the controlled drugs book/
sedation room and staff   education, the case notes were analysed over 
another 2-month period (24 sets of notes) to assess practise against 
safety guidelines.
Results See Table 1 (key for shorthand in Methods).
Conclusion The re-audit notices within the procedural sedation room 
and controlled drug book front cover served as a reminder of good 
practise. The visibility of this reminder (within the CD book) helped 
ensure better adherence to the audit standard. This reminder will now 
be kept within the CD book.
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Introduction Daily sedation interruption and protocol implementation 
have been recommended to reduce excessive sedation; however, 
their use has been inconsistent. We hypothesized that the use of an 
age, kidney and liver function adjusted sedation protocol would be 
associated with reduced doses and improved outcomes compared 
with a standard protocol.
Methods This was a prospective cohort study comparing 3 months 
of a standard protocol (control group) with 3 months of an adjusted 
protocol (intervention group). In the adjusted protocol, patients 
were divided into three categories: category 1 (age <60 years, and 
normal kidney and liver function), category 2 (age = 60 to 70 years, 
or moderate kidney or liver function impairment), and category 3 
(age >70 years, or severe kidney or liver function impairment). The 
upper limits of analgesics and sedatives doses were determined 
by age, and kidney and liver function, being lowest in category 
3, and lower in category 2 than category 1. All consecutive adults 
mechanically ventilated patients who required infusion of analgesics 
and/or sedatives for >24  hours were included in the study. We 
compared the main outcomes of both groups including average daily 
doses of analgesics and sedatives; average Sedation–Agitation Scale 
(SAS), pain and GCS scores; mechanical ventilation duration (MVD); 
sedation-related complications during ICU stay; ICU and hospital 
length of stay (LOS), and ICU and hospital mortality.
Results Two hundred and four patients were included in the study 
(control group = 105; adjusted protocol group = 99). There was no 
diff  erence in baseline characteristics between the two groups. The 
adjusted protocol group, compared with the control group, received 
signifi  cantly lower average daily doses of fentanyl (2,162 ± 2,110 μg 
vs. 3,650 ± 3,253 μg, P = 0.0001), nonsignifi  cant lower average daily 
doses of midazolam and dexmedetomidine, and a trend toward 
higher average daily doses of propofol. Pain score was higher in the 
adjusted protocol group (0.98 ± 0.72 vs. 0.16 ± 0.35, P <0.0001) with 
no diff  erence in SAS or GCS scores. Sedation-related complications 
during ICU stay were not diff  erent between the two groups; however, 
agitation (SAS = 5) was less frequent in the adjusted protocol group 
(3% vs. 30%, P <0.0001). ICU mortality was signifi  cantly lower in the 
Figure 1 (abstract P379). Microvascular response to fl  uid challenge: eff  ects of diff  erent colloids.
Table 1 (abstract P380). Before and after education programme and 
reminder in the controlled drugs book
  Before (%)  After (%)
  Yes No Yes  No
Consent  35 65 50  50
Pmhx  55 45 67  33
Midaz 58 42 88  12
Pre  25 75 54  46
Post  10 90 71  29
1hr  55 45 54  46
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S143adjusted protocol group (18% vs. 36%, P = 0.004) with no signifi  cant 
diff  erences in MVD, ICU and hospital LOS, and hospital mortality.
Conclusion  The use of an age, kidney and liver function adjusted 
sedation protocol is associated with lower doses of analgesics and 
sedatives, lower risk of agitation and lower ICU mortality.
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Introduction Protocol-directed sedation (PS) and daily interruption of 
sedation (DIS) are two major strategies to optimize sedation depth for 
mechanically ventilated patients. To clarify the clinical risk and benefi  ts 
of PS and DIS, we performed a systematic review of randomized 
controlled trials (RCTs) in previous literature.
Methods  We searched the MEDLINE database from January 1990 
to October 2012 for studies on PS and DIS in critically ill patients. 
English-language manuscripts were included when they assessed 
the impact of PS or DIS on outcomes in critically ill patients requiring 
mechanical ventilation for >48  hours. PS is defi   ned as sedation 
practices implemented by ICU staff   using a sedation scale and a 
written protocol. DIS is defi  ned as strategies with cessation of the 
continuous sedatives.
Results We retrieved 902 citations. Among them, nine RCTs fulfi  lled 
inclusion criteria. PS was compared with the standard practice in one 
RCT, DIS with the standard practice in four, PS with DIS in two, and PS 
with PS plus DIS (PS/DIS) in two. PS or DIS reduced the duration of 
mechanical ventilation by 28.9% and ICU stay by 27.8% compared with 
the standard practice. Neither the duration of mechanical ventilation 
nor ICU stay diff  ered among DIS, PS and PS/DIS. Mortality did not diff  er 
among the three strategies. DIS increased the daily dose of sedatives 
and the workload of nurses in one recent RCT.
Conclusion PS or DIS decreased the duration of mechanical ventilation 
and ICU stay. PS seems to be superior to DIS based on the doses of 
sedatives and the workload of nurses.
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Introduction The aim of this research was to provide clinically relevant 
evidence for Y-site compatibility of drug infusion combinations used in 
the PICU. Pharmacists and clinicians regularly have to interpret limited 
published data, particularly when more than two drugs are Y-sited. 
The risk of potential incompatibility must be balanced against that of 
additional line insertion.
Methods  A full 28-factorial design (total 256 combinations) was 
used to investigate chemical and physical compatibility of fi  ve drugs 
(clonidine, morphine, ketamine, midazolam and furosemide). The 
drugs were studied at their highest commonly infused concentrations 
and exposed to three variations in environmental conditions (diluent: 
sodium chloride 0.9% or glucose 10%; temperature 25 or 37°C; 
and normal room lighting or blue light phototherapy). Chemical 
stability was assessed using HPLC; >10% reduction in concentration 
indicated incompatibility. Physical incompatibility was confi  rmed by 
precipitation, pH or colour change.
Results Environmental conditions had no eff  ect on the drug mixtures. 
The precipitation observed in incompatible combinations was due to 
either a change in pH, or with ketamine the presence of benzethonium 
chloride. Of 31 possible drug combinations, 12 were incompatible. A 
further three combinations were incompatible at extreme pH, or were 
of concern and so should be avoided. The incompatible formulations 
all contained furosemide. All combinations of the sedative agents 
studied were chemically and physically compatible.
Conclusion  This work provides evidence for Y-site compatibility of 
morphine, midazolam, clonidine and ketamine in any combination, 
which will potentially reduce the need for extra intravenous lines. 
Furosemide is incompatible with any of these sedative drugs and must 
be infused via a separate line. These results will aid clinical decision-
making and help satisfy the requirements of recent UK Department of 
Health legislation relating to the mixing of medicines.
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Introduction  In light of the interest in the relationship between 
glycemia control in critically ill subjects and outcome, we set up a study 
to investigate whether benzodiazepine, commonly used in anesthesia 
and ICUs, interferes with glucose metabolism and to explore the 
mechanism.
Methods A total of 40 sedated and paralyzed Sprague–Dawley rats 
(301  ±  55  g) were investigated in four consecutive studies. (1)  To 
investigate the eff  ects of diazepam on blood glucose, 15 rats were 
randomly assigned to intraperitoneal anesthesia with tiopenthal 
80 mg/kg (DZP0), tiopenthal 40 mg/kg + diazepam 5 mg/kg (DPZ5) 
or tiopenthal 40 mg/kg + diazepam 15 mg/kg (DZP15). Blood levels of 
glucose (GEM premier 3000; IL) were measured at time intervals over 
2 hours. (2) Ten animals randomized to DZP0 or DZP5 underwent an 
intravenous glucose tolerance test with glucose bolus (0.5 g/kg). Acute 
insulin response, the mean value of blood insulin (Insulin ELISA kit; 
Millipore) from 2 to 10 minutes after glucose bolus, was measured as 
index of insulin secretion. (3) A hyperinsulinemic euglycemic clamp 
obtained by a continuous intravenous infusion of insulin (130 mUI/
kg/minute) was run in 10 animals randomized to DZP0 or DZP5 and 
the glucose infusion rate (GIR, mg/kg/minute) was assessed [1]. (4) The 
eff  ect of midazolam on blood glucose was tested in fi  ve additional 
animals (M5: tiophental 40 mg/kg + midazolam 5 mg/kg). Data are 
presented as mean  ±  SEM. Statistical analysis (ANOVA, t  test) was 
conducted with Sigma Stat 3.1 (Systat Software).
Results  (1)  Diazepam was associated with higher levels of blood 
glucose in a dose–response fashion: DZP0 128  ±  7  mg/dl, DZP5 
166 ± 7.3, DZP15 197 ± 7 (P <0.05). (2) The acute insulin response 
to intravenous glucose tolerance test was similar in DZP0 and DZP5 
(DZP0 3.97 ± 0.42 ng/ml, DZP5 3.68 ± 0.44, P = 0.68), while blood 
glucose levels were diff  erent (DZP0 192 ± 5 mg/dl, DZP5 217 ± 5, 
P  <0.05). (3)  During hyperinsulinemic euglycemic clamp, blood 
glucose levels were similar (109 ± 3 mg/dl, P = 0.2), but the DZP5 
group showed a trend through lower values of GIR (DZP0 30.8 ± 2 mg/
kg/minute, DZP5 24.7 ± 2, P = 0.08). (4) Infusion of midazolam was 
associated with higher blood glucose levels (DZP0 128 ± 5 mg/dl, M5 
151 ± 6, P <0.05).
Conclusion Both diazepam and midazolam signifi  cantly alter plasma 
glucose levels in rats. Peripheral disposal of glucose rather than altered 
pancreas secretion of insulin explains the benzodiazepine-associated 
hyperglycemia.
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Introduction We report our experience in the use of isofl  urane for 
prolonged sedation in severe ARDS patients. Prolonged sedation in 
the ICU may be diffi   cult because of tolerance, drug dependence and 
withdrawal, drug interactions and side eff  ects. Inhaled anesthetics 
have been proposed for sedation in ventilator-dependent ICU patients. 
AnaConDa is a device that allows a safety and easy administration of 
inhaled anesthetics in the ICU.
Methods From January 2009 to June 2012, 15 patients were sedated 
with isofl   urane by means of the AnaConDa device. We consider 
administration of isofl   urane as a washout period from common 
sedative drugs in patients with (at least one of): high sedative drug 
dosage (propofol ≥300 mg/hour or midazolam ≥8 mg/hour) to reach 
the target Richmond Agitation Sedation Score (RASS) or inadequate 
paralysis; two or more hypnotic drugs to reach the target RASS 
(propofol, midazolam, hydroxyzine, haloperidol, diazepam, quetiapine); 
and hypertriglyceridemia. During isofl  urane administration previous 
hypnotic drugs were interrupted. We retrospectively collected data 
before, during and after administration of isofl  urane: hemodynamic 
parameters, renal and hepatic function, level of sedation (RASS) 
and sedative drug dosage. All data are reported as mean ± standard 
deviation, otherwise as median (minimum to maximum).
Results Mean age was 43 ± 12 years and SAPS II was 35.7 ± 11; 13 
patients were treated with ECMO for severe ARDS and four had a 
history of drug abuse; median ICU length of stay was 41 (15 to 127) 
days and they were ventilated for 41 (12 to 114) days. Due to severe 
critical illness, target RASS was –4 for all patients, most of which were 
also paralysed. Isofl  urane was administered in nine patients because 
of a high level of common sedative drugs, in fi  ve patients due to the 
use of two or more hypnotic drugs and in one patient because of 
hypertrigliceridemia. Isofl  urane administration lasted 5.6 ± 1.8 days. 
During isofl   urane administration no alteration in renal function or 
hemodynamic instability was recorded. After the isofl  urane washout 
period we observed a reduction in sedative drug dosage in 10 patients 
while two patients were quickly weaned from mechanical ventilation 
and the target RASS raised to 0. In two patients isofl  urane  was 
precautionarily interrupted because of concomitant alteration of liver 
function and suspected seizures respectively.
Conclusion Inhaled anesthetics could be successfully used in the ICU 
especially in case of an inadequate sedation plan; for example, in 
patients with a history of drug abuse or young severe ARDS patients 
that required deep sedation and paralysis for a long period.
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Introduction Pharmacological agents used to treat critically ill patients 
may alter mitochondrial function. The aim of the present study was 
to investigate whether fentanyl, a commonly used analgesic drug, 
interacts with hepatic mitochondrial function.
Methods  The human hepatoma cell line HepG2 was exposed to 
fentanyl at 0.5, 2 or 10 ng/ml for 1 hour, or pretreated with naloxone 
(an opioid receptor antagonist) at 200 ng/ml or 5-hydroxydecanoate 
(5-HD; a specifi  c inhibitor of mitochondrial ATP-sensitive K+ (KATP) 
channels) at 50  μM for 30  minutes, followed by incubation with 
fentanyl at 2 ng/ml for an additional hour. The mitochondrial complex 
I-dependent, II-dependent and IV-dependent oxygen consumption 
rates of the permeabilized cells were measured using a high-resolution 
oxygraph (Oxygraph-2k; Oroboros Instruments, Innsbruck, Austria). 
The respiratory electron transfer capacity of intact cells was evaluated 
using FCCP (carbonyl cyanide p-trifl  uoromethoxyphenylhydrazone) to 
obtain the maximum fl  ux.
Results  Incubation of HepG2 cells with fentanyl (1  hour, 2  ng/ml) 
induced a reduction in complex II-dependent and IV-dependent 
respiration (Figure 1). Cells pretreated with 5-HD before the addition 
of fentanyl exhibited no signifi  cant changes in complex activities in 
comparison with controls. Pretreatment with naloxone tended to 
abolish the fentanyl-induced mitochondrial dysfunction. Treatment 
with fentanyl led to a reduction in cellular ATP content (0.24 ± 0.06 in 
controls vs. 0.17 ± 0.14 μmol/mg cellular protein in stimulated cells; 
P = 0.02). We did not observe any diff  erence in basal or FCCP-uncoupled 
respiration rates of cells treated with fentanyl at 2 ng/ml compared 
with controls (data not shown).
Conclusion  Fentanyl reduces cultured human hepatocyte mito-
chondrial respiration by a mechanism that is blocked by a KATP channel 
antagonist. In contrast, antagonism with naloxone does not seem to 
completely abolish the eff  ect of fentanyl.
Acknowledgement This study was supported by the Swiss National 
Science Foundation (grant number 32003B_127619).
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Introduction  Endothelial dysfunction during endotoxemia is 
responsible for the functional breakdown of microvascular perfusion 
and microvessel permeability. The cholinergic anti-infl  ammatory 
pathway (CAP) is a neurophysiological mechanism that regulates 
the infl  ammatory response by inhibiting proinfl  ammatory cytokine 
synthesis, thereby preventing tissue damage. Endotoxemia-induced 
Figure 1 (abstract P387). Cellular oxygen consumption after incubation with fentanyl, naloxone or 5-HD.
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activation. Clonidine improves survival in experimental sepsis [1] by 
reducing the sympathetic tone, resulting in the parasympathetic-
mediated CAP activation. The aim of this study was to determine the 
eff  ects of clonidine on microcirculatory alterations during endotoxemia.
Methods  Using fl   uorescent intravital microscopy, we determined 
the venular wall shear rate, macromolecular effl   ux  and  leukocyte 
adhesion in mesenteric postcapillary venules of male Wistar rats. 
Endotoxemia was induced over 120 minutes by intravenous infusion 
of lipopolysaccharide (LPS). Control groups received an equivalent 
volume of saline. Clonidine 10  μg/kg was applied as i.v. bolus in 
treatment groups. Animals received either (i) saline alone, (ii) clonidine 
10 minutes prior to saline administration, (iii) clonidine 45 minutes 
prior to LPS administration, (iv)  clonidine 10  minutes prior to LPS 
administration, (v) clonidine 30 minutes after LPS administration or 
(vi) LPS alone.
Results All LPS groups (iii to vi) showed a signifi  cantly reduced venular 
wall shear rate compared with the saline group after 120 minutes. There 
were no signifi  cant  diff  erences between the numbers of adhering 
leukocytes in the clonidine/LPS groups (iii, iv, v) and the LPS group 
after 120 minutes. Macromolecular effl   ux signifi  cantly increased in all 
groups over the time period of 120 minutes. After 120 minutes there 
was no diff  erence between the LPS group and the clonidine 10 minutes 
prior to LPS administration group (iv) whereas all other groups (i, ii, iii, v) 
showed a signifi  cantly reduced macromolecular effl   ux compared with 
the LPS group.
Conclusion Clonidine has no positive eff  ect on microhemodynamic 
alterations and leukocyte–endothelial interaction during endotoxemia. 
The reduction of capillary leakage in clonidine-treated groups 
depends on the time interval relative to the initiation of endotoxemia. 
Endothelial permeability and leukocyte activation are regulated by 
diff  erent pathways when stimulated by clonidine during endotoxemia. 
We conclude that clonidine might have an important time-dependent 
anti-infl   ammatory and protective eff   ect on endothelial activation 
during infl  ammation.
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Introduction Delivering analgesics via conjunctival application could 
provide rapid and convenient pain relief in disaster medicine. There are 
sporadic reports from the USA concerning inhalation administration 
of aerosol with various drugs producing a wide variety of eff  ects from 
anxiolysis, sedation, and loss of aggressiveness to immobilisation. We 
attempted to determine in an animal experiment whether conjunctival 
administration of S+ketamine could produce signifi  cant eff  ect without 
side eff  ects.
Methods After ethic committee approval, 10 rabbits were administered 
conjunctival S+ketamine 2.5 mg/kg. Measured parameters were SpO2, 
blood pressure (BP) and heart rate (HR) before administration and in 
1-minute intervals and immobilisation time (loss of righting refl  ex). The 
measurements were performed for 20 minutes. Conjunctival irritation 
was measured 1, 10 and 20 minutes after administration according to 
modifi  ed technical standard EN IS O 10993-10. ANOVA test was used for 
statistical analysis of hemodynamic parameters.
Results The immobilisation time was 207 ± 60 seconds. There were 
no changes in cardiorespiratory parameters (initial, 10 and 20 minutes 
after administration: HR 255.5 ± 24.7, 265.8 ± 26.0 and 267.8 ± 20.4, 
systolic BP 114.3 ± 8.6, 108.2 ± 10.7 and 113.9 ± 11.9 mmHg, diastolic 
BP 66.8 ± 11.6, 68.4 ± 10.6 and 69.7 ± 9.3 mmHg and SpO2 99.2 ± 1.0, 
98.2 ± 0.6 and 98.7 ± 0.5). These results are in contrast to conjunctival 
administration of sufentanil 5 μg/kg that caused a signifi  cant decrease 
of SpO2 and HR [1]. We can speculate that the reason for stability of 
cardiorespiratory parameters was due to the sympathoadrenergic 
eff  ect of ketamine or due to the method of administration. There 
were no signs of conjunctival irritation in any animal (S+ketamine is a 
preservative-free solution).
Conclusion Conjunctival S+ketamine 2.5 mg/kg in rabbits produced 
rapid onset without changes in cardiorespiratory parameters and 
without signs of irritation of the eye. The results of our project warrant 
further research to increase the variety of drugs and methods of 
their administration for anxiolysis, sedation and analgesia in disaster 
medicine.
Acknowledgement The study was supported by scientifi  c grant IGA NT 
11284.
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Introduction Procedural sedation is used in the emergency department 
(ED) to facilitate short but painful interventions. Many patients are 
suitable for discharge after completion. Ideally, the agent used to 
achieve sedation should not have a prolonged eff  ect, allowing safe 
discharge in the shortest time frame. We hypothesised that propofol, 
with its short onset and off  set, may reduce length of stay (LOS) in 
comparison with traditional benzodiazepines.
Methods  Data from a prospective registry were analysed for the 
period 1 August 2011 to 31 January 2012. Patients who underwent 
procedural sedation and who were discharged from the ED were 
identifi   ed. Individuals were grouped as having received propofol, 
midazolam or a combination of the two. All were discharged when 
fully alert and able to eat and drink. Demographic details and the type 
of procedure undertaken were extracted. ANOVA was performed to 
identify diff  erences in the length of stay between groups, in addition 
to descriptive analysis.
Results During the study period 75 patients underwent procedural 
sedation and were discharged from the ED. The median age was 40 
years and 57% were male. The commonest procedure performed was 
shoulder reduction (52%). In the propofol group (n = 20) the mean 
LOS was 100 minutes compared with 165 minutes in those receiving 
midazolam (n = 40) and 141 minutes in those receiving a combination 
(n = 15), P = 0.004. There was no diff  erence in adverse events between 
groups. See Figure 1.
Conclusion Propofol is increasingly used in EDs for procedural sedation 
due to its short duration of action. This study suggests that a shorter 
duration of action and faster recovery may result in a reduced LOS in 
the ED.
Figure 1 (abstract P390). Length of stay (minutes) in the ED.
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Introduction The use of propofol for sedation in intensive care has been 
associated with the propofol infusion syndrome (PRIS) characterised by 
cardiac dysfunction, metabolic acidosis, renal failure, rhabdomyolysis 
and hyperlipidaemia. We prospectively monitor biochemical markers 
that we believe demonstrate early signs of this dangerous, often fatal 
syndrome. When this Pre-PRIS state is identifi  ed, propofol is withdrawn 
whilst the syndrome is still reversible.
Methods We prospectively audited our monitoring of these markers 
over a 4-month period in propofol-sedated patients: propofol infusion 
rate, creatine kinase (CK), triglycerides (TG), creatinine, lactate, pH 
and base defi  cit. We defi  ned the criteria for Pre-PRIS as requiring a 
CK ≥320 mmol/l that had doubled from its base level and a rise in TG 
≥1.7 IU/l; both that followed a trend with propofol dose.
Results Data were collected from 54 adults; 50 received an infusion for 
≥24 hours. We noted a signifi  cant CK rise in 11 (22%) of our patients 
that could be attributed to propofol alone. They all had raised TG 
(≥1.7  IU/l); six (12%) were markedly raised (≥3.4  IU/l). No patients 
became signifi  cantly acidotic, developed cardiac arrhythmias or renal 
failure as a result of propofol. In the 11 patients who met our criteria, 
highest daily propofol dose varied from 1.5 to 4 mg/kg/hour. Pre-PRIS 
developed from between 2 and 6 days of infusion. The mean propofol 
dose in patients displaying Pre-PRIS was 2.2 mg/kg/hour whilst in those 
not meeting our criteria it was 2.0 mg/kg/hour. No patients developed 
sequelae of full PRIS. See Table 1.
Table 1 (abstract P391)
 Total  Trauma  Nontrauma
≥24 hours infusion  50  34  16
CK + TG  ≥3.4 6 6 0
CK + TG  ≥1.7 5 3 2
Conclusion We propose that a paired rise in CK and TG that can be 
attributed to propofol alone represents a Pre-PRIS state that is at risk 
of developing into full PRIS. We noted this in 22% of our patients, all 
on modest doses of propofol. It is unclear what proportion of patients 
will develop the full syndrome as it is not ethically possible to continue 
propofol in this situation. We advocate daily monitoring of CK and TG 
to identify Pre-PRIS so that propofol can be reduced or substituted to 
avoid the morbidity and mortality of the full syndrome.
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Introduction Until recently there were no guidelines for the reporting 
of adverse events (AEs) during procedural sedation [1,2]. A consensus 
document released in 2012 by the world SIVA International Sedation 
Task Force proposed a benchmark for defi  ning AEs [3]. We analysed 
1,008 cases of procedural sedation in the emergency department.
Methods The study is based on 1,008 patients who received procedural 
sedation with propofol in the emergency department between 
December 2006 and March 2012. Patients were selected and sedated 
to a strict protocol by ED consultant staff  . We applied the AE tool 
by performing a search through patient records, discussion with 
consultants performing the sedation and consensus opinion.
Results From 1,008 cases we identifi  ed 11 sentinel (six of hypotension, 
fi  ve cases of hypoxia), 34 moderate, 25 minor and three minimal risk 
adverse events.
Conclusion The study shows a 1% adverse event rate. This supports use 
of propofol sedation by emergency physicians but within the limits of a 
strict governance framework. Our safety analysis using the World SIVA 
adverse events tool provides a reference point for further studies.
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Introduction  Physical restraints are used to facilitate essential care 
and prevent secondary injuries. However, physical restraint may be 
regarded as humiliating. It may lead to local injury and increase the risk 
of delirium and post-traumatic stress syndrome. Research on physical 
restraint is scarce. The aim of this study is to investigate the scope of 
physical restraint use.
Methods Twenty-one ICUs ranging from local hospitals to academic 
centres were each visited twice and 327 patients were included. We 
recorded characteristics of restrained patients, motives and awareness 
of nurses and physicians.
Results Physical restraint was applied in 74 (23%) patients, ranging 
from 0 to 54% in diff  erent hospitals. Frequent motives for restraint 
use were ‘possible threat to airway’ (36%) and ‘pulling lines/probes’ 
(31%). Restrained subjects more often had a positive CAM-ICU (34% 
vs. 16%, P <0.001), could less frequently verbally communicate (14% 
vs. 49%, P <0.001), and received more often antipsychotics (49% vs. 
28%, P <0.001), or benzodiazepines (55% vs. 36%, P = 0.003). The use 
of physical restraint was registered in the patient’s fi  les in 48% of cases. 
Of the 310 interviewed nurses, 258 (83%) were familiar with a physical 
restraint protocol and 89 (29%) used it in any situation. Thirty percent 
of the 60 interviewed physicians were aware of the physical restraint 
status of their patients.
Conclusion Physical restraint is frequently used in Dutch ICUs, but the 
frequency diff  ers strongly between diff  erent ICUs. Attending physicians 
are often not aware of physical restraint use.
P394
Factors infl  uencing the use of physical restraints in Canadian ICUs
B Sneyers1, E Luk2, M Perreault3, D Williamson3, L Rose2, S Mehta4, L Burry4
1Université Catholique de Louvain, Brussels, Belgium; 2Lawrence S. Bloomberg 
Faculty of Nursing, University of Toronto, Ontario, Canada; 3Université de 
Montréal, Canada; 4Mount Sinai Hospital, University of Toronto, Ontario, 
Canada
Critical Care 2013, 17(Suppl 2):P394 (doi: 10.1186/cc12332)
Introduction  Physical restraint (PR) use in critically ill patients has 
been associated with delirium, unplanned extubation, prolonged ICU 
length of stay, and post-traumatic stress disorder. Our objectives were 
to defi  ne prevalence of PR use, and to examine patient, treatment, or 
institutional factors associated with their use in Canadian ICUs.
Methods We conducted an analysis of a database of sedative, analgesic, 
antipsychotic and neuromuscular blocker prescribing practices and PR 
use in 711 mechanically ventilated (MV) adults in 51 Canadian ICUs 
(3,619 patient-days). Data were collected during a 2-week period (2008 
to 2009). Logistic and Poisson regression analysis were used to identify 
factors associated with PR use and number of days of use respectively.
Results PR was used on 1 or more days in 52.6% (374/711) of patients. 
For patients restrained, the mean number of days restrained was 
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1.2 ± 0.5. Treatment characteristics associated with PR use were: daily 
benzodiazepine dose (OR = 1.01, 95% CI: 1.00 to 1.01), daily opiate dose 
(OR = 1.00, 95% CI: 1.00 to 1.01), daily sedation interruption (OR = 1.84, 
95% CI: 1.24 to 2.72), use of antipsychotics (OR = 3.42, 95% CI: 1.98 to 
5.91) and agitation (Sedation–Agitation Scale (SAS) >4, OR = 2.55, 95% 
CI: 1.20 to 5.44). Additionally, number of days of PR use was increased 
according to the following: daily sedation interruption (IRR  =  4.52, 
95% CI: 2.09 to 9.75), use of antipsychotics (IRR = 18.65, 95% CI: 7.95 
to 43.77), the presence of a heavily sedated score (SAS <3, IRR = 2.57, 
95% CI: 1.06 to 6.24) or the presence of an adverse event, such as self-
extubation (IRR = 10.46, 95% CI: 2.55 to 42.92). Hospital characteristics 
associated with PR use included the proportion of MV patients in 
the ICU. University hospitals were associated with reduced PR use, 
compared with community hospitals (OR = 0.272, 95% CI: 0.15 to 0.50). 
Nonmodifi  able patient characteristics (age, sex, APACHE score, patient 
category, prior substance abuse, prior psychotropic medication, pre-
existing psychiatric condition or dementia) were not associated with 
PR use.
Conclusion  We identifi   ed multiple factors associated with PR use 
and number of days of PR use. Particularly among those related to 
treatment, strategies such as daily sedation interruption or use of 
antipsychotics are associated with PR use and increasing the number 
of days of use.
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Introduction As part of a multicenter prospective study on barriers 
and facilitators for implementation of protocolled care for delirious 
critically ill patients, we aimed to describe current practices in delirium 
management in a representative cohort of ICU patients.
Methods  We included consecutively admitted patients during a 
4-month period in a prospective multicenter study in six ICUs (one 
academic, teaching and nonteaching hospitals) in the southwest of 
the Netherlands. We assessed: percentage of patients screened for 
delirium with validated screening tools; pharmacological treatment 
with haloperidol or other antipsychotic drugs; psychohygiene (use of 
hearing aids and or glasses, preventing sleep disturbances); and access 
to early mobilization and physiotherapy. Delirium was pragmatically 
defi  ned as administration of haloperidol and/or delirium reported by 
physicians or ICU nurses in patient records, as assessed by a designated 
research nurse. Diff  erences between centers were tested with non-
parametric tests.
Results  We assessed 1,576 patients, corresponding with 8,150 ICU 
treatment days with a median length of stay of 3 days (IQR 2 to 5). 
The mean age of the patients was 62 years (SD = 16) and 58% were 
male. Delirium occurred in 23% (356/1,576) of patients with a median 
duration of 3 days (IQR 2 to 7) and ranged from 11 to 40% for each ICU. 
Delirium assessment with the CAM-ICU at any point during ICU stay 
was performed in 38% of all patients. Screening with CAM-ICU was 
applied in three ICUs, in 29 to 96% of the patients in these centers. Of 
3,564 documented screening days with the CAM-ICU, it was positive 
in 1,459 (41%); in only 120 (8%) of these CAM-ICU-positive days there 
was a documented action or treatment started for delirium. However, 
patients still received haloperidol on 52% (n = 766) of all CAM-ICU-
positive days. Patients received benzodiazepines in 49% (n = 1,141) 
of patient sedation days. Delirium preventive interventions were 
physiotherapy (19% of 8,150 ICU days), mobilization (10%), glasses 
use (2.6%) and hearing aid use (0.3%). Presence of hearing or visual 
impairment at admission was not documented in 65% of patients.
Conclusion Daily screening for ICU delirium with a validated screening 
instrument is applied in less than one-half of the time in critically ill 
patients and management of delirium is often not guided by this 
screening. Haloperidol was used as the fi  rst-choice  medication. 
Measures aimed at delirium prevention (psychohygiene and early 
mobilization) were carried only in a small minority or were not 
documented. To implement protocolled delirium care in the region at 
study, a multifaceted tailored implementation program is needed.
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Introduction The objective of this study is to investigate the eff  ect of 
intraoperative administration of dexamethasone versus placebo on the 
incidence of delirium in the fi  rst four postoperative days after cardiac 
surgery.
Methods Within the context of the large multicenter Dexamethasone 
for Cardiac Surgery (DECS) trial [1] for which patients were randomized 
to 1 mg/kg dexamethasone or placebo at induction of anesthesia, a 
monocenter substudy was conducted. The primary outcome of this 
study was the incidence of delirium in the fi  rst four postoperative 
days. Secondary outcomes were duration of delirium, use of restrictive 
measures and sedative, antipsychotic and analgesic requirements. 
Delirium was assessed daily by trained research personnel, using the 
Richmond Agitation Sedation Scale and the Confusion Assessment 
Method. Medical, nursing and medication charts were evaluated for 
signs of delirium and use of prespecifi  ed medication. Analysis was by 
intention to treat.
Results  Of 768 eligible patients, complete data on delirium could 
be collected in 738 patients. The incidence of delirium was 14.2% in 
the dexamethasone group and 14.9% in the placebo group (odds 
ratio = 0.95, 95% CI = 0.63 to 1.43). No signifi  cant diff  erence was found 
on the duration of delirium between the intervention (median = 2 days, 
interquartile range 1 to 3  days) and placebo (median  =  2 days, 
interquartile range 1 to 2 days) group (P = 0.45). The use of restrictive 
measures and administration of sedatives, haloperidol, benzodiazepine 
and opiates were comparable between both groups.
Conclusion  Intraoperative injection of dexamethasone seems not 
to aff  ect the incidence or duration of delirium in the fi  rst 4 days after 
cardiac surgery, suggesting this regimen is safe to use in the operative 
setting with respect to psychiatric adverse events.
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Introduction  The beliefs, knowledge and practices regarding ICU 
delirium among ICU professionals may vary. This may interfere with 
the implementation of the Dutch ICU Delirium guideline. We aimed to 
get insight into potential barriers and facilitators for delirium guideline 
implementation that may help to fi  nd an eff  ective implementation 
strategy.
Methods An online survey was sent to healthcare professionals from 
the six participating ICUs. Respondents included ICU physicians, nurses 
and delirium experts (psychiatrists, neurologists, geriatricians, nurse 
experts). The survey consisted of statements on beliefs, knowledge 
and practices towards ICU delirium. Agreement with statements by 
more than 75% of respondents were regarded as facilitating items and 
agreement lower than 50% as barriers for implementing protocolled 
care.
Results Of the 565 surveys distributed, 360 were completed (63.7%). 
The majority of respondents were ICU nurses (79%). Delirium was 
considered a major problem (83%) that requires adequate treatment 
(99%) and is underdiagnosed (81%). Respondents considered that 
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only a minority (20%) answered that delirium is preventable. Only 
39% of the respondents had received any training about delirium 
in the previous 3 years and 77% of them found training useful. The 
mean delirium knowledge score was 6.6 out of 10 (SD = 1.54). When 
all groups were mutually compared, nurses scored lower than delirium 
experts (ANOVA, P = 0.013). The respondents (58%; n = 210) from three 
ICUs indicated that CAM-ICU assessment was department policy. 
However, 50% (n = 106) of these respondents felt unfamiliar with CAM-
ICU and only 47% (n = 99) of them indicated that a positive CAM-ICU 
was used for treatment decisions. Haloperidol was the fi  rst-choice 
pharmacological treatment. Only 21% of all respondents knew that a 
national ICU delirium guideline existed, but in-depth knowledge was 
generally low.
Conclusion  Our survey showed that healthcare professionals 
considered delirium an important but underdiagnosed form of 
organ failure. In contrast, screening tools for delirium are scarcely 
used, knowledge can be improved and protocolled treatment based 
on positive screening is often lacking. These results suggest that the 
focus of implementation of ICU delirium management should not be 
on motivational aspects, but on knowledge improvements, training 
in screening tools and implementation of treatment and prevention 
protocols.
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Introduction Delirium is a serious and frequent disorder in ICU patients. 
The aim of this study was to internationally validate the existing 
Prediction of Delirium ICU (PREDELIRIC) model to predict delirium in 
ICU patients.
Methods A prospective multicenter cohort study was performed in 
eight ICUs in six countries (Table 1). The 10 predictors (age, APACHE 
II score, urgent and admission category, infection, coma, sedation, 
morphine use, urea level, metabolic acidosis) were collected within 
24  hours after ICU admission. CAM-ICU was used to identify ICU 
delirium.
Results A total of 2,852 adult ICU patients were screened and 1,824 
(64%) were included. Main exclusion reasons were length of stay <1 day 
(19.1%) and sustained coma (4.1%). Mean  ±  CAM-ICU compliance 
was 82 ± 16% and inter-rater reliability 0.87 ± 0.17. Overall delirium 
incidence was 19.9% (range 27.2%). Despite signifi  cant  diff  erences 
between centres on all 10 predictors, the overall area under the receiver 
operating characteristic curve (AUROC) of the eight centers was 0.77 
(95% CI: 0.74 to 0.79).
Conclusion  The overall predictive value of the PREDELIRIC model 
was good, indicating that the prediction model can now be used 
internationally.
P399
Delirium in ICU patients is associated with increased temperature 
variability
AW Van der Kooi, TH Kappen, RJ Raijmakers, IJ Zaal, AJ Slooter
University Medical Center Utrecht, the Netherlands
Critical Care 2013, 17(Suppl 2):P399 (doi: 10.1186/cc12337)
Introduction  Delirium is an acute disturbance of consciousness 
and cognition. It is a common disorder in the ICU and associated 
with impaired long-term outcome [1,2]. Despite its frequency and 
impact, delirium is poorly recognized by ICU physicians and nurses 
using delirium screening tools [3]. A completely new approach to 
detect delirium is to use monitoring of physiological alterations. 
Temperature variability, a measure for temperature regulation, could 
be an interesting parameter for monitoring of ICU delirium, but this has 
never been investigated before. The aim of this study was to investigate 
whether temperature variability is aff  ected during ICU delirium.
Methods  We included patients in whom days with delirium could 
be compared with days without delirium, based on the Confusion 
Assessment Method for the ICU and inspection of medical records. 
Patients with conditions aff   ecting thermal regulation, including 
infectious diseases, and those receiving therapies aff  ecting  body 
temperature were excluded. Twenty-four ICU patients were included 
after screening 334 delirious ICU patients. Daily temperature variability 
was determined by computing the mean absolute second derivative 
of the temperature signal. Per patient, temperature variability 
during delirious days was compared with nondelirium days using a 
Wilcoxon signed-rank test. With a linear mixed model, diff  erences 
between delirium and nondelirium days with regard to temperature 
variability were analysed adjusted for daily mean Richmond Agitation 
and Sedation Scale scores, daily maximum Sequential Organ Failure 
Assessment score, and within-patient correlation.
Results  Temperature variability was increased during delirium days 
compared with days without delirium (mean diff  erence = –0.007, 95% 
CI = –0.004; –0.011, P <0.001). Adjusting for confounders did not alter 
our fi  ndings (adjusted mean diff  erence  =  –0.005, 95% CI  =  –0.008; 
–0.002, P <0.001).
Conclusion  Temperature variability is increased during delirium 
in ICU patients, which refl   ects the encephalopathy that underlies 
delirium. Opportunities for delirium monitoring using temperature 
variability should be further explored. Particularly, in combination with 
electroencephalography it could provide the input for an objective tool 
to monitor delirium.
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Introduction In ICU patients, little research has been performed on 
the relationship between delirium and long-term outcome, including 
health-related quality of life (HRQoL), cognitive functioning and 
mortality. In addition, results seem to be inconsistent. Furthermore, 
in studies that reported increased mortality in delirious patients, 
no proper adjustments were made for severity of illness during ICU 
admission. This study was conducted to investigate the association 
Table 1 (abstract P398). PREDELIRIC AUROC of diff  erent centers
  Delirium (%)  AUROC  95% CI
Belgium (%)  86 (15.2)  0.79  0.74 to 0.84
Germany (%)  60 (26.9)  0.85  0.80 to 0.91
Spain (%)  23 (18.0)  0.88  0.81 to 0.94
Sweden (%)  30 (39.0)  0.71  0.60 to 0.83
Australia Brisbane (%)  42 (12.8)  0.81  0.75 to 0.88
Australia Canberra (%)  23 (11.8)  0.80  0.72 to 0.89
UK_Prescot (%)  73 (30.8)  0.65  0.57 to 0.73
UK_Kent (%)  26 (36.6)  0.76  0.65 to 0.88
PREDELIRIC overall  363 (19.9)  0.77  0.74 to 0.79
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and mortality. The hypothesis was that delirious patients have worse 
long-term outcome in comparison with nondelirious patients.
Methods A prospective observational cohort study was conducted. 
A median of 12 months after ICU discharge, questionnaires were sent 
to all survivors. HRQoL and cognitive functioning were measured with 
the EuroQol-6D. Age, gender and severity of illness were considered 
relevant covariates. Severity of illness was estimated using the APACHE 
IV score and the maximal SOFA score during admission. HRQoL was 
investigated with linear regression analysis, cognitive functioning 
using logistic regression and mortality with Cox regression analysis.
Results The patient population consisted of 690 patients admitted to 
the ICU, subdivided into delirious (n = 257) and nondelirious patients 
(n = 433). During follow-up, 181 (26%) patients died. The response rate 
of the questionnaire was 70.6%. After adjusting for the predefi  ned 
covariates, delirium was signifi  cantly associated with a lower HRQoL 
(adjusted β: –0.137; 95% CI = –0.140 to –0.005) and more mild and 
severe cognitive impairment (adjusted odds ratio: respectively: 2.3; 95% 
CI = 1.3 to 4.2 and 5.8; 95% CI = 1.3 to 15.2). No signifi  cant association 
between delirium and long-term mortality was found (adjusted hazard 
ratio: 1.0; 95% CI = 0.7 to1.4).
Conclusion  Delirium during ICU admission was associated with 
lower HRQoL and worse cognitive functioning, 1 year after discharge. 
Furthermore, delirium on the ICU was not associated with long-term 
mortality after adjusting for relevant covariates, including severity of 
illness during ICU admission.
P401
Gastrointestinal symptoms in the ICU: a comparison of primary and 
secondary acute gastrointestinal injury
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Introduction We aimed to clarify the diff  erences between primary and 
secondary acute GI injury.
Methods  A total of 2,690 consecutive adult patients were retro-
spectively studied during their fi  rst week in the ICU. Pathology in the 
GI system or laparotomy defi  ned the primary GI insult. If GI symptoms 
developed without primary GI insult it was considered secondary GI 
injury. Absent bowel sounds (BS), vomiting/regurgitation, diarrhoea, 
bowel distension, GI bleeding, and high gastric residuals (GRV 
>1,000 ml/24 hours) were recorded daily.
Results  In total, 2,690 patients (60.4% male), median age 59 years 
(range 16 to 92), were studied. Eighty-four per cent of them were 
ventilated, 72% received vasopressor/inotrope. Median (IQR) APACHE 
II score was 14 (9 to 21) and SOFA on the fi  rst day was 6 (3 to 10). A 
total 35.5% had primary GI pathology. During the fi  rst week 34% of 
patients had absent BS, 38% vomiting/regurgitation, 9% diarrhoea, 
7% bowel distension, 6% high GRV and 5% GI bleeding. All symptoms 
except diarrhoea occurred more often (<0.001) in patients with primary 
GI insult. Eighty-fi  ve per cent of patients with primary GI insult versus 
46% without developed at least one GI symptom. The incidence of GI 
symptoms was signifi  cantly higher in nonsurvivors. ICU mortality was 
lower in patients with primary than secondary GI injury (43.6% vs. 
61.2%, P = 0.046). Nonsurvivors without primary GI insult developed GI 
symptoms later (Figure 1).
Conclusion  Primary and secondary acute GI injury have diff  erent 
incidence, dynamics and outcome.
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Eff  ects of proton pump inhibitor versus H2-receptor antagonist 
stress ulcer prophylaxis on ventilator-associated pneumonia: 
a pilot study
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University of Szeged, Hungary
Critical Care 2013, 17(Suppl 2):P402 (doi: 10.1186/cc12340)
Introduction  Ventilator-associated pneumonia (VAP) is the most 
frequent ICU-acquired infection among patients receiving mechanical 
ventilation with relative risk of 9 to 27% and with mortality of 25 to 
50% [1,2]. One of the promoting factors of VAP is the increased pH of 
the gastric acid, which occurs when H2-receptor antagonists (H2RA) 
or proton pump inhibitors (PPI) are used for stress ulcer prophylaxis. 
The aim of this study was to investigate eff  ects of PPI versus H2RA 
on the occurrence of VAP and, as second endpoint, the occurrence of 
gastrointestinal bleeding (GIB).
Methods  After ethics committee approval mechanically ventilated 
(>48  hours) adults were recruited in a prospective randomized 
controlled, double-blind clinical trial and randomised into PPI or H2RA 
groups. Patients with admission diagnosis of pneumonia or other 
acute infl   ammatory pulmonary disease, severe sepsis/septic shock, 
and/or regular PPI/H2RA users were excluded. The diagnostic criteria 
for VAP were: leukocytosis, increased PCT level, fever, purulent tracheal 
secretion, positive microbiological result of tracheal sample, and new/
increased infi   ltrate on chest X-ray. Data are presented as median 
(interquartile range, IQR). For statistical analysis Mann–Whitney U test 
and chi-square tests were used.
Results Out of 94 patients recruited 14 were excluded due to early 
weaning/death (n = 9) or protocol violation (n = 6). The remaining 
79 patients were analysed (PPI, n  =  38; H2RA, n  =  41). There was 
no signifi  cant  diff  erence  (P  >0.05) between the groups regarding 
demographics: age 67 (56 to 77) versus 72 (58 to 79)  years; male/
female: 23/15 versus 25/16; length of mechanical ventilation: 5 (3 to 
9) versus 5 (2 to 8) days; APACHE II score: 28 (22 to 32) versus 26 (21 to 
36) (PPI vs. H2RA, respectively). There was no signifi  cant diff  erence in 
the number of cases with VAP in the PPI versus H2RA groups: 9 (24%) 
versus 10 (24%). None of the patients developed GI bleeding during 
their stay on the ICU.
Conclusion  The results of this pilot study suggest that there may 
be no diff  erence in the incidence of VAP and GI bleeding if stress 
ulcer prophylaxis is performed by H2RA or PPI. As the latter is more 
expensive, its use as fi  rst choice in critical care should be questioned. 
Figure 1 (abstract P401). Daily dynamics of the number of GI symptoms. 
P <0.001 between survivors and nonsurvivors in all time points.
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required to come to the fi  nal conclusions.
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Introduction Patients with bacterial sepsis often suff  er from multiorgan 
failure. No reliable parameter exists for the exact estimation of the liver 
function. The indocyaningreen test (ICG test) showed a correlation 
between liver function and mortality rate. The new maximal liver 
function capacity test (LiMAx test) is a real-time method to investigate 
the liver function.
Methods  Thirty septic patients were prospectively included in the 
study. The LiMAx test was performed on days 0, 2, 5 and 10 after sepsis 
onset and was compared with ICG test and liver-specifi  c laboratory 
parameters. Primary endpoint was the mortality rate after 90 days. 
Secondary endpoint was the comparison with the ICG test.
Results  The LiMAx test showed low results initially with increasing 
values on days 5 and 10. The 90-day mortality rate in patients with a 
low LiMAx test on day 2 (<100 μg/kg/hour) was signifi  cantly higher 
than in patients with a LiMAx test >100 μg/kg/hour. The LiMAx test 
was comparable with the ICG test. Patients with indication for renal 
replacement therapy during hospital treatment showed signifi  cantly 
lower LiMAx values than patients without dialysis. See Figure 1.
Conclusion With the LiMAx test we can detect a liver dysfunction in 
septic patients early on days 0 to 2. The LiMAx test is equal with the 
ICG test and a result of <100 μg/kg/hour on day 2 suggests a low 
probability of survival in septic patients.
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Introduction  Liver dysfunction  – in correlation to the severity of 
functional impairment – but also any increase in portal pressure per 
se (hepatorenal refl  ex) can induce alterations in renal function and 
ultimately result in hepatorenal syndrome (HRS). In this prospective 
investigation we determined the impact of liver resection on portal 
venous pressure by measuring the hepatic venous pressure gradient 
(HVPG), on concentrations of vasoactive peptides and on renal function.
Methods Twenty patients (mean age 66.3 years) undergoing elective 
liver resection surgery because of malignant tumor were assessed 
and grouped according to resection size: (Group 1) hemihepatectomy, 
n = 13 versus (Group 2) segmentectomy, n = 7. HPVG was measured 
before and after resection by canulation of a hepatic vein under 
fl  uoroscopic guidance, liver function was assessed by the indocyanine 
green plasma disappearance rate (ICG-PDR).
Results HVPG increased in Group 1 from 3.7 to 5.4 mmHg (P <0.05) and 
decreased in Group 2 (4.8 to 4.3 mmHg, P = NS) (Table 1). Liver function 
as assessed by ICG-PDR decreased in Group 1 by day 1 (18.5 to 15.3, 
P <0.05) and remained stable in Group 2 (25.5 to 26.8, P = NS). Renin, 
aldosterone, ADH, adrenaline, noradrenaline and dopamine increased 
signifi  cantly (P <0.05) in Group 1 during operation. Group 2 showed 
a signifi   cant rise only in ADH and dopamine. Acute kidney injury 
occurred in fi  ve of 13 patients in Group 1 (P <0.05).
Table 1 (abstract P404)
    Group 1  Group 2
Renin 36.4  7.9
 PostOP  189.7*  30.5
 Day  1  258  31.3
ADH 3.49  2.59
 PostOP  16.11*  10.8*
 Day  1  10.8  2.39
Creatine 0.8  0.83
 Day  1  1.25*  0.91
*P <0.05 compared with preOP value.
Conclusion  Depending on resection size liver resection acutely 
increases portal venous pressure and induces neurohumoral activation 
resulting in compromised renal function and increased risk of 
developing AKI.
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Value of the preoperative Model for End-stage Liver Disease 
score in predicting postoperative outcome in living donor liver 
transplantation recipients
Y Nassar, K Omar, A Battah, A Mwafy
Cairo University, Giza, Egypt
Critical Care 2013, 17(Suppl 2):P405 (doi: 10.1186/cc12343)
Introduction Partial liver grafting predisposes recipients to a unique 
set of potential technical and anatomic complications that are 
not prevalent in whole deceased donor grafts. We aimed to assess 
the preoperative Model for End-stage Liver Disease (MELD) score, 
postoperative 30-day clinical and laboratory follow-up, and detection 
of the value of MELD score in predicting 30-day postoperative outcome 
of LDLT recipients.
Methods A prospective multicenter registry involving 142 patients who 
underwent LDLT from October 2004 to December 2010. Preoperative 
Figure 1 (abstract P403). Kaplan–Meier survival curve of patients with 
high and low LiMAx results.
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(INR) + 0.957×log (creatinine) (mg/dl) + 0.643)×10 then rounded to 
the nearest integer. Postoperative daily recording of all the clinical and 
laboratory data was done for a period of 30 days.
Results  The survival rate recorded in our study was 86.62%. The 
most frequent complications were renal complications (86.6%), 
pulmonary complications (73.9%), neurological complications (14%), 
cardiovascular complications (12.6%), infectious complications (13.3%), 
intra-abdominal infections (10.5%) and immunosuppressant toxicity 
(7.7%). MELD score proved to be a good predictor of perioperative 
outcome, patients with MELD score (>12) was associated with less 
favorable outcome, accuracy was (80.3%).
Conclusion  MELD score >12 was associated with less favorable 
outcome with an accuracy of 80.3%.
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Introduction  Patients with liver cirrhosis (LC) are susceptible to a 
variety of complications. Especially, infection disorders can reduce their 
life expectancy markedly. The aim of this retrospective analysis was 
to detect the incidence and prognosis in patients with LC and fungal 
evidence (FE).
Methods  A 3-year retrospective analysis of ICU patients with LC. 
Patients with LC with/without FE were compared with a matched 
control group based on comparable age and APACHE II score. 
Specimens were collected based on clinical and/or laboratory 
(infection signs) reasons and were analyzed by microbiological 
standard methods.
Results A total of 101 patients with LC were enrolled in this analysis. 
Basic data for both groups: Child–Pugh Score: 4*A, 18*B, 79*C; reason 
for ICU admission: 28*hepatorenal syndrome, 18*SBP, 20*GI bleeding, 
19*sepsis, 16*pneumonia; etiology of LC: 83*alcoholic, 8*NASH, 8*viral 
(hepatitis B/C), 2*PSC. Fifty-fi  ve (54%) patients with LC had FE (mean age: 
57.6 ± 14 years, sex M/F: 40/15, APACHE II score 27 ± 2). Compared with 
the 46 patients with LC but without FE (mean age: 59.2 ± 12 years, sex 
M/F: 35/11, APACHE II score 23 ± 4), these patients have a signifi  cantly 
higher APACHE II score (27 ± 2 vs. 23 ± 4; P <0.001) and signifi  cantly 
higher mortality (43/55 (78%) vs. 15/46 (33%); P <0.001). Multivariate 
analysis showed that FE is associated with a higher mortality (P <0.001) 
but is not associated with age, sex or CHILD score. Seventeen (31%) of 
the 55 patients in the control group had FE (screening patients n = 147, 
mean age 65.8 ± 12 years, sex M/F: 35/20, APACHE II score 26.5 ± 3, 
reason for ICU admission: 19*pneumonia, 16*sepsis, 9*intracerebral 
haemorrhage, 7*acute abdomen, 4*lymphatic disorder). The mortality 
rate was signifi  cantly lower (27/55 (49%) vs. 43/55 (78%); P = 0.003) as 
compared with patients with LC and FE. The main localisation of fungal 
was in both groups the lung (46 vs. 14), followed by urine (18 vs. 2), 
blood culture (6 vs. 1) and ascites (4 vs. 0). Predominantly candida 
species were detected (especially C. albicans/glabrata), fi  ve patients 
in the LC group had aspergillus fumigatus. In LC patients, FE could be 
detected in many cases in several compartments.
Conclusion  ICU patients with LC have a high incidence of FE. The 
mortality rate is therefore signifi   cantly higher as compared with 
patients with LC without FE and also as compared with a control 
group without LC. Therefore early antimycotic treatment should be 
considered.
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Predictors of persistent organ failure in ICU patients with severe 
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Introduction Severe acute pancreatitis (SAP) requiring admission to an 
ICU is associated with high mortality (hospital mortality reached 42%) 
and long lengths of stay [1]. Survival among patients with predicted 
SAP at admission has been shown to correlate with the duration of 
organ failure (OF) [2]. The systemic determinant of severity in a new 
classifi  cation of acute pancreatitis (AP) is also based on identifi  cation of 
patients with transient or persistent OF [3].
Methods The aim of the study was to retrospectively determine the 
predictors of early persistent OF in ICU patients with SAP. The analysis 
involved 152 patients. The median time interval between the onset of 
AP and admission was 24 (9; 48) hours. The patients were divided into 
two groups: the fi  rst group (n = 46) had transient OF and the second 
group (n = 106) had persistent OF. The ability of the APACHE II score, 
total SOFA score and number of organ/system failure to discriminate 
transient from persistent OF was explored with receiver operating 
characteristic (ROC) curves.
Results  Hospital mortality was signifi   cantly higher in the second 
group as compared with the fi  rst group (45% vs. 7%, P = 0.000); while 
infectious complications were 39% versus 11% (P = 0.001) and median 
lengths of ICU stay were 8 (5; 18) days for the second group and 6 (4; 7) 
days for the fi  rst group (P = 0.001). Optimum cutoff   levels (by ROC curve 
analysis) were APACHE II score ≥12 (sensitivity 0.790; 1 – specifi  city 
0.119), total SOFA score ≥4 (sensitivity 0.829; 1 – specifi  city 0.190), and 
failure ≥2 organs/systems (sensitivity 0.819; 1 – specifi  city 0.214). See 
Table 1.
Table 1 (abstract P407)
Variable  AUC  Standard error  95% CI
APACHE II score  0.934  0.023  0.889 to 0.980
SOFA score  0.908  0.026  0.857 to 0.960
Number OF  0.901  0.026  0.849 to 0.952
AUC, areas under the curves.
Conclusion Persistent OF in ICU patients with SAP is associated with the 
highest risk of hospital mortality. Early identifi  cation of patients with a 
high likelihood of persistent OF (APACHE II score ≥12, total SOFA score 
≥4, failure ≥2 organs/systems) is an important goal in determining 
optimal management of ICU patients with SAP.
References
1. Harrison  DA,  et al.: Crit Care 2007, 11(Suppl 1):S1.
2. Johnson  CD,  et al.: Gut 2004, 53:1340-1344.
3. Dellinger  EP,  et al.: Ann Surg 2012. [Epub ahead of print]
P408
Increased plasma levels of thrombopoietin in patients with severe 
acute pancreatitis
L Pigozzi1, O Bosco2, B Vizio2, M Loiacono1, M Lucchiari1, G Mengozzi1, 
C Moiraghi1, G Montrucchio2, E Lupia1
1Città della Salute e della Scienza Hospital, Torino, Italy; 2University of Torino, 
Italy
Critical Care 2013, 17(Suppl 2):P408 (doi: 10.1186/cc12346)
Introduction The aim of this study was to evaluate the accuracy of 
thrombopoietin (TPO) plasma levels as a biomarker of clinical severity 
in patients with acute pancreatitis (AP). TPO is a humoral growth factor 
that stimulates megakaryocyte proliferation and diff  erentiation [1]. 
Furthermore, it favors platelet aggregation and polymorphonuclear 
leukocyte activation [2]. Elevated plasmatic concentrations of TPO have 
been shown in patients with critical diseases, including ACS, burn injury 
and sepsis [2]. In particular, clinical severity is the major determinant of 
elevated TPO levels in patients with sepsis [3]. AP is a relatively common 
disease whose diagnosis and treatment are often diffi   cult, especially in 
the clinical setting of the emergency department (ED). About 20% of 
patients with AP develop a severe form of the disease. In order to early 
identify those patients aff  ected by severe AP, several biomarkers have 
been studied. No data regarding TPO plasma levels in patients with AP 
are currently available.
Methods  We enrolled patients with AP at the moment of the fi  rst 
clinical evaluation in the ED. AP patients were classifi  ed as having mild 
or severe forms of AP on the basis of the APACHE II score (≥8). TPO 
concentrations were determined by ELISA.
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pancreatitis). No diff   erences for gender and age were detected 
between patients with mild and severe disease. TPO plasma levels 
were signifi  cantly higher in patients with severe AP (99.33 ± 23.68 pg/
ml) than in those with mild AP (50.81 ± 6.73 pg/ml) (Figure 1). The 
ROC curve led us to calculate a cutoff   value of 51.55 pg/ml. This value 
identifi  ed correctly 12 out of the 17 patients aff  ected by severe AP.
Conclusion TPO may be proposed as biomarker of clinical severity 
in patients with AP at the time of fi  rst evaluation in the ED. Further 
studies, involving larger numbers of patients, are needed in order to 
validate these preliminary data.
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Introduction  The objective was to evaluate the eff  ect of the renal 
dysfunction measured by pRIFLE on clinical outcome in children 
admitted to the pediatric intensive care unit (PICU).
Methods  A retrospective cohort involving all children admitted 
between August 2009 and July 2010 to a Brazilian PICU located in a 
university-affi   liated hospital. Patients were classifi  ed according to the 
pRIFLE at admission as well the maximum pRIFLE during the PICU 
stay. The endpoints were: length of stay (LOS) in the PICU, LOS on 
mechanical ventilation, mortality rate quoted by predicted mortality of 
the Pediatric Index of Mortality (PIM2).
Results In total, 375 children were included in the study. A total 169 
(45%) of them presented renal dysfunction according to the pRIFLE. 
Renal injury and renal failure were associated with higher LOS in the 
PICU and length of mechanical ventilation. The observed and predicted 
mortality by PIM2 did not show diff  erences. However, the more severe 
renal presentation (Injury and Failure) was associated with higher 
mortality rate and was not predicted by PIM2 (8% vs. 11%, P <0.01).
Conclusion Renal dysfunction measured by pRIFLE is a very common 
fi  nding (45%) among pediatric patients admitted to the PICU. The more 
severe renal aff  ection is associated with higher mortality, length of MV 
and length of PICU stay.
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Introduction Two previous classifi  cations of acute kidney injury (AKI) 
that are known as RIFLE criteria and AKIN criteria have shown that 
AKI is associated with increased morbidity and mortality. Diff  erences 
in predicting ability for prognosis, however, have been reported. In 
2012, Kidney Disease Improving Global Outcomes (KDIGO) created the 
new AKI criteria, combining RIFLE and AKIN criteria. However, such a 
combination might cause inconsistency among each defi  nition in the 
criteria. We have investigated all of the defi  nitions in the new KDIGO 
criteria in detail.
Methods This is a retrospective historical cohort study including adult 
patients admitted to the ICU (Jikei University, Tokyo, Japan) between 
January 2010 and October 2011. Patients undergoing chronic dialysis 
were excluded. KDIGO criteria were applied to all patients to diagnose 
AKI. Hospital mortality of patients with AKI diagnosed by the 10 
defi  nitions in the criteria was compared.
Results A total of 2,399 patients were evaluated. AKI occurred in 26.6% 
with standard defi  nition of KDIGO; 18.0% with creatinine criteria alone; 
15.5% with urine output alone. By multivariable analysis, each AKI 
stage was associated with hospital mortality: 5.6%, odds ratio 2.95, for 
Stage 1; 10.1%, odds ratio 5.52, for Stage 2; 30.2%, odds ratio 21.30, 
for Stage 3. Crude hospital mortality stratifi  ed by the 10 defi  nitions 
showed increasing trends with stage progression. Mortality of the 
three defi  nitions in Stage 1 was from 4.2% to 8.8%. Stage 2 had two 
defi  nitions and their mortality was 12.1% and 12.9%. Stage 3 had fi  ve 
defi  nitions and their mortality was from 20.5% to 55.6%.
Conclusion  AKI defi  ned by the new KDIGO criteria was associated 
with increased hospital mortality. In addition, defi  nitions in the KDIGO 
criteria seem to be appropriate because of clear relations between 
mortality and stage progression.
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Introduction  To evaluate whether urinary neutrophil gelatinase-
associated lipocalin (uNGAL) detects acute kidney injury (AKI) earlier 
than the estimated glomerular fi  ltration rate (eGFR) in cardiac surgery 
patients.
Methods Two-hundred and seventy-four adult patients undergoing 
cardiac surgery were consecutively included from February to 
December 2011. Exclusion criteria were absence of diuresis due to 
end-stage renal disease or chronic renal failure and a previous cardiac 
catheterism with i.v. contrast use the week before surgery. Four serial 
blood and urine samples immediately before (PRE) and after (POST) 
surgery, and 1 day (1d) and 2 days (2d) after surgery were obtained. 
uNGAL was measured in an Architect 6200 (Abbott Diagnostics). AKIN 
criteria were used to diagnose AKI. The study was approved by the 
local ethics committee and all patients gave informed consent. Delta 
uNGAL was defi  ned as the diff  erence between the PRE and the POSTs 
concentrations.
Results  One-hundred and eighty-one patients (66.1%) were men; 
mean age was 68.2 ± 12.2 years. Valve replacement was performed 
in 123, coronary artery bypass graft (CABG) in 81, valve surgery + 
CABG in 48, cardiac transplant in fi  ve, aorta aneurism surgery in nine, 
and other procedures in eight patients. ICU and hospital stays were 
6.7 ± 8.1 and 15.7 ± 13.9 days, respectively. Renal replacement therapy 
(RRT) was required in 16 patients (5.8%) within 48 hours of ICU stay and 
in 28 patients (10.2%) within 4 weeks. Mortality at 28 days was 2.9%. 
Eighty-six patients (31.4%) were diagnosed with AKI within 48 hours of 
surgery. Area under the ROC curve of POST uNGAL for AKI diagnosis 
was 0.72 (0.66 to 0.79) (P <0.0001) at an optimal cutoff   value of 180 μg/l, 
Figure 1 (abstract P408). Plasma TPO levels in patients with AP.
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advanced diagnosis of AKI in 44 patients (51.2%), whereas diagnosis 
was achieved at the same time as AKI criteria in 11 patients; AKI criteria 
outperformed uNGAL in only 36% of cases. Accordingly, uNGAL was 
useful to diagnose postoperative AKI in 63.9% of cases. Median delta 
uNGAL was 12.5 (from –1.9 to 71.1) and 154.5 (from 16.6 to 484.5) μg/l 
in non-AKI and AKI patients, respectively (P <0.0001) and its area under 
the ROC curve for AKI prediction was 0.70 (0.63 to 0.77) (P <0.0001).
Conclusion Compared with AKIN criteria, a urinary NGAL concentration 
>180 μg/l anticipates AKI diagnosis in more than 50% of cardiac surgery 
patients in the fi  rst 24 to 48 hours after intervention.
P412
Atrial natriuretic peptide attenuates metabolic acidosis and 
infl  ammation of the kidney, lung and heart in a rat model of renal 
ischemia–reperfusion injury
M Khin Hnin Si, C Mitaka, M Tulafu, S Abe, S Ikeda
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Introduction  Renal ischemia–reperfusion injury (IRI) is a common 
cause of acute kidney injury and occurs in various clinical conditions 
including shock and cardiovascular surgery. Renal IRI releases 
proinfl  ammatory cytokines within the kidney. Atrial natriuretic peptide 
(ANP) has natriuretic, diuretic and anti-infl  ammatory eff  ects [1] and 
plays an important role of regulating blood pressure and volume 
homeostasis. The hypothesis was that renal IRI induces infl  ammation 
not only in the kidney but also in remote organs such as the lung and 
heart and ANP attenuates renal injury and infl  ammation in the kidney, 
lung and heart.
Methods  Male Sprague–Dawley rats were anesthetized with pento-
barbital. Tracheostomy was performed and rats were ventilated at VT 
10 ml/kg with 5 cmH2O PEEP. The right carotid artery was catheterized 
for blood sampling and continuous blood pressure measurements. The 
right femoral vein was catheterized for infusion of saline or ANP. Rats 
were divided into three groups; IRI group (n = 10), left renal pedicle was 
clamped for 30 minutes; IRI+ANP group (n = 10), left renal pedicle was 
clamped for 30 minutes, ANP (0.2 μg/kg/minute, for 3 hours 25 minutes) 
was started 5 minutes after clamp; and Sham group (n = 6), the sham-
operated rats. Hemodynamics, arterial blood gas, and plasma lactate 
levels were measured at baseline and at 1 hour, 2 hours and 3 hours after 
declamp. The mRNA expression of IL-6 in the kidney, lung, and heart were 
measured. The kidney, lung and heart were immunostained to examine 
the localization of IL-6 and NF-κB and assigned an expression score. The 
wet/dry ratio of the lung was also measured.
Results Renal IRI induced metabolic acidosis, pulmonary edema, mRNA 
expression of IL-6 in the kidney, lung and heart. Renal IRI increased 
immunohistochemical localization of IL-6 in the proximal convoluted 
tubule of the left kidney and NF-κB in the bronchial epithelial cells of 
the lung. ANP attenuated metabolic acidosis, pulmonary edema and 
expression of IL-6 mRNA in the kidney, heart, and lung. ANP decreased 
immunohistochemical localization of IL-6 in the left kidney and NF-κB 
in the lung.
Conclusion  These fi  ndings suggested that infl  ammation within the 
kidney after renal IRI was extended into the lung and heart. ANP 
attenuated metabolic acidosis and infl  ammation in the kidney, lung 
and heart in a rat model of renal IRI. ANP may attenuate organ cross-
talk between the kidney, lung and heart.
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Introduction Evidence suggests a nephroprotective eff  ect of urinary 
alkalinization in patients at risk of acute kidney injury (AKI).
Methods In a multicenter, double-blind, RCT we enrolled 350 adult 
cardiac surgery patients. At induction of anesthesia, patients received 
either 24  hours of intravenous infusion of sodium bicarbonate 
(5.1 mmol/kg) or sodium chloride (5.1 mmol/kg). The primary endpoint 
was the proportion of patients developing AKI.
Results  Sodium bicarbonate increased urinary pH (from 6.0 to 7.5, 
P <0.001). More patients in the bicarbonate group (83/174 (47.7%)) 
developed AKI compared with control (64/176 (36.4%), OR  =  1.60 
(95% CI, 1.04 to 2.45); unadjusted P = 0.032). A greater postoperative 
Figure 1 (abstract P413).
Critical Care 2013, Volume 17 Suppl 2 
http://ccforum.com/supplements/17/S2
S154increase in urinary NGAL in patients receiving bicarbonate infusion 
was observed compared with control (P = 0.011). The incidence of 
postoperative RRT was similar but hospital mortality was increased 
in patients treated with bicarbonate compared with chloride (11/174 
(6.3%) vs. 3/176 (1.7%), OR 3.89 (1.07 to 14.2), P = 0.031). See Figure 1.
Conclusion On this basis of our fi  ndings we do not recommend the 
use of perioperative infusions of sodium bicarbonate to reduce the 
incidence or severity of AKI in this patient group.
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Introduction Here, we compare the value of acute tubular damage 
markers measured early in the course after cardiac surgery for 
prediction of postoperative AKI compared with conventional markers 
used in clinical routine for risk assessment of acute renal function loss.
Methods One hundred adult patients undergoing cardiac surgery in 
the control arm of a RCT (NCT00672334) were analyzed. We quantifi  ed 
the following biomarkers in urine: NGAL, hepcidin, midkine, IL-6, α1-
microglobulin; in plasma: NGAL, hepcidin, haptoglobin, CK, CKMB, CRP, 
leukocytes, lactate, urea and creatinine.
Results Preoperatively, no biomarker predicted AKI. At ICU arrival, four 
urinary tubular damage markers showed good discriminatory ability 
(AUC ≥0.80) for subsequent development or absence of AKI (Figure 1). 
An excellent predictive value was found for uNGAL/uhepcidin ratio 
(AUC 0.90, Figure  1). This ratio combines an AKI prediction marker 
(NGAL) and a marker of protection from AKI (hepcidin), potentiating 
their individual discriminatory values. Contrarily, at ICU admission, 
none of the plasma biomarkers was a good early AKI predictor with 
AUC-ROC ≥0.80.
Conclusion Several urinary markers of acute tubular damage predict 
AKI after cardiac surgery and the biologically plausible combination of 
NGAL and hepcidin provides excellent AKI prediction.
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Introduction Furosemide is one of the most employed diuretics in 
the ICU for its ability to induce negative water balance. However, one 
common side eff  ect is metabolic alkalosis [1]. We aimed to describe the 
time course of urinary excretion and changes in plasmatic acid–base 
balance in response to the administration of furosemide.
Methods  We connected the urinary catheter of 39 ICU patients to 
a quasi-continuous urine analyzer (Kidney INstant monitorinG®), 
allowing measurement of pH (pHU), sodium, chloride, potassium 
and ammonium concentrations (Na+U, Cl–U, K+U, NH4+U) every 
10 minutes. The study period lasted 3 hours after a single intravenous 
bolus of furosemide (time 0). In 13 patients receiving two or more 
administrations over a longer period (46 (26 to 49) hours), according to 
clinical needs, we reviewed data on fl  uid therapy, hemodynamics and 
acid–base balance from the beginning to the end of the observation.
Results  Ten minutes after furosemide administration, Na+U and 
Cl–U rose from 65 ± 6 to 140 ± 5 and from 109 ± 6 to 150 ± 5 mEq/l 
respectively, while K+U fell from 60 ± 5 to 39 ± 4 mEq/l (P <0.001 for 
all electrolytes vs. time 0) with a consequent increase in urinary anion 
gap (AGU = Na+U + Cl–U – K+U). Urinary output increased from 10 (5 
to 19) to 53 (29 to 71) ml/10 minutes (P <0.05). After the fi  rst hour Cl–U 
remained higher than Na+U, which progressively decreased, leading 
to a reduction in AGU and pHU over time. In parallel, a progressive 
increment in NH4+U was observed. In patients receiving more than 
one administration we observed an increase in arterial base excess 
(1.8 ± 0.8 vs. 5.0 ± 0.6 mmol/l, P <0.001) and plasmatic strong ion 
diff  erence (SIDpl) (31 (30 to 33) vs. 35 (34 to 36) mEq/l, P = 0.01) during 
the study period. These changes were due to a decrease in plasmatic 
Cl– concentration (109.0 ± 1.1 vs. 106.6 ± 0.9 mEq/l, P = 0.009). Plasmatic 
sodium and potassium concentrations did not change. In these 
patients, considering the total amount of administered fl  uids and urine, 
a negative water and chloride balance was observed (–460 ± 403 ml 
and –48 ± 48 mEq, respectively).
Conclusion Furosemide acts immediately after administration, causing 
a rise in urinary output, Na+U and Cl–U concentrations. Loop-diuretic-
induced metabolic alkalosis may be due to an increased urinary 
chloride loss and the associated increase in SIDpl.
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Introduction Given the signifi  cant morbidity and mortality associated 
with acute kidney injury (AKI), there is a need to fi  nd factors to help 
aid decision-making regarding levels of therapeutic support. As 
a prognostic biomarker, the red cell distribution width (RDW) has 
attracted interest in the setting of critical care when added to existing 
scoring systems [1]. By examining RDW in a previously studied AKI 
cohort, we aimed to evaluate the utility of this routine blood test.
Methods A cohort of 209 mixed critical care patients who received renal 
replacement therapy for AKI had their demographic and biochemical 
data retrieved from electronic databases. Outcomes were gathered for 
ICU and hospital mortality. Incomplete datasets were discarded, leading 
to 153 complete sets. RDW data were taken from the fi  rst sample after 
admission to the ICU, as were all other biochemical values apart from 
pre-RRT creatinine and potassium. Overall cohort characteristics were 
gathered, and two groups were created: those with a RDW value within 
normal range (≤14.5%) and those with a greater than normal value 
Figure 1 (abstract P414).
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between rising levels and ICU mortality.
Results A total 77.1% of our cohort had a RDW greater than the normal 
laboratory range at time of ICU admission. Key baseline characteristics 
(age, APACHE II score, length of stay, ICU mortality) did not diff  er 
signifi  cantly between patients with normal and abnormal RDW. When 
subgroup analysis was performed, no statistically signifi  cant correlation 
between rising RDW and ICU mortality was found (Spearman 
correlation = 0.426, P = 0.233).
Conclusion In this cohort of critically ill patients with AKI, RDW was 
not found to be a predictor of mortality. Our results contradict those of 
recent studies [1,2]. However, both groups of RDW patients in our study 
suff  ered a higher ICU mortality than in other studies. To further explain 
these fi  ndings, we intend to perform multivariate logistic regression 
analysis and assess the eff  ect of social deprivation on RDW.
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Introduction Acute renal failure (ARF) is a common complication in 
patients admitted to the ICU. Sepsis is also a well-known risk factor for 
the development of ARF. The combination of ARF and severe sepsis was 
reported to carry a mortality up to 70% whereas the mortality of ARF 
alone is 40 to 45%. The aim of the study is to evaluate the role of renal 
perfusion scanning in detecting the prognosis and outcome of patients 
with acute renal failure due to sepsis.
Methods Forty patients with acute renal failure due to sepsis, aged 
between 15 and 74  years, were enrolled in the study. They were 
monitored for their ICU prognosis and outcome after doing renal 
perfusion scanning. All patients were subjected to routine ICU and 
laboratory investigations including APACHE II and SOFA score.
Results Thirty patients had normal renal scan and 10 patients had 
abnormal renal scan. The mortality percentage was higher among 
abnormal renal scan cases (three out of 10, 30%) compared with cases 
with normal renal scan (seven out of 30, 23.3%) with nonsignifi  cant 
P value: 0.6. The median length of stay/day in ICU was longer among 
nonsurvivors than survivors 15.5  ±  10, 11.5  ±  8, P  value: 0.058 
(approaching signifi  cance). APACHE II score was higher in nonsurvivors 
than survivors 23.9± 3.2, 19.6± 4.2, P value: 0.0001. The percentage of 
mortality among cases that needed mechanical ventilation was higher 
(nine out of 16, 56.3%) compared with mortality cases that did not 
need mechanical ventilation (one out of 24, 4.2% with P value: 0.0001).
Conclusion ARF may exert an independent adverse eff  ect on outcome 
in septic and septic shock patients. It is also a risk factor for mortality. 
Tc-99m DMSA scanning is useful for detecting renal dysfunction and 
help to predict the outcome and prognosis.
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Introduction Acute kidney injury (AKI) complicates over 50% of ICU 
admissions. Episodes of AKI are a major risk factor for development 
or progression of chronic kidney disease (CKD); however, methods of 
estimated glomerular fi  ltration rate (eGFR) may be poorly calibrated 
to survivors of critical illness who may have reduced muscle mass. We 
hypothesized that eGFR may underestimate rates and severity of CKD 
in ICU survivors.
Methods A retrospective observational study of renal function in all 
patients admitted to a London teaching hospital ICU for ≥5 days and 
surviving to hospital discharge in 2011. We excluded cases with current 
or new diagnosis of end-stage renal disease or renal transplant. We 
assessed AKI in ICU by KDIGO 1 criteria and hospital discharge eGFR by 
the CKD-EPI equation. For comparison we assumed a normal GFR in a 
healthy individual as 120 ml/minute/1.73 m2 at age 20 decreasing by 
0.8 per year over age 20.
Results We identifi  ed 282 patients, 180 of whom had AKI. Median age 
was 50 and 68% were male. Median hospital discharge serum creatinine 
was 57 μmol/l (range 16 to 654), median eGFR was signifi  cantly higher 
than predicted normal GFR for age at 115 versus predicted 95 (P <0.001, 
median diff  erence 16). In patients who had not had AKI discharge the 
eGFR was 119 versus normal predicted 98 (P <0.001, median diff  erence 
19), suggesting that eGFR could be overestimating true GFR in our 
population by at least a factor of 1.23 (Figure 1). Applying this correction 
factor to eGFRs of patients who had recovered from AKI resulted in 44% 
more diagnoses of CKD (eGFR <60) at hospital discharge (36 vs. 25).
Conclusion eGFR may overestimate renal function in survivors of critical 
illness confounding identifi  cation of CKD in this at-risk population. 
Prospective studies with measurement of actual GFR are required to 
assess the burden of CKD in survivors of critical illness.
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Introduction Intra-abdominal hypertension (IAH) is an independent 
predictor of renal impairment and mortality [1]. Organ dysfunction 
caused by the pressure eff  ect of IAH is well understood, but how this 
is modifi  ed in the presence of bowel obstruction is unclear. The aim 
of this study was to determine how diff  erent IAH models cause renal 
dysfunction in a pig model.
Methods Twenty-four pigs were divided into three groups; a control 
group (n = 5), a pneumoperitoneum (Pn) (n = 10), and an intestinal 
occlusion (Oc) model (n  =  10). IAP was maintained for 3  hours at 
20 mmHg during which time creatinine, urea, urine output, potassium, 
and glomerular fi   ltration pressure (GFP) were measured. Statistical 
analysis was performed using repeated-measures ANOVA.
Results  Over the fi   rst 3  hours there was a statistically signifi  cant 
diff   erence between the control group and both IAH models for 
Figure 1 (abstract P418). eGFR at hospital discharge versus expected 
normal GFR for age in 280 ICU survivors.
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(P <0.001), and urine output (P = 0.003). Over the full 5-hour period there 
was a statistically signifi  cant diff  erence in the potassium measurement 
between the Pn and the Oc model (P = 0.01). The other parameters did 
not show a signifi  cant diff  erence: urea (P = 0.171), creatinine (P = 0.074), 
GFP (P = 0.141), and urine output (P = 0.242).
Conclusion As expected the IAH models resulted in signifi  cantly worse 
renal function after 3 hours. This early renal dysfunction may be as a 
result of an early infl  ammatory process that has been associated with 
the pathophysiology of acute kidney injury. Potassium was signifi  cantly 
elevated in the Pn group as compared with the Oc group. Early changes 
in potassium levels with IAH may be a marker of early renal dysfunction 
and the usefulness of other renal biomarkers, such as NGAL, prompts 
further investigation.
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Introduction Oliguria is common in septic patients and is frequently 
therapeutically addressed with loop diuretics; that is, furosemide. 
Diuretic treatment in shock and hypovolemia is not rational, but can 
be tried in oliguric patients with normovolemia or hypervolemia and 
without hypotension. In such patients it still does not always increase 
dieresis and can also be harmful. The resistive index is a measure of 
pulsatile blood fl  ow that refl  ects the resistance to blood fl  ow caused by 
the microvascular bed distal to the site of measurement. It can refl  ect 
functional status of the tissue distal to the point of measurement. We 
investigated whether measuring the renal resistive index (RI) could 
be helpful in determining which patients will respond to furosemide 
treatment.
Methods We included medical ICU patients with sepsis and oliguria (urine 
output <1 ml/kg/hour) who were prescribed i.v. furose  mide. Patients with 
known chronic renal failure, hypovolemia (CVP  <10  mmHg) or severe 
hypotension (MAP <80 mmHg) were excluded. Resistive index (1 − (end 
diastolic velocity / maximum systolic velocity)×100) was measured 
in at least three segmental arteries of both kidneys, the average of all 
measurements was reported as the result. Repeated assessments were 
viewed as independent if separated by more than 24 hours. Furosemide 
was given intravenously in the dose of 40  mg after RI measurement. 
Positive response to furosemide was defi  ned as doubling of hourly dieresis 
or achieving urine output >1.5 ml/kg/hour after drug administration.
Results We included 47 patients with a total of 59 measurements. In 
28 cases patients had positive response to furosemide. Median RI in 
responders was 0.67 (range 0.55 to 0.78) and in nonresponders 0.79 
(range 0.58 to 0.81); P  =  0.027. Construction of receiver operating 
characteristic curve showed 83% sensitivity and 81% specifi  city for the 
cutoff   RI 0.73. No other measured patient characteristic was found to 
be predictive of response to diuretic treatment.
Conclusion Our results show that the RI could be used to guide diuretic 
treatment in nonhypovolemic, nonhypotensive septic patients. Further 
studies are needed to confi  rm those preliminary results.
P421
Urinary chitinase 3-like 1, a novel biomarker for acute kidney injury 
in adult cardiac intensive care patients: a pilot study
J De Loor1, E Hoste2, I Herck2, K Francois2, L De Crop2, C Clauwaert2, 
K Demeyere1, E Meyer1
1Faculteit diergeneeskunde, Merelbeke, Belgium; 2UZ Gent, Belgium
Critical Care 2013, 17(Suppl 2):P421 (doi: 10.1186/cc12359)
Introduction As a proof of concept, the potential added value of chitinase 
3-like 1 (CHI3L1) as a more early and specifi  c diagnostic parameter for 
acute kidney injury (AKI) was investigated in adult ICU patients that 
underwent elective cardiac surgery.
Methods A prospective single-center cohort study started in May 2012 
in an academic cardiac surgery ICU. Blood and urine were collected 
preoperatively (baseline), at ICU admission and at several time points 
until 48 hours after ICU admission. Patients of age <18 years were 
excluded, as well as patients with AKI based on the KDIGO sCr and urine 
output criteria, patients with chronic kidney disease stage 5 and/or 
with recent renal transplantation (≤3 months before cardiac surgery). 
AKI was defi  ned on KDIGO sCr criteria only. Baseline sCr was assessed as 
the sCr concentration measured before start of cardiac surgery. Urinary 
CHI3L1 was normalized to urinary creatinine. For both serum and urine 
CHI3L1, we measured changes from baseline. Data are expressed as 
median (interquartile range), and number (%).
Results Data for 17 patients (nine males, eight females) were generated 
for interim analysis. Five patients (29.4%), of which four were females, 
developed AKI KDIGO class 1. AKI patients were older compared 
with non-AKI patients (82.0 years (77.5 to 83.5) vs. 66.5 (60.3 to 75.8); 
P = 0.002). The baseline sCr did not diff  er signifi  cantly between the 
AKI (1.12 mg/dl (0.80 to 1.15)) and non-AKI (0.90 mg/dl (0.86 to 1.01); 
P = 0.383) group. Baseline serum CHI3L1 was highly variable in both 
AKI and non-AKI patients. Moreover, no trend towards a higher serum 
CHI3L1 level in AKI versus non-AKI patients was observed either at 
baseline or during the study follow-up. In contrast, the increase in the 
urinary CHI3L1 to urinary creatinine ratio from baseline was higher in 
the AKI versus non-AKI group at time points 4 hours and 6 hours after 
admission to the ICU (2.00 ng/mg Cr (1.38 to 3.03) vs. 0.26 (0.05 to 0.88); 
P = 0.002, resp. 2.47 (1.09 to 7.26) vs. 0.23 (–0.18 to 0.74); P = 0.006) 
and, more importantly, occurred before the diagnosis of AKI by sCr 
(>16 hours after ICU admission).
Conclusion This interim analysis of an ongoing pilot study, with 300 
ICU patients in three cohorts (general ICU, pediatric and adult cardiac 
surgery ICU), shows promising results for urinary CHI3L1 (ng/mg Cr) as 
an early diagnostic biomarker for AKI in adult ICU patients that undergo 
elective cardiac surgery.
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Use, type and duration of cardiopulmonary bypass are related to 
acute kidney injury occurrence and urinary NGAL concentrations
T García Rodríguez San Miguel
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Introduction To analyze whether variables related to cardiopulmonary 
bypass (CPB) infl  uence acute kidney injury (AKI) occurrence and urinary 
neutrophil gelatinase-associated lipocalin (uNGAL) in cardiac surgery 
patients.
Methods A total of 274 adult cardiac surgery patients were consecu-
tively included from February to December 2011. Exclusion criteria 
were absence of diuresis due to end-stage renal disease or chronic 
renal failure and cardiac catheterism with i.v. contrast in the week 
before surgery. CPB, when performed, was used as standard CPB 
(SCPB) or MiniCPB. We obtained four serial blood and urine samples, 
immediately before (PRE) and after (POST) surgery, and 1  day (1d) 
and 2 days (2d) after surgery. uNGAL was measured by Architect 6200 
(Abbott Diagnostics). AKIN criteria were used to diagnose AKI. The 
study was approved by the local ethics committee and all patients gave 
informed consent.
Results One hundred and eighty-one patients (66.1%) were men; mean 
age was 68.2 ± 12.2 years. ICU and hospital stays were 6.7 ± 8.1 and 
15.7 ± 13.9 days, respectively. Twenty-eight-day mortality was 2.9%. 
Eighty-six patients (31.4%) were diagnosed with AKI within 48 hours 
after surgery. In total, 219 patients required CPB (195 SCPB, 24 MiniCPB) 
and 55 did not (no-CPB). Seven no-CPB patients (12.7%) developed AKI 
and their median uNGAL POST was 330 (42.6 to 489.9) μg/l compared 
with 13.6 (6.9 to 38.3) μg/l in the 48 patients without AKI (P <0.0001). 
Of the 195 patients undergoing SCPB, 76 (38.9%) developed AKI and 
119 did not; POST uNGAL was 204 (34.8 to 575.7) μg/l and 44.5 (13.2 to 
175.8) μg/l (P <0.0001), respectively. In the 24 patients under MiniCPB, 
POST uNGAL was 113 (58.8 to 211.8) μg/l in those (three patients, 12.5%) 
developing AKI and 19.1 (9.2 to 41.8) μg/l in those without AKI (P = 0.01). 
Aortic clamp time (r = 0.31, P <0.0001) and cardiopulmonary bypass 
time (r = 0.30, P <0.0001) correlated with POST uNGAL concentrations. 
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and signifi  cantly lower (P <0.0001) than in SCPB patients.
Conclusion The incidence of AKI was higher in patients undergoing 
SCPB. Aortic clamp and cardiopulmonary bypass time correlated with 
the POST uNGAL concentration. The higher values found in patients 
without AKI undergoing SCPB suggest that a subclinical AKI, only 
detectable by uNGAL, could exist in this group.
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Symmetrical dimethylarginine is a more sensitive biomarker of 
renal dysfunction than creatinine
JJ Dixon1, K Lane1, RN Dalton2, IA MacPhee1, BJ Philips1
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Introduction Current defi  nitions of acute kidney injury (AKI) are based 
upon changes in serum creatinine (SCr) concentration and urine 
output: both have limitations in patients with AKI. Diagnosis may be 
delayed if using these criteria alone. We have previously validated a 
method of measuring the glomerular fi  ltration rate (GFR) intended for 
use in patients with AKI (a continuous infusion of very low dose iohexol; 
CIVLDI). In this study we compare the performance of symmetrical 
dimethylarginine (SDMA) against SCr and CIVILDI. SDMA is the 
structural isomer of the endogenous nitric oxide inhibitor asymmetrical 
dimethylarginine. SDMA increases in parallel with SCr. Despite this, 
no formula exists to estimate GFR from SDMA concentration. Tubular 
secretion of SCr may be as high as 40%. SDMA may be a more sensitive 
biomarker of renal dysfunction than SCr; however, the tubular 
reabsorption of SDMA is unknown. The aims were to compare the 
performance of SDMA against SCr and accurately measured GFR, and 
to derive a formula to estimate GFR from SDMA concentration.
Methods Seventeen volunteers had GFR measured twice via measuring 
the clearance of a 5 ml i.v. bolus of iohexol, or CIVLDI. Serum and urine 
iohexol, Cr and SDMA were measured by high-performance liquid 
chromatography/tandem mass spectrometry (HPLC-ms/ms) at 10 time 
points. Fractional excretion of SDMA and SCr were calculated using 
iohexol as the denominator. SDMA was plotted against measured GFR, 
and estimated GFR equations were derived from linear, quadratic and 
third-order polynomial plots.
Results Mean GFR measured by single injection was 78.7 ± 28.5 ml/
minute/1.73 m2, and 78.9 ± 28.6 ml/minute/1.73 m2 when measured 
by CIVLDI (P = 0.82). Mean SDMA concentration was similar on both 
occasions (641 ± 38 vs. 623 ± 22 nmol/l; P = 0.68). Tubular reabsorption 
of SDMA was lower in subjects with GFR <60  ml/minute/1.73  m2 
(12 ± 8% vs. 18 ± 8% in subjects with GFR >60 ml/minute/1.73 m2; 
P = 0.0002), and tubular secretion of SCR was higher in subjects with 
GFR <60 ml/minute/1.73 m2 (29% vs. 23%; P <0.0001). The third-order 
polynomial equation (r = 0.93) estimated GFR better than quadratic 
(r = 0.92) and linear (r = 0.87) equations. Bland–Altman comparison 
revealed no bias when the third-order equation was used (precision: 
±20 ml/minute/1.73 m2).
Conclusion SDMA appears to be an accurate and precise estimate of 
GFR and a more sensitive biomarker of renal dysfunction than SCr. We 
predict SDMA will perform better than SCr as a biomarker of AKI. This 
forms the basis of a future study.
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and transpulmonary thermodilution-derived parameters within 
48 hours after admission
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Introduction Outcome of ICU patients is predicted by multifactorial 
scores such as APACHE II and SOFA. Furthermore, markers of single 
organ failure such as the extravascular lung water index (EVLWI) and 
several biomarkers of acute kidney injury (AKI) have been associated 
with mortality. Regarding a delayed increase in creatinine, other 
biomarkers of AKI including neutrophil gelatinase-associated lipocalin 
(NGAL) have been suggested. It was the aim of our study to compare 
the predictive capabilities of NGAL and transpulmonary thermodilution 
(TPTD)-derived parameters within 48 hours after ICU admission.
Methods Urinary NGAL, serum creatinine and BUN as well as TPTD-
derived parameters were measured 0 hours, 12 hours, 24 hours and 
48  hours after ICU admission. Primary endpoint: prediction of ICU 
mortality. Secondary endpoint: requirement of renal replacement 
therapy (RRT). Statistics: ROC-AUC. IBM SPSS 20.
Results There were 91 patients (34 female, 57 male), 65 ± 14 years, 
APACHE II score 20.6 ± 8.3, SOFA score 9.3 ± 4.2. Etiology: 10 ARDS, 
36 sepsis, 22 cirrhosis, six pancreatitis, eight cardiogenic shock, two 
CNS-aff  ections, seven various. Mortality was best predicted by SOFA 
(ROC-AUC: 0.747; P  <0.001) and APACHE II (AUC: 0.705; P  <0.001). 
Among admission parameters of renal function only NGAL signifi  cantly 
predicted mortality (AUC: 0.647; P  =  0.023), whereas creatinine 
(P = 0.290) and BUN (P = 0.067) were not predictive. ROC-AUCs for 
NGAL further increased after 12 hours (0.659), 24 hours (0.691; P = 0.01) 
and 48 hours (0.728; P = 0.004). NGAL on admission also predicted 
requirement of RRT during the ICU stay (AUC: 0.678; P = 0.015), which 
was also predicted by creatinine (AUC 0.688; P  =  0.010) and BUN 
(AUC: 0.649; P = 0.043). Among baseline TPTD parameters, only the 
pulmonary vascular permeability index (PVPI) signifi  cantly predicted 
mortality (AUC: 0.700; P = 0.007). The EVLWI (AUC 0.628; P = 0.083) 
slightly failed signifi  cance. Cardiac index, global end-diastolic volume 
index and heart rate were not predictive. Furthermore, PVPI was the 
only TPTD-derived parameter to predict requirement of RRT (AUC: 
0.693; P = 0.009).
Conclusion Urinary NGAL on admission signifi  cantly predicts mortality, 
whereas creatinine and BUN were not predictive. The predictive 
capabilities of NGAL further increased after 12 hours, 24 hours and 
48 hours, with the ROC-AUC of NGAL 48 hours exceeding the AUC of the 
APACHE II score. NGAL on admission also predicts requirement of RRT. 
Among TPTD-derived parameters, PVPI on admission is signifi  cantly 
associated with mortality and requirement of RRT.
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Assessment of neutrophil gelatinase-associated lipocalin as a 
biomarker of acute kidney injury in acute heart failure patients
H Michalopoulou, H Michalopoulou, P Stamatis, J Xenogiannis, D Stamatis
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Introduction  Growing evidence hints that bidirectional interaction 
between heart failure and kidney disease and renal insuffi   ciency 
is a strong predictor of mortality as well as causally linked to the 
progression of heart failure. Neutrophil gelatinase-associated lipocalin 
(NGAL) is an early predictor of acute kidney injury (AKI). We evaluated 
the impact of NGAL on morbidity and mortality in patients with acute 
heart failure.
Methods Seventy-six patients presenting with symptoms consistent 
with acute heart failure (median age 72 years, 56% male) were enrolled. 
Plasma NGAL levels were measured by an ELISA at admission and 
compared with the glomerular fi  ltration rate (eGFR) and B-natriuretic 
peptide (BNP) levels. The primary outcome was AKI development 
defi  ned by RIFLE criteria (fall in GFR >25% or creatinine rise ≥50% 
from baseline, or a fall in urine output <0.5 ml/kg/hour) and secondary 
outcomes were duration of hospital stay and in-hospital mortality.
Results AKI developed in 11 patients (14.4%). The subgroup that during 
hospitalization developed renal dysfunction had increased NGAL 
values with respect to patients with preserved renal function (146 ± 42 
vs. 84 ± 24 ng/ml, P <0.05). NGAL signifi  cantly associated with admission 
eGFR (r = 0.72, P <0.01) and BNP levels (r = 0.80, P <0.01). For prediction 
of AKI, NGAL >140 ng/ml has been related to renal insuffi   ciency with 
sensitivity of 83% and specifi  city of 74% with area under the receiver 
operator curve of 0.70 (0.58 to 0.82). In the follow-up setting, NGAL was 
associated with recurrent hospital admission for heart failure (HR: 3.1, 
CI: 1.5 to 6.2) and cardiac death (HR: 2.2, CI: 1.8 to 4.5).
Conclusion NGAL is emerging as a promising biomarker of AKI in the 
setting of acute heart failure and elevated NGAL levels indicate a poor 
prognosis in this population regarding morbidity and mortality.
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Neutrophil gelatinase-associated lipocalin predicts postoperative 
fl  uid overload after cardiac surgery
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Introduction  Neutrophil gelatinase-associated lipocalin (NGAL), 
measured early after cardiac surgery, has been demonstrated to predict 
postoperative acute kidney injury (AKI). Fluid overload potentially 
masks a subsequent acute renal function loss through dilution of 
serum creatinine and maintenance of urine output just above AKI-
defi  ning criteria.
Methods  We investigated the early postoperative value of NGAL 
versus that of simultaneously measured serum creatinine to 
predict subsequent fl   uid overload. We studied 100 adult cardiac 
surgery patients in the control arm of a RCT (NCT00672334). Severe 
postoperative fl   uid overload was defi   ned as positive fl  uid  balance 
>10% of preoperative body weight within 48 hours after surgery.
Results  Severe postoperative fl   uid overload was present in 5% of 
patients with a mean positive fl  uid balance of 15.8  ±  9.5  l. At ICU 
admission, urine NGAL predicted severe fl  uid overload (AUC-ROC 0.82 
(95% CI = 0.70 to 0.94)) (Figure 1) and mortality (AUC 0.88 (0.78 to 0.97)). 
Serum creatinine measured at the same time did not predict severe 
fl  uid overload (AUC 0.52 (0.26 to 0.79)) or mortality (AUC 0.61 (0.16 to 
0.99)).
Conclusion  Early NGAL-guided adjustments to fl  uid  management 
may reduce organ edema after cardiac surgery. Findings should be 
validated in larger cohorts.
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Survivors of acute kidney injury requiring renal replacement 
therapy rarely receive follow-up: identifi  cation of an unmet need
CJ Kirwan, R Taylor, JR Prowle
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Introduction Acute kidney injury (AKI) occurs in more than 50% of 
ICU admissions, requiring renal replacement therapy (RRT) in around 
10% of cases. There is now increasing evidence that AKI is a risk factor 
for the development and progression of chronic kidney disease 
(CKD); however, when AKI occurs as a complication of critical illness 
appropriate follow-up may be neglected. Accordingly, we reviewed the 
follow-up of renal function in all patients who received RRT on our ICU 
and survived to hospital discharge.
Methods A retrospective audit of patients who received RRT in a central 
London adult critical care unit during 2011.
Results Of 921 patients admitted, 203 received RRT with 109 surviving 
to hospital discharge. We excluded 52 patients who had end-stage 
renal disease, renal transplant or known glomerular disease. Of the 
remaining 57 AKI patients, median age was 60 (range: 18 to 77) and 
37 (65%) were male. Median discharge creatinine was 74.5  μmol/l 
(27 to 662). Forty-two (74%) were off  ered follow-up, but in only six 
cases (11%) was this to nephrology services. Twenty-eight attended 
follow-up (fi  ve to nephrology) at a median time of 6 weeks; however, 
creatinine was measured at in only 14 and in six of these it had risen (by 
median 16.5 μmol/l). In addition, 14 patients had creatinine measured 
3 to 6 months post discharge and in eight it had risen (by median 
31.5 μmol/l).
Conclusion  Follow-up of patients who received RRT for AKI in the 
ICU was poor and they were rarely referred to nephrologists. Where 
renal function was measured after discharge, there was evidence of 
progressive renal dysfunction; however, renal function was often not 
assessed. We propose an algorithm for clinicians to guide follow-up. 
See Figure 1.
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Introduction AKI is a common occurrence in sick hospitalized patients, 
in particular those admitted to intensive care. Published data suggest 
that 4 to 5% of all critically ill patients develop severe AKI and require 
initiation of renal replacement therapy (RRT) [1,2]. Such patients have 
high mortality rates often exceeding 60% [2]. We aimed to review 
the outcomes of patients admitted to the ICU and required renal 
replacement therapy for AKI. We examined whether aetiology of AKI, 
comorbidity burden, hospital length of stay and treatment in ICU had 
any signifi  cant association with survival in the study cohort.
Methods During 2009, 56 patients were identifi  ed to have received RRT 
with AKI who were admitted to the ICU at the Royal Wolverhampton 
Hospitals NHS Trust. Computerised and paper-based case records were 
examined for these patients to collect the data. AKIN classifi  cation was 
used to classify the severity of AKI.
Figure 1 (abstract P426). NGAL at ICU admission predicts fl  uid overload 
of >10% of body weight.
Figure 1 (abstract P427). A suggested follow-up pathway for AKI survivors.
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and 27 females. Thirty-one (55.4%) patients had sepsis and 20 (35.7%) 
patients had ATN as the main cause of AKI. Thirty-two patients (57%) 
had three organ failures at the time of commencement of RRT. Forty-
six patients (82.1%) received haemofi  ltration only. Thirty-two (57%) 
patients died, with more than 80% of these occurring in the ITU. There 
was no signifi  cant diff  erence in survival when compared with duration 
of haemofi  ltration, length of stay, number of organs failed and number 
of comorbidities. However, signifi  cantly more patients that died had 
AKI due to sepsis (P = 0.003) or if they received mechanical ventilation 
(P = 0.48) or inotropes (0.04). Of the 27 patients who survived until 
discharge from hospital, 18 (66.7%) had normal renal function, eight 
(29.6%) had AKIN stage I and only one patient required maintenance 
haemodialysis.
Conclusion  Individuals who develop dialysis-dependent AKI in the 
ICU setting in general terms either die or recover. Sepsis is the most 
common association with death. The need for mechanical ventilation 
and inotropic therapy are both associated with increased incidence of 
death.
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Introduction This study was to evaluate the effi   ciency of the early start 
of intermittent substitutive renal therapy in patients with polytrauma 
complicated by multiple organ failure syndrome.
Methods  Forty-two patients with polytrauma complicated by 
multiple organ failure syndrome were included in the study. The age 
of the patients was from 20 to 60 years (38.3 ± 1.6 years average). All 
patients were divided into two equal groups. In the control group 
(CG) the criteria for the start of the substitutive renal therapy were: 
hyperkalemia ≥6  mmol/l, plasma creatinine ≥280  μmol/l, diuresis 
≤20 ml/hour. In the investigation group (IG) there were subtests to 
carry out the substitutive renal therapy, allowing one to start it in 
the earlier period of the multiple organ failure progression. These are 
increase of Na+ >150 mmol/l, osmolarity >300 mOsm/l, elevation of 
the plasma toxicity according to the average molecule concentration 
≥1.0, diuresis decrease ≤40 ml/hour. These were examined: lethality, 
quantity of the substitutive renal therapy procedures, mechanical lung 
ventilation duration (MLV), intensive care and hospital duration. The 
substitutive renal therapy was carried out by AK-200-Ultra apparatus 
(Gambro, Sweden). The statistical analysis was realized using Statistica 
6.1 and the Mann–Whitney U test.
Results  The average quantity of the substitutive renal therapy 
procedures in the CG was 13.4 ± 0.7, in the IG it was 8 ± 0.6 (P <0.05). 
The recuperation of the renal excretory functions was on 19 ± 1 day in 
12 patients of the CG, and on 11 ± 1.3 day in the IG, from the moment 
of substitutive renal therapy start (P <0.05). Lethality in the CG was 
43% (nine patients), and in the IG it was 29% (six patients, P <0.05). The 
duration of the MLV in the CG and IG was 21 ± 1.2 days and 16 ± 1.2, 
respectively (P <0.05). In the IG the duration of the ICU was lower by 
23%, hospitality duration was lower by 17% (P <0.05).
Conclusion The effi   ciency of the substitutive renal therapy depends 
directly on the hydroelectrolytic and metabolic changes and toxicosis 
degrees in the polytrauma complicated by multiple organ failure 
syndrome. The early start of the dialysis methods treatment allows 
one to achieve the earlier recuperation of the renal functions and to 
decrease the lethality level by 14%.
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be the solution for type-1 hepatorenal syndrome?
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Introduction The aim of this retrospective study was to determine 
whether the molecular adsorbent recirculation system (MARS) can 
improve renal function in HSR1 patients.
Methods Thirty-two patients with chronic liver disease and HRS1 were 
treated by MARS sessions that were performed every other day. The 
endpoint was renal function improvement by 28 days after diagnosis 
of HRS1 that was defi  ned as a serum creatinine level <133  μmol/l. 
Partial renal recovery was defi  ned as a 10% decrease in baseline serum 
creatinine level.
Results The mean number of MARS sessions required by each patient 
was 3.5  ±  1.5. The median time between admission and the start 
of MARS therapy was 3 (0 to 15) days. Of the total patients, 13 (40%) 
had improved renal function. Among these, nine (28%) had complete 
renal recovery. Among the patients that survived, only 40% (6/15) had 
improved renal function. When MARS was started, 53% of patients had 
failed renal failure according to RIFLE criteria. Seven patients received 
a liver transplant after diagnosis of HRS. Of these, four had complete 
or partial recovery after transplantation (57%) versus nine of the 25 
patients who did not undergo liver transplantation (36%), P = NS. The 
28-day survival rate was 47%.
Conclusion MARS therapy improved renal function in only very few 
patients with HRS1. Even if liver transplantation is the best option, MARS 
could be used as a bridge until transplantation. Some authors argue 
that prolonged duration of dialysis (>1 month) before transplantation 
may result in chronic renal failure probably because there are two 
etiologies of AKI in end-stage liver disease: acute tubular necrosis (ATN) 
and real functional renal failure. ATN before liver transplantation has 
been identifi  ed as a risk factor for patients’ mortality and chronic renal 
failure at 1 and 5 years post liver transplantation. Further prospective 
controlled studies including large number of patients are required.
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Introduction The aim of this study was to investigate the eff  ects of 
intermittent venovenous high-volume hemofi   ltration (IHVHF) on 
extravascular lung water, respiratory function and cytokine removal 
in patients with acute respiratory distress syndrome (ARDS) associated 
with postoperative multiple organ dysfunction syndrome in severe 
abdominal infection patients.
Methods  Thirty patients with severe abdominal infection and 
ARDS were randomized into the IHVHF group (n = 15) and control 
group (n = 15). All patients were mechanically ventilated. The IHVHF 
technique with a rate of 100 to 120 ml/kg/hour during 6 to 8 hours was 
used. The PiCCOplus system was used to monitor cardiac output (CO), 
extravascular lung water index (EVLWI) and intrathoracic blood volume 
index (ITBVI). Arterial partial pressure of oxygen (PaO2), arterial partial 
pressure of carbon dioxide (PaCO2), oxygenation index (PaO2/FiO2) 
and dynamic lung compliance (Cdyn), oxygen delivery and oxygen 
consumption were measured. Serum concentrations of TNFα, IL-6, IL-8 
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before and after IHVHF therapy were detected.
Results All indexes in the control group did not show any signifi  cant 
improvement before and after treatment (P  <0.05). There was a 
signifi  cant decrease of serum concentrations of TNFα, IL-6, IL-8 and 
lactate, increase of CO and decrease of EVLWI 24 hours after IHVHF 
(P <0.05). The indexes of oxygen delivery, consumption, PaO2, and Cdyn 
improved signifi  cantly, PaO2/FiO2 increased markedly compared with 
those before IHVHF and the control group. Signifi  cant diff  erences were 
detected in all of the hemodynamics and oxygen indexes (P <0.05).
Conclusion  IHVHF presents with a signifi  cant  benefi  cial  eff  ect  on 
respiratory function in patients with ARDS as a result of removal 
of cytokines, decrease in EVLWI, improvement of hemodynamic 
parameters, and correction of disturbances in oxygen balance. IHVHF 
adjuvant treatment for ARDS reduces pulmonary edema, improves 
PaO2/FiO2 and Cdyn and mechanical ventilation parameters. IHVHF 
may be a promising treatment for ARDS in postoperative multiple 
organ dysfunction syndrome in severe abdominal infection patients.
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Introduction Rhabdomyolysis-associated acute kidney injury can be 
treated with various modes of renal replacement therapy (RRT) [1,2]. 
We have used continuous venoveno hemodialysis (CVVHD) with 
middle molecule fi   lter and low extracorporeal blood fl   ow (100 to 
180 ml/minute) to avoid albumin loss and hemodynamic instability.
Methods We treated nine patients suff  ering from rhabdomyolysis and 
acute kidney injury with various causes. We used a CVVHD mode with 
low (100 to 180 ml/minute) blood fl  ow and a middle molecule fi  lter 
(Ultrafl  ux EMiC2; 1.8 m2 surface area, polysulfone membrane, cutoff   at 
40 kDa, blood fi  lling volume 130 ml, blood fl  ow range 100 to 350 ml/
minute, maximum dialysate fl  ow 1,000  ml/minute). Myoglobin and 
albumin concentrations were measured from prefi  lter and postfi  lter 
samples and dialyzer clearances were calculated (CLdial  =  blood 
fl  ow×Cpre – Cpost/Cpre + UF×Cpre/Cpost). Measurements were taken 
at 0, 15 minutes, 30 minutes, 4 hours, 12 hours, 24 hours, 36 hours and 
48 hours from the start of the CRRT or until CRRT was no longer needed.
Results The baseline and prefi  lter plasma albumin concentrations varied 
from 8 to 29 g/l. Postfi  lter and post-treatment albumin concentrations 
remained comparable. Prefi  lter concentrations of myoglobin (17.8 kDa) 
varied from 96,109 to 747 μg/l and the dialyzer clearance of myoglobin 
from 50.6 to 0 ml/minute. The mean dialyzer clearance was 23.1 ml/
minute and the median clearance 22.2 ml/minute. Maximal changes 
between corresponding prefi  lter and postfi  lter samples were: absolute 
concentration change 27,091 μg/l, percentage 34%, dialyzer clearance 
50.6  ml/minute. Clearances were achieved with low extracorporeal 
blood fl  ow between 100 and 180 ml/minute, most commonly 120 ml/
minute. Ultrafi  ltration (UF) was used only at fi  ve of the 56 time points 
calculated, because of hemodynamic instability. All patients required 
either vasopressor or vasopressor and inotrope support. The highest 
dialyzer clearance of myoglobin (50.6 ml/minute) was measured at the 
prefi  lter myoglobin of 29,266 μg/l, blood fl  ow 180 ml/ml and no UF.
Conclusion  In a rhabdomyolysis-associated kidney injury a middle 
molecule fi  lter and a low blood fl  ow CVVHD off  er a safe and eff  ective 
treatment choice for patients requiring vasopressor or vasopressor and 
inotrope for hemodynamic support.
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Introduction It has been suggested that fl  uid balance is a biomarker 
in critically ill patients [1]. There is a paucity of randomized trials 
examining the eff  ect of daily fl  uid balance on outcomes in patients 
on continuous renal replacement therapy (CRRT). The RENAL trial did 
not fi  nd mortality diff  erence with higher CRRT dose [2], but did not 
investigate the eff  ect of daily fl  uid balance on patient outcomes. A post 
hoc analysis suggested survival benefi  t in patients with negative fl  uid 
balance [3]. In this study, we hypothesize that daily fl  uid balance is an 
independent predictor of mortality in critically ill patients.
Methods We conducted a retrospective cohort study in eight ICUs of 
a tertiary academic center. We constructed a robust clustered linear 
regression model of daily fl  uid balance and all-cause hospital mortality 
among 595 critically ill patients receiving CRRT. We adjusted the model 
for the Charlson comorbidity score, the daily SOFA scores in the fi  rst 
week after initiation of CRRT as well the type of ICU.
Results  After adjusting for the type of ICU and the daily severity 
of illness, patients who died had on average 779  ml higher daily 
fl  uid balance compared with patients who survived (P <0.001, 95% 
CI = 385 to 1,173 ml, Figure 1). Severity of illness predicted daily fl  uid 
accumulation; each additional point of the SOFA score predicted an 
additional 57 ml of extra daily fl  uid (P = 0.002).
Conclusion Among critically ill patients who are receiving CRRT, daily 
fl   uid balance is an independent predictor of mortality, even after 
adjusting for the daily severity of illness and comorbidities.
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Introduction Fluid overload is associated with mortality in critically 
ill patients with acute kidney injury (AKI) [1-3]. We explored this 
relationship in patients with AKI who received renal replacement 
therapy (RRT) in the ICU to investigate the relationship between fl  uid 
Figure 1 (abstract P433). Daily fl  uid balance and 95% CIs among 
survivors and nonsurvivors.
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renal function.
Methods We conducted a retrospective cohort study among patients 
aged ≥16 years who had RRT initiated and continued for ≥2 days in a 
level 2 or 3 ICU at two academic centres, and had fl  uid balance data 
available. Patients with end-stage kidney disease, within 1  year of 
a renal transplant or who had RRT initiated to treat a toxic ingestion 
were excluded. We used multivariable logistic regression to determine 
the relationship between mean daily fl   uid balance over the fi  rst 
7 days following RRT initiation and the outcomes of mortality and RRT 
dependence in survivors.
Results A total of 522 patients were included (319 male, mean age 
64 years); 264 (50.6%) died in hospital. Survivors and those who died 
were similar with respect to age, weight and incidence of heart failure, 
liver cirrhosis and primary renal diagnoses. Independent risk factors for 
hospital mortality were higher Sequential Organ Failure Assessment 
score at RRT initiation (odds ratio (OR)  =  1.18, 95% confi  dence 
interval = 1.11 to 1.25), higher Charlson comorbidity index (OR = 1.22, 
1.09 to 1.37), lower baseline creatinine (OR  =  0.984 per 10  μmol/l, 
0.970 to 0.998), lower minimum mean arterial pressure (MAP) on day 1 
(OR = 0.81 per 10 mmHg, 0.66 to 0.95) and more positive fl  uid balance 
for the fi  rst 7 days (OR 1.03 per 100 ml, 1.02 to 1.05). Of 172 hospital 
survivors, 57 (33.1%) were RRT dependent at discharge. Although 
univariable analysis suggested lower SOFA scores and higher baseline 
serum creatinine levels in those who remained RRT dependent, 
no factor was independently associated with RRT dependence at 
discharge in a multivariate model.
Conclusion In this cohort of patients with AKI requiring RRT, a more 
positive fl  uid balance over 1 week and lower initial minimum MAP 
were associated with mortality. Among survivors, a less positive fl  uid 
balance was not associated with increased risk of RRT dependence at 
discharge, suggesting that conservative fl  uid management does not 
signifi  cantly attenuate renal recovery.
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Introduction Esomeprazole, a proton pump inhibitor, and ranitidine, a 
histamine-2 receptor antagonist are frequently used in intensive care 
patients requiring stress ulcer prophylaxis. Continuous venovenous 
hemodiafi   ltration (CVVHDF) is an important extracorporeal renal 
replacement therapy in critically ill patients suff  ering from multiple 
organ failure. This study investigates the pharmacokinetics and 
pharmacodynamics of esomeprazole and ranitidine in anuric critically 
ill patients undergoing CVVHDF.
Methods  Esomeprazole 40  mg was administered intravenously 
once daily in nine intensive care patients and ranitidine 50 mg was 
administered intravenously three times daily in nine intensive care 
patients with acute renal failure undergoing CVVHDF who required 
stress ulcer prophylaxis. The concentration of esomeprazole and 
ranitidine in serum and ultradiafi   ltrate was determined by high-
performance liquid chromatography. The intragastric pH was obtained 
via intragastric pH-metry.
Results  The mean peak prefi  lter concentration, AUC0–24, volume of 
distribution, half-life, total clearance and hemodiafi  ltration clearance of 
esomeprazole were 6.9 μmol/l, 30.6 μmol.hour/l, 53.3 l, 2.0 hours, 1.4 l/
hour and 0.2 l/hour, respectively. In the ranitidine group the mean peak 
prefi  lter concentration, AUC0–8, volume of distribution, half-life, total 
clearance and hemodiafi  ltration clearance were 5.5 μmol/l, 12.0 μmol.
hour/l, 91.4 l, 14.4 hours, 5.8 l and 1.3 l, respectively. Median time of 
intragastric pH >5 and median intragastric pH decreased signifi  cantly 
in the ranitidine group over time (P <0.05) but not in the esomeprazole 
group.
Conclusion Although pharmacokinetics of esomeprazole and raniti-
dine are only little infl   uenced by CVVHDF, we found a signifi  cant 
decrease of intragastric pH in patients treated with ranitidine. Esome-
prazole may be superior for long-term stress ulcer prophylaxis in 
critically ill patients undergoing CVVHDF.
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Introduction Acute kidney injury (AKI) is a common complication of 
critical illness and sepsis [1]. Dosing of antibacterial agents in septic 
patients is complicated by altered pharmacokinetics due to both 
acute renal failure and critical illness [2]. Current dosing regimens for 
administration of gentamicin and vancomycin to septic patients with 
AKI on continuous venovenous hemofi  ltration (CVVH) at a fi  ltration rate 
of 45 ml/kg/hour are missing.
Methods Seventeen septic patients with AKI treated with vancomycin 
and seven patients with gentamicin on CVVH were included. In the 
vancomycin group, patients received the fi  rst dose of 1.0 g intravenously 
followed by 1.0 g/12 hours if not adjusted. In the gentamicin group, 
patients received a loading dose of 240 mg followed by a maintenance 
dose every 24 hours. The vancomycin maintenance dose was optimized 
to achieve AUC0–24/MIC ≥400 (Cmin >10 mg/l), gentamicin target was 
Cmax/MIC of 8 to 10. Maintenance doses were adjusted according to 
drug level simulation using a pharmacokinetic programme.
Results The median vancomycin total clearance (Cltot) was 0.89 and 
0.55  ml/minute/kg on the fi  rst and second day of the study. CRRT 
clearance accounted for about 50 to 60% of vancomycin Cltot found 
in a population with normal renal function (0.97  ml/minute/kg). 
Vancomycin serum concentrations after the fi  rst dose were below the 
required target of 10 mg/l as early as 6 hours in 10 patients. AUC0–24/
MIC ≥400 ratio was achieved in 67% of patients on the fi  rst day. The 
median gentamicin Cltot was 0.68 and 0.79 ml/minute/kg on the fi  rst 
and second day of the study. CRRT clearance accounted for about 50% 
of gentamicin Cltot found in a population without renal impairment 
(0.73 ml/minute/kg). The target Cmax/MIC ratio was achieved in 78% of 
patients after the fi  rst dose.
Conclusion CVVH at a fi  ltration rate of 45 ml/kg/hour leads to high 
removal of both antibiotics. Due to rapid change in patient’s clinical 
status it was impossible to predict a fi   xed dosage regimen. We 
recommend administration of unreduced loading dose and: blood 
sampling as early as 6  hours after fi   rst vancomycin dose; blood 
sampling 30 to 60 minutes after gentamicin administration and before 
the next dose; and the maintenance dose should be based on drug-
level monitoring.
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Introduction  Regional citrate anticoagulation (RCA) is increasingly 
used in high bleeding risk patients undergoing CRRT. Regardless of 
anticoagulation protocol, hypophosphatemia occurs frequently in 
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status of a new RCA-CVVH protocol using an 18 mmol/l citrate solution 
combined with a phosphate-containing replacement fl  uid, compared 
with a previously adopted RCA-CVVH protocol combining a 12 mmol/l 
citrate solution with a conventional replacement fl  uid.
Methods Until September 2011, RCA-CVVH was routinely performed 
in our centre with a 12  mmol/l citrate solution and a postdilution 
replacement fl  uid with bicarbonate (HCO3
– 32, Ca2+ 1.75, Mg2+ 0.5, K+ 
2 mmol/l) (protocol A). In cases of metabolic acidosis, not related to 
inappropriate citrate metabolism and persisting after optimization of 
RCA-CVVH parameter setting, bicarbonate infusion was scheduled. 
Starting from September 2011, in order to optimize buff  er balance 
and to reduce the need for phosphate supplementation, a new 
RCA-CVVH protocol has been designed using an 18  mmol/l citrate 
solution combined with a recently introduced phosphate-containing 
replacement fl  uid with bicarbonate (HCO3
– 30, phosphate 1.2, Ca2+ 1.25, 
Mg2+ 0.6, K+ 4 mmol/l) (protocol B).
Results  In 30 cardiac surgery patients with AKI, acid–base status 
and electrolytes have been evaluated comparing protocol A (20 
patients, running time 5,283  hours) versus protocol B (10 patients, 
1,170 hours) (median (IQR)): pH 7.40 (7.36 to 7.44) versus 7.43 (7.41 
to 7.47) (P <0.0001), bicarbonate 22.1 (20.9 to 23.5) versus 24.4 (23.2 
to 25.6) mmol/l (P <0.0001), base excess –3.1 (–4.6 to –1.15) versus 0 
(–1.5 to 1.1) (P <0.0001), systemic Ca2+ 1.16 (1.1 to 1.23) versus 1.14 
(1.08 to 1.19)  mmol/l (P  <0.0001), phosphate 0.7 (0.5 to 1) versus 
1.1 (0.9 to 1.4) mmol/l (P <0.0001). Protocol A required bicarbonate 
infusion in 90% of patients (6 ± 6.4 mmol/hour) and sodium phosphate 
supplementation in all cases (4.1  ±  2.4  g/day). A lower amount of 
phosphate supplementation (0.9 ± 2 g/day) was needed in 30% of 
patients undergoing protocol B while bicarbonate infusion was never 
required. Filter life was comparable (51.8 ± 36.5 vs. 46.8 ± 30.3 hours, 
P = NS).
Conclusion Protocol B provided a buff  er balance more positive than 
protocol A and allowed one to adequately control acid–base status 
without additional bicarbonate infusion and in the absence of alkalosis, 
despite the use of a standard bicarbonate concentration replacement 
solution. Furthermore, the combination of a phosphate-containing 
replacement fl  uid appeared eff  ective to prevent hypophosphatemia.
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Introduction The aim of this study was to establish the intraobserver 
and interobserver variation of ultrasonographic measurements of the 
rectus femoris muscle cross-section area (RF-CSA). Muscle wasting is 
frequent in the ICU, aff  ecting more than one-half of the patients with 
severe sepsis [1]. Muscle mass reduces rapidly, and 15 to 20% is lost 
within the fi  rst week [1]. To monitor muscle mass, ultrasound has the 
benefi  ts of being both readily available in the ICU and non-invasive. 
Ultrasonographic measurement of RF-CSA has an almost perfect 
correlation with MRI (mean interclass correlation (ICC) = 0.999) [2] and 
RF-CSA is linearly related to maximum voluntary contraction strength 
in both healthy subjects and COPD patients (r = 0.78) [3].
Methods The study had two purposes: to determine the intraobserver 
variation for RF-CSA by one observer scanning 15 healthy adult 
volunteers three times each at 2-day intervals; and to determine the 
interobserver variation for RF-CSA by two observers each scanning 15 
adult ICU patients on the same day. Patients were in a supine position, 
legs in passive extension. The transducer was placed perpendicular 
to the long axis of the right thigh over the RF, two-thirds of the 
distance from the anterior superior iliac spine to the superior patellar 
border [1]. RF-CSA was calculated by planimetry. At each scan, three 
measurements were made. For intraobserver variation, the 3×3 
scans were analyzed using the interclass correlation coeffi   cient. For 
interobserver variation, the three measurements from each observer 
were averaged and compared using Bland–Altman statistics.
Results Intraobserver variation: 15 healthy adults, age 39.6 ± 2.4 years, 
weight 66.8 ± 2.3 kg, sex three male/12 female. ICC: 0.996 (95% CI: 0.990 
to 0.998). Interobserver variation: 15 ICU patients, age: 77 ± 8.3 years, 
weight: 71.3 ± 9.1 kg, sex nine male/six female. Bland–Altman: bias: 
–0.07 cm2, 95% limits of agreement –0.188 to 0.048 cm2.
Conclusion  Ultrasonographic measurement of RF-CSA is easily 
learned and quickly performed. It has a very low intraobserver and 
interobserver variation and can be recommended as a reliable method 
for monitoring muscle wasting in the ICU.
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Introduction  In artifi   cially fed critically ill patients, adipose tissue 
reveals an increased number of small adipocytes and accumulation of 
M2-type macrophages [1]. We hypothesized that nutrient-independent 
factors of critical illness explain these fi   ndings, and also that M2-
macrophage accumulation during critical illness may not be limited to 
adipose tissue.
Methods We performed a randomized investigation in a septic mouse 
model of critical illness and a study of ICU patient biopsies. In the 
critically ill mouse, we compared the eff  ect of parenteral nutrition 
(n = 13) with fasting (n = 11) on body composition, adipocyte cell 
size, and macrophage accumulation in adipose tissue, liver and lung. 
Fed healthy control mice (n = 11) were studied for comparison. In 
vivo adipose tissue was harvested after 1 week of illness from human 
patients (n = 40) who participated in a RCT on early parenteral nutrition 
versus tolerating nutrient restriction [2], adipose tissue morphology 
was characterized and compared with healthy controls (n = 13).
Results Irrespective of nutritional intake, critically ill mice lost body 
weight, total fat and fat-free mass. Part of the fat loss was explained 
by reduced ectopic fat accumulation. Adipocyte cell number and 
the adipogenic markers peroxisome proliferator-activated receptor 
γ and CCAT/enhancer binding-protein β increased with illness, again 
irrespective of nutritional intake. Macrophage accumulation with 
predominant M2-phenotype was observed in adipose tissue, liver and 
lungs of critically ill mice, further accentuated by fasting in visceral 
tissues. Macrophage M2-markers correlated with chemoattractant 
factor expression in all studied tissues. In human subcutaneous 
adipose tissue biopsies of critically ill patients, increased adipogenic 
markers and M2 macrophage accumulation were present irrespective 
of nutritional intake.
Conclusion Adipogenesis and accumulation of M2-macrophages are 
hallmarks of critical illness, irrespective of nutritional management 
in humans and mice. Critical illness evokes macrophage polarization 
to the M2-state not only in adipose tissue but also in liver and lungs, 
which is further accentuated by fasting.
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Introduction  Intravenous magnesium sulfate is commonly used 
in obstetric patients with pre-eclampsia. Following a case of acute 
symptomatic hypocalcemia we retrospectively examined a cohort of 
patients to investigate the frequency of hypocalcemia.
Methods Obstetric patients were identifi  ed from the ICU admissions 
database and divided into two groups – those treated with magnesium 
(for suspected pre-eclampsia) and those admitted for other obstetric 
indications (postpartum hemorrhage, infection, etc.). The baseline 
calcium values were compared, as well as the lowest and discharge 
values. Albumin and magnesium values were also compared. All 
comparisons used Student’s t test.
Results Data were collected on 88 parturients admitted over 2 years 
including 40 (45%) who received magnesium and 48 (55%) who did not. 
Magnesium-treated women were younger (age: 31 ± 7 vs. 36 ± 5 years, 
P = 0.02). The baseline calcium concentrations were similar for the 
two groups (2.2 ± 0.2 vs. 2.2 ± 0.1 mmol/l, P = 0.85). Patients receiving 
magnesium had signifi   cantly higher magnesium concentrations 
(2.1  ±  0.4 vs. 0.7  ±  0.2  mmol/l, P  <0.001), and signifi  cantly  lower 
calcium concentrations during therapy (1.6 ± 0.3 vs. 1.9 ± 0.3 mmol/l, 
P <0.001). At discharge, the calcium levels were closer (magnesium 
treated 1.9 ± 0.2 vs. untreated 2.1 ± 0.1 mmol/l, P = 0.02). The albumin 
concentrations did not diff  er between the two groups (magnesium 
treated 27 ± 13 vs. nontreated 33 ± 23 g/l, P = 0.134). Normal values: 
calcium 2.15 to 2.55 mmol/l, magnesium 0.7 to 0.95 mmol/l, albumin 
35 to 50 g/l.
Conclusion Magnesium therapy was associated with hypocalcemia. 
Potential causative mechanisms include a renal excretion interaction 
and magnesium-induced suppression of parathyroid hormone 
secretion. Physicians should be aware of the potential for symptomatic 
hypocalcemia during magnesium therapy.
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Introduction Disorders of sodium (Na+) and water homeostasis are 
common in hospitalised patients. Hyponatremia in particular has 
been associated with worse hospital outcome and length of stay 
[1]. We aimed to defi  ne the incidence of hyponatremia (serum Na+ 
≤134  mmol/l) in our intensive care population and to determine 
whether it was associated with ICU outcome or length of stay.
Methods Demographics, APACHE II score, outcome data and admission 
sodium were retrieved from the Ward Watcher system in the Victoria 
Infi  rmary ICU for 2,440 consecutive admissions from January 2005 to 
present. We divided patients into three groups depending on serum 
Na+ (≤134 mmol/l, 135 to 144 mmol/l, ≥145 mmol/l) and compared 
APACHE II score, length of stay and ICU outcome between patients 
with a low versus a normal serum Na+. Data were analysed using the 
chi-squared test, Student’s t test and the Mann–Whitney test where 
appropriate.
Results Of the 2,440 patients studied, 1,993 had APACHE II data and 
serum Na+ recorded and so were included for analysis. In total, 453 
patients (22.7%) had a serum Na+ ≤134  mmol/l and 1,388 patients 
(67.1%) had a serum Na+ of 135 to 144 mmol/l. Patients with a low Na+ 
had a higher mortality (OR = 1.48, 95% CI = 1.16 to 1.90, P <0.001), a 
higher APACHE II score (22 vs. 19, P <0.001) and higher mean age 
(60 years vs. 58 years, P <0.001) than patients with a normal serum Na+. 
Mean length of stay of patients with low serum Na+ was also longer 
(5.1 days vs. 4.6 days) although this was not statistically signifi  cant 
(P = 0.09).
Conclusion In summary, hyponatremia is a useful index of severity of 
illness in our ICU population. Whether this is a direct adverse eff  ect 
of low serum sodium levels, or if hyponatremia is simply a marker for 
‘sicker’ patients, is not known.
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Introduction The anion gap (AG) is used routinely in the assessment 
of metabolic acidosis, but can be misleading in patients with 
hypoalbuminemia and other disorders commonly encountered in 
intensive care. This approach to acid–base analysis relies on assessment 
of pH, pCO2, sodium, bicarbonate and chloride, and can lead to 
underestimation or overestimation of the true electrochemical status 
of a patient, as it does not include important ions such as lactate, 
calcium, magnesium, and albumin. The strong ion gap (SIG) is an 
alternative to the AG and is based upon Stewart’s physical chemistry 
approach. However, the SIG is cumbersome to calculate. As such, a 
number of shortcut equations have been developed in an eff  ort to 
approximate the SIG. We sought to compare three such equations, the 
Kellum corrected anion gap (KellAGc), the Moviat equation, and EZSIG, 
in an eff  ort to evaluate precision and accuracy [1-3].
Methods We conducted a retrospective chart review of consecutive 
patients admitted to the ICU of George Washington University Medical 
Center from September 2010 to March 2011. Of the 1,516 patients 
screened, 200 met inclusion criteria, which included availability of all 
laboratory components to calculate the SIG, obtained within 1 hour of 
each other. Demographic data and serum values for pH, pCO2, albumin, 
lactate, sodium, potassium, chloride, bicarbonate, magnesium, 
phosphate, and calcium were collected. The AG, SIG, KellAGc, EZSIG, 
and Moviat equations were subsequently calculated and compared 
using Pearson correlation and Bland–Altman analysis.
Results The mean SIG was 3.25 ± 3.5. Mean values for KellAGc, Moviat, 
and EZSIG were 4.5 ± 5.0, 1.77 ± 2.2, and 3.6 ± 3.7, respectively. Pearson 
correlation coeffi   cients for KellAGc, Moviat, and EZSIG when compared 
with the SIG were r = 0.77, P = 0.0001; r = 0.88, P = 0.001; and r = 0.89, 
P = 0.001, respectively. In Bland–Altman analysis, the mean bias for the 
test equations versus the SIG were: KellAGc (1.25), Moviat (–1.48), and 
EZSIG (0.40).
Conclusion While all three equations correlated highly with the SIG, 
the EZSIG and Moviat outperformed the KellAGc in Pearson and Bland–
Altman analysis. The EZSIG had a smaller bias than the Moviat equation 
and a slightly better correlation (0.89 vs. 0.88). In the assessment of 
critically ill patients, EZSIG is a candidate scanning equation for the 
measurement of the SIG when all SIG components are not available.
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Introduction  Relative adrenal insuffi     ciency (RAI) is an uncommon 
disorder among burn patients, which can often go unrecognized. 
However, there are no or almost no data about the incidence of this 
disease in burns. The goal of the current study is to evaluate the 
incidence of RAI in burn patients during the acute phase.
Methods  A prospective study, approved by our Institutional 
Ethics Committee, was conducted in a 20-bed adult burn ICU at a 
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the fi  rst 24 hours post burn with greater than 10% total body surface 
area (TBSA) burned were enrolled in this study from 1 January 2009 
to 30 June 2010. Exclusion criteria were pregnancy, history of adrenal 
insuffi   ciency, or steroid therapy within 6  months prior to burns. A 
short corticotrophin test (250 μg) was performed, and cortisol levels 
were measured at baseline (CS T0) and 60 minutes post test. Adrenal 
insuffi   ciency was defi  ned by a response ≤9 μg/dl. Relative adrenal 
insuffi   ciency was further defi  ned by a baseline cortisol >20 μg/dl.
Results Patients were assigned into two groups: G1 (RAI, n = 7) and G2 
(absence AI, n = 11). Comparative study of the two groups shows the 
results presented in Table 1.
Table 1 (abstract P445). Characteristics of the two groups
 G1  G2  P value
Age 38 ± 13  34 ± 12  NS
TBSA 57.8 ± 30  26 ± 22  0.019
UBS 158 ± 100  70 ± 99 NS
ABSI 8 ± 3  6 ± 3  NS
CS T0  37 ± 11  19 ± 14  0.01
D CS  2.2 ± 1.8  19 ± 6  <0.001
Shock  6 (86%)  4 (36%)  0.04
Conclusion  RAI is common in severely burned patients during the 
acute phase, and is associated with shock. Further prospective 
controlled studies will be necessary to establish risk factors of RAI in 
severely burned patients and its impact on their prognosis.
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Introduction Hypocalcaemia is common in critical illness and accurate 
assessment is crucial. Small studies have shown that albumin-adjusted 
calcium (adjCa) does not accurately predict the ionised calcium (iCa) 
concentration in critically ill patients, yet adjCa continues to be widely 
used [1]. We investigated the reliability of using adjCa to identify 
hypocalcaemia in a large, diverse population requiring intensive care.
Methods In a retrospective study of patients admitted to the ICUs of a 
tertiary care hospital between January 2008 and 2012, iCa and pH were 
extracted from routine blood gas results and total calcium, albumin 
and phosphate from routine biochemistry results. adjCa was calculated 
using a formula derived from and validated on the local population 
[2]. Sensitivity, specifi   city, positive and negative predictive values 
(PPV and NPV) and area under the curve (AUC) of adjCa for predicting 
hypocalcaemia (iCa <1.1 mmol/l) were calculated.
Results  Data from 1,038 patients were included. Admission iCa 
was available for 976 (94%) patients. A total of 539 (55%) were 
hypocalcaemic (iCa <1.1 mmol/l). adjCa was available for 1,031 (99%), 
with 602 (58%) classifi  ed as hypocalcaemic (adjCa <2.2 mmol/l). adjCa 
<2.2 mmol/l had sensitivity of 78% and specifi  city of 63% for detecting 
iCa <1.1 mmol/l. The best previously published formula had an AUC of 
0.81 (95% CI = 0.78 to 0.83), compared with an AUC of 0.78 (0.75 to 0.81) 
for the locally validated formula [1]. It was hypothesized that albumin, 
pH or phosphate derangements could aff  ect the proportion of albumin-
bound calcium and the performance of adjustment formulae. Albumin 
concentration was not correlated with the diff  erence between adjCa 
and iCa. Weak but statistically signifi  cant correlations were found for pH 
(r = 0.164; P <0.001) and phosphate (r = 0.135; P <0.001). The sensitivity 
and specifi  city of adjCa <2.2 mmol/l for detecting hypocalcaemia did 
not improve when looking at patients with normal pH (sensitivity 
60.4%; specifi  city 69%) or phosphate (32.2%; 78.9%).
Conclusion  adjCa is a relatively poor predictor of iCa in critically 
ill patients. This cannot be explained by abnormalities of albumin, 
phosphate or pH. With direct iCa measurements now readily available 
on ward-based analysers, adjCa should not be used to determine 
calcium status in critical illness.
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Introduction  Vitamin D status may aff   ect hospital mortality and 
infectious complications in critical illness.
Methods  A total of 655 mixed critically ill patients with available 
25(OH)D levels hospitalized between 2008 and 2010 were included. 
Cox regression analysis adjusted for SAPS 2, age and gender was 
performed. 25(OH)D levels were categorized by month-specifi  c tertiles 
(high, intermediate, low) to refl  ect seasonal variation. Primary endpoint 
was the correlation between 25(OH)D and hospital mortality. Secondary 
endpoints were sepsis mortality and blood culture positivity.
Results Hospital mortality was signifi  cantly higher in patients in the 
low (HR = 1.98) and the mid-range tertile (HR = 1.88) compared with 
the highest tertile. Vitamin D levels were signifi  cantly lower in patients 
with lethal sepsis compared with other causes of death (12.3 ± 5.0 
vs. 18.2 ± 11.2, P = 0.02). Blood culture positivity rates did not diff  er 
between the groups (23.0% vs. 26.8% vs. 17.3%, P = 0.361). See Table 1.
Table 1 (abstract P447)
 Low  Intermediate  High 
Tertile (n = 216) (n = 219) (n = 220)  P value
25(OH)D (ng/ml)  10.4 (± 3.6)  17.6 (± 5.1)  30.7 (± 11.4)  <0.001
SAPS 2  32 (± 15)  28 (± 16)  28 (± 16)  0.007
Hospital mortality  58 (26.9%)  48 (21.2%)   29 (13.2%)  0.002
Lethal sepsis  11 (5.1%)  9 (4.1%)   0 (0.0%)   0.005
Conclusion Low 25(OH)D status is predictive of all-cause and sepsis 
mortality in the critically ill. Interventional studies are needed to 
investigate the eff  ect of vitamin D on mortality and sepsis incidence 
and outcomes.
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Introduction Low testosterone levels are frequently found in critically 
ill male patients. The etiology and clinical signifi  cance is still poorly 
understood. In the present study we have investigated the kinetics 
and pathophysiology of altered gonadal hormone synthesis in male 
patients with severe sepsis and respiratory failure.
Methods All male patients with severe sepsis and respiratory failure 
who were admitted to the ICU of a large teaching hospital in the 
Netherlands between September 2011 and June 2012 were included. 
Steroid hormone levels were measured on days 1, 3 and 7.
Results  In total, 18 patients were included. The mean age was 
69 ± 2 years, mean weight 76 ± 2 kg, APACHE II score 23 ± 2 and most 
patients suff  ered from pneumosepsis. On the fi  rst day of intubation, 
total and free testosterone levels were extremely low in most patients 
and remained low during the fi  rst week (Figure 1). 17β-Estradiol levels 
were elevated on day 1 and decreased during the fi  rst week. LH and 
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apo-proteins were reduced as well as 17-OH-progesterone, DHEA and 
DHEAS. In contrast, androstenedione (adione) levels were elevated. 
This suggests preferential and stimulated synthesis of androstenedione 
(Figure 2). The high 17β-estradiol levels indicate that androstenedione 
is shunted into the estrogen pathway, a process that requires high 
aromatase activity. The high estradiol/total testosterone ratio supports 
this conclusion.
Conclusion  Hyperestrogenic hypotestosteronemia is a frequent 
fi   nding in the acute phase of severe sepsis in male patients with 
respiratory failure. It is suggested to be caused by decreased androgen 
production and shunting of androgen to estrogen synthesis as a result 
of increased aromatase activity. The clinical relevance of gonadal 
hormone substitution needs further study.
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Introduction The aim of the study is to examine the effi   cacy of calcium 
replacement in patients with hypocalcaemia in the ICU. Hypocalcaemia 
aff  ects between 15 and 50% of admissions to the ICU [1].
Methods  Adjusted calcium results <2.0  mmol/l were followed up 
from admission for 5 days or until discharge or death. On each day 
the adjusted calcium result and the calcium replacement were 
documented. Adequate replacement is defi   ned as 40 ml of 10% 
calcium gluconate if the adjusted calcium is <2.0 mmol/l and 20 ml of 
10% calcium gluconate if the adjusted calcium result is between 2.0 
and 2.15 mmol/l.
Results Eighty-eight adjusted calcium results were <2.0 mmol/l. In 74 
results adequate replacement was given and the average increase in 
calcium was 0.2 mmol/l. This led to an increase in the adjusted calcium 
to >2.15 mmol/l in 36% of results and improvement to >2.0 mmol/l 
in 89% of results. In 14 results no replacement was given and the 
average increase in calcium was 0.07 mmol/l, which equated to 57% 
of calcium results remaining <2.0 mmol/l. Unpaired t test showed a P 
value of 0.0006. A total of 150 adjusted calcium results were between 
2.0 and 2.15 mmol/l. In 111 results adequate replacement was given 
and the average increase was 0.006  mmol/l. The adjusted calcium 
fell to <2.0 mmol/l in 26% of results and normalised to >2.15 mmol/l 
in 23%. Where the adjusted calcium fell despite replacement, 51% 
of results were below 2.05 mmol/l. In 39 results no replacement was 
given, leading to an average fall in calcium of 0.03  mmol/l. Thirty-
three percent of calcium results fell to <2.0 mmol/l and 20% of results 
normalised. Unpaired t test showed a P value of 0.07.
Conclusion Calcium replacement with 40 ml of 10% calcium gluconate 
is eff  ective when the adjusted calcium is <2.0 mmol/l. Replacement 
with 20 ml of 10% calcium gluconate when the adjusted calcium 
is between 2.0 and 2.15 mmol/l is not much more eff  ective than no 
replacement. This suggests that either replacement is not needed or 
there is under-replacement in mild hypocalcaemia. Adjusted calcium 
may be giving falsely low calcium results in mild hypocalcaemia. The 
measurement of ionised calcium is a possible solution [2,3].
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Introduction Melatonin could have a meaningful role in critically ill 
patients, because of its immunomodulatory, antioxidant and sleep 
regulation properties; it is reduced in critical illness. The purpose of 
Figure 1 (abstract P448).
Figure 2 (abstract P448).
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patients and their correlation with clinical parameters.
Methods  Seventy-three high-risk critically ill patients mechanically 
ventilated for >48 hours were enrolled. Blood samples for melatonin 
assay were collected between the 3rd and the 8th day of the ICU stay. 
Melatonin was determined by radioimmunoassay and ELISA. The 
peak and the area under the curve (AUC) calculated for each patient 
were correlated with the clinical parameters using the regression for 
quantiles test.
Results Endogenous melatonin was found lower in critically ill patients 
compared with healthy subjects (Figure  1), although it showed a 
great individual variability and it generally maintained a night-time 
increase. In the univariate analysis the peak was found related to: blood 
creatinine (P = 0.034); patients in coma (P = 0.024); hospital mortality 
(P = 0.016). The AUC was found related to: SAPS II (P = 0.047); creatinine 
(P <0.001); AST (P <0.001); ALT (P <0.001); hospital mortality (P <0.022). 
Peak and AUC were found higher in nonsurvivor patients.
Conclusion In accord with previous studies, the endogenous blood 
melatonin was found reduced in ICU patients. The higher melatonin 
peak in renal failure may be due to an increased distribution volume; 
greater AUC in patients with liver failure could be due to a less effi   cient 
removal of the hormone from the systemic circulation. The fi  nding of 
increased peak and AUC in nonsurvivor patients could be due to a 
hormonal response increased by the body stress reaction, potentially 
similar to cortisol [1], or to a higher production of a physiological 
antioxidant [2] with a decreased ability to use it.
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Introduction Metformin intoxication inhibits mitochondrial complex 
I and oxygen consumption (VO2). Succinate bypasses complex I by 
donating electrons to complex II. The aim of this study was to clarify 
whether succinate ameliorates mitochondrial VO2 of metformin-
intoxicated human platelets.
Methods  Platelet-rich-plasma was incubated for 72  hours with 
metformin at a fi   nal concentration of 0  mg/l (control), 1.66  mg/l 
(therapeutic dose) or 166  mg/l (toxic dose). Platelet VO2 was then 
measured with a Clark-type electrode, in the presence of glutamate plus 
malate (complex I electron donors) (fi  nal concentration: 20 mmol/l for 
both) or succinate (complex II electron donor) (30 mmol/l), before and 
after adding cyanide (40  mmol/l). Mitochondrial (cyanide-sensitive) 
and extra-mitochondrial (cyanide-insensitive) VO2 were corrected for 
platelet count.
Results  The main results, from four preliminary experiments, are 
shown in Figure  1. In the presence of glutamate plus malate, only 
platelets incubated with a high dose of metformin had a mitochondrial 
VO2 signifi  cantly lower than controls. In the presence of succinate, 
mitochondrial VO2 of controls did not change signifi  cantly whereas 
that of platelets incubated with metformin did. The eff  ect of succinate 
tended to become larger as the dose of metformin was increased from 
0 up to 166 mg/l (0.3 ± 0.2 vs. 0.6 ± 0.3 vs. 1.0 ± 0.3 nmol/minute*106 
cells) (P = 0.068). Even so, mitochondrial VO2 of platelets incubated with 
the highest dose of metformin did not return to the levels of controls. 
Extra-mitochondrial VO2 was always the same.
Figure 1 (abstract P450).
Figure 1 (abstract P451). Mitochondrial oxygen use of human platelets 
incubated with metformin.
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mitochondrial VO2 of human platelets incubated with a toxic dose of 
metformin.
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Introduction Metformin, widely used as an antidiabetic drug, activates 
the AMP activated protein kinase, a key regulator of the metabolism 
providing protection under fuel defi  ciency. Chronic metformin therapy 
has been shown in long-term follow-up clinical studies to reduce 
cardiovascular mortality [1]. In animal experiments, acute metformin 
pretreatment has been shown to reduce ischemia–reperfusion injury 
on cardiomyocytes [2]. We want to evaluate whether outcomes are 
aff  ected in coronary artery bypass grafting (CABG) surgery.
Methods  We performed a retrospective case–control study on 341 
patients admitted exclusively for CABG surgery with cardiopulmonary 
bypass between January 2006 and April 2012. Eighty-one patients 
chronically on metformin were matched 1:3 with nonmetformin-
treated ones using gender, age, body mass index and number of 
arterial bypass grafts. Global mortality, ICU-free 28 postoperative days 
and creatinine kinase MB (CKMB) at postoperative baseline, 8 and 
18 hours post baseline were compared.
Results  Metformin-treated patient mortality was not signifi  cantly 
lower than in nonmetformin (1.2% vs. 3.1%, P = 0.24, Fischer exact test). 
ICU-free 28 postoperative days were higher in the metformin group 
(median 23.4 days; 95% CI = 22.5 to 24.3) than in the nonmetformin 
group (median 22.9 days; 95% CI 22.3 to 23.5, P <0.04, Wilcoxon test). 
Median CKMB levels at postoperative baseline were 21 versus 26 ng/ml 
(P <0.003), at 8 hours were 22 versus 53 ng/ml (P <0.004) and 18 hours 
post baseline were 21.5 versus 27.5 ng/ml (P <0.012). See Table 1.
Table 1 (abstract P452). Case–control analysis
     Statistics, 
 Metformin  Nonmetformin  P value
Mortality 1/81  8/260  0.24
28 days free ICU (days)  23.4  22.9  <0.04
CKMB T 0 hours (ng/ml)  21  26  <0.003
CKMB T+8 hours (ng/ml)  22  53  <0.004
CKMB T+18 hours (ng/ml)  21.5  27.5  <0.012
Conclusion These data suggest that chronic preoperative treatment 
with metformin is associated with lower CKMB levels at postsurgery 
baseline, 8 and 18 hours post baseline with a shorter ICU stay in patients 
receiving CABG surgery under extracorporeal circulation.
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Introduction Metformin, an oral hypoglycemic drug, belongs to the 
biguanide class and is now generally accepted as fi  rst-line treatment in 
type 2 diabetes mellitus, especially in overweight patients [1]. In some 
predisposing conditions, the use of metformin may result in metformin-
associated lactic acidosis (MALA), a rare adverse event associated with a 
high mortality rate [2]. The aim of this study is to assess risk factors and 
prognostic factors in patients with MALA.
Methods We conducted a retrospective study of patients with MALA 
admitted to the ICU of ASL 2 Chieti between 1 January 2008 and 
30 September 2012. The eligibility criteria were: diagnosis of diabetes 
mellitus type 2, treatment with oral hypoglycemic drugs containing 
metformin, increased anion gap metabolic acidosis (pH <7.35, HCO3
– 
<22 mmol/l, lactate >5 mmol/l). For each patient we evaluated: sex, 
age, home care, SAPS II score [3], blood tests.
Results Ten patients were selected, fi  ve males and fi  ve females, with a 
mean age of 72.2. On admission, nine of 10 patients had a framework 
of general illness and acute renal failure; one patient appeared with 
a probable acute abdomen not subsequently confi  rmed on CT. Eight 
patients had a state of dehydration resulting from gastroenteritis, 
diarrhea, fever; two patients had taken NSAIDs in the days prior to 
hospitalization. No patient, in these conditions, has discontinued 
treatment with metformin. All patients showed a critical clinical 
framework with a SAPS II mean score of 77.5. Cardiovascular and 
respiratory support was required in all cases. The hemogas analysis 
showed that patients had a severe metabolic acidosis (mean pH = 6.96) 
with increased plasma lactate (mean lactate  =  15.93  mmol/l). 
Prothrombin activity was normal in eight of 10 patients. The overall 
mortality was 70%.
Conclusion Patient education on correct use of metformin is essential 
to prevent MALA, specially in those clinical conditions of increased risk 
(for example, acute renal failure), as recommended by the AIFA 2011 
guidelines [4]. In our study, a higher plasma concentration of lactate 
represents the main negative prognostic factor, as pointed out by 
other studies [5]. The prothrombin activity, which is considered to be a 
decisive prognostic factor in the study of Peters and colleagues [6], was 
not impaired in patients with poor outcome.
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Introduction  Stress hyperglycemia in the critically ill is a complex 
process in which insulin signaling is systematically hijacked to 
provide energy substrate for metabolic priorities such as cell healing 
or infection containment. Fluctuating levels of plasma glucose are 
associated with increased mortality in the ICU [1]. We develop a 
multiscale mathematical model that can characterize the severity of 
stress hyperglycemia based on a fundamental understanding of the 
signaling molecules involved.
Methods  Insulin resistance following insult has been shown to be 
driven primarily by the immune response via the cytokine IL-6 [2]. We 
created a multiscale mathematical model that links circulating glucose 
and insulin concentration dynamics from the extended minimal 
model [3] to a cellular insulin response model [4] that captures insulin-
mediated glucose uptake in an insulin-responsive cell.
Results Inhibitory dynamics driven by IL-6 were incorporated into the 
cellular model to attenuate an insulin signaling intermediate (insulin 
receptor substrate 1) according to the proposed biological mechanisms. 
The percentage reduction in glucose uptake as a function of IL-6 
concentration was fi  t to data from patients who underwent elective 
abdominal surgery [2], shown in Figure 1. The overall multiscale model 
captures decreased insulin signaling as a result of increased IL-6 levels 
and the subsequent hyperglycemia that may ensue.
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inhibitory eff  ects of IL-6 on insulin-mediated glucose uptake. Cellular 
inhibitory dynamics were shown to capture reduced insulin sensitivity 
on the macroscale, which could then be used to characterize insulin 
sensitivity and to provide insulin treatment advice to reduce glucose 
variability.
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glucose control in the ICU
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Introduction  Hyperglycemia is frequently encountered in critically 
ill patients, and associated with adverse outcome. Improvement of 
glucose protocol adherence may be accomplished using electronic 
alerts. We confi  gured a non-intrusive real-time electronic alert, called a 
GLYC sniff  er, as part of our Intensive Care Information System (ICIS) that 
continuously evaluates the occurrence of persistent hyperglycemia 
and hypoglycemia. The GLYC sniff  er is confi  gured in such a way to 
give an alert: if two consecutive glucose values are >150 mg/dl, with 
a minimum interval of 60 minutes; or if a glucose value is <80 mg/dl. 
We wanted to evaluate whether the GLYC sniff  er would improve the 
glucose control.
Methods  A single-center, prospective intervention study during a 
6-month period in our 22-bed surgical ICU. Two study phases were 
compared: a 3-month pre-alert phase with no alerting to the nurses, 
and a 3-month intervention phase where the GLYC sniff  er was alerting 
through the Clinical Notifi  cation System of our ICIS.
Results A total of 652 diff  erent patients having a total of 699 admission 
episodes was recorded during the study period. There were no 
signifi  cant  diff   erences between the two study groups regarding 
baseline demographic data, fi   rst glucose value upon admission. A 
total of 2,335 GLYC sniff  er alerts were recorded during the whole study 
period: 84.3% persistent hyperglycemia alerts (1,021 in the pre-alert 
group, 948 in the alert group), and 15.7% hypoglycemia alerts (139 
vs. 227). A signifi  cantly lower percentage of glucose values in the alert 
group were hyperglycemic (19.5% vs. 26.5%, P <0.001). The proportion 
of persistent hyperglycemic values (i.e. consecutive glucose values 
exceeding the limit of 150 mg/dl) was signifi  cantly lower in the alert 
group (9.9% vs. 15.4%, P <0.001). The patients in the alert group spend 
signifi  cantly more time within the set target glucose interval of 80 to 
150 mg/dl (82.3% vs. 75.0%, P = 0.009). A signifi  cantly lower proportion 
of patients experienced a new-onset hypoglycemic event (<80 mg/dl) 
in the alert group (19.3% vs. 26.2%, P = 0.04).
Conclusion A real-time electronic persistent glycemia sniff  er resulted 
in a signifi   cantly higher proportion of normoglycemia, without 
increasing the variability. Furthermore, hypoglycemic events occurred 
less frequently, and were resolved more timely. Smart alerting is able to 
improve quality of care, while diminishing the problem of alert fatigue.
P456
Individualized targeted glucose control to avoid hypoglycemia
SP Gawel1, G Clermont2, T Ho1, BM Newman3, B Yegneswaran2, RS Parker1
1University of Pittsburgh, PA, USA; 2University of Pittsburgh Medical Center, 
Pittsburgh, PA, USA; 3Iowa State University, Ames, IA, USA
Critical Care 2013, 17(Suppl 2):P456 (doi: 10.1186/cc12394)
Introduction Hyperglycemia and hypoglycemia have been linked to 
worse outcomes in critically ill patients. While there is controversy as 
to the optimal tightness of glucose control in critically ill patients, there 
is agreement that an upper limit to safe glucose levels exists and that 
avoiding hypoglycemic episodes should be prioritized. Our algorithm 
can assist clinicians in maintaining blood glucose ([Gbl]) within a 
desired target range while avoiding hypoglycemia.
Methods Our model predictive control (MPC) algorithm uses insulin 
and glucose as control inputs and a linearized model of glucose–
insulin–fatty acid interactions. To allow the controller model to learn 
from data, a moving horizon estimation (MHE) technique tailored 
the tissue sensitivity to insulin to individual responses. Patient data 
([Gbl] measurements, insulin and nutritional infusion rates) were from 
the HIDENIC database at the University of Pittsburgh Medical Center. 
[Gbl] measurements, typically  hourly, were interpolated to impute 
a measurement every 5 minutes. The model captured patient [Gbl] 
via nonlinear least squares by adjusting insulin sensitivity (SI) and 
endogenous glucose production (EGP0). The resulting virtual patient 
(VP) is used to evaluate the performance of the MPC–MHE algorithm.
Results MPC controller performance on one VP is shown in Figure 1. 
Across a population of 10 VPs, the average [Gbl] under MPC is 
6.31  mmol/l, the average minimum is 4.62  mmol/l, the population 
individual minimum is 3.49 mmol/l and the average absolute average 
residual error is 0.83 mmol/l from a 5.6 mmol/l target. With standard 
intervention, the 10 VPs have an average [Gbl] of 9.32  mmol/l, an 
average minimum [Gbl] of 3.77 mmol/l, and a population minimum 
[Gbl] of 2.78 mmol/l. Algorithm performance deteriorates signifi  cantly 
if the imputed sampling time exceeds 30 minutes, underlining 
the importance of dynamic variations in insulin sensitivity in this 
population.
Conclusion  The MPC–MHE algorithm achieves targeted glucose 
control in response to changing patient dynamics and multiple 
measured disturbances for a pilot population of 10 VPs. Furthermore, 
the MHE scheme updates patient parameters in real time in response 
to changing patient dynamics.
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Hyperglycemia in intensive care identifi  es patients at high risk of 
developing diabetes: preliminary data of a multicentre study
E Lukic, I Gornik, M Grgic-Medic, D Milicic, V Vegar, V Ivancan, M Peric, 
V Gasparovic, I Pavlic Renar
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Introduction  A recent study showed that hyperglycaemia (blood 
glucose ≥7.8 mmol/l) in nondiabetic patients hospitalised in a medical 
ICU is associated with increased risk of diabetes [1]. We investigated a 
large mixed ICU population to confi  rm these results.
Methods This study retrospectively included patients with negative 
history of diabetes admitted to ICUs during the year 2007. We excluded 
patients receiving steroids, with newly diagnosed diabetes and those 
with end-stage disease. Patients were followed-up 5 years after index 
Figure 1 (abstract P454). Reduced glucose uptake driven by increased 
plasma IL-6 levels.
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admission was presumed as revealing DM at inclusion, which excluded 
the patient. Patients who were taking glucocorticoids during the follow-
up period were excluded. The rest of the patients, if consented, were 
assessed for their diabetic status with a single HbA1c measurement.
Results A total of 2,696 patients were included in the study: 1,441 
medical and 1,255 surgical, hyperglycaemia (≥7.8  mmol/l) was 
registered in 1,419 (52%). During the 5 years from index admission 409 
died and 38 were taking glucocorticoids, and 10 refused participation. 
Diabetes was diagnosed in 189 patients during the 6 months after index 
admission. The remaining cohort of 2,320 patients had 1,169 patients 
who were hyperglycaemic during hospitalisation. Diabetes was already 
diagnosed in 132 patients, of whom 112 were hyperglycaemic in the 
ICU; prediabetes was already diagnosed in 121 patients, of whom 
83 had ICU hyperglycaemia. Since 125 patients (55 hyperglycaemic) 
refused HbA1c testing, it was performed on 1,852 patients and revealed 
diabetes in 136 patients (107 had hyperglycaemia) and prediabetes 
in 103 patients (75 were hyperglycaemic in ICU). Overall, patients 
who had hyperglycaemia had 19.8% cumulative 5-year incidence of 
diabetes and 14.3% of prediabetes. Nonhyperglycaemic ICU patients 
had cumulative incidences of 4.5% and 6.6%, respectively. Relative risk 
for developing diabetes during 5 years after ICU admission is 4.2 (95% 
CI = 3.2 to 5.9) for patients who did have hyperglycaemia.
Conclusion The results of this study confi  rm in a large mixed medical/
surgical ICU population that hyperglycaemia occurring in severe 
illness or the perioperative period is associated with increased risk 
of developing diabetes. Suggesting lifestyle changes to reduce the 
risk and regular follow-up should be implemented at least for these 
patients.
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Introduction  The objective of the study was to determine the 
association between average glucose level (AVG) and hospital 
outcomes in critically ill patients.
Methods We performed a chart review of the MIMICII and HIDENIC 
databases, prospective cohorts of over 32,000 and 46,000 patients 
admitted to the ICUs at Beth Israel Deaconess Medical Center between 
2001 and 2007 and the ICUs at University of Pittsburgh Medical Center 
between 1991 and 2008, respectively. All admissions of patients 
≥18  years without the diagnosis of DKA and NKHS were included. 
Diabetics were identifi  ed from ICD-9 documentation. Propensity score 
for death (pDead) was computed from either SAP1 (MIMICII) or APACHE 
III (HIDENIC) to assess the risk of death. Hypoglycemia was defi  ned as 
AVG ≤60 mg/dl. AVG was computed as the area under the glucose 
curve throughout ICU admission. Mortality was examined within 
bins (each bin is categorized by a 10 mg/dl increase in AVG) and was 
compared between adjacent categories using a chi-square test. The 
same method was repeated among diabetics, nondiabetics, patients 
with lower (pDead greater than median) and higher (pDead lower than 
Figure 1 (abstract P456).
Figure 1 (abstract P458).
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Bonferroni correction.
Results  MIMICII database: 21,209 admissions met inclusion criteria. 
Mean age: 62.5 ± 16.4 years; female: 9,070 (42.8%); diabetes: 5,496 
(25.9%); mean admission SAP1 score: 13.8 ± 5.2; mean LOS: 9 days (IQR 
6.15); hospital mortality: 10.3%. HIDENIC database: 38,872 admissions 
met inclusion criteria. Mean age: 59.4  ±  17.3  years; female: 16,675 
(42.9%); diabetes: 11,326 (29.1%); mean admission APACHE III score: 
80.2 ± 14; mean LOS: 11 days (IQR 7.22); hospital mortality: 14.3%. In 
both databases, association between average glucose and hospital 
mortality followed a bathtub shape with mortality nadir between 
80 and 130  mg/dl. No mortality diff  erence was observed between 
adjacent AVG glucose bins in the bottom of the bathtub (Figure 1). 
This relationship was preserved in nondiabetics, and for patients with 
higher risk of death.
Conclusion  Low and high average glucose are associated with 
mortality.
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Introduction We evaluated the clinical and numerical accuracy of the 
Freestyle Navigator continuous glucose monitoring (CGM) system, in 
critically ill adults using two diff  erent methods of calibration. Studies 
looking at intensive glucose control have yielded confl  icting results 
with increased rates of iatrogenic hypoglycemia. Availability of accurate 
real-time glucose information may improve safety and effi   cacy  of 
glucose control in the critical care unit.
Methods In a randomized prospective trial, paired CGM and reference 
glucose (hourly arterial blood gas (ABG)) were collected from 24 adults 
with critical illness (age 60 ± 14 years, BMI 29.6 ± 9.3 kg/m2, APACHE 
score range 6 to 19) and hyperglycemia (glucose ≥10 mmol/l or treated 
with intravenous insulin), over 48 hours. In 12 subjects, CGM was force-
calibrated at variable 1 to 6 hourly intervals using ABG glucose (FC 
arm). In the other 12 subjects, the sensor was calibrated according to 
the manufacturer’s instructions (1, 2, 10, 24 hours after insertion) using 
arterial blood and built-in glucometer (MC arm).
Results Two groups had similar characteristics at baseline. A total of 
1,060 CGM/ABG pairs were analyzed and reference glucose ranged 
from 4.3 to 18.8 mmol/l. Median (IQR) absolute relative deviation was 
lower in the FC arm (7.0% (3.5, 13.0) vs. 12.8% (6.3, 21.8), FC vs. MC, 
P <0.001). Similarly, the percentage of points in the Clarke error grid 
zone A points meeting ISO criteria were higher with FC (87.8% vs. 
70.2%). Sensor bias (median (IQR)) was signifi  cantly lower in the FC 
arm (–0.1 (–0.7, 0.4) mmol/l vs. –1.1 (–2.3, –0.1) mmol/l, P <0.001). The 
median (IQR) interval between calibrations in FC arm was 169 (122, 
213) minutes.
Conclusion CGM accuracy in the MC arm was comparable with accuracy 
in subjects with type 1 diabetes. Further signifi  cant improvements to 
CGM accuracy in critical care are possible by increasing the frequency 
of calibrations. Such accurate CGM may provide valuable information 
to guide insulin therapy in critically ill subjects.
References
1. Weinstein  RL,  et al.: Diabetes Care 2007, 30:1125-1130.
2. Kovatchev  B,  et al.: Diabetes Care 2008, 31:1160-1164.
P460
Root cause analysis of hypoglycemic events in critically ill patients
A McDonald, J Krinsley
Stamford Hospital, Stamford, CT, USA
Critical Care 2013, 17(Suppl 2):P460 (doi: 10.1186/cc12398)
Introduction Hypoglycemia (H) is a complication of intensive insulin 
(IN) therapy of critically ill patients and is independently associated 
with increased risk of mortality (M). Heightened attention to identifi  ed 
risk factors (RF) and causes of hypoglycemic events (HE) may lead to 
improvement in glycemic control. A limited literature describes RF for 
H but a detailed root cause analysis (RCA) of individual HE has not been 
published.
Methods This is a retrospective analysis of prospectively collected data 
including 835 patients admitted consecutively between 1 February 
2012 and 31 October 2012 to the 16-bed medical–surgical ICU of a 
university-affi   liated teaching hospital. The blood glucose (BG, mg/dl) 
target was 90 to 120 and the monitoring frequency was every 3 hours, 
or every 1 hour when the patient received i.v. IN infusion. HE data were 
collected by the bedside nurse, using a cutoff   of BG <60, and information 
was abstracted from the unit’s database. RF included: shock (SH), renal 
insuffi   ciency (RI), hepatic failure (HF), mechanical ventilation (MV), and 
diabetes mellitus (DM). Attributable causes included: IN treatment, 
improper monitoring frequency (MF), interruption of feeding (FE), 
and spontaneous (SP). We measured rates of severe (<40) and mild (40 
to 69) H, and compared them as well as percentage of values in the 
optimum range (70 to 139) and hyperglycemic range (>139) with data 
from the preceding 3 months (PRE).
Results Sixty-three (7.5%) patients sustained a total of 79 HE. They were 
older, more likely to be diabetic, and had higher APACHE IV predicted 
(37.3% vs. 15.4%, P <0.0001) and observed (25.4% vs. 8.6%, P <0.0001) 
M than those without H. RF: SH 24.1%; RI 24.1%; HF 8.9%; MV 46.8%; DM 
36.5%. Attributable causes: IN 58.2%; MF 8.9%; FE 6.3%; SP 36.7%. BG 
<40, 40 to 69 and >139 decreased 78.6%, 39.0% and 9.3% (P = 0.0006, 
P <0.0001, P <0.0001). BG 70 to 139 increased 5.5% (P <0.0001). In 
total, 4.2% and 22.4% of PRE patients sustained severe and mild H. 
In total, 0.7% and 14.1% of RCA patients sustained severe and mild H 
(P = 0.0029, P = 0.0003).
Conclusion  IN treatment was associated with barely more than 
one-half of HE in this population of intensively monitored patients. 
Implementation of an initiative mandating RCA of every HE, including 
identifi  cation of RF and attributable causes, was associated with a 
signifi  cant improvement in glycemic control.
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Introduction Continuous glucose monitoring (CGM) in ICUs has the 
potential to improve patient safety outcomes. The GluCath Intravascular 
CGM System uses a novel quenched chemical fl  uorescence sensing 
mechanism to measure glucose concentration in venous or arterial 
blood (BG). This is the fi  rst report of this system deployed for 48 hours 
in both arteries and veins of ICU patients.
Methods This ongoing clinical study evaluates up to two sensors per 
subject in 20 patients undergoing cardiac surgery. An arterial sensor is 
deployed via a standard 20 G radial artery catheter inserted for routine 
care and an optional venous sensor is deployed percutaneously in an 
upper arm vein. Data are presented from the fi  rst fi  ve patients. Outcome 
measures are qualitative (ease of use, workfl  ow fi  t) and quantitative 
(accuracy vs. reference analyzer). Sensors were inserted shortly after 
ICU admission, with ultrasound guidance for venous sensor insertion. 
In vivo calibration was performed at 1 and 2 hours, then each morning. 
Glucose values were recorded every 10 seconds by the system. Hourly 
arterial reference samples were analyzed via Radiometer ABL 800 Flex 
Blood Gas Analyzer (BGA).
Results Arterial sensors were successfully deployed in all fi  ve patients 
and did not interfere with clinical care, blood pressure monitoring 
or sampling. One arterial catheter failed resulting in sensor removal 
at 36 hours. The venous sensor was deployed in three patients, but 
removed from two patients due to thrombosis identifi  ed  during 
surveillance ultrasound examinations. A total of 202 reference BG 
samples ranging from 5.3 to 11.3  mmol/l were collected. Precision 
between arterial and venous sensors (n = 2) was 9.3% CV. Arterial 
sensor accuracy compared with BGA was 5.5% MARD. One hundred 
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criteria (within =/–20% of reference measurements if BG ≥4.2 mmol/l; 
Figure 1).
Conclusion  The GluCath System measured glucose concentration 
continuously in cardiac surgery ICU patients. Arterial catheter 
deployment did not appear to compromise line function or patient 
care. Percutaneous venous deployment was feasible, but may be 
associated with risk of local venous thrombosis.
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Introduction Blood glucose (BG) control reduces morbidity and length 
of stay, and is standard practice in patients undergoing cardiac surgery 
[1]. However, maintaining BG in the target range, while avoiding 
hypoglycemia, is challenging. Continuous glucose monitoring (CGM) 
is a promising technology that may help address these challenges. 
We investigated the performance and safety of Medtronic Sentrino®, a 
newly developed CGM for critically ill adults, in the cardiac ICU.
Methods Adult patients with actual or planned cardiac ICU admission 
at a single tertiary center were approached for participation and 
signed consent. Other inclusion criteria were treatment with i.v. insulin 
(target BG <140 mg/dl) and life expectancy >96 hours. After initiation 
of i.v. insulin, Sentrino® subcutaneous glucose sensors were inserted 
into patients’ anterior thighs with planned study participation of 72 
to 96 hours. Reference BG was collected according to ICU protocol, 
obtained from central venous catheter and analyzed with bedside 
blood gas analyzer (BGA; i-STAT®, Abbott, USA). Sensor glucose 
(SG) results were displayed, and its predictive alerts and alarms fully 
enabled. Additional reference BGs were obtained during alarms and 
calibration. All treatment decisions were based on BGA data, not on SG 
values.
Results A total of 21 patients were enrolled; all successfully completed 
the study. Mean age was 65 years, 38% were women, 67% had diabetes. 
Types of surgery were CABG (38%), valve replacement (29%), combined 
CABG and valve (19%) and cardiac transplant (14%). SG was displayed 
95% of the time during the study, and 864 paired BG–SG points were 
used for analysis. Overall mean absolute relative diff  erence (MARD) 
was 12.2%. No diff  erences in CGM system accuracy were seen within 
subgroups of low versus high Society of Thoracic Surgeons (STS) 
score (MARD 12.1% and 10.6% for STS >8% vs. ≤8%, respectively) 
or hemodynamic status (MARD 12.0% and 12.4% for compromised 
vs. stable hemodynamics). Consensus grid analysis showed >99% 
of SG values within A/B zones, and 0% in D/E zones. No device or 
study-related adverse events were reported. In total, 80% and 100% 
of clinicians found Sentrino® easy to use after one and two patients, 
respectively.
Conclusion The Sentrino® CGM system demonstrated good analytic 
and clinically relevant accuracy, excellent reliability and safety in 
critically ill cardiac patients; and was easy to use and integrate in the 
cardiac ICU. Future studies are needed to determine whether CGM can 
improve BG control and reduce hypoglycemia in this patient group.
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Introduction A large RCT showed that tight glucose control (TGC), 
targeting age-adjusted normal fasting blood glucose levels with insulin 
infusion, decreased morbidity and mortality in critically children [1]. 
However, the incidence of hypoglycemia increased substantially in the 
TGC group. We aimed to assess the eff  ect of TGC on the three domains 
of blood glucose dynamics (hyperglycemia, hypoglycemia and blood 
glucose variability) and their independent association with mortality 
in the pediatric ICU.
Methods This is a preplanned substudy of a published RCT in one 
10-bed pediatric ICU. Seven hundred patients (age 1 to 16  years), 
admitted to the PICU between October 2004 and December 2007, were 
randomized to either TGC (50 to 80 mg/dl in infants, 70 to 100 mg/dl in 
children) or to the usual care tolerating hyperglycemia up to 215 mg/
dl (UC). Patients with at least two arterial blood glucose measurements 
were included (UC n = 349; TGC n = 348).
Results Mean blood glucose levels were lowered from 143 ± 34 mg/dl 
in the UC group to 104 ± 24 mg/dl (P <0.0001). The median number 
of samples per patient did not diff  er between UC (21 (13 to 48)) and 
TGC (22 (15 to 49)). TGC lowered the hyperglycemic index, a marker of 
Figure 1 (abstract P461). Arterial sensor ISO-modifi  ed Bland–Altman plot.
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12 (7 to 23) mg/dl, as well as the glycemic penalty index, an aggregate 
measure of dysglycemia, from median 44 (32 to 58) in UC to 22 (16 
to 30) (both P <0.0001). Despite frequent hypoglycemia <40 mg/dl 
(1.4% in UC, 25.0% in TGC, P <0.0001), TGC did not result in increased 
blood glucose variability, as refl  ected by the standard deviation of 
the blood glucose time series (TGC: 36 (24 to 50) mg/dl, UC 34 (26 
to 48) mg/dl, P = 0.82). In multivariable logistic regression analysis, 
adjusting for baseline risk factors (age, severity of illness, malignancy, 
type of admission), hypoglycemia (OR = 1.6, 95% CI = 0.19 to 2.22) and 
blood glucose variability (OR = 1.0, 95% CI = 0.97 to 1.02, per mg/dl) 
were not associated with PICU mortality. In contrast, hyperglycemic 
index (OR = 1.02, 95% CI = 1.01 to 1.04, per mg/dl) was independently 
associated with mortality and its lowering statistically explained the 
outcome benefi  t of the intervention.
Conclusion TGC substantially reduced the hyperglycemic index, at the 
expense of increased hypoglycemia incidence, but without aff  ecting 
blood glucose variability. Statistical analysis suggested strictly avoiding 
hyperglycemia in order to bring about outcome benefi  t with insulin in 
critically ill children.
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Introduction  There has been enormous interest in measuring 
ICU performance in terms of mortality and resource use, owing to 
increased public and health insurer scrutiny. We elected to describe the 
performance of our surgical ICU, using a standardized mortality ratio 
(SMR = observed / predicted mortality).
Methods The primary cohort was all patients admitted to the surgical 
ICU from March 2010 through February 2012 and related outcomes. 
The change in SMR was longitudinally determined from the latest 15-
year study period (1997 to 2011) comprised of 10,172 patients.
Results There were 1,799 ICU admissions in the primary cohort. Hospital 
mortality, observed and predicted by APACHE IV, was measured. Crude 
hospital mortality was 8.4%. The hospital SMR (observed / predicted 
mortality) was 0.58 (95% CI: 0.49 to 0.65). The SMR decreased by 20% 
from 0.73 to 0.58 over the 15-year study period, an absolute 1% per year 
decrease (P = 0.039; 95% CI: –0.02 to –0.002), as shown in Figure 1.
Conclusion Mortality was less than predicted and steadily declined 
during the previous 15 years. The SMR can be used to track success 
when new quality measures are introduced or changes in the delivery 
of care are made. ICUs should report their standardized mortality ratios 
to evaluate performance.
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Introduction  How decubitus ulcers (DU) diagnosed on admission 
to the ICU aff  ect resource use is unknown. We hypothesize that this 
easily identifi  able clinical fi  nding would be associated with longer 
hospitalizations.
Methods Clinical assessment was used to identify patients with DU on 
admission to the ICU. The association of DU on hospital and ICU length 
of stay (LOS) was assessed with generalized linear models that adjusted 
for ICU admission source, age, APACHE IV score, diabetes, sepsis, 
hepatic failure, dialysis and mechanical ventilation.
Results DU was present on admission in 180 of 2,723 (6.6%) during a 
19-month period in 2011 to 2012 at a single teaching hospital in New 
England. Patients with decubiti were sicker on admission (mean (SD) 
APACHE IV 80.2 (28.2) vs. 58.7 (30.7), P <0.001), more likely to be age 65 
or older (58.9% vs. 41.8%, P <0.001) and require more organ supportive 
therapies (Table 1). DU patients had a higher in-hospital mortality rate 
(32.2% vs. 18.3%, P <0.001) and longer mean ICU and hospital LOS 
(4.9 vs. 3.3 days and 15.6 vs. 10.5 days, respectively (P <0.001)). After 
multivariate adjustment, DU patients stayed 3.2  days, 95% CI (1.6, 
4.8) longer in the hospital than non-DU patients and stayed 2.5 days 
longer, 95% CI (0.7, 0.43) among survivors. DU patients had longer ICU 
stays (1.3 days, 95% CI (0.3, 1.3)) in general but were statistically similar 
among survivors.
Table 1 (abstract P465)
   Admitted  Admitted
   with  without
   decubitus  decubitus  P
Variable (n = 180) (n = 2,543) value
Age 65 or older  106 (58.9%)  1,062 (41.8%)  <0.001
APACHE IV score on admission  80.2 (28.2%)  58.7 (30.7)  <0.001
Diabetes  53 (29.4%)  420 (16.5%)  <0.001
Dialysis  16 (8.9%)  58 (2.3%)  <0.001
Hepatic failure  3 (1.7%)  56 (2.2%)  1.000
Mechanically ventilated during   123 (68.3%)  1,457 (57.3%) 
hospitalization
Admission source to the ICU     
  Direct admit  10 (5.6%)  154 (6.1%) 
  ER  84 (46.7%)  1,206 (47.4%) 
  Floor  25 (13.9%)  214 (8.4%)  0.017
  OR  19 (10.6%)  459 (18.1%) 
  Other location  42 (23.3%)  510 (20.1%) 
Outcomes    
  ICU LOS (days)  4.9 (4.9)  3.3 (4.7)  <0.001
  Hospital LOS (days)  15.6 (20.7)  10.5 (11.1)  <0.001
  ICU mortality  30 (16.7%)  308 (12.1%)  0.073
  Hospital mortality  58 (32.2%)  464 (18.3%)  <0.001
  Readmission rate for   20 out of 112  173 out of 2,079  0.002
 survivors  (16.4%)  (8.3%)
Conclusion  The presence of decubiti on admission to the ICU is 
associated with longer hospitalizations even after adjusting for age, 
acuity, and organ supportive therapies. DU on admission to ICU provide 
a unique, unambiguous marker of increased resource utilization.
Figure 1 (abstract P464). Tufts surgical ICU, 15-year outcome 
standardized hospital mortality ratio.
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experience of 15 years: 1995 to 2009
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Introduction HIV infection is a major public health problem in the 
world. The use of prophylaxis against opportunist infection and 
the introduction of HAART in 1996 increased life expectancies. The 
therapeutic use of ICU resources for HIV patients has been controversial, 
questioning the admission of these patients especially in advanced 
stages of the disease, given the poor prognosis. The aim of this study 
was to determine the experience of the past 15 years in relation to the 
income of these patients in an ICU.
Methods  A retrospective case series consisting of patients with 
diagnosis of HIV infection (known or unknown) admitted between 
January 1995 and December 2009. We collected demographic and 
epidemiological data, process of acquisition of the disease, infection 
status: known or unknown patient infected, whether or not receiving 
antiretroviral therapy and whether it was eff  ective (undetectable viral 
load at the time of admission), APACHE II, cause of admission, need 
for mechanical ventilation (MV), pathology related or unrelated to HIV 
infection and ICU mortality.
Results  During this period 12,607 patients were admitted to the 
ICU, 188 (1.5%) HIV-positive. Mean APACHE II score 17.6, median age 
39 years, 73% men and 90% Spanish nationality. Principal risk behavior: 
addiction drugs injection (67%). Seventeen percent of patients did 
not know who was infected with HIV at the time of admission to the 
ICU. Fifty-three percent were not receiving HAART. Of the 88 patients 
treated, 93% were receiving HAART (eff  ective in 88% of cases). Sixty 
percent of the patients came from the emergency department of the 
hospital. Main admission diagnoses: acute respiratory failure caused 
by infection (Streptococcus pneumoniae and Pneumocystis jirovecii), 
neurological disorders (coma for illicit drugs and psychotropic) and 
septic shock. Seventy percent required MV. Of patients whose HIV 
infection was not known, 93.5% were admitted for related pathology. 
In patients of known infection, the pathology associated with HIV was 
30%. Average length of stay 9 was days. ICU mortality was 35%. Most 
frequent causes of death: septic shock and multiple organ failure.
Conclusion Depending on the patient and the cause of admission, 
ICU admission may represent an excellent opportunity as a screening 
method to determine HIV status. Given the greater effi   cacy of HAART 
at present, most patients with medical or surgical conditions unrelated 
to HIV infection will be eligible to join the ICU. People with HIV can and 
should benefi  t from using reasonable and individualized care in an ICU.
References
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Introduction The aim was to analyze the prognosis of AIDS patients 
with organ dysfunctions at ICU admission.
Methods A prospective cohort study, including all patients with HIV/
AIDS diagnosis, who were admitted to a specialized ICU from November 
2009 until May 2012. Patients with less than 24 hours of ICU stay were 
excluded. Demographics and nutritional status were collected. The 
organ dysfunctions were classifi  ed according to the SOFA score, and 
categorized as absent (0 SOFA point), mild (1 to 2 points) and severe (3 to 
4 points). We expressed numeric variables as median and interquartile 
interval (25% to 75%). We performed a multivariate analysis of possible 
variables associated with hospital mortality (P <0.2), and we explored 
the 7-day, 28-day and 60-day survival of patients with and without 
independent risk factors.
Results  We included 139 patients with HIV/AIDS admitted to the 
ICU. Median age was 40 (31 to 48) years and 71% were male. Severe 
malnutrition was common (34%). The CD4 cell count was 84 (25 to 274) 
cells/mm3 and viral load was 17,733 (67 to 174,214) copies/ml; 57% had 
at least one opportunistic infection; 55% had used antiretroviral therapy 
previous to ICU admission. Mechanical ventilation was used by 46% of 
patients and hospital mortality was 42%. Total SOFA score was 5 (2 to 
9) points. Cardiovascular dysfunction was the most common on the 
fi  rst day of stay (51%), followed by respiratory (42%), neurological (40%), 
renal (35%), hematological (27%) and hepatic (17%). Cardiovascular and 
renal dysfunctions presented with higher rate of severe dysfunction 
(30% and 15%, respectively). Rates of neurological (P = 0.002), renal 
(P = 0.009) and hematological (P = 0.003) dysfunctions were higher 
in nonsurvivors. Age, CD4 cell count, malnutrition, and opportunistic 
infections were included in the multivariate analysis. Neurological 
dysfunction was the independent risk factor for hospital mortality 
(odds 3.2 (1.4 to 7.2)). The presence of neurological dysfunction was 
dichotomized: associated or not with primary neurological diagnosis; 
survival was lower in the patients with neurological dysfunction and 
without primary neurological diagnosis (log-rank test 0.001 in the 
7-day and 0.02 in the 28-day analysis). Sixty-day survival was similar 
in primary and secondary neurological dysfunction, but it remained 
lower than in patients without neurological impairment.
Conclusion Neurological dysfunction was independently associated 
with hospital survival, mainly in those AIDS critically patients without 
primary neuropathy.
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Introduction  Sepsis in HIV patients carries a high mortality. Our 
purpose is to identify mortality predictors in this population.
Methods  A retrospective study of HIV patients admitted to our 
ICU between January 2005 and December 2009. We identify septic 
patients and analyzed demographic factors, etiology, organ failure 
and outcome. We used logistic regression to calculate the relative 
mortality risk for each qualitative variable and the beta (β) coeffi   cient 
for quantitative variables.
Results  Sixty-two septic patients were admitted to our ICU during 
the study period (71% men, mean age: 40.59  ±  8.12). A total of 
56.5% came from the ED, mean hospital stay before ICU admission: 
6.14 ± 10.96 days. A total of 66.1% had a history of intravenous drug 
use, other comorbidities: COPD (9.7%), cirrhosis (8.1%), solid or 
hematologic malignancy (12.9%). A total of 40.3% were under HAART. 
Mean CD4 count at admission: 219.62 ± 353.93 cells/mm3. Mean viral 
load: 4.57 ± 3.25 log. Mean albumin levels: 2.3 ± 0.53 g/dl. APACHE 
II: 21.98 ± 7.97. The lung was the most frequent focus of infection 
(65.6%) followed by the CNS. The most common pathogen was 
S. pneumoniae (28.8%), followed by P. jirovecii (13.6%). In total, 62.9% 
needed vasopressors, 79% mechanical ventilation and 19.4% renal 
replacement. Mean ICU and hospital length of stay: 10.43 ± 10.52 and 
34.76 ± 29.64 days. ICU mortality: 33.9%; hospital mortality: 41.9%. ICU 
mortality increases for each day of hospital stay before ICU admission 
(β = 1.062, 95% CI = 1.009 to 1.118, P = 0.022), each point of: cardiac 
frequency at admission (β = 1.059, 95% CI = 1.024 to 1.096, P = 0.001), 
FiO2 (β = 1.034, 95% CI = 1.011 to 1.057, P = 0.003), pCO2 (per mmHg) 
(β = 1.052, 95% CI = 1.007 to 1.098, P = 0.023); and decreases for each 
point of: albumin (g/dl) (β = –0.307, 95% CI = 0.095 to 0.986, P = 0.047), 
mean arterial pressure (mmHg) (β = 0.951, 95% CI = 0.904 to 0.999, 
P = 0.048), pH (β = 0.002, 95% CI = 0.0 to 0.172, P = 0.006), fi  rst ICU 
24-hour diuresis (ml) (β = 0.999, 95% CI = 0.998 to 1.000, P = 0.004) and 
base excess (β = 0.912, 95% CI = 0.836 to 0.995, P = 0.039). Mortality 
increases threefold (β = 3.134, 95% CI = 1.051 to 9.345, P = 0.04) if 
patients do not come from the ED, almost 10-fold if the patients 
need vasopressors for more than 24 hours (β = 9.975, 95% CI = 2.054 
to 48.451, P = 0.004) and fi  vefold if patients need renal replacement 
(β = 5.692, 95% CI = 1.466 to 22.099, P = 0.012).
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S174Conclusion Neither immune status-related variables nor comorbidity 
or infection focus are mortality predictors. Poor nutritional status, 
delayed ICU admission, shock or renal failure increase the ICU relative 
mortality risk. Tachycardia, hypotension, hypercapnia, acidosis, and 
oliguria in the fi  rst ICU 24 hours increase signifi  cantly ICU mortality. 
Mechanical ventilation is not a mortality predictor.
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Introduction  Patients with lung cancer commonly require the ICU 
for a variety of acute illnesses related to the underlying malignancy, 
treatment, or comorbid conditions. ICU admission of patients with 
nonresectable lung cancer has been criticized based on the high 
mortality rate in this population. However, recent advances in critical 
care may have changed this scenario. The aim of this study was to 
identify factors associated with hospital mortality in this group of 
patients.
Methods A retrospective study was conducted in consecutive medical 
and surgical patients with lung cancer admitted to a university hospital 
ICU in São Paulo, between 2007 and 2012. A univariate analysis was 
performed to identify associated variables with hospital mortality. 
Selected variables were included in the multivariate model.
Results From 597 patients included in the study, 477 were medical 
admissions (79.8%) and 120 were surgical admissions (20.2%). Four 
hundred and twenty (70%) patients had metastasis, 222 patients (37%) 
required the ICU because of respiratory failure and 121 (20%) because 
of septic shock. The ICU and hospital mortality rates were 53.9% and 
64%, respectively. In the univariate analysis, variables associated 
with hospital mortality were diagnosis of nonsmall-cell lung cancer, 
higher Charlson morbidity index, medical admission, active neoplasm, 
vasopressor need at admission to and at 24 hours of ICU, acute renal 
failure at admission, non-invasive ventilation or mechanical ventilation 
need at admission to and at 24 hours of ICU and a higher admission 
arterial lactate. By multivariate analysis, risk factors of hospital mortality 
were diagnosis of nonsmall-cell lung cancer (OR = 3.32; 95% CI, 2.08 
to 5.29, P <0.001), medical admission (OR = 2.89; 95% CI, 1.75 to 4.77, 
P <0.001), acute renal failure at admission (OR = 4.09; 95% CI, 1.49 to 
11.21, P <0.001), non-invasive ventilation at 24 hours of ICU (OR = 2.50; 
95% CI, 1.48 to 4.23, P = 0.001) and mechanical ventilation at 24 hours 
of ICU (OR = 3.68; 95% CI, 1.87 to 7.26, P <0.001).
Conclusion Hospital survival in patients with lung cancer requiring 
ICU admission was 36%. Our results provide evidence that ICU 
management may be appropriate in patients with nonresectable lung 
cancer and appoint risk factors for mortality, helping to better triage 
cancer patients who will benefi  t from ICU care.
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Introduction Because the prognosis of older patients with cancer may 
be poor compared with younger patients, it remains controversial 
whether they benefi  t from ICU treatment. The objective of this study 
was to identify factors associated with hospital mortality in older 
patients with cancer requiring the ICU.
Methods A retrospective study was conducted in consecutive medical 
and surgical older patients with cancer admitted to a university hospital 
ICU in São Paulo, between 2007 and 2012. Univariate and multivariate 
analysis were performed to identify associated and independent 
factors related to hospital mortality.
Results From 8,976 patients with cancer requiring ICU at the period, 
600 patients were 80 years old or higher. Most patients were male 
(53%), had solid neoplasm (86%), were from medical admission (54%) 
and 37% had metastatic disease. The mean age was 84 years (± 3). 
The ICU and hospital mortality rates were 30% and 44%, respectively. 
In the univariate analysis, variables associated with hospital mortality 
were diagnosis of lung cancer, medical admission, active neoplasm, 
vasopressor need at 24 hours of ICU, acute renal failure at admission, 
mechanical ventilation need at admission to and at 24 hours of ICU and 
a higher admission arterial lactate. By multivariate analysis, risk factors 
of hospital mortality were diagnosis of lung cancer (OR = 2.32; 95% CI, 
1.08 to 3.29, P <0.001), medical admission (OR = 6.473; 95% CI, 2.76 to 
15.15, P <0.001), acute renal failure at admission (OR = 3.09; 95% CI, 1.49 
to 9.21, P <0.001), mechanical ventilation at 24 hours of ICU (OR = 5.68; 
95% CI, 2.87 to 7.26, P <0.001) and lactate levels at admission (OR = 1.02; 
95% CI, 1.006 to 1.051, P <0.001).
Conclusion Hospital survival in older patients with cancer requiring 
ICU admission is acceptable. Our results provide evidence that ICU 
management may be appropriate in older patients with cancer and 
appoint risk factors for mortality, helping to better triage cancer 
patients who will benefi  t from ICU care.
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Introduction Readmission to the ICU within 48 hours is an indicator of 
quality of intensive care and is associated with an increase in mortality. 
During the last years several groups have published data based on 
multivariate logistic regression analysis to describe characteristics of 
patients who needed readmission to the ICU. Older age, comorbid 
conditions and severity of illness (APACHE score) have been among 
the strongest predictors for readmission. In our ICU most patients are 
in the groups formerly identifi  ed as risk groups, which means that 
stratifi  cation and prediction of readmission is diffi   cult. Because of the 
unusual high severity of acute and pre-existing illnesses we could 
not fi  nd a data match on comparable patient groups. To investigate 
whether we could reduce our rate of readmission we therefore decided 
to perform a qualitative investigation to identify risk factors related to 
readmission. After identifi  cation of the risk factors we will take actions 
to optimize care and perform ongoing control of the implemented 
actions to secure that they decreases the rate of readmission.
Methods Retrospective data on patients readmitted to the ICU within 
48 hours during an 8-month period (November 2011 to June 2012) were 
drawn from the Critical Information System (CIS) at ICU ZIT, Bispebjerg 
Hospital, Denmark. ZIT is a multidisciplinary unit with 10 beds and 500 
to 600 admissions/year and a median SAPS II score of 47. A group of 
consultants, junior doctors and nurses from the ICU and the ward each 
read the patient fi  les with focus on pattern recognition and suggested 
trigger points to focus on. Data on trigger points were then drawn from 
the CIS system and re-evaluated. Finally, fi  ve key points were identifi  ed 
and serves as basis for future actions.
Results In a qualitative analysis, readmissions to the ICU are related 
to the following fi  ve key points – discharge outside day hours, lack of 
infection control, stay in ICU <2 days, lung physiotherapy ordinated but 
not eff  ectuated, and several minor organ dysfunctions (atrial fi  brillation 
and acute kidney injury). Age, diagnosis, SAPS II score or ventilator 
treatment during intensive care was not diff  erent in patients with 
successful discharge and patients readmitted in this group of patients.
Conclusion It is possible and suitable to identify key points for future 
eff  orts in a given subgroup of patients using a systematic qualitative 
approach.
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Introduction  Adult recipients of living donor liver transplantation 
have a wide range of postoperative medical comorbidities altering 
various clinical and laboratory parameters. We aimed to assess 30-
day postoperative clinical and laboratory changes and their value in 
predicting outcome of LDLT recipients.
Methods A prospective registry involving patients who underwent LDLT 
in the period from October 2004 to December 2010. Postoperative 30-
day clinical and laboratory data included: clinical BP, HR, temperature, ICU 
stay, liver functions AST, ALT, GGT, ALP, TotPtn, Alb, TBil, DBil, INR, PTT, CRP, 
kidney functions Crea, Na, K, blood picture Hb, Hct, TLC and Plt count.
Results Our study involved 142 recipients, 124 (87%) males and 18 
(13%) females, who underwent living donor liver transplantation; 
mean age was 53 ± 14.8 years, ranging from 24 to 66 years; 29 cases 
(20.43%) at Kasr Al Aini University Hospital and 113 cases (79.57%) at 
the International Medical Center. The 30-day mortality rate was 13.38%. 
Clinical and laboratory parameters showed gradual resolution towards 
normal values in survivors or deterioration in nonsurvivors, allowing 
one to predict mortality at various cutoff   points. Clinical parameters: HR 
>94 cutoff   (Acc 76.8%, Sens 89.5%, Spec 62.6%, PPV 27, NPV 97) and ICU 
stay >8 days (Acc 76.2%, Sens 75.3%, Spec 95.7%, PPV 95.7, NPV 35.3). 
Laboratory parameters: INR >3.06 cutoff   (Acc 87.5%, Sens 92.9%, Spec 
78.6%, PPV 96.3, NPV 64.7), followed by PTT >53.3 (Acc 79.2%, Sens 
78.6%, Spec 75%, PPV 93.6, NPV 42.9), Na >142.9 (Acc 72.9%, Sens 80%, 
Spec 72.3%, PPV 26.7, NPV 96.6), TBil >15 (Acc 71.3%, Sens 95.5%, Spec 
50%, PPV 92.4, NPV 63.6), ALT >379 (Acc 67.5%, Sens 72.2%, Spec 73.8%, 
PPV 28.9, NPV 94.7), TProt <4.6 (Acc 63.5%, Sens 55.6%, Spec 73.3%, PPV 
24.4, NPV 91.4), AST >145 (Acc 57.4%, Sens 50%, Spec 84.4%, PPV 32.1, 
NPV 92), Hct <24.4 (Acc 54.2%, Sens 47.4%, Spec 81.5%, PPV 34.6, NPV 
88.2), CRP >12 (Acc 51.6%, Sens 43.7%, Spec 73.3%, PPV 90.5, NPV 17.7), 
GGT >22 (Acc 51.4%, Sens 83.3%, Spec 36.9%, PPV 16.3, NPV 93.7).
Conclusion Predictors of mortality were INR >3.06 (accuracy 87.5%) 
followed by PTT >53.3 (79.2%), HR >94 (76.8%), ICU stay >8  days 
(76.2%), Na >142.9 (72.9%), TBil >15 (71.3%), ALT >379 (67.5%), TProt 
<4.6 (63.5%), AST >145 (57.4%), Hct <24.4 (54.2%), CRP >12 (Acc 51.6%) 
and GGT >22 (51.4%).
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Introduction Even though more accurate and updated versions such 
as APACHE III and IV have been developed, APACHE II has remained the 
most widely used severity scoring system in the ICU [1]. In the present 
study, we aimed to develop a model mainly based on the laboratory 
data available upon admission to predict mortality and to compare its 
performance with that of APACHE II in a mixed ICU in Turkey.
Methods A total of 645 adult patients who were over 18 years old 
and who stayed in the ICU for more than 24 hours were included in 
this study. Using stepwise multivariate logistic regression analysis, a 
mortality prediction model was developed based on the laboratory 
data, diagnostic category and age. The adjusted probability of death, 
according to the diagnostic category of the APACHE II score (adj-APACHE 
II), was calculated. The ability of the laboratory model and the adj-
APACHE II model to discriminate between survivors and nonsurvivors 
was assessed using receiver operating characteristic (ROC) curves. The 
calibration of the laboratory model and the adj-APACHE II model was 
assessed by the Hosmer and Lemeshow goodness-of-fi  t test.
Results The areas under the ROC curves of the laboratory models and 
the adj-APACHE II scores for the prediction of mortality were 0.80 (95% 
CI: 0.76 to 0.85) and 0.78 (95% CI: 0.74 to 0.83), respectively (P >0.05, z 
statistic). The Hosmer–Lemeshow statistic had a chi-squared value of 
2.01 (P = 0.98) for the laboratory model and 13.2 (P = 0.10) for the adj-
APACHE II model.
Conclusion If the aim is to predict mortality as accurately as APACHE 
II, the mortality prediction model based mainly on routine admission 
laboratory tests can achieve this using computer technology, without 
labor-related costs, as soon as the patient is admitted to the ICU. 
However, it is necessary to perform multicenter validation studies.
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Introduction The aim of this study is to evaluate the performance of 
SAPS 3 and EuroSCORE and whether there is complementarity between 
them in ICU patients admitted after cardiac surgery.
Methods  An observational, prospective and multicenter study of 
patients included in the ARIAM registry of adult cardiac surgery. We 
analyzed clinical variables, surgery data and postoperative compli-
cations, outcomes and scores (SAPS 3 and EuroSCORE). Discrimination 
was assessed using the area under the ROC curve. With the standardized 
mortality ratio (SMR) we evaluated the agreement between predicted 
and observed mortality. We used multiple logistic regression for 
multivariate analysis.
Results A total of 5,642 patients were included, admitted to any fi  ve 
hospitals, consecutively between 2008 and 2012. Mean age was 
63.62 ± 12.80 years. Surgery room mortality was 1.4%, ICU mortality 
was 7.9% and in-hospital mortality was 11.2%. SAPS 3 was calculated 
in 5,383 patients. SAPS 3 was 40.91 ± 10.46, and the expected rate of 
mortality was 11.09% (with the southwestern Europe equation), with 
an observed hospital mortality of 9.6%, SMR = 0.87 (0.79 to 0.94). With 
the general equation, the expected mortality was 10.47%, SMR = 0.917 
(0.843 to 0.996). Discrimination of SAPS 3 was evaluated using the area 
under the ROC curve, it was 0.77 (0.75 to 0.79). The 30-day mortality was 
9.6%, with an expected 30-day mortality predicted by EuroSCORE of 
7.86% (SMR = 1.22; CI = 1.12 to 1.32). The area under the ROC curve was 
0.734 for EuroSCORE (0.712 to 0.755). Multivariate analysis with logistic 
regression showed complementarity between SAPS 3 and logistic 
EuroSCORE (vers. I). There is a relationship between hospital mortality 
and the probability of dying predicted by SAPS 3 (general equation), 
OR 1.05 (1.04 to 1.06), and logistic EuroSCORE (vers. I), OR 1.024 (1.015 
to 1.032). The model with both variables has a similar discrimination to 
SAPS 3 alone. The area under the ROC curve of the combined model 
was 0.778 (0.758 to 0.799) and 0.77 (0.75 to 0.79) using SAPS 3 only.
Conclusion There is complementarity between the SAPS 3 model and 
EuroSCORE. However, a joint model with both prognosis scores has no 
appreciable improvement in discrimination, compared with the SAPS 
3 model. In our study, SAPS 3 shows very useful to rule out that the 
superior observed mortality (compared with the mortality predicted 
by EuroSCORE) is not attributable to inadequate care of patients in the 
ICU, the observed mortality being even slightly below the predicted 
mortality for patients undergoing cardiac surgery at the reference 
hospitals in which the SAPS 3 system was developed.
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status might aff  ect the clinical picture and outcome of a subsequent 
septic insult. To test this hypothesis, patients were categorized 
according to previous infl  ammatory activity and analyzed with respect 
to clinical picture and outcome in a retrospective study.
Methods  The Swedish ICU registry was used to identify all adult 
patients diagnosed with severe sepsis or septic shock in a single 
Swedish ICU during 2006 to 2011. The charts were reviewed and 
patients categorized into four groups based on whether the patient 
had suff  ered systemic infl  ammatory-inducing insults previous to the 
septic episode. The patients were categorized as: (A) primary sepsis, 
no recent (<30 days) trauma/infection, ongoing systemic infl  ammatory 
or immunosuppressive disease or malnutrition; (B) secondary sepsis, 
recent (<7 days) trauma/infection or systemic infl  ammatory disease, 
but no immunosuppressive disease or malnutrition; (C) tertiary 
sepsis, >1 fulfi  lled criteria of secondary sepsis during the last 10 days 
or immunosuppressive disease or malnutrition; and (D) patients not 
attributable to A to C. After the categorization, physiological and 
laboratory parameters during the ICU stay as well as therapy and 
outcome were extracted from the charts. Only signifi  cant diff  erences 
(P <0.05) are presented; Mann–Whitney and chi-squared tests were 
used.
Results  A total of 273 charts were reviewed. In total, 242 were 
categorized into A (n = 126), B (n = 79) or C (n = 37). D (n = 31) consisted 
mainly of patients with hematological malignancies (n  =  12) and 
patients with chemotherapy or immunosuppressive treatment 
(n = 14). The groups diff  ered in length of stay with A< B< C. During the 
fi  rst 3 days the SOFA score was higher in A compared with C and in 
B compared with C. The duration of antibiotic therapy was longer in 
both B and C compared with A. There were no diff  erences in 28-day 
mortality (A: 34/126 = 27%, B: 30/79 = 38%, C: 15/37 = 40%); however, 
the proportions of patients dying between days 8 and 28 were higher 
in B (14/63 = 22%) and C (7/29 = 24%) compared with A (5/95 = 5%).
Conclusion In this retrospective material it was possible to categorize 
88.6% of all patients as having primary, secondary or tertiary sepsis. 
The categories diff  ered in clinical picture at presentation as well as in 
outcome. A prospective study is warranted to validate the results of this 
study.
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Introduction We aimed to assess the survival of older patients after 
admission to critical care compared with the population in general.
Methods  We reviewed admission data for a 12-bed critical care 
unit in a district general hospital in the UK between 2001 and 2010. 
We calculated critical care and hospital discharge survival rates and 
studied the trend in these through the decade. We searched hospital 
records to establish whether these patients were still alive at November 
2012 to determine life-expectancy (minimum 22-month follow-up on 
all patients). This was compared with UK Offi   ce of National Statistics 
data for the local population [1]. Discharge destination (care facility or 
home address) was recorded as a surrogate marker of change in quality 
of life post discharge.
Results A total of 481 patients aged 80 or over were admitted between 
1 January 2001 and 31 December 2010, representing 9.6% of the 
admissions during this time with minimal annual change. Admission 
age ranged from 80 to 96 years (median 83) with a median APACHE II 
score of 20 (6 to 48, IQR 16 to 25). In total, 318 (66.1%) survived to critical 
care discharge and 256 (53.2%) survived to hospital discharge; 228 
(89.0%) went home rather than to a care facility. Those under 80 years 
demonstrated 80.6% critical care survival, 65.5% hospital survival and a 
median APACHE II score of 17 (0 to 51, IQR 13 to 23). Eighty patients died 
within the 22-month follow-up period with an average life expectancy 
of 7.4 months. None reached life expectancy (average curtailment of 
5.6 years compared with age-matched and sex-matched population 
statistics). Neither of these fi  gures changed signifi  cantly through the 
decade. However, 10-year follow-up on 2001/2002 admissions showed 
that, despite this early mortality eff  ect, the average post-discharge 
lifespan was 5.1 years with 2.2 years shortfall in life expectancy.
Conclusion  Older people represent a growing proportion of the 
population although their representation in the critical care population 
remained constant in this 10-year study. These patients had a slightly 
higher median APACHE II score and 14.5% greater critical care mortality 
than the younger patients. The majority of survivors were able to 
go home; however, 31% died within 22 months with signifi  cant life 
expectancy curtailment, surviving on average only 7.4 months after 
discharge; this has not changed in the last 10 years. Those who survived 
this initial period (69%) had a much better outlook. This information 
may be vital to patients and physicians when discussing admission to 
critical care.
Reference
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Introduction The indication for ICU admission is poorly defi  ned and 
identifying patients who may benefi  t from it is extremely diffi   cult. As 
reported in literature, the Eldicus scores require further validation in 
centers in diff  erent countries and with diff  erent patient populations [1]. 
Previous studies have demonstrated that patients with intermediate 
severities of illness are those that benefi  t from ICU treatment; instead, 
patients who are too well or too sick should not be admitted. There are 
many unmeasurable factors that infl  uence the triage decision and can 
infl  uence the subsequent outcome. The Eldicus scores could be the fi  rst 
triage decision rule. The aim of this study was to confi  rm the ability of 
the Eldicus scores to discriminate the survival status in our general ICU.
Methods We retrospectively enrolled all patients >18 years admitted to 
the Ferrara ICU from January to June 2012. Patients’ data were recorded 
using Prosafe international data collection software and consulting 
the individual medical records. Data were chosen based on variables 
used in the Eldicus scores. As indicated in the Eldicus algorithm, for 
each patient the initial refusal score was calculated, to evaluate the 
too severe patients. Then we counted the fi  nal triage score, to discover 
whether some patients were too healthy to be admitted to the ICU. 
Correlation between the severity of the scores and patients’ outcome 
was estimated using the Wilcoxon’s rank-sum test.
Results Ninety-eight patients were fi  nally enrolled. Data are presented 
as median ± SD. The SAPS II score was 33 ± 13 and was similar to those 
reported in the literature [1]. The Karnofsky performance status scale 
was 69 ± 20. The Eldicus initial score was 56 ± 30. The fi  nal score was 
70 ± 48. Seventy-eight percent of the analyzed patients were alive at 
hospital discharge. A signifi  cant correlation between the severity scores 
and in-hospital outcome was found (P <0.001). Limitations of our study 
were the low sample size and the fact that patients not admitted to the 
ICU were not considered.
Conclusion  The Eldicus scores appear to be useful in identifying 
patients that may benefi  t more from ICU admission. Further studies 
should confi  rm the ability of these scores in helping identify those 
patients who really benefi  t from ICU admission.
Reference
1. Sprung  CL,  et al.: Crit Care Med 2012, 40:125-131.
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Introduction  The purpose was to develop a predictive screening 
instrument for use at ICU discharge to identify patients at risk for post-
traumatic stress, anxiety or depression.
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prospectively collected at ICU discharge. Two  months after ICU 
discharge 252 ICU survivors received the questionnaires Post-
Traumatic Stress Symptom scale-10 (PTSS-10) and Hospital Anxiety 
and Depression Scale (HADS) to estimate the degree of post-traumatic 
stress, anxiety and depression.
Results  Of the 150 responders, 31% had adverse psychological 
outcome, defi  ned as PTSS-10 >35 and/or HADS subscales ≥8. After 
analysis, six predictors with weighted risk scores were included in the 
screening instrument: major pre-existing disease, being a parent to 
children younger than 18 years of age, previous psychological problems, 
in-ICU agitation, being unemployed or sick-listed at ICU admission and 
appearing depressed in the ICU. Each predictor corresponded to a 
given risk score. The total risk score, the sum of individual risk scores, 
was related to the probability for adverse psychological outcome in the 
individual patient. The predictive accuracy of the screening instrument, 
as assessed with area under the receiver operating curve, was 0.77. 
When categorizing patients in three risk probability groups – low (0 to 
29%), moderate (30 to 59%) and high (60 to 100%) risk – the actual 
prevalence of adverse psychological outcome in respective groups was 
12%, 50% and 63%.
Conclusion The preliminary screening instrument may aid ICU clinicians 
in identifying patients at risk for adverse psychological outcome after 
critical illness. Prior to wider clinical use, external validation is needed.
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Introduction  The multiorgan dysfunction syndrome (MODS) is a 
dynamic process involving simultaneously or consecutively two 
or more organ systems [1]. The organ dysfunction’s degree can be 
assessed by three severity scores (SOFA [2], MODS [3], LODS [4]), but 
they have some limitations: they do not allow the evaluation of the 
clinical course of a patient, they are not reliable in populations diff  erent 
from the reference one, and they do not support clinicians’ decisions. 
Because MODS implies a systemic infl  ammatory reaction leading to 
microcirculatory dysfunction, our hypothesis was that organ failures 
follow a predictable sequence of appearance. Our aims were to verify 
the presence of more likely organ failure sequences and to assess an 
online method to predict the evolution of MODS in a patient. The high 
mortality and morbidity rate of MODS in ICUs can in fact be reduced 
only by a prompt and well-timed treatment [5].
Methods We selected 73 patients consecutively admitted to the ICU of 
Sant’Andrea Hospital from January to June 2012. The inclusion criteria 
were at least two organ systems with SOFA ≥2, ICU length of stay 
>48 hours. For each patient we calculated the SOFA since the beginning 
of the inclusion criteria and daily for 8 days. For the statistical analysis 
we used Dynamic Bayesian Networks (DBNs) [6]. DBNs were applied to 
model SOFA changes in order to identify the most probable sequences 
of organs failures in a patient who experienced a fi  rst known failure.
Results  We created a DBN for the analysis of MODS studying the 
relations between organ failures at diff  erent times. The DBN was made 
so that each organ failure is dependent on the previous one. We also 
considered a corrective factor to take account that not all patients 
completed the observation. Using software (GeNie) we obtained the 
probabilities of the organ failure sequences.
Conclusion The use of DBNs, although with our limited set of data, 
allowed us to identify the most likely organ dysfunction sequences 
associated with a fi  rst known one. Capability to predict these sequences 
in a patient makes DBNs a promising prognostic tool for physicians in 
order to treat patients in a timely manner, or to test a treatment effi   cacy.
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Introduction The aim of this study was to compare the IGS 2 score with 
a predictive model built using clinical characteristics and biomarkers 
associated with 1-year mortality from procalcitonin, C-reactive protein, 
troponin I (TnI) and NT-Pro-BNP.
Methods  We conducted a prospective observational cohort study 
in a polyvalent ICU. We calculated the IGS 2 severity score in the fi  rst 
24  hours. We dosed NT-Pro-BNP, TnI, procalcitonin and C-reactive 
protein at admission to the ICU. To test the biomarker model, the patient 
database was divided into training (70%) and test (30%) databases. A 
neural network model was trained from variables associated with 
1-year mortality. All statistics were done using R v.2.15.1. We used the 
pROC package to plot and compare ROC curves.
Results Lower age, NT-Pro-BNP and TnI were signifi  cantly associated 
with 1-year survival. We built a neural network model using the training 
database. We used the test database to compare our model with the 
IGS 2 score. The diff  erence between the AUC of the biomarker score 
and the IGS 2 score was statistically signifi  cant (Figure 1).
Conclusion Our new neural network model built using age, NT-PRO-
BNP and TnI succeeded the internal-validation processes and predicts 
1-year mortality better than IGS 2.
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Figure 1 (abstract P480). Comparison of area under ROC curves (AUC) of 
the biomarker score and IGS 2.
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admitted to an ICU remains diffi     cult and mortality amongst ICU 
patients is high. To render intensive care with no prospect of success 
is an immense emotional burden for both patient and relatives, and 
a great socioeconomic burden for society as well. Therefore, validated 
strategies that can help identify patients who will benefi  t  from 
intensive care are in demand. This study seeks to investigate whether 
preadmission quality of life can act as a predictor of mortality amongst 
patients admitted to the ICU.
Methods All patients (>18 years) admitted to the ICU for more than 
24 hours are included. In order to assess preadmission quality of life, 
the patient or close relatives complete the Short-Form 36 (SF-36) 
within 72 hours after ICU admission. Mortality is evaluated from ICU 
admission until 30  days hereafter. Logistic regression and receiver 
operating characteristic analyses are employed to assess predictive 
value for mortality using fi   ve models: SF-36 Physical Component 
Summary (PCS) and APACHE II (model A), SF-36 PCS (model B), SF-36 
General Health (GH) and APACHE II (model C), SF-36 GH (model D), 
and APACHE II (model E). Classifi  cation tables are composed in order 
to assess sensitivity, specifi  city, positive and negative predictive values 
and likelihood ratios.
Results Preliminary results, based upon data from 175 included patients, 
reveal an ICU mortality of 12.6% and 30-day mortality of 22.9%. No 
patients were lost to follow-up. When the Physical Component of SF-36 
(PCS) was used as an estimate of preadmission quality of life, the area 
under the curve for model B (AUC = 0.80) was comparable with model E 
(AUC = 0.81), and better than model A (AUC = 0.85). The General Health 
item of SF-36 (GH), used as an estimate of preadmission quality of life, 
gave an AUC = 0.76 (model D). All models were controlled for sex and 
age.
Conclusion  Preliminary results indicate that the SF-36 GH and the 
SF-36 PCS are as good as APACHE II to predict mortality 30 days after 
ICU admission. However, in order to conclude whether preadmission 
quality of life can contribute to triage, by successfully identifying 
patients suitable for intensive care, fi  nal analyses, due in 2013, are 
awaited. These results will clarify whether future randomized controlled 
trials, in which preadmission quality of life acts as a supplement to 
triage, are justifi  able.
P482
Predicting physical function and mental health in trauma intensive 
care patients 2 years after hospitalisation
L Aitken1, B Macfarlane1, W Chaboyer2, M Schuetz1, C Joyce1, AG Barnett3
1Princess Alexandra Hospital, Brisbane, Australia; 2Griffi   th University, 
GoldCoast, Australia; 3Queensland University of Technology, Brisbane, 
Australia
Critical Care 2013, 17(Suppl 2):P482 (doi: 10.1186/cc12420)
Introduction  Long-term compromise after traumatic injury is 
signifi  cant; however, few modifi  able factors that infl  uence outcome 
have been identifi  ed. The aim of this study was to identify acute and 
early post-acute predictors of long-term recovery amenable to change 
through intervention.
Methods Adults (>17 years) admitted to the ICU, Princess Alexandra 
Hospital, Australia following injury were prospectively followed. 
Data were collected on demographics, pre-injury health, injury 
characteristics and acute care factors. Psychosocial measures (self-
effi     cacy (SE), illness perception (IP), post-traumatic stress disorder 
(PTSD) symptoms and psychological distress) and health status (SF-36) 
were collected via questionnaire 1, 6, 12, and 24 months post injury. 
Outcomes of interest were the Physical Function (PF) and Mental Health 
(MH) subscales of the SF-36. Regression models were used to estimate 
predictors of physical function and mental health over a 2-year period. 
A subject-specifi  c intercept in a mixed model was used to account for 
repeated data from participants over time.
Results  Participants (n  =  123) were young (median 37, IQR 22 to 
55  years), predominantly male (83%) and spent on average 3  days 
in the ICU and 3 weeks in hospital. Response rates were over 55% at 
each follow-up, with responders similar to nonresponders except for 
being generally older. PF and MH scores improved over time, although 
the averages remained below the Australian norms at 24  months. 
Predictors of PF included IP (β = –1.5, 95% CI = –3.1 to –1.1, P <0.01), SE 
(β = 1.8, 95% CI = 1.3 to 2.6, P <0.01), hospital length of stay (β = –1.7, 
95% CI = –2.0 to –0.8, P <0.01), never having been married (β = 1.8, 95% 
CI = 0.3 to 5.5, P = 0.03), and having injury insurance (β = –2.7, 95% 
CI = –6.9 to –1.9, P <0.01). Predictors of MH included PTSD symptoms 
(β = –2.4, 95% CI –3.4 to –1.4, P <0.01), psychological distress (β = –6.9, 
95% CI = –8.9 to –5.2, P <0.01), SE (β = 0.6, 95% CI = 0.2 to 1.1, P <0.01), 
and unemployment (β = –2.3, 95% CI = –5.0 to –0.2, P = 0.04).
Conclusion  Trauma ICU patients experience compromised physical 
function and mental health 24  months after injury. Psychological 
distress, self-effi   cacy and illness perception infl  uence outcomes and are 
potentially amenable to change in response to interventions initiated 
during hospital stay.
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Introduction Swiss Diagnosis Related Groups (SwissDRG) have been 
eff  ective since 1 January 2012. The infl  uence of this new system on 
patients’ discharge characteristics from a large ICU is not known. With 
the introduction of the DRG we expect patients to be discharged after 
a shorter length of stay on the ICU and with higher severity of illness.
Methods The ICU of the City Hospital Triemli in Zurich has an inter-
disciplinary organization with surgical and internal medical patients, 
with a maximum occupancy of 18 beds and a center function for the 
surrounding hospitals. In this ongoing prospective observational 
study, we collect and analyze the anonymized data of all patients 
discharged from our ICU prior to and after the introduction of the 
SwissDRG. The primary endpoint was the length of stay on the ICU 
in hours. The secondary endpoints were the severity of illness of the 
patients at the time of discharge, detected by the scoring system SAPS 
II as well as measured by the number of readmissions to the ICU. Initially 
all patients were analyzed and in a second step only patients within 
percentiles 6 to 94 were considered. We also analyzed the subgroups of 
patients referred internally, patients sent back to referring hospital and 
patients regionalized to a homebase hospital. The statistics have been 
done with SPSS and P <0.05 was considered signifi  cant.
Results We present the results of an 18-month period, 9 months prior 
to and 9 months after the introduction of the SwissDRG. Data of 1,491 
and 1,492 patients were analyzed, respectively. When all patients were 
included, we found prior to and after the introduction of the DRGs a 
comparable length of stay on the ICU (mean ± SD of 52.1 ± 2.2 hours vs. 
50.82 ± 2.2 hours), no diff  erence in the severity of illness at discharge 
detected by the SAPS II (mean ± SD of 27.9 ± 0.3 vs. 28.4 ± 0.3) and 
the number of readmissions (91 vs. 92). There was also no signifi  cant 
diff  erence when only percentiles 6 to 94 were included or when the 
three subgroups were analyzed.
Conclusion  Up to now, the introduction of the SwissDRG has no 
infl  uence on patients’ discharge characteristics from a large ICU. Data 
assessment will continue and further data analysis has to be performed.
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Introduction The new Swiss fi  nancing system by means of Diagnosis 
Related Groups (DRG), eff  ective 1 January 2012, forms the basis of a 
performance-based system to reimburse general hospital services. 
There are only few data on the infl  uence of DRG on ICU patients [1,2]. 
We expect that the introduction of the DRG in Switzerland will change 
the number of admissions from external hospitals to a large ICU with 
a centre function and will infl  uence the severity of disease of the 
admitted patients.
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disciplinary organisation with surgical and internal medical patients, 
with a maximum occupancy of 18 beds and a centre function for 
the surrounding hospitals of the region. In this prospective ongoing 
observational study, we collect and analyse the anonymised data of all 
patients admitted to our ICU from an external hospital during 12 months 
prior to (1 January to 31 December 2011) and after (1 January to 31 
December 2012) the introduction of the DRG in Switzerland. Exclusion 
criteria are admissions by the emergency department, self-assignments 
into the hospital and internal relocations. The primary endpoint is the 
number of admissions from an external hospital to our ICU. Secondary 
endpoints are the severity of the disease of the admitted patients, 
detected by the scoring systems SAPS II and APACHE II as well as the 
length of stay in external hospitals before admission. The statistical 
analysis is descriptive.
Results We present the preliminary data for 10 months (in each case 
January to October) before and after the introduction of the DRG. 
We observed an increase of 9.2% (391 vs. 427 patients) of admissions 
to our ICU after the introduction of the DRG. The severity of disease 
determined by the SAPS II score is unchanged (mean 26.7 vs. 26.0 
points, P = 0.466). The severity of disease determined by the APACHE 
II score is signifi  cantly lower (15.4 vs. 14 points, P = 0.017). We also 
noted that after the introduction of the DRG the patients were earlier 
transferred from an external hospital to our ICU (mean time until 
transfer 29.9 vs. 18.7 hours), but this value was not signifi  cant (P = 0.55).
Conclusion Up to now the introduction of the DRG in Switzerland 
has had a complex infl  uence on the number and the kind of patients 
admitted from an external hospital to an ICU with centre function. Data 
assessment and analysis will continue.
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Introduction The ICU consumes almost 20% of total hospital resources, 
despite accounting for less than 10% of hospital beds. Medical 
cost can be divided into a fi  xed part, consisting of personnel and 
accommodation expenses, and a variable part, determined by the 
needs of each patient (medications, consumables, examinations). In 
order to rationalize medical cost, estimation of expenses must be real 
and individualized. The aim of this study was to assess the variable cost 
of critically ill patients in a new, seven-bed, adult, general ICU, using 
bottom-up costing methodology.
Methods All 138 patients who were treated during 2011, and stayed for 
at least 24 hours, were included in the study. Data were retrospectively 
collected from patient records and included demographics, cause 
of admission, APACHE II score at admission, length of stay (LOS) and 
outcome. Cost was recorded for every day and for every patient, based 
on a hospital-specifi  c cost catalogue and on national agreements. Data 
are presented as mean ± SEM. Analysis of data was carried out using 
Graph Pad Prism 5.0., applying Student’s t test.
Results The age of participants (84 men and 54 women, 71 medical and 
67 surgical) was 68.75 ± 1.18, APACHE II score was 18.64 ± 0.61, LOS was 
18.46 ± 2.54, and mortality was 19%. The majority of the patients (61%) 
were mechanically ventilated. The total days of ICU stay were 2,548 and 
the total variable cost was €1,460,465 (€573.18 per patient and per day). 
Cost per patient was subdivided as follows: medication (including drugs, 
fl   uids, blood products, nutrition): 56.49%, examinations (including 
laboratory, microbiological assays and diagnostic procedures): 
22.23%, consumables: 21.26%. As for medication cost, the largest part 
was comprised of antibiotics (45.69%), followed by blood products 
(17.61%) and cardiovascular drugs (12.39%). Costs for medical patients 
were signifi  cantly higher than those for surgical patients (P <0.0001).
Conclusion The total average cost per patient and per day was found 
to be €573.18. Medication expenditure was responsible for the highest 
variable cost of intensive care treatment. Among drugs, antibiotics 
accounted for the largest part. A medical cause of admission was 
correlated with higher costs.
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Introduction Leicester Royal Infi  rmary is a (funded) 15-bed ICU, annual 
admission 1,102 patients per year (ICNARC data 2011 to 2012). It houses 
a broad range of specialty, has over 1,000 beds and an emergency 
department (ED) responsible for 297 admissions over the 2011 to 2012 
period. Unit guidelines state that a doctor should be immediately 
available to the unit at all times, ideally physically present on the unit. 
This audit looked in detail at each occasion a junior doctor left the unit, 
the timings, reason, and outcome of each episode.
Methods  Between 17 October 2011 and 14 November 2011, and 
between 2 July 2012 and 30 July 2012, junior doctors on the ICU 
completed a data-capture form after each occasion that they left the 
unit for a clinical need. Data collected were matched to the objectives. 
The 2011 audit results were communicated at the University Hospitals 
of Leicester Trust ICU Audit Meeting. A system was introduced so 
that daytime referrals were directed to the ICU consultant. The impact 
of this intervention was assessed by the 2012 re-audit.
Results There were 105 occasions when a junior doctor left the unit 
in 2011, totalling 118 hours and 38 minutes (5 days), a continuation of 
the upward trend from the previous 2 years. In 2012 this reduced to 47 
occasions totalling 40 hours and 55 minutes. Most attended referrals 
were during the daytime, 54% in 2011 and 68% in 2012. The majority 
of referrals originated from the ED/medicine, combined numbers 
58% in 2011 and 38% in 2012. In 2011 only 30% of ED referrals had 
been discussed with a consultant of the referring team and only 32% 
of medical referrals. Just two of the 14 inappropriate ED referrals were 
discussed with the referring consultant, and none of the six inappropriate 
medical referrals were discussed with a medical consultant. In 2012 just 
33% of ED/medical referrals had prior discussion with a consultant from 
the referring team. At the point of leaving, the ICU was left without a 
doctor on 22 occasions in 2011 and six occasions in the 2012 audit. Most 
occasions occurred at either night shift/weekend (86% in 2011/100% 
in 2012). Referral resulted in a patient being admitted to the ICU on 20 
occasions in 2011 and 12 in 2012.
Conclusion The latest audit follows introduction of a referral system 
directly to the ICU consultant and may account for the reduction in 
numbers of referrals attended by junior doctors. ED/medicine persist 
as the main source of referral to the ICU. Discussion with the referring 
team consultant may reduce inappropriate referrals. ICU staffi   ng 
should not be reduced.
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Introduction Measures to ensure an appropriate early treatment for 
critically ill patients result in signifi  cant decreases in mortality [1,2]. This 
study aims to evaluate the impact of the time elapsed from request 
until admission to the ICU on mortality and ICU length of stay (LOS).
Methods A retrospective cohort study performed on patients in the 
ICU of Hospital Regional de Samambaia over a period of 4 years, from 
January 2008 to December 2011. The patients were allocated into two 
groups: patients who waited longer than 6 hours, long waiting period 
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than that period, short waiting period (SWP, n = 113).
Results In total, 413 patients were included, 300 of which belonged to 
the LWP group (65.4%). For the entire cohort, the mean APACHE II score 
was 19 ± 7, the mean age was 52 ± 22 years, and 211 patients were male 
(51.1%). The LWP group did not show diff  erence in the APACHE II score 
(19 ± 7 vs. 18 ± 8, P = 0.13), but was older (55 ± 20 vs. 49 ± 23, P = 0.01). 
LWP also had a higher incidence of primary bloodstream infection (23.8% 
vs. 10.4%, P = 0.01) and catheter-associated urinary tract infection (10.2% 
vs. 1.9%, P = 0.01). LWP patients had higher mortality (37.8% vs. 25.9%, 
P = 0.02) and longer ICU LOS (21 ± 47 vs. 14 ± 18 days, P = 0.01). Relative 
risk for death in the LWP was 1.74 (95% CI: 1.11 to 2.72).
Conclusion Despite showing no signifi  cant diff  erences on APACHE II 
scores from the SWP group, patients from the LWP group presented 
greater incidence of primary bloodstream infection, catheter-
associated urinary tract infection, higher mortality outcomes and 
longer ICU LOS.
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Introduction  Intensivists are expected to have many roles during 
and after a major disaster/catastrophe; that is, triage, intensive care, 
education for people, and so forth. The roles of intensivists against 
special disaster or nuclear disaster are studied based on actual 
experiences.
Methods Several disasters are studied. The Fukushima Daiichi Nuclear 
plant explosion after the Higashinihon earthquake 2011 was medically 
reviewed based on the total 30-day stay on-site in addition to several days 
around the site. The Chernobyl incident 1986 was inspected 15 years 
after the incident. Other nuclear disasters are included.
Results Many serious problems were revealed in the medical teams, 
which are as follows: inappropriate basic preparedness against large 
special disasters, including nuclear disaster; lack of appropriate 
education and training for medical teams against nuclear disaster – 
that is, most members of Japan DMAT or the disaster medical assistance 
team are still laypersons; incorrect standard/rules of Japan DMAT, which 
were excessively focused upon cure of the usual type of injury and 
planned short period or nearly 48 hours, which should be abandoned; 
and insuffi   cient consideration to the weak/vulnerable people or CWAP, 
children, (pregnant) women, aged people, and the poor people/sicker 
patients. Many of them died because of an insuffi   cient emergency 
transportation system from their contaminated houses or hospital.
Conclusion In order to cope with the special disasters, such as NBC 
or nuclear, biological and chemical disaster, it is insuffi   cient to take 
makeshift measures or use cheap tricks. Working out the systematization 
of disaster medicine, based upon the academic viewpoints and 
philosophy/reliability, is essential to protect the people and the nation.
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Introduction The World Bank has warned that the rapid growth of the 
world’s urban population can only be accommodated safely if cities 
adequately develop key infrastructure, such as the provision of acute 
care resources. Yet, even basic descriptive information on urban acute 
care supply and demand is extremely limited. We therefore conducted 
a pilot assessment across seven diverse urban settings across the world.
Methods We selected a convenience sample of seven large cities with 
varying geographical and socioeconomic characteristics: Boston, Paris, 
Bogota, Recife, Liaocheng, Chennai, and Kumasi. To estimate acute care 
supply, we developed an instrument to collect data on acute and critical 
care infrastructure. We collected data from municipal authorities and 
local research collaborators. We expressed the burden of acute disease 
as the number of deaths due to acute illnesses, estimated from the 
2008 Global Burden of Disease Study. Results were expressed as acute 
care supply and acute deaths per 100,000 population and acute care 
supply per 100 acute deaths.
Results  The supply of hospital beds varied from 72.4/100,000 
population in Kumasi to 245.8/100,000 in Boston. ICU beds with 
capacity for invasive mechanical ventilation and intensive nursing 
services ranged from 0.4/100,000 in Kumasi to 19/100,000 population 
in Boston. The number of ambulances varied 70-fold between cities. 
The gap between cities widened when demand was estimated based 
on disease burden, with a 70-fold diff  erence between cities in ICU 
beds/acute deaths. In general, most of the data were unavailable from 
municipal authorities.
Conclusion The provision of acute care services, a key aspect of urban 
infrastructure, varied substantially across the seven diverse urban 
settings we studied. Furthermore, the local municipal authorities 
generally appeared to have little knowledge of their acute care 
infrastructure, with implications for future planning and development.
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Introduction  Medical and surgical patients use the ICU diff  erently. 
Resources may not always be allocated by severity of illness, but by 
custom or habit, particularly if diff  erent groups administer bed control 
and triage. Specialty-specifi  c diff  erences may exist even when a single 
team controls triage. Variability in resource utilization has important 
implications for cost-containment and triage.
Methods  Patients admitted to a single, closed medical/surgical 
ICU with full-time intensivists and unifi  ed triage control in a large, 
university-affi     liated hospital were evaluated during 2011 to 2012. 
Patients who died in the ICU were excluded. The day of discharge (D/C) 
and severity using APACHE IV and its related Acute Physiology Score 
Figure 1 (abstract P490).
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assessed across days by Cuzick’s test.
Results A total of 719 surgical and 925 medical patients met inclusion 
criteria. In total, 20.2% of surgical and 21.3% of medical patients had an 
ICU LOS <1; P = 0.58. Admission severity was correlated with length of 
stay, P = 0.014 for both medical and surgical patients. Medical patients 
are sicker on admission and D/C from the ICU than surgical patients 
(P <0.05) (Figure 1).
Conclusion ICU utilization diff  ered by patient type even with unifi  ed 
triage control within a single unit. Surgical patients were less severely 
ill on admission to and D/C from the ICU. A signifi  cant percentage of 
medical and surgical patients are D/C within 1 day and may be more 
effi   ciently served in a less resource-intensive environment. The reasons 
for the diff  erences in ICU utilization for surgical versus medical patients 
require clarifi   cation and may have implications for both resource 
utilization and cost.
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Introduction  Interest in safety and clinical outcomes of inpatients 
has been growing in Japan, because the 100,000 Lives Campaign was 
introduced under the Japanese Patient Safety Act in 2008. In this act, 
an introduction of the Rapid Response System (RRS) was one of the 
mainstreams to inpatients’ care. However, many Japanese healthcare 
providers cannot understand how to achieve the introduction of 
the RRS, because there are few who have knowledge of the system. 
Therefore, we developed a new introductory training course for 
the RRS. The educational eff   ectiveness was analyzed through the 
surveillance questionnaires after the course.
Methods The educational program includes a lecture series con  cern-
ing the outline and management methods, introduction of facilities 
that have already deployed, small group discussions, and teaching 
methods-of-training for the medical emergency team using a simulator. 
Evaluation was made in the fi  ve-point scale by 82 participants (58 
physicians, 16 nurses and eight other professions) throughout seven 
courses. The questionnaires are: A. understanding of RRS, B. knowledge 
acquisition about patient safety, C. expectation for decreasing the 
cardiopulmonary arrest by RRS, and D. expectation for decreasing the 
psychological burden by RRS.
Results  Seventy-three participants (89.0%) answered the question-
naires. The numbers of participants who scored more than four points 
were as follows: A. was 71 (97.2%), B. was 70 (95.9%), C. was 64 (87.7%), 
and D. was 68 (93.2%), respectively. The majority of participants 
obtained the correct knowledge, and had a solid understanding for 
the RRS. It was evident that providing abundant material and didactic 
lectures traced from the introduction to management, and collecting 
and resolving the questions, promoted comprehension. However, 
there is a limitation of whether or not the participants introduce the 
RRS into their own institutions. It is essential to improve the course and 
continue to support the activities of the participants.
Conclusion Our training course may promote the introduction and 
dissemination of the RRS in Japan.
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Introduction The management of emergency medical admissions has 
been a subject of recent clinical incidents. There was a high percentage 
of patients that were referred to the ICU by staff   in training, and 21% 
of referrals were made by junior doctors. Consultant physicians had no 
knowledge of the case in 57% of referrals.
Methods A prospective study of 21 cases of referrals and admissions to 
the ICU was conducted at the Glasgow Victoria Infi  rmary Hospital from 
8 to 21 September 2012. A questionnaire was produced relating to the 
referrals, admissions, seniority involvement, cause of referral, and time 
of patient review by the ICU consultant after ICU admission. They were 
distributed to specialist registrars and the ICU consultants. All data 
were electronically recorded into an Excel database. Questionnaires 
that were not completely fi  lled were further investigated using patient 
clinical notes and contact with medical staff  . Information that may 
identify a patient or clinician was removed from the questionnaire for 
confi  dentiality purposes.
Results  Twenty-one complete questionnaires were collected. Fifty-
seven percent (12/21) of cases involved admission to the ICU. Nine 
percent of the cases involved contacting either a specialist registrar 
or ICU consultant intensivist for assistance in practical procedures. Of 
the patients admitted to the ICU, 33% (4/12) were from medical wards, 
33% were admitted from A&E. Consultants were the most common 
professionals who referred patients to critical care (48%; 10/21). 
Fourteen percent of cases (3/21) involved the referral of patients into 
ICU by a junior doctor, but only one of the referrals was accepted by 
the ICU intensivist. Consultants referred or were aware of the referral 
in 71% (15/21) of cases. Of admissions, 58% (7/12) were accepted by 
the ICU consultant and the remaining by the specialist registrars. All 
accepted were acknowledged by the ICU consultant. After admission 
all of the patients were reviewed by the ICU consultant and the time of 
review after admission was on average 1 hour 23 minutes (25 minutes 
to 3 hours 45 minutes).
Conclusion There is still an issue with junior doctors referring patients 
to the ICU without the acknowledgement of consultant physicians, 
resulting in unnecessary admissions and decreased time that ICU 
trainees spend in the ICU. There are more appropriate ICU admissions 
when there is involvement with seniority. Contact with ICU staff   to 
perform practical procedures outside the ICU and not about admissions 
should be explored further.
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Introduction Teaching of medical ethical issues including confi  den-
tia  lity and consent have long been a small part of the medical 
curriculum. These issues are more complex in an ICU where patients 
may lack capacity. Documents such as Good Medical Practice 1995, 
Confi  dentiality 2009 and the Mental Capacity Act 2005 give guidance 
to medical professionals in these matters in the UK.
Methods A questionnaire was distributed amongst staff   in four ICUs in 
South London. Results were analysed according to level of experience 
and background (medical/nursing or allied health professional (AHP)).
Results  Of 225 questionnaires distributed, the response rate was 
66% (31% doctors, 56% nurses and 13% AHP). Staff   with either less 
than 1 year experience or greater than 10 years experience had the 
greatest exposure to the Mental Capacity Act and Data Protection 
Act, suggesting a gap in knowledge in staff    with intermediate 
experience. Knowledge of the Caldicott principles were unaff  ected 
by experience, with many experienced respondents having ‘No Idea’. 
The majority of respondents (unaff   ected by experience) felt that 
Critical Care 2013, Volume 17 Suppl 2 
http://ccforum.com/supplements/17/S2
S182when giving information to relatives face to face, relatives should be 
kept fully informed. When giving information over the telephone, 
most doctors felt the response should be tailored to the knowledge 
of the person being spoken to whilst nurses were split between 
tailoring the response, giving full information, setting up a password 
system and not giving any information at all. Most respondents felt 
date of birth and hospital number constituted ‘Patient Identifi  able 
Information’. However, experienced staff    did not appreciate the 
importance of unusual diagnosis and clinical photographs as also 
being able to identify patients. Similarly, the majority knew that the 
patient themselves identifi   ed the ‘Next of Kin’ but 7% (unaff  ected 
by experience) felt this was decided by the family and felt the family 
could decide on resuscitation status. When consent is required for an 
elective procedure in a patient who lacks capacity, doctors tended 
to have a better understanding of the need to delay the procedure 
where possible than nurses, the majority of which felt this could be 
decided by the next of kin or two consultant doctors. Most doctors 
felt that ‘Acting in the Patient’s Best Interests’ would mean doing what 
would give the patient the best outcome rather than doing what the 
patient would have wanted (unaff  ected by experience). The majority 
of staff  , on answering this questionnaire, felt that they lacked suffi   cient 
knowledge on the subject and most felt annual reminders would be 
useful.
Conclusion  The ICU is an environment where issues of consent, 
confi  dentiality and disclosure of information occur daily. Staff   feel they 
lack knowledge in these areas that is unaff  ected by their experience. 
We need to ensure that all staff   have the necessary knowledge to deal 
with these situations.
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Introduction Alcohol-related hospital and ICU admissions are known 
to have a huge impact on healthcare resources in the UK. Excessive 
use of alcohol is independently associated with sepsis, septic shock 
and hospital mortality among ICU patients. This study assesses the 
relationship between alcohol abuse and intensive care resource 
utilisation in a mixed medical, surgical and neurosurgical ICU.
Methods  A prospective survey of emergency alcohol-related 
admissions over a 1-year period was undertaken at a tertiary university 
adult general and neurosurgical ICU. All patients were screened for 
acute and chronic alcohol abuse on admission. Acute alcohol abuse was 
defi  ned as being intoxicated with alcohol at the time of admission and 
chronic alcohol abuse was defi  ned as chronic alcohol use exceeding 
recommended UK national guidelines on consumption. The amount 
of alcohol consumption was obtained, diagnosis on admission, ICU 
and hospital mortality, length of stay, and total cost were recorded. All 
patients were screened for alcohol-related comorbidities. Comparative 
retrospective data were obtained for the same time period for 
nonalcohol-related emergency ICU admissions. Data were analyzed 
using SPSS.
Results  In total, 7.7% of patients were admitted with a history 
of acute/chronic alcohol excess. Sixty-seven per cent of alcohol-
related admissions were due to acute alcohol excess. Neurosurgical 
patients admitted due to alcohol excess had higher ITU mortality 
than nonalcohol-related neurosurgical patients: 32.1% versus 14.39% 
(P  =  0.02), respectively. Ninety-three per cent of alcohol-related 
neurosurgical admissions were caused by acute alcohol intoxication. 
The intensive care cost was signifi  cantly higher for alcohol-related 
(£12,396 per patient) compared with nonalcohol-related neurosurgical 
admissions (£7,284 per patient). Of the medical patients admitted, 
60% of these admissions were due to acute alcohol excess. The cost 
of intensive care treatment was lower for alcohol-related medical 
admissions.
Conclusion  This is one of the largest studies of alcohol-related 
admissions to critical care. Our survey confi  rms that alcohol-related 
admissions to the ICU are commonplace; however, our frequency 
is signifi   cantly less than previously reported. Our study reveals 
interspecialty variations in demographic data, APACHE II scores, 
mortality and cost of admission. Neurosurgical alcohol-related 
admissions bear higher mortality and result in greater resource 
utilisation relative to nonalcohol-related neurosurgical admissions. 
Alcohol continues to burden both our patients and critical care.
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Introduction  The prevalence of sleep disordered breathing (SDB) 
is presumably high among individuals with cardiac diseases [1], 
nonetheless SDB remains predominantly undiagnosed. However, 
unrecognized SDB might have relevant impact on the postoperative 
course of patients undergoing cardiac surgery [2].
Methods  Polygraphic recordings of 181 patients, without previous 
diagnosis of SDB, undergoing standard cardiac surgical procedures 
with extracorporeal circulation were obtained during a preoperative 
night. The apnea–hypopnea index (AHI  – the number of apneas, 
hypopneas per hour recorded) was determined and compared with 
clinical characteristics and postoperative course.
Results  The prevalence of SDB was considerably high among all 
examined patients. Median AHI was 20.8 (interquartile range, 10.6 to 
36.4). Preoperative AHI was >30 in 32% of all examined individuals. 
During the fi  rst three postoperative days, preoperative AHI >30 was 
associated with a prolonged weaning time, a reduced oxygenation 
index (arterial pO2/FiO2), an impaired kidney function, an augmented 
infl  ammatory response and an overall increased length of stay in the 
ICU. The observed association of high preoperative AHI values with 
postoperative clinical characteristics remained statistically signifi  cant 
throughout the fi  rst three postoperative days.
Conclusion  Undiagnosed SDB is highly prevalent among cardiac 
surgical patients. Clinical trajectories of individuals with severe SDB 
are described by a prolonged recovery of pulmonary function, delayed 
weaning and a pronounced infl   ammatory response after surgery. 
Screening for SDB might identify patients that are susceptible for a 
complicated postoperative course.
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Introduction  A literature review was performed to assess whether 
massage benefi  ts patients postoperatively following coronary bypass 
grafts (CABG) and or valve replacement/repair. A case study on a patient 
who had suff  ered a hypoxic brain post cardiac arrest was conducted.
Methods  A review on MEDLINE and Cochrane using search terms 
massage, cardiac and ICU identifi   ed nine research papers on the 
benefi  ts of massage postoperatively for the aforementioned patient 
group. Other papers were listed but unrelated to cardiac surgery. None 
of the nine papers identifi  ed for this review were ICU specifi  c in the title 
but the ICU was mentioned in the main text body. For the purpose of 
this review the selected papers are researching the eff  ects of massage 
on physiological parameters, anxiety, pain, calm and perceived stress 
indicators in the CABG and/or valve repair/replacement. Out of these 
nine papers, one is British (2002). Five are American (2006 to 2012), 
two are Brazilian (2010) and one is an Indian paper (2010). All papers 
are randomised control trials (RCTs). Papers written prior to 1999 were 
excluded from this literature review.
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in prior papers and very few large-scale studies prior to this date, 
destabilising the validity and reliability of research from the papers 
written before 1999. The later research suggests that any change in 
the measured physiological parameters of blood pressure, heart rate 
and respiratory rate are insignifi  cant (P >0.05). Pain, anxiety, rest and 
a calm score perform better with P >4.71 overall. Another American 
study showed that the length of stay is reduced if a patient receives 
healing touch postoperatively. However, in one RCT pain and anxiety 
increases and in some case SpO2 decreases. A case study was chosen 
by the author and the results support the benefi  ts of massage with the 
cardiac patient group.
Conclusion There appears to be some benefi  ts but larger-scale studies 
are required within this and other ICUs in Britain. The author will be 
inquiring at her workplace whether further studies can be performed 
and whether she can initiate the research. She will identify further case 
studies and trial massage on select patients. The author recommends 
training for nurses interested in massage therapy so a bigger caseload 
can be identifi  ed.
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Introduction In our hospital there are a general intensive care unit 
(GICU) and a neurointensive care unit (NICU). Despite the preference 
for the NICU, in both there are admissions for ischemic stroke. There 
are diff  erent staff   for each ICU, with the same physician’s leadership. 
We have decided to evaluate the performance of both ICUs, analysing 
whether there are diff  erences in results as some authors publish best 
results in specialized ICUs.
Methods  Using prospectively collected data, we undertook a 
retrospective evaluation of all patients admitted to the GICU and NICU 
of our hospital with the diagnosis of ischemic stroke, from December 
2010 to November 2012. In both ICUs there are intensivists, but in the 
NICU the intensivists have special expertise in neuroscience. Data were 
collected from Epimedmonitor.
Results A total of 3,854 admissions were registered in the period in 
both ICUs, with 257 (6.7%) being by ischemic stroke – 49 in GICU and 
208 in NICU. Mean age of patients: 73 years in GICU and 70.1 years in 
NICU. Admissions from emergency unit: 44 (89.8%) GICU, 181 (87%) 
NICU. Mean SAPS 3 score: 50.7 (29 to 71) GICU, 50.6 (29 to 98) NICU. 
Patients admitted with infection: 6 (12.2%) GICU, 10 (4.81%) NICU. Mean 
Charlson comorbidity index points: 1.61 (median 1.0) GICU, 1.1 (median 
1.0) NICU. Mean length of ICU stay: 4.8 days (median 3) GICU, 4.3 days 
(median 3) NICU. Mean length of hospital stay: 12.2  days (median 
8) GICU, 14.5  days (median 8) NICU. Predicted hospital mortality 
(mean  ±  SD): 20.07%  ±  13.48 GICU, 20.4%  ±  13.83 NICU. Hospital 
mortality rate: 12.5% GICU, 5.39% NICU. Observed-to-expected (O/E) 
mortality ratios: 0.62 GICU, 0.26 NICU.
Conclusion Despite the similar proportions numbers for patients in 
both ICUs, the mortality rate and the O/E mortality ratio for ischemic 
stroke were higher in patients of the GICU when compared with the 
NICU.
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Introduction  VAP has continued to be a major cause of morbidity 
and mortality in critically ill patients in Thailand for decades. Previous 
research found that the implementation of VAP care bundles and the 
educational program can reduce VAP incidence in the ICU [1]. In this 
research we aimed to observe the reduction of VAP incidence after the 
implementation of VAP care bundles to ICU medical personnel.
Methods Inclusion criteria: all adult surgical patients (>18 years old) 
who are on ventilatory support in the surgical ICU at Siriraj Hospital. 
There are two groups, divided into pre-educational group (group I) and 
post-educational group (group II) (n = 220/group). We also observed 
the adherence rate to VAP care bundles according to the educational 
program. The pretest and post-test to determine the effi   cacy of the 
educational program were done. The VAP care bundles consisted of 
weaning according to weaning protocol, sedation vacation, head-
of-bed elevation, measurement of cuff   pressures four times/day, 2% 
chlorhexidine use for mouth care and emptying of ventilator circuit 
condensate.
Results There were 45.38 and 25.25 episodes of VAP per 1,000 ventilator-
days in group I and group II, respectively (P = 0.020). The incidence of 
VAP was 21.82% in group I and 9.09% in group II (P = 0.000). There was 
signifi  cant reduction in the length of ventilatory support per person 
(group I = 2, group II = 1 (median), P = 0.013, 95% CI = 0.319 to 0.936) 
and mortality rate (group I = 15.5%, group II = 8.2%, P = 0.017). There 
was no signifi  cant diff  erence in LOI, LOH and ATB cost. The pretest 
scores were 15.53 and 17.53 on average from 40 medical personnel in 
group I and group II, respectively (P = 0.000). The head-of-bed elevation 
adherence rate was improved after the educational program (group 
I = 50.1%, group II = 70.36%, P = 0.017). But the adherence to other 
bundles was not improved. See Tables 1 and 2.
Table 1 (abstract P498). Impact of the educational program on outcomes
Outcome Pre-education  Post-education  P value
VAP 45.38  25.25  0.020
Ventday 2  1  0.013
LOI 3  3  0.054
LOH 17  17  0.960
ATB cost  2,842.50  2,098.00  0.994
% death  15.5  8.2  0.017
Table 2 (abstract P498). Adherence rate to VAP care bundles
Bundle Pre-education  Post-education  P value
Wean 95.04  96.08  0.723
Sedate 92.26  95.28  0.467
HOB 50.10  70.36  0.017
Cuff   pressure  87.29  80.78  0.278
M care  89.60  80.86  0.204
Drain 95.42  99.42  0.130
Conclusion The educational program and the implementation of VAP 
care bundles can reduce the incidence of VAP, length of ventilatory 
support and mortality rate in the ICU.
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patients with viral pneumonia requiring ventilation and particularly 
aff  ected high-dependency medical services such as ICUs in settings 
that lack suffi   cient personnel and resources to provide optimal care. 
Ministries of Health of several countries asked the World Health 
Organization (WHO) for clinical management guidance.
Methods We developed (2009 to 2011) and piloted (2011 to 2012) 
curriculum and training materials targeted at clinicians without formal 
critical care training who care for adult and paediatric patients with 
severe acute respiratory infections in ICUs in resource-limited settings.
Results With contributions from 37 global experts, we developed a 
3-day course including 14 learning units in early recognition, patho-
physiology, oxygen therapy, infl  uenza diagnostics, infection control, 
resuscitation of septic shock, antimicrobial therapy, monitoring, lung-
protective ventilation for acute respiratory distress syndrome, sedation, 
weaning, preventive care, quality improvement, and ethics. Teaching 
techniques are appropriate for adult learners and include short 
slideshow-based lectures, interactive small-group role-play sessions 
and a toolkit with practical resources such as checklists. With funding 
from the WHO and local Ministries of Health, the training course was 
piloted among 67 clinician participants in the Caribbean and Indonesia 
(29 and 38, respectively) and taught by external critical care specialists. 
Participants’ daily evaluations rated all units as at least very good. 
Test scores to assess participant critical care knowledge improved 
signifi  cantly from before the training to immediately after (Caribbean, 
58 to 80%; Indonesia, 56 to 75%; P <0.001 for both).
Conclusion It was feasible to develop and deliver an advanced critical 
care curriculum and related training materials in a short, interactive 
workshop for noncritical care trained clinicians in resource-limited 
settings. However, the small-scale programme was labour and time 
intensive. Widespread dissemination of these materials requires 
identifi  cation of target countries, engagement of Ministries of Health, 
and secure funding. Longer-term evaluation is necessary to determine 
whether such programmes improve processes of care and clinical 
outcomes for critically ill patients.
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Introduction Following our study of severe sepsis care across three 
centres [1], we aimed to introduce a rapid feedback mechanism into 
our rolling audit programme. Whilst previous audits raised awareness 
of severe sepsis, only whole organisation performance was reported 
and no feedback was given to individual clinicians. It is recognised that 
such feedback loops can improve clinical practice [2].
Methods Patients admitted to critical care (58 beds, four units) with 
a primary admission diagnosis of infection were screened for severe 
sepsis. Pre-ICU care was then audited against the Surviving Sepsis 
Guidelines [3]. Time zero is defi  ned as when criteria for severe sepsis 
were fi  rst met. An individualised traffi   c-light report was then generated 
and emailed to the patient’s consultant and other stakeholders 
involved in care (Figure 1). We aimed to report cases within 7 days of 
critical care admission. A cumulative report is generated monthly to 
track organisation-wide performance.
Results Since November 2011, 153 cases of severe sepsis have been 
audited and reported back to clinicians. Compliance with antibiotics 
in <1 hour has risen from 35 to 75% and compliance with the pre-
ICU elements of the resuscitation bundle has risen from 20 to 70% 
(Figure  2). Feedback from clinicians has been encouraging as our 
reports highlight both positive and negative examples of practice.
Conclusion  Individualised feedback on sepsis care has led to 
substantial improvements in guideline compliance. This concept could 
be translated to other time-dependent patient pathways.
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Introduction When we talk about safety culture, we speak of being 
aware that things can go wrong. We must be able to recognize mistakes 
and learn from them, sharing that information fairly and impartially 
to try to prevent its recurrence. Organizations such as the Agency for 
Healthcare Research and Quality (AHRQ) have developed tools to help 
organizations measure their safety culture and there is little information 
about our country.
Methods A descriptive survey study. We sent the Spanish version of the 
questionnaire on patient safety culture (AHRQ) to the nursing staff   of a 
polyvalent ICU of 42 beds in a tertiary hospital.
Results The questionnaire was sent to 179 nurses, receiving correctly 
answered 88 surveys (response rate of 49.16%). On a scale of 0 to 
10, 6.97 points was obtained to estimate the safety climate for staff   
respondents. The item best scored was teamwork in the unit (65.9%). 
Detected as a fortress, ‘communication between nurses at shift 
changes’ (76.1% positive responses). The worst rating was obtained in 
the section on human resources, followed by management support in 
the fi  eld of patient safety.
Conclusion The perception of safety culture in an ICU by nursing staff   is 
far from optimal levels. The team work dimension was identifi  ed as the 
most valued by workers, with the transmission of information on shift 
changes the most valued item.
Figure 1 (abstract P500). Example report.
Figure 2 (abstract P500). Compliance with pre-ICU resuscitation bundle.
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Introduction The requirements for the intensivist in handling medical 
technology are constantly growing. It appears necessary to acquire 
technological competences particularly within the fi  elds of medical 
technology and physics. In the master’s degree program ‘MasterOnline 
Physico-Technical Medicine’, such technical authority is conveyed. 
To cope with the intensive vocational situation of the physician, 
this study course follows the blended-learning concept; that is, it is 
conceived as an online study course with small portions of intermittent 
presence phases. Within the fi  rst year, technical basic skills such as 
‘measurement technique’, ‘informatics’, and ‘advanced physics’ are 
covered. Subsequently, two of various advanced courses in diff  erent 
fi  elds of medical technology (‘technology in intensive care medicine’, 
‘technology in surgery’, ‘technical cardiology’, ‘radiology’, and other) are 
selected.
Methods  In a survey, we evaluated the study course. Therefore, a 
questionnaire was distributed among all students including the topics 
course contents, learning materials, time management, supervision, 
and overall impression. The students were asked to score their 
agreement to the statements ‘content is well structured’, ‘content 
extent is appropriate’ and ‘content is relevant for medical purposes’ on 
a scale ranging from 1 (fully disagree) to 5 (fully agree).
Results The students participated actively in this study course with 
highest motivation and large commitment. The students’ workload 
was in the targeted range of about 10 hours/week. Content structure 
was scored with 4.3 ± 0.1, content extent with 4.1 ± 0.2 and medical 
relevance with 4.3 ± 0.2.
Conclusion  The blended-learning concept fulfi   lls the requirements 
for occupation-accompanying continued medical education, since it 
off  ers the possibility to study self-employed accessing text documents, 
lecture recordings, and electronic lectures and to convert in 
concentrated presence phases this knowledge into practical exercises.
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Introduction The fi  rst-hour protocol determines the patient-specifi  c 
resources for the start of an ICU stay [1]. Staff   resources are decided 
through triage. Task charts direct the start of intensive care. Our primary 
goal is to improve patient care.
Methods A triage method (red, yellow, green) is used to manage ICU 
resources according to the severity of illness. For example, one doctor 
and one nurse would admit a stable (green) patient coming from the 
operating room for postoperative ICU care. A patient in septic shock 
with multiple organ disorder (red), on the other hand, would be 
admitted by a team of two doctors and three nurses. Each staff   member 
has a task chart in a checking-list format. Also, an admission chart is used 
to improve data collection. The use of the protocol started as a pilot 
study in early 2012. Simulation education for staff   members started in 
August 2012 and has included video recordings and debriefi  ng of each 
simulated ICU admission. Primary goal-directed therapy goals have 
been mean arterial pressure (MAP >65 mmHg), SpO2 >94%, timing 
of the laboratory tests, start of antibiotics, and blood glucose level 
6 to 8 mmol/l. Quality indicators have been followed from the data 
provided by The Finnish Intensive Care Consortium. Questionnaires for 
the staff   members have been used to evaluate opinions about the fi  rst-
hour protocol.
Results According to the questionnaire replies, 80% (n = 64/80) of our 
nurses estimate that the fi  rst-hour protocol has improved the starting 
process of our patients’ intensive care. Twenty percent (n = 16/80) of the 
nurses considered that the protocol has no eff  ect, and none thought 
it to be adverse for patient care. Corresponding numbers for our ICU 
doctors were 87% (benefi  cial n = 13/15), 13% (no eff  ect n = 2/15) and 
0% (adverse). Furthermore, 82.5% (n = 66/80) of the nurses replied that 
education of new nurse staff   members has improved because of the 
fi  rst-hour protocol. A total of 17.5% (n = 14/80) thought there has been 
no eff  ect, and none considered the protocol harmful for education. 
For ICU doctors the protocol did not bring either clear educational 
advantages or disadvantages. The variable life-adjusted display curves 
(The Finnish Intensive Care Consortium) have shown improvement in 
our patient care after the implementation of the fi  rst-hour protocol. 
However, we cannot determine whether it is a signifi  cant factor in our 
intensive care results.
Conclusion  The fi   rst-hour protocol has helped us in resource 
management, start of the patients’ intensive care and education of 
nursing staff  .
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Introduction  Demand for critical care services is increasing yet a 
comprehensive understanding of how critical care nurses – the largest 
group of ICU direct care providers – impact outcomes remains unclear. 
The purpose of this study was to determine how critical care nurse 
education (hospital proportion of bachelor’s prepared ICU nurses) and 
ICU work environment infl  uenced 30-day mortality of mechanically 
ventilated older adults.
Methods  A multi-state cross-sectional nurse survey was linked to 
hospital administrative data and Medicare claims (2006 to 2008). The 
fi  nal sample included 55,159 mechanically ventilated older adults in 303 
hospitals. Logistic regression modeling was employed to jointly assess 
the relationship of critical care nurse education, work environment and 
staffi   ng on 30-day mortality while adjusting for hospital and patient 
characteristics and accounting for clustering.
Results A 10% increase in the proportion of ICU nurses with a bachelor’s 
degree or higher was associated with 2% lower odds of death while 
controlling for patient and hospital characteristics. Patients cared for 
in better work environments experienced 11% lower odds of risk-
adjusted death than those cared for in poorer ICU work environments.
Conclusion Patients cared for in hospitals with a greater proportion of 
bachelor’s prepared ICU nurses and in better ICU work environments 
experienced signifi  cantly lower odds of death. As the demand for 
critical care services increases, attention to the education level of ICU 
nurses and ICU work environment may be warranted to optimize 
currently available resources and potentially yield better outcomes.
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Activity and case-mix changes in a medical ICU after the 
geographical transfer of a third-level university hospital
JC Cebrián, FM Monsalve, JB Bonastre
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Introduction  Information about big hospital geographical transfer is 
scarce in the medical literature. On 20 February 2011 our hospital (in fact, 
a big university complex) was transferred from their previous location 
in the north-center of our city towards a new southern peripheral, 
geographical location. This transfer has been done without any changes 
in assisted population or nursing/medical staff  . The only change was a 
slight increase in bed number (21 to 24). Our aim is to analyze changes 
in activity indexes (length of stay, occupancy rate, and so forth) and case 
mix (origin, previous quality of life and NYHA score, main diagnostic 
groups, severity scores, in-ICU and in-hospital mortality).
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case-mix indicators 1 year before and after the geographical change 
was done. We analyzed our whole number of patients admitted to the 
ICU. We used the chi-square test for categorical variables and one-way 
analysis of variance for quantitative data. Minitab and Statbas statistical 
programs were used. We plotted activity data using the Barber–
Johnson 1 diagram.
Results A total of 2,774 cases (63% males; mean age 61 years) were 
admitted to our ICU during the period (1 year before and after the 
transfer). No diff   erences between both groups were founded in 
demographic data, Knaus score and NYHA status. Regarding their 
origin, we found more patients admitted from other hospital centers 
(20 vs. 29%; P <0.001). APACHE II score increased from 17.24 to 19.08% 
(P <0.001) and a slight increase change in SAPS 3 score was also found 
(52.29 to 53.75; P <0.01). Our in-ICU mortality remains lower (15.5 
to 15.6%) whereas observed mortality decreased (22.37 to 19.88%; 
P <0.001). An increase in our neurologic patients has been the most 
consistent change regarding diagnostic groups. The activity indexes 
show a slightly decrease in occupancy rate (79.2 vs. 76.8).
Conclusion According to the previous data our ICU seems to perform 
better in the new location with a decrease in the standardized mortality 
rate. On the other hand, we are admitting more patients transferred 
from other hospitals. A better occupancy rate was found.
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Introduction There are several defi  nitions of level 1 (L1) care, all refer 
to a group at risk of clinical deterioration on the ward [1-3]. There is 
evidence that ward patients who become acutely unwell often receive 
suboptimal care [4]. A regional study commissioned by Norfolk, Suff  olk 
& Cambridgeshire Critical Care Network (NSCCCN) found that a majority 
of ward patients may be of L1 dependency and death rates appear to be 
correlated with L1 status. We aim to examine the relationship between 
the ward distribution of illness acuity, staffi   ng and patient outcome.
Methods  Data were collected as part of NSCCCN’s observational 
prevalence study in 2010. Ward surveys included acuity of illness, 
staffi   ng levels and skill mix. Secondary data were obtained from the 
Patient Administration System. Emergency, oncology, paediatric and 
maternity units were excluded.
Results Complete datasets were obtained from 1,402 patients in 22 
wards in our university hospital over two seasons. This constitutes 
98.3% of inpatients from those wards. The mean ward occupancy rate 
was 94% (10th to 90th percentile: 85% to 100%). At least one L1 acuity 
criterion was scored by 898 (64%) patients, with 25% from geriatrics 
followed by orthopaedics (17%) and general surgery (10%). Each ward 
had an average of eight qualifi  ed nursing staff   (range: 4 to 12) equating 
to an average staff  :patient ratio (SPr) of 0.253. There was no correlation 
between ward occupancy and nursing staff   (Pearson correlation, corr: 
0.55), nor between prevalence of L1 criteria and staffi   ng (corr: 0.34). The 
admission rate to intensive care was noted to be higher if the patients 
were nursed in a ward with lower than average SPr compared with 
higher SPr (2.7% vs. 1.2%, P = 0.058 Fisher’s exact), but this was not 
statistically signifi  cant. Senior nursing (Band 6) staff   were part of the 
skill mix on only nine of 44 ward surveys.
Conclusion Better outcome with improved SPr may be unsurprising, 
although if proven conclusively would signifi  cantly inform workforce 
planning. Lack of correlation between staffi   ng levels and occupancy or 
acuity is also interesting given that we know L1 criteria are associated 
with worse outcome.
References
1.  Levels of Critical Care for Adult Patients. Intensive Care Society; 2002. 
[http://www.ics.ac.uk/professional/standards_safety_quality/standards_and_
guidelines/levels_of_critical_care_for_adult_patients]
2.  Acutely Ill Patients in Hospital. NICE Guideline 50. NICE; 2007. 
[http://www.nice.org.uk/cg50]
3.  AUKUH Acuity/Dependency Tool. Association of UK University Hospitals; 2007. 
[http://www.aukuh.org.uk/index.php/affi   liate-groups/directors-of-nursing/
patient-care-portfolio]
4.  An Acute Problem? NCEPOD; 2005. 
[http://www.ncepod.org.uk/2005report/index.html]
P507
Sleep quality among ICU workers
G Burghi1, I Serkochian1, B Frache2, P Alzugaray2, K Goinheix1, 
M Rodriguez Verde3, H Bagnulo1, E Azoulay4
1Hospital Maciel, Montevideo, Uruguay; 2Sanatorio Americano, Montevideo, 
Uruguay; 3Hospital de Paysandú, Uruguay; 4Hôpital Saint Louis, Paris, France
Critical Care 2013, 17(Suppl 2):P507 (doi: 10.1186/cc12445)
Introduction  Prolonged shifts, workload, stress, and diff  erent con-
fl  icts are associated with burnout, loss of psychological wellbeing, 
and probably with an inadequate sleep quality (ISQ). This relevant 
disturbance leads to deterioration of the work performance, may impair 
quality of care provided to patients and increases the incidence of 
serious adverse events. The objective was to determine the prevalence 
of ISQ and sleepiness among Uruguayan ICU workers, and to evaluate 
risk factors associated with ISQ.
Methods A survey was conducted in six Uruguayan ICUs. The sleep 
quality was evaluated on the basis of the Pittsburgh score (PS), and the 
sleepiness was identifi  ed by the Epworth scale. ISQ was defi  ned as PS 
greater than 5 points and sleepiness by an Epworth scale higher than 
6 points. ICU’s, patient’s, and clinician’s characteristics were assessed for 
their association with the prevalence of ISQ. All variables with P <0.2 
in univariate analysis were included in a model of ordinal regression. 
P <0.05 was considered statistically signifi  cant.
Results The survey was completed by 129 ICU workers. The global 
prevalence of ISQ in ICU was 67.4%. ISQ was observed in 45% of 
physicians and 82% of nurses and nurses assistant (P <0.001). Sleep 
medication was used by 13.3% of the ICU team. Univariate analysis 
showed that ISQ was signifi   cantly associated with sex (73% vs. 
43%, P = 0.03 in women and men, respectively), marital status (84% 
vs. 61%, P = 0.01 in single and couple workers, respectively), more 
than 60 hours working in the last week (76% vs. 61%, P = 0.07) and 
less than 6 sleeping  hours (95% vs. 54%, P <0.0001). Multivariable 
analysis demonstrated that a sleep duration less than 6  hours was 
independently associated with ISQ (OR = 24.5; 95% CI = 5.2 to 115.8; 
P <0.0001). Furthermore, pathologic sleepiness was present in 59.3% 
of ICU workers. Sleepiness was independently associated with use of 
sleep medication (OR = 5.9; 95% CI = 1.2 to 28.5; P = 0.025).
Conclusion The prevalence of ISQ and sleepiness is very high among 
ICU workers. Those disturbances are independently associated with a 
sleep duration less than 6 hours, and sleep medication use, respectively. 
These results highlights that strategies to decrease ISQ and sleepiness 
in ICU clinicians are urgently needed to improve work performance, 
improve quality of care provided and prevent adverse events.
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Introduction  Work-related stress is a potential problem among 
doctors and is associated with anxiety, depression, reduced job 
satisfaction, days off   work, errors and near misses [1]. To compare stress 
levels between diff  erent groups of doctors and identify causes of stress, 
we conducted a survey at University Hospital Lewisham using the UK 
Health and Safety Executive’s Management Standards (HSEMS). HSEMS 
is a validated tool developed to identify work conditions that warrant 
interventions to reduce stress levels across organisations [2].
Methods  We conducted an anonymous survey of doctors working 
in anaesthetics, intensive care, general medicine and accident and 
emergency (A&E) departments over 6 weeks using the HSEMS 
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management services and whether staff   had a designated supervisor 
or mentor. Results were analysed using the HSEMS Analysis Tool, which 
rates stressors with a score from 1 to 5 (5 represents the lowest amount 
of stress). We compared the Trust’s results against HSEMS national 
standards.
Results  Seventy-two doctors completed the survey. Lowest stress 
levels were found in doctors working in intensive care (n = 12, mean 
3.63, SD 0.39). This was followed by medicine (n = 26, mean 3.55, 
SD 0.47), anaesthetics (n = 27, mean 3.40, SD 0.44), and A&E (n = 7, 
mean 3.11, SD 0.65), which had the highest stress levels. There was 
no signifi  cant diff  erence in stress levels between diff  erent grades of 
doctors. When compared with HSEMS targets, staff   relationships and 
peer support exceeded national standards. However, management 
of organisational change and demands at work need improvement. 
The majority of doctors (82%) had no idea what stress management 
services were provided by the Trust. Seventy-nine per cent of doctors 
had an allocated supervisor or mentor, 91% of those felt able to 
approach their supervisor.
Conclusion These survey results provide reassurance that stress levels 
in intensive care compare well, despite critically unwell patients and 
higher mortality rates. We identifi  ed areas that need improvement 
within the Trust and will present these results to all relevant 
departments. With the support of hospital management we will initiate 
HSEMS-validated measures to reduce stress.
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Introduction South-east London (SEL) presents unique challenges to 
healthcare providers due to its diverse demographic. The high levels of 
poverty, immigration and psychiatric illness impact delivery of obstetric 
care. These were identifi  ed as risk factors for poor outcome in the latest 
CMACE report [1]. The Intensive Care National Audit and Research 
Centre (ICNARC) produced data on obstetric critical care admissions in 
2007 [2]. We reviewed the obstetric critical care admissions in three SEL 
hospitals and compared this with the national average determined in 
the ICNARC and CMACE data.
Methods All critical care admissions in three high-risk obstetric units 
in SEL (1 August 2009 to 31 July 2011) were screened for patients who 
were currently or recently pregnant. We compared local results with 
national data by ICNARC and CMACE.
Results  There were 68 obstetric critical care admissions in the SEL 
hospitals within the audited time frame. The mean age was 30.05 in 
ICNARC data compared with 33.93 in SEL. Average APACHE II scores 
were lower in SEL compared with the ICNARC data, but length of 
stay was greater in SEL (2.72 days) compared with ICNARC (1.5 days). 
Haemorrhage was the most common reason for admission in SEL, 
whilst sepsis was the leading cause of death according to the latest 
CMACE report (Figure 1).
Conclusion Data from national audits may guide protocol, but services 
must be tailored to local circumstances. SEL has unique population 
characteristics and obstetric critical care admissions diff  er signifi  cantly 
from national statistics; in particular, haemorrhage is over-represented 
in our region. Critical care services were generally required for a short 
period of time; during this period, routine postpartum care may be 
omitted as treatment priorities diff  er. Dedicated critical care services on 
the labour ward may be a way to combine postnatal care with transient 
high-dependency requirements. This may enhance patient experience 
and prove cost-eff  ective.
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Introduction  Adverse drug events (ADEs) are associated with a 
substantial increase in morbidity and mortality in any setting. Because 
patients in ICUs were critically ill with complex diseases and varied 
organ dysfunction, the incidence of ADEs on such patients is much 
more crucial than the counterparts. We thus assessed the nature of 
ADEs and their infl  uence in ICUs.
Methods We conducted a prospective cohort study at ICUs at three 
large tertiary-care hospitals in Japan. Trained research nurses reviewed 
all medical charts, incident reports and reconciliations from the 
pharmacy to identify suspected ADEs as well as the background of 
patients. ADEs are any injuries that result from the use of a drug. After 
suspected ADEs are collected by research nurses, physician reviewers 
independently evaluated them and classifi  ed them as ADEs or rule 
violations. We used the validated methodology [1].
Results We included 459 patients with 3,231 patient-days. The median 
age was 70 years and the median length of stay was 3 days. In total, 70 
patients (15%) had at least one ADE during their stay in the ICU. The 
median ICU stay in patients who had ADEs was 14 days while 2 days 
in patients who had no ADEs (P <0.0001). The median length of the 
ADE onset days since admission was 3 days. Regarding the mortality, 
73 patients (16%) were dead during their ICU stay: 12 deaths (17%) in 
patients who had ADEs and three of 12 deaths were caused by an ADE, 
and 61 deaths (16%) in counterparts (P = 0.8). There were no signifi  cant 
diff  erences of patients’ characteristics between patients with ADEs and 
without ADEs (Table 1).
Conclusion ADEs were associated with longer stay and caused a part of 
death in ICU (4%) although they did not increase the mortality. Because 
the characteristics of patients were not associated with ADEs, early 
detection and intervention for ADEs could be important to improve the 
morbidity and reduce the death caused by ADEs in ICUs.
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Figure 1 (abstract P509). Causes for critical care admission in SEL, 
CMACE and ICNARC.
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Introduction In Hungary, despite the high level of social support, the 
number of organ recoveries from deceased donors has not changed 
signifi  cantly. The donation activity shows a positive relationship with 
the level of education of staff   in ICUs as well as with their attitude 
towards transplantation. The aim of this cross-sectional study is to 
estimate the attitude and knowledge of intensive care specialists and 
nurses as regard donation and transplantation.
Methods The self-completed questionnaire that consisted of 20 items 
was completed at the Congress of Hungarian Society of Anesthesiology 
and Intensive Therapy in 2011. Besides the epidemiological data, the 
intensive care specialists (n = 179) and nurses (n = 103) were asked 
about donation activity, participation in an organ donation course, self-
reported knowledge of joining Eurotransplant, donor management, 
legislation, and transplantation. The data were analyzed by SPSS 17.0.
Results A total of 53.6% of physicians and 16.7% of nurses attended 
an earlier organ donation course (P <0.01). The average age of those 
who participated in training was signifi  cantly higher among doctors 
(P <0.01). Fifty-nine percent of doctors and 65.1% of nurses did not 
even want to participate in such training. Donation activity was 
higher among staff    who joined training (P  <0.01). Independently 
from accepting the presumed consent legislation (91.1%), 66% of 
physicians agreed with the hospital practice that requests the adult 
donor’s relatives to consent to organ recovery. This standpoint did 
not depend on donation activity, participation in an organ donation 
course, opinion about legislation and the nature of staff   . A total 
95.4% of participants consented to their organ retrieval after death. 
The staff   who participated in an organ donation course had more 
knowledge regarding the law and ethics of donation (P <0.01), donor 
management (P  <0.01), living and deceased donor transplantation 
(P <0.01) and joining Eurotransplant (P <0.01). Older professionals had 
more information about all fi  elds (P <0.01). Nurses had less knowledge 
concerning donor management (P <0.01), law and ethics (P <0.01) and 
deceased donor transplantation (P <0.01) than doctors.
Conclusion  Education about organ donation needs to be part of 
specialist training of intensive care staff  , and refresher courses every 
fi  fth year as well. The course should include knowledge regarding brain 
death, donor management and communication with family. This is the 
fi  rst step to improve the number of transplantations.
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Introduction In the UK, three people die each day awaiting trans  plan-
tation, due to the unavailability of donor organs. Traditionally, donor 
identifi  cation has been restricted to the ICU. However, following the UK 
Organ Donation Taskforce report in 2008 [1], a number of emergency 
departments (EDs) have been working with specialist nurses for organ 
donation (SN:OD) to identify potential donors and approach their 
families for consent in the ED. We present our initial experience after 
the introduction of a SN:OD to an Irish teaching hospital’s ED.
Methods  We conducted a retrospective review of deaths in our 
ED during a 28-month period. For those who died in the ED, case 
notes were reviewed to identify those suitable for organ donation. 
Referral and donation rates were compared in two cohorts, pre and 
post introduction of a SN:OD. Fisher’s exact test was used to assess 
diff  erences between groups.
Results  Ninety-one deaths occurred in the study period. Following 
introduction of the SN:OD, referrals increased from zero to eight. Of 
the eight referred, three received consent and were transferred to the 
ICU, two of whom became successful donors. The number of missed 
potential donors fell from six to one (P = 0.009).
Conclusion Introduction of a SN:OD and a clinical pathway has led to 
the identifi  cation of previously missed potential organ donors in the 
ED. Several patients have subsequently been admitted to critical care 
solely to facilitate organ donation.
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Introduction Our objective was to analyze septic HIV patients admitted 
to intensive care.
Methods A retrospective study of HIV patients admitted to our ICU 
between January 2005 and December 2009. We identify patients 
admitted to the ICU with sepsis and analyze demographic factors, 
etiology, organ failure and outcome, and we compare immune status, 
frequency of organ failure and outcome between these patients and 
those admitted for other reasons. We use Student’s t test to compare 
quantitative variables, and the chi-square test for qualitative data.
Results A total of 104 HIV patients were admitted to our ICU during 
the study period, 62 with sepsis (71% men, mean age: 40.59 ± 8.12). 
Of sepsis patients, 56.5% were admitted from the ER and 38.7% from 
a medical ward; 66.1% had history of intravenous drugs use, other 
comorbidities: COPD (9.7%), cirrhosis (8.1%), solid or hematologic 
malignancy (12.9%); 8.1% patients were unaware of their condition 
Table 1 (abstract P510). Patient characteristics
   Patients  Patients
   with  without
   ADEs  ADEs
Characteristic (n = 70) (n = 389)  P value
Age ≥65 years, n (%)  49 (70)  227 (58)  0.08
Male, n (%)  40 (57)  250 (64)  0.2
Department
  Medicine  35 (50)  228 (59)
  Surgery  35 (50)  161 (41)  0.2
Unconsciousness, GCS ≤8  13 (19)  91 (23)  0.4
Heart failure, NYHA = 4  37 (53)  216 (56)  0.7
Respiratory failure  44 (62)  262 (67)  0.5
Kidney failure  6 (9)  58 (15)  0.2
Clinical laboratory measurements, median (25%, 75%)
  Blood urea nitrogen (mg/dl)  21 (15, 39)  19 (14, 31)  0.2
 Creatinine  (mg/dl)  0.8 (0.5, 1.5)  0.9 (0.7, 1.7)  0.8
  Aspartate aminotransferase (IU/l)  27 (20, 47)  30 (22, 48)  0.5
 Alanine  transaminase (IU/l)  20 (13, 42)  20 (12, 33)  1.0
  Total protein (g/dl)  6.7 (5.9, 7.4)  6.6 (5.9, 7.3)  0.8
Number of medications on admission ≥4,  38 (54)  223 (57)  0.6
n (%)
Number of medications on admission,   5 (3, 7)  5 (4, 8)  0.7
median (25%, 75%)
GCS, Glasgow Common Scale; NYHA, New York Heart Association.
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(64.3% in patients admitted without infection, P = 0.016). Mean CD4 
count at admission: 219.62 ± 353.93 cells/mm3 (vs. 370.22 ± 362.56, 
P = 0.048). Mean viral load: 4.57 ± 3.25 log (vs. 2.257 ± 1.96, P = 0.001). 
Of sepsis patients, 62.1% were on their CD4 nadir (vs. 34.5% in 
nonseptic patients, P = 0.009). Mean albumin levels were 2.3 ± 0.53 g/
dl (vs. 2.92 ± 0.94, P <0.001). APACHE II at admission was 21.98 ± 7.97 
(vs. 18.15 ± 8.47, P = 0.046). At admission, 52.8% were on severe sepsis 
and 44.3% on septic shock. The lung was the most frequent source of 
infection (65.6%) followed by CNS (16.4%), UTI (4.9%) and IE (4.9%). The 
most common pathogen isolated on these patients was S. pneumoniae 
(28.8%), followed by P. jirovecii (13.6%), toxoplasma (8.5%), E. coli (5.1%) 
and H. infl  uenzae (5.1%). In total, 62.9% needed vasopressors (vs. 28.6% 
in non-infected patients, P = 0.001), 79% mechanical ventilation (vs. 
42.85%,  P <0.001) and 19.4% renal replacement (9.5% in no septic 
patients, P = 0.173). Mean ICU and hospital LOS was 10.43 ± 10.52 and 
34.76 ± 29.64 days in septic patients versus 6.04 ± 8.45 (P = 0.026) and 
20.54 ± 27.93 days (P = 0.016). ICU mortality: 33.9% (19% in nonseptic 
patients, P = 0.098), hospital mortality: 41.9% (vs. 23.8%, P = 0.057).
Conclusion Sepsis is a common reason for admission to the ICU in 
HIV patients and is accompanied by high mortality. Pneumonia is the 
most frequent source of infection. Septic patients are less frequently 
under HAART and have a worse inmune status (lower CD4 count 
and higher viral load). Despite a higher APACHE II, and a higher need 
for hemodynamic and respiratory support, there is no statistically 
signifi  cant diff  erence in ICU and hospital mortality between septic and 
nonseptic patients.
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Introduction Although recent reports show an improvement in out-
comes for pediatric hematology patients requiring intensive care [1,2], 
respiratory failure remains one of the major risks of pediatric mortality. 
This study was conducted to assess our hypothesis that mortality 
associated with respiratory failure is higher than that for other organ 
failures in pediatric hematology patients admitted to our ICU.
Methods A retrospective study analyzed children with hematological 
disorders admitted to our ICU between April 2005 and June 2012. All 
of the included children required emergency admission and invasive 
mechanical ventilation. Those who did not need intubation, or required 
intubation only for therapeutic intervention and died within 24 hours 
of ICU admission were excluded. The survival group was defi  ned as 
patients who were discharged from the ICU, and the nonsurvival 
group was defi  ned as those who died in the ICU or within 7 days after 
discharge from the ICU. The PELOD score and PIM-II were applied as 
morbidity scoring systems
Results Twenty-seven patients, including 18 males and nine females, 
with a median age of 6.1 years (range, 0.2 to 16.6 years) were analyzed. 
Sixteen patients had leukemia, fi  ve had hemophagocytic syndrome, 
six had solid tumors. The average predicted mortality rate was 31.3% 
in PIM-II. The survival group included 15 patients (56%) and the 
nonsurvival group included 12 patients (44%). When the survival group 
was compared with the nonsurvival group, there were no signifi  cant 
diff  erences in the systolic blood pressure (101.3  ±  13.9 mmHg vs. 
92.8  ±  25.4 mmHg; P  =  0.15), the proportion of patients requiring 
continuous renal replacement therapy (33.3% vs. 50.0%; P = 0.30), and 
PELOD score (15.5 ± 10.4 vs. 21.8 ± 15.4; P = 0.22). In the nonsurvival 
group, the PIM-II was higher than that in the survival group (27.9 ± 10.4 
vs. 35.7 ± 9.0; P = 0.06); the PaO2/FiO2 (272.5 ± 136.7 vs. 153.3 ± 123.3; 
P = 0.03) and oxygenation index (6.7 ± 8.1 vs. 14.1 ± 9.5; P = 0.04) were 
signifi  cantly worse in the nonsurvival group than in the survival group.
Conclusion  The data show that respiratory failure is more strongly 
associated with mortality than other organ failures in pediatric 
hematology patients requiring intensive care. These results also suggest 
that mechanical ventilation intervention in patients with respiratory 
failure must occur earlier to improve the outcomes for these patients.
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Introduction Critically ill patients with haematological malignancies 
(HM) have high hospital mortality [1]. Severity of illness scores may 
underestimate mortality in such patients [2].
Methods Data collection was conducted at three hospitals from 2008 
to 2011. Patients with any active HM condition were matched with 
two control patients at two hospitals and with one control at Christie 
Hospital. Control patients had the same APACHE II (within 2 points) and 
admission diagnosis, but no HM. Readmissions and planned surgical 
cases were excluded.
Results  A total of 163 patients with HM were compared with 237 
control patients. Seventy-four admissions with HM were identifi  ed at 
two hospitals, and each was matched with two control patients. Eighty-
nine admissions with HM from Christie Hospital were identifi  ed. These 
were matched with 89 controls. Patients with HM spent signifi  cantly 
longer in hospital before ICU admission (Table 1). Unit and hospital 
mortality rates were not statistically diff  erent between patients with 
HM and without HM (Table 2).
Table 1 (abstract P515). Patient characteristics
 Haematology  Controls  P value
Age, mean (SD)  56.5 (15.1)  57.1 (15.7)  0.717
APACHE II, mean (SD)  22.7 (6.1)  23.1 (6.0)  0.484
ICU LOS (median)  3.2 (1.8 to 6.2)  3.1 (1.3 to 8.4)  0.948
LOS prior (median)  6.5 (2 to 17)  2.0 (0 to 7)  <0.0001
Table 2 (abstract P515). Unit and hospital mortality
  Patients  ICU mortality,   Hospital mortality, 
 ( n)  n (%)  n (%)
Haematology   163  52 (31.9%)  81 (49.7%)
Controls  237  73 (30.8%)  99 (41.8%)
P value     0.827  0.126
Conclusion Unit mortality of critically ill patients with HM was similar 
to those without HM. Hospital mortality in patients with HM was higher 
than those without HM, although not statistically signifi  cant. Severity 
of illness at presentation to critical care is the main determinant of 
outcome in patients with HM.
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Introduction ICU admission policies regarding patients with haemato-
logical malignancy still vary despite data showing an acceptable 
prognosis. Our aim was to review ICU and 6-month outcomes in this 
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cancer centre.
Methods A retrospective review of medical notes between 2004 and 
2012.
Results A total of 249 patients were admitted, of whom 54 had more 
than one admission. There were 310 episodes in total. Leukaemia n = 85; 
lymphoma n = 90; myeloma n = 36. We compared the characteristics of 
those who survived ICU admission with those who failed to survive to 
discharge from ICU. The two populations were similar (age 51 vs. 57; 
males 59% vs. 57%). Those who survived had a lower APACHE II score 
on admission (19 vs. 23; P <0.001), lower mean organ failure scores (1 
vs. 2; P <0.05), lower requirements of inotropes (26% vs. 50%; P = 0.001), 
ventilation (31% vs. 64%; P  =  0.001) and fi   ltration (11% vs. 26%; 
P = 0.004). There was no diff  erence in the prevalence of sepsis at the 
time of admission (64% vs. 70%). Both groups included patients with 
prior bone marrow transplant (38% vs. 40%). Of note, ICU and 6-month 
survival were 27% and 50%, respectively. These values are lower than 
those reported in the literature to date.
Conclusion ICU and 6-month mortalities were 27% and 50%, respectively. 
Patients with haematological malignancy stand to benefi  t from intensive 
care, and should be off  ered admission based on clinical need.
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Introduction In the year 2009, the organizational structure of the ICU 
in the Kanazawa University Hospital changed from an open to a semi-
closed format ICU. The objective of this study was to evaluate the eff  ect 
of this organizational change on outcome in high-risk surgical patients.
Methods  The medical records of all consecutive high-risk surgical 
patients admitted to the ICU from 2006 to 2009 (open format, n = 1,598) 
and from 2009 to 2012 (semi-closed format, n = 1,521) were reviewed. 
Parameters studied were mortality and ICU length of stay.
Results Mortality of ICU patients was 9.9% in the open format group 
and 6.6% in the closed format group (P <0.05). The average length of 
hospital stay was 4.9 days in the open format group and 4.8 days in the 
closed format group.
Conclusion Our results suggest that a semi-closed format is a more 
favorable setting than an open format to improve mortality in the ICU 
and to warrant safe outcome in this patient group.
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Introduction Many evidence-based interventions are not delivered to 
patients [1]. This may not be due to a clinician’s intentional decisions. 
The aim of this project was to compare the use of starch before and 
after removing it as an option from an e-prescribing template.
Methods  Our e-prescribing software enables users to prescribe 
intravenous fl  uids from a series of menus. One of these is a template 
that has several fl  uids available to use as a bolus when instructed by 
a clinician. We removed starch as an option from the template in April 
2009. Starch could still be prescribed elsewhere on the prescribing 
system. Data on the use of starch from November 2008 to November 
2012 were analysed as the mean volume of starch infused per patient 
per month. The mean of each set of parameters was then compared 
using a Student’s t test.
Results The mean volume of starch per patient administered before 
and after electronic prescription options were altered was 480 ml and 
21 ml, respectively (P = 0.004). See Figure 1.
Conclusion Despite clinicians intending to reduce the use of starch it 
was still regularly administered on our ICU. The removal of a default 
prescribing option dramatically reduced the volume of starch used 
whilst not restricting the ability to make a conscious choice to prescribe 
it. Adjusting default options has potential to infl  uence clinical decisions 
and ensure more reliable, evidence-based care.
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Introduction  Early detection of sepsis is important for a suffi   cient 
treatment to reduce mortality. We hypothesized that using modifi  ed 
systemic infl  ammatory response syndrome criteria over 1 hour using an 
electronic software program facilitates the clinical diagnosis of sepsis.
Methods After IRB approval and informed consent we enrolled in this 
prospective, observational, single-center study 1,119 consecutive 
patients (age 68.6  ±  16.4, female/male 476/649) admitted over a 
6-month period to a surgical ICU. A total 149 of them met modifi  ed 
systemic infl  ammatory response criteria. Patients were monitored by 
an electronic software program using live data from the laboratory and 
bedside monitors to detect modifi  ed systemic infl  ammatory response 
syndrome criteria persisting over 1 hour. The physicians were blinded 
to the software program alerts that notifi  ed in real time when modifi  ed 
systemic infl  ammatory response syndrome criteria were detected and 
persisted over 1 hour, but did not provide treatment recommendations.
Results  There was a total of 149 modifi   ed systemic infl  ammatory 
response syndrome criteria alerts. Seventy-four were confi  rmed  as 
true sepsis cases by physicians. The overall incidence of sepsis was 7%. 
Patients were categorized into length of stay <24 hours, 24 to 96 hours 
and >96 hours. The overall sensitivity of our system for detecting sepsis 
was 68% and the specifi  city was 91%. The positive predictive value is 
34% and the negative predictive value is 98%.
Conclusion Real-time alerts using an automated, electronic monitoring 
of modifi  ed systemic infl  ammatory response syndrome criteria facili-
tate the clinical diagnosis of sepsis.
Figure 1 (abstract P518). Starch administration between November 
2008 and November 2012.
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Admission to the ICU overnight: is it really a bad thing?
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Introduction  Admission to hospital overnight has been shown 
to increase mortality and decrease hospital length of stay [1]. The 
objective of this study was to determine whether this relationship is 
valid in patients admitted to our ICU, and whether length of stay was 
aff  ected.
Methods  A retrospective data collection identifi   ed 5,827 patients 
admitted to a fi  ve-bed ICU from April 1994 to November 2012. Data 
regarding patient age, sex, APACHE II score and ICU admission date 
and time were collected along with the length of stay in the unit and 
hospital. Defi  nitions of day and night were set to local ICU standards of 
9:00 am to 8:00 pm. Patients were then separated into two groups and 
analysed using Analyse-It software for Excel.
Results Crude ICU and hospital mortality rates in patients admitted 
during the day and overnight were examined. There was no signifi  cant 
diff  erence in unit mortality (day 22.3% vs. night 22.7%, OR = 1.02, 95% 
CI = 0.91 to 1.16, P = 0.718) or hospital mortality (day 30.7% vs. night 
29.1%, OR = 0.93, 95% CI = 0.83 to 1.04, P = 0.203). The mean unit length 
of stay showed no diff  erence in patients admitted during  daytime 
compared with those admitted overnight (4.27  days vs. 4.09  days, 
P = 0.162). The mean hospital length of stay was decreased in patients 
admitted during daytime compared with patients admitted overnight 
(19.3 days vs. 21.7 days, P = 0.004). The average age of patients was 
less in those admitted out of hours (night 56.5 years vs. day 59.2 years, 
P = <.0001). There was no signifi  cant diff  erence in APACHE II scores of 
patients between the groups (day 19 vs. night 19, P = 0.580).
Conclusion There is no signifi  cant diff  erence between the mortality of 
patients admitted overnight and patients admitted during the day to 
our unit. The hospital length of stay is increased in patients who are 
admitted overnight to intensive care; however, ICU length of stay is 
not aff  ected. Adjustment for other confounders such as current bed 
occupancy and staffi   ng ratios during the entire patient stay may help 
to understand the diff  erences seen in the hospital length of stay.
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Introduction Interdisciplinary rounds (IDRs) in the ICU are increasingly 
recommended to support quality improvement and to reduce 
confl  icts, but uncertainty exists about assessing the quality of IDRs. 
We developed, tested, and applied a scoring instrument to assess the 
quality of IDRs in ICUs.
Methods  A literature search was performed to identify criteria for 
instruments about assessing team processes in the ICU. Then, 10 
videotaped patient presentations led by diff  erent intensivists were 
analyzed by Delphi rounds. Appropriate and inappropriate behaviors 
were highlighted. The IDR-Assessment Scale was developed and 
statistically tested. The inter-rater reliability was evaluated by 
rating nine randomly selected videotaped patient presentations by 
three raters. Finally, the scale was applied to 98 videotaped patient 
presentations during 22 IDRs in three ICUs for adults in two hospitals 
in Groningen.
Results  The IDR-Assessment Scale had 19 quality indicators, 
subdivided into two domains: Patient Plan of Care, and Process. The 
domain Patient Plan of Care refl  ects the technical performance from 
the initial identifi  cation of a goal to the evaluative phase. The domain 
Process refl  ects the team processes that are important to ensure that 
the appropriate plan of care is agreed, understood, and executed as 
planned by all care providers. Indicators were essential or supportive. 
The inter-rater reliability of nine videotaped patient presentations 
among three raters was satisfactory (κ  =  0.85). The overall item 
score correlations between three raters were excellent (r  =  0.80 to 
0.94). Internal consistency in 98 videotaped patient presentations 
was acceptable (α = 0.78). Application to 22 IDRs led by 14 diff  erent 
intensivists in three ICUs in two hospitals demonstrated that indicators 
could be unambiguously rated. The staff   and management of all three 
ICUs that were rated had considered their IDRs to be adequately 
performed, and they were surprised by these study results.
Conclusion This study showed that the quality of IDRs can be reliably 
assessed for patient plan of care and process. The IDR-Assessment 
Scale had satisfactory inter-rater reliability, excellent overall item score 
correlations, and acceptable internal consistency. Our instrument 
may provide feedback for ICU professionals and managers to develop 
adjustments in quality of care. Testing the IDR-Assessment Scale in 
other ICUs may be required to establish general applicability.
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Introduction  The development of patient-centered care by inter-
disciplinary teams in the ICU has focused attention on leadership 
behavior. The purpose of this intervention study was to measure 
the eff  ect of leadership training on the quality of performed inter-
disciplinary rounds (IDRs) in the ICU.
Methods  In this nonrandomized intervention study, participants 
included nine intensive care medicine fellow trainees (intervention 
group) and 10 experienced intensivists (control group). Participants 
in the intervention and control groups previously were untrained in 
leading IDRs in the ICUs. After each participant led an IDR that was 
videotaped, the fellow trainees participated in a 1-day leadership 
training, which was consistent with principles of adult learning and 
behavioral modeling. After training, each fellow trainee led another 
IDR that was videotaped. Quality of the performed IDRs was measured 
by review of videotapes of the 19 IDRs lead by 19 intensivists, including 
198 patient discussions subdivided into four ICUs, and assessment with 
the IDR-Assessment Scale.
Results Comparison of the intervention versus control groups shows 
that the intervention group has more yes scores on the IDR-Assessment 
Scale than the control group. This diff  erence was signifi  cant in 12 of the, 
in total, 19 quality indicators.
Conclusion Quality of leadership will be reliably trained and measured 
in the context of IDRs in ICUs. Training in a simulation environment, with 
real-life IDR scenarios including confl  icting situations, and workplace-
based feedback in the preparation and feedback phases, appears to be 
eff  ective to train leadership behaviour.
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Introduction  Harefi  eld Hospital is a 150-bed cardiothoracic tertiary 
referral centre with transplantation, artifi  cial heart, ECMO and primary 
angioplasty services. Our 35-bed critical care department consists of 
18 intensive therapy unit, seven recovery and 10 high-dependency 
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by the Royal College of Physicians and the Royal College of Nursing [1] 
as structured, evidence-based processes for nurses to carry out regular 
checks with individual patients at set intervals. The senior nursing team 
decided to adapt this initiative to the intensive care setting in order 
to address clinical challenges and provide guidance for shift leaders to 
focus on key elements of care.
Methods Our intentional rounds, performed once per shift (twice daily), 
include two components. First, pressure area care – this component 
involves the shift leader checking whether key elements of pressure 
sore prevention have been performed. These include completion 
of the Waterlow risk assessment tool [2], noting the frequency of 
repositioning, use of lateral positioning and pressure-relieving pads. 
Second, renal replacement therapy rates – this element was identifi  ed 
as an area for focus after we established that our haemofi  ltration fl  uid 
use per hour of therapy was twice that of a near identical clinical setting. 
This pattern continued even after adopting similar therapy guidelines. 
The shift leader was guided to check whether therapy rates had been 
adjusted in line with latest biochemical results.
Results The incidence of pressure ulcers in the 4 months since the 
initiative began has averaged 2.25 per month compared with 7.8 per 
month prior to commencement of intentional rounding. Added to the 
rounding tool at the end of September 2012, RRT rates in the preceding 
4 months averaged 31.5 ml/kg/hour over 24 hours, an 11.9% reduction 
from the previous average of 35.75 ml/kg/hour. If the pattern of RRT 
was to continue, this could equate to a cost saving of UK£40,000 per 
annum.
Conclusion The use of a modifi  ed targeted intentional rounding tool 
by the nursing shift leader can help ensure that best practice guidelines 
are adhered to. This strategy can improve patient outcomes and 
provide potentially signifi  cant fi  scal benefi  ts.
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Introduction Handovers are often associated with poor communi  ca-
tion. ICU patients with multiple complex problems are ideal to study 
naturally occurring handovers. However, few studies have been 
conducted in the ICU.
Methods  We conducted questionnaires of physicians and nurses 
involved and observed handovers in real time of medical ICU patients 
over 1 month.
Results We interviewed 580 of 672 physicians and nurses involved 
(86.3%) and observed 90 real-time handovers (45 patients, 26.8%) of 
168 patients. Mean duration of handover was 391.3 (± 263.6) seconds, 
78.5% were face to face and 1.26 (± 1.75) distractions per handover 
were noted, person-to-person calling being the commonest mode 
of distraction (46.7%). Nurses received training during induction 
in signifi   cantly higher numbers, covered allied specialties more 
and reviewed the patients early (all P  <0.05). Perception of the 
relative importance of diff  erent components of the handover varied 
signifi  cantly between donors, recipients, physicians and nurses. Both 
physicians and nurses seldom (39.7%) reviewed the available electronic 
past medical records of the patient before handover, which in addition 
to training in handover and overall confi  dence level in the management 
following handover are signifi  cantly associated with better satisfaction 
in univariate analysis; only the confi  dence level in patient management 
remained signifi  cant after multivariate analysis. However, agreement 
between donor and recipient on overall satisfaction was poor 
(P >0.05). Nursing handovers were signifi  cantly longer than physicians’ 
(572.08  ±  214.68 vs. 168.6  ±  97.27 seconds, P <0.001) but are also 
associated with higher distractions particularly during evening shifts.
Conclusion A higher percentage of nurses received handover training; 
nursing handovers are longer and more inclusive of other components 
of patient management; perceived importance of components of 
handover varies among healthcare professionals; distractions are 
common during handovers and associated with longer duration, 
by nurses and in the evening shifts; and higher confi  dence level in 
patient’s management following the handover is associated with 
better satisfaction.
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Introduction  Emergency survival rates vary signifi  cantly  according 
to the quality of care, which depends on human and technological 
resources. Emergency and critical care medicine physicians must make 
fast decisions; the presence of experienced consultants improves 
survival. In developing countries, there is a shortage of skilled 
doctors. The aim is to describe the fi  rst Brazilian initiative of real-
time teleconferencing telemedicine (TM) providing 24/7 emergency 
department (ED) and ICU coverage.
Methods Since May 2012 a TM program has been implemented at 
two hospitals in São Paulo, Brazil  – Hospital Municipal Dr. Moysés 
Deutsch (HMMD), a public, secondary hospital, and Hospital Israelita 
Albert Einstein (HIAE), a tertiary private philanthropic entity – due to 
a partnership with the Brazilian Health Ministry. TM Central Command 
was located at HIAE with Endpoint 97 MXP Cisco® Solution and a 
mobile Intern MXP ISDN/IP Cisco® for the remote hospital (HMMD) via 
dedicated GB/sec connection. Imaging examinations were evaluated 
using PACS technology. Every recruited patient was assessed by the 
Central Command through TM with an experienced consultant.
Results Over a 6-month period, 131 teleconsultations (114 patients) 
were done. Mean age was 50.1  years, 57.1% was male and mean 
APACHE II score was 24.3. A total of 64.8% originated from the ICU and 
35.2% from the ED. Main consultation diagnoses were sepsis (31.3%); 
stroke (29.8%); survival from cardiac arrest (6.1%); trauma (6.1%); and 
acute myocardial infarction (5.3%). TM improved diagnosis in 14.5% 
and infl  uenced the clinical management in 85.5% of the consultations. 
Invasive procedures were indicated in 61.1%. Life-saving procedures 
were TM related in seven patients (6.1%): stroke thrombolysis (n = 6) 
and limb amputation (n = 1). Seven patients (6.1%) were transferred and 
submitted to surgical procedures (heart surgery (n = 2), neurosurgery 
(n = 4) and liver transplantation (n = 1)). The majority of the patients 
remained at HMMD and were discharged.
Conclusion A TM program is feasible to be implemented in a community 
hospital. The major benefi   t is expertise medical transfer from the 
tertiary hospital to the community setting, improving diagnosis and 
management of critical care patients, and avoiding routine transfer to 
a major urban center.
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Introduction Our objective is to present our experience from Shriner’s 
Hospital and Massachusetts General Hospital in Boston, MA, USA in 
Critical Care 2013, Volume 17 Suppl 2 
http://ccforum.com/supplements/17/S2
S193using telemedicine to provide acute burn and critical care consultation 
on pediatric and adult burn patients in Lviv, Ukraine, as well as in triage 
and transport of critically ill patients from Lviv to a tertiary-care facility 
in the USA for further management.
Methods Using a new telemedicine learning center established at City 
Hospital #8 in Lviv, Ukraine, consultations regarding acutely injured 
burn victims occurred between physicians in Ukraine and physicians at 
Shriners Hospital and Massachusetts General Hospital in Boston. After 
the initial presentation, each patient was reviewed on a daily basis by 
physicians in Boston. Skype, an Internet-based communication tool, 
was used in communication with the Burn Center in Lviv. Radiographic 
images were scanned and digitalized using an electronic scanner, 
and JPEG image compression was used to facilitate the transmission 
of radiographic images and patient charts. Informed consent and 
HIPPA guidelines were followed in transmitting any patient-related 
information.
Results Since 2011 we have provided consultation on 14 patients in 
Lviv, Ukraine, ranging in age from 15 months to 63 years. Each patient 
had an average of six consultations. We present two of these cases as 
examples of the capabilities of our telemedicine program. The fi  rst 
case involved a 15-month-old female with 40% TBSA from scald injury, 
where telemedicine was instrumental in the primary assessment as 
well as to arrange a direct assessment from a nearby burn surgeon. The 
second case resulted from a house fi  re with multiple casualties, where 
physicians in Boston were able to utilize telemedicine to guide the 
initial resuscitation and airway management of three critically burned 
children, as well as to arrange for transport of one of the victims, an 
11-year-old male with 87% TBSA, from Ukraine to the USA for acute 
management. Multiple diffi   culties were overcome in implementing the 
system between the two countries including: time zone diff  erences, 
language barrier, and diff  erent approaches to patient care.
Conclusion  We have established a telemedicine program linking 
physicians in Boston, MA, USA with City Hospital #8 in Lviv, Ukraine 
to improve care in pediatric and adult burn patients. Our program has 
provided consultation on 14 patients since 2011, and it highlights the 
capabilities of telemedicine for acute consultation as well as triage and 
transport of critically ill patients to tertiary-care facilities.
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Introduction  During the last few  years the frequency of end-of-
life decisions (EOLD) signifi  cantly increased in ICUs. The method of 
nurse involvement in making EOLD is diff  erent worldwide [1,2]. The 
purpose of this study was to analyze opinions of nurses about therapy 
restriction. We have examined with a multicenter study the opinions of 
the medical stuff   about end-of-life care in Hungarian ICUs.
Methods We performed a questionnaire evaluation among physicians 
and nurses of ICUs about infl  uencing factors of therapy restriction, the 
method of the decision-making process, and the frequency of diff  erent 
EOLD. The questionnaire, containing 21 questions, was delivered 
electronically to Hungarian ICUs, and then we analyzed the responses 
anonymously. The retrieved 302 answers (191 physicians, 102 nurses) 
were analysed using a nonparametric Student’s test.
Results A total 71% of the nurse responders work in university clinics, 
2% in regional centrum, 24% in municipal hospital, 3% in other ICUs. 
The nurses found both human (2.72/5 vs. 1.98/5) and material (2.81/5 
vs. 2.12/5) resources more restrictive factors during patient admission 
than physicians (P = 0.025, P = 0.0024). Nurses working in municipal 
hospital were more strongly infl  uenced by lack of material and human 
resources (3.34/5, 3.3/5) than nurses working in university clinics (2.2/5, 
2.43/5), P = 0.01, P = 0.025. Younger nurses (working between 6 and 
10 years) were more interested in the patient’s or surrogate’s wishes 
than older nurses (working more than 10  years). Religion did not 
infl  uence patient admission and forego therapy; however, religious 
nurses compared with atheists and nonpracticing believers preferred 
to prolong therapy against the patient’s will (P = 0.04). Nurses felt that 
physicians slightly involved them in the end-of-life decision-making 
process (2.1/5 vs. 2.4/5 P = 0.0001).
Conclusion We found that the workplace, level of medical attendance, 
godliness, work experience, and position in medical staff   strongly 
infl   uenced making EOLD. While limitation of the therapy should 
be team work, nurses felt their opinions were hardly taken into 
consideration, although nurses seemed to be more realistic in the 
decision-making process.
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Introduction More than one in fi  ve people admitted to an ICU will die 
there. Research has highlighted concerns about support for patients 
and families and decision-making in this context [1,2]. Here, we describe 
the development and evaluation of a tool to improve palliative care in a 
32-bed general ICU in a central London teaching hospital.
Methods Medical Research Council guidance for complex interventions 
Phase 0 to I comprised literature review, theoretical modelling, obser-
vation and qualitative interviews and focus groups with staff   and 
families exploring concerns and views of interventions identifi  ed in 
the literature review. Phase II comprised intervention development, 
implementation and evaluation of tool feasibility and eff  ects using staff   
survey, observation, audit of records and relative survey.
Results Phase I: 47 staff   and 24 family members were interviewed. 
The short time between decisions for treatment withdrawal and 
death, plus concerns for support management, communication and 
decision-making, highlighted a need to ensure excellent psychosocial 
assessment for all. Phase II: as part of integrated care guidelines, we 
developed the King’s Psychosocial Assessment and Care tool (K-PACE). 
K-PACE is used for all patients entering the ICU, completed within 
24  hours of admission. It contains psychosocial assessment of the 
family and patient needs, and identifi  es key individuals for contact. 
Educational training was supported by K-PACE and was implemented 
in two waves. Post-implementation survey of 95 ICU staff   found that 
most (80%) were aware of K-PACE. Eighty-two per cent of nurses but 
only 17% of doctors had completed the tool. In total, 158/213 (74%) 
family members responded to the survey (additionally three patients 
responded). There were high levels of satisfaction for symptom control 
and psychosocial care but concerns continued regarding explanation 
of treatment and care.
Conclusion K-PACE is a feasible tool to improve the palliative care of 
patients and their families in the ICU. Further refi  nement is needed and 
planned, with consideration of roll-out into the wider medical centre.
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Introduction  The decision of terminal care in the ICU is a very 
tough issue because the law, ethics, traditions and futility should 
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withdrawing therapy is a quite diffi   cult operation in Japan because of 
legal issues. Our hypothesis is that some diff  erence exists in thoughts 
between physicians and nurses for terminal patients in the ICU. The aim 
of this study is to know their real thoughts.
Methods A questionnaire survey was performed on physicians and 
nurses in our medico-surgical ICU. The questionnaire consists of 
11 questions with fi  ve optional answers related to the thoughts of 
participants about treatment of hopeless or brain death patients. 
Concretely, the questions were; whether to withhold therapy or not, 
whether to accept to withdraw therapy or not and with family’s will, 
whether to accept to immediately stop therapy and with family’s will, 
whether to positively or not donate organs from a brain death patient, 
necessity of ICU care for brain death patients, and feeling guilty and 
stress for stopping or withdrawing therapy. The optional answer has 
fi  ve gradations from ‘Yes’ to ‘No’ for all questions. The participants were 
asked to answer the questionnaire by expressing themselves without 
regarding legal issues or the consensus. It was guaranteed to be 
anonymous for them in the data analysis. The answers were compared 
between physicians and nurses. The Mann–Whitney U test was used 
for statistical analysis. P <0.05 was considered statistically signifi  cant.
Results There were in total 52 participants (response rate 98.1%) with 
20 physicians and 32 nurses. Withdrawing therapy was signifi  cantly 
accepted in nurses than in physicians (83% vs. 55%, P = 0.039), when the 
family well understood. Withholding therapy should not be operated 
for brain death patients for physicians (65%), while it seemed a diffi   cult 
judgement for nurses (23%, P = 0.021). ICU care for brain death patients 
is less necessary for physicians than nurses (80% vs. 53%, P = 0.016). 
There were no signifi  cant  diff   erences in other questions between 
physician and nurses such as feeling guilty or stress for stopping or 
withdrawing therapy.
Conclusion Some of end-of-life thoughts in the ICU showed diff  erences 
between physicians and nurses.
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Introduction The purpose of our study was to assess the attitudes of 
Slovenian intensivists towards end-of-life (EOL) decision-making and to 
analyze the decision-making process in their clinical practice.
Methods A cross-sectional survey among Slovenian intensivists and 
intensive care medicine residents from 35 diff  erent ICUs was performed 
using a questionnaire containing 43 questions about views on EOL 
decision-making. Fisher’s exact test and the Fisher–Freeman–Halton 
test were applied to cross-tabulated data; signifi  cance level was set at P 
≤0.001 due to the large number of tested hypotheses.
Results  The response rate was 72.1% (267 questionnaires were 
returned out of 370 distributed), which represented roughly the same 
percentage of all Slovenian intensivists. Termination of futile treatment 
was assessed as ethically acceptable (P <0.001). The statement that 
there is no ethical distinction between withholding and withdrawing 
of treatment could not be confi  rmed (the answers ‘there is a diff  erence’ 
and ‘undecided’ were less frequent, but not statistically signifi  cant; 
P = 0.216). A do-not-resuscitate order (DNR) was used more often than 
other withholding treatment limitations (P <0.001). A DNR was used 
most frequently in internal medicine ICUs (P <0.001; compared with 
paediatric and surgical ICUs). Withdrawal of inotropes or antibiotics 
was used more often than withdrawal of mechanical ventilation or 
extubation (66.7% vs. 12.0%; P  <0.001). Withdrawal of mechanical 
ventilation or extubation was more often used in the paediatric ICUs 
(21.7%) as compared with the internal medicine ICUs (19.6%) and the 
surgical ICUs (3%) (P <0.001). Over two-thirds (70.6%) of intensivists 
were against termination of hydration, which would be more often 
used in the internal medicine ICUs (P <0.001). Thirty-one percent of 
intensivists used written DNR orders.
Conclusion Termination of futile treatment was found to be ethically 
acceptable for Slovenian intensivists, although they were not convinced 
that withholding and withdrawing of treatment were ethically equal. A 
DNR would be used most often. Withdrawal of inotropes or antibiotics 
would be used more often than withdrawal of mechanical ventilation 
or extubation. Termination of artifi  cial hydration would be rarely used 
in practice.
P531
Attitudes of intensivists in the UK to withdrawal of futile therapy
M Mariyaselvam, M Irvine, J Carter, M Blunt, P Young
Queen Elizabeth Hospital, Kings Lynn, UK
Critical Care 2013, 17(Suppl 2):P531 (doi: 10.1186/cc12469)
Introduction  We aimed to determine the current practice and 
attitudes of consultants in intensive care medicine when withdrawing 
futile life-sustaining therapy. Published guidelines suggest variation 
in withdrawal of futile life-sustaining therapy and are therefore not 
prescriptive [1]. Although there is an awareness of diff  ering practices, 
the extent of these variations is not established.
Methods  We surveyed a convenience sample of delegates at the 
Intensive Care Society (UK) State of the Art Meeting (2012) on attitudes 
and practice regarding withdrawal practice. Anonymised data were 
collected using surveymonkey.com.
Results Of 457 consultant attendees from the UK, 149 completed the 
survey (33%). For 58% of consultants there was no formal institutional 
protocol for withdrawal of futile therapy. When deciding to withdraw 
therapy, 57% of consultants routinely seek and document a second 
opinion. Regarding donation after cardiac death (DCD), 93% of 
consultants were happy to delay withdrawal to facilitate successful 
donation, 85% have already done so in their practice and 14% 
routinely withdraw therapy in theatres rather than on the ICU. Even 
if it would impact on the care of other patients, 48% would delay 
withdrawal of therapy to facilitate DCD. For patients accepted for 
DCD, 36% think that some intensivists withdraw more aggressively 
(in essence, hasten death) in the hope of improving the likelihood of a 
successful organ donation and 29% have felt pressurised to withdraw 
therapy more quickly than their usual practice. Furthermore, 45% 
experienced pressure to refer a patient for DCD when it they felt it 
was not appropriate.
Conclusion This survey confi  rms variation in the practice and attitudes 
to withdrawal of futile therapy amongst UK consultant intensivists. 
Formal protocols were frequently unavailable to guide withdrawal 
and second opinions were often not sought. Nearly one-half of the 
intensivists delay withdrawal to facilitate donation, even if this may 
impact on the care of other patients. Many intensivists have felt 
pressure to refer for donation when they feel this is inappropriate 
and there is a perception that some intensivists may withdraw care 
more aggressively in those who are accepted for DCD to improve the 
likelihood of a successful donation. This survey may help inform debate 
in this ethically challenging area.
Reference
1.  Organ Donation after Circulatory Death 
[http://www.ics.ac.uk/professional/standards_and_guidelines/dcd]
P532
Parent’s perception on end-of-life care in Brazil
P Lago, J Piva, G Halal, M Halal
Hospital de Clinicas de Porto Alegre, Brazil
Critical Care 2013, 17(Suppl 2):P532 (doi: 10.1186/cc12470)
Introduction  The aim of the study is evaluate the perceptions of 
parents of children who died in two Brazilian pediatric ICUs.
Methods An exploratory-descriptive study with a qualitative approach 
in the PICU of Hospital São Lucas and Hospital de Clinicas de Porto 
Alegre involving 15 parents of children who died. Data collection was 
performed through three steps: (a) the researchers contacted the 
parents through a telephone call to invite them to attend the hospitals; 
(b) at the hospital, the doctors who assisted the children clarifi  ed doubts 
about the therapy off  ered; and (c) an interview was carried out by two 
researchers not involved in the care. Data analysis was performed using 
the technique of thematic content analysis.
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muni  cation is a factor that impacts negatively on the grieving process. 
Moreover, it stresses the importance for parents to rediscuss the 
moment of their child’s death with health professionals.
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Introduction Despite our eff  orts in making patients healthy and going 
home, critical illness has a mortality, in Danish ICUs, of 10 to 12%. 
Approximately 90% of deaths in ICUs happen after life-sustaining 
therapy has been withheld or withdrawn. Although trying to provide 
patients and family with what we suppose is a good death, most 
patients would prefer dying at home, and sometimes patients and 
family ask for the possibility of doing that. The last 2 years we transferred 
seven patients from our unit to end-of-life care in their own home.
Methods After making the decision of withholding or withdrawing 
intensive care therapy, the care of the patient changes from an active, 
medical, technological treatment to relief and care. In that period we 
determine whether the patient’s condition is stable enough to go 
home. We try to fi  nd out if it is a wish for the patient to go home, and 
if the family has resources to take care of the patient at home. If that is 
the case, we start planning care at home, arrange for transportation, 
and contact the primary care physician and nurse. Due to the patient’s 
condition on the day of transferring, we plan following the patient by 
either a nurse or a doctor.
Results Seven terminally ill patients wishing to go home for dying were 
transferred home. Diagnoses varied: end-stage lung disease, cancer, 
surgical complications. Ages ranged from 68 to 84 years. All patients 
survived transport home, and time at home varied from a few hours to 
4 days. Later contacts with patients’ families indicated that both patient 
and family were grateful, and that they did not experience the patient 
having pain or dyspnea at home.
Conclusion Sending critically ill patients home to die is not common. 
Anyhow, our experiences doing that are only positive. Terminally ill 
patients, awake to make a decision of their own, and in a condition 
making it possible, should have the choice to go home to die, with our 
help in logistics, planning and transportation.
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Introduction This study assessed the eff  ect of a hospital-based aerobic 
exercise programme on physical fi  tness and health-related quality of 
life (HRQoL) for survivors of ICU admission. Including the qualitative 
arm of the study, we examined the patient experience after critical 
illness, their views of the exercise programme and the eff  ects on their 
HRQoL.
Methods  A randomised controlled trial was undertaken in adult 
survivors of ICU admission. They were allocated to receive an 
8-week in-hospital supervised aerobic programme consisting of two 
cycle ergometry and one unsupervised session per week (exercise 
group) or no exercise (control group). Primary outcomes were the 
anaerobic threshold (in ml O2/kg mass/minute), physical function 
and mental health scores (SF-36 questionnaire), measured at weeks 
9 and 26. Participants were then allocated to focus groups where the 
interpretation of experiences was compared with outcomes from the 
PIX study.
Results Fifty-nine patients were recruited to the study. The anaerobic 
threshold increased at week 9 in the exercise group by a clinically and 
statistically signifi  cant amount of 2 ml O2/kg mass/minute (90% CI, 1 
to 3 ml/kg/minute). There was further improvement in fi  tness levels in 
both groups by week 26 (although no signifi  cant diff  erence between 
groups). No signifi  cant  diff   erence in HRQOL measures between 
groups was demonstrated; however, the exercise group did show an 
improvement in their mental health scores. The focus groups centred 
on feelings of isolation, abandonment, vulnerability, dependency and 
reduced physical activity post hospital discharge. Many reported a 
lack of social inclusion as they did not have the energy or confi  dence 
to venture outside. However, those in the exercise group felt that 
the rehabilitation programme was motivating, built up confi  dence, 
improved fi  tness, helped social interaction and gave them a sense of 
achievement.
Conclusion The 8-week exercise intervention resulted in statistically 
signifi   cant improvements in fi   tness at 9 weeks while focus group 
participants highlighted the positive eff  ects of the exercise intervention 
leading to enhanced energy levels, motivation and achievement. 
Psychological benefi  ts of the exercise programme are apparent from 
the focus group, emphasising the important link between physical and 
mental health.
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Introduction Survivors of critical illness often have a prolonged stay 
on the ICU. These patients may suff  er from ICU-acquired weakness. It 
has been shown that reduction in muscle mass and muscle strength 
occurs early after admission to the ICU. However, in the very early stage 
on the ICU, patients are often sedated and not able to participate in 
any active mobilizations. Therefore the use of neuromuscular electrical 
stimulation (NMES) is becoming a treatment of interest in the ICU. The 
aim was to study the feasibility and safety of NMES in a surgical and 
medical ICU of a large, tertiary referral university hospital.
Methods Fifty patients with an expected prolonged stay on the ICU 
of 5 more  days (judged on  day 3) with no trauma or neurological 
disease were included. They then received daily a NMES session (DUO 
500; Gymna, Belgium) for 25 minutes on the quadriceps bilaterally 
during their entire stay on the ICU. The main outcome was the ability 
to produce a contraction of the quadriceps through NMES. The muscle 
contraction was quantifi   ed on a 5-point scale: 1 (no contraction 
palpable and visible) up to 5 (contraction very well palpable and visible). 
Patients were classifi  ed as responders when an adequate muscle bulk 
was obtained in ≥75% of the sessions. The potential factors associated 
with the feasibility were: gender, age, body mass index (BMI), diagnosis 
of sepsis, Barthel index prior to admission to the hospital, APACHE II 
score, Glasgow Coma Scale (GCS), fi  ve questions for adequacy, stimulus 
intensity and leg edema. A multiple regression analysis was performed 
to identify the factors determining whether or not a contraction could 
be expected in a patient. Safety of NMES was assessed through heart 
rate, blood pressure, oxygen saturation and respiratory rate.
Results In 48% of the patients we were able to achieve adequate muscle 
contractions in more than 75% of the sessions. GCS (P = 0.047), edema 
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responders and nonresponders. Responders had a lower mean GCS 
(7 ± 3 vs. 9 ± 3), lower amount of edema and were less likely to have 
had sepsis. In a multiple regression analysis, sepsis, edema, BMI and age 
explained 51% of the variance. As for safety, none of the parameters 
changed signifi  cantly.
Conclusion In patients with a better neurological condition, sepsis and/
or leg edema it was more diffi   cult to obtain an adequate quadriceps 
contraction with NMES. NMES is safe to apply on the ICU.
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Introduction Trauma is the most common cause of morbidity in young 
people. It has a high social impact both because of the high cost of 
the acute treatments and because of the physical and psychological 
consequences that it may cause. A prospective, observational, single-
center study on quality of life 12 to 24 months after trauma was carried 
out. The aim of the study is to evaluate life quality after trauma and to 
identify the most important needs of the patients, in order to improve 
the level of care after an ICU stay and to implement a faster and more 
eff  ective reintegration into the active and productive society.
Methods All patients admitted to the 18-bed ICU of our university 
hospital between 5 May 2010 and 28 February 2011 because of a 
trauma who stayed in the ICU for at least 48 hours were eligible for the 
study. Patients were contacted and invited to attend a multidisciplinary 
interview. Data concerning family, working and economic status, main 
disabilities and medical needs were collected. The SF12 questionnaire 
was administered to defi  ne physical component summary (PCS) and 
mental component summary (MCS) scores. SPSS 20.0 was used to 
perform statistical analysis.
Results  Sixty-two patients matched inclusion criteria and were 
contacted. Thirty-three patients (90.9% males; age 38.7 ± 14.3 years; 
mean SAPS II 33.75  ±  11.79) were interviewed. Mean ICU stay was 
25.7 ± 15.3 days. Fifteen patients (45.5%) had undergone temporary 
tracheostomy. Twenty-six patients were employed at the moment 
of trauma: of these, 11 (42.3%) stated to be jobless and one was 
pensioned at follow-up. In the whole cohort, the unemployment 
rate increased from 12.1 to 45.6%. Mean PCS was 43.59 ± 6.43, mean 
MCS was 41.04 ± 7.69. At follow-up, the 14 employed patients had a 
lower MCS versus the 19 jobless patients (37.94 ± 7.14 vs. 43.33 ± 7.44; 
P = 0.04), while no diff  erences concerning PCS were found. The three 
patients that were living on their own when the trauma occurred 
showed, at follow-up, a lower mean MCS score towards the rest of the 
cohort (32.2 ± 0.47 vs. 41.93 ± 7.51; P <0.001).
Conclusion Trauma is associated with an increase of the unemployment 
rate in young people. Patients that are employed at follow-up seemed 
to have a worse mental health status towards the unemployed ones. 
Conversely, the employed patients did not show any trend to a 
lower physical health status. Thus a counseling service that provides 
psychological care would be useful to implement more eff  ective work 
reintegration for trauma patients.
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Introduction Post-traumatic stress disorder (PTSD) is a well-recognised 
complication in patients discharged from the ICU. ICU clinics have 
been recommended to treat physical and psychosocial problems post 
discharge, with guidelines issued by the Department of Health UK [1]. 
Recent evidence has advocated the use of patient diaries to reduce the 
incidence of new-onset PTSD [2]. Family support groups may also play 
a pivotal role [3]. We performed a national survey via the Intensive Care 
Society (ICS) to determine the provision of follow-up clinics, patient 
diary services and family support groups.
Methods An online structured questionnaire was sent via the ICS to all 
ICU linkmen at 124 hospitals in the UK. Responses were received from 
77 ICUs, a 62% response rate.
Results Out of 77 ICUs, 37 (48%) run a follow-up clinic. The majority 
of clinics (51%) only invite patients who have been admitted for more 
than 3 to 4 days. Only 10 clinics (30%) receive funding from the ICU 
budget or PCT, with the majority (67%) receiving no funding at all. Only 
44% (34) of ICUs use patient diaries, mostly as a nonfunded service 
(68%). Additionally, 91% of ICUs do not run family support groups; from 
the minority that do, these are mostly held quarterly and are largely not 
funded (55%).
Conclusion This survey demonstrates that the provision of ICU clinics 
in the UK is not well established, with only 48% currently providing 
a regular service. Currently 67% of clinics are not funded and further 
resources should be employed so this service becomes an integral 
part of the ICU pathway. Despite recent evidence demonstrating that 
diaries reduce new-onset PTSD, only 44% of ICUs in our study provide 
this service. Ninety-one per cent of ICUs do not provide family support 
groups; similarly, it appears that fi  nancial constraints are the limiting 
factor.
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Introduction  The aim was to analyse the outcomes and patient 
satisfaction of a recently implemented ICU follow-up clinic. These 
clinics are National Institute for Clinical Excellence recommended [1].
Methods  A retrospective analysis of prospective collected data 
from January to December 2012. The clinic is run monthly by an ICU 
consultant and a critical care outreach sister. Criteria to be invited to the 
clinic are mechanical ventilation ≥3 days. Patients fi  lled an anonymous 
satisfaction survey after the clinic.
Results Our attendance rate is 50% (26 patients), which is similar to 
other series reported in the literature. Those patients who attended the 
clinic required a longer length of mechanical ventilation (5.3 days vs. 
7.1) and a longer length of stay in the ICU (7.6 vs. 13) and in hospital 
(14 vs. 28). We identifi  ed a wide range of physical and nonphysical 
morbidities on these patients (Figure  1). We referred them to the 
appropriate specialities. Patients were very satisfi   ed with this new 
service (Figure 2).
Figure 1 (abstract P538). Physical and nonphysical morbidity.
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of complications related to ICU admission and coordinate their future 
management. This clinic improved patient satisfaction.
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Introduction This study aims to quantify the acute exercise response to 
early passive and active activities in order to inform exercise prescription 
when designing rehabilitation programmes for the critically ill. Critical 
care survival is often associated with a poor functional outcome [1], 
with recent investigations presenting the case for early rehabilitation 
in order to optimise functional recovery [2]. There, remains, however, 
a scarcity of research investigating the immediate response to exercise 
and subsequent exercise prescription, in the acute phase following 
critical illness.
Methods This study is a prospective randomised controlled trial with 
a repeated-measures crossover design. Eligible participants, requiring 
mechanical ventilation for 4 or more days, completed two exercise 
activities routinely used in early critical care rehabilitation, a passive 
chair transfer (PCT) and active sitting on the edge of the bed (SOEOB). 
The oxygen consumption and cardiovascular parameters were 
measured to quantify and compare the exercise response between the 
two activities.
Results Data are presented as the median (interquartile range). Data for 
fi  ve patients have been collected, aged 68 years (23), with an ITU stay of 
15 days (10.5) and duration of mechanical ventilation 8 days (12), at the 
point of intervention. Exercise response results are reported (Table 1).
Conclusion  Intensive care patients with prolonged mechanical 
ventilation demonstrate a higher rate of oxygen consumption when 
actively sitting on the edge of the bed, compared with a passive chair 
transfer. This may have important consequences for early mobilisation 
of the critically ill.
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Introduction Optimal patient evaluations of ICU rehabilitation therapy 
remain unclear.
Methods  One hundred ICU patients with acute respiratory failure 
were randomized to receive early rehabilitation (ER) or usual-care (UC). 
Cohort 1 (n = 50) received ER as one physical therapy (PT) session/day 
versus UC; Cohort 2 (n = 50) received ER as 2 PT/day with the second 
session resistance training, versus UC. UC was without ER. Blood was 
drawn for cytokines through day 7. Cohort 2 underwent strength and 
physical functional assessments using the Short Physical Performance 
Battery (SPPB), a valid and reliable measure of physical function 
consisting of walking speed, balance, and repeated chair stands. It is 
a well-studied composite measure in older persons, but has not been 
used in ICU survivors. Small changes of 0.5 to 0.6 points in the SPPB 
have been shown to be clinically meaningful.
Results  Baseline parameters were similar between groups. Median 
days from enrollment to fi  rst PT were 4 (IQR 1 to 7.25). Deaths occurred 
in eight UC subjects and four in ER (P = 0.22). For both arms, ventilator 
days, ICU days and hospital days were not statistically diff  erent. ER had 
ventilator-free days of 22, 95% CI = 19.9 to 24.6, where UC had 22.3 days, 
19.9 to 24.6, P = 0.99. ICU-free days for ER was 21, 95% CI = 19.1 to 23.6, 
and that for UC was 21.0, 18.8 to 23.2, P = 0.84. Similarly, hospital days 
for ER was 16.7, 95% CI = 11.8 to 21.4, and for UC was 18.2, 13.8 to 22.7, 
P = 0.45. TNF, IL-6 and IL-8 through day 7 were not diff  erent between 
groups. Despite similar baseline acuity and infl  ammatory  profi  les, 
Cohort 2 ER group strength scores were numerically but not statistically 
higher. Grip strength, as a percentage of predicted for ER was 66 versus 
Figure 2 (abstract P538). Patient satisfaction survey.
Table 1 (abstract P539)
Parameter PCT  (n = 5) SOEOB  (n = 5)
Oxygen consumption (ml/minute)  270 (46.5)  334 (121)
Carbon dioxide production (ml/minute)  142 (45.5)  185 (121)
Heart rate (bpm)  92 (24)  77.5 (29)
Mean arterial pressure (mmHg)  100.3 (20)  97.3 (13)
Minute ventilation (l/minute)  11.0 (3.5)  12.1 (3.4)
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P = 0.124. Although the diff  erence in SPPB values for ER versus UC (5 
vs. 3, P = 0.172) was not statistically diff  erent, it was greater than the 
minimal clinically signifi  cant diff  erence. There were no diff  erences in 
adverse events.
Conclusion In this pilot study, early ICU rehabilitation was safe, and was 
associated with numerically although not statistically shorter hospital 
stay, greater strength and improved functional scores. Particularly, the 
SPPB demonstrated discriminatory ability in groups of ICU survivors 
with low physical function. Future early ICU rehabilitation studies 
should consider ICU survivor assessments using the SPPB due to its 
ease, reproducibility and discriminatory ability following ICU and 
hospital discharge.
Acknowledgement Supported by NIH grants 1R011186-01 and P30 
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Introduction The aim of this study was to investigate the eff  ect of 
a 6-week exercise programme on outcomes in post-ICU patients. 
With improvements in intensive care medicine, increasing numbers 
of patients are surviving catastrophic illness [1]. Severe weakness 
is common in patients with prolonged critical illness and results in 
considerable morbidity, mortality and healthcare costs [2]. The NICE83 
guidelines Rehabilitation in Critical Care recommend follow-up for 
post-ICU patients and that further research is needed in this fi  eld [3].
Methods  Patients who have been discharged home from hospital 
following an ICU stay of 48 hours or more were recruited to the study. 
Patients were only excluded if they were not considered safe for 
exercise. Baseline measurements were completed prior to stratifi  ed 
(age, gender, APACHE II score) random allocation to either the exercise 
or control group. Outcome measures included cardiopulmonary 
fi  tness (6-minute walk test), balance (Berg Balance Scale), grip strength 
(JAMAR grip dynamometer) and hospital anxiety and depression (HAD 
score). The exercise group completed a 6-week supervised exercise 
programme, twice a week for up to 1 hour. In the seventh week, all 
patients repeated the baseline measurements. An unpaired Student’s 
t test was used to compare any diff  erences between the control and 
exercise groups.
Results At baseline measurements, there were no statistical diff  erences 
in age, gender, length of stays or APACHE II scores between the two 
groups. Results indicate that the exercise group (n = 10) had signifi  cantly 
greater improvements in cardiopulmonary fi  tness  (P  <0.001) and 
balance (P <0.05) compared with the control group (n = 10). Greater 
improvements were also evident in anxiety, depression and grip 
strength in the exercise group, although not statistically signifi  cant.
Conclusion  This pilot study highlights that a 6-week supervised 
exercise programme can signifi  cantly improve cardiopulmonary fi  tness 
and balance in post-ICU patients. Further recruitment to the study and 
6-month/1-year follow-up is needed.
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Introduction  Intensive care patients suff  er  psychological  and 
physiological distress that may have debilitating and long-lasting 
eff  ects [1-3]. Healthcare professionals are in a position to help avoid 
or alleviate this stress [4]. To action this it is important to identify the 
main stressors from the patient’s perspective. A systematic review 
was performed to provide a list of what patients consider stressors 
in intensive care. These were then ranked in order to provide an 
identifi  cation tool that can be used to shape appropriate care.
Methods A systematic review was performed using MEDLINE, CINAHL, 
Psych INFO and Academic Search Complete. Grey literature was 
included and searches were not restricted to type of intensive care or 
country. Criteria were used to fi  lter those articles that identifi  ed the 
patients’ views of their stressor, not the patient experience. Eligible 
articles were critiqued using the Critical Appraisal Skills Programme for 
qualitative studies [5] and brought together using a narrative synthesis. 
All of the reviewed studies used a questionnaire as a means to identify 
what elements on the intensive care patients found stressful. A list 
of the top-10 stressors could then be expressed for each study and 
compared. From this information, a set of guidelines for best practice 
were devised.
Results A total 1,424 articles were systematically assessed for suitability 
and applicability. Of these, 14 articles remained eligible for review. The 
stressors were ranked by their frequency in the individual studies’ top-
10 lists. In rank order: 1, Tubes. 2, Pain. 3, Sleep Diffi   culties. 4, Thirst. 
5, Lack of Patient Understanding. Overall, stressors were found to be 
similar throughout all of the studies.
Conclusion The review identifi  ed a list of the most pertinent common 
stressors. Awareness of these and ranking in priority may enable plans 
of care to be instigated to eff  ectively alleviate patient stress.
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Introduction  This study describes the development and validation 
of the Consumer Quality Index Relatives in ICUs (CQI ‘R-ICU’), which 
aims to measure the satisfaction of relatives and to identify aspect 
of care that need improvement in the ICU in a reliable and valid way. 
According to the quality standards of the Dutch Society of Intensive 
Care, every ICU needs to record the satisfaction of relatives [1]. At this 
moment there is insuffi   cient insight into the quality of care off  ered to 
relatives on the ICU because an evidence-based Dutch measurement 
instrument is missing.
Methods The CQI ‘R-ICU’ has been developed based on a scientifi  c and 
standardised method [2]. A mixed design method is used, consisting of 
qualitative and quantitative survey studies. Factor analyses are carried 
out to determine the underlying structure of the newly developed 
questionnaire. Multiple regression analysis is used to explore the 
relationship between demographic variables and the perceived quality 
of care.
Results In six hospitals the CQI ‘R-ICU’ is sent to relatives after receiving 
informed consent (n = 441), 55.1% of the respondents are the patient’s 
partner. Respondents seem to be most satisfi  ed with the presence 
of a professional at fi  rst entrance to the ICU. The highest need for 
improvement scores relate to information about meals, parking 
and other disciplines (for example, social worker, spiritual worker or 
psychologist). Factor analysis shows that quality of care is determined 
by four clusters of items: Support, Communication, General Information 
and Organisation. The reliability of the CQI ‘R-ICU’ is suffi   ciently high, 
only Communication and Support are signifi  cant predictors of total 
quality judgement of relatives (adj. R2 = 0.74). In addition, there is a 
signifi  cant diff  erence in mean total quality judgement between the six 
hospitals as well as between the four wards within Erasmus MC. None 
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length of stay had an eff  ect on perceived quality of care.
Conclusion The CQI ‘R-ICU’ turned out to be a valid, reliable, sensitive 
and feasible instrument. Large-scale implementation is recommended.
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Introduction  Following recommendations made by the Scottish 
Intensive Care Society [1], we have introduced an annual Family 
Satisfaction Survey in the intensive care unit (FS-ICU), in anticipation 
that this will become an integral part of how we measure, improve 
and strive to advance patient care in the future. We aim to recognise 
factors impacting patient care and highlight areas for improvement. 
Improving understanding of patients’ needs is currently a UK national 
goal for CQUIN 2011/2012. An estimated £6.9 billion per year can be 
saved by reaching these goals [2] and a positive patient experience 
results in improved long-term outcomes and shorter hospital stays [2].
Methods We performed a study to assess Family Satisfaction over a 10-
week period in a 16-bed critical care unit (CCU). A modifi  ed version of 
an FS-ICU published in US and Canadian studies [3] was distributed to 
up to two family members per patient. Five-point Likert scale responses 
were linearly transformed to give percentage scores. Higher values 
represented a greater degree of satisfaction.
Results  We received and analysed 32 completed surveys. Seventy-
eight per cent of relatives reported that the treatment of the patient 
was excellent, including symptom control such as pain, breathlessness 
and agitation (72%, 69%, 100%, respectively). Ninety-one per cent 
felt the care and frequency of communication provided by nurses 
was excellent or very good, compared with 81% by doctors. Only 9% 
of family members were off  ered spiritual support during their CCU 
experience. Forty-seven per cent felt they would have liked more 
involvement in the decision-making process.
Conclusion The vast majority of relatives rated their overall experience 
on CCU as excellent or very good. The study highlighted two main areas 
for improvement: provision of spiritual support as well as family and 
patient involvement in the decision-making process. We will arrange 
multi-disciplinary teaching sessions focusing on the positive impact, 
and therefore importance of patient satisfaction. A poster providing 
information about available spiritual support will be displayed around 
our CCU. Further studies are required to evaluate these measures.
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Introduction We are conducting a cluster randomized trial with two 
parallel arms to evaluate strategies to improve family satisfaction with 
the care that themselves and their critically ill relatives receive in the 
ICUs of nonacademic Brazilian public hospitals. Here we report the 
results of the baseline phase of this trial.
Methods In this baseline phase, we interviewed the family member 
most closely involved with the care of critically ill patients who stayed 
in the ICU for at least 72 hours. We applied a form with 24 questions 
divided into four domains: overall ICU experience, communication, 
decision-making, and questions related to end-of-life care for patients 
who died in the ICU. Each question scored from 0 (very poor) to 100 
(excellent). The form was adapted from the Family Satisfaction with 
Care in the ICU (FS-ICU 24). As many questions assessed the quality 
of intensivist care or communication, the interview was applied by a 
psychologist or a nurse.
Results  Families of 564 patients were interviewed. A total 45/564 
(8.3%) died in the ICU. Most respondents were satisfi  ed with overall ICU 
experience (mean ± SD score 85.5 ± 11.9). However, family satisfaction 
with communication (67.8 ± 18.0) and decision-making (69.5 ± 21.1) 
resulted in somewhat lower scores. Most families of patients who 
died in the ICU (38/45 (82.6%)) considered that their relative’s life 
was neither extended nor shortened unnecessarily. Also, most of the 
families believed that their relative did not suff  er or suff  ered little in the 
ICU (37/46 (80.4%)) and felt supported by the healthcare team (40/46 
(87.0%)).
Conclusion Most families were satisfi  ed with the care themselves and 
their critically ill relatives received in the ICU. Also, most relatives of 
patients who died in the ICU felt that end-of-life care was adequate. 
Although we believe there is much room for improvement in 
communication, decision-making and support critically ill patients and 
their families, as their baseline satisfaction with patient care is quite 
high, it may be hard to demonstrate substantial improvement after 
interventions.
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